id,original,paraphrased
id_01903,"In patients with CLTI, primary amputation is indicated when life over limb is the prevailing consideration and clinical factors suggest the threatened limb to be the cause of the patient’s instability (eg, ischemia, meta- bolic derangement, or advanced infection).","For patients with CLTI, primary amputation is recommended when prioritizing survival over limb preservation, and clinical evidence indicates that the compromised limb is causing the patient's instability, such as due to ischemia, metabolic imbalance, or severe infection."
id_00463,"In patients with acute chest pain where there is clinical concern for aortic dissection, computed tomography angiography (CTA) of the chest, abdomen, and pelvis is recommended for diagnosis and treatment planning.","For patients experiencing acute chest pain with suspected aortic dissection, it is advised to perform a computed tomography angiography (CTA) of the chest, abdomen, and pelvis for diagnostic and treatment planning purposes."
id_01423,"In patients with CCD, minimization of sodium (<2300 mg/d; optimally 1500 mg/d) and minimi- zation of processed meats (eg, cured bacon, hot dogs) can be beneficial to reduce the risk of CVD events.*2,3,6,7","For patients with CCD, reducing sodium intake to less than 2300 mg per day, ideally 1500 mg per day, and limiting consumption of processed meats such as cured bacon and hot dogs may help lower the risk of cardiovascular events."
id_00464,"In patients with acute chest pain where there is clinical concern for aortic dissection, TEE or CMR should be performed to make the diagnosis if CT is contraindicated or unavailable. Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing acute chest pain with suspected aortic dissection, TEE or CMR should be utilized for diagnosis if CT cannot be used or is not accessible."
id_02383,"In patients with uncomplicated acute type B IMH, medical therapy as the initial manage- ment strategy is recommended.1-3,13","For patients with uncomplicated acute type B IMH, it is advised to begin treatment with medical therapy."
id_02384,"In patients with type B IMH who require repair of the distal aortic arch or descending thoracic aorta (zones 2-5) and have favorable anatomy, endo- vascular repair is reasonable when performed by surgeons with endovascular expertise.2,14","For patients with type B IMH needing repair of the distal aortic arch or descending thoracic aorta (zones 2-5) and possessing suitable anatomy, it is advisable to consider endovascular repair when conducted by surgeons skilled in endovascular techniques."
id_00465,"In stable patients with acute chest pain with high clinical suspicion for PE, CTA using a PE protocol is recommended.1-4","For stable patients experiencing acute chest pain with a strong clinical suspicion of PE, it is advised to perform a CTA following a PE protocol."
id_01425,"In patients with CCD, the intake of trans fat should be avoided because trans fat is associated with increased morbidity and mortality rates.*9,10 Nutrition Supplements","For individuals with CCD, trans fat consumption should be eliminated as it is linked to higher morbidity and mortality rates."
id_01904,"In patients with CLTI, a patient-centered approach using objective classification of the threatened limb, patient risk, and anatomic pattern of disease combined with patient and family goals is recom- mended to identify those patients in whom primary amputation or palliative management is appropriate.","For patients with CLTI, it is advised to employ a patient-centered strategy that incorporates an objective assessment of the limb's condition, patient risk factors, and the anatomical disease pattern, alongside the goals of the patient and family, to determine which patients are suitable for primary amputation or palliative care."
id_01424,"In patients with CCD, limiting refined carbohy- drates (eg, containing <25% whole grain by weight, including refined cold ready-to-eat break- fast cereal, white bread, white rice), and sugar- sweetened beverages (eg, soft drinks, energy drinks, fruit drinks with added sugars) can be beneficial to reduce the risk of CVD events.*2–4,6,8","For individuals with CCD, reducing intake of refined carbohydrates (such as those with less than 25% whole grain by weight, including refined cold cereals, white bread, and white rice) and sugar-sweetened drinks (like sodas, energy drinks, and fruit beverages with added sugars) may help lower the risk of CVD events."
id_00466,"For patients with acute chest pain and possible PE, need for further testing should be guided by pretest probability.","For individuals experiencing sudden chest pain with suspected pulmonary embolism, additional testing should be determined by the likelihood of the condition before testing."
id_01905,"In patients with CLTI undergoing minor amputation (ie, inframalleolar level), a customized program of follow-up care that can include local wound care, pressure offloading, serial evaluation of foot biome- chanics, and use of therapeutic footwear is recommended to prevent wound recurrence.","For patients with CLTI undergoing minor amputation at the inframalleolar level, it is advised to implement a tailored follow-up care plan that may involve local wound management, pressure relief, regular assessment of foot biomechanics, and the use of therapeutic footwear to prevent wound recurrence."
id_02385,"In patients with type B IMH who require repair of the distal aortic arch or descending tho- racic aorta (zones 2-5) and have unfavorable anatomy for endovascular repair, open surgical repair is reasonable.2,3","For patients with type B IMH needing repair of the distal aortic arch or descending thoracic aorta (zones 2-5) and possessing anatomy unsuitable for endovascular repair, open surgical repair is a reasonable option."
id_01427,"In patients with CCD, targeted discussions and screening for mental health is reasonable for clini- cians to assess and to refer for additional mental health evaluation and management.1–4","For patients with CCD, it is appropriate for clinicians to engage in focused conversations and conduct mental health screenings to evaluate and refer them for further mental health assessment and treatment."
id_01426,"In patients with CCD, the use of nonprescription or dietary supplements, including omega-3 fatty acid, vitamins C, D, E, beta-carotene, and calcium, is not beneficial to reduce the risk of acute CVD events.11–22 *Modified from the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.23","For individuals with CCD, taking over-the-counter supplements or dietary additions such as omega-3 fatty acids, vitamins C, D, E, beta-carotene, and calcium does not effectively lower the risk of sudden cardiovascular disease events."
id_02386,"In patients with uncomplicated type B IMH and high-risk imaging features (Table 30), intervention may be reasonable.13-16","For patients with uncomplicated type B IMH who exhibit high-risk imaging characteristics (refer to Table 30), it might be appropriate to consider intervention.13-16"
id_00467,"In patients with acute chest pain and myocardial injury who have nonobstructive coronary arteries on anatomic testing, CMR with gadolinium contrast is effective to distinguish myopericarditis from other causes, including myocardial infarction and nonobstructive coronary arteries (MINOCA).1-6","For patients experiencing acute chest pain and myocardial injury with nonobstructive coronary arteries identified through anatomic testing, CMR with gadolinium contrast is useful in differentiating myopericarditis from other conditions, such as myocardial infarction and MINOCA."
id_01906,"For patients with CLTI, retrospective assessment of institutional outcomes (including amputation) with objective limb threat classification tools can be useful for quality improvement.","For individuals with CLTI, evaluating institutional outcomes retrospectively, such as amputation rates, using objective limb threat classification tools can aid in quality enhancement."
id_01907,Patients with ALI should be evaluated on an emergency basis by a clinician with sufficient experience to assess limb viability and implement appropriate therapy.,Patients experiencing ALI must be urgently assessed by a clinician who is experienced enough to determine limb viability and initiate suitable treatment.
id_02387,"In patients with PAU of the aorta with rupture, urgent repair is recommended.1-3","For patients experiencing a ruptured PAU of the aorta, immediate repair is advised."
id_02388,"In patients with PAU of the ascending aorta with associated IMH, urgent repair is recom- mended.1-3","For patients with an ascending aorta PAU accompanied by IMH, immediate surgical intervention is advised."
id_00468,"In patients with acute chest pain with suspected acute myopericarditis, CMR is useful if there is diagnostic uncertainty, or to determine the presence and extent of myocardial and pericardial inflammation and fibrosis.7-12","For patients experiencing acute chest pain with a suspicion of acute myopericarditis, CMR is beneficial when the diagnosis is uncertain or to assess the presence and extent of inflammation and fibrosis in the myocardium and pericardium."
id_01908,"In patients with suspected ALI, the initial clinical evaluation should rapidly assess limb viability and potential for salvage and can be achieved without noninvasive imaging (ie, duplex ultrasound, CTA, or MRA).1–6","For patients suspected of having ALI, promptly evaluate limb viability and salvage potential, which can be done without using noninvasive imaging techniques such as duplex ultrasound, CTA, or MRA."
id_00469,"In patients with acute chest pain and suspected myopericarditis, TTE is effective to determine the presence of ventricular wall motion abnormalities, pericardial effusion, valvular abnormalities, or restrictive physiology.","For patients experiencing acute chest pain with a suspicion of myopericarditis, TTE is useful for identifying ventricular wall motion abnormalities, pericardial effusion, valvular issues, or restrictive physiology."
id_01428,"In patients with CCD, treatment for mental health conditions with either pharmacologic or nonphar- macologic therapies, or both, is reasonable to improve cardiovascular outcomes.2,4–6","For patients with CCD, addressing mental health conditions using pharmacologic, nonpharmacologic, or a combination of therapies is advisable to enhance cardiovascular outcomes."
id_01909,"In patients with ALI who have a complicated history of revascularization procedures, it may be reason- able to obtain noninvasive imaging (ie, duplex ultra- sound, CTA, or MRA) before deciding to proceed with revascularization.","For patients with ALI and a complex history of revascularization, it might be advisable to perform noninvasive imaging, such as duplex ultrasound, CTA, or MRA, prior to making a decision on revascularization."
id_01429,"In patients with CCD, tobacco use should be assessed at every health care visit to facilitate identification of those who may benefit from behavioral or pharmacologic interventions.*1–3","For patients with CCD, evaluate tobacco use at each healthcare appointment to identify individuals who might benefit from behavioral or pharmacological treatments."
id_02389,"In patients with PAU of the aortic arch or descending thoracic aorta with associated IMH, urgent repair is reasonable.1-3","For patients with PAU in the aortic arch or descending thoracic aorta accompanied by IMH, it is advisable to consider urgent repair."
id_01430,Patients with CCD who regularly smoke tobacco should be advised to quit at every visit.*4,Patients with CCD who are habitual tobacco smokers should receive advice to stop smoking during each appointment.
id_00470,"In patients with acute chest pain with suspected acute pericarditis, noncontrast or contrast cardiac CT scanning may be reasonable to determine the presence and degree of pericardial thickening.7,8,13 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing acute chest pain with a suspicion of acute pericarditis, it might be appropriate to use either noncontrast or contrast cardiac CT scans to assess the presence and extent of pericardial thickening."
id_01910,"In patients with ALI and a salvageable limb, revascularization (endovascular or surgical, including catheter-directed thrombolysis) is indicated to prevent amputation.1–5","For patients with acute limb ischemia and a limb that can be saved, revascularization—whether endovascular, surgical, or through catheter-directed thrombolysis—is recommended to avert amputation."
id_02390,"In patients with PAU of the abdominal aorta with associated IMH, urgent repair may be considered.4","For patients with an abdominal aortic PAU accompanied by IMH, urgent repair might be considered."
id_00471,"In patients presenting with acute chest pain with suspected or known history of VHD, TTE is useful in determining the presence, severity, and cause of VHD.","For patients with acute chest pain and a suspected or known history of valvular heart disease, transthoracic echocardiography is beneficial for assessing the existence, severity, and etiology of the condition."
id_01431,"In patients with CCD who regularly smoke tobacco, behavioral interventions are recommended to maximize cessation rates in combination with pharmacotherapy, including bupropion, varenicline, or combination long- and short-acting nicotine replacement therapy (NRT).*5–7","For patients with CCD who are habitual tobacco smokers, it is advised to use behavioral interventions alongside pharmacotherapy, such as bupropion, varenicline, or a combination of long- and short-acting nicotine replacement therapies, to optimize cessation success."
id_02391,"In patients with isolated PAU who are symp- tomatic and have persistent pain that is clini- cally correlated with the radiologic findings, repair is recommended.1-3","For patients experiencing symptoms and ongoing pain that aligns with radiological findings of isolated PAU, repair is advised."
id_01911,"In patients with ALI and a salvageable limb who are treated with catheter-directed thrombolysis, adjunctive revascularization (ie, endovascular or surgical) procedures can be useful.","For patients with ALI and a limb that can be saved, catheter-directed thrombolysis may be complemented effectively by additional revascularization procedures, whether endovascular or surgical."
id_00472,"In patients presenting with acute chest pain with suspected or known VHD in whom TTE diagnostic quality is inadequate, TEE (with 3D imaging if available) is useful in determining the severity and cause of VHD.","For patients experiencing acute chest pain with suspected or confirmed VHD, when TTE does not provide sufficient diagnostic quality, TEE (preferably with 3D imaging if possible) is beneficial for assessing the severity and etiology of VHD."
id_02392,"In patients with isolated PAU who are asymp- tomatic but have high-risk imaging features (Table 31), elective repair may be consid- ered.1,2,4","For patients with isolated PAU who show no symptoms but present high-risk imaging characteristics (Table 31), elective repair can be contemplated."
id_01432,"In patients with CCD who regularly smoke tobacco, varenicline may be considered versus bupropion or NRT to increase cessation rates.6","For patients with CCD who are habitual tobacco smokers, varenicline can be considered as an alternative to bupropion or NRT to enhance cessation success rates."
id_01912,"In patients presenting with ALI from chemotherapeutic or prothrombotic viral states, it may be reasonable to take a more deliberate planning strategy before engaging in a definitive revascularization or medical treatment plan.6–14","For patients with ALI due to chemotherapy or prothrombotic viral conditions, it might be prudent to adopt a more careful planning approach prior to initiating a definitive revascularization or medical treatment strategy."
id_00473,"In patients presenting with acute chest pain with known or suspected VHD, CMR imaging is reasonable as an alternative to TTE and/or","For patients experiencing acute chest pain with confirmed or suspected valvular heart disease, using CMR imaging as a substitute for TTE is a reasonable option."
id_00474,"Patients with acute chest pain should be evaluated for noncardiac causes if they have persistent or recurring symptoms despite a negative stress test or anatomic cardiac evaluation, or a low-risk designation by a CDP.","If patients experience ongoing or recurrent acute chest pain despite a negative stress test, anatomic cardiac evaluation, or a low-risk classification by a CDP, they should be assessed for noncardiac causes."
id_01913,"Patients with ALI should be monitored and treated for compartment syndrome with fasciotomy after revascularization (endovascular or surgical, including catheter-directed thrombolysis) to prevent the sequelae of reperfusion injury and need for amputation.","After revascularization, whether endovascular or surgical, including catheter-directed thrombolysis, patients with ALI should be observed and managed for compartment syndrome using fasciotomy to avert reperfusion injury complications and avoid amputation."
id_02393,"In patients who require repair of a PAU in the ascending aorta or proximal aortic arch (zones 0-1), open surgical repair is ­recommended.","For patients needing repair of a PAU in the ascending aorta or proximal aortic arch (zones 0-1), open surgical repair is advised."
id_01433,"In patients with CCD who regularly smoke tobacco, the short-term use of nicotine-containing e-ciga- rettes may be considered to aid smoking cessation, although the risk of sustained use and unknown long-term safety may outweigh the benefits.8–10","For patients with CCD who are habitual tobacco smokers, short-term use of nicotine e-cigarettes might be an option to support quitting smoking, but the potential for ongoing use and uncertain long-term safety could surpass the advantages."
id_01434,"Patients with CCD should avoid secondhand smoke exposure to reduce risk of cardiovascular events.*11,12 *Modified from the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.13",Individuals with CCD are advised to steer clear of secondhand smoke to lower the likelihood of cardiovascular incidents.
id_01914,"In patients with ALI with a threatened but salvageable limb (ie, category IIa or IIb), prophylactic fasciotomy is reasonable based on the clinical findings.1,2","For patients with ALI who have a limb at risk but potentially recoverable (category IIa or IIb), considering prophylactic fasciotomy is justifiable according to clinical assessment."
id_00475,"In patients with recurrent acute chest pain without evidence of a cardiac or pulmonary cause, evaluation for gastrointestinal causes is reasonable.","For patients experiencing repeated episodes of acute chest pain with no cardiac or pulmonary origin, it is advisable to investigate potential gastrointestinal causes."
id_01435,Patients with CCD should be routinely asked and counseled about substance use to reduce ASCVD events.1–5,Patients with CCD should regularly be inquired about and advised on substance use to lower the risk of ASCVD events.
id_02394,"In patients who require repair of a PAU in the distal aortic arch (zones 2-3), descend- ing thoracic aorta, or abdominal aorta, either open surgical repair1-3 or endovascular repair is reasonable, based on anatomy and medical comorbidities.4-6","For patients needing repair of a PAU in the distal aortic arch (zones 2-3), descending thoracic aorta, or abdominal aorta, it is appropriate to consider either open surgical repair or endovascular repair, depending on anatomical considerations and medical comorbidities."
id_01916,"In patients with ALI, regardless of cause or anatomic level of occlusion, systemic anticoagulation with unfractionated heparin should be administered on diagnosis unless contraindicated.","For patients diagnosed with ALI, systemic anticoagulation using unfractionated heparin should be initiated at the time of diagnosis, unless there are contraindications, irrespective of the occlusion's cause or location."
id_01915,"In patients with ALI and prolonged ischemia in whom revascularization (endovascular or surgical, including catheter-directed thrombolysis) is performed, concur- rent and early amputation can be beneficial to avoid the morbidity of reperfusion.","For patients with ALI and extended ischemia undergoing revascularization (whether endovascular, surgical, or catheter-directed thrombolysis), early and simultaneous amputation may help prevent the complications associated with reperfusion."
id_02395,"In patients with BTTAI, management and treatment at a trauma center with the facili- ties and expertise to treat aortic pathology is recommended.","For patients with BTTAI, it is advised to seek care and treatment at a trauma center equipped with the necessary facilities and expertise for aortic pathology."
id_01436,"In patients with CCD who consume alcohol, it is reasonable to limit alcohol intake (≤1 drink/d for women, ≤2 drinks/d for men) to reduce cardiovascular and all-cause death.6–8","For patients with CCD who drink alcohol, it is advisable to restrict alcohol consumption to no more than 1 drink per day for women and 2 drinks per day for men to lower the risk of cardiovascular and overall mortality."
id_00476,"For patients with recurrent, similar presentations for acute chest pain with no evidence of a physiological cause on prior diagnostic evaluation including a negative workup for myocardial ischemia, referral to a cognitive-behavioral therapist is reasonable.1-14","For patients experiencing repeated episodes of acute chest pain with no physiological cause found in previous diagnostic assessments, including a negative evaluation for myocardial ischemia, it is appropriate to refer them to a cognitive-behavioral therapist."
id_02396,"In patients with BTTAI, anti-impulse therapy to reduce the risk of injury extension and rupture should be implemented, except in patients with hypotension or hypovolemic shock.1,2 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with BTTAI, anti-impulse therapy should be applied to minimize the risk of injury extension and rupture, except for those experiencing hypotension or hypovolemic shock."
id_00477,"In patients with sickle cell disease who report acute chest pain, emergency transfer by EMS to an acute care setting is recommended.1-5","For patients with sickle cell disease experiencing sudden chest pain, it is advised to arrange emergency transport via EMS to a facility equipped for acute care."
id_01917,"In patients with ALI, a comprehensive medical history and physical examination should be performed to determine the cause of thrombosis or embolization.","For patients with ALI, a thorough medical history and physical exam are necessary to identify the cause of thrombosis or embolization."
id_01437,"Patients with CCD should not be advised to consume alcohol for the purpose of cardiovascular protection. 9,10 Downloaded from http://ahajournals.org by on June 19, 2025",Individuals with CCD should not be encouraged to drink alcohol as a means of safeguarding cardiovascular health.
id_00478,"In patients with sickle cell disease who report acute chest pain, ACS should be excluded.3-5","For patients with sickle cell disease experiencing acute chest pain, it is essential to rule out ACS."
id_01918,"In patients with ALI, testing for a cardiovascular cause of thromboembolism can be useful.1–4 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with ALI, evaluating for a cardiovascular origin of thromboembolism may be beneficial."
id_02397,"In patients with grade 1 BTTAI (Figure 23), nonoperative management and follow-up imaging are recommended.1,2","For patients with grade 1 BTTAI (refer to Figure 23), it is advised to manage without surgery and conduct follow-up imaging."
id_01438,"In patients with CCD, it is reasonable to individual- ize resumption of sexual activity based on type of sexual activity, exercise capacity, and postproce- dural healing.*1,2","For patients with CCD, tailoring the recommencement of sexual activity according to the type of activity, exercise tolerance, and recovery after procedures is advisable."
id_02398,"In patients with grade 3 to 4 BTTAI (Figure 23) and nonprohibitive comorbidities or inju- ries, aortic intervention is recommended.1,3","For patients with grade 3 to 4 BTTAI and manageable comorbidities or injuries, aortic intervention is advised."
id_00479,"For patients with stable chest pain and no known CAD presenting to the outpatient clinic, a model to estimate pretest probability of obstructive CAD is effective to identify patients at low risk for obstructive CAD and favorable prognosis in whom additional diagnostic testing can be deferred.1-5","In patients with stable chest pain and no history of CAD visiting an outpatient clinic, using a model to assess the pretest probability of obstructive CAD effectively identifies those at low risk for obstructive CAD and with a favorable prognosis, allowing for the postponement of further diagnostic tests."
id_02399,"In patients with grade 2 BTTAI (Figure 23) and with high-risk imaging features (Table 32), aortic intervention is reasonable.3,4","For patients with grade 2 BTTAI who exhibit high-risk imaging characteristics, considering aortic intervention is appropriate."
id_01439,"In patients with CCD, cardiac rehabilitation and regular exercise can be useful to reduce the risk of cardiovascular complications with sexual activity.*3","For individuals with CCD, engaging in cardiac rehabilitation and consistent exercise may help lower the risk of cardiovascular issues during sexual activity."
id_00480,"For patients with stable chest pain and no known CAD categorized as low risk, CAC testing is reasonable as a first-line test for excluding calcified plaque and identifying patients with a low likelihood of obstructive CAD.6-9","For patients experiencing stable chest pain without known coronary artery disease and classified as low risk, it is appropriate to use CAC testing initially to rule out calcified plaque and determine those unlikely to have obstructive CAD."
id_01919,"In patients with PAD, with or without revascularization, longitudinal follow-up with routine clinical evaluation, including assessment of limb symptoms and functional status, lower extremity pulse and foot assessment, and progress of risk factor management, is recommended.","For patients with PAD, whether they have undergone revascularization or not, it is advised to conduct regular follow-up appointments that include evaluating limb symptoms and functional status, checking lower extremity pulses and foot health, and monitoring the management of risk factors."
id_01440,"In patients with CCD, phosphodiesterase type 5 inhibi- tors should not be used concomitantly with nitrate medications because of risk for severe hypotension.*4 *Modified from the 2012 AHA Scientific Statement on Sexual Activity and Cardiovascular Disease.5","For patients with CCD, avoid using phosphodiesterase type 5 inhibitors alongside nitrate drugs due to the potential for significant hypotension."
id_01920,"In patients with PAD, coordination of care among clinicians to improve the management of PAD and comorbid conditions and to optimize patient outcomes is recommended. Functional Status and QOL","For patients with PAD, it is advised that healthcare providers collaborate to enhance the treatment of PAD and associated conditions, aiming to improve patient outcomes, functional status, and quality of life."
id_00001,A first aid provider who is assisting a person with a potentially serious illness or injury should immediately activate the emergency response system.,A first aid responder aiding someone with a potentially severe illness or injury should promptly call the emergency response system.
id_02400,"In patients with grade 2 BTTAI (Figure 23) and without high-risk imaging features (Table 32), nonoperative management and follow-up surveillance imaging may be ­reasonable.3,4","For patients with grade 2 BTTAI (refer to Figure 23) who do not exhibit high-risk imaging characteristics (see Table 32), it may be appropriate to consider nonoperative management along with follow-up surveillance imaging."
id_01921,"In patients with PAD, with or without revascularization, periodic assessment of functional status as well as overall health-related QOL as a component of longitudinal follow-up is recommended.1–6 Medical Therapy","For patients with PAD, regardless of revascularization status, it is advised to regularly evaluate both functional status and overall health-related quality of life as part of ongoing follow-up."
id_02401,"In patients with BTTAI who meet indica- tions for repair and with appropriate anat- omy, TEVAR is recommended over open repair.1-3","For patients with BTTAI who qualify for repair and have suitable anatomy, TEVAR is advised instead of open repair."
id_00002,A first aid provider who is assisting a person with a potentially serious illness or injury should remain with the person until trained rescuers arrive as long as it is safe to do so.,"A first aid provider should stay with an individual experiencing a potentially serious illness or injury until professional help arrives, provided it is safe to remain."
id_00481,"For patients with stable chest pain and no known CAD categorized as low risk, exercise testing without imaging is reasonable as a first-line test for excluding myocardial ischemia and determining functional capacity in patients with an interpretable ECG.10","For patients with stable chest pain and no known coronary artery disease who are considered low risk, it is appropriate to use exercise testing without imaging as an initial test to rule out myocardial ischemia and assess functional capacity, provided the ECG is interpretable."
id_01441,"In patients with CCD, high-intensity statin ther- apy is recommended with the aim of achieving a ≥50% reduction in LDL-C levels to reduce the risk of MACE.*1–3","For patients with CCD, it is advised to use high-intensity statin therapy to lower LDL-C levels by at least 50% in order to decrease the risk of MACE."
id_00482,"For intermediate-high risk patients with stable chest pain and no known CAD, CCTA is effective for diagnosis of CAD, for risk stratification, and for guiding treatment decisions.1-12 Stress Testing","For patients at intermediate to high risk who have stable chest pain and no known coronary artery disease, coronary CT angiography is effective for diagnosing coronary artery disease, assessing risk, and guiding treatment decisions."
id_01922,"In patients with PAD, long-term use of GDMT to prevent MACE and MALE is recommended.7–12 Postrevascularization Follow-Up","For patients with PAD, it is advised to use GDMT over the long term to prevent MACE and MALE."
id_01442,"In patients in whom high-intensity statin therapy is contraindicated or not tolerated, moderate-intensity statin therapy is recom- mended with the aim of achieving a 30% to 49% reduction in LDL-C levels to reduce the risk of MACE.*2,4–8","For patients who cannot undergo high-intensity statin therapy due to contraindications or intolerance, it is advised to use moderate-intensity statin therapy to achieve a 30% to 49% reduction in LDL-C levels, thereby lowering the risk of MACE."
id_02402,"In patients with grade 1 to 2 BAAI (Table 33) without malperfusion, anti- impulse therapy, if clinically tolerated, and repeat imaging within 24 to 48 hours of the initial scan is recommended to reduce risk of injury progression.1","For patients with grade 1 to 2 BAAI (Table 33) who do not have malperfusion, it is advised to administer anti-impulse therapy, if tolerated, and to perform follow-up imaging 24 to 48 hours after the initial scan to minimize the risk of injury progression."
id_00483,"For intermediate-high risk patients with stable chest pain and no known CAD, stress imaging (stress echocardiography, PET/SPECT MPI or CMR) is effective for diagnosis of myocardial ischemia and for estimating risk of MACE.8,13-35","For patients at intermediate to high risk with stable chest pain and no known coronary artery disease, stress imaging techniques such as stress echocardiography, PET/SPECT MPI, or CMR are effective for diagnosing myocardial ischemia and assessing the risk of major adverse cardiac events."
id_00003,"If the area is unsafe, the first aid provider should move an ill or injured person to a safe location if possible and safe for the first aid provider to do so.","If the environment is hazardous, the first aid provider should relocate the ill or injured individual to a secure place, provided it is feasible and safe for the provider."
id_01443,"In patients with CCD, adherence to changes in lifestyle and effects of lipid-lowering medication should be assessed by measurement of fasting lipids in 4 to 12 weeks after statin initiation or dose adjustment and then every 3 to 12 months thereafter based on need to assess response or adherence to therapy.*2,9–11 Cost Value Statement: High Value B-NR","For patients with CCD, evaluate lifestyle modifications and the impact of lipid-lowering drugs by measuring fasting lipids 4 to 12 weeks after starting or adjusting statin doses, and subsequently every 3 to 12 months as necessary to monitor therapy response or adherence."
id_02403,"In patients with grade 4 BAAI (Table 33), repair should be performed to address life- threatening aortic injury.2-4","For patients with grade 4 BAAI (refer to Table 33), surgical intervention is necessary to treat the life-threatening aortic injury."
id_00004,"If a person has been injured, is responsive, and is breathing normally and the nature of the injury suggests a neck, back, hip, or pelvic injury, the person should be left in the position in which they were found to avoid potential further injury unless the area is unsafe.","In cases where an individual is injured, conscious, and breathing normally, and the injury indicates possible neck, back, hip, or pelvic damage, they should remain in their current position to prevent further harm, unless the location poses a danger."
id_00484,"For intermediate-high risk patients with stable chest pain and no known CAD for whom rest/stress nuclear MPI is selected, PET is reasonable in preference to SPECT, if available to improve diagnostic accuracy and decrease the rate of nondiagnostic test results.36-39","For patients at intermediate to high risk with stable chest pain and no known coronary artery disease, choosing PET over SPECT for rest/stress nuclear MPI is advisable, if accessible, to enhance diagnostic precision and reduce nondiagnostic outcomes."
id_01923,"In patients with PAD who have undergone lower extremity revascularization (ie, surgical and/or endo- vascular), longitudinal follow-up that includes periodic clinical evaluation of lower extremity symptoms and pulse and foot assessment is recommended.13–16","For patients with PAD who have had lower extremity revascularization, it is advised to conduct ongoing follow-up that involves regular clinical evaluation of symptoms in the lower extremities, as well as assessment of pulses and feet."
id_02404,"In patients with grade 2 BAAI (Table 33) and associated malperfusion, it is reasonable to consider repair.1","For patients with grade 2 BAAI (refer to Table 33) who have malperfusion, considering repair is a reasonable option."
id_01924,"In patients with PAD who have undergone lower extremity revascularization (ie, surgical, endovascular, or both) with new lower extremity signs or symptoms, ABI and arterial duplex ultrasound is recommended.14,17–20","For patients with PAD who have had lower extremity revascularization, whether surgical, endovascular, or both, and present with new signs or symptoms in the lower extremities, it is advised to perform ABI and arterial duplex ultrasound."
id_01444,"In patients with CCD who are judged to be at very high risk (Table 10) and on maximally tol- erated statin therapy with an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), ezetimibe can be ben- eficial to further reduce the risk of MACE.*14–19 Cost Value Statement: High Value B-NR","For patients with CCD assessed as very high risk (refer to Table 10) and receiving the highest tolerable dose of statins with an LDL-C level of 70 mg/dL (1.8 mmol/L) or higher, adding ezetimibe may help further decrease the risk of MACE.*14–19 Cost Value Statement: High Value B-NR"
id_00485,"For intermediate-high risk patients with stable chest pain and no known CAD with an interpretable ECG and ability to achieve maximal levels of exercise (≥5 METs), exercise electrocardiography is reasonable.8,13,15,40-45","Exercise electrocardiography is appropriate for patients at intermediate to high risk who have stable chest pain, no known coronary artery disease, an interpretable ECG, and can reach maximal exercise levels of at least 5 METs."
id_00006,Individuals who are ill or injured should be protected from hyperthermia or hypothermia due to exposure.,People who are sick or injured should be safeguarded against excessive heat or cold exposure.
id_02405,"In patients with BAAI, treatment with either endovascular or open repair is reasonable and depends on degree of injury, aortic anatomy, and the patient’s overall clinical status.1-4","For patients with BAAI, choosing between endovascular or open repair is appropriate and should be based on the severity of the injury, the anatomy of the aorta, and the patient's overall clinical condition."
id_00005,"An awake and alert person who is having difficulty breathing should be allowed to assume a position most comfortable for breathing, which will be sitting up in most situations.","A conscious and alert individual experiencing breathing difficulties should be permitted to adopt the most comfortable position for breathing, typically sitting upright."
id_01445,"In patients with CCD who are judged to be at very high risk (Table 10) and who have an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), or a non–high-density lipoprotein cholesterol (HDL-C) level ≥100 mg/dL (≥2.6 mmol/L), on maximally tolerated statin and ezetimibe, a PCSK9 monoclonal antibody can be beneficial to further reduce the risk of MACE.*22–29 Cost Value Statement: Uncertain B-NR","For patients with CCD assessed as very high risk (refer to Table 10) and having an LDL-C level of 70 mg/dL (1.8 mmol/L) or higher, or a non-HDL-C level of 100 mg/dL (2.6 mmol/L) or higher, despite being on the highest tolerated doses of statins and ezetimibe, using a PCSK9 monoclonal antibody may help further decrease the risk of MACE.*22–29 Cost Value Statement: Uncertain B-NR"
id_01925,"In patients with PAD who have undergone infrain- guinal, autogenous vein bypass graft(s) without new lower extremity signs or symptoms, it is reasonable to perform ABI and arterial duplex ultrasound surveillance within the first 1 to 3 months postprocedure, then repeat at 6 and 12 months, and then annually.13,14,20–22","For patients with PAD who have had infrain- guinal autogenous vein bypass grafts and show no new symptoms in the lower extremities, it is advisable to conduct ABI and arterial duplex ultrasound monitoring within 1 to 3 months after the procedure, followed by assessments at 6 and 12 months, and then yearly thereafter."
id_00486,"In intermediate-high risk patients with stable chest pain selected for stress MPI using SPECT, the use of attenuation correction or prone imaging may be reasonable to decrease the rate of false-positive findings.46-51 Assessment of Left Ventricular Function","For patients at intermediate-high risk with stable chest pain undergoing stress MPI with SPECT, employing attenuation correction or prone imaging can be a sensible approach to reduce false-positive results."
id_01926,"In patients with PAD who have undergone endovascular procedures without new lower extremity signs or symptoms, it is reasonable to per- form ABI and arterial duplex ultrasound surveillance within the first 1 to 3 months postprocedure, then repeat at 6 and 12 months, and then annually.17,19,20","For patients with PAD who have had endovascular interventions and show no new signs or symptoms in the lower extremities, it is advisable to conduct ABI and arterial duplex ultrasound monitoring within the first 1 to 3 months after the procedure, followed by assessments at 6 and 12 months, and then annually."
id_02406,"In patients with grade 3 BAAI (Table 33), it may be reasonable to consider repair to reduce risk of progression to life-threatening injury.5","For patients with grade 3 BAAI (refer to Table 33), considering repair might be appropriate to lower the risk of advancing to a life-threatening condition."
id_00007,It is reasonable to position a person with decreased alertness of nontraumatic cause who is breathing normally in a recovery (side-lying) position. Recommendation-Specific Supportive Text,"For an individual with reduced alertness due to a nontraumatic cause who is breathing normally, placing them in a recovery (side-lying) position is advisable."
id_01446,"In patients with CCD on maximally tolerated statin therapy with an LDL-C level <100 mg/ dL (<2.6 mmol/L) and a persistent fasting tri- glyceride level of 150 to 499 mg/dL (1.7–5.6 mmol/L) after addressing secondary causes, icosapent ethyl may be considered to further reduce the risk of MACE and cardiovascular death.32","For patients with CCD who are on the highest tolerated dose of statins and have an LDL-C level below 100 mg/dL (2.6 mmol/L), along with a fasting triglyceride level between 150 and 499 mg/dL (1.7–5.6 mmol/L) after secondary causes have been managed, icosapent ethyl can be considered to further lower the risk of MACE and cardiovascular mortality."
id_01927,"In patients with PAD who have undergone infrain- guinal, prosthetic bypass graft(s) without new lower extremity signs or symptoms, the effectiveness of ABI and arterial duplex ultrasound surveillance is uncertain.14,20,23,24 Telehealth","For patients with PAD who have received infrain- guinal prosthetic bypass grafts and show no new signs or symptoms in the lower extremities, the benefit of using ABI and arterial duplex ultrasound for surveillance remains unclear."
id_00487,"In intermediate-high risk patients with stable chest pain who have pathological Q waves, symptoms or signs suggestive of heart failure, complex ventricular arrhythmias, or a heart murmur with unclear diagnosis, use of TTE is effective for diagnosis of resting left ventricular systolic and diastolic ventricular function and detection of myocardial, valvular, and pericardial abnormalities.13,14,52 Sequential or Add-on Testing: What to Do if Index Test Results are Positive or Inconclusive","For patients at intermediate-high risk with stable chest pain who exhibit pathological Q waves, heart failure symptoms or signs, complex ventricular arrhythmias, or an undiagnosed heart murmur, TTE is effective for assessing resting left ventricular systolic and diastolic function and identifying myocardial, valvular, and pericardial abnormalities."
id_00008,"If a person shows evidence of shock with a normal level of alertness, it is reasonable to place or maintain the person in a supine position.","For individuals exhibiting signs of shock but remaining alert, it is advisable to position or keep them lying flat on their back."
id_02407,"In patients with BAAI, the usefulness of routine application of resuscitative endovascular balloon occlusion of the aorta (REBOA) for hemorrhage control is unclear and, in some cases, may cause harm.6-8","For patients with BAAI, the routine use of resuscitative endovascular balloon occlusion of the aorta (REBOA) for controlling hemorrhage is uncertain and may be harmful in certain situations."
id_01447,"In patients with CCD who are not at very high risk and on maximally tolerated statin therapy with an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), it may be reasonable to add ezetimibe to further reduce the risk of MACE.*14,15,18,19","For patients with CCD who are not at extremely high risk and are on the highest tolerated dose of statins with an LDL-C level of 70 mg/dL (1.8 mmol/L) or higher, adding ezetimibe could be a reasonable option to further decrease the risk of MACE."
id_00488,"For intermediate-high risk patients with stable chest pain and known coronary stenosis of 40% to 90% in a proximal or middle coronary segment on CCTA, FFR-CT can be useful for diagnosis of vessel-specific ischemia and to guide decision-making regarding the use of coronary revascularization.12,53-58","For patients at intermediate to high risk who have stable chest pain and coronary stenosis between 40% and 90% in a proximal or middle coronary segment as shown by CCTA, FFR-CT may aid in diagnosing vessel-specific ischemia and assist in making decisions about coronary revascularization."
id_01448,"In patients with CCD on maximally tolerated statin therapy who have an LDL-C level ≥70 mg/dL (≥1.8 mmol/L), and in whom ezetimibe and PCSK9 monoclonal antibody are deemed insufficient or not tolerated, it may be reason- able to add bempedoic acid33,34 or inclisiran35 (in place of PCSK9 monoclonal antibody) to further reduce LDL-C levels.","For patients with CCD on the highest tolerated dose of statins who have an LDL-C level of 70 mg/dL (1.8 mmol/L) or higher, and where ezetimibe and PCSK9 monoclonal antibodies are either inadequate or not tolerated, it may be appropriate to add bempedoic acid or replace the PCSK9 monoclonal antibody with inclisiran to further lower LDL-C levels."
id_01928,"For patients with PAD, telehealth can be an alterna- tive mode for vascular evaluation and management and longitudinal follow-up, but the use of these visits should be consistent with the urgency of presenting symptoms.25–28","For individuals with PAD, telehealth may serve as an alternative method for vascular assessment, management, and ongoing follow-up, provided that the urgency of the symptoms is taken into account."
id_02408,"In patients with BTAI who have undergone aortic repair, surveillance imaging at intervals appropriate for the repair approach and loca- tion (see Section 7.8, “Long-Term Manage- ment and Surveillance Imaging Following AAS”) is reasonable.1-4","For patients with BTAI who have had aortic repair, it is advisable to conduct surveillance imaging at intervals suitable for the type and site of the repair, as detailed in Section 7.8, ""Long-Term Management and Surveillance Imaging Following AAS."""
id_00489,"For intermediate-high risk patients with stable chest pain after an inconclusive or abnormal exercise ECG or stress imaging study, CCTA is reasonable.5,59-63",CCTA is a suitable option for patients at intermediate to high risk who have stable chest pain following an inconclusive or abnormal exercise ECG or stress imaging test.
id_00009,"If a person showing signs of shock is at risk for airway obstruction (decreased alertness, active vomiting) or cannot be continuously watched, it is reasonable to place the person in the recovery position.","For individuals exhibiting shock symptoms who are at risk of airway blockage due to reduced alertness or active vomiting, or if they cannot be monitored continuously, positioning them in the recovery position is advisable."
id_01449,"In patients with CCD receiving statin therapy, adding niacin,36,37 or fenofibrate38 or dietary supplements containing omega-3 fatty acids, are not beneficial in reducing cardiovascular risk.39–41 *Modified from the 2018 AHA/ACC/Multisociety Guideline on the Manage- ment of Blood Cholesterol.42","For patients with CCD on statin treatment, incorporating niacin, fenofibrate, or omega-3 fatty acid supplements does not effectively lower cardiovascular risk."
id_01929,It may be reasonable for appropriately trained rescuers to provide in-water rescue breathing to an unresponsive person who has drowned if it does not compromise their own safety. Recommendation-Specific Supportive Text,"Trained rescuers might consider performing rescue breathing in the water on an unresponsive drowning victim, provided their own safety is not at risk."
id_00490,"For intermediate-high risk patients with stable chest pain and no known CAD undergoing stress testing, the addition of CAC testing can be useful.64-70 Downloaded from http://ahajournals.org by on June 19, 2025","For patients at intermediate to high risk with stable chest pain and no established coronary artery disease who are undergoing stress tests, incorporating CAC testing may be beneficial."
id_02409,"In patients with BTAI who have not undergone repair, surveillance imaging with a CT at 1 month, 6 months, and 12 months after the diagnosis and, if stable, at appropriate inter- vals thereafter (depending on the type and extent of the injury), may be ­reasonable.5","For patients with BTAI who have not received repair, it may be reasonable to conduct surveillance imaging using a CT scan at 1 month, 6 months, and 12 months post-diagnosis, and subsequently at suitable intervals if the condition remains stable, based on the injury's type and severity."
id_01930,Trained rescuers should provide supplemental oxygen if available to persons with cardiac arrest following drowning. Recommendation-Specific Supportive Text,"If possible, trained rescuers should administer supplemental oxygen to individuals experiencing cardiac arrest after drowning."
id_00010,"If there is no evidence of trauma or injury (eg, simple fainting, shock from nontraumatic bleeding, sepsis, dehydration), raising the feet about 6 to 12 in (≈30°–45°) from supine position may be reasonable while awaiting the arrival of EMS.","In the absence of trauma or injury, such as in cases of simple fainting, shock from nontraumatic bleeding, sepsis, or dehydration, elevating the feet 6 to 12 inches (approximately 30°–45°) from a lying position may be appropriate while waiting for EMS to arrive."
id_02410,"In patients who have had an acute aortic dis- section and IMH treated with either open or endovascular aortic repair and have residual aortic disease, surveillance imaging with a CT (or MRI) is recommended after 1 month, 6 months, and 12 months and then, if stable, annually thereafter.1-6","For patients with a history of acute aortic dissection and intramural hematoma managed through open or endovascular aortic repair, and who have remaining aortic disease, it is advised to perform surveillance imaging using CT or MRI at 1 month, 6 months, and 12 months post-treatment, followed by annual imaging if the condition remains stable."
id_00011,"If a person is placed in a leg-raised position that results in pain, discomfort, or worsened symptoms, returning the person to a supine position may be considered. Recommendation-Specific Supportive Text","If elevating a person's legs causes pain, discomfort, or exacerbates symptoms, it may be advisable to reposition them to lie flat."
id_00491,"For patients with obstructive CAD and stable chest pain, it is recommended to optimize GDMT.1-3","For individuals with obstructive coronary artery disease and stable angina, it is advised to enhance guideline-directed medical therapy."
id_01931,"In cardiac arrest following drowning, CPR with rescue breaths should be started before AED application.","For cardiac arrest due to drowning, initiate CPR with rescue breaths prior to using an AED."
id_01450,"In adults with CCD, nonpharmacologic strategies are recommended as first-line therapy to lower BP in those with elevated BP (120-129/<80 mm Hg) (see Table 12).*1–9","For adults with CCD and elevated BP (120-129/<80 mm Hg), it is advised to initially employ nonpharmacologic methods to reduce BP (refer to Table 12).*1–9"
id_01451,"In adults with CCD who have hypertension, a BP target of <130/<80 mm Hg is recommended to reduce CVD events and all-cause death.*10–14","For adults with CCD and hypertension, aiming for a blood pressure below 130/80 mm Hg is advised to decrease the risk of cardiovascular events and mortality."
id_00492,"For patients with known nonobstructive CAD and stable chest pain, it is recommended to optimize preventive therapies.4,5","For individuals with diagnosed nonobstructive coronary artery disease and stable angina, enhancing preventive treatments is advised."
id_00012,"The effectiveness/usefulness of oxygen adminis- tered in the first aid setting for adults or children exhibiting signs or symptoms of shortness of breath, difficulty breathing, or hypoxia is unknown.","The benefit of providing oxygen in a first aid scenario for adults or children showing signs of breathlessness, respiratory distress, or low oxygen levels is uncertain."
id_02411,"In patients who have had an acute aortic dis- section and IMH that was managed with medi- cal therapy alone, surveillance imaging with a CT (or MRI) is recommended after 1 month, 6 months, and 12 months and then, if stable, annually thereafter.7","For patients treated solely with medical therapy for an acute aortic dissection and intramural hematoma, it is advised to perform surveillance imaging using CT or MRI at 1 month, 6 months, and 12 months, followed by annual imaging if the condition remains stable."
id_01932,AED use is reasonable in cardiac arrest following drowning.,It is appropriate to use an AED in cases of cardiac arrest after drowning.
id_00013,It is not beneficial to administer oxygen over room air in the first aid setting for adults experiencing acute stroke.,Providing oxygen instead of room air is not advantageous for adults with acute stroke in a first aid context.
id_00493,"For patients with obstructive CAD who have stable chest pain despite GDMT and moderate- severe ischemia, ICA is recommended for guiding therapeutic decision-making.1-4","For patients with obstructive CAD experiencing stable chest pain despite GDMT and moderate to severe ischemia, it is advised to use ICA to guide treatment decisions."
id_01452,"In adults with CCD and hypertension (systolic BP ≥130 and/or diastolic BP ≥80 mm Hg), in addition to nonpharmacological strategies, GDMT angiotensin-converting enzyme (ACE) inhibitors, angiotensin-receptor blockers (ARB), or beta blockers15–17 are recommended as first-line ther- apy for compelling indications (eg, recent MI or angina), with additional antihypertensive medica- tions (eg, dihydropyridine calcium channel block- ers [CCB], long-acting thiazide diuretics, and/or mineralocorticoid receptor antagonists) added as needed to optimize BP control.*13,18 *Modified from the 2017 ACC/AHA Multisociety Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults.19","For adults with CCD and hypertension (systolic BP ≥130 and/or diastolic BP ≥80 mm Hg), alongside nonpharmacological approaches, it is recommended to use GDMT ACE inhibitors, ARBs, or beta blockers as the primary treatment for compelling indications such as recent MI or angina. Additional antihypertensive medications, like dihydropyridine CCBs, long-acting thiazide diuretics, and/or mineralocorticoid receptor antagonists, should be added as necessary to achieve optimal BP control."
id_01933,The initiation of CPR should not be delayed to obtain or apply an AED in cardiac arrest following drowning. Recommendation-Specific Supportive Text,"In cases of cardiac arrest due to drowning, start CPR immediately without waiting to acquire or use an AED."
id_02412,"In patients with a previous acute aortic dissection and IMH, whether initially treated medically or with intervention, who have chronic residual TAD and an aneurysm with a total aortic diameter of ≥5.5 cm, elective thoracic aortic repair is ­recommended.1-4","For patients with a history of acute aortic dissection and intramural hematoma, regardless of initial medical or interventional treatment, who present with chronic residual thoracic aortic disease and an aneurysm with a total aortic diameter of 5.5 cm or larger, elective thoracic aortic repair is advised."
id_00014,A physical examination and history should be the primary assessment methods for first aid provid- ers to evaluate an ill or injured person.,First aid providers should primarily rely on physical examination and history-taking to assess an ill or injured individual.
id_01453,"In patients with CCD who have type 2 diabetes, the use of either an SGLT2 inhibitor1–8 or a GLP-1 receptor agonist9–17 with proven cardio- vascular benefit is recommended to reduce the risk of MACE. Cost Value Statement: High Value B-NR","For patients with CCD and type 2 diabetes, it is advised to use an SGLT2 inhibitor or a GLP-1 receptor agonist with established cardiovascular benefits to lower the risk of MACE. Cost Value Statement: High Value B-NR"
id_02413,"In patients with a PAU who have under- gone aortic repair, surveillance imaging at intervals appropriate for the repair approach and location (see Section 6.5.6, “Surveillance After Aneurysm Repair”) is reasonable.1-3","For patients with a PAU who have received aortic repair, it is advisable to conduct surveillance imaging at intervals suitable for the type and site of the repair, as detailed in Section 6.5.6, ""Surveillance After Aneurysm Repair."""
id_00494,"For patients with obstructive CAD who have stable chest pain despite optimal GDMT, those referred for ICA without prior stress testing benefit from FFR or instantaneous wave free ratio.3,5-7","Patients with obstructive CAD experiencing stable chest pain despite optimal GDMT, who are referred for ICA without prior stress testing, gain from FFR or instantaneous wave-free ratio."
id_01454,"In patients with CCD and heart failure with LVEF ≤40%, use of an SGLT2 inhibitor is rec- ommended to reduce the risk of cardiovascular death and heart failure hospitalization19–22 and to improve QOL,23,24 irrespective of diabetes status.* Cost Value Statement: Intermedi- ate Value B-NR","For patients with CCD and heart failure with an LVEF of 40% or less, it is advised to use an SGLT2 inhibitor to lower the risk of cardiovascular death and heart failure hospitalization and to enhance quality of life, regardless of diabetes status. Cost Value Statement: Intermediate Value B-NR."
id_01934,"In cardiac arrest following drowning and after removal from the water, CPR with rescue breaths and chest compressions should be provided to all persons.","For individuals experiencing cardiac arrest due to drowning, once they are out of the water, perform CPR with both rescue breaths and chest compressions."
id_02414,"In patients with a PAU that is being managed medically, surveillance imaging with a CT is reasonable at 1 month after the diagnosis and, if stable, every 6 months for 2 years, and then at appropriate intervals thereafter (depending on patient age and PAU charac- teristics).1,4","For patients with a PAU undergoing medical management, it is advisable to perform surveillance imaging using a CT scan 1 month post-diagnosis, followed by every 6 months for 2 years if stable, and subsequently at suitable intervals based on the patient's age and PAU characteristics."
id_00015,It is reasonable for first aid providers to use pulse oximetry results in the context of a complete assessment and to be aware of the limitations of pulse oximetry before acting on any results. Recommendation-Specific Supportive Text,First aid providers should consider pulse oximetry readings as part of a comprehensive evaluation and understand the limitations of these readings before making decisions based on them.
id_01455,"In patients with CCD and heart failure with LVEF >40%, use of an SGLT2 inhibitor can be beneficial in decreasing heart failure hospitalizations27,28 and to improve QOL,4,29 irrespective of diabetes status. Cost Value Statement: Intermedi- ate Value B-NR","For patients with CCD and heart failure with an LVEF greater than 40%, administering an SGLT2 inhibitor may help reduce hospitalizations due to heart failure and enhance quality of life, regardless of diabetes status. Cost Value Statement: Intermediate Value B-NR."
id_01935,"In cardiac arrest following drowning, if the rescuer is unwilling, untrained, or unable to provide rescue breaths, it is reasonable to provide chest compressions only, until help arrives.","If a person experiences cardiac arrest due to drowning and the rescuer cannot, is not trained to, or is unwilling to give rescue breaths, performing only chest compressions until assistance arrives is a reasonable approach."
id_02415,"In patients with genetic aortopathies attributable to syndromic (Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome) and nsHTAD and who are contemplating preg- nancy, genetic counseling before pregnancy to discuss the heritable nature of their condition is recommended.1-4","For individuals with genetic aortopathies linked to syndromic conditions such as Marfan syndrome, Loeys-Dietz syndrome, vascular Ehlers-Danlos syndrome, and nsHTAD who are considering pregnancy, it is advised to undergo genetic counseling prior to conception to discuss the inheritable aspects of their condition."
id_00016,First aid providers should assist a person with asthma who is having difficulty breathing with the administration of their own prescribed bronchodilators as needed.,First aid responders should help an individual with asthma experiencing breathing difficulties by facilitating the use of their prescribed bronchodilators as required.
id_00496,"For patients who have stable chest pain with previous coronary revascularization, CCTA is reasonable to evaluate bypass graft or stent patency (for stents ≥3 mm).9-13 Stress Testing","For patients with stable chest pain and a history of coronary revascularization, it is appropriate to use CCTA to assess the patency of bypass grafts or stents that are 3 mm or larger."
id_00495,"For symptomatic patients with obstructive CAD who have stable chest pain with CCTA- defined ≥50% stenosis in the left main coronary artery, obstructive CAD with FFR with CT ≤0.80, or severe stenosis (≥70%) in all 3 main vessels, ICA is effective for guiding therapeutic decision-making.4,8","For patients with obstructive coronary artery disease (CAD) experiencing stable chest pain, who have CCTA-defined stenosis of 50% or more in the left main coronary artery, an FFR with CT of 0.80 or less, or severe stenosis of 70% or more in all three main vessels, invasive coronary angiography (ICA) is effective for guiding treatment decisions."
id_01456,"In patients with CCD, assessment of BMI with or without waist circumference is recommended dur- ing routine clinical follow-up.1–6","For patients with CCD, it is advised to evaluate BMI, optionally alongside waist circumference, during regular clinical follow-up."
id_01936,"In cardiac arrest following drowning, it may be reasonable for trained rescuers to initiate CPR with rescue breaths followed by chest compressions. Recommendation-Specific Supportive Text","For cardiac arrest due to drowning, trained rescuers might consider starting CPR with rescue breaths before performing chest compressions."
id_00017,"It is reasonable to use either an inhaler with a spacer or a nebulizer when assisting a person with asthma to use their own inhaled bronchodilator medication, in preference to using an inhaler alone.","When helping someone with asthma use their inhaled bronchodilator, it is advisable to opt for either an inhaler with a spacer or a nebulizer, rather than just an inhaler alone."
id_00497,"For patients with obstructive CAD who have stable chest pain despite optimal GDMT, stress PET/SPECT MPI, CMR, or echocardiography is recommended for diagnosis of myocardial ischemia, estimating risk of MACE, and guiding therapeutic decision-making.14-36","For patients with obstructive CAD experiencing stable chest pain despite optimal GDMT, it is advised to use stress PET/SPECT MPI, CMR, or echocardiography to diagnose myocardial ischemia, assess MACE risk, and inform treatment decisions."
id_01457,"Patients with CCD and overweight or obesity should receive counseling on diet, lifestyle, and goals for weight loss.7–10","Individuals with CCD who are overweight or obese should be advised on dietary habits, lifestyle changes, and weight loss objectives."
id_01937,"Implementation of PAD programs is reasonable in areas where there is a high risk of cardiac arrest, including aquatic environments (eg, areas with high population density, frequent utilization, other forms of exercise, long distances or response times to nearest AED). Recommendation-Specific Supportive Text","It is advisable to establish PAD programs in locations with a high likelihood of cardiac arrest, such as aquatic settings, particularly where there is a dense population, frequent use, other exercise activities, or significant distance or delay to the nearest AED."
id_02416,"In patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic dilation, and other aortopathy conditions, aortic imaging (with TTE, MRI or CT, or both as appropriate) before pregnancy is recommended to determine aortic ­diameters.1-3,5-13","For patients with syndromic and non-syndromic hereditary thoracic aortic disease, Turner syndrome, bicuspid aortic valve with aortic enlargement, and other aortopathies, it is advised to perform aortic imaging using TTE, MRI, CT, or a combination of these methods, as suitable, prior to pregnancy to assess aortic diameters."
id_00498,"For patients with obstructive CAD who have stable chest pain despite optimal GDMT, when selected for rest/stress nuclear MPI, PET is reasonable in preference to SPECT, if available, to improve diagnostic accuracy and decrease the rate of nondiagnostic test results.37","For patients with obstructive CAD experiencing stable chest pain despite optimal GDMT, choosing PET over SPECT for rest/stress nuclear MPI is advisable, if accessible, to enhance diagnostic precision and reduce nondiagnostic outcomes."
id_02417,"In patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic dilation, and other aortopathy conditions, who are contem- plating pregnancy, counseling about the risks of aortic dissection related to pregnancy is recommended.2-5,10,12,14 During Pregnancy","For patients with syndromic and nsHTAD, Turner syndrome, BAV with aortic enlargement, and other aortopathy conditions considering pregnancy, it is advised to provide counseling on the risks of aortic dissection associated with pregnancy."
id_01458,"For patients with CCD and overweight or obesity in whom pharmacologic therapy is warranted for further weight reduction, a GLP-1 receptor agonist can be beneficial in addition to counseling for diet and physical activity,11,12 and it is reasonable to choose semaglutide over liraglutide.13,14 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with CCD who are overweight or obese and require medication for additional weight loss, a GLP-1 receptor agonist may be advantageous alongside dietary and exercise counseling, and selecting semaglutide over liraglutide is a sensible option."
id_00019,"If stroke is suspected, the EMS system should be activated immediately.","In the event of a suspected stroke, promptly activate the EMS system."
id_01938,"It is reasonable for trained rescuers to provide rescue breaths by the first means available (mouth- to-mouth, pocket mask, or bag-mask ventilation) for persons in cardiac arrest following drowning to avoid any delay in ventilation.","Trained rescuers should promptly deliver rescue breaths using the first available method, such as mouth-to-mouth, pocket mask, or bag-mask ventilation, to individuals in cardiac arrest after drowning to prevent any delay in ventilation."
id_02418,"In patients with aortic aneurysms, or at increased risk of aortic dissection, or both, it is recom- mended that pregnancy be managed by a multidisciplinary team including a maternal fetal medicine specialist and cardiologist, and, if logistically feasible, that delivery be planned in a hospital where the capability for emergency aortic repair is available.","For patients with aortic aneurysms, those at heightened risk of aortic dissection, or both, it is advised that pregnancy be overseen by a multidisciplinary team comprising a maternal-fetal medicine specialist and a cardiologist, and, if possible, that delivery occur in a hospital equipped for emergency aortic repair."
id_00499,"For patients with obstructive CAD who have stable chest pain despite GDMT, exercise treadmill testing can be useful to determine if the symptoms are consistent with angina pectoris, assess the severity of symptoms, evaluate functional capacity and select management, including cardiac rehabilitation.4,38-40","Exercise treadmill testing may be beneficial for patients with obstructive CAD experiencing stable chest pain despite GDMT, as it helps confirm if the symptoms align with angina pectoris, gauge symptom severity, evaluate functional capacity, and guide management decisions, including cardiac rehabilitation."
id_00018,"If a commercially available spacer is not available, it is reasonable to use an improvised spacer when assisting a person who is having an asthma attack to use their own inhaled bronchodilator medication. Recommendation-Specific Supportive Text","In the absence of a commercially available spacer, it is acceptable to use a makeshift spacer to help someone experiencing an asthma attack use their inhaled bronchodilator medication."
id_01459,"In patients with CCD and severe obesity who have not met weight loss goals with lifestyle and pharmacologic intervention, and who have acceptable surgical risk, referral for consideration of a bariatric procedure is reasonable for weight loss and cardiovascular risk factor reduction.15–18","For patients with CCD and severe obesity who have not achieved weight loss targets through lifestyle changes and medication, and who are suitable candidates for surgery, it is reasonable to refer them for evaluation of a bariatric procedure to aid in weight loss and reduce cardiovascular risk factors."
id_01939,Provision of rescue breathing using equipment (bag-mask or advanced airways) should be optimized by providing rescuers a competency- based training program with regular retraining and maintenance of equipment. Recommendation-Specific Supportive Text,"To enhance the effectiveness of rescue breathing with equipment like bag-mask or advanced airways, rescuers should undergo a competency-based training program with periodic retraining and ensure equipment is well-maintained."
id_02419,"In patients with aortopathies who are preg- nant, guideline-directed treatment of hyper- tension is recommended.61517","For pregnant patients with aortopathies, it is advised to manage hypertension according to established guidelines."
id_01940,"In patients with rheumatic heart disease, secondary prevention of rheumatic fever is indicated (Tables 6 and 7).1","For individuals with rheumatic heart disease, it is recommended to implement secondary prevention measures for rheumatic fever (refer to Tables 6 and 7)."
id_00020,"The use of a stroke recognition scale such as the Face, Arms, Speech, Time (FAST) or Cincinnati Prehospital Stroke Scale is recommended to aid in the recognition of acute stroke in adults.",It is advised to utilize a stroke recognition tool like the FAST or Cincinnati Prehospital Stroke Scale to help identify acute stroke in adults.
id_00500,"For patients with obstructive CAD who have stable chest pain symptoms undergoing stress PET MPI or stress CMR, the addition of MBFR is useful to improve diagnosis accuracy and enhance risk stratification.31-36","For patients with obstructive CAD experiencing stable chest pain and undergoing stress PET MPI or stress CMR, incorporating MBFR is beneficial for enhancing diagnostic precision and improving risk assessment."
id_02420,"In patients with syndromic and nsHTAD, beta-blocker therapy during pregnancy and postpartum is recommended, unless contrain- dicated.","For patients with syndromic and nsHTAD, it is advised to use beta-blockers during pregnancy and after childbirth, unless there are contraindications."
id_00501,"In patients who have had prior CABG surgery presenting with stable chest pain whose noninvasive stress test results show moderate- to-severe ischemia,1-7 or in those suspected to have myocardial ischemia with indeterminate/ nondiagnostic stress test, ICA is recommended for guiding therapeutic decision-making.1","For patients with a history of CABG surgery who present with stable chest pain and have noninvasive stress test results indicating moderate to severe ischemia, or when myocardial ischemia is suspected but stress test results are inconclusive, ICA is advised to guide treatment decisions."
id_00021,It is reasonable for first aid providers to measure capillary blood glucose in adults with suspected stroke if it is available and does not delay activating EMS. Recommendation-Specific Supportive Text,"First aid providers may measure capillary blood glucose in adults suspected of having a stroke, provided it is accessible and does not postpone contacting EMS."
id_01460,"In patients with CCD, use of sympathomimetic weight loss drugs is potentially harmful.19","For individuals with CCD, sympathomimetic weight loss medications may pose a risk."
id_02421,"In pregnant patients with aortic disease who require surveillance imaging of the aortic arch, descending, abdominal aorta, or all 3, MRI with- out gadolinium is recommended over CT to avoid radiation exposure to the fetus.19,20","For pregnant patients with aortic disease needing imaging of the aortic arch, descending aorta, abdominal aorta, or all three, MRI without gadolinium is advised instead of CT to prevent fetal radiation exposure."
id_00022,"If pediatric stroke is suspected, EMS should be activated, and the person should be transported to an ED.","In cases where a pediatric stroke is suspected, emergency medical services should be called, and the individual should be taken to an emergency department."
id_01461,"For patients with CCD who do not have contrain- dications, an exercise regimen is recommended, including ≥150 minutes/wk of moderate-intensity aerobic activities or ≥75 minutes/wk of higher- intensity aerobic activities to improve functional capacity and QOL, and to reduce hospital admis- sion and mortality rates.1–3","For patients with CCD without contraindications, it is advised to engage in an exercise routine consisting of at least 150 minutes per week of moderate-intensity aerobic activities or at least 75 minutes per week of high-intensity aerobic activities to enhance functional capacity and quality of life, and to decrease hospital admissions and mortality rates."
id_00502,"In patients who have had prior CABG surgery presenting with stable chest pain who are suspected to have myocardial ischemia, it is reasonable to perform stress imaging or CCTA to evaluate for myocardial ischemia or graft stenosis or occlusion.8-15","For patients with a history of CABG surgery who present with stable chest pain and are suspected of having myocardial ischemia, conducting stress imaging or CCTA to assess for myocardial ischemia or graft stenosis or occlusion is advisable."
id_01462,"For patients with CCD who do not have contraindi- cations, resistance (strength) training exercises are recommended on ≥2 days/wk to improve muscle strength, functional capacity, and cardiovascular risk factor control.4–6","For individuals with CCD without contraindications, it is advised to engage in resistance (strength) training exercises on at least two days per week to enhance muscle strength, functional capacity, and manage cardiovascular risk factors."
id_02422,"In pregnant patients with a history of chronic aortic dissection, cesarean delivery is recom- mended.","For pregnant individuals with a history of chronic aortic dissection, a cesarean section is advised."
id_00023,It is reasonable to consider stroke when common pediatric symptoms are present in association with other neurological signs and symptoms.,Considering stroke is advisable when typical pediatric symptoms occur alongside additional neurological signs and symptoms.
id_00503,"For symptomatic patients with known nonobstructive CAD who have stable chest pain, CCTA is reasonable for determining atherosclerotic plaque burden and progression to obstructive CAD, and guiding therapeutic decision-making.1-7","For patients with symptoms and diagnosed nonobstructive CAD experiencing stable chest pain, CCTA is a suitable option to assess atherosclerotic plaque load and its progression to obstructive CAD, aiding in therapeutic decisions."
id_01941,"Antibiotic prophylaxis is reasonable before dental procedures that involve manipulation of gingival tissue, manipulation of the periapical region of teeth, or perforation of the oral mucosa in patients with VHD who have any of the following1–9: a.   Prosthetic cardiac valves, including transcatheter-implanted prostheses and homografts. b.   Prosthetic material used for cardiac valve repair, such as annuloplasty rings, chords, or clips. c.   Previous IE. d.   Unrepaired cyanotic congenital heart disease or repaired congenital heart disease, with residual shunts or valvular regurgitation at the site of or adjacent to the site of a prosthetic patch or prosthetic device. e.   Cardiac transplant with valve regurgitation attributable to a structurally abnormal valve.","It is advisable to administer antibiotic prophylaxis prior to dental procedures that involve manipulation of gingival tissue, the periapical region of teeth, or perforation of the oral mucosa in patients with VHD who have any of the following conditions: a. Prosthetic cardiac valves, including those implanted via transcatheter and homografts. b. Prosthetic materials used in cardiac valve repair, such as annuloplasty rings, chords, or clips. c. A history of IE. d. Unrepaired cyanotic congenital heart disease or repaired congenital heart disease with residual shunts or valvular regurgitation at or near a prosthetic patch or device. e. Cardiac transplant recipients with valve regurgitation due to a structurally abnormal valve."
id_01463,"For patients with CCD who do not have contra- indications, lower-intensity lifestyle activities (eg, walking breaks at work) to reduce sedentary behavior (ie, sitting time) are reasonable to improve functional capacity and reduce cardiovascular risk, especially in individuals with low levels of habitual leisure time physical activity.7–9","For patients with CCD without contraindications, engaging in low-intensity lifestyle activities, such as taking walking breaks at work, to decrease sedentary behavior (such as sitting time) is advisable to enhance functional capacity and lower cardiovascular risk, particularly for those with low levels of regular leisure-time physical activity."
id_00024,Adult stroke scores are not validated in the pediatric population and should not solely be used to identify the broad presentation of stroke in children. Recommendation-Specific Supportive Text,Stroke assessment tools for adults have not been validated for use in children and should not be relied upon exclusively to recognize the diverse manifestations of stroke in the pediatric population.
id_02423,"In pregnant patients with an aortopathy and an aortic diameter of <4.0 cm, vaginal delivery (when otherwise appropriate) is recom- mended.","For pregnant patients with an aortopathy and an aortic diameter less than 4.0 cm, vaginal delivery is advised if there are no other contraindications."
id_00504,"For patients with known coronary stenosis from 40% to 90% on CCTA, FFR can be useful for diagnosis of vessel-specific ischemia and to guide decision-making regarding the use of ICA.8-14 Stress Testing","For patients with coronary stenosis ranging from 40% to 90% as identified by CCTA, FFR is beneficial for diagnosing vessel-specific ischemia and assisting in decisions about performing ICA."
id_01464,"In patients with CCD, minimization of exposure to ambient air pollution is reasonable to reduce the risk of cardiovascular events.1–7","For patients with CCD, it is advisable to limit exposure to air pollution to lower the risk of cardiovascular events."
id_01942,"In patients with VHD who are at high risk of IE, antibiotic prophylaxis is not recommended for nondental procedures (eg, TEE, esophagogastroduodenoscopy, colonoscopy, or cystoscopy) in the absence of active infection.10,11 Table 6.  Secondary Prevention of Rheumatic Fever Antibiotics for Prevention Dosage* Penicillin G benzathine","For patients with VHD at elevated risk for IE, antibiotic prophylaxis is not advised for non-dental procedures such as TEE, esophagogastroduodenoscopy, colonoscopy, or cystoscopy unless there is an active infection."
id_01944,"For patients with AF and rheumatic MS, long-term VKA oral anticoagulation is recommended.",Long-term oral anticoagulation with VKA is advised for patients with AF and rheumatic MS.
id_01943,"For patients with AF and native valve heart disease (except rheumatic mitral stenosis [MS]) or who received a bioprosthetic valve >3 months ago, a non–vitamin K oral anticoagulant (NOAC) is an effective alternative to VKA anticoagulation and should be administered on the basis of the patient’s CHA2DS2-VASc score.1,2","For patients with atrial fibrillation and native valve heart disease (excluding rheumatic mitral stenosis) or those who had a bioprosthetic valve implanted over three months ago, a non-vitamin K oral anticoagulant (NOAC) serves as an effective alternative to VKA anticoagulation and should be prescribed according to the patient's CHA2DS2-VASc score."
id_00025,"In adults with acute chest pain, the emergency response system should be activated to initiate transport to the closest ED by EMS.","For adults experiencing sudden chest pain, the emergency response system must be engaged to ensure EMS transports them to the nearest emergency department."
id_01465,"In patients with CCD, minimization of climate-related exposures (eg, extreme temperatures, wildfire smoke) may be reasonable to reduce the risk of cardiovascular events.8–10","For individuals with CCD, it may be advisable to limit exposure to climate-related factors (such as extreme temperatures and wildfire smoke) to potentially lower the risk of cardiovascular events."
id_00505,"For patients with known extensive nonobstructive CAD with stable chest pain symptoms, stress imaging (PET/SPECT, CMR, or echocardiography) is reasonable for the diagnosis of myocardial ischemia.15-24","For patients with established extensive nonobstructive coronary artery disease and stable chest pain, it is appropriate to use stress imaging (such as PET/SPECT, CMR, or echocardiography) to diagnose myocardial ischemia."
id_01945,"For patients with new-onset AF ≤3 months after surgical or transcatheter bioprosthetic valve replacement, anticoagulation with a VKA is reasonable.3–6",Anticoagulation with a VKA is advisable for patients who develop new-onset AF within 3 months following surgical or transcatheter bioprosthetic valve replacement.
id_00506,"For patients with persistent stable chest pain and nonobstructive CAD and at least mild myocardial ischemia on imaging, it is reasonable to consider invasive coronary function testing to improve the diagnosis of coronary microvascular dysfunction and to enhance risk stratification.1-4","For individuals experiencing ongoing stable chest pain with nonobstructive coronary artery disease and at least mild myocardial ischemia shown on imaging, invasive coronary function testing can be a reasonable option to better diagnose coronary microvascular dysfunction and improve risk assessment."
id_02425,"In pregnant patients with a diameter of the aortic root, ascending aorta, or both, of 4.0 cm to 4.5 cm, vaginal delivery with regional anes- thesia, expedited second stage, and assisted delivery may be reasonable.","For pregnant patients with an aortic root or ascending aorta measuring between 4.0 cm and 4.5 cm, it may be appropriate to consider vaginal delivery using regional anesthesia, a shortened second stage, and assisted delivery."
id_02424,"In pregnant patients with a diameter of the aortic root, ascending aorta, or both, of ≥4.5 cm, cesarean delivery is reasonable. Downloaded from http://ahajournals.org by on June 19, 2025","For pregnant patients with an aortic root or ascending aorta measuring 4.5 cm or larger, opting for a cesarean delivery is advisable."
id_01946,"In patients with mechanical heart valves with or without AF who require long-term anticoagulation with VKA to prevent valve thrombosis, NOACs are not recommended.7","For patients with mechanical heart valves, regardless of the presence of AF, who need long-term VKA anticoagulation to prevent valve thrombosis, NOACs are not advised."
id_01466,"In patients with CCD and no indication for oral anticoagulant therapy, low-dose aspirin 81 mg (75-100 mg) is recommended to reduce atherosclerotic events.*1–3","For patients with CCD who do not require oral anticoagulant treatment, it is advised to use low-dose aspirin, 81 mg (ranging from 75 to 100 mg), to decrease the risk of atherosclerotic events."
id_00027,"If there is any uncertainty that aspirin should be taken, it is reasonable to wait for EMS arrival without administration of aspirin. Recommendation-Specific Supportive Text","In cases of doubt regarding aspirin administration, it is advisable to refrain from giving aspirin until EMS arrives."
id_00026,"While awaiting the arrival of EMS, first aid provid- ers may encourage alert adults experiencing non- traumatic chest pain to chew and swallow aspirin (162–325 mg), unless the person experiencing pain has a known aspirin allergy or has been advised by a health care professional not to take aspirin.","While waiting for EMS, first aid providers can advise conscious adults with non-traumatic chest pain to chew and ingest aspirin (162–325 mg), unless they have a known allergy to aspirin or have been instructed by a healthcare professional to avoid it."
id_02426,"In pregnant patients with syndromic and nsHTAD, and a diameter of the aortic root, ascending aorta, or both, of 4.0 cm to 4.5 cm, cesarean delivery may be considered.","For pregnant patients with syndromic and nsHTAD, and an aortic root or ascending aorta measuring between 4.0 cm and 4.5 cm, a cesarean delivery might be an option."
id_00507,"For patients with persistent stable chest pain and nonobstructive CAD, stress PET MPI with MBFR is reasonable to diagnose microvascular dysfunction and enhance risk stratification.5-11","For individuals experiencing ongoing stable chest pain with nonobstructive coronary artery disease, it is appropriate to use stress PET MPI with MBFR to identify microvascular dysfunction and improve risk assessment."
id_01947,"For patients with VHD for whom intervention is contemplated, individual risks should be calculated for specific surgical and/or transcatheter procedures, using online tools when available, and discussed before the procedure as a part of a shared decision-making process.","For patients with VHD considering intervention, individual risks for specific surgical and/or transcatheter procedures should be assessed using online tools when possible and discussed prior to the procedure as part of shared decision-making."
id_01467,"In patients with CCD treated with PCI, dual antiplatelet therapy (DAPT) consisting of aspirin and clopidogrel for 6 months post PCI followed by single antiplatelet therapy (SAPT) is indicated to reduce MACE and bleeding events.*4–7","For patients with CCD undergoing PCI, it is advised to administer dual antiplatelet therapy (DAPT) with aspirin and clopidogrel for 6 months after the procedure, followed by single antiplatelet therapy (SAPT), to decrease the risk of MACE and bleeding events."
id_02427,"In patients with Marfan syndrome and an aortic root diameter of >4.5 cm, aortic surgery before pregnancy is recommended.1-4","For patients with Marfan syndrome who have an aortic root diameter exceeding 4.5 cm, it is advised to undergo aortic surgery prior to pregnancy."
id_00508,"For patients with persistent stable chest pain and nonobstructive CAD, stress CMR with the addition of MBFR measurement is reasonable to improve diagnosis of coronary myocardial dysfunction and for estimating risk of MACE.12-14","For individuals experiencing ongoing stable chest pain with nonobstructive coronary artery disease, it is advisable to use stress CMR along with MBFR measurement to enhance the diagnosis of coronary myocardial dysfunction and assess the risk of major adverse cardiac events."
id_00028,"If a person experiences anaphylaxis and an epinephrine autoinjector is available, the person should self-administer the autoinjector.","In the event of anaphylaxis, if an epinephrine autoinjector is accessible, the individual should use it on themselves."
id_02428,"In patients with Loeys-Dietz syndrome attributable to pathogenic variants in TGFB2 or TGFB3 and an aortic diameter of ≥4.5 cm, surgery before pregnancy is rea- sonable.","For patients with Loeys-Dietz syndrome due to pathogenic variants in TGFB2 or TGFB3 and an aortic diameter of 4.5 cm or greater, it is advisable to undergo surgery prior to pregnancy."
id_01948,Patients with severe VHD should be evaluated by a Multidisciplinary Heart Valve Team (MDT) when intervention is considered.,"For patients with severe VHD, a Multidisciplinary Heart Valve Team (MDT) should assess them when an intervention is being contemplated."
id_00029,A first aid provider should assist a person experi- encing anaphylaxis to use their autoinjector if assistance is required.,"If needed, a first aid provider ought to help someone experiencing anaphylaxis with using their autoinjector."
id_01468,"In select patients with CCD treated with PCI and a drug-eluting stent (DES) who have completed a 1- to 3-month course of DAPT, P2Y12 inhibitor monotherapy for at least 12 months is reasonable to reduce bleeding risk.8–12","For certain patients with CCD who have undergone PCI with a drug-eluting stent and have finished 1 to 3 months of DAPT, continuing P2Y12 inhibitor alone for a minimum of 12 months is advisable to lower the risk of bleeding."
id_02429,"In patients with nsHTAD and an aortic diam- eter of ≥4.5 cm, surgery before pregnancy is recommended.",Surgery is advised for patients with nsHTAD and an aortic diameter of 4.5 cm or greater prior to pregnancy.
id_00509,"For patients with persistent stable chest pain and nonobstructive CAD, stress echocardiography with the addition of coronary flow velocity reserve measurement may be reasonable to improve diagnosis of coronary myocardial dysfunction and for estimating risk of MACE.","For individuals experiencing ongoing stable chest pain with nonobstructive coronary artery disease, it may be appropriate to use stress echocardiography along with coronary flow velocity reserve measurement to enhance the diagnosis of coronary myocardial dysfunction and assess the risk of major adverse cardiac events."
id_00030,"If a person experiences anaphylaxis, the emer- gency response system should be activated.","In the event of anaphylaxis, the emergency response system must be called."
id_01949,"Consultation with or referral to a Primary or Comprehensive Heart Valve Center is reasonable when treatment options are being discussed for 1) asymptomatic patients with severe VHD, 2) patients who may benefit from valve repair versus valve replacement, or 3) patients with multiple comorbidities for whom valve intervention is considered.1–19","It is advisable to seek consultation or refer patients to a Primary or Comprehensive Heart Valve Center when considering treatment options for 1) asymptomatic individuals with severe valvular heart disease, 2) those who might benefit from valve repair instead of replacement, or 3) patients with multiple comorbidities where valve intervention is contemplated."
id_01470,"In patients with CCD and a previous history of MI without a history of stroke, transient ischemic attack (TIA), or ICH, vorapaxar may be added to aspirin therapy to reduce MACE.15–17","For patients with CCD and a past MI but no history of stroke, TIA, or ICH, adding vorapaxar to aspirin therapy can help lower the risk of MACE."
id_02430,"In patients with Turner syndrome and ASI of ≥2.5 cm/m2, surgery before pregnancy is rec- ommended.9-11","For patients with Turner syndrome and an ASI of 2.5 cm/m² or greater, it is advised to undergo surgery prior to pregnancy."
id_01469,"In patients with CCD who have had a previous MI and are at low bleeding risk, extended DAPT beyond 12 months for a period of up to 3 years may be reasonable to reduce MACE.*13,14","For patients with CCD who have experienced a prior MI and present a low risk of bleeding, continuing DAPT for up to 3 years beyond the initial 12 months may be advisable to lower MACE."
id_01950,"In asymptomatic patients with any type of valve intervention, a baseline postprocedural TTE followed by periodic monitoring with TTE is recommended, depending on type of intervention, length of time after intervention, ventricular function, and concurrent cardiac conditions.","For patients without symptoms who have undergone any valve intervention, it is advised to perform an initial post-procedure TTE and continue with regular TTE assessments, taking into account the intervention type, time elapsed since the procedure, ventricular function, and any existing cardiac conditions."
id_01471,"In patients with CCD, the use of DAPT after CABG may be useful to reduce the incidence of saphenous vein graft occlusion.18","For patients with CCD, administering DAPT following CABG might help lower the risk of saphenous vein graft occlusion."
id_02431,"In patients with a BAV (in the absence of Turner syndrome or an HTAD) and an aortic diameter of ≥5.0 cm, surgery before preg- nancy is recommended.","For patients with a BAV, without Turner syndrome or HTAD, and an aortic diameter of 5.0 cm or larger, it is advised to undergo surgery prior to pregnancy."
id_01951,"In patients with signs or symptoms of AS or a BAV, TTE is indicated for accurate diagnosis of the cause of AS, assessment of hemodynamic severity, measurement of LV size and systolic function, and determination of prognosis and timing of valve intervention.1,2","For patients exhibiting signs or symptoms of aortic stenosis (AS) or a bicuspid aortic valve (BAV), a transthoracic echocardiogram (TTE) is recommended to accurately diagnose the cause of AS, evaluate the severity of hemodynamics, measure left ventricular size and systolic function, and determine prognosis and appropriate timing for valve intervention."
id_00032,"First aid providers should activate EMS for individuals with first-time seizure; seizures last- ing >5 minutes; >1 seizure that occurs without the person returning to baseline mental status in between; seizures occurring in the water; seizures with traumatic injuries, difficulty breathing, or choking; seizure in an infant <6 months of age; seizure in pregnant individuals; or if the individual does not return to baseline within 5 to 10 minutes once seizure activity has stopped.","First aid responders should contact emergency medical services for individuals experiencing a first-time seizure; seizures exceeding 5 minutes; multiple seizures without a return to normal mental status between them; seizures occurring in water; seizures accompanied by traumatic injuries, breathing difficulties, or choking; seizures in infants under 6 months old; seizures in pregnant individuals; or if the person does not return to their usual state within 5 to 10 minutes after the seizure ends."
id_01472,"In patients with CCD without recent ACS or a PCI-related indication for DAPT, the addition of clopidogrel to aspirin therapy is not useful to reduce MACE.*19","For patients with CCD who have not experienced a recent ACS and do not have a PCI-related reason for DAPT, adding clopidogrel to aspirin therapy does not effectively lower MACE."
id_01952,"In patients with suspected low-flow, low- gradient severe AS with normal LVEF (Stage D3), optimization of blood pressure control is recommended before measurement of AS severity by TTE, TEE, cardiac catheterization, or CMR.3–7","For patients suspected of having low-flow, low-gradient severe aortic stenosis with normal left ventricular ejection fraction (Stage D3), it is advised to optimize blood pressure management prior to assessing AS severity using TTE, TEE, cardiac catheterization, or CMR."
id_00031,"If a person with anaphylaxis does not respond to the initial dose of epinephrine and arrival of EMS will exceed 5 to 10 minutes, a repeat dose may be considered. Recommendation-Specific Supportive Text","If an individual experiencing anaphylaxis does not improve after the first epinephrine dose and emergency medical services will take more than 5 to 10 minutes to arrive, administering a second dose may be considered."
id_02432,"In patients with sporadic aortic root aneu- rysms, ascending aortic aneurysms, or both and a diameter of ≥5.0 cm, surgery before pregnancy is recommended.","For patients with sporadic aortic root or ascending aortic aneurysms measuring 5.0 cm or larger, it is advised to undergo surgery prior to pregnancy."
id_00993,"In patients suspected of having a stroke or TIA, an ECG is recommended to screen for atrial fibrillation (AF) and atrial flutter and to assess for other concomitant cardiac condi- tions.40,41","For patients suspected of experiencing a stroke or TIA, it is advised to perform an ECG to detect atrial fibrillation and atrial flutter, as well as to evaluate for other associated cardiac conditions."
id_00033,"First aid providers should minimize the risk of injury to the individual who is having a seizure by helping the person to the ground, placing the person on their side in the recovery position, and clearing the area around them.","First aid responders should reduce the risk of harm to a person experiencing a seizure by assisting them to the ground, positioning them on their side in the recovery position, and removing nearby obstacles."
id_01473,"In patients with CCD and previous stroke, TIA, or ICH, vorapaxar should not be added to DAPT because of increased risk of major bleeding and ICH.15,20","For patients with CCD who have a history of stroke, TIA, or ICH, vorapaxar should not be combined with DAPT due to the heightened risk of major bleeding and ICH."
id_00034,"First aid providers should stay with the person having a seizure. Downloaded from http://ahajournals.org by on June 19, 2025",First aid responders should remain with the individual experiencing a seizure.
id_00994,"In patients with ischemic stroke or TIA, a diag- nostic evaluation is recommended for gaining insights into the etiology of and planning opti- mal strategies for preventing recurrent stroke, with testing completed or underway within 48 hours of onset of stroke symptoms.42–45","For patients experiencing an ischemic stroke or TIA, it is advised to conduct a diagnostic evaluation to understand the cause and develop effective prevention strategies for future strokes, with testing initiated or completed within 48 hours of symptom onset."
id_01953,"In patients with suspected low-flow, low- gradient severe AS with reduced LVEF (Stage D2), low-dose dobutamine stress testing with echocardiographic or invasive hemodynamic measurements is reasonable to further define severity and assess contractile reserve.8–10","For patients suspected of having low-flow, low-gradient severe aortic stenosis with decreased left ventricular ejection fraction (Stage D2), it is reasonable to use low-dose dobutamine stress testing alongside echocardiographic or invasive hemodynamic assessments to better determine severity and evaluate contractile reserve."
id_01474,"In patients with CCD and previous stroke, TIA, or ICH, prasugrel should not be used because of risk of significant or fatal bleeding.21","Prasugrel is not recommended for patients with CCD who have a history of stroke, TIA, or ICH due to the potential for severe or life-threatening bleeding."
id_02433,"In patients experiencing an acute type A aortic dissection during the first or second trimester of pregnancy, urgent aortic surgery with fetal monitoring is ­recommended.1-3","For patients with an acute type A aortic dissection in the first or second trimester of pregnancy, immediate aortic surgery with fetal monitoring is advised."
id_02434,"In patients experiencing an acute type A aortic dissection during the third trimester of pregnancy, urgent cesarean delivery imme- diately followed by aortic surgery is recom- mended.1-4","For patients in the third trimester of pregnancy with an acute type A aortic dissection, it is advised to perform an emergency cesarean section immediately followed by aortic surgery."
id_00035,"For children who have experienced a febrile seizure, administration of antipyretics such as acetaminophen, ibuprofen, or paracetamol is not effective for stopping a seizure or preventing a subsequent febrile seizure.","Administering antipyretics like acetaminophen, ibuprofen, or paracetamol to children who have had a febrile seizure does not halt the seizure or prevent future febrile seizures."
id_00995,"In patients with symptomatic anterior circulation cerebral infarction or TIA who are candidates for revascularization, noninva- sive cervical carotid imaging with carotid ultrasonography, CT angiography (CTA), or magnetic resonance angiography (MRA) is recommended to screen for stenosis.46–50","For patients experiencing symptomatic anterior circulation stroke or TIA who qualify for revascularization, it is advised to use noninvasive cervical carotid imaging, such as carotid ultrasonography, CT angiography (CTA), or magnetic resonance angiography (MRA), to check for stenosis."
id_01954,"In patients with suspected low-flow, low- gradient severe AS with normal or reduced LVEF (Stages D2 and D3), calculation of the ratio of the outflow tract to aortic velocity is reasonable to further define severity.1,11–13","For patients suspected of having low-flow, low-gradient severe aortic stenosis with either normal or reduced left ventricular ejection fraction (Stages D2 and D3), it is reasonable to calculate the outflow tract to aortic velocity ratio to better assess severity."
id_01475,"In patients with CCD, chronic nonsteroidal anti-inflammatory drugs should not be used because of increased cardiovascular and bleeding complications.*22 Antiplatelet Therapy With Direct Oral Anticoagulant (DOAC)","For patients with CCD, avoid using chronic nonsteroidal anti-inflammatory drugs due to heightened risks of cardiovascular and bleeding issues.*22 Antiplatelet Therapy With Direct Oral Anticoagulant (DOAC)"
id_00036,The person having the seizure should not be restrained.,Do not hold down the individual experiencing the seizure.
id_01955,"In patients with suspected low-flow, low- gradient severe AS with normal or reduced LVEF (Stages D2 and D3), measurement of aortic valve calcium score by CT imaging is reasonable to further define severity.14–18","For patients suspected of having low-flow, low-gradient severe aortic stenosis with either normal or decreased left ventricular ejection fraction (Stages D2 and D3), it is advisable to use CT imaging to measure the aortic valve calcium score to better assess severity."
id_02435,"In patients experiencing an acute type B aortic dissection during pregnancy, medical therapy is recommended, unless endovascular or surgical therapy is required to manage acute complications.5","For pregnant patients with an acute type B aortic dissection, medical treatment is advised unless endovascular or surgical intervention is necessary to address acute complications."
id_00996,"In patients suspected of having a stroke or TIA, CT or MRI of the brain is recommended to confirm the diagnosis of symptomatic ischemic cerebral vascular disease.51–53","For patients suspected of experiencing a stroke or TIA, it is advised to perform a CT or MRI of the brain to verify the diagnosis of symptomatic ischemic cerebrovascular disease."
id_01476,"In patients with CCD who have undergone elective PCI and who require oral anticoagulant therapy, DAPT for 1 to 4 weeks followed by clopidogrel alone for 6 months should be administered in addition to DOAC.†23","For patients with CCD who have had elective PCI and need oral anticoagulant therapy, administer DAPT for 1 to 4 weeks, then continue with clopidogrel alone for 6 months, alongside DOAC."
id_01956,"In asymptomatic patients with severe AS (Stage C1), exercise testing is reasonable to assess physiological changes with exercise and to confirm the absence of symptoms.1–4","For patients with severe AS (Stage C1) who show no symptoms, it is appropriate to conduct exercise testing to evaluate physiological responses during exercise and verify the lack of symptoms."
id_00037,"Nothing should be put in the mouth and no food, liquids, or oral medicines should be given to a person who is experiencing a seizure or who has decreased responsiveness after a seizure. Recommendation-Specific Supportive Text","Do not place anything in the mouth or provide food, drinks, or oral medications to someone having a seizure or who is less responsive following a seizure."
id_02436,"In patients with progressive aortic dilation during pregnancy, prophylactic aortic surgery may be considered, depending on individual circumstances.1,2,4","For pregnant patients experiencing progressive aortic enlargement, preventive aortic surgery might be an option, contingent upon specific individual factors."
id_00997,"In patients with a confirmed diagnosis of symptomatic ischemic cerebrovascular disease, blood tests, including complete blood count, prothrombin time, partial throm- boplastin time, glucose, HbA1c, creatinine, and fasting or nonfasting lipid profile, are recommended to gain insight into risk factors for stroke and to inform therapeutic goals.54,55","For individuals diagnosed with symptomatic ischemic cerebrovascular disease, it is advised to conduct blood tests such as a complete blood count, prothrombin time, partial thromboplastin time, glucose, HbA1c, creatinine, and either fasting or nonfasting lipid profile to assess stroke risk factors and guide treatment objectives."
id_01957,"In symptomatic patients with severe AS (Stage D1, aortic velocity ≥4.0 m/s or mean pressure gradient ≥40 mm Hg), exercise testing should not be performed because of the risk of severe hemodynamic compromise.5","Exercise testing is contraindicated in symptomatic patients with severe AS (Stage D1, aortic velocity of 4.0 m/s or higher, or mean pressure gradient of 40 mm Hg or more) due to the potential for significant hemodynamic instability."
id_00038,"For a person with suspected hypoglycemia who is awake and able to swallow, the first aid provider should encourage the person to swallow oral glucose.","If someone is suspected of having hypoglycemia and is conscious with the ability to swallow, the first aid responder should prompt them to ingest oral glucose."
id_01477,"In patients with CCD who have undergone PCI and who require oral anticoagulant therapy, continuing aspirin in addition to clopidogrel for up to 1 month is reasonable if the patient has a high thrombotic risk and low bleeding risk.*23–25","For patients with CCD who have had PCI and need oral anticoagulant therapy, it is reasonable to maintain aspirin alongside clopidogrel for up to one month if the patient presents a high risk of thrombosis and a low risk of bleeding.*23–25"
id_02437,"In patients with large vessel vasculitis (LVV), prompt evaluation of the entire aorta and branch vessels with MRI or CT, with or without 18F-FDG positron emission tomography (FDG-PET), is ­recommended.1-6 Treatment","For patients diagnosed with large vessel vasculitis (LVV), it is advised to quickly assess the full aorta and its branch vessels using MRI or CT, optionally combined with 18F-FDG positron emission tomography (FDG-PET)."
id_00998,"In patients with cryptogenic stroke, echocar- diography with or without contrast is reason- able to evaluate for possible cardiac sources of or transcardiac pathways for cerebral embolism.56,57","For patients experiencing cryptogenic stroke, it is advisable to perform echocardiography, with or without contrast, to assess potential cardiac origins or transcardiac routes for cerebral embolism."
id_02438,"In patients with active GCA or Takayasu arteri- tis, initial medical therapy should include high- dose glucocorticoids.7-12","For patients with active GCA or Takayasu arteritis, treatment should start with high-dose glucocorticoids."
id_01478,"In patients with CCD who require oral anticoagula- tion and have a low atherothrombotic risk, discon- tinuation of aspirin therapy with continuation of DOAC alone may be considered 1 year after PCI to reduce bleeding risk.*26","For patients with CCD needing oral anticoagulation and presenting a low risk of atherothrombosis, it may be advisable to stop aspirin and continue only DOAC one year post-PCI to minimize bleeding risk."
id_01958,"In patients at risk of developing AS (Stage A) and in patients with asymptomatic AS (Stages B and C), hypertension should be treated according to standard GDMT, started at a low dose, and gradually titrated upward as needed, with appropriate clinical monitoring.1–3","For patients at risk of AS (Stage A) and those with asymptomatic AS (Stages B and C), hypertension management should follow standard GDMT, beginning with a low dose and gradually increasing as necessary, accompanied by suitable clinical monitoring."
id_00039,"EMS should be activated for a person with hypoglycemia who is unable to swallow, has a seizure, or does not improve within 10 minutes of oral glucose administration.","Emergency medical services should be called for an individual experiencing hypoglycemia if they cannot swallow, experience a seizure, or do not show improvement within 10 minutes after receiving oral glucose."
id_01959,"In all patients with calcific AS, statin therapy is indicated for primary and secondary prevention of atherosclerosis on the basis of standard risk scores.4–6","For all patients with calcific AS, statin therapy is recommended for both primary and secondary prevention of atherosclerosis, based on standard risk assessments."
id_01479,"In patients with CCD who require oral anticoagula- tion, DOAC monotherapy may be considered if there is no acute indication for concomitant anti- platelet therapy.27–29 Antiplatelet Therapy and Low-Dose DOAC","For patients with CCD needing oral anticoagulation, DOAC alone can be an option if there is no urgent need for additional antiplatelet therapy."
id_00040,"If they are available, it is reasonable to use oral glucose tablets in preference to gel or dietary sources of glucose to treat hypoglycemia.","When accessible, oral glucose tablets are a preferable choice over gel or food sources of glucose for managing hypoglycemia."
id_02439,"In patients with GCA who have evidence of active aortitis, tocilizumab is recommended as adjunctive therapy to glucocorticoids, with methotrexate as an alternative.7,13,14","For patients with GCA showing signs of active aortitis, it is advised to use tocilizumab alongside glucocorticoids, with methotrexate as an alternative option."
id_00999,"In patients with cryptogenic stroke who do not have a contraindication to anticoagula- tion, long-term rhythm monitoring with mobile cardiac outpatient telemetry, implantable loop recorder, or other approach is reasonable to detect intermittent AF.58–60","For patients with cryptogenic stroke without contraindications to anticoagulation, it is reasonable to use long-term rhythm monitoring, such as mobile cardiac outpatient telemetry or an implantable loop recorder, to identify intermittent atrial fibrillation."
id_02440,"In all patients with Takayasu arteritis, non- biological disease-modifying anti-rheumatic drugs (DMARD) should be given in combina- tion with glucocorticoids.7,15,16","For every patient with Takayasu arteritis, glucocorticoids should be administered alongside non-biological disease-modifying anti-rheumatic drugs (DMARDs)."
id_01000,"In patients suspected of having ischemic stroke, if CT or MRI does not demonstrate symptomatic cerebral infarct, follow-up CT or MRI of the brain is reasonable to confirm diagnosis.61–65","For patients suspected of ischemic stroke, if initial CT or MRI does not show a symptomatic cerebral infarct, it is reasonable to perform a follow-up CT or MRI of the brain to confirm the diagnosis."
id_00041,It is reasonable to use simple dietary sugars as an alternative if glucose tablets or gel is not available to treat hypoglycemia.,"If glucose tablets or gel are unavailable for treating hypoglycemia, using simple dietary sugars is a sensible alternative."
id_01960,"In patients who have undergone TAVI, renin–angiotensin system blocker therapy (ACE inhibitor or ARB) may be considered to reduce the long-term risk of all-cause mortality.7,8","For patients who have received TAVI, considering therapy with renin–angiotensin system blockers, such as ACE inhibitors or ARBs, may help lower the long-term risk of death from any cause."
id_01480,"In patients with CCD without an indication for ther- apeutic DOAC or DAPT and who are at high risk of recurrent ischemic events but low-to-moderate bleeding risk, the addition of low-dose rivaroxaban 2.5 mg twice daily to aspirin 81 mg daily is reason- able for long-term reduction of risk for MACE.30–32 DAPT and Proton Pump Inhibitor (PPI)","For patients with CCD who do not require therapeutic DOAC or DAPT and are at high risk for recurrent ischemic events but have a low-to-moderate bleeding risk, it is reasonable to add low-dose rivaroxaban 2.5 mg twice daily to aspirin 81 mg daily for long-term reduction of MACE risk."
id_01961,"In patients with calcific AS (Stages B and C), statin therapy is not indicated for prevention of hemodynamic progression of AS.4–6","For patients with calcific AS in Stages B and C, statin treatment is not recommended to prevent the hemodynamic progression of AS."
id_01481,"In patients with CCD on DAPT, the use of a PPI can be effective in reducing gastrointestinal bleed- ing risk.*33 *Modified from the 2016 ACC/AHA Guideline Focused Update on DAPT.34 †Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.35","For patients with CCD undergoing DAPT, administering a PPI may effectively lower the risk of gastrointestinal bleeding."
id_01001,"In patients suspected of having had a TIA, if the initial head imaging (CT or MRI) does not demonstrate a symptomatic cerebral infarct, follow-up MRI is reasonable to predict risk of early stroke and to support the diagnosis.66–69","For patients suspected of experiencing a TIA, if the initial CT or MRI does not show a symptomatic cerebral infarct, a follow-up MRI is advisable to assess early stroke risk and aid in diagnosis."
id_02441,"In patients with active GCA or Takayasu arteritis, treatment efficacy should be periodically assessed by monitoring inflam- matory serum markers (C-reactive protein and erythrocyte sedimentation rate), imag- ing with CT, MRI, or FDG-PET, and clinical symptoms.1,7,15,17-20","For patients with active GCA or Takayasu arteritis, the effectiveness of treatment should be regularly evaluated by checking inflammatory serum markers such as C-reactive protein and erythrocyte sedimentation rate, utilizing imaging techniques like CT, MRI, or FDG-PET, and observing clinical symptoms."
id_00042,"For children with suspected hypoglycemia who are awake but unwilling or unable to swallow glucose, it may be reasonable to apply a slurry of granulated sugar and water under the tongue.","For children suspected of having hypoglycemia who are conscious but refuse or cannot swallow glucose, it might be appropriate to place a mixture of granulated sugar and water beneath the tongue."
id_01962,"In adults with severe high-gradient AS (Stage D1) and symptoms of exertional dyspnea, HF, angina, syncope, or presyncope by history or on exercise testing, AVR is indicated.1–7","For adults experiencing severe high-gradient aortic stenosis (Stage D1) with symptoms such as exertional shortness of breath, heart failure, chest pain, fainting, or near-fainting, aortic valve replacement is recommended."
id_02442,"In patients with GCA or Takayasu arteritis who are in remission, elective endovascular or open surgical intervention is reasonable to treat aortic and branch vessel complica- tions.7,21","For patients with GCA or Takayasu arteritis in remission, it is appropriate to consider elective endovascular or open surgical procedures to address complications involving the aorta and its branches."
id_01002,"In patients with cryptogenic stroke, tests for inherited or acquired hypercoagulable state, bloodstream or cerebral spinal fluid infections, infections that can cause central nervous system (CNS) vasculitis (eg, HIV and syphilis), drug use (eg, cocaine and amphetamines), and markers of systemic inflammation and genetic tests for inherited diseases associated with stroke are reason- able to perform as clinically indicated to identify contributors to or relevant risk factors for stroke.70–72","For patients experiencing cryptogenic stroke, it is appropriate to conduct tests for inherited or acquired hypercoagulable conditions, bloodstream or cerebrospinal fluid infections, infections that may lead to CNS vasculitis (such as HIV and syphilis), drug use (including cocaine and amphetamines), systemic inflammation markers, and genetic tests for hereditary diseases linked to stroke, as clinically warranted to identify potential contributors or risk factors."
id_00043,"If a person experiences signs or symptoms of presyncope (including pallor, sweating, lightheadedness, visual changes, and weakness) of vasovagal or orthostatic origin, that person should maintain or assume a safe position such as assisted sitting or lying down.","If an individual shows signs or symptoms of presyncope, such as pallor, sweating, lightheadedness, visual disturbances, or weakness, due to vasovagal or orthostatic causes, they should remain in or move to a secure position like assisted sitting or lying down."
id_01482,"In patients with CCD and LVEF ≤40% with or without previous MI, the use of beta-blocker ther- apy is recommended to reduce the risk of future MACE, including cardiovascular death.1–3","For patients with CCD and an LVEF of 40% or less, regardless of prior MI history, beta-blocker therapy is advised to lower the risk of future MACE, such as cardiovascular death."
id_01003,"In patients with ischemic stroke or TIA, noninvasive imaging of the intracranial large arteries and imaging of the extracranial vertebrobasilar arterial system with MRA or CTA can be effective to identify atheroscle- rotic disease, dissection, moyamoya, or other etiologically relevant vasculopathies.73–75","For patients experiencing an ischemic stroke or TIA, utilizing MRA or CTA for noninvasive imaging of the intracranial large arteries and the extracranial vertebrobasilar arterial system can effectively detect atherosclerotic disease, dissection, moyamoya, or other relevant vasculopathies."
id_01963,"In asymptomatic patients with severe AS and an LVEF <50% (Stage C2), AVR is indicated.8–11","For asymptomatic individuals with severe aortic stenosis and a left ventricular ejection fraction below 50% (Stage C2), aortic valve replacement is recommended."
id_01483,"In patients with CCD and LVEF <50%, the use of sustained release metoprolol succinate, carvedilol, or bisoprolol with titration to target doses is recom- mended in preference to other beta blockers.*1,3–8","For patients with CCD and an LVEF below 50%, it is advised to use sustained release metoprolol succinate, carvedilol, or bisoprolol, titrated to target doses, rather than other beta blockers."
id_00044,"Once the person with presyncope is in a safe position, it can be beneficial for that person to use physical PCMs to avoid syncope.","After ensuring the individual with presyncope is safely positioned, employing physical PCMs may help prevent syncope."
id_02443,"In patients with infectious aortitis and associ- ated aneurysms or dissection of the thoracic or abdominal aorta, open surgical repair is recommended.","For patients with infectious aortitis accompanied by aneurysms or dissection of the thoracic or abdominal aorta, open surgical repair is advised."
id_01964,"In asymptomatic patients with severe AS (Stage C1) who are undergoing cardiac surgery for other indications, AVR is indicated.12–16","For asymptomatic patients with severe aortic stenosis (Stage C1) who are having cardiac surgery for other reasons, aortic valve replacement is recommended."
id_01484,"In patients with CCD who were initiated on beta- blocker therapy for previous MI without a history of or current LVEF ≤50%, angina, arrhythmias, or uncontrolled hypertension, it may be reasonable to reassess the indication for long-term (>1 year) use of beta-blocker therapy for reducing MACE.9–15","For patients with CCD who started beta-blocker treatment after a previous MI and do not have a history of or current LVEF ≤50%, angina, arrhythmias, or uncontrolled hypertension, reconsidering the necessity of beta-blocker therapy for more than one year to reduce MACE might be appropriate."
id_01004,"In patients with ischemic stroke and a treatment plan that includes anticoagulant therapy, CT or MRI of the brain before therapy is started may be considered to assess for hemorrhagic transformation and final size of infarction.76","For patients with ischemic stroke who are planned to receive anticoagulant therapy, it may be advisable to perform a CT or MRI of the brain prior to starting treatment to evaluate for hemorrhagic transformation and determine the final infarct size."
id_00045,Lower-body PCMs may be preferable to upper-body and abdominal PCMs in first aid for presyncope.,"For first aid in presyncope, lower-body PCMs might be more advantageous than those applied to the upper body or abdomen."
id_01005,"In patients with ESUS, transesophageal echocardiography (TEE), cardiac CT, or cardiac MRI might be reasonable to identify possible cardioaortic sources of or transcardiac pathways for cerebral embolism.57,77–79","For patients with ESUS, it may be appropriate to use transesophageal echocardiography (TEE), cardiac CT, or cardiac MRI to detect potential cardioaortic origins or transcardiac routes for cerebral embolism."
id_01965,"In symptomatic patients with low-flow, low- gradient severe AS with reduced LVEF (Stage D2), AVR is recommended.17–24","For patients exhibiting symptoms of low-flow, low-gradient severe aortic stenosis with decreased left ventricular ejection fraction (Stage D2), aortic valve replacement is advised."
id_02444,"In patients with infectious aortitis compli- cated by rupture, either open or endovas- cular repair is reasonable, based on the patient’s status at presentation and institu- tional expertise.","For patients with infectious aortitis complicated by rupture, choosing either open or endovascular repair is appropriate, depending on the patient's condition at presentation and the expertise available at the institution."
id_02445,"In patients with infectious aortitis, intravenous antimicrobial therapy of at least 6 weeks’ duration may be considered, with lifelong sup- pressive therapy in select cases not amenable to interventional repair or who have recurrent infection.","For patients with infectious aortitis, a minimum of six weeks of intravenous antimicrobial treatment can be considered, with lifelong suppressive therapy for those who cannot undergo interventional repair or experience recurrent infections."
id_00046,"If no improvement occurs within 1 to 2 minutes, if syncope occurs, or if symptoms worsen or reoccur, the first aid provider should activate emergency services.","If there is no improvement within 1 to 2 minutes, if fainting happens, or if symptoms deteriorate or return, the first aid provider should call emergency services."
id_01485,"In patients with CCD without previous MI or LVEF ≤50%, the use of beta-blocker therapy is not ben- eficial in reducing MACE, in the absence of another primary indication for beta-blocker therapy.†16–19 *Modified from the 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.20 †Adapted from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.21","For patients with CCD who have not experienced a prior MI and have an LVEF greater than 50%, beta-blocker therapy does not effectively lower MACE unless there is another primary reason to prescribe beta-blockers."
id_01966,"In symptomatic patients with low-flow, low- gradient severe AS with normal LVEF (Stage D3), AVR is recommended if AS is the most likely cause of symptoms.25–27","For patients exhibiting symptoms with low-flow, low-gradient severe aortic stenosis and normal left ventricular ejection fraction (Stage D3), aortic valve replacement is advised if aortic stenosis is the probable cause of the symptoms."
id_01006,"In patients with ischemic stroke or TIA in whom patent foramen ovale (PFO) closure would be contemplated, TCD (transcranial Doppler) with embolus detection might be reasonable to screen for right-to-left shunt.57,80","For patients who have experienced an ischemic stroke or TIA and are considering patent foramen ovale (PFO) closure, using transcranial Doppler (TCD) to detect emboli could be a reasonable method to screen for a right-to-left shunt."
id_01486,"In patients with CCD who also have hypertension, diabetes, LVEF ≤40%, or CKD, the use of ACE inhibitors, or ARBs if ACE inhibitor–intolerant, is recommended to reduce cardiovascular events.1–5","For patients with CCD who also suffer from hypertension, diabetes, LVEF ≤40%, or CKD, it is advised to use ACE inhibitors, or ARBs if they cannot tolerate ACE inhibitors, to lower the risk of cardiovascular events."
id_00047,"If a person experiences anaphylaxis due to a bee, wasp, or hornet sting and an epinephrine autoinjector is available, the person should self-administer the autoinjector.","In the event of anaphylaxis from a bee, wasp, or hornet sting, an individual should use an epinephrine autoinjector if one is accessible."
id_01487,"In patients with CCD without hypertension, dia- betes, or CKD and LVEF >40%, the use of ACE inhibitors or ARBs may be considered to reduce cardiovascular events. 6–10 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with CCD who do not have hypertension, diabetes, or CKD and have an LVEF greater than 40%, considering the use of ACE inhibitors or ARBs could help lower the risk of cardiovascular events."
id_02447,"In patients with an infected prosthetic aor- tic graft who are hemodynamically stable and have appropriate anatomy, it is reason- able to perform open surgery with either in situ reconstruction or extra-anatomic bypass.7-13","For patients with an infected aortic prosthetic graft who are hemodynamically stable and have suitable anatomy, open surgery with either in situ reconstruction or extra-anatomic bypass is a reasonable option."
id_02446,"In patients with a prosthetic aortic graft, who have signs and symptoms or culture evidence of unexplained infection or have unexplained gastrointestinal bleeding, cross-sectional imaging is reasonable to evaluate for an underlying aortic graft infection.1-6 Treatment","For patients with a prosthetic aortic graft experiencing unexplained infection symptoms, culture evidence of infection, or unexplained gastrointestinal bleeding, it is advisable to use cross-sectional imaging to assess for a potential aortic graft infection."
id_00048,A first aid provider should assist a person experiencing anaphylaxis to use the autoinjector if assistance is required.,"If help is needed, a first aid provider ought to aid an individual undergoing anaphylaxis in using the autoinjector."
id_01967,"In apparently asymptomatic patients with severe AS (Stage C1) and low surgical risk, AVR is reasonable when an exercise test demonstrates decreased exercise tolerance (normalized for age and sex) or a fall in systolic blood pressure of ≥10 mm Hg from baseline to peak exercise.13,28–30","For patients with severe AS (Stage C1) who appear asymptomatic and have low surgical risk, it is reasonable to consider AVR if an exercise test shows reduced exercise tolerance (adjusted for age and sex) or a drop in systolic blood pressure of ≥10 mm Hg from baseline to peak exercise."
id_01007,"In patients with stroke and TIA, it is reason- able to counsel individuals to follow a Mediterranean-type diet, typically with empha- sis on monounsaturated fat, plant-based foods, and fish consumption, with either high extra virgin olive oil or nut supplementation, in preference to a low-fat diet, to reduce risk of recurrent stroke.95,96","For patients who have experienced a stroke or TIA, advising them to adopt a Mediterranean-style diet—focusing on monounsaturated fats, plant-based foods, and fish, along with high extra virgin olive oil or nut supplementation—is preferable to a low-fat diet to lower the risk of another stroke."
id_01488,"In patients with CCD, the addition of colchicine for secondary prevention may be considered to reduce recurrent ASCVD events.1,2","For individuals with CCD, considering colchicine as an adjunct for secondary prevention could help decrease the recurrence of ASCVD events."
id_01008,"In patients with stroke or TIA and hypertension who are not currently restricting their dietary sodium intake, it is reasonable to recommend that individuals reduce their sodium intake by at least 1g/d sodium (2.5 g/d salt) to reduce the risk of cardiovascular disease (CVD) events (including stroke).97,98","For patients with stroke or TIA and hypertension who are not limiting their dietary sodium, it is advisable to suggest reducing sodium consumption by at least 1g per day (equivalent to 2.5g of salt daily) to lower the risk of cardiovascular events, including stroke."
id_00049,"If a person experiences anaphylaxis due to a bee, wasp, or hornet sting, the emergency response system should be activated.","In the event of anaphylaxis from a bee, wasp, or hornet sting, the emergency response system must be contacted."
id_01968,"In asymptomatic patients with very severe AS (defined as an aortic velocity of ≥5 m/s) and low surgical risk, AVR is reasonable.15,31–35","For asymptomatic individuals with extremely severe aortic stenosis, characterized by an aortic velocity of 5 m/s or higher, and who have a low risk for surgery, aortic valve replacement is a reasonable option."
id_02448,"In patients with an infected prosthetic aortic graft who are hemodynamically unstable, it is reasonable to perform open surgery with either explant or in situ ­reconstruction.7","For patients with an infected prosthetic aortic graft who are hemodynamically unstable, open surgery involving either explantation or in situ reconstruction is a reasonable approach."
id_00050,Stings to the eye should be evaluated by a trained medical professional.,Eye stings require assessment by a qualified healthcare provider.
id_01489,"In patients with CCD, an annual influenza vaccina- tion is recommended to reduce cardiovascular mor- bidity, cardiovascular death, and all-cause death.1–7","For individuals with CCD, it is advised to receive a yearly flu vaccine to decrease the risk of cardiovascular complications, cardiovascular mortality, and overall mortality."
id_01969,"In apparently asymptomatic patients with severe AS (Stage C1) and low surgical risk, AVR is reasonable when the serum B-type natriuretic peptide (BNP) level is >3 times normal.32,36–38","For patients with severe AS (Stage C1) who show no symptoms and have low surgical risk, it is reasonable to consider AVR if the serum B-type natriuretic peptide (BNP) level exceeds three times the normal value."
id_02449,"In patients with an infected prosthetic aortic graft, endovascular therapy is reasonable, either as bridge therapy in those with hemo- dynamic instability or as long-term therapy in those who are unsuitable candidates for open surgery.13-15 Late Management","For patients with an infected prosthetic aortic graft, endovascular treatment is a viable option, either as interim therapy for those experiencing hemodynamic instability or as a long-term solution for those who cannot undergo open surgery."
id_01009,"In patients with stroke or TIA who are capable of physical activity, engaging in at least moderate- intensity aerobic activity for a minimum of 10 min- utes 4 times a week or vigorous-intensity aerobic activity for a minimum of 20 minutes twice a week is indicated to lower the risk of recurrent stroke and the composite cardiovascular end point of recurrent stroke, MI, or vascular death.110","For patients who have experienced a stroke or TIA and can participate in physical exercise, it is recommended to perform moderate-intensity aerobic activity for at least 10 minutes, four times weekly, or vigorous-intensity aerobic activity for at least 20 minutes, twice weekly, to reduce the risk of another stroke and the combined cardiovascular outcomes of recurrent stroke, myocardial infarction, or vascular death."
id_01490,"In patients with CCD, coronavirus disease 2019 (COVID-19) vaccination is recommended per public health guidelines to reduce COVID-19 com- plications.8–10","For individuals with CCD, it is advised to follow public health guidelines for COVID-19 vaccination to minimize complications from the virus."
id_01970,"In asymptomatic patients with high-gradient severe AS (Stage C1) and low surgical risk, AVR is reasonable when serial testing shows an increase in aortic velocity ≥0.3 m/s per year.39,40","For asymptomatic patients with high-gradient severe AS (Stage C1) and low surgical risk, it is reasonable to consider AVR if serial tests indicate an annual increase in aortic velocity of at least 0.3 m/s."
id_02450,"In patients who have undergone treatment of an acute prosthetic aortic graft infection, targeted intravenous antimicrobial therapy of at least 6 weeks’ duration, with prolonged suppressive oral therapy in select cases, plus a consultation and follow-up with an infectious disease specialist, is recommen ded.7,11,12,16,17","For patients treated for an acute infection of a prosthetic aortic graft, it is advised to administer targeted intravenous antimicrobial therapy for a minimum of 6 weeks, followed by extended suppressive oral therapy in certain cases, along with consultation and ongoing monitoring by an infectious disease specialist."
id_01010,"In patients with stroke or TIA who are able and willing to increase physical activity, engaging in an exercise class that includes counseling to change physical activity behavior can be beneficial for reducing cardiometabolic risk fac- tors and increasing leisure time physical activity participation.111–114","For patients who have experienced a stroke or TIA and are open to enhancing their physical activity, participating in an exercise class that incorporates counseling to modify physical activity behavior can help lower cardiometabolic risk factors and boost involvement in leisure physical activities."
id_00051,Removal of a stinger remaining in the skin as soon as possible by plucking or scraping can be beneficial.,Prompt removal of a stinger left in the skin by plucking or scraping may be advantageous.
id_01491,"In patients with CCD, a pneumococcal vaccine is reasonable to reduce cardiovascular morbidity and mortality and all-cause death.11–13","For patients with CCD, administering a pneumococcal vaccine is advisable to decrease cardiovascular morbidity, mortality, and overall mortality."
id_01971,"In asymptomatic patients with severe high- gradient AS (Stage C1) and a progressive decrease in LVEF on at least 3 serial imaging studies to <60%, AVR may be considered.8–11,33","For asymptomatic patients with severe high-gradient AS (Stage C1) experiencing a progressive decline in LVEF to below 60% across at least three consecutive imaging studies, AVR can be considered."
id_00052,Over-the-counter oral antihistamines can be used to alleviate local itching.,Oral antihistamines available without a prescription may be taken to relieve localized itching.
id_01011,"In patients with deficits after stroke that impair their ability to exercise, supervision of an exercise program by a health care professional such as a physical therapist or cardiac reha- bilitation professional, in addition to routine rehabilitation, can be beneficial for secondary stroke prevention.","For patients with post-stroke impairments affecting their exercise capacity, having a health care professional like a physical therapist or cardiac rehabilitation specialist oversee an exercise regimen, alongside standard rehabilitation, may aid in preventing a secondary stroke."
id_02451,"In patients with an infected prosthetic aor- tic graft and either an extensive perigraft abscess or an infection caused by methicillin- resistant S. aureus, Pseudomonas aeruginosa, or a multidrug-resistant microorganism, or who have undergone in situ reconstruction, lifelong suppressive oral antimicrobial therapy may be considered after the initial course of therapy.14,15,18,19","For patients with an infected aortic prosthetic graft accompanied by a large perigraft abscess, or an infection due to methicillin-resistant S. aureus, Pseudomonas aeruginosa, or a multidrug-resistant organism, or those who have had in situ reconstruction, lifelong suppressive oral antimicrobial therapy might be considered following the initial treatment course."
id_00053,Topical corticosteroids can be used to alleviate local itching.,Local itching can be relieved by applying topical corticosteroids.
id_01972,"In patients with moderate AS (Stage B) who are undergoing cardiac surgery for other indications, AVR may be considered.","For patients with moderate aortic stenosis (Stage B) undergoing cardiac surgery for other reasons, considering AVR is an option."
id_01492,"In patients with CCD and angina, antianginal therapy with either a beta blocker, CCB, or long- acting nitrate is recommended for relief of angina or equivalent symptoms.*1–3","For patients with CCD and angina, it is advised to use antianginal treatment with a beta blocker, calcium channel blocker, or long-acting nitrate to alleviate angina or similar symptoms."
id_01012,"In individuals with stroke or TIA who sit for long periods of uninterrupted time during the day, it may be reasonable to recommend breaking up sedentary time with intervals as short as 3 minutes of standing or light exer- cise every 30 minutes for their cardiovascular health.115","For those who have experienced a stroke or TIA and remain seated for extended periods during the day, it might be advisable to interrupt sedentary behavior with brief intervals of standing or light exercise, lasting at least 3 minutes every half hour, to benefit cardiovascular health."
id_02452,"In patients with aortic atherosclerotic disease and concomitant coronary artery disease, PAD or both, it is recommended to prescribe antiplatelet therapy, anticoagu- lant therapy or both, guided by the clinical ­setting.1-3","For patients with aortic atherosclerotic disease who also have coronary artery disease, peripheral artery disease, or both, it is advised to administer antiplatelet therapy, anticoagulant therapy, or a combination of both, depending on the clinical context."
id_01493,"In patients with CCD and angina who remain symptomatic after initial treatment, addition of a second antianginal agent from a different thera- peutic class (beta blockers, CCB, long-acting nitrates) is recommended for relief of angina or equivalent symptoms.*3–6","For patients with CCD and angina who continue to experience symptoms after initial therapy, it is advised to add a second antianginal medication from a different therapeutic class, such as beta blockers, calcium channel blockers, or long-acting nitrates, to alleviate angina or similar symptoms."
id_02453,"In patients with aortic atherosclerotic disease and risk factors for confirmed coronary artery disease, it is reasonable to prescribe a moderate- or high-intensity statin.4-6","For patients with aortic atherosclerosis and risk factors for confirmed coronary artery disease, prescribing a moderate- or high-intensity statin is advisable."
id_00054,"It is reasonable to wash the area of a bee, wasp, or hornet sting with soap and water.","Washing the site of a bee, wasp, or hornet sting with soap and water is advisable."
id_01013,"In patients with stroke or TIA who smoke tobacco, counseling with or without drug therapy (nicotine replacement, bupropion, or varenicline) is recommended to assist in quit- ting smoking.139–142","For patients who have experienced a stroke or TIA and use tobacco, it is advised to provide counseling, with or without pharmacotherapy such as nicotine replacement, bupropion, or varenicline, to aid in smoking cessation."
id_01973,"In patients with an indication for AVR, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.","For patients requiring AVR, selecting a prosthetic valve should involve a collaborative decision-making approach that considers the patient's values and preferences, while discussing the indications and risks of anticoagulant therapy, as well as the potential need for and risks of valve reintervention."
id_01014,"Patients with stroke or TIA who continue to smoke tobacco should be advised to stop smoking (and, if unable, to reduce their daily smoking) to lower the risk of recurrent stroke.143–146","Patients who have experienced a stroke or TIA and still smoke should be counseled to quit smoking, or at least cut down their daily intake if quitting is not possible, to decrease the likelihood of another stroke."
id_01974,"For patients of any age requiring AVR for whom VKA anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a bioprosthetic","For patients of any age needing AVR who cannot use VKA anticoagulant therapy due to contraindications, improper management, or personal preference, a bioprosthetic is recommended."
id_00055,Administration of over-the-counter acetaminophen and nonsteroidal anti-inflammatory agents may be considered to alleviate local pain.,Consider using over-the-counter acetaminophen and NSAIDs to relieve localized pain.
id_01494,"In patients with CCD, ranolazine is recommended in patients who remain symptomatic despite treatment with beta blockers, CCB, or long- acting nitrate therapies.*7,8","For patients with CCD who continue to experience symptoms despite using beta blockers, calcium channel blockers, or long-acting nitrates, ranolazine is advised."
id_01015,In patients with stroke or TIA. avoidance of environmental (passive) tobacco smoke is recommended to reduce risk of recurrent stroke.147–150,"For individuals who have experienced a stroke or TIA, it is advised to avoid exposure to secondhand tobacco smoke to lower the risk of another stroke."
id_02454,"In patients with aortic atheromas of a thick- ness ≥4 mm, statin therapy may be reason- able.1,7-9",Statin therapy could be considered for patients with aortic atheromas measuring 4 mm or more in thickness.
id_01975,"For patients <50 years of age who do not have a contraindication to anticoagulation and require AVR, it is reasonable to choose a mechanical aortic prosthesis over a bioprosthetic valve.1","For patients under 50 years old without contraindications to anticoagulation, opting for a mechanical aortic valve instead of a bioprosthetic one is advisable when AVR is needed."
id_01495,"In patients with CCD, sublingual nitroglycerin or nitroglycerin spray is recommended for immediate short-term relief of angina or equivalent symp- toms.*9,10","For patients with CCD, it is advised to use sublingual nitroglycerin or nitroglycerin spray for prompt short-term alleviation of angina or similar symptoms."
id_00056,Administration of ice or cold packs may be con- sidered for local pain relief. Recommendation-Specific Supportive Text,Applying ice or cold packs can be considered for alleviating localized pain.
id_02455,"In patients with CoA, including those who have undergone surgical or endovascular intervention, an MRI or CT is recommended for initial, surveillance, and follow-up aortic imaging.1-4","For patients with CoA, whether they have had surgical or endovascular treatment, an MRI or CT is advised for initial, ongoing, and follow-up imaging of the aorta."
id_01016,"Patients with ischemic stroke or TIA who drink >2 alcoholic drinks a day for men or >1 alco- holic drink a day for women should be coun- seled to eliminate or reduce their consumption of alcohol to reduce stroke risk.141,161–163",Patients who have experienced an ischemic stroke or TIA and consume more than two alcoholic drinks daily for men or more than one for women should receive guidance to cut down or stop their alcohol intake to lower their risk of stroke.
id_02456,"In patients with CoA, BPs should be mea- sured in both arms and one of the lower extremities.","For patients with CoA, blood pressures should be taken in both arms and in one lower limb."
id_01976,"For patients 50 to 65 years of age who require AVR and who do not have a contraindication to anticoagulation, it is reasonable to individualize the choice of either a mechanical or bioprosthetic AVR with consideration of individual patient factors and after informed shared decision-making.1–10","For patients aged 50 to 65 needing AVR without anticoagulation contraindications, it is appropriate to tailor the decision between mechanical and bioprosthetic AVR based on personal patient factors and informed shared decision-making."
id_00057,Tick bites occurring in regions with high prevalence of Lyme disease should receive prompt consultation with a health care professional within 72 hours after removal of an engorged tick.,"In areas where Lyme disease is common, individuals should seek medical advice within 72 hours after removing an engorged tick."
id_01496,"In patients with CCD and normal LV function, the addition of ivabradine to standard anti-anginal therapy is potentially harmful.*11 *Modified from the 2012 ACC/AHA Multisociety Guideline for the Diagnosis and Management of Patients With SIHD.12","For patients with CCD who have normal LV function, incorporating ivabradine into standard anti-anginal treatment may be detrimental."
id_01497,"In patients with CCD, refractory angina, and no other treatment options, enhanced external coun- terpulsation may be considered for relief of symp- toms.*1 *Modified from the 2012 ACC/AHA Multisociety Guideline for the Diagnosis and Management of Patients With SIHD.2","For patients with CCD who experience refractory angina and have exhausted other treatment options, enhanced external counterpulsation can be considered to alleviate symptoms."
id_00058,We recommend removal of a tick as soon as possible.,We advise prompt extraction of a tick.
id_01977,"In patients >65 years of age who require AVR, it is reasonable to choose a bioprosthesis over a mechanical valve.1","For patients older than 65 needing AVR, opting for a bioprosthesis instead of a mechanical valve is advisable."
id_02457,"In patients with significant native or recurrent CoA (Table 37) and hypertension, endovascular stenting or open surgical repair of the coarcta- tion is ­recommended.2,3,5-12","For patients with notable native or recurrent CoA (Table 37) and hypertension, it is advised to perform endovascular stenting or open surgical repair of the coarctation."
id_01017,"In patients with stroke or TIA who use stimulants (eg, amphetamines, amphetamine derivatives, cocaine, or khat) and in patients with infective endocarditis (IE) in the context of intravenous drug use, it is recommended that health care providers inform them that this behavior is a health risk and counsel them to stop.","For patients who have experienced a stroke or TIA and use stimulants such as amphetamines, cocaine, or khat, as well as those with infective endocarditis related to intravenous drug use, healthcare providers should advise them of the associated health risks and recommend cessation of these behaviors."
id_01498,"In patients with CCD and lifestyle-limiting angina despite GDMT and with significant coronary artery stenoses amenable to revascularization, revascularization is recom- mended to improve symptoms.*1–7","For patients with CCD who experience lifestyle-limiting angina despite GDMT and have significant coronary artery stenoses that can be treated with revascularization, revascularization is advised to alleviate symptoms."
id_01018,"In patients with stroke or TIA who have a substance use disorder (drugs or alcohol), specialized services are recommended to help manage this dependency.","For patients with stroke or TIA who have a substance use disorder involving drugs or alcohol, it is advised to utilize specialized services to address this dependency."
id_01978,"In patients <50 years of age who prefer a bioprosthetic AVR and have appropriate anatomy, replacement of the aortic valve by a pulmonic autograft (the Ross procedure) may be considered at a Comprehensive Valve Center.11–13","For patients under 50 years old with suitable anatomy who opt for a bioprosthetic aortic valve replacement, the Ross procedure, involving the use of a pulmonic autograft, can be considered at a Comprehensive Valve Center."
id_02458,"In patients with CoA, guideline-directed medi- cal therapy is recommended for the treatment of hypertension.13","For patients with CoA, it is advised to use guideline-recommended medical treatment to manage hypertension."
id_00059,"To remove a tick, we recommend grasping the head of the tick as close to the skin as possible with tweezers or a commercial tick removal device and pulling upward with steady, even pressure. Recommendation-Specific Supportive Text","We advise using tweezers or a commercial tick removal tool to firmly grip the tick's head near the skin and apply consistent, upward pressure to extract it."
id_01499,"In patients with CCD who have significant left main disease or multivessel disease with severe LV dysfunction (LVEF ≤ 35%), CABG in addition to medical therapy is rec- ommended over medical therapy alone to improve survival.*8–11 Cost Value Statement: Intermediate Value B-NR","For patients with CCD experiencing significant left main disease or multivessel disease accompanied by severe LV dysfunction (LVEF ≤ 35%), it is advised to perform CABG alongside medical therapy rather than relying solely on medical therapy to enhance survival."
id_01019,"In patients with hypertension who experience a stroke or TIA, treatment with a thiazide diuretic, angiotensin-converting enzyme inhibitor, or angiotensin II receptor blockers is useful for lowering BP and reducing recurrent stroke risk.185–189","For patients with hypertension who have had a stroke or TIA, using a thiazide diuretic, an angiotensin-converting enzyme inhibitor, or angiotensin II receptor blockers is beneficial for lowering blood pressure and decreasing the risk of another stroke."
id_00060,"As soon as exposure to poison ivy, oak, or sumac is recognized, the exposed area should be washed with soap and water or a commercially available decontamination product.","Upon identifying contact with poison ivy, oak, or sumac, cleanse the affected skin with soap and water or use a commercial decontamination product."
id_02459,"In adult patients with CoA, screening for intracranial aneurysms by MRI or CT may be reasonable.14-18","For adult patients with CoA, it may be appropriate to screen for intracranial aneurysms using MRI or CT."
id_01979,"For symptomatic and asymptomatic patients with severe AS and any indication for AVR who are <65 years of age or have a life expectancy >20 years, SAVR is recommended.1–3","SAVR is advised for patients under 65 years old or those with a life expectancy exceeding 20 years, whether they show symptoms or not, if they have severe AS and any reason for AVR."
id_01020,"In patients with hypertension who experience a stroke or TIA, an office BP goal of <130/80 mm Hg is recommended for most patients to reduce the risk of recurrent stroke and vascu- lar events.185,190–194","For patients with hypertension who have had a stroke or TIA, it is advised to maintain an office blood pressure target of less than 130/80 mm Hg for most individuals to lower the risk of another stroke and vascular events."
id_01500,"In patients with CCD and multivessel CAD appropriate for either CABG or PCI, revascu- larization in addition to GDMT is reasonable to lower the risk of cardiovascular events such as spontaneous MI, unplanned urgent revascularizations, or cardiac death.*13–20","For patients with CCD and multivessel CAD who are suitable candidates for CABG or PCI, it is advisable to pursue revascularization alongside GDMT to reduce the likelihood of cardiovascular events, including spontaneous MI, unplanned urgent revascularizations, or cardiac death."
id_02460,"In patients discovered to have an ASCA in the absence of thoracic aortic imaging, dedicated imaging to assess for TAA is ­reasonable.1,2","For patients identified with an ASCA without prior thoracic aortic imaging, it is reasonable to perform dedicated imaging to evaluate for TAA."
id_01980,"For symptomatic patients with severe AS who are 65 to 80 years of age and have no anatomic contraindication to transfemoral TAVI, either SAVR or transfemoral TAVI is recommended after shared decision-making about the balance between expected patient longevity and valve durability.1,4–8","For patients aged 65 to 80 with severe AS and no anatomical barriers to transfemoral TAVI, it is advised to consider either SAVR or transfemoral TAVI following a shared decision-making process that evaluates the trade-off between anticipated patient lifespan and valve longevity."
id_00061,"The usefulness of over-the-counter topical steroids to alleviate local symptoms from poison ivy, oak, or sumac is uncertain.","The effectiveness of non-prescription topical steroids in relieving local symptoms caused by poison ivy, oak, or sumac is unclear."
id_01021,"In patients with hypertension who experience a stroke or TIA, individualized drug regimens that take into account patient comorbidities, agent pharmacological class, and patient preference are recommended to maximize drug efficacy.188,189,195,196","For patients with hypertension who suffer a stroke or TIA, it is advised to tailor drug regimens based on comorbidities, pharmacological class of the medication, and patient preferences to enhance drug effectiveness."
id_01501,"In selected patients with CCD and significant left main stenosis for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is reasonable to improve survival.*21 Decision-Making for Revascularization","For certain patients with CCD and notable left main stenosis, where PCI can achieve revascularization comparable to CABG, opting for PCI is a reasonable approach to enhance survival."
id_01981,"For symptomatic patients with severe AS who are >80 years of age or for younger patients with a life expectancy <10 years and no anatomic contraindication to transfemoral TAVI, transfemoral TAVI is recommended in preference to SAVR.1,4–10","For patients over 80 with severe AS who show symptoms, or for younger patients with a life expectancy under 10 years and no anatomical barriers to transfemoral TAVI, transfemoral TAVI is advised over SAVR."
id_00062,"Cool compresses may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.","Applying cool compresses can be an option to alleviate local symptoms caused by contact with poison ivy, oak, or sumac."
id_01022,"In patients with no history of hypertension who experience a stroke or TIA and have an aver- age office BP of ≥130/80 mm Hg, antihyper- tensive medication treatment can be beneficial to reduce the risk of recurrent stroke, ICH, and other vascular events.190,191,193,197","For patients without a history of hypertension who suffer a stroke or TIA and have an average office blood pressure of 130/80 mm Hg or higher, using antihypertensive medication may help lower the risk of another stroke, intracerebral hemorrhage, and other vascular events."
id_02461,"In patients with Kommerell’s diverticulum, depending on patient anatomy and comor- bidities, repair may be reasonable when the diverticulum orifice is >3.0 cm, the combined diameter of the diverticulum and adjacent descending aorta is >5.0 cm, or both (Figure 27).3","For patients with Kommerell’s diverticulum, it may be appropriate to consider repair if the orifice of the diverticulum exceeds 3.0 cm, the total diameter of the diverticulum and the nearby descending aorta is greater than 5.0 cm, or both, taking into account patient anatomy and comorbidities."
id_02462,"In patients with an aberrant left vertebral artery origin arising directly from the thoracic aorta who require aortic repair involving recon- struction or coverage of the vertebral artery origin, revascularization of the vertebral artery is reasonable.","For patients whose left vertebral artery originates anomalously from the thoracic aorta and need aortic repair that includes reconstructing or covering the vertebral artery origin, it is advisable to consider revascularizing the vertebral artery."
id_01982,"In asymptomatic patients with severe AS and an LVEF <50% who are ≤80 years of age and have no anatomic contraindication to transfemoral TAVI, the decision between TAVI and SAVR should follow the same recommendations as for symptomatic patients in Recommendations 1, 2, and 3 above.1,2,4–10","For asymptomatic patients with severe aortic stenosis (AS) and a left ventricular ejection fraction (LVEF) below 50% who are 80 years old or younger and have no anatomical barriers to transfemoral transcatheter aortic valve implantation (TAVI), the choice between TAVI and surgical aortic valve replacement (SAVR) should adhere to the same guidelines as those for symptomatic patients outlined in Recommendations 1, 2, and 3."
id_00063,"Oatmeal baths may be considered for relief of local symptoms from exposure to poison ivy, oak, or sumac.","Consider using oatmeal baths to alleviate localized symptoms caused by contact with poison ivy, oak, or sumac."
id_01023,"In patients with ischemic stroke with no known coronary heart disease, no major cardiac sources of embolism, and LDL cholesterol (LDL-C) >100 mg/dL, atorvastatin 80 mg daily is indicated to reduce risk of stroke recurrence.208,209","For patients who have experienced an ischemic stroke and do not have known coronary heart disease or significant cardiac embolism sources, and have LDL cholesterol levels exceeding 100 mg/dL, a daily dose of 80 mg atorvastatin is recommended to lower the risk of another stroke."
id_01503,"In patients with CCD with complex 3-vessel disease or for whom the optimal treatment strategy is unclear, a Heart Team approach that includes representatives from interven- tional cardiology and cardiac surgery is recom- mended to improve patient outcomes.*26–29 *Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.30","For patients with CCD who have complex 3-vessel disease or when the best treatment strategy is uncertain, it is advised to employ a Heart Team approach involving both interventional cardiology and cardiac surgery specialists to enhance patient outcomes."
id_01502,"In patients with CCD who have angina or an anginal equivalent, no previous evaluation for ischemia, and angiographically intermediate stenoses, the use of FFR or other proven nonhyperemic pressure ratios (eg, iFR) is recommended before proceeding with PCI.*2,22,23 Cost Value Statement: High Value B-NR","For patients with CCD experiencing angina or similar symptoms, who have not undergone prior ischemia evaluation and have angiographically intermediate stenoses, it is advised to use FFR or validated nonhyperemic pressure ratios like iFR before considering PCI."
id_01983,"For asymptomatic patients with severe AS and an abnormal exercise test, very severe AS, rapid progression, or an elevated BNP (COR 2a indications for AVR), SAVR is recommended in preference to TAVI.1–3,11","For patients with severe AS who are asymptomatic but have an abnormal exercise test, very severe AS, rapid progression, or high BNP levels (COR 2a indications for AVR), SAVR is advised over TAVI."
id_02463,"In patients with bovine arch (common innominate and left carotid artery), imaging to assess for TAA may be ­reasonable.1-3","For patients with a bovine arch (shared innominate and left carotid artery), it may be appropriate to perform imaging to evaluate for TAA."
id_00064,"The usefulness of over-the-counter antihistamines to alleviate local symptoms from poison ivy, oak, or sumac is uncertain. Recommendation-Specific Supportive Text","The effectiveness of non-prescription antihistamines in relieving localized symptoms caused by poison ivy, oak, or sumac is unclear."
id_01504,"In patients with CCD who require revascularization for significant left main involvement associated with high-complexity CAD, CABG is recommended in preference to PCI to improve survival.*1,2","For patients with CCD needing revascularization due to significant left main disease and high-complexity CAD, CABG is advised over PCI to enhance survival."
id_01024,"In patients with ischemic stroke or TIA and ath- erosclerotic disease (intracranial, carotid, aortic, or coronary), lipid-lowering therapy with a statin and also ezetimibe, if needed, to a goal LDL-C of <70 mg/dL is recommended to reduce the risk of major cardiovascular events.210","For patients with ischemic stroke or TIA and atherosclerotic disease (intracranial, carotid, aortic, or coronary), it is advised to use lipid-lowering therapy with a statin, and ezetimibe if necessary, to achieve an LDL-C target of less than 70 mg/dL to decrease the risk of major cardiovascular events."
id_00065,Emergency services should be activated for any person bitten by a venomous or possibly venomous snake.,"For anyone bitten by a venomous or potentially venomous snake, emergency services must be contacted."
id_01984,"For patients with an indication for AVR for whom a bioprosthetic valve is preferred but valve or vascular anatomy or other factors are not suitable for transfemoral TAVI, SAVR is recommended. 1–3,11","For patients needing AVR who prefer a bioprosthetic valve but have anatomical or other constraints that make transfemoral TAVI unsuitable, SAVR is advised. 1–3,11"
id_02464,"For patients with significant aortic dis- ease, education and guidance should be provided about avoiding intense isomet- ric exercises (eg, heavy weightlifting or activities requiring the Valsalva maneuver), burst exertion and activities, and collision sports.1,2","Patients with severe aortic conditions should receive advice and information on steering clear of intense isometric exercises (such as heavy weightlifting or activities involving the Valsalva maneuver), sudden exertion, and contact sports."
id_02465,"For patients who have undergone sur- gery for aortic aneurysm or dissection, postoperative cardiac rehabilitation is ­recommended.3,4",Postoperative cardiac rehabilitation is advised for individuals who have had surgery for an aortic aneurysm or dissection.
id_01505,"In patients with CCD who require revasculariza- tion for multivessel CAD with complex and diffuse CAD (eg, SYNTAX score >33), it is reasonable to choose CABG over PCI to improve survival.*1,3–6 Patients With CCD at High Surgical Risk","For patients with CCD needing revascularization due to multivessel CAD with complex and extensive disease (such as a SYNTAX score above 33), opting for CABG instead of PCI is advisable to enhance survival."
id_01985,"For symptomatic patients of any age with severe AS and a high or prohibitive surgical risk, TAVI is recommended if predicted post- TAVI survival is >12 months with an acceptable quality of life.12,13,14,15","TAVI is advised for symptomatic patients of any age with severe aortic stenosis who face high or prohibitive surgical risks, provided their anticipated survival post-TAVI exceeds 12 months with a satisfactory quality of life."
id_00066,It is reasonable to rest and immobilize the bitten extremity and minimize exertion by the person who was bitten if it does not delay access to emergency medical care.,"If it does not postpone emergency medical treatment, it is advisable to keep the bitten limb still and limit the bitten person's physical activity."
id_01506,"In patients with CCD who are appropriate for revascularization but poor candidates for surgery, it is reasonable to choose PCI over CABG to improve symptoms and reduce MACE.7–9 Patients With CCD and Diabetes","For patients with CCD who are suitable for revascularization yet unsuitable for surgery, opting for PCI instead of CABG is advisable to alleviate symptoms and decrease MACE."
id_01025,"In patients with ischemic stroke who are very high risk (defined as stroke plus another major ASCVD or stroke plus multiple high-risk conditions), are taking maximally tolerated statin and ezetimibe therapy and still have an LDL-C >70 mg/dL, it is reasonable to treat with PCSK9 (proprotein convertase subtili- sin/kexin type 9) inhibitor therapy to prevent ASCVD events.211–213 Monitoring","For patients with ischemic stroke at very high risk—characterized by having a stroke along with another major ASCVD or multiple high-risk conditions—who are on the highest tolerated doses of statin and ezetimibe therapy but still have LDL-C levels exceeding 70 mg/dL, it is advisable to consider PCSK9 inhibitor therapy to prevent ASCVD events."
id_01026,"In patients with stroke or TIA and hyperlip- idemia, patients’ adherence to changes in lifestyle and the effects of LDL-C–lowering medication should be assessed by measure- ment of fasting lipids and appropriate safety indicators 4 to 12 weeks after statin initiation or dose adjustment and every 3 to 12 months thereafter, based on need to assess adher- ence or safety.214,215","For patients with stroke or TIA and hyperlipidemia, evaluate adherence to lifestyle modifications and the impact of LDL-C–lowering drugs by measuring fasting lipids and relevant safety markers 4 to 12 weeks after starting or adjusting statins, and subsequently every 3 to 12 months, depending on the necessity to monitor adherence or safety."
id_00067,It is reasonable to remove rings and other con- stricting objects from the bitten extremity.,Removing rings and other constricting items from the bitten limb is advisable.
id_02466,"In patients with thoracic or abdominal aortic aneurysms whose BP is adequately con- trolled, it is reasonable to encourage 30 to 60 minutes of mild-to-moderate intensity aerobic activity at least 3 to 4 days per week.5,6","For patients with thoracic or abdominal aortic aneurysms who have well-managed blood pressure, it is advisable to promote engaging in 30 to 60 minutes of mild-to-moderate intensity aerobic exercise on at least 3 to 4 days each week."
id_01986,"For symptomatic patients with severe AS for whom predicted post-TAVI or post-SAVR survival is <12 months or for whom minimal improvement in quality of life is expected, palliative care is recommended after shared decision-making, including discussion of patient preferences and values.","For patients with severe AS who exhibit symptoms and have a predicted survival of less than 12 months following TAVI or SAVR, or for whom only minimal quality of life improvement is anticipated, palliative care is advised after engaging in shared decision-making that incorporates the patient's preferences and values."
id_00068,Application of ice to a snakebite wound is of unproven benefit and may be harmful in some situations.,Using ice on a snakebite wound has not been proven beneficial and could potentially be harmful in certain cases.
id_01027,"In patients with ischemic stroke or TIA, with fasting triglycerides 135 to 499 mg/dL and LDL-C of 41 to 100 mg/dL, on moderate- or high-intensity statin therapy, with HbA1c <10%, and with no history of pancreatitis, AF, or severe heart failure, treatment with icosa- pent ethyl (IPE) 2 g twice a day is reasonable to reduce risk of recurrent stroke.219,220","For patients who have experienced an ischemic stroke or TIA, have fasting triglyceride levels between 135 and 499 mg/dL, LDL-C levels from 41 to 100 mg/dL, are on moderate- or high-intensity statin therapy, have an HbA1c below 10%, and have no history of pancreatitis, atrial fibrillation, or severe heart failure, it is reasonable to prescribe icosapent ethyl (IPE) 2 g twice daily to lower the risk of recurrent stroke."
id_01987,"In critically ill patients with severe AS, percutaneous aortic balloon dilation may be considered as a bridge to SAVR or TAVI.","For critically ill patients with severe aortic stenosis, percutaneous aortic balloon dilation can be considered as an interim step before SAVR or TAVI."
id_01507,"In patients with CCD, diabetes, and multivessel CAD with involvement of the left anterior descend- ing artery who are appropriate candidates for CABG, CABG (with a left internal mammary artery to the left anterior descending artery) is recom- mended in preference to PCI to reduce mortality and repeat revascularizations.*5,10–17","For patients with CCD, diabetes, and multivessel CAD affecting the left anterior descending artery who are suitable for CABG, it is advised to opt for CABG (using a left internal mammary artery graft to the left anterior descending artery) over PCI to lower mortality rates and the need for repeat revascularizations."
id_02467,"For patients with clinically significant aortic disease, it is reasonable to screen for anxiety, depression, and posttraumatic stress disorder and, when indicated, provide resources for support7,8; it is also reason- able to provide education and resources to minimize patients’ concerns, support opti- mal decision-making, and enhance quality of life.5,9-11","For individuals with clinically significant aortic disease, it is advisable to assess for anxiety, depression, and posttraumatic stress disorder, and to offer support resources when necessary; additionally, it is advisable to offer education and resources to alleviate patient concerns, aid in optimal decision-making, and improve quality of life."
id_00069,"A first aid provider should observe a person with a jellyfish sting for systemic reaction and call emergency services for difficulty breathing, signs of shock, or severe pain.","A first aid responder should monitor an individual with a jellyfish sting for any systemic reactions and contact emergency services if the person experiences breathing difficulties, shock symptoms, or intense pain."
id_01988,"In patients with signs or symptoms of AR, TTE is indicated for assessment of the cause and severity of regurgitation, LV size and systolic function, prognosis, and timing of valve intervention.1–19","For patients exhibiting signs or symptoms of aortic regurgitation, a transthoracic echocardiogram is recommended to evaluate the cause and severity of regurgitation, left ventricular size and systolic function, prognosis, and the appropriate timing for valve intervention."
id_02468,"In individuals 40–79 years of age, estimation of risk for atherosclerotic CVD (ie, nonfatal MI, non- fatal stroke, and fatal CVD) every 1 to 5 years is beneficial to guide decisions on treatments and lifestyle recommendations that may reduce risk for stroke.58","For individuals aged 40 to 79, assessing the risk of atherosclerotic cardiovascular disease, including nonfatal myocardial infarction, nonfatal stroke, and fatal cardiovascular disease, every 1 to 5 years is advantageous for informing treatment and lifestyle changes that could lower stroke risk."
id_01028,"In patients with severe hypertriglyceridemia (ie, fasting triglycerides ≥500 mg/dL [≥5.7 mmol/L]), it is reasonable to identify and address causes of hypertriglyceridemia and, if triglycerides are persistently elevated or increasing, to further reduce triglycerides in order to lower the risk of ASCVD events by implementation of a very low-fat diet, avoidance of refined carbohydrates and alcohol, consump- tion of omega-3 fatty acids, and, if necessary to prevent acute pancreatitis, fibrate therapy.221–223","For patients with severe hypertriglyceridemia (fasting triglycerides ≥500 mg/dL [≥5.7 mmol/L]), it is advisable to identify and manage the underlying causes. If triglyceride levels remain high or continue to rise, further reduction is recommended to decrease the risk of ASCVD events. This can be achieved by adopting a very low-fat diet, avoiding refined carbohydrates and alcohol, consuming omega-3 fatty acids, and, if needed to prevent acute pancreatitis, using fibrate therapy."
id_01509,"In patients with CCD who have experienced SCAD, counseling should be provided regard- ing potential triggers and risk of SCAD recur- rence.1–12",Patients with CCD who have had SCAD should receive counseling about possible triggers and the risk of SCAD happening again.
id_01989,"In patients with a BAV or with known dilation of the aortic sinuses or ascending aorta, TTE is indicated to evaluate the presence and severity of AR.1","For patients with a bicuspid aortic valve or documented dilation of the aortic sinuses or ascending aorta, a transthoracic echocardiogram is recommended to assess the presence and severity of aortic regurgitation."
id_02469,"In individuals with AF, calculation of the CHA2DS2- VASc score is recommended to guide decisions on prescription of oral anticoagulation to reduce risk for stroke.59","For patients with AF, it is advised to calculate the CHA2DS2-VASc score to inform decisions regarding the use of oral anticoagulants to lower stroke risk."
id_00070,It is reasonable to remove any remaining tentacles by lifting or pulling while avoiding manual contact. Rinsing the affected area with seawater to remove the tentacle is a reasonable alternative if mechanical removal is not available.,"It is advisable to eliminate any leftover tentacles by lifting or pulling without direct hand contact. If mechanical removal isn't possible, rinsing the area with seawater is a suitable alternative."
id_01030,"In patients with an ischemic stroke or TIA who also have diabetes, treatment of diabetes should include glucose-lowering agents with proven cardiovascular benefit to reduce the risk for future major adverse cardiovas- cular events (ie, stroke, MI, cardiovascular death).231–236","For patients with an ischemic stroke or TIA and diabetes, diabetes management should involve glucose-lowering medications that have demonstrated cardiovascular benefits to decrease the risk of future major adverse cardiovascular events, such as stroke, myocardial infarction, or cardiovascular death."
id_01510,"In patients with CCD who have experienced SCAD, evaluation for underlying vasculopathies is reason- able to identify abnormalities in other vascular beds.1–4,7,10,13–15","For patients with CCD who have had SCAD, it is advisable to assess for underlying vasculopathies to detect abnormalities in other vascular regions."
id_01029,"In patients with an ischemic stroke or TIA who also have diabetes, the goal for glycemic control should be individualized based on the risk for adverse events, patient characteris- tics and preferences, and, for most patients, especially those <65 years of age and without life-limiting comorbid illness, achieving a goal of HbA1c ≤7% is recommended to reduce risk for microvascular complications.229,230","For patients with ischemic stroke or TIA who have diabetes, glycemic targets should be personalized considering the risk of adverse events, patient characteristics, and preferences. For most patients, particularly those under 65 and without life-limiting comorbidities, aiming for an HbA1c of 7% or lower is advised to minimize the risk of microvascular complications."
id_01508,"In patients with CCD and diabetes who have left main stenosis and low- or intermediate-complexity CAD (eg, SYNTAX score ≤33), PCI may be considered as an alternative to CABG to reduce MACE.*10,18 *Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.19","For patients with CCD and diabetes presenting with left main stenosis and CAD of low to intermediate complexity (such as a SYNTAX score of 33 or less), PCI can be an option instead of CABG to decrease MACE."
id_01990,"In patients with moderate or severe AR and suboptimal TTE images or a discrepancy between clinical and TTE findings, TEE, CMR, or cardiac catheterization is indicated for the assessment of LV systolic function, systolic and diastolic volumes, aortic size, and AR severity.20–25","For patients with moderate to severe AR who have inadequate TTE images or inconsistent clinical and TTE results, TEE, CMR, or cardiac catheterization should be used to evaluate LV systolic function, systolic and diastolic volumes, aortic dimensions, and the severity of AR."
id_02470,"In individuals ≥18 years of age, periodic screening for modifiable behaviors and medical conditions that increase stroke risk is recommended to reduce risk for stroke.60,61","For those aged 18 and older, it is advised to regularly screen for changeable behaviors and medical conditions that elevate stroke risk to lower the likelihood of stroke."
id_00071,"After removal of tentacles, it is reasonable to use nonscalding hot water immersion/irrigation or to apply a heat source to relieve pain.","Following tentacle removal, it is advisable to immerse or irrigate with hot water that is not scalding, or to use a heat source to alleviate pain."
id_01031,"In patients with an ischemic stroke or TIA who also have diabetes, multidimensional care (ie, lifestyle counseling, medical nutritional therapy, diabetes self-management education, support, and medication) is indicated to achieve glyce- mic goals and to improve stroke risk factors.","For patients with diabetes who have experienced an ischemic stroke or TIA, comprehensive care—including lifestyle guidance, nutritional therapy, diabetes self-management education, support, and medication—is recommended to attain glycemic targets and enhance stroke risk factors."
id_01511,"In patients with CCD who have experienced SCAD, beta-blocker therapy may be reasonable to reduce the incidence of recurrent SCAD.1","For patients with CCD who have had SCAD, it might be appropriate to use beta-blockers to lower the risk of SCAD recurrence."
id_00072,Topical lidocaine cream or gel may be reasonable for pain control if hot water is not available. Recommendation-Specific Supportive Text,"If hot water is unavailable, using lidocaine cream or gel topically could be a suitable option for managing pain."
id_02471,"In individuals ≥18 years of age, periodic screening for SDOH (eg, food insecurity, lack of transporta- tion) is beneficial to identify additional factors that contribute to stroke risk.35,62–65","For those aged 18 and older, regular screening for social determinants of health, such as food insecurity and transportation issues, is advantageous for identifying additional stroke risk factors."
id_01991,"In asymptomatic patients with chronic AR (Stages B and C), treatment of hypertension (systolic blood pressure >140 mm Hg) is recommended.1–3","For asymptomatic individuals with chronic AR in Stages B and C, it is advised to manage hypertension when systolic blood pressure exceeds 140 mm Hg."
id_02472,"In adults without prior CVD and who are at high or intermediate CVD risk, a Mediterranean diet is recommended to reduce the risk of incident stroke.86,87","For adults with no history of cardiovascular disease but at high or intermediate risk, adopting a Mediterranean diet is advised to lower the likelihood of a first-time stroke."
id_01512,"In symptomatic patients with nonobstructive CAD, a strategy of stratified medical therapy* guided by invasive coronary physiologic testing can be useful for improving angina severity and QOL.1,2 *See recommendation-specific supportive text for details. Table 14.  Screening Questions for SCAD-Associated Arteriopathies and Connective Tissue Disorders Personal history (Have you ever been diagnosed with or experienced any of the following?) Early-onset hypertension Stroke or transient ischemic attack Pulsatile tinnitus Migraine headaches Renal infarction Subarachnoid hemorrhage Aneurysm (aortic, peripheral, brain) Dissection (aortic, peripheral) Rupture of hollow organs (intestinal, bladder, uterine) Pneumothorax Tendon or muscle rupture Joint dislocation Talipes equinovarus (clubfoot) Umbilical or inguinal hernia Scoliosis or pectus deformity Pregnancy complications (cervical incompetence, hemorrhage, uterine prolapse, hypertension) Poor wound healing Ectopia lentis Myopia Detached retina, early glaucoma, or early cataracts Tall stature Abnormality of cardiac valve Systemic inflammatory disease Family history (Does anyone in your family have the following?) Dissection (coronary, aortic, peripheral) Inherited arteriopathy or connective tissue disorder (eg, vascular Ehlers-Danlos syndrome, Marfan syndrome, Loeys-Dietz syndrome) Early stroke, early myocardial infarction, sudden cardiac death Review of systems (Are you currently experiencing any of the following?) Headaches Pulsatile tinnitus Postprandial abdominal pain Flank pain Claudication Easy bruising Joint hypermobility or laxity","For patients with symptoms of nonobstructive CAD, employing a stratified medical treatment approach based on invasive coronary physiologic assessments may be beneficial in alleviating angina severity and enhancing quality of life."
id_00073,"Emergency services should be called if a person bitten by a spider or stung by a scorpion develops symptoms throughout the body such as difficulty breathing, muscle rigidity, dizziness, or confusion.","If someone experiences systemic symptoms like breathing difficulties, muscle stiffness, dizziness, or confusion after a spider bite or scorpion sting, emergency services must be contacted."
id_01992,"In patients with severe AR who have symptoms and/or LV systolic dysfunction (Stages C2 and D) but a prohibitive surgical risk, GDMT for reduced LVEF with ACE inhibitors, ARBs, and/or sacubitril/valsartan is recommended.4","For patients with severe aortic regurgitation experiencing symptoms and/or left ventricular systolic dysfunction (Stages C2 and D) who are at prohibitive surgical risk, it is advised to use guideline-directed medical therapy for reduced left ventricular ejection fraction, including ACE inhibitors, ARBs, and/or sacubitril/valsartan."
id_01032,"In patients with prediabetes and ischemic stroke or TIA, lifestyle optimization (ie, healthy diet, regular physical activity, and smoking cessation) can be beneficial for the preven- tion of progression to diabetes.237,238","For individuals with prediabetes who have experienced an ischemic stroke or TIA, improving lifestyle factors such as adopting a healthy diet, engaging in regular exercise, and quitting smoking may help prevent the development of diabetes."
id_01513,"In young adults with CCD, after optimization of traditional cardiovascular risk factors, a compre- hensive evaluation and treatment of nontraditional cardiovascular risk factors can be beneficial in reducing the risk of cardiovascular events.1–3","For young adults with CCD, once traditional cardiovascular risk factors are optimized, thoroughly assessing and addressing nontraditional cardiovascular risk factors may help lower the risk of cardiovascular events."
id_00074,"A person bitten by a spider or stung by a scorpion should seek medical care if pain extends beyond the site of the bite/sting, becomes severe, and is not controlled by over-the-counter pain medica- tions; if an open wound develops; or if the person experiences symptoms throughout the body.","If an individual is bitten by a spider or stung by a scorpion, they should obtain medical attention if the pain spreads beyond the bite or sting site, intensifies, and is not alleviated by non-prescription pain relievers; if an open sore forms; or if systemic symptoms occur."
id_01993,"In symptomatic patients with severe AR (Stage D), aortic valve surgery is indicated regardless of LV systolic function.1–7","For patients with severe AR (Stage D) who exhibit symptoms, aortic valve surgery is recommended irrespective of LV systolic function."
id_02473,"In adults who are ≥60 years of age and have uncontrolled BP (systolic BP [SBP] ≥140 mm Hg if taking antihypertensive medication or ≥160 mm Hg if not), compared with using 100% sodium chloride, salt substitution (75% sodium chloride and 25% potassium chloride) is reasonable to reduce the risk of incident stroke.88","For adults aged 60 and older with uncontrolled blood pressure (systolic BP ≥140 mm Hg on antihypertensive medication or ≥160 mm Hg without), using a salt substitute containing 75% sodium chloride and 25% potassium chloride, instead of 100% sodium chloride, is a reasonable approach to lower the risk of a first-time stroke."
id_01033,"In patients with TIA or ischemic stroke, it is reasonable to screen for prediabetes/dia- betes using HbA1c which, among available methods (HbA1c, fasting plasma glucose, oral glucose tolerance), has the advantage of convenience because it does not require fast- ing and is measured in a single blood sample.","For patients who have experienced a TIA or ischemic stroke, it is advisable to test for prediabetes or diabetes using HbA1c. This method is preferable among the options (HbA1c, fasting plasma glucose, oral glucose tolerance) due to its convenience, as it does not require fasting and can be assessed with just one blood sample."
id_01034,"In patients with an ischemic stroke or TIA who also have diabetes, the usefulness of achieving intensive glucose control (ie, HbA1c ≤7%) beyond the acute phase of the ischemic event for prevention of recurrent stroke is unknown.239–244","For patients with diabetes who have experienced an ischemic stroke or TIA, the benefit of maintaining strict glucose control (HbA1c ≤7%) after the acute phase to prevent another stroke remains uncertain."
id_01514,"In patients with CCD and cancer, a multidisciplinary team including cardiology and oncology expertise is recommended to improve long-term CVD out- comes.1,2","For patients with CCD and cancer, it is advised to involve a multidisciplinary team with cardiology and oncology specialists to enhance long-term cardiovascular outcomes."
id_00075,Over-the-counter acetaminophen and nonsteroi- dal anti-inflammatory agents can be used to allevi- ate local pain from scorpion stings.,Non-prescription acetaminophen and NSAIDs may be utilized to relieve localized pain caused by scorpion stings.
id_02474,"In adults, folic acid supplementation and B- complex (folic acid, B12, B6) vitamins supplementa- tion for reducing the risk of stroke are not well established.89–91","The efficacy of folic acid and B-complex vitamins (including folic acid, B12, and B6) in lowering stroke risk in adults is not well supported by evidence.89–91"
id_01995,"In patients with severe AR (Stage C or D) who are undergoing cardiac surgery for other indications, aortic valve surgery is indicated.",Aortic valve surgery is recommended for patients with severe AR (Stage C or D) who are having cardiac surgery for other reasons.
id_01035,"In patients with prediabetes and ischemic stroke or TIA, particularly those with a body mass index (BMI) ≥35 kg/mP2, ≥35 kg/m2 those <60 years of age, or women with a history of gestational diabetes, metformin may be beneficial to control blood sugar and to prevent progression to diabetes.245–247","For individuals with prediabetes who have experienced an ischemic stroke or TIA, especially those with a BMI of 35 kg/m² or higher, those under 60 years old, or women with a history of gestational diabetes, metformin might be advantageous for managing blood sugar levels and preventing the development of diabetes."
id_01515,"Women with CCD who are contemplating preg- nancy or who are pregnant should be risk-stratified and counseled regarding risks of adverse maternal, obstetric, and fetal outcomes.1–4","Women with CCD who are considering pregnancy or are already pregnant should undergo risk assessment and receive counseling about potential adverse outcomes for the mother, pregnancy, and fetus."
id_01994,"In asymptomatic patients with chronic severe AR and LV systolic dysfunction (LVEF ≤55%) (Stage C2), aortic valve surgery is indicated if no other cause for systolic dysfunction is identified.3,5,8–12","For asymptomatic individuals with chronic severe aortic regurgitation and left ventricular systolic dysfunction (LVEF ≤55%) classified as Stage C2, aortic valve surgery is recommended if no alternative cause for the systolic dysfunction is found."
id_02475,"In adults without prior CVD, long-chain fatty acids are not effective for reducing the risk of stroke.89,91–96","For adults with no history of cardiovascular disease, long-chain fatty acids do not effectively lower the risk of stroke."
id_00076,"If the skin is intact, topical lidocaine can be useful to relieve local pain from scorpion stings.",Topical lidocaine may effectively alleviate local pain from scorpion stings if the skin remains unbroken.
id_01036,"In patients ≤6 months after TIA or ischemic stroke with insulin resistance, HbA1c <7.0%, and without heart failure or bladder cancer, treatment with pioglitazone may be consid- ered to prevent recurrent stroke.248","For patients within 6 months post-TIA or ischemic stroke who have insulin resistance, an HbA1c below 7.0%, and no history of heart failure or bladder cancer, pioglitazone can be considered to reduce the risk of another stroke."
id_00077,Ice can be useful for local pain relief from scor- pion stings. Recommendation-Specific Supportive Text,Applying ice may help alleviate localized pain caused by scorpion stings.
id_01516,"Women with CCD who are contemplating preg- nancy or who are pregnant should receive care from a multidisciplinary cardio-obstetric care team beginning before conception and continuing throughout pregnancy, delivery, and postpartum to improve maternal and fetal outcomes.1,2,5","Women with CCD who are planning to become pregnant or are already pregnant should be managed by a multidisciplinary cardio-obstetric team starting before conception and continuing through pregnancy, childbirth, and the postpartum period to enhance outcomes for both mother and baby."
id_02476,"In adults, vitamin C, vitamin E, selenium, anti- oxidants, calcium, calcium with vitamin D, and multivitamin supplementation are not effective for reducing the risk of stroke.89–91,97–99","For adults, taking supplements such as vitamin C, vitamin E, selenium, antioxidants, calcium, calcium with vitamin D, and multivitamins does not lower the risk of stroke."
id_01517,"In women with CCD, continuation of statin use dur- ing pregnancy may be considered.6","For women with CCD, maintaining statin therapy throughout pregnancy can be considered."
id_01996,"In asymptomatic patients with severe AR and normal LV systolic function (LVEF >55%), aortic valve surgery is reasonable when the LV is severely enlarged (LVESD >50 mm or indexed LVESD >25 mm/m2) (Stage C2).10,11,13–24","For asymptomatic individuals with severe aortic regurgitation and normal left ventricular systolic function (LVEF over 55%), it is appropriate to consider aortic valve surgery if the left ventricle is significantly enlarged (LVESD exceeds 50 mm or indexed LVESD is greater than 25 mm/m²) (Stage C2)."
id_02477,"In adults, screening for physical activity is recom- mended as part of a comprehensive effort to estimate stroke risk.104–107 Other interventions","For adults, evaluating physical activity is advised as a component of a thorough approach to assess stroke risk."
id_01037,"In patients with ischemic stroke or TIA and who are overweight or obese, weight loss is recommended to improve the ASCVD risk factor profile.259,276–279","For patients who have experienced an ischemic stroke or TIA and are overweight or obese, losing weight is advised to enhance the ASCVD risk factor profile."
id_01997,"In patients with moderate AR (Stage B) who are undergoing cardiac or aortic surgery for other indications, aortic valve surgery is reasonable.","For patients with moderate aortic regurgitation (Stage B) who are having cardiac or aortic surgery for other reasons, it is reasonable to perform aortic valve surgery."
id_00078,"A person with signs and symptoms of hypother- mia should be protected from further heat loss by moving from the cold environment to a warm one, having saturated clothing removed, being allowed to passively rewarm with blankets, and being actively rewarmed if resources are available.","If someone exhibits hypothermia symptoms, they should be shielded from additional heat loss by relocating to a warmer area, removing wet clothing, allowing passive rewarming with blankets, and undergoing active rewarming if possible."
id_01518,"Women with CCD who are contemplating pregnancy or who are pregnant should not use ACE inhibitors, ARBs, direct renin inhibitors, angiotensin receptor- neprilysin inhibitors, or aldosterone antagonists dur- ing pregnancy to prevent harm to the fetus.2,7,8 Postmenopausal Hormone Therapy","Women with CCD who are considering pregnancy or are already pregnant should avoid using ACE inhibitors, ARBs, direct renin inhibitors, angiotensin receptor-neprilysin inhibitors, or aldosterone antagonists during pregnancy to prevent fetal harm."
id_01038,"In patients with ischemic stroke or TIA who are obese, referral to an intensive, multicompo- nent, behavioral lifestyle-modification program is recommended to achieve sustained weight loss.238,258,280,281","For obese patients with ischemic stroke or TIA, it is advised to refer them to a comprehensive, intensive behavioral lifestyle-modification program to attain long-term weight loss."
id_02478,"In adults, counseling patients to engage in at least 150 minutes of moderate-intensity physical activity, 75 minutes of vigorous-intensity physical activity, or an equivalent combination per week is recommended to reduce the risk of stroke.108–111","For adults, it is advised to counsel patients to participate in a minimum of 150 minutes of moderate-intensity exercise, 75 minutes of vigorous-intensity exercise, or a comparable mix weekly to lower the risk of stroke."
id_01998,"In asymptomatic patients with severe AR and normal LV systolic function at rest (LVEF >55%; Stage C1) and low surgical risk, aortic valve surgery may be considered when there is a progressive decline in LVEF on at least 3 serial studies to the low–normal range (LVEF 55% to 60%) or a progressive increase in LV dilation into the severe range (LV end- diastolic dimension [LVEDD] >65 mm).12,16,17,20,25–28","For asymptomatic patients with severe aortic regurgitation and normal left ventricular systolic function at rest (LVEF >55%; Stage C1) who have low surgical risk, aortic valve surgery may be considered if there is a progressive decrease in LVEF to the low-normal range (55% to 60%) across at least three consecutive studies, or if there is a progressive increase in left ventricular dilation to a severe level (LV end-diastolic dimension [LVEDD] >65 mm)."
id_01039,"In patients with ischemic stroke or ASCVD, calculation of BMI is recommended at the time of their event and annually thereafter, to screen for and to classify obesity.","For patients experiencing an ischemic stroke or ASCVD, it is advised to calculate BMI at the time of the event and once a year subsequently, to screen for and classify obesity."
id_01519,"Women with CCD should not receive systemic postmenopausal hormone therapy because of a lack of benefit on MACE and mortality, and an increased risk of venous thromboembolism.9–11","Systemic postmenopausal hormone therapy is not advised for women with CCD due to no observed benefits on MACE and mortality, along with a heightened risk of venous thromboembolism."
id_00079,"If a person with hypothermia cannot be immedi- ately moved from a cold environment to a warm one, they should be protected from further heat loss by insulation from the ground, covering of head and neck, and shielding from heat loss by wind using a plastic or foil layer in addition to a dry insulating layer.","If an individual with hypothermia cannot be promptly relocated from a cold setting to a warm one, they should be safeguarded against additional heat loss by insulating them from the ground, covering their head and neck, and using a plastic or foil layer along with a dry insulating layer to protect against wind-induced heat loss."
id_02479,"In adults, counseling to avoid excessive time spent in sedentary behavior (characterized by low- energy expenditure while sitting, reclining, or lying while awake) is recommended to reduce the risk of stroke.112–115","It is advised that adults receive guidance to limit prolonged sedentary behavior, such as sitting, reclining, or lying down with low energy use while awake, to lower the risk of stroke."
id_01999,"In patients with isolated severe AR who have indications for SAVR and are candidates for surgery, TAVI should not be performed.29–32","For patients with isolated severe aortic regurgitation who qualify for surgical aortic valve replacement and are suitable for surgery, transcatheter aortic valve implantation should not be conducted."
id_01520,"In patients with CCD and CKD, measures should be taken to minimize the risk of treatment-related acute kidney injury.*1–3 *Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.4","For patients with CCD and CKD, steps should be implemented to reduce the likelihood of acute kidney injury caused by treatment."
id_00080,"When using rewarming devices of any kind, the first aid provider should follow the manufacturer’s instructions for the device used, place insulation between the heat source and skin, and frequently monitor for burns and pressure injury.","For any rewarming device, the first aid provider must adhere to the manufacturer's guidelines, ensure insulation is placed between the heat source and the skin, and regularly check for burns and pressure injuries."
id_02480,"In adults >18 years of age, screening for over- weight and obesity is recommended to inform the risk of stroke.158–162 Other intervention","For individuals older than 18, it is advised to screen for overweight and obesity to assess stroke risk."
id_02000,"In patients with a known BAV, TTE is indicated to evaluate valve morphology, measure severity of AS and AR, assess the shape and diameter of the aortic sinuses and ascending aorta, and evaluate for the presence of aortic coarctation for prediction of clinical outcome and to determine timing of intervention.1–4","For patients diagnosed with a BAV, a TTE should be performed to assess valve structure, quantify the severity of AS and AR, examine the configuration and size of the aortic sinuses and ascending aorta, and check for aortic coarctation to predict clinical outcomes and decide on the timing of intervention."
id_01040,"In patients with an ischemic stroke or TIA and OSA, treatment with positive airway pressure (eg, continuous positive airway pressure [CPAP]) can be beneficial for improved sleep apnea, BP, sleepiness, and other apnea- related outcomes.302–314","For patients experiencing an ischemic stroke or TIA who also have OSA, using positive airway pressure therapy, such as CPAP, may be advantageous for enhancing sleep apnea, blood pressure, sleepiness, and other outcomes related to apnea."
id_00560,"For patients with HCM or at risk for HCM, shared decision-making is recommended in developing a plan of care (including, but not limited to, decisions regarding genetic evaluation, activity, lifestyle, and therapy choices) that includes a full disclosure of the risks, benefits, and anticipated outcomes of all options, as well the opportunity for the patient and caregivers to express their goals and concerns.1–5","For individuals diagnosed with or at risk for HCM, it is advised to engage in shared decision-making to formulate a care plan. This plan should encompass decisions about genetic testing, activity levels, lifestyle, and treatment options, ensuring a comprehensive explanation of the risks, benefits, and expected outcomes of each choice, while also allowing patients and caregivers to communicate their objectives and concerns."
id_01521,"In adults with CCD and HIV, antiretroviral therapy is beneficial to decrease the risk of cardiovascular events.1,2","For adults with CCD and HIV, using antiretroviral therapy helps reduce the likelihood of cardiovascular events."
id_00081,"If a person with hypothermia has a decreased level of responsiveness such as unresponsive- ness, inability to remain awake, mumbling speech, confusion, or inability to participate in removal of clothing or has pallor, cyanosis, or frozen skin, the emergency response system should be activated while the person is rewarmed by any available method.","In cases where an individual with hypothermia exhibits reduced responsiveness, such as being unresponsive, unable to stay awake, having slurred speech, showing confusion, or being unable to assist in removing clothing, or if they display pallor, cyanosis, or frozen skin, it is crucial to activate the emergency response system while rewarming the person using any available means."
id_02001,"In patients with BAV, CMR angiography or CT angiography is indicated when morphology of the aortic sinuses, sinotubular junction, or ascending aorta cannot be assessed accurately or fully by echocardiography.4,5","For patients with BAV, CMR or CT angiography is recommended when echocardiography does not provide a complete or precise evaluation of the aortic sinuses, sinotubular junction, or ascending aorta."
id_01041,"In patients with an ischemic stroke or TIA, an evaluation for OSA may be considered for diagnosing sleep apnea.302,303,315,316","For patients who have experienced an ischemic stroke or TIA, assessing for OSA might be considered to diagnose sleep apnea."
id_00561,"In patients with HCM in whom SRT is indicated, the procedure should be performed at experienced centers (comprehensive or primary HCM centers) with demonstrated excellence in clinical outcomes for these procedures (Tables 4 and 5).1–3","For patients with HCM requiring SRT, the procedure ought to be conducted at specialized centers (either comprehensive or primary HCM centers) that have proven success in clinical outcomes for such procedures."
id_00082,"For patients experiencing cold stress or mild hypothermia who are alert and can safely con- sume oral food or fluids, it is recommended to provide high-calorie foods or drinks.","For patients who are alert and able to safely ingest food or fluids while experiencing cold stress or mild hypothermia, it is advised to offer high-calorie foods or beverages."
id_00562,"In patients with HCM, consultation with or referral to a comprehensive or primary HCM center is reasonable to aid in complex disease-related management decisions (Table 4).4–14","For patients with HCM, it is advisable to consult or refer to a specialized or primary HCM center to assist with intricate management decisions related to the disease (Table 4).4–14"
id_01042,"In patients with a stroke or TIA caused by 50% to 99% stenosis of a major intracranial artery, aspirin 325 mg/d is recommended in prefer- ence to warfarin to reduce the risk of recurrent ischemic stroke and vascular death.335,336","For patients who have experienced a stroke or TIA due to 50% to 99% narrowing of a significant intracranial artery, a daily dose of 325 mg aspirin is advised over warfarin to lower the risk of another ischemic stroke and vascular mortality."
id_02481,"In patients with class II obesity (35–39.9 kg/m2) or greater, bariatric surgical procedures to pro- mote weight loss may be considered to reduce the risk of stroke.163–167","For individuals with class II obesity (BMI 35–39.9 kg/m2) or higher, bariatric surgery can be contemplated as a means to lower stroke risk."
id_02002,"In first-degree relatives of patients with a known BAV, a screening TTE might be considered to look for the presence of a BAV or asymptomatic dilation of the aortic sinuses and ascending aorta.6","For first-degree relatives of individuals diagnosed with a BAV, it may be advisable to perform a screening TTE to detect a BAV or asymptomatic enlargement of the aortic sinuses and ascending aorta."
id_01522,"In adults with CCD and HIV, it is reasonable to choose antiretroviral therapy regimens associated with more favorable lipid and cardiovascular risk pro- files with consideration of drug-drug interactions.3–5","For adults with CCD and HIV, selecting antiretroviral therapy regimens that have better lipid and cardiovascular risk profiles, while considering potential drug-drug interactions, is advisable."
id_02482,The effectiveness of screening adults for OSA to prevent stroke is unclear.191 Other intervention,The impact of screening adults for OSA on stroke prevention is uncertain.
id_00563,"In patients with suspected HCM, comprehensive physical examination and complete medical and","For individuals suspected of having HCM, a thorough physical assessment and a full medical history are essential."
id_01043,"In patients with recent stroke or TIA (within 30 days) attributable to severe stenosis (70%–99%) of a major intracranial artery, the addition of clopidogrel 75 mg/d to aspirin for up to 90 days is reasonable to further reduce recurrent stroke risk.336–339","For patients who have experienced a stroke or TIA within the past 30 days due to significant stenosis (70%–99%) of a major intracranial artery, it is advisable to add clopidogrel 75 mg daily to aspirin for up to 90 days to further decrease the risk of recurrent stroke."
id_01523,"In adults with CCD and HIV, lovastatin or simvastatin should not be administered with protease inhibitors as this may cause harm.6,7 Autoimmune Disorders in CCD","For adults with CCD and HIV, avoid prescribing lovastatin or simvastatin alongside protease inhibitors due to potential harm."
id_00083,"If a person with hypothermia with a decreased level of responsiveness is wearing damp (not saturated) clothing such as polyester fleece and cannot be immediately moved into a warm environment, active rewarming through the damp clothing is reasonable to initiate with the hypo- thermia wrap technique, using chemical heat blankets, plastic or foil layers, and insulative blankets.","For a hypothermic individual with reduced responsiveness wearing damp (but not soaked) clothing like polyester fleece, and if immediate relocation to a warm area is not possible, it is advisable to start active rewarming through the damp clothing using the hypothermia wrap method, which involves chemical heat blankets, plastic or foil layers, and insulating blankets."
id_00084,It is not beneficial to use body-to-body rewarming for active rewarming over other active rewarming techniques such as chemical heat packs or forced air systems.,Body-to-body rewarming is not advantageous compared to other active rewarming methods like chemical heat packs or forced air systems.
id_00564,"In patients with suspected HCM, a transthoracic echocardiogram (TTE) is recommended in the initial evaluation.1–6","For patients suspected of having HCM, an initial assessment should include a transthoracic echocardiogram (TTE)."
id_01044,"In patients with recent (within 24 hours) minor stroke or high-risk TIA and concomitant ipsilat- eral >30% stenosis of a major intracranial artery, the addition of ticagrelor 90 mg twice a day to aspirin for up to 30 days might be considered to further reduce recurrent stroke risk.340","For patients who have experienced a minor stroke or high-risk TIA within the past 24 hours and have more than 30% stenosis in a major intracranial artery on the same side, adding ticagrelor 90 mg twice daily to aspirin for up to 30 days may be considered to further decrease the risk of recurrent stroke."
id_02483,"In patients with OSA, continuous positive airway pressure (CPAP) might be reasonable to reduce the risk of stroke.192–194","For patients with OSA, using continuous positive airway pressure (CPAP) could be a sensible approach to lower stroke risk."
id_01524,"In adults with CCD and rheumatoid arthritis, initia- tion and maintenance of disease-modifying anti- rheumatoid drugs is beneficial to decrease the risk of cardiovascular events.8–11","For adults with CCD and rheumatoid arthritis, starting and continuing treatment with disease-modifying antirheumatic drugs is advantageous for reducing the likelihood of cardiovascular events."
id_02003,"In patients with BAV and a diameter of the aortic sinuses or ascending aorta of ≥4.0 cm, lifelong serial evaluation of the size and morphology of the aortic sinuses and ascending aorta by echocardiography, CMR, or CT angiography is reasonable, with the examination interval determined by the degree and rate of progression of aortic dilation and by family history.1–5","For patients with BAV and an aortic sinus or ascending aorta diameter of 4.0 cm or more, it is advisable to conduct lifelong periodic assessments of the size and structure of these areas using echocardiography, CMR, or CT angiography. The frequency of these evaluations should be based on the extent and speed of aortic enlargement and family history."
id_02484,"In asymptomatic adults ≥18 years of age who have overweight, obesity, or atherosclerotic CVD, screening for prediabetes and diabetes is recom- mended to inform stroke risk.202–204 Other interventions","Screening for prediabetes and diabetes is advised in adults aged 18 and older with overweight, obesity, or atherosclerotic cardiovascular disease to assess stroke risk."
id_00565,"For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is recommended.9,14–17",It is advised to perform a repeat TTE for patients with HCM who undergo a change in clinical condition or encounter a new clinical event.
id_00085,It is not effective to treat a person with hypothermia by using small glove or boot insert chemical heat packs as the sole or primary means of rewarming.,Using small chemical heat packs for gloves or boots alone is ineffective for rewarming someone with hypothermia.
id_01045,"In patients with stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, the addition of cilostazol 200 mg/day to aspirin or clopidogrel might be considered to reduce recurrent stroke risk.341–344 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing a stroke or TIA due to 50% to 99% narrowing of a major intracranial artery, it may be advisable to add cilostazol 200 mg/day to aspirin or clopidogrel to help lower the risk of another stroke."
id_02004,"In patients with a BAV who have undergone AVR, continued lifelong serial interval imaging of the aorta is reasonable if the diameter of the aortic sinuses or ascending aorta is ≥4.0 cm.6,7","For patients with a BAV who have had AVR, it is advisable to maintain lifelong periodic imaging of the aorta if the aortic sinuses or ascending aorta measure 4.0 cm or more in diameter."
id_00086,The preferred method for warming frostbitten tissue is clean lukewarm water immersion at 37° C to 40° C (99° F–104° F).,The recommended approach for warming frostbitten tissue involves immersing it in clean water at a temperature of 37°C to 40°C (99°F–104°F).
id_01525,"In adults with CCD and autoimmune diseases, treatment with biologics and other immune modu- lating therapies that reduce disease activity may be considered to decrease the risk of cardiovascular events.10,11","For adults with CCD and autoimmune disorders, considering biologics and other immune-modulating treatments that lower disease activity might help reduce the risk of cardiovascular events."
id_00566,"For patients with HCM and resting peak LVOT gradient <50 mm Hg, a TTE with provocative maneuvers is recommended.18–21","For patients with HCM and a resting peak LVOT gradient of less than 50 mm Hg, it is advised to perform a TTE with provocative maneuvers."
id_02005,"In asymptomatic or symptomatic patients with a BAV and a diameter of the aortic sinuses or ascending aorta >5.5 cm, operative intervention to replace the aortic sinuses and/ or the ascending aorta is recommended.1–3","For patients with a BAV, whether they show symptoms or not, surgical replacement of the aortic sinuses and/or ascending aorta is advised when the diameter exceeds 5.5 cm."
id_01526,"In patients with CCD and rheumatoid arthritis, high- dose glucocorticoids should not be used long term if alternative therapies are available because of increased cardiovascular risk.11,12","For patients with CCD and rheumatoid arthritis, long-term use of high-dose glucocorticoids should be avoided if other treatment options exist due to the heightened risk of cardiovascular issues."
id_02486,"In patients with type 1 diabetes or diabetes, intensive glycemic control (targeting a hemo- globin A1c ≤6.5%) is not beneficial for stroke prevention.209–215","For individuals with type 1 diabetes or diabetes, maintaining strict glycemic control with a hemoglobin A1c target of ≤6.5% does not aid in preventing strokes."
id_01046,"In patients with stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, the usefulness of clopidogrel alone, the combination of aspirin and dipyridam- ole, ticagrelor alone, or cilostazol alone for secondary stroke prevention is not well established. Risk Factor Management","For patients experiencing a stroke or TIA due to 50% to 99% narrowing of a major intracranial artery, the effectiveness of clopidogrel alone, aspirin combined with dipyridamole, ticagrelor alone, or cilostazol alone for preventing subsequent strokes is not clearly determined."
id_00087,"Frostbitten tissue should be rewarmed at the earliest opportunity, as long as there is no risk of refreezing.","Rewarm frostbitten tissue as soon as possible, provided there is no danger of it freezing again."
id_02485,"In patients with diabetes and high cardiovascular risk or established CVD and hemoglobin A1c ≥7%, treatment with a GLP-1 receptor agonist is effective to reduce the risk of stroke.180,205–208 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with diabetes who have a high risk of cardiovascular events or existing cardiovascular disease and a hemoglobin A1c of 7% or higher, using a GLP-1 receptor agonist is effective in lowering the risk of stroke."
id_01527,"In patients with cardiac allograft vasculopathy, statins are recommended for secondary prevention to reduce MACE.1","For patients with cardiac allograft vasculopathy, statins are advised for secondary prevention to lower the risk of major adverse cardiovascular events."
id_00567,"For symptomatic patients with HCM who do not have a resting or provocable outflow tract peak gradient ≥50 mm Hg on TTE, exercise TTE is recommended for the detection and quantification of dynamic LVOTO.20–25","For patients with HCM who exhibit symptoms but lack a resting or inducible outflow tract peak gradient of ≥50 mm Hg on TTE, exercise TTE is advised to identify and measure dynamic LVOTO."
id_02487,"In adults ≥18 years of age, screening for hyper- tension is recommended to identify individuals at increased risk for stroke and eligible for antihy- pertensive treatment.221 Other interventions","For adults aged 18 and older, it is advised to screen for hypertension to detect those at higher risk for stroke and who may benefit from antihypertensive therapy."
id_02006,"In asymptomatic patients with a BAV, a diameter of the aortic sinuses or ascending aorta of 5.0 to 5.5 cm, and an additional risk factor for dissection (eg, family history of aortic dissection, aortic growth rate >0.5 cm per year, aortic coarctation), operative intervention to replace the aortic sinuses and/or the ascending aorta is reasonable if the surgery is performed at a Comprehensive Valve Center.3,4 Figure 5. Intervals for imaging the aorta in patients with a BAV. Colors correspond to Table 2. BAV indicates bicuspid aortic valve; CTA, computed tomographic angiography; CMR, cardiac magnetic resonance;","For asymptomatic individuals with a bicuspid aortic valve (BAV) and an aortic sinus or ascending aorta diameter between 5.0 and 5.5 cm, along with an additional dissection risk factor (such as a family history of aortic dissection, an aortic growth rate exceeding 0.5 cm per year, or aortic coarctation), it is advisable to consider surgical replacement of the aortic sinuses and/or ascending aorta at a Comprehensive Valve Center."
id_02007,"In patients with a BAV with indications for SAVR and a diameter of the aortic sinuses or ascending aorta ≥4.5 cm, replacement of the aortic sinuses and/or ascending aorta is reasonable if the surgery is performed at a Comprehensive Valve Center.4–7","For patients with a BAV who require SAVR and have an aortic sinus or ascending aorta diameter of 4.5 cm or more, it is advisable to replace the aortic sinuses and/or ascending aorta if the procedure is conducted at a Comprehensive Valve Center."
id_01047,"In patients with a stroke or TIA attributable to 50% to 99% stenosis of a major intracranial artery, maintenance of SBP below 140 mm Hg, high-intensity statin therapy, and at least moderate physical activity are recom- mended to prevent recurrent stroke and vascular events.110,210,337,345–349 Angioplasty and Stenting","For patients experiencing a stroke or TIA due to 50% to 99% narrowing of a major intracranial artery, it is advised to maintain systolic blood pressure under 140 mm Hg, engage in high-intensity statin therapy, and participate in at least moderate physical activity to prevent recurrent strokes and vascular events."
id_01528,"In patients with cardiac allograft vasculopathy, aspirin can be beneficial for secondary prevention to reduce MACE.2","For patients with cardiac allograft vasculopathy, aspirin may be advantageous for secondary prevention to lower the risk of major adverse cardiovascular events."
id_00568,"For patients with HCM who are undergoing surgical septal myectomy, intraoperative transesophageal echocardiogram (TEE) is recommended to assess mitral valve anatomy and function and adequacy of septal myectomy.26–29","It is advised that patients with HCM undergoing surgical septal myectomy have an intraoperative transesophageal echocardiogram (TEE) to evaluate the mitral valve's structure and function, as well as the sufficiency of the septal myectomy."
id_00088,"If clean lukewarm water immersion is not feasible, frostbitten tissue should be allowed to rewarm spontaneously in warm room air or next to the person’s own warm skin.","If immersing in clean lukewarm water is not possible, frostbitten areas should be left to naturally rewarm in a warm room or against the individual's own warm skin."
id_02008,"In patients with a BAV who meet criteria for replacement of the aortic sinuses, valve-sparing surgery may be considered if the surgery is performed at a Comprehensive Valve Center.8,9","For patients with a BAV who qualify for aortic sinus replacement, valve-sparing surgery can be an option if conducted at a Comprehensive Valve Center."
id_02488,"In adults with stage 2 hypertension or stage 1 hypertension with a higher risk for atherosclerotic CVD, lifestyle improvement and antihypertensive drug treatment to a SBP/diastolic BP (DBP) <130/80 mm Hg are recommended to prevent stroke.222–229","For adults with stage 2 hypertension or stage 1 hypertension at increased risk for atherosclerotic cardiovascular disease, it is advised to implement lifestyle changes and use antihypertensive medication to achieve a systolic/diastolic blood pressure below 130/80 mm Hg to reduce the risk of stroke."
id_00089,A person with frostbite should seek prompt medical attention.,Individuals experiencing frostbite need to obtain immediate medical care.
id_01048,"In patients with severe stenosis (70%-99%) of a major intracranial artery and actively pro- gressing symptoms or recurrent TIA or stroke after institution of aspirin and clopidogrel therapy, achievement of SBP <140 mm Hg, and high- intensity statin therapy (so-called medical failures), the usefulness of angio- plasty alone or stent placement to prevent ischemic stroke in the territory of the stenotic artery is unknown.350–352","For patients with severe stenosis (70%-99%) of a major intracranial artery who continue to experience worsening symptoms or recurrent TIA or stroke despite aspirin and clopidogrel treatment, achieving an SBP <140 mm Hg, and high-intensity statin therapy (referred to as medical failures), the effectiveness of angioplasty alone or stent placement in preventing ischemic stroke in the affected artery's territory remains uncertain."
id_00569,"For patients with HCM who are undergoing alcohol septal ablation, TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection of the candidate’s septal perforator(s) is recommended.30–34","For patients with HCM undergoing alcohol septal ablation, it is advised to use TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection into the candidate's septal perforator(s)."
id_01529,"In patients with severe cardiac allograft vasculopathy, revascularization is reasonable in those with suitable anatomy to potentially mitigate the adverse long-term consequences of cardiac allograft vasculopathy.*3–6 *Modified from the 2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.7","For patients experiencing severe cardiac allograft vasculopathy, revascularization is advisable for those with appropriate anatomical conditions to possibly reduce the negative long-term effects of the condition."
id_01049,"In patients with stroke or TIA attributable to severe stenosis (70%–99%) of a major intracranial artery, angioplasty and stenting should not be performed as an initial treat- ment, even for patients who were taking an antithrombotic agent at the time of the stroke or TIA.353–359","For patients experiencing stroke or TIA due to significant narrowing (70%–99%) of a major intracranial artery, angioplasty and stenting should not be used as the first-line treatment, even if the patient was on an antithrombotic medication during the stroke or TIA."
id_00090,Jewelry or other constricting materials should be removed from a frostbitten extremity as soon as possible.,Remove any jewelry or constricting items from a frostbitten limb promptly.
id_02489,"In adults with hypertension, thiazide and thiazide- like diuretics, calcium channel blockers, angiotensin-converting enzyme inhibitors, and angiotensin receptor blockers are recommended as initial antihypertensive drug therapies to pre- vent stroke.68,230–232","For adults with high blood pressure, it is advised to use thiazide and thiazide-like diuretics, calcium channel blockers, ACE inhibitors, and angiotensin receptor blockers as the first-line antihypertensive medications to prevent stroke."
id_00570,"For patients with HCM who have undergone SRT, TTE within 3 to 6 months after the procedure is recommended to evaluate the procedural results.35–38",It is advised that patients with HCM who have had SRT undergo a TTE 3 to 6 months post-procedure to assess the outcomes.
id_02009,"In asymptomatic patients with a BAV who are at low surgical risk, have a diameter of the aortic sinuses or ascending aorta of 5.0 to 5.5 cm, and have no additional risk factors for dissection, operative intervention to replace the aortic sinuses and/or the ascending aorta may be considered if the surgery is performed at a Comprehensive Valve Center.4–7,10–14","For asymptomatic individuals with a bicuspid aortic valve (BAV) who are at low risk for surgery, have aortic sinuses or ascending aorta measuring between 5.0 and 5.5 cm, and lack other dissection risk factors, surgical replacement of the aortic sinuses and/or ascending aorta can be contemplated if conducted at a Comprehensive Valve Center."
id_01050,"In patients with a stroke or TIA attributable to moderate stenosis (50%–69%) of a major intracranial artery, angioplasty or stenting is associated with excess morbidity and mortal- ity compared with medical management alone.336,354,355,360 Other Procedures","For patients experiencing a stroke or TIA due to moderate stenosis (50%–69%) of a major intracranial artery, angioplasty or stenting results in higher morbidity and mortality than medical management alone."
id_00091,A person with moderate to severe hypothermia should receive core rewarming before frostbite is treated.,Core rewarming should be prioritized over frostbite treatment in individuals experiencing moderate to severe hypothermia.
id_02010,"In patients with BAV and severe AR who meet criteria for AVR, aortic valve repair may be considered in selected patients if the surgery is performed at a Comprehensive Valve Center.1–3","For patients with BAV and severe AR who qualify for AVR, aortic valve repair can be an option for certain individuals if the procedure is conducted at a Comprehensive Valve Center."
id_01051,"In patients with stroke or TIA attributable to 50% to 99% stenosis or occlusion of a major intracranial artery, extracranial-intracra- nial bypass surgery is not recommended.361",Extracranial-intracranial bypass surgery is not advised for patients experiencing stroke or TIA due to 50% to 99% narrowing or blockage of a significant intracranial artery.
id_02011,"In patients with BAV and symptomatic, severe AS, TAVI may be considered as an alternative to SAVR after consideration of patient- specific procedural risks, values, trade-offs, and preferences, and when the surgery is performed at a Comprehensive Valve Center.4–6","For patients with BAV and severe, symptomatic AS, TAVI can be an alternative to SAVR, taking into account individual procedural risks, values, trade-offs, and preferences, provided the procedure is conducted at a Comprehensive Valve Center."
id_01531,"In patients with CCD without a change in clinical or functional status on optimized GDMT, routine periodic testing with coronary CTA or stress testing with or without imaging is not recommended to guide therapeutic decision-making.8–10","For patients with CCD who show no alteration in clinical or functional status while on optimized GDMT, it is not advised to routinely perform coronary CTA or stress testing, with or without imaging, for guiding treatment decisions."
id_02490,"In most adults with hypertension, antihypertensive drug treatment incorporating ≥2 antihypertensive medications is indicated to achieve the BP control necessary to prevent stroke.224,229,234–237","For the majority of adults with high blood pressure, using a combination of two or more antihypertensive drugs is recommended to attain the blood pressure control needed to prevent stroke."
id_00571,"Screening: In first-degree relatives of patients with HCM, a TTE is recommended as part of initial family screening and periodic follow-up (Figure 1, Table 7).3–5,7,14,32","For initial family screening and ongoing follow-up, it is advised that first-degree relatives of individuals with HCM undergo a TTE."
id_00092,"If possible, a person should protect frostbitten tissue from further injury and avoid walking on frozen feet and toes.","Whenever feasible, individuals should shield frostbitten areas from additional harm and refrain from walking on feet and toes that are frozen."
id_01532,"In patients with CCD without a change in clinical or functional status, routine periodic reassessment of LV function is not recommended to guide thera- peutic decision-making.11,12","For patients with CCD who have stable clinical and functional status, regular reassessment of LV function is not advised for guiding treatment decisions."
id_02491,"In adults who qualify for treatment with lipid- lowering therapy according to the 2019 ACC/ AHA guideline on the primary prevention of CVD (eg, 20–75 years of age with LDL cholesterol [LDL-C] level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 risk enhancers), treat- ment with a statin is recommended to reduce the risk of a first stroke.243,244","For adults eligible for lipid-lowering therapy based on the 2019 ACC/AHA guidelines for primary CVD prevention—such as those aged 20–75 with LDL cholesterol levels over 190 mg/dL (4.9 mmol/L), a 10-year ASCVD risk of 20% or higher, or a 10-year ASCVD risk between 7.5% and 20% with at least one risk enhancer—statin treatment is advised to lower the risk of an initial stroke."
id_01052,"In patients with a TIA or nondisabling ischemic stroke within the past 6 months and ipsilateral severe (70%–99%) carotid artery stenosis, carotid endarterectomy (CEA) is recommended to reduce the risk of future stroke, provided that perioperative morbidity and mortality risk is estimated to be <6%.369","For patients who have experienced a TIA or nondisabling ischemic stroke in the last 6 months and have severe (70%–99%) stenosis of the ipsilateral carotid artery, carotid endarterectomy (CEA) is advised to lower the risk of subsequent stroke, as long as the estimated risk of perioperative morbidity and mortality is below 6%."
id_01530,"In stable patients with CCD and with previous ACS or coronary revascularization, referral to telehealth programs, community-based programs, or both for lifestyle interventions may be reasonable as an adjunct to usual care to improve management of cardiovascular risk factors.1–7","For stable patients with CCD who have a history of ACS or coronary revascularization, it may be appropriate to refer them to telehealth or community-based programs, or both, for lifestyle interventions as a supplement to standard care to enhance the management of cardiovascular risk factors."
id_00572,"Screening: In individuals who are genotype- positive, phenotype-negative, echocardiography is recommended at periodic intervals depending on age (1-2 years in children and adolescents, 3-5 years in adults) and change in clinical status (Figure 1, Table 7).39–43","For those who have a positive genotype but no phenotypic expression, it is advised to perform echocardiography at regular intervals, which vary by age—every 1-2 years for children and adolescents, and every 3-5 years for adults—or if there is a change in clinical condition (refer to Figure 1, Table 7)."
id_02012,"In patients with signs or symptoms of rheumatic MS, TTE is indicated to establish the diagnosis, quantify hemodynamic severity, assess concomitant valvular lesions, and demonstrate valve morphology (to determine suitability for mitral commissurotomy).1–3","For patients exhibiting signs or symptoms of rheumatic mitral stenosis, a transthoracic echocardiogram is recommended to confirm the diagnosis, evaluate the severity of hemodynamic impairment, identify any associated valvular abnormalities, and assess valve structure to determine eligibility for mitral commissurotomy."
id_01533,"In patients with CCD without a change in clinical or functional status, routine periodic invasive coronary angiography should not be performed to guide therapeutic decision-making.13–17","For patients with CCD who have no alteration in clinical or functional status, regular invasive coronary angiography should not be conducted to inform treatment decisions."
id_02013,"In patients considered for percutaneous mitral balloon commissurotomy (PMBC), TEE should be performed to assess the presence or absence of LA thrombus and to evaluate the severity of MR.4–6","For patients being evaluated for percutaneous mitral balloon commissurotomy (PMBC), transesophageal echocardiography (TEE) is necessary to determine if there is an LA thrombus and to assess the severity of mitral regurgitation."
id_00573,"For patients with HCM, TEE can be useful if TTE is inconclusive in clinical decision-making regarding medical therapy, and in situations such as planning for myectomy, exclusion of subaortic membrane or MR secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.26–29","For patients with HCM, TEE may be beneficial when TTE does not provide sufficient information for clinical decisions about medical treatment, and in cases such as planning myectomy, ruling out a subaortic membrane or MR due to structural issues with the mitral valve apparatus, or evaluating the suitability for alcohol septal ablation."
id_00093,"For frozen and thawed tissue and between the toes and fingers, bulky, clean, dry gauze or sterile cotton dressings should be applied. Circumfer- ential dressings should be wrapped loosely to allow for swelling without placing pressure on the underlying tissue.","For tissue that has been frozen and thawed, as well as areas between the toes and fingers, apply thick, clean, dry gauze or sterile cotton dressings. Wrap these dressings loosely around the area to accommodate swelling without exerting pressure on the tissue beneath."
id_00094,It may be reasonable to give ibuprofen to a person with frostbite to prevent further tissue damage and to treat pain.,Administering ibuprofen to an individual with frostbite might be advisable to alleviate pain and prevent additional tissue damage.
id_00574,"For patients with HCM in whom the diagnosis of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhancing agent is reason- able, particularly if other imaging modalities such as CMR are not readily available or are contraindi- cated.44,45","For patients with HCM where the diagnosis of apical HCM, apical aneurysm, or unusual hypertrophy patterns is uncertain on TTE, it is reasonable to use an intravenous ultrasound contrast agent, especially if other imaging methods like CMR are unavailable or contraindicated."
id_02493,"In adults who do not tolerate statin therapy and who have LDL-C >100 mg/dL and elevated car- diovascular risk, treatment with bempedoic acid to reduce the risk of a first stroke is not well estab- lished.246","For adults unable to tolerate statins, with LDL-C levels exceeding 100 mg/dL and increased cardiovascular risk, the use of bempedoic acid to lower the risk of an initial stroke is not well supported."
id_02492,"In adults without CVD who qualify for treatment with lipid-lowering therapy, according to the 2019 ACC/AHA guideline on the primary prevention of CVD (eg, 20–75 years of age with LDL-C level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 risk enhancers), who cannot reach goals or cannot tolerate other therapies such as statins, the benefit of treatment with alirocumab or evo- locumab compared with other active lipid-lowering therapy for the reduction of the risk of a first stroke is uncertain.245","For adults without cardiovascular disease who meet the criteria for lipid-lowering therapy per the 2019 ACC/AHA guidelines on primary prevention of CVD (such as those aged 20–75 with LDL-C levels over 190 mg/dL [>4.9 mmol/L], a 10-year ASCVD risk of 20% or higher, or a 10-year ASCVD risk between 7.5% and 20% with at least one risk enhancer), and who are unable to achieve targets or tolerate other treatments like statins, the advantage of using alirocumab or evolocumab over other active lipid-lowering therapies for reducing the risk of a first stroke remains uncertain."
id_02494,"In adults with moderate or low intake of long-chain omega-3 fatty acid, supplementation is not recom- mended to reduce the risk of a first stroke.92","For adults with moderate or low consumption of long-chain omega-3 fatty acids, taking supplements is not advised to lower the risk of an initial stroke."
id_01534,"When discussing treatment and prevention with patients who have CCD, it is recommended that the health care team discuss out-of-pocket costs for medications at the time of initiating a new med- ication and at least annually thereafter to preempt cost-related nonadherence.1–6","For patients with CCD, it is advised that healthcare providers address the out-of-pocket expenses for medications when starting a new medication and at least once a year thereafter to prevent nonadherence due to cost."
id_01053,"In patients with ischemic stroke or TIA and symptomatic extracranial carotid stenosis who are scheduled for carotid artery stent- ing (CAS) or CEA, procedures should be performed by operators with established periprocedural stroke and mortality rates of <6% to reduce the risk of surgical adverse events.370","For patients experiencing ischemic stroke or TIA with symptomatic extracranial carotid stenosis who are planned for carotid artery stenting (CAS) or carotid endarterectomy (CEA), it is recommended that these procedures be conducted by operators whose periprocedural stroke and mortality rates are below 6% to minimize the risk of surgical complications."
id_01054,"In patients with carotid artery stenosis and a TIA or stroke, intensive medical therapy, with antiplatelet therapy, lipid-lowering therapy, and treatment of hypertension, is recom- mended to reduce stroke risk.210","For patients with carotid artery stenosis who have experienced a TIA or stroke, it is advised to implement intensive medical treatment, including antiplatelet therapy, lipid-lowering therapy, and hypertension management, to decrease the risk of stroke."
id_02014,"In patients with rheumatic MS and a discrepancy between resting echocardiographic findings and clinical symptoms, exercise testing with Doppler or invasive hemodynamic assessment is recommended to evaluate symptomatic response, exercise capacity, and the response of the mean mitral gradient and pulmonary artery pressure.1–5","For patients with rheumatic mitral stenosis who exhibit a mismatch between resting echocardiographic results and clinical symptoms, it is advised to perform exercise testing with Doppler or invasive hemodynamic evaluation to assess symptomatic response, exercise capacity, and changes in the mean mitral gradient and pulmonary artery pressure."
id_00095,It is not recommended for first aid providers to debride blisters associated with frostbite. Recommendation-Specific Supportive Text,First aid providers are advised against debriding blisters caused by frostbite.
id_01535,"In patients with known CVD being considered for NCS, a validated risk-prediction tool can be useful to estimate the risk of perioperative MACE.1–4","For patients with established cardiovascular disease undergoing evaluation for non-cardiac surgery, employing a validated risk-prediction tool can help assess the likelihood of perioperative major adverse cardiac events."
id_02495,"In all patients, screening for cigarette smoking, use of other forms of tobacco, use of electronic nicotine delivery systems such as electronic ciga- rettes (e-cigarettes) and vapes, and environmental tobacco smoke exposure (secondhand smoke exposure) is effective to inform stroke risk and target cessation interventions.254–270 Prevention intervention","Screening for cigarette smoking, other tobacco use, electronic nicotine delivery systems like e-cigarettes and vapes, and exposure to secondhand smoke is effective in assessing stroke risk and guiding cessation efforts in all patients."
id_02015,"In patients with rheumatic MS and 1) AF, 2) a prior embolic event, or 3) an LA thrombus, anticoagulation with a VKA is indicated.1–7","For patients with rheumatic mitral stenosis who have atrial fibrillation, a history of embolic events, or a left atrial thrombus, anticoagulation with a vitamin K antagonist is recommended."
id_00575,"For asymptomatic patients with HCM who do not have a resting or provocable outflow tract peak gradient ≥50 mm Hg on standard TTE, exercise TTE is reasonable for the detection and quantification of dynamic LVOTO.15,19,20,22–25","In asymptomatic patients with HCM lacking a resting or inducible outflow tract peak gradient of ≥50 mm Hg on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO."
id_00576,"For patients suspected of having HCM in whom echocardiography is inconclusive, CMR imaging is indicated for diagnostic clarification.1–7","If echocardiography results are inconclusive in patients suspected of having HCM, CMR imaging should be used for further diagnostic clarity."
id_00096,"For people with exertional hyperthermia or heatstroke, first aid providers should move the individual from the hot environment, remove excess clothing, limit exertion, and provide cool liquids if the person is able to swallow.","For individuals experiencing exertional hyperthermia or heatstroke, first aid responders should relocate them to a cooler area, remove unnecessary clothing, reduce physical activity, and offer cool fluids if they can swallow."
id_01056,"In patients ≥70 years of age with stroke or TIA in whom carotid revascularization is being considered, it is reasonable to select CEA over CAS to reduce the periprocedural stroke rate.371","For patients aged 70 and older with stroke or TIA who are candidates for carotid revascularization, choosing CEA instead of CAS is advisable to lower the risk of stroke during the procedure."
id_02016,"In patients with rheumatic MS and AF with a rapid ventricular response, heart rate control can be beneficial.8","For patients with rheumatic mitral stenosis and atrial fibrillation with a fast ventricular rate, controlling the heart rate may be advantageous."
id_01536,"In patients undergoing elevated-risk NCS, a structured assessment of functional capac­ ity (such as the Duke Activity Status Index [DASI]) is reasonable to stratify the risk of perioperative adverse cardiovascular events.1–8","For patients facing high-risk non-cardiac surgery, it is advisable to evaluate functional capacity using tools like the Duke Activity Status Index (DASI) to assess the risk of adverse cardiovascular events during the perioperative period."
id_00097,"For people with heatstroke (heat illness with altered mental status), first aid providers should activate emergency services.","First aid responders should contact emergency services for individuals experiencing heatstroke, characterized by changes in mental status."
id_01055,"In patients with recent TIA or ischemic stroke and ipsilateral moderate (50%–69%) carotid steno- sis as documented by catheter-based imaging or noninvasive imaging, CEA is recommended to reduce the risk of future stroke, depending on patient-specific factors such as age, sex, and comorbidities, if the perioperative morbidity and mortality risk is estimated to be <6%.369","For patients who have experienced a recent TIA or ischemic stroke and have ipsilateral carotid stenosis of 50%–69% confirmed by catheter-based or noninvasive imaging, carotid endarterectomy (CEA) is advised to lower the risk of subsequent strokes, taking into account individual factors like age, sex, and existing health conditions, provided the estimated risk of perioperative complications and death is below 6%."
id_00577,"For patients with LVH in whom there is a suspicion of alternative diagnoses, including infiltrative or stor- age disease as well as athlete’s heart, CMR imaging is useful (Figure 1).1–7","CMR imaging is beneficial for patients with LVH when alternative diagnoses, such as infiltrative or storage diseases and athlete's heart, are suspected."
id_02496,"For patients who are nonusers of tobacco products, continued complete abstention from cigarette smoking, in addition to other tobacco products and electronic nicotine delivery systems, and avoidance of exposure to environmental tobacco smoke (secondhand smoke exposure) are recommended to avoid the associated increased risk of stroke.254,255,257–263,265–270 Cessation intervention","For individuals who do not use tobacco, it is advised to maintain total abstinence from smoking cigarettes, using other tobacco products, and electronic nicotine delivery systems, as well as to steer clear of secondhand smoke exposure, to reduce the heightened risk of stroke."
id_01057,"In patients in whom revascularization is planned within 1 week of the index stroke, it is reasonable to choose CEA over CAS to reduce the periprocedural stroke rate.372 Downloaded from http://ahajournals.org by on June 19, 2025","For patients scheduled for revascularization within a week following the initial stroke, opting for CEA instead of CAS is advisable to lower the risk of stroke during the procedure."
id_02017,"In patients with rheumatic MS in normal sinus rhythm with symptomatic resting or exertional sinus tachycardia, heart rate control can be beneficial to manage symptoms.9–15","For patients with rheumatic mitral stenosis who are in normal sinus rhythm and experience symptomatic sinus tachycardia at rest or during exertion, controlling the heart rate may help alleviate symptoms."
id_02497,"For patients who are active cigarette smokers, smoking cessation pharmacotherapy delivered along with behavioral counseling is recommended, in preference to behavioral counseling alone, to facilitate smoking cessation.271–277","For patients who actively smoke cigarettes, it is advised to combine smoking cessation medication with behavioral counseling, rather than relying solely on behavioral counseling, to aid in quitting smoking."
id_00098,"For adults with heatstroke, it is reasonable to initiate immediate active cooling by using whole- body (neck-down) cool- to cold-water immersion for 15 minutes or until neurological symptoms resolve (whichever occurs first).","For adults experiencing heatstroke, promptly starting active cooling with full-body immersion in cool to cold water for 15 minutes or until neurological symptoms subside, whichever comes first, is advisable."
id_01537,"In all patients ≥65 years of age and in those <64 years with perceived frailty who are undergoing elevated-risk NCS, preoperative frailty assessment using a validated tool can be useful for evaluating perioperative risk and guiding management.1–5","For patients aged 65 and older, as well as those under 64 who are considered frail, undergoing high-risk non-cardiac surgery, assessing frailty preoperatively with a validated tool can aid in evaluating perioperative risk and informing management strategies."
id_01058,"In patients with TIA or nondisabling stroke, when revascularization is indicated, it is reasonable to perform the procedure within 2 weeks of the index event rather than delay surgery to increase the likelihood of stroke- free outcome.373","For patients experiencing TIA or a nondisabling stroke, if revascularization is warranted, it is advisable to carry out the procedure within 2 weeks of the initial event to enhance the chances of avoiding a subsequent stroke."
id_01538,"In patients with known CVD, or age ≥65 years, or age ≥45 years with symptoms suggestive of CVD undergoing elevated-risk NCS, it is reasonable to measure B-type natriuretic peptide (BNP) or N- terminal pro–B-type natriuretic peptide (NT-proBNP) before surgery to supplement evaluation of perioperative risk.1–3","For patients with established cardiovascular disease, those aged 65 or older, or individuals aged 45 or older exhibiting symptoms indicative of cardiovascular disease who are undergoing high-risk non-cardiac surgery, it is advisable to assess B-type natriuretic peptide (BNP) or N-terminal pro–B-type natriuretic peptide (NT-proBNP) preoperatively to enhance the assessment of perioperative risk."
id_02498,"For patients who are active cigarette smokers and users of other tobacco products (eg, electronic nicotine delivery systems), assistance with cessation is recommended to reduce the risk of stroke.260,271,278–286","It is advised that individuals who actively smoke cigarettes or use other tobacco products, such as electronic nicotine delivery systems, receive support to quit in order to lower their risk of stroke."
id_02018,"In symptomatic patients (NYHA class II, III, or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) and favorable valve morphology with less than moderate (2+) MR* in the absence of LA thrombus, PMBC is recommended if it can be performed at a Comprehensive Valve Center.1–12","For patients exhibiting symptoms (NYHA class II, III, or IV) with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage D) and suitable valve morphology with no more than moderate (2+) mitral regurgitation and without left atrial thrombus, PMBC is advised if it can be conducted at a Comprehensive Valve Center."
id_00578,"For patients with HCM who are not otherwise identified as high risk for SCD, or in whom a deci- sion to proceed with ICD remains uncertain after clinical assessment that includes personal or family history, echocardiography, and ambulatory electrocar- diographic monitoring, CMR imaging is beneficial to assess for maximum LV wall thickness, EF, LV apical aneurysm, and extent of myocardial replacement fibrosis with late gadolinium enhancement (LGE).1–15","For patients with HCM who are not clearly at high risk for SCD, or when the decision to implant an ICD is still uncertain after evaluating personal or family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum LV wall thickness, EF, LV apical aneurysm, and the degree of myocardial replacement fibrosis using late gadolinium enhancement (LGE)."
id_00099,"For adults with heatstroke, it is reasonable to initiate other forms of active cooling, including commercial ice packs, cold showers, ice sheets and towels, cooling vests and jackets, and evaporative, fanning, or a combination of techniques when water immersion is not available.","For adults experiencing heatstroke, it is advisable to begin alternative active cooling methods, such as using commercial ice packs, taking cold showers, applying ice sheets and towels, wearing cooling vests and jackets, or employing evaporative and fanning techniques, or a combination thereof, when water immersion is not an option."
id_00579,"For patients with obstructive HCM in whom the ana- tomic mechanism of obstruction is inconclusive on echocardiography, CMR imaging is indicated to inform the selection and planning of SRT.16–20","CMR imaging is recommended for patients with obstructive HCM when echocardiography does not clearly identify the anatomical cause of obstruction, to aid in the selection and planning of SRT."
id_01059,In patients with symptomatic severe stenosis (≥70%) in whom anatomic or medical condi- tions are present that increase the risk for surgery (such as radiation-induced stenosis or restenosis after CEA) it is reasonable to choose CAS to reduce the periprocedural complication rate.374,"For patients with symptomatic severe stenosis (≥70%) who have anatomical or medical factors that elevate surgical risk, like radiation-induced stenosis or restenosis following CEA, opting for CAS is a reasonable approach to lower the risk of periprocedural complications."
id_01539,"In patients with known CVD, or age ≥65 years, or age ≥45 years with symptoms suggestive of CVD undergoing elevated-risk NCS, it may be reasonable to measure cardiac troponin (cTn) before surgery to supplement evaluation of peri­ operative risk.4–6","For patients with established cardiovascular disease (CVD), those aged 65 or older, or individuals aged 45 or older exhibiting symptoms indicative of CVD who are undergoing high-risk non-cardiac surgery, it may be appropriate to assess cardiac troponin (cTn) levels preoperatively to enhance the assessment of perioperative risk."
id_02019,"In severely symptomatic patients (NYHA class III or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) who 1) are not candidates for PMBC, 2) have failed a previous PMBC, 3) require other cardiac procedures, or 4) do not have access to PMBC, mitral valve surgery (repair, commissurotomy, or valve replacement) is indicated.6,7,13","For patients with severe symptoms (NYHA class III or IV) and advanced rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage D) who are either unsuitable for PMBC, have had an unsuccessful PMBC, need additional cardiac procedures, or lack access to PMBC, mitral valve surgery (repair, commissurotomy, or replacement) is recommended."
id_00100,"For children with heatstroke, it is reasonable to initi- ate immediate active cooling by using whole-body (neck-down) cool- to cold-water immersion for 15 minutes or until neurological symptoms resolve (whichever occurs first).","For children experiencing heatstroke, it is advisable to promptly begin active cooling by immersing the entire body from the neck down in cool to cold water for 15 minutes or until neurological symptoms subside, whichever comes first."
id_02499,"For patients who are active cigarette smokers encountered in the hospital setting, providing smoking cessation pharmacotherapy along with behavioral counseling as the default treatment (“opt-out”), in preference to providing such treat- ment only for patients expressing a willingness to quit smoking (“opt-in”), can be beneficial to facili- tate short-term smoking cessation and to increase engagement in smoking cessation treatment.287,288","For hospitalized patients who actively smoke cigarettes, offering smoking cessation medications and behavioral counseling as the standard treatment option, unless declined (""opt-out""), rather than only to those who express a desire to quit (""opt-in""), can aid in achieving short-term smoking cessation and enhance participation in cessation programs."
id_00580,"For patients with HCM, repeat contrast-enhanced CMR imaging on a periodic basis (every 3-5 years) for the purpose of SCD risk stratification may be considered to evaluate changes in LGE and other morphologic changes, including EF, development of apical aneurysm, or LV wall thickness (Figure 1,","For individuals with HCM, it may be advisable to periodically perform contrast-enhanced CMR imaging every 3-5 years to assess SCD risk by evaluating alterations in LGE and other morphological changes, such as EF, apical aneurysm formation, or LV wall thickness."
id_01060,"In symptomatic patients at average or low risk of complications associated with endovascular intervention, when the ICA stenosis is ≥70% by noninvasive imaging or >50% by catheter-based imaging and the anticipated rate of periprocedural stroke or death is <6%, CAS may be considered as an alternative to CEA for stroke preven- tion, particularly in patients with significant cardiovascular comorbidities predispos- ing to cardiovascular complications with endarterectomy.375","For symptomatic patients with average or low risk of endovascular intervention complications, when internal carotid artery stenosis is 70% or greater as determined by noninvasive imaging, or more than 50% by catheter-based imaging, and the expected periprocedural stroke or death rate is under 6%, carotid artery stenting (CAS) can be considered as an alternative to carotid endarterectomy (CEA) for stroke prevention, especially in those with significant cardiovascular comorbidities that increase the risk of complications from endarterectomy."
id_02500,"For patients who are active cigarette smokers, the long-term health benefits of using e-cigarettes in place of nicotine replacement therapy to facilitate cigarette smoking cessation are not well estab- lished.289–291",The long-term health advantages of substituting e-cigarettes for nicotine replacement therapy to aid in quitting smoking are not well-defined for patients who actively smoke cigarettes.
id_01540,"For patients with known coronary heart disease, signifi­ cant arrhythmia, peripheral arterial disease, cerebrovas­ cular disease, other significant structural heart disease, or symptoms* of CVD undergoing elevated-risk sur­ gery, a preoperative resting 12-lead electrocardiogram (ECG) is reasonable to establish a preoperative base­ line and guide perioperative management.1,2","For individuals with established coronary heart disease, notable arrhythmias, peripheral arterial disease, cerebrovascular disease, other significant structural heart conditions, or symptoms of cardiovascular disease who are undergoing high-risk surgery, it is advisable to perform a preoperative resting 12-lead electrocardiogram (ECG) to establish a baseline and assist in perioperative management."
id_00581,"In adult patients with suspected HCM, cardiac CT may be considered for diagnosis if the echocardiogram is not diagnostic and CMR imaging is unavailable.1–3","For adult patients suspected of having HCM, consider using cardiac CT for diagnosis when the echocardiogram is inconclusive and CMR imaging cannot be performed."
id_01541,"In patients undergoing NCS with a preoperative ECG exhibiting new abnormalities,† further evalu­ ation is reasonable to refine assessment of cardio­ vascular risk.3–8","For patients having NCS with a preoperative ECG showing new abnormalities, it is reasonable to conduct further evaluation to better assess cardiovascular risk."
id_00101,"For children with heatstroke, it is reasonable to initiate other forms of active cooling, including commercial ice packs, cold showers, ice sheets and towels, cooling vests and jackets, and evaporative, fanning, or a combination of techniques when water immersion is not available.","When water immersion is unavailable for children with heatstroke, it is appropriate to start other active cooling methods such as using commercial ice packs, taking cold showers, applying ice sheets and towels, wearing cooling vests and jackets, or employing evaporative and fanning techniques, either alone or in combination."
id_02501,"In the asymptomatic population, routine screen- ing for carotid artery stenosis is not recom- mended to reduce the risk of stroke.306,307 Other interventions",Routine screening for carotid artery stenosis is not advised for asymptomatic individuals to lower stroke risk.
id_02020,"In asymptomatic patients with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage C) and favorable valve morphology with less than 2+ MR in the absence of LA thrombus who have elevated pulmonary pressures (pulmonary artery systolic pressure >50 mm Hg), PMBC is reasonable if it can be performed at a Comprehensive Valve Center.14","For asymptomatic individuals with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage C) who exhibit favorable valve morphology, have less than 2+ mitral regurgitation, no left atrial thrombus, and elevated pulmonary artery systolic pressure (>50 mm Hg), percutaneous mitral balloon commissurotomy is a reasonable option if conducted at a Comprehensive Valve Center."
id_01061,"In patients with a recent stroke or TIA (past 6 months), the usefulness of transcarotid artery revascularization (TCAR) for prevention of recurrent stroke and TIA is uncertain.376",The effectiveness of transcarotid artery revascularization (TCAR) in preventing recurrent stroke and TIA in patients who have experienced a stroke or TIA within the last 6 months is unclear.
id_00582,"In patients with HCM, a 12-lead ECG is recommended in the initial evaluation and as part of periodic follow-up (every 1-2 years) (Figure 1, Table 7).1–3","For individuals with HCM, it is advised to perform a 12-lead ECG during the initial assessment and regularly thereafter, every 1-2 years."
id_01062,"In patients with recent TIA or ischemic stroke and when the degree of stenosis is <50%, revascularization with CEA or CAS to reduce the risk of future stroke is not recom- mended.369","For patients who have experienced a recent TIA or ischemic stroke and have stenosis less than 50%, it is advised against performing revascularization with CEA or CAS to lower the risk of subsequent strokes."
id_00102,"It may be reasonable for first aid providers, who are trained and willing, to measure core temperature during active cooling for heatstroke. The target core temperature to cool until is 39° C (102.2° F). Recommendation-Specific Supportive Text","For first aid providers who are trained and willing, it might be appropriate to monitor core temperature during active cooling for heatstroke, aiming to reduce it to 39°C (102.2°F)."
id_02021,"In asymptomatic patients with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage C) and favorable valve morphology with less than 2+/ MR* in the absence of LA thrombus who have new onset of AF, PMBC may be considered if it can be performed at a Comprehensive Valve Center.15","For asymptomatic patients with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage C) who have favorable valve morphology and less than 2+ mitral regurgitation, and no left atrial thrombus, percutaneous mitral balloon commissurotomy may be an option if they develop new-onset atrial fibrillation and the procedure can be done at a Comprehensive Valve Center."
id_01542,"For asymptomatic patients undergoing elevated-risk surgeries without known CVD, a preoperative rest­ ing 12-lead ECG may be considered to establish a baseline and guide perioperative management.3,9,10","For patients without known cardiovascular disease who are asymptomatic and facing high-risk surgeries, a preoperative resting 12-lead ECG can be considered to establish a baseline and assist in perioperative management."
id_02502,"In patients with asymptomatic carotid artery stenosis (ACS) >70%, shared decision-making between the patient and the health care team to decide between the 2 courses of treatment (carotid revascularization or medical manage- ment) is recommended to determine the best method of reducing stroke risk.","For patients with asymptomatic carotid artery stenosis greater than 70%, it is advised that the patient and healthcare team engage in shared decision-making to choose between carotid revascularization and medical management as the optimal approach to lower stroke risk."
id_00103,"In the absence of shock, confusion, or inability to swallow, first aid providers should assist or encourage individuals with exertional dehydration to orally rehydrate with any available rehydration drink or potable water.","If there is no shock, confusion, or swallowing difficulty, first aid responders should help or motivate those experiencing exertional dehydration to drink any available rehydration solution or safe water."
id_00583,"In patients with HCM, 24- to 48-hour ambulatory electrocardiographic monitoring is recommended in the initial evaluation and as part of periodic follow-up (every 1-2 years) to identify patients who are at risk for SCD and to guide management of arrhythmias (Figure 1).4–6","For individuals with HCM, it is advised to conduct 24- to 48-hour ambulatory ECG monitoring during the initial assessment and regularly every 1-2 years thereafter to detect those at risk for SCD and to manage arrhythmias effectively."
id_02022,"In symptomatic patients (NYHA class II, III, or IV) with rheumatic MS and an mitral valve area >1.5 cm2, if there is evidence of hemodynamically significant rheumatic MS on the basis of a pulmonary artery wedge pressure >25 mm Hg or a mean mitral valve gradient >15 mm Hg during exercise, PMBC may be considered if it can be performed at a Comprehensive Valve Center.16","For patients with symptoms classified as NYHA class II, III, or IV who have rheumatic mitral stenosis and a mitral valve area greater than 1.5 cm², percutaneous mitral balloon commissurotomy (PMBC) may be considered if performed at a Comprehensive Valve Center, provided there is hemodynamically significant rheumatic mitral stenosis indicated by a pulmonary artery wedge pressure exceeding 25 mm Hg or a mean mitral valve gradient over 15 mm Hg during exercise."
id_01543,"For asymptomatic patients undergoing low-risk surgi­ cal procedures, a routine preoperative resting 12-lead ECG is not recommended to improve outcomes.11 *Active symptoms and signs of CVD include chest pain, dyspnea, undiagnosed palpitations, tachycardia, syncope, or murmurs. †Abnormalities may include ST-segment elevation, ST depression, T-wave inversions, left ventricular (LV) hypertrophy, significant pathologic Q-waves, Mo­ bitz type II or higher atrioventricular block, bundle branch block, QT prolonga­ tion, or AF.","For patients without symptoms undergoing low-risk surgical procedures, performing a routine preoperative resting 12-lead ECG is not advised to enhance outcomes."
id_02503,"In patients with asymptomatic atherosclerotic carotid artery stenosis, medical treatment with statin can be beneficial to reduce the risk of stroke.308–311","For patients with asymptomatic carotid artery stenosis due to atherosclerosis, administering statins may help lower the risk of stroke."
id_01063,"In patients with a recent (within 120 days) TIA or ischemic stroke ipsilateral to atherosclerotic stenosis or occlusion of the middle cerebral or carotid artery, extracranial- intracranial bypass surgery is not recom- mended.377",Extracranial-intracranial bypass surgery is not advised for patients who have experienced a TIA or ischemic stroke within the past 120 days on the same side as atherosclerotic stenosis or blockage of the middle cerebral or carotid artery.
id_00584,"In patients with HCM who develop palpitations or lightheadedness, extended (>24 hours) elec- trocardiographic monitoring or event recording is recommended for arrhythmia diagnosis and clinical correlation.6","For patients with HCM experiencing palpitations or dizziness, it is advised to conduct extended electrocardiographic monitoring or event recording for more than 24 hours to diagnose arrhythmias and correlate clinically."
id_01064,"In patients with recently symptomatic extra- cranial vertebral artery stenosis, intensive medical therapy (antiplatelet therapy, lipid lowering, BP control) is recommended to reduce stroke risk.378","For patients with recent symptoms of extracranial vertebral artery stenosis, it is advised to implement intensive medical treatment, including antiplatelet therapy, lipid management, and blood pressure control, to lower the risk of stroke."
id_00104,"It is reasonable to choose 4% to 9% carbohydrate- electrolyte drink over potable water, 0% to 3.9% carbohydrate-electrolyte drinks, coconut water, or low-fat cow’s milk, if each is readily available. Recommendation-Specific Supportive Text","Opting for a carbohydrate-electrolyte drink with a concentration of 4% to 9% is advisable over potable water, drinks with 0% to 3.9% carbohydrate-electrolyte content, coconut water, or low-fat cow's milk, provided all options are easily accessible."
id_02023,"In severely symptomatic patients (NYHA class III or IV) with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) who have a suboptimal valve anatomy and who are not candidates for surgery or are at high risk for surgery, PMBC may be considered if it can be performed at a Comprehensive Valve Center.17–19 *2+ on a 0 to 4+ scale according to Sellar’s criteria or less than moderate by Doppler echocardiography.20","For patients with severe symptoms (NYHA class III or IV) and advanced rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage D) who have unsuitable valve anatomy and are either ineligible for surgery or face high surgical risks, PMBC may be an option if conducted at a Comprehensive Valve Center, provided the regurgitation is graded *2+ on a 0 to 4+ scale by Sellar’s criteria or is less than moderate by Doppler echocardiography."
id_02024,"In severely symptomatic patients (NYHA class III or IV) with severe MS (mitral valve area ≤1.5 cm2, Stage D) attributable to extensive mitral annular calcification, valve intervention may be considered only after discussion of the high procedural risk and the individual patient’s preferences and values.1–3","For patients with severe symptoms (NYHA class III or IV) and significant mitral stenosis (mitral valve area ≤1.5 cm², Stage D) due to extensive mitral annular calcification, valve intervention should be contemplated only after evaluating the high procedural risk and considering the patient's personal preferences and values."
id_01544,"In patients undergoing NCS with new dyspnea, physical examination findings of HF, or suspected new/worsening ventricular dysfunction, it is recom­ mended to perform preoperative evaluation of LV function to help guide perioperative management.1–8","For patients undergoing NCS who present with new shortness of breath, signs of heart failure, or suspected new or worsening ventricular dysfunction, a preoperative assessment of left ventricular function is advised to assist in perioperative management."
id_00585,"In first-degree relatives of patients with HCM, a 12-lead ECG is recommended as a component of the screening algorithm (Figure 1, Table 7).1–3","For screening first-degree relatives of individuals with HCM, it is advised to include a 12-lead ECG as part of the evaluation process (Figure 1, Table 7).1–3"
id_02504,"In patients with asymptomatic atherosclerotic carotid artery stenosis >70% and low periopera- tive risk, the use of carotid revascularization, in addition to intensive medical therapy, may be reasonable to reduce the risk of stroke.309,312–314","For patients with asymptomatic carotid artery stenosis exceeding 70% and low risk for perioperative complications, carotid revascularization alongside intensive medical treatment might be a reasonable approach to lower stroke risk."
id_01545,"In patients with a known diagnosis of HF with wors­ ening dyspnea or other change in clinical status undergoing NCS, preoperative assessment of LV function is reasonable to help guide perioperative management.1,4,7,9–11","For patients diagnosed with HF experiencing increased dyspnea or other clinical status changes undergoing NCS, it is reasonable to assess LV function preoperatively to assist in guiding perioperative management."
id_01065,"In patients with ischemic stroke or TIA and extracranial vertebral artery stenosis who are having symptoms despite optimal medical treatment, the usefulness of stenting is not well established.378","For patients experiencing symptoms from ischemic stroke or TIA with extracranial vertebral artery stenosis, despite receiving optimal medical therapy, the efficacy of stenting remains uncertain."
id_02025,"In patients with known or suspected primary MR, TTE is indicated for baseline evaluation of LV size and function, RV function, LA size, pulmonary artery pressure, and the mechanism and severity of primary MR (Stages A to D).1–5","For patients with confirmed or suspected primary MR, TTE should be performed to assess baseline LV size and function, RV function, LA size, pulmonary artery pressure, and to determine the mechanism and severity of primary MR (Stages A to D)."
id_00105,"It is beneficial for first aid providers to receive training in responding to opioid overdose, including the provision of naloxone.","First aid responders should be trained in handling opioid overdoses, including administering naloxone."
id_02505,"In patients with ACS >50%, annual carotid duplex ultrasound every 6 to 12 months might be reasonable to assess progression of disease and subsequent increased risk of stroke.308,315–318","For patients with ACS greater than 50%, it may be advisable to perform a carotid duplex ultrasound every 6 to 12 months to monitor disease progression and the associated elevated risk of stroke."
id_00106,"A first aid provider who encounters a person with suspected opioid overdose who is unresponsive and not breathing or not breathing normally should activate the emergency response system, provide high-quality CPR (compressions plus ventilation), and administer naloxone. Recommendation-Specific Supportive Text","If a first aid provider finds an individual suspected of opioid overdose who is unresponsive and either not breathing or breathing abnormally, they should call emergency services, perform high-quality CPR (including compressions and ventilation), and give naloxone."
id_00586,"In patients with HCM who are deemed to be at high risk for developing AF based on the presence of risk factors or as determined by a validated risk score, and who are eligible for anticoagulation, extended ambulatory monitoring is recommended to screen for AF as part of initial evaluation and annual follow-up (Figure 1).7–12","For patients with HCM identified as high risk for AF due to risk factors or a validated risk score, and who qualify for anticoagulation, it is advised to conduct extended ambulatory monitoring to detect AF during the initial assessment and annually thereafter."
id_01066,"In patients with ischemic stroke or TIA and extracranial vertebral artery stenosis who are having symptoms despite optimal medical treatment, the usefulness of open surgical procedures, including vertebral endarterec- tomy and vertebral artery transposition, is not well established.","For patients experiencing symptoms from ischemic stroke or TIA with extracranial vertebral artery stenosis, despite receiving optimal medical therapy, the effectiveness of open surgical interventions such as vertebral endarterectomy and vertebral artery transposition remains uncertain."
id_01546,"In asymptomatic and clinically stable patients undergo­ ing NCS, routine preoperative evaluation of LV func­ tion is not recommended due to lack of benefit.12–15","Routine preoperative assessment of left ventricular function is not advised for asymptomatic and clinically stable patients undergoing non-cardiac surgery, as it offers no benefit."
id_02506,"In patients with asymptomatic atherosclerotic carotid artery stenosis and high perioperative risk, the effectiveness of carotid revascular- ization to reduce risk of stroke is not estab- lished.314,319,320","For patients with asymptomatic atherosclerotic carotid artery stenosis who are at high risk during surgery, the benefit of carotid revascularization in lowering stroke risk has not been determined."
id_00107,Immediate skin decontamination is recommended after a chemical exposure.,Prompt skin decontamination is advised following chemical exposure.
id_02026,"In patients with primary MR, when TTE provides insufficient or discordant information, TEE is indicated for evaluation of the severity of MR, mechanism of MR, and status of LV function (Stages B to D).","For patients with primary MR, if TTE yields inadequate or conflicting data, TEE is recommended to assess MR severity, MR mechanism, and LV function status (Stages B to D)."
id_01067,"In patients with a stroke or TIA and evidence of an aortic arch atheroma, intensive lipid management to an LDL cholesterol target <70 mg/dL is recommended to prevent recur- rent stroke.210","For patients who have experienced a stroke or TIA and have an aortic arch atheroma, it is advised to manage lipids intensively to achieve an LDL cholesterol level below 70 mg/dL to prevent another stroke."
id_00587,"In adult patients with HCM without risk factors for AF and who are eligible for anticoagulation, extended ambulatory monitoring may be considered to assess for asymptomatic paroxysmal AF as part of initial evaluation and periodic follow-up (every 1-2 years).7–12","For adult patients with HCM who lack AF risk factors and qualify for anticoagulation, extended ambulatory monitoring can be considered to detect asymptomatic paroxysmal AF during the initial assessment and at regular follow-ups every 1-2 years."
id_02507,"In adults with asymptomatic cerebral SVD (CSVD), including silent infarcts, assessment and management of risk factors (eg, hypertension, dyslipidemia, tobacco use, and diabetes) are recommended to reduce stroke risk.336–341","For adults with asymptomatic cerebral small vessel disease (CSVD), such as silent infarcts, it is advised to evaluate and control risk factors like hypertension, dyslipidemia, smoking, and diabetes to lower the risk of stroke."
id_01547,"For patients undergoing elevated-risk NCS with poor or unknown functional capacity and elevated risk for perioperative cardiovascular events based on a validated risk tool, stress testing may be consid­ ered to evaluate for inducible myocardial ischemia.1","For patients facing high-risk non-cardiac surgery with inadequate or uncertain functional capacity and a high likelihood of perioperative cardiovascular events as determined by a validated risk assessment, stress testing can be considered to assess for inducible myocardial ischemia."
id_01068,"In patients with a stroke or TIA and evidence of an aortic arch atheroma, antiplatelet therapy is recommended to prevent recurrent stroke.380–385","For patients who have experienced a stroke or TIA and have an aortic arch atheroma, it is advised to use antiplatelet therapy to prevent another stroke."
id_00108,"Unless otherwise recommended by local guide- lines or chemical-specific information, skin exposed to caustic chemical should be irrigated with running water for at least 15 minutes.","If not advised differently by local protocols or specific chemical data, skin that has come into contact with a caustic substance should be rinsed with flowing water for a minimum of 15 minutes."
id_02027,"In patients with primary MR, CMR is indicated to assess LV and RV volumes and function and may help with assessing MR severity when there is a discrepancy between the findings on clinical assessment and echocardiography.6–9","For patients with primary MR, CMR is recommended to evaluate LV and RV volumes and function, and it can aid in determining MR severity when clinical assessment and echocardiography results differ."
id_02028,"In patients with severe primary MR undergoing mitral intervention, intraoperative TEE is indicated to establish the anatomic basis for primary MR (Stages C and D) and to guide repair.10,11","For patients with severe primary MR who are undergoing mitral intervention, intraoperative TEE is recommended to determine the anatomical cause of primary MR (Stages C and D) and to assist in the repair process."
id_01548,"In patients who are at low risk for perioperative cardiovascular events, have adequate* functional capacity with stable symptoms, or who are undergo­ ing low-risk procedures, routine stress testing before NCS is not recommended due to lack of benefit.1–3 *Poor functional capacity is considered <4 METs or a DASI score of ≤34.","For patients with low risk of perioperative cardiovascular events, sufficient functional capacity with stable symptoms, or those undergoing low-risk procedures, routine preoperative stress testing before non-cardiac surgery is not advised, as it offers no benefit. Poor functional capacity is defined as less than 4 METs or a DASI score of 34 or lower."
id_00588,"For patients with symptomatic HCM for whom there is uncertainty regarding the presence or severity of LVOTO on noninvasive imaging studies, invasive hemodynamic assessment with cardiac catheterization is recommended.1–4","In patients with symptomatic HCM where noninvasive imaging does not clearly determine the presence or severity of LVOTO, cardiac catheterization for invasive hemodynamic evaluation is advised."
id_02029,"In patients with primary MR (Stages B to D) and new-onset or changing symptoms, TTE is indicated to evaluate the mitral valve apparatus and LV function.1,2","For patients with primary MR (Stages B to D) who experience new or altered symptoms, TTE is recommended to assess the mitral valve structure and LV function."
id_01549,"For patients undergoing elevated-risk surgery with poor* or unknown functional capacity, and elevated risk for perioperative cardiovascular events based on a validated risk tool, coronary computed tomog­ raphy angiography (CCTA) for the detection of high-risk coronary anatomy† may be considered.1–4","For patients facing high-risk surgery with inadequate or uncertain functional capacity and an increased likelihood of perioperative cardiovascular events as determined by a validated risk assessment tool, considering coronary computed tomography angiography (CCTA) to identify high-risk coronary anatomy may be appropriate."
id_02508,"In adults with silent cerebral infarcts (SCIs) who do not have an indication for statin therapy according to the 2019 ACC/AHA guideline (eg, 20–75 years of age with LDL-C level >190 mg/dL [>4.9 mmol/L], 10-year ASCVD risk ≥20%, or 10-year ASCVD risk ≥7.5%–<20% plus ≥1 more risk enhancers), use of low-dose statin therapy might be considered to reduce the risk of ischemic stroke.342–345","For adults with silent cerebral infarcts (SCIs) who do not meet the 2019 ACC/AHA guideline criteria for statin therapy (such as those aged 20–75 with LDL-C levels over 190 mg/dL, a 10-year ASCVD risk of 20% or higher, or a 10-year ASCVD risk between 7.5% and 20% with at least one additional risk enhancer), considering low-dose statin therapy may help lower the risk of ischemic stroke."
id_01069,"In patients with moyamoya disease and a history of ischemic stroke or TIA, surgi- cal revascularization with direct or indirect extracranial-intracranial bypass can be beneficial for the prevention of ischemic stroke or TIA.391–397","For patients with moyamoya disease who have experienced an ischemic stroke or TIA, surgical revascularization using either direct or indirect extracranial-intracranial bypass may help prevent further ischemic strokes or TIAs."
id_00109,"It can be beneficial to follow local guidelines, fol- low chemical-specific procedures, or consult a regional poison center when assisting a person with chemical exposures.","Adhering to local protocols, using procedures tailored to specific chemicals, or seeking advice from a regional poison center can be advantageous when managing chemical exposures."
id_02509,"In adults with SCI, the benefit of antiplatelet therapy to reduce the risk of ischemic stroke is uncertain.346,347","For adults with SCI, it is unclear whether antiplatelet therapy effectively lowers the risk of ischemic stroke."
id_00590,"In patients with HCM who are at risk of coronary atherosclerosis, coronary angiography (CT or invasive) is recommended before surgical myectomy.6 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with HCM who may develop coronary atherosclerosis, it is advised to perform coronary angiography (either CT or invasive) prior to undergoing surgical myectomy."
id_00110,"Contaminated clothing, jewelry, and other surrounding material should be removed from the area of a chemical exposure.","Clothing, jewelry, and other materials in contact with a chemical exposure should be taken off and removed from the vicinity."
id_00589,"In patients with HCM who have symptoms or evidence of myocardial ischemia, coronary angiography (CT or invasive) is recommended.5","For patients with HCM experiencing symptoms or signs of myocardial ischemia, it is advised to perform coronary angiography, either via CT or invasive methods."
id_01550,"In patients who are at low risk for perioperative cardiovascular events, have adequate* functional capacity with stable symptoms, or who are undergo­ ing low-risk procedures, routine CCTA before NCS is not recommended due to lack of benefit.1,5 *Poor functional capacity is considered <4 METs or a DASI score of ≤34. †High-risk coronary anatomy is defined as patients with obstructive stenosis who have ≥50% left main stenosis or anatomically significant 3-vessel disease (≥70% stenosis).6","For patients with low risk of perioperative cardiovascular events, sufficient functional capacity with stable symptoms, or those undergoing low-risk procedures, routine CCTA prior to NCS is not advised as it offers no benefit."
id_01070,"In patients with moyamoya disease and a his- tory of ischemic stroke or TIA, the use of anti- platelet therapy, typically aspirin monotherapy, for the prevention of ischemic stroke or TIA may be reasonable.393,394,397–401","For individuals with moyamoya disease who have experienced an ischemic stroke or TIA, it may be appropriate to use antiplatelet therapy, commonly aspirin alone, to prevent further ischemic strokes or TIAs."
id_00111,"EMS should be called when a person with chemi- cal exposure has respiratory symptoms, systemic symptoms, or large chemical exposures.","Contact emergency medical services if an individual exposed to chemicals exhibits respiratory or systemic symptoms, or if the exposure is extensive."
id_00591,"For symptomatic patients with HCM who do not have resting or provocable outflow tract peak gradient ≥50 mm Hg on TTE, exercise TTE is recommended for the detection and quantification of dynamic LVOTO.1–6","For patients with HCM who exhibit symptoms but lack a resting or provocable outflow tract peak gradient of ≥50 mm Hg on TTE, exercise TTE is advised to identify and measure dynamic LVOTO."
id_02510,"In adults 18 to 64 years of age with migraine with or without aura, evaluation and modification of vascular risk factors are recommended to address the elevated risk of stroke in this patient population.362–369","For adults aged 18 to 64 who experience migraines, whether accompanied by aura or not, it is advised to assess and adjust vascular risk factors to mitigate their increased stroke risk."
id_02030,"For asymptomatic patients with severe primary MR (Stages B and C1), TTE is indicated every 6 to 12 months for surveillance of LV function (estimated by LVEF, LVEDD, and LVESD) and assessment of pulmonary artery pressure.1–11","In asymptomatic individuals with severe primary MR (Stages B and C1), it is recommended to perform TTE every 6 to 12 months to monitor LV function (assessed by LVEF, LVEDD, and LVESD) and evaluate pulmonary artery pressure."
id_01551,"In patients undergoing NCS, routine preoperative invasive coronary angiography (ICA) is not recom­ mended to improve perioperative outcomes.1,2","For patients having non-cardiac surgery, performing routine preoperative invasive coronary angiography is not advised to enhance perioperative outcomes."
id_01071,"In patients with ischemic stroke related to small vessel disease, the usefulness of cilostazol for secondary stroke prevention is uncertain.382,384,408–410",The effectiveness of cilostazol for preventing recurrent strokes in patients with ischemic stroke due to small vessel disease remains unclear.
id_00112,It is reasonable to brush off any dry chemical be- fore irrigation with water. Recommendation-Specific Supportive Text,"Before rinsing with water, it is advisable to remove any dry chemicals."
id_01072,"In patients with nonvalvular AF and stroke or TIA, oral anticoagulation (eg, apixaban, dabi- gatran, edoxaban, rivaroxaban, or warfarin) is recommended to reduce the risk of recurrent stroke.419–426","For patients with nonvalvular atrial fibrillation and a history of stroke or transient ischemic attack, it is advised to use oral anticoagulants such as apixaban, dabigatran, edoxaban, rivaroxaban, or warfarin to lower the risk of another stroke."
id_00592,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV), cardiopul- monary exercise stress testing should be performed to quantify the degree of functional limitation and aid in selection of patients for heart transplantation or mechanical circulatory support.7–9","For patients with nonobstructive hypertrophic cardiomyopathy and severe heart failure (classified as NYHA class III or IV), cardiopulmonary exercise stress testing is recommended to assess the extent of functional impairment and assist in determining eligibility for heart transplantation or mechanical circulatory support."
id_01552,"In patients with ACS being considered for elective NCS, coronary revascularization as appropriate and deferral of surgery is recommended to reduce peri­ operative cardiovascular events.1–9","For patients with ACS who are candidates for elective NCS, it is advised to perform coronary revascularization when suitable and postpone the surgery to minimize perioperative cardiovascular events."
id_02031,"In asymptomatic patients with severe primary MR (Stages B and C1), use of serum biomarkers and novel measurements of LV function, such as global longitudinal strain, may be considered as an adjunct to guide timing of intervention.12–21","For asymptomatic individuals with severe primary MR (Stages B and C1), considering serum biomarkers and new LV function metrics, like global longitudinal strain, can aid in determining the timing for intervention."
id_02511,"In adults with migraine with aura who desire contraception, progestin-only or nonhormonal forms are recommended to avoid the increased risk of ischemic stroke associated with combined hormonal contraception.370–372","For adults experiencing migraine with aura who seek contraception, it is advised to use progestin-only or nonhormonal methods to prevent the heightened risk of ischemic stroke linked to combined hormonal contraceptives."
id_02032,"In patients with primary MR (Stages B and C) and symptoms that might be attributable to MR, hemodynamic exercise testing using Doppler echocardiography or cardiac catheterization or cardiopulmonary exercise testing is reasonable.1–4","For patients with primary MR in Stages B and C who exhibit symptoms potentially linked to MR, it is reasonable to conduct hemodynamic exercise testing using Doppler echocardiography, cardiac catheterization, or cardiopulmonary exercise testing."
id_00593,"In pediatric patients with HCM, regardless of symptom status, exercise stress testing is recom- mended to determine functional capacity and to provide prognostic information.10","For children with HCM, exercise stress testing is advised to assess functional capacity and offer prognostic insights, irrespective of their symptom status."
id_02512,"In children 2 to 16 years of age with SCD (Hb SS or Hb S-beta0-thalassemia), transcranial Doppler (TCD) screening at a frequency based on the highest mean flow velocity in the terminal portion of the internal carotid or the proximal portion of the middle cerebral artery is recommended.381–384 Other interventions","For children aged 2 to 16 with SCD (Hb SS or Hb S-beta0-thalassemia), it is advised to conduct transcranial Doppler (TCD) screening, with the frequency determined by the highest mean flow velocity in the terminal segment of the internal carotid or the proximal segment of the middle cerebral artery."
id_00113,Decontamination by irrigation should be performed immediately after chemical exposure to the eyes.,Irrigate the eyes right away following chemical exposure to ensure decontamination.
id_01553,"In patients with CCD and hemodynamically signifi­ cant left main coronary artery stenosis ≥50% who are planning elective NCS, coronary revasculariza­ tion and deferral of surgery is reasonable to reduce perioperative cardiovascular events.10,11","For patients with CCD and significant left main coronary artery stenosis of 50% or more who are considering elective NCS, it is advisable to undergo coronary revascularization and postpone the surgery to lower the risk of cardiovascular events during the perioperative period."
id_02033,"In symptomatic or asymptomatic patients with severe primary MR and LV systolic dysfunction (Stages C2 and D) in whom surgery is not possible or must be delayed, GDMT for systolic dysfunction is reasonable.1–3","For patients with severe primary MR and LV systolic dysfunction (Stages C2 and D), whether symptomatic or not, where surgery is not feasible or must be postponed, it is reasonable to implement GDMT for systolic dysfunction."
id_01073,"In patients with AF and stroke or TIA, oral anticoagulation is indicated to reduce the risk of recurrent stroke regardless of whether the AF pattern is paroxysmal, persistent, or permanent.427","For patients with AF who have experienced a stroke or TIA, oral anticoagulation is recommended to lower the risk of another stroke, irrespective of whether the AF is paroxysmal, persistent, or permanent."
id_00114,"Unless otherwise recommended by local guide- lines, irrigation with a copious amount of tap water for 15 minutes should be performed.","If not advised differently by local guidelines, a thorough rinse with plenty of tap water for 15 minutes should be conducted."
id_00594,"In adult patients with HCM, exercise stress testing is reasonable to determine functional capacity and to provide prognostic information as part of initial evaluation.9,11,12","For adult patients with HCM, conducting an exercise stress test is advisable to assess functional capacity and offer prognostic insights during the initial evaluation."
id_02513,"In children 2 to 16 years of age with SCD at elevated risk per TCD measurements, regularly scheduled transfusion therapy (target reduction of hemoglobin S <30%) is effective for reducing stroke risk.382,383","For children aged 2 to 16 with SCD who are at high risk according to TCD results, routine transfusion therapy aimed at lowering hemoglobin S to below 30% effectively reduces the risk of stroke."
id_01554,"In patients with non–left main CAD who are planned for NCS, routine preoperative coronary revascularization is not recommended to reduce perioperative cardiovascular events.*12–15 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re­ vascularization.”16","For patients with non-left main coronary artery disease scheduled for non-cardiac surgery, preoperative coronary revascularization should not be routinely performed to decrease perioperative cardiovascular events."
id_02034,"In asymptomatic patients with primary MR and normal LV systolic function (Stages B and C1), vasodilator therapy is not indicated if the patient is normotensive.4–8","For asymptomatic individuals with primary MR and normal LV systolic function (Stages B and C1), vasodilator therapy is not recommended if they are normotensive."
id_01074,"In patients with stroke or TIA and AF who do not have moderate to severe mitral stenosis or a mechanical heart valve, apixaban, dabi- gatran, edoxaban, or rivaroxaban is recom- mended in preference to warfarin to reduce the risk of recurrent stroke.419–426","For patients with stroke or TIA and AF who do not have moderate to severe mitral stenosis or a mechanical heart valve, it is advised to use apixaban, dabigatran, edoxaban, or rivaroxaban over warfarin to lower the risk of recurrent stroke."
id_02514,"In children 2 to 16 years of age and young adults with Hb SS or Hb S-beta0-thalassemia, an MRI of the brain without sedation should be performed as soon as possible to evaluate for SCI and to deter- mine the need for chronic red cell transfusions (CRCTs) for stroke prevention.385,386","For children aged 2 to 16 and young adults with Hb SS or Hb S-beta0-thalassemia, a non-sedated brain MRI should be conducted promptly to assess for SCI and determine if chronic red cell transfusions are necessary for stroke prevention."
id_00115,"When providing first aid for chemical eye injury, first aid providers should avoid contaminating other individuals, areas, or the other eye with the caustic substance.","In administering first aid for chemical eye injuries, caregivers must prevent the spread of the corrosive material to other people, surfaces, or the unaffected eye."
id_00595,"For asymptomatic patients with HCM who do not have a resting or provocable outflow tract peak gradient ≥50 mm Hg on standard TTE, exercise TTE is reasonable for the detection and quantification of dynamic LVOTO.1,3–6,13,14","For patients with HCM who show no symptoms and lack a resting or inducible outflow tract peak gradient of 50 mm Hg or more on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO."
id_01555,"In most* patients with hypertension planned for elec­ tive NCS, it is reasonable to continue medical therapy for hypertension throughout the perioperative period.†","For the majority of patients with hypertension scheduled for elective non-cardiac surgery, it is advisable to maintain their hypertension medication during the perioperative period."
id_01075,"In patients with atrial flutter and stroke or TIA, anticoagulant therapy similar to that in AF is indicated to reduce the risk of recurrent stroke.427","For patients with atrial flutter who have experienced a stroke or TIA, anticoagulant treatment akin to that used in AF is recommended to lower the risk of another stroke."
id_02515,"In children 2 to 16 years of age with SCD whose TCD velocities revert to normal, continued transfu- sion therapy can be beneficial to reduce the risk of stroke.384","For children aged 2 to 16 with SCD who have normalized TCD velocities, ongoing transfusion therapy may help lower the risk of stroke."
id_02035,"In symptomatic patients with severe primary MR (Stage D), mitral valve intervention is recommended irrespective of LV systolic function.1,2","For patients with severe primary MR (Stage D) who are symptomatic, mitral valve intervention is advised regardless of LV systolic function."
id_00116,"Eye irrigation with normal saline, Ringer’s lactate solution, or a commercial eye wash solution if immediately available is reasonable.","It is appropriate to perform eye irrigation using normal saline, Ringer's lactate solution, or a commercial eye wash solution if one is readily accessible."
id_00596,"In patients with obstructive HCM and ambiguous functional capacity, exercise stress testing may be reasonable to guide therapy (Figure 1).15,16","For patients with obstructive HCM and unclear functional capacity, it may be appropriate to use exercise stress testing to inform treatment decisions (Figure 1)."
id_01076,"In patients with AF and stroke or TIA, without moderate to severe mitral stenosis or a mechanical heart valve, who are unable to maintain a therapeutic INR level with warfa- rin, use of dabigatran, rivaroxaban, apixaban, or edoxaban is recommended to reduce the risk of recurrent stroke.","For patients with atrial fibrillation and a history of stroke or TIA, who do not have moderate to severe mitral stenosis or a mechanical heart valve and cannot consistently achieve a therapeutic INR with warfarin, it is advised to use dabigatran, rivaroxaban, apixaban, or edoxaban to lower the risk of another stroke."
id_02516,"In children 2 to 16 years of age with SCD and normalized mean flow velocities and no intra- cranial stenosis, transition from transfusion to hydroxyurea therapy can be considered to prevent stroke.387","For children aged 2 to 16 with SCD who have normalized mean flow velocities and no intracranial stenosis, switching from transfusion to hydroxyurea therapy may be considered to prevent stroke."
id_02036,"In asymptomatic patients with severe primary MR and LV systolic dysfunction (LVEF ≤60%, LVESD ≥40 mm) (Stage C2), mitral valve surgery is recommended.3–10","Mitral valve surgery is advised for asymptomatic individuals with severe primary mitral regurgitation and left ventricular systolic dysfunction, indicated by an LVEF of 60% or less and an LVESD of 40 mm or more (Stage C2)."
id_00117,It is reasonable for individuals with ocular exposure to industrial chemicals to adhere to local guidelines or recommendations from a poison center. Recommendation-Specific Supportive Text,"For those exposed to industrial chemicals in the eyes, following local guidelines or advice from a poison center is advisable."
id_01556,"In patients undergoing elective elevated-risk surgery who have cardiovascular risk factors for periopera­ tive complications‡ and recent history of poorly con­ trolled hypertension (systolic blood pressure [SBP] ≥180 mm Hg or diastolic blood pressure [DBP] ≥110 mm Hg before the day of surgery), deferring surgery may be considered to reduce the risk of perioperative complications.†1,2 Intraoperative Blood Pressure Management","For patients scheduled for elective high-risk surgery with cardiovascular risk factors for perioperative complications and a recent history of poorly controlled hypertension (SBP ≥180 mm Hg or DBP ≥110 mm Hg prior to the surgery day), postponing the surgery might be considered to lower the risk of perioperative complications."
id_00597,"In patients with HCM for whom it is unclear if their functional capacity has declined, exercise stress testing may be considered every 2 to 3 years (Figure 1).","For patients with HCM where there is uncertainty about a decline in functional capacity, exercise stress testing can be considered every 2 to 3 years (Figure 1)."
id_00118,Direct manual pressure should be applied to achieve initial control of external bleeding.,"To initially manage external bleeding, apply direct manual pressure."
id_01557,"In patients undergoing NCS, maintaining an intraop­ erative mean arterial pressure (MAP) ≥60 to 65 mm Hg or SBP ≥90 mm Hg is recommended to reduce the risk of myocardial injury.3–9 Postoperative Blood Pressure Management","For patients having non-cardiac surgery, it is advised to keep the intraoperative mean arterial pressure at or above 60 to 65 mm Hg or the systolic blood pressure at or above 90 mm Hg to minimize the risk of myocardial injury."
id_01077,"In patients with stroke at high risk of hemor- rhagic conversion in the setting of AF, it is reasonable to delay initiation of oral antico- agulation beyond 14 days to reduce the risk of ICH.428–431","For stroke patients with a high risk of hemorrhagic transformation due to atrial fibrillation, postponing the start of oral anticoagulation for more than 14 days is advisable to lower the risk of intracerebral hemorrhage."
id_02037,"In patients with severe primary MR for whom surgery is indicated, mitral valve repair is recommended in preference to mitral valve replacement when the anatomic cause of MR is degenerative disease, if a successful and durable repair is possible.11–15","For patients with severe primary MR who require surgery, mitral valve repair is advised over replacement when the MR is due to degenerative disease, provided a successful and lasting repair can be achieved."
id_00598,"In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is recommended as part of the initial assessment.1–7","For patients with HCM, it is advised to assess familial inheritance by obtaining a family history spanning three generations during the initial evaluation."
id_01078,"In patients with TIA in the setting of nonvalvu- lar AF, it is reasonable to initiate anticoagu- lation immediately after the index event to reduce the risk of recurrent stroke.","For patients experiencing a TIA with nonvalvular AF, starting anticoagulation right after the initial event is advisable to lower the risk of another stroke."
id_01558,"In patients undergoing NCS, treatment of hypoten­ sion (MAP <60-65 or SBP <90 mm Hg) in the postoperative period is recommended to limit the risk of cardiovascular, cerebrovascular, renal events, and mortality.6","For patients undergoing NCS, it is advised to manage hypotension (MAP below 60-65 or SBP under 90 mm Hg) after surgery to reduce the risk of cardiovascular, cerebrovascular, renal complications, and death."
id_02518,"In patients with CADASIL, counseling on smok- ing cessation and treatment of hypertension and other vascular risk factors are beneficial to reduce the risk of incident stroke.407–412","For patients with CADASIL, advising them to quit smoking and managing hypertension along with other vascular risk factors can help lower the risk of a first-time stroke."
id_02517,"In children 2 to 16 years of age with SCD at high risk for stroke (TCD mean flow velocities ≥200 cm/s) but without intracranial stenosis who are unable to continue or cannot be treated with periodic red cell transfusion, hydroxyurea or bone marrow transplantation may be reasonable to prevent stroke.387–390","For children aged 2 to 16 with SCD who are at high risk for stroke (TCD mean flow velocities of 200 cm/s or higher) and do not have intracranial stenosis, but cannot undergo regular red cell transfusions, considering hydroxyurea or bone marrow transplantation may be appropriate to prevent stroke."
id_00119,A hemostatic dressing can be useful as adjunctive therapy to improve the effectiveness of direct manual pressure.,A hemostatic dressing may enhance the efficacy of direct manual pressure when used as a supplementary treatment.
id_00599,"In patients with HCM, genetic testing is beneficial to elucidate the genetic basis to facilitate the identification of family members at risk for developing HCM (cascade testing).8–11","For patients with HCM, genetic testing is advantageous to clarify the genetic cause, aiding in the detection of family members who may be at risk for HCM through cascade testing."
id_02519,"In adults with hereditary hemorrhagic telangiecta- sia (HHT), screening for pulmonary arteriovenous malformations (PAVMs) is reasonable to identify the need for multidisciplinary evaluation to man- age stroke risk.413–421","For adults with hereditary hemorrhagic telangiectasia (HHT), it is advisable to screen for pulmonary arteriovenous malformations (PAVMs) to determine the necessity for a multidisciplinary assessment to address stroke risk."
id_01559,"In patients with hypertension undergoing NCS, it is recommended that preoperative antihypertensive medications be restarted as soon as clinically rea­ sonable to avoid complications from postoperative hypertension. *Caution is advised when continuing antihypertensive therapy in patients with low or low-normal perioperative BPs, older adults (≥65 years),10 and patients in whom the risk for perioperative hypotension is high based on an evaluation of the patient’s overall clinical status, surgery type, and anesthetic plan. †Modified from the “2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ ASH/ASPC/NMA/PCNA High Blood Pressure Guideline.”11 ‡One or more components of the RCRI: CAD, congestive heart failure, cere­ brovascular accident, baseline serum creatinine >2.0 mg/dL, or preoperative in­ sulin treatment.12","For patients with hypertension undergoing non-cardiac surgery, it is advised to resume preoperative antihypertensive medications as soon as it is clinically appropriate to prevent postoperative hypertension complications. Exercise caution when maintaining antihypertensive treatment in patients with low or low-normal perioperative blood pressures, those aged 65 and older, and individuals at high risk for perioperative hypotension, based on their overall clinical condition, type of surgery, and anesthetic plan."
id_00120,"Once bleeding has been controlled, it may be reasonable to apply a pressure dressing to maintain bleeding cessation.","After achieving hemostasis, it might be appropriate to use a pressure dressing to sustain the cessation of bleeding."
id_00600,"In patients with an atypical clinical presentation of HCM or when another genetic condition is suspected to be the cause, a workup including genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy (“HCM phenocopies”) is recommended.12–14","For patients exhibiting unusual symptoms of HCM or when another genetic disorder is suspected as the underlying cause, it is advised to conduct an evaluation that includes genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy, known as ""HCM phenocopies."""
id_02039,"In asymptomatic patients with severe primary MR and normal LV systolic function (LVEF >60% and LVESD <40 mm) (Stage C1) but with a progressive increase in LV size or decrease in EF on ≥3 serial imaging studies, mitral valve surgery may be considered irrespective of the probability of a successful and durable repair.16","For asymptomatic individuals with severe primary mitral regurgitation and normal left ventricular systolic function (LVEF over 60% and LVESD under 40 mm) (Stage C1), who exhibit a progressive increase in left ventricular size or a decrease in ejection fraction across three or more consecutive imaging studies, mitral valve surgery can be considered regardless of the likelihood of achieving a successful and lasting repair."
id_01560,"In patients with HF undergoing elective NCS, sodium-glucose cotransporter-2 inhibitors (SGLT2i) should be withheld for 3 to 4 days* before surgery when feasible to reduce the risk of perioperative metabolic acidosis.1–3","For patients with heart failure scheduled for elective non-cardiac surgery, it is advisable to discontinue sodium-glucose cotransporter-2 inhibitors (SGLT2i) 3 to 4 days prior to the procedure, if possible, to minimize the risk of metabolic acidosis during the perioperative period."
id_01079,"In patients with stroke or TIA in the setting of nonvalvular AF who have contraindications for lifelong anticoagulation but can tolerate at least 45 days, it may be reasonable to consider percutaneous closure of the left atrial appendage with the Watchman device to reduce the chance of recurrent stroke and bleeding.432–436","For patients with stroke or TIA and nonvalvular AF who cannot undergo lifelong anticoagulation but can manage at least 45 days, considering percutaneous left atrial appendage closure with the Watchman device might be a reasonable option to lower the risk of recurrent stroke and bleeding."
id_01080,"In patients with stroke at low risk for hemor- rhagic conversion in the setting of AF, it may be reasonable to initiate anticoagulation 2 to 14 days after the index event to reduce the risk of recurrent stroke.428,429,437","For patients with stroke who have a low risk of hemorrhagic conversion and are experiencing atrial fibrillation, starting anticoagulation therapy between 2 and 14 days after the initial event might be advisable to lower the chance of another stroke."
id_02520,"In patients with Fabry disease, the effectiveness of enzyme replacement therapy (ERT) to reduce the risk of stroke is not well established.422–427","For individuals with Fabry disease, the ability of enzyme replacement therapy (ERT) to lower the risk of stroke remains uncertain."
id_00121,"The utility of indirect manual pressure (ie, pres- sure points) for bleeding control is uncertain.","The effectiveness of using indirect manual pressure, such as pressure points, for controlling bleeding is unclear."
id_02040,"In severely symptomatic patients (NYHA class III or IV) with primary severe MR and high or prohibitive surgical risk, transcatheter edge-to- edge repair (TEER) is reasonable if mitral valve anatomy is favorable for the repair procedure and patient life expectancy is at least 1 year.17,18","For patients with severe symptoms (NYHA class III or IV) and primary severe MR who are at high or prohibitive risk for surgery, transcatheter edge-to-edge repair (TEER) is a reasonable option if the mitral valve anatomy is suitable for the procedure and the patient is expected to live at least one more year."
id_02521,"In adults with a recent MI, the addition of low- dose colchicine to intensive statin therapy might be reasonable to decrease the risk of ischemic stroke.457,458","For adults who have recently experienced an MI, incorporating low-dose colchicine alongside intensive statin therapy could be a sensible approach to reduce the risk of ischemic stroke."
id_00601,"In patients with HCM, genetic counseling by an expert in the genetics of cardiovascular disease is recommended so that risks, benefits, test results, and their clinical significance can be reviewed and discussed with the patient in a shared decision-making process.1–3,15 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with HCM, it is advised to consult a specialist in cardiovascular genetics for genetic counseling, enabling a collaborative discussion with the patient about the risks, benefits, test outcomes, and their clinical implications."
id_01081,"In patients with AF and stroke or TIA who have end-stage renal disease or are on dialysis, it may be reasonable to use warfarin or apixaban (dose adjusted if indicated) for anticoagulation to reduce the chance of recurrent stroke.438","For patients with atrial fibrillation and a history of stroke or TIA who have end-stage renal disease or are undergoing dialysis, using warfarin or apixaban (with dose adjustments if necessary) for anticoagulation might be a reasonable approach to lower the risk of another stroke."
id_02038,"In asymptomatic patients with severe primary MR and normal LV systolic function (LVEF ≥60% and LVESD ≤40 mm) (Stage C1), mitral valve repair is reasonable when the likelihood of a successful and durable repair without residual MR is >95% with an expected mortality rate of <1%, when it can be performed at a Primary or Comprehensive Valve Center.4,13,16","For asymptomatic individuals with severe primary mitral regurgitation and normal left ventricular systolic function (LVEF ≥60% and LVESD ≤40 mm) (Stage C1), it is reasonable to consider mitral valve repair if the probability of achieving a successful and lasting repair without residual mitral regurgitation exceeds 95% and the anticipated mortality rate is below 1%, provided the procedure is conducted at a Primary or Comprehensive Valve Center."
id_02041,"In symptomatic patients with severe primary MR attributable to rheumatic valve disease, mitral valve repair may be considered at a Comprehensive Valve Center by an experienced team when surgical treatment is indicated, if a durable and successful repair is likely.19","For patients showing symptoms of severe primary mitral regurgitation due to rheumatic valve disease, mitral valve repair can be contemplated at a Comprehensive Valve Center by a skilled team when surgery is warranted, provided a lasting and effective repair is probable."
id_00122,Mechanical pressure such as pressure bandages or devices might be considered in some situa- tions when direct manual pressure is not feasible. Recommendation-Specific Supportive Text,"In certain cases where direct manual pressure cannot be applied, mechanical pressure using bandages or devices may be an option."
id_01561,"In patients with compensated HF undergoing NCS, it is reasonable to continue GDMT (excluding SGLT2i) in the perioperative period, unless contraindicated, to reduce the risk of worsening HF.4–8 *Canagliflozin, dapagliflozin, and empagliflozin should be stopped ≥3 days and ertugliflozin ≥4 days before scheduled surgery.3","For patients with compensated heart failure undergoing non-cardiac surgery, it is advisable to maintain guideline-directed medical therapy during the perioperative period, except for SGLT2 inhibitors, unless contraindications exist, to minimize the risk of heart failure exacerbation. Canagliflozin, dapagliflozin, and empagliflozin should be discontinued at least 3 days prior to the planned surgery, while ertugliflozin should be stopped at least 4 days before."
id_01082,"In patients with ischemic stroke or TIA and valvular AF (moderate to severe mitral steno- sis or any mechanical heart valve), warfarin is recommended to reduce the risk of recurrent stroke or TIA.452–457","For patients with ischemic stroke or TIA who have valvular AF, such as moderate to severe mitral stenosis or any mechanical heart valve, warfarin is advised to lower the risk of another stroke or TIA."
id_00602,"When performing genetic testing in a proband with HCM, the initial tier of genes tested should include genes with strong evidence to be disease-causing in HCM.*8,11,16,17","In a proband with HCM, the first set of genes to be tested should consist of those with robust evidence of being causative for the disease."
id_01562,"In patients receiving stable doses of targeted medi­ cal therapies* for pulmonary arterial hypertension (PAH) undergoing NCS, it is recommended to con­ tinue these agents to reduce the risk for the devel­ opment of perioperative MACE.1","For patients on stable doses of targeted medical therapies for pulmonary arterial hypertension (PAH) who are undergoing non-cardiac surgery (NCS), it is advised to maintain these medications to lower the risk of perioperative major adverse cardiovascular events (MACE)."
id_02042,"In patients with severe primary MR where leaflet pathology is limited to less than one half the posterior leaflet, mitral valve replacement should not be performed unless mitral valve repair has been attempted at a Primary or Comprehensive Valve Center and was unsuccessful.11–14,20–22","For patients with severe primary MR and posterior leaflet pathology affecting less than half of the leaflet, mitral valve replacement should only be considered if mitral valve repair has been attempted and failed at a Primary or Comprehensive Valve Center."
id_00123,"For life-threatening extremity bleeding, a tourniquet should be applied and tightened until the bleeding stops.","In cases of life-threatening bleeding from an extremity, apply a tourniquet and tighten it until the bleeding ceases."
id_02522,"In patients without a history of stroke and no clini- cal indication for anticoagulation, with a high-risk aPL profile (ie, triple-positive antiphospholipid testing [lupus anticoagulant, anticardiolipin anti- body, anti–β2 glycoprotein 1] or double-positive [any combination] or isolated lupus anticoagulant or isolated persistently positive anticardiolipin antibody at medium to high titers), prophylactic treatment with aspirin (75–100 mg daily) is rec- ommended to reduce the risk of stroke.462,463","For patients who have no history of stroke and lack a clinical need for anticoagulation, but possess a high-risk antiphospholipid antibody profile—such as triple-positive results (lupus anticoagulant, anticardiolipin antibody, anti–β2 glycoprotein 1), double-positive results (any combination), or isolated lupus anticoagulant or persistently positive anticardiolipin antibody at medium to high levels—daily aspirin (75–100 mg) is advised to lower the risk of stroke."
id_01563,"In patients with severe† PH undergoing elevated- risk NCS, referral to or consultation with a special­ ized PH center that can support risk assessment, optimization, and postoperative management (with consideration of intensive care after NCS) is reason­ able to reduce perioperative cardiopulmonary compli­ cations.2","For patients with severe† PH facing high-risk NCS, it is advisable to refer them to or consult with a specialized PH center capable of providing risk evaluation, optimization, and postoperative care (including potential intensive care post-NCS) to minimize perioperative cardiopulmonary complications."
id_00603,"In first-degree relatives of patients with HCM, both clinical screening (ECG and 2D echocardiogram) and cascade genetic testing (when a pathogenic/ likely pathogenic variant has been identified in the proband) should be offered.3,7,12,18–20","For first-degree relatives of individuals with HCM, it is advised to provide both clinical evaluations (including ECG and 2D echocardiogram) and cascade genetic testing if a pathogenic or likely pathogenic variant has been detected in the proband."
id_01083,"In patients with a mechanical mitral valve and a history of ischemic stroke or TIA before valve replacement, aspirin (75–100 mg/d) is recom- mended in addition to warfarin with an INR target of 3.0 (range, 2.5–3.5) to reduce the risk of thrombosis and recurrent stroke or TIA.458,459","For patients who have a mechanical mitral valve and a prior ischemic stroke or TIA before valve replacement, it is advised to use aspirin (75–100 mg daily) alongside warfarin, aiming for an INR of 3.0 (range 2.5–3.5), to lower the risk of thrombosis and recurrent stroke or TIA."
id_00124,A commercial tourniquet is probably superior to an improvised tourniquet.,A commercial tourniquet is likely more effective than an improvised one.
id_02043,"In patients with chronic secondary MR (Stages B to D), TTE is useful to establish the etiology and to assess the extent of regional and global LV remodeling and systolic dysfunction, severity of MR, and magnitude of pulmonary hypertension.1,2","For patients with chronic secondary MR (Stages B to D), TTE is beneficial for determining the cause and evaluating the degree of both regional and global LV remodeling, systolic dysfunction, MR severity, and the extent of pulmonary hypertension."
id_01084,"In patients with ischemic stroke or TIA and native aortic or nonrheumatic mitral valve disease (eg, mitral annular calcification or mitral valve prolapse) who do not have AF or another indication for anticoagulation, anti- platelet therapy is recommended to reduce the risk of recurrent stroke or TIA.","For patients experiencing ischemic stroke or TIA with native aortic or nonrheumatic mitral valve conditions (such as mitral annular calcification or mitral valve prolapse) and without AF or another reason for anticoagulation, it is advised to use antiplatelet therapy to lower the risk of another stroke or TIA."
id_00604,"In families where a sudden unexplained death has occurred with a postmortem diagnosis of HCM, postmortem genetic testing is beneficial to facilitate cascade genetic testing and clinical screening in first-degree relatives.21,22","In cases where a sudden unexplained death has been attributed to HCM after autopsy, conducting postmortem genetic testing is advantageous for enabling cascade genetic testing and clinical screening in first-degree relatives."
id_02044,"In patients with chronic secondary MR (Stages B to D), noninvasive imaging (stress nuclear/ PET, CMR, or stress echocardiography), coronary CT angiography, or coronary arteriography is useful to establish etiology of","For patients with chronic secondary MR (Stages B to D), utilizing noninvasive imaging techniques such as stress nuclear/PET, CMR, stress echocardiography, coronary CT angiography, or coronary arteriography is beneficial for determining the etiology."
id_00605,"In patients with HCM who have undergone genetic testing, serial reevaluation of the clinical significance of the variant(s) identified is recommended to assess for variant reclassification, which may impact diagnosis and cascade genetic testing in family members23–25 (Figures 1 and 2).","For patients with HCM who have had genetic testing, it is advised to periodically reassess the clinical relevance of the identified variant(s) to determine if reclassification is needed, as this could affect diagnosis and genetic testing of family members."
id_00125,"If an improvised tourniquet is used, it is reason- able for the tourniquet to be at least 2 in width. Recommendation-Specific Supportive Text","When using an improvised tourniquet, it is advisable for it to be a minimum of 2 inches wide."
id_02523,"In patients with systemic lupus erythematosus (SLE) and no history of thrombosis or pregnancy complications and with a high-risk antiphospholipid profile (ie, lupus anticoagulant, anticardiolipin antibody, anti–β2-glycoprotein 1, or double-positive [any combination] or isolated lupus anticoagulant or isolated persistently positive anticardiolipin antibody at medium to high titers), prophylactic treatment with aspirin (75–100 mg daily) is rec- ommended to reduce the risk of stroke.462,463","For patients with systemic lupus erythematosus (SLE) who have no history of thrombosis or pregnancy complications but possess a high-risk antiphospholipid profile—such as lupus anticoagulant, anticardiolipin antibody, anti–β2-glycoprotein 1, or any combination thereof, or isolated lupus anticoagulant, or consistently elevated anticardiolipin antibody at medium to high levels—daily prophylactic aspirin (75–100 mg) is advised to lower the risk of stroke."
id_01564,"In patients with severe† PH undergoing elevated- risk NCS, invasive hemodynamic monitoring is reasonable to guide intraoperative and postoperative care.3–5 Table 9.  Preoperative and Intraoperative Management Considerations in Patients With Hypertrophic Cardiomyopathy Management Considerations Continue beta blockers and/or nondihydropyridine calcium channel blockers without interruption in the perioperative period Avoid hypovolemia and reduced preload (can worsen LVOT obstruction) Avoid hypotension and reduced afterload (can worsen LVOT obstruction) Avoid tachycardia to ensure adequate LV filling If hypotension develops: Prioritize intravenous fluid administration to correct hypovolemia Use alpha-agonists, such as phenylephrine or vasopressin,7 rather than beta-agonists, which can worsen LVOT obstruction Consider intraoperative echocardiography to evaluate LVOT obstruction in the setting of hypotension In selected cases, intravenous beta-blockade may be necessary to reduce LV myocardial contractility and relieve LVOT obstruction","For patients with severe PH undergoing high-risk NCS, it is advisable to use invasive hemodynamic monitoring to guide care during and after surgery. Table 9. Preoperative and Intraoperative Management Considerations for Patients with Hypertrophic Cardiomyopathy Management Considerations: Maintain continuous use of beta blockers and/or nondihydropyridine calcium channel blockers during the perioperative period; avoid hypovolemia and decreased preload, as they may exacerbate LVOT obstruction; prevent hypotension and decreased afterload, which can worsen LVOT obstruction; avoid tachycardia to ensure sufficient LV filling. If hypotension occurs: prioritize intravenous fluids to address hypovolemia; use alpha-agonists like phenylephrine or vasopressin instead of beta-agonists, which may aggravate LVOT obstruction; consider intraoperative echocardiography to assess LVOT obstruction in cases of hypotension. In certain situations, intravenous beta-blockade may be required to decrease LV myocardial contractility and alleviate LVOT obstruction."
id_02524,"In patients with antiphospholipid syndrome (APS) with prior unprovoked venous thrombosis, it is reasonable to choose vitamin K antagonist (VKA) therapy with a target international normalized ratio of 2 to 3 in preference to aspirin or direct oral anticoagulants for prevention of recurrent throm- botic events, including stroke.457,458.464,465","For patients with antiphospholipid syndrome (APS) who have experienced previous unprovoked venous thrombosis, opting for vitamin K antagonist (VKA) therapy with a target international normalized ratio of 2 to 3 is advisable over aspirin or direct oral anticoagulants to prevent recurrent thrombotic events, such as stroke."
id_02045,"In patients with chronic secondary MR with severe symptoms (Stage D) that are unresponsive to GDMT who are being considered for transcatheter mitral valve interventions, TEE is indicated to determine suitability for the procedure.3–8","For patients with chronic secondary MR experiencing severe symptoms (Stage D) that do not respond to GDMT, TEE is recommended to assess their eligibility for transcatheter mitral valve procedures."
id_01085,"In patients with a bioprosthetic aortic or mitral valve, a history of ischemic stroke or TIA before valve replacement, and no other indication for anticoagulation therapy beyond 3 to 6 months from the valve placement, long-term therapy with aspirin is recommended in preference to long-term anticoagulation to reduce the risk of recur- rent stroke or TIA.","For patients with a bioprosthetic aortic or mitral valve who have experienced an ischemic stroke or TIA prior to valve replacement and lack other reasons for anticoagulation therapy beyond 3 to 6 months post-surgery, it is advised to opt for long-term aspirin therapy over long-term anticoagulation to lower the risk of recurrent stroke or TIA."
id_02525,"In patients with rheumatoid arthritis, statin treat- ment may be reasonable to reduce major adverse cardiovascular events, including stroke.466,467","For individuals with rheumatoid arthritis, using statins could be a sensible approach to lower the risk of significant cardiovascular events, such as stroke."
id_00126,An open chest wound is a medical emergency requiring immediate activation of the emergency response system.,A chest wound that is open is an urgent medical situation necessitating the prompt initiation of the emergency response system.
id_02046,"In patients with chronic secondary MR undergoing transcatheter mitral valve intervention, intraprocedural guidance with TEE is recommended.4,7,9–13","For patients with chronic secondary mitral regurgitation undergoing transcatheter mitral valve procedures, it is advised to use TEE for guidance during the procedure."
id_01566,"In patients with intermediate- to elevated-risk congenital heart disease (CHD) lesions (Table 10) undergoing elective NCS, preoperative con­ sultation with an adult congenital heart disease (ACHD) specialist is recommended before the surgery.*1–4 *Modified from the “2018 AHA/ACC Guideline for Management of ACHD.”5 Table 10.  Adult Congenital Heart Disease Risk Stratification Before Noncardiac Surgery Risk Anatomy Functional/Hemodynamic Status Low Risk Patients with isolated small CHD lesions Patients with repaired CHD lesion with no residual shunt Patients with bicuspid aortic valve disease and aortopathy NYHA class I functional status, normal exercise capacity No chamber enlargement on imaging No residual shunt No PAH No arrhythmias Intermediate risk Unrepaired moderate-large shunts (ASD, VSD, PDA, AVSD) Repaired CHD with moderate to large residual shunt (ASD, VSD, PDA, AVSD) Obstructive left-sided lesions (congenital mitral stenosis, subaortic stenosis, supravalvular aortic stenosis, coarctation of aorta) except the ones described as low risk Obstructive right-sided lesion (pulmonary stenosis, branch pulmonary stenosis, repaired tetralogy of Fallot) Ebstein anomaly (disease spectrum includes mild, moderate, and severe variations) Anomalous coronary artery arising from the pulmonary artery Anomalous aortic origin of a coronary artery from the opposite sinus, especially with an interarterial or intramural course NYHA class II-IV functional status Limited exercise capacity Presence of residual shunt Presence of PAH Presence of cardiac chamber enlargement Significant valvular dysfunction (more than mild in severity) Arrhythmias requiring treatment Presence of HF Elevated risk Single-ventricle patients (palliated or status post Fontan procedure), unrepaired or palliated cyanotic CHD, double outlet right ventricle, pulmonary atresia, truncus arteriosus, TGA (classic or d-TGA; CCTGA or l-TGA), interrupted aortic arch NYHA class II-IV functional status Limited exercise capacity Significant valvular dysfunction (more than mild in severity) Arrhythmias requiring treatment Presence of PAH Presence of HF","For patients with congenital heart disease (CHD) lesions of intermediate to high risk who are undergoing elective noncardiac surgery, it is advised to have a preoperative consultation with an adult congenital heart disease (ACHD) specialist prior to the procedure."
id_00606,"In affected families with HCM, preconception and prenatal reproductive and genetic counseling should be offered.1–3,15","For families impacted by HCM, it is advised to provide reproductive and genetic counseling before conception and during pregnancy."
id_01086,"In patients with ischemic stroke or TIA and IE who present with recurrent emboli and persistent vegetations despite appropri- ate antibiotic therapy, early surgery (during initial hospitalization before completion of a full therapeutic course of antibiotics) is reasonable to reduce the risk of recurrent embolism if there is no evidence of intracra- nial hemorrhage or extensive neurological damage.460–465","For patients experiencing ischemic stroke or TIA and IE with ongoing embolic events and persistent vegetations despite adequate antibiotic treatment, it is advisable to consider early surgical intervention during the initial hospital stay, prior to completing the full antibiotic course, to lower the risk of recurrent embolism, provided there is no intracranial hemorrhage or significant neurological injury."
id_00607,"In adult patients with HCM, the usefulness of genetic testing in the assessment of risk of SCD is uncertain.10,25–27",The value of genetic testing for evaluating SCD risk in adults with HCM remains unclear.
id_00127,"If a dressing is placed, the first aid provider should monitor the person for worsening of breathing/symptoms and loosen or remove the dressing if breathing worsens.","If a dressing is applied, the first aid provider must observe the individual for any deterioration in breathing or symptoms and should loosen or remove the dressing if breathing becomes more difficult."
id_01567,"In patients with a left ventricular assist device (LVAD), coordination with the LVAD care team on the appro­ priate timing and perioperative considerations of elective NCS is recommended to mitigate the risk of perioperative MACE.","For patients with a left ventricular assist device (LVAD), it is advised to collaborate with the LVAD care team regarding the optimal timing and perioperative factors of elective non-cardiac surgery (NCS) to reduce the risk of major adverse cardiac events (MACE) during the perioperative period."
id_02047,"Patients with chronic severe secondary MR (Stages C and D) and HF with reduced LVEF should receive standard GDMT for HF, including ACE inhibitors, ARBs, beta blockers, aldosterone antagonists, and/or sacubitril/valsartan, and biventricular pacing as indicated.1–11","Individuals with chronic severe secondary mitral regurgitation (Stages C and D) and heart failure with reduced left ventricular ejection fraction should be treated with standard guideline-directed medical therapy for heart failure, which includes ACE inhibitors, ARBs, beta blockers, aldosterone antagonists, and/or sacubitril/valsartan, along with biventricular pacing when appropriate."
id_01087,"In patients with history of ischemic stroke or TIA and a mechanical aortic valve, anti- coagulation with higher-intensity warfarin to achieve an INR of 3.0 (range, 2.5–3.5) or the addition of aspirin (75–100 mg/d) can be beneficial to reduce the risk of thromboem- bolic events.","For patients with a history of ischemic stroke or TIA and a mechanical aortic valve, using higher-intensity warfarin to maintain an INR of 3.0 (range 2.5–3.5) or adding aspirin (75–100 mg daily) may help lower the risk of thromboembolic events."
id_01565,"In patients with precapillary PH undergoing elevated- risk NCS, perioperative administration of short-acting inhaled pulmonary vasodilators (eg, nitric oxide, aero­ solized prostacyclins) may be reasonable to reduce elevated RV afterload and prevent acute decompen­ sated right HF.6 *For example, nitric oxide pathway mediators, endothelin receptor antagonists, prostacyclin pathway agonists, or a combination of these. †Severe PH is defined according to hemodynamics (severe precapillary PH component by right heart catheterization and echocardiography) and additional data derived from clinical assessment, exercise tests, and laboratory biomarkers. Hemodynamically, severe PH displays a mean pulmonary artery (PA) pressure >40 mm Hg, pulmonary vascular resistance >5 Wood units, or echocardiographic evidence of significant RV dysfunction (eg, RV-to-LV diastolic diameter ratio >0.8 or RV dysfunction that is graded as moderate or severe). Although all 5 World Symposium on Pulmonary Hypertension group classifications display some de­ gree of risk for developing severe PH, Group 1 (PAH), Group 3 (PH due to lung disease), and Group 4 (chronic thromboembolic PH) are at high risk for devel­ oping severe PH if left untreated and may be best managed and followed at a center with PH specialists.","For patients with precapillary pulmonary hypertension undergoing high-risk non-cardiac surgery, it may be advisable to administer short-acting inhaled pulmonary vasodilators, such as nitric oxide or aerosolized prostacyclins, during the perioperative period to lower elevated right ventricular afterload and prevent acute right heart failure. *Examples include nitric oxide pathway mediators, endothelin receptor antagonists, prostacyclin pathway agonists, or their combinations. †Severe pulmonary hypertension is defined by hemodynamic criteria (severe precapillary pulmonary hypertension component via right heart catheterization and echocardiography) and additional clinical, exercise, and laboratory data. Hemodynamically, severe pulmonary hypertension is characterized by a mean pulmonary artery pressure >40 mm Hg, pulmonary vascular resistance >5 Wood units, or echocardiographic signs of significant right ventricular dysfunction (e.g., RV-to-LV diastolic diameter ratio >0.8 or moderate to severe RV dysfunction). Although all five World Symposium on Pulmonary Hypertension groups have some risk of severe pulmonary hypertension, Groups 1 (pulmonary arterial hypertension), 3 (PH due to lung disease), and 4 (chronic thromboembolic PH) are at high risk if untreated and may benefit from management at a specialized PH center."
id_02526,"In nonpregnant adults with a history of obstetric APS only, prophylactic treatment with aspirin (75–100 mg daily) after adequate risk/benefit evaluation (ie, aPL profile, coexistent traditional cardiovascular risk fac- tors, intolerance, or contraindication to aspirin) may be considered to reduce the risk of stroke.462,468","For nonpregnant adults who have a history of obstetric APS alone, considering prophylactic aspirin therapy at a dose of 75–100 mg daily may be appropriate to lower stroke risk, following a thorough assessment of risks and benefits, including aPL profile, existing traditional cardiovascular risk factors, and any aspirin intolerance or contraindications."
id_02527,"In patients with SLE and no history of thrombosis or pregnancy complications and with a low-risk antiphospholipid profile (ie, isolated anticardiolipin antibody or anti–β2-glycoprotein 1 antibodies at low to medium titers, particularly if transiently pos- itive), prophylactic treatment with aspirin (75–100 mg daily) may be considered to reduce the risk of stroke.462,463,469,470","For patients with SLE who have no history of thrombosis or pregnancy complications and exhibit a low-risk antiphospholipid profile (such as isolated anticardiolipin or anti–β2-glycoprotein 1 antibodies at low to medium levels, especially if temporarily positive), considering daily aspirin (75–100 mg) as a preventive measure against stroke may be appropriate."
id_01568,"Patients with severe AS should be evaluated for the need for aortic valve intervention before elective NCS to reduce perioperative risk.*1,2","Before undergoing elective non-cardiac surgery, patients with severe aortic stenosis should be assessed for potential aortic valve intervention to minimize perioperative risk."
id_00128,"In the first aid situation, it is reasonable to leave an open chest wound exposed to ambient air; place a clean, nonocclusive, dry dressing (eg, gauze dressing, part of a tee shirt); or place a specialized dressing such as a vented chest seal. Recommendation-Specific Supportive Text","In a first aid scenario, it is appropriate to either leave an open chest wound uncovered, apply a clean, dry, nonocclusive dressing like gauze or a piece of a tee shirt, or use a specialized dressing such as a vented chest seal."
id_00608,"In patients with HCM who have a variant of uncertain significance (VUS), the usefulness of clinical genetic testing of phenotype-negative relatives for the purpose of variant reclassification is uncertain.4,7,8,28","For patients with HCM possessing a variant of uncertain significance (VUS), the effectiveness of conducting clinical genetic testing on relatives without the phenotype to aid in variant reclassification remains unclear."
id_01088,"In patients with ischemic stroke or TIA and native left-sided valve endocarditis who exhibit mobile vegetations >10 mm in length, early surgery (during initial hospitalization before completion of a full therapeutic course of anti- biotics) may be considered to reduce the risk of recurrent embolism if there is no evidence of intracranial hemorrhage or extensive neurologi- cal damage.460–465","For patients experiencing ischemic stroke or TIA with native left-sided valve endocarditis and mobile vegetations exceeding 10 mm, early surgical intervention during the initial hospital stay, prior to completing a full course of antibiotics, can be considered to lower the risk of recurrent embolism, provided there is no intracranial hemorrhage or significant neurological damage."
id_02048,"In patients with chronic severe secondary MR and HF with reduced LVEF, a cardiologist expert in the management of patients with HF and LV systolic dysfunction should be the primary MDT member responsible for implementing and monitoring optimal GDMT.9,12","For patients with chronic severe secondary MR and heart failure with reduced LVEF, a cardiologist specializing in heart failure and left ventricular systolic dysfunction should lead the multidisciplinary team in administering and overseeing optimal guideline-directed medical therapy."
id_00129,Superficial wounds and abrasions should be thoroughly irrigated until there is no obvious debris or foreign matter in the wound.,Superficial wounds and abrasions need to be carefully rinsed until all visible debris or foreign material is removed.
id_02528,"In patients with periodontal disease (PD), good oral hygiene and regular dental care can be ben- eficial to lower stroke risk.486–488","For patients with periodontal disease, maintaining good oral hygiene and receiving regular dental care can help reduce the risk of stroke."
id_00609,"For patients with HCM who have undergone genetic testing and were found to have no pathogenic variants (ie, harbor only benign or likely benign variants), cascade genetic testing of the family is not useful.4,8–10","Cascade genetic testing of the family is not beneficial for patients with HCM who have had genetic testing and only possess benign or likely benign variants, with no pathogenic variants detected."
id_01569,"In patients with suspected moderate or severe AS who are undergoing elevated-risk NCS, preoperative echocardiography is recommended before elective NCS to guide perioperative management.*","For patients suspected of having moderate or severe AS and facing high-risk NCS, it is advised to perform preoperative echocardiography prior to elective NCS to inform perioperative management."
id_00130,A superficial wound caused by an animal or human bite or with contamination with human or animal saliva should be evaluated in a medical facility as soon as possible.,"A superficial wound resulting from an animal or human bite, or contaminated with human or animal saliva, should be promptly assessed at a medical facility."
id_01089,"In patients with ischemic stroke or TIA and IE, early valve surgery (during initial hospital- ization before completion of a full therapeutic course of antibiotics) may be considered in patients with an indication for surgery who have no evidence of intracranial hemorrhage or extensive neurological damage.466,467","For patients with ischemic stroke or TIA and infective endocarditis, early valve surgery during the initial hospitalization, before completing a full course of antibiotics, can be considered if surgery is indicated and there is no evidence of intracranial hemorrhage or significant neurological damage."
id_02529,"In patients hospitalized with COVID-19, treat- ment with full-dose anticoagulation (eg, enoxa- parin, apixaban) is not recommended to prevent stroke.489,490","For patients admitted to the hospital with COVID-19, using full-dose anticoagulation (such as enoxaparin or apixaban) is not advised for stroke prevention."
id_00610,"Ongoing clinical screening is not indicated in genotype-negative relatives in families with genotype-positive HCM, unless the disease- causing variant is downgraded to a VUS, likely benign, or benign variant during follow-up.23,29–32 *Strong evidence HCM genes include, at the time of this publication: MYH7,","Routine clinical screening is unnecessary for relatives without the genotype in families with genotype-positive HCM, unless the pathogenic variant is reclassified as a variant of uncertain significance, likely benign, or benign during follow-up."
id_02049,"In patients with chronic severe secondary MR related to LV systolic dysfunction (LVEF <50%) who have persistent symptoms (NYHA class II, III, or IV) while on optimal GDMT for HF (Stage D), TEER is reasonable in patients with appropriate anatomy as defined on TEE and with LVEF between 20% and 50%, LVESD ≤70 mm, and pulmonary artery systolic pressure ≤70 mm Hg.1–8","For patients with chronic severe secondary MR due to LV systolic dysfunction (LVEF <50%) who continue to experience symptoms (NYHA class II, III, or IV) despite optimal GDMT for HF (Stage D), TEER is a reasonable option if they have suitable anatomy as determined by TEE, with LVEF between 20% and 50%, LVESD ≤70 mm, and pulmonary artery systolic pressure ≤70 mm Hg."
id_02530,"In all adults, screening for substance misuse and substance use disorders (eg, alcohol, cannabis, cocaine, opioids, amphetamines) is recommended to inform stroke risk.506–520 Other interventions","It is advised to screen all adults for substance misuse and substance use disorders, such as alcohol, cannabis, cocaine, opioids, and amphetamines, to assess stroke risk."
id_02050,"In patients with severe secondary MR (Stages C and D), mitral valve surgery is reasonable when CABG is undertaken for the treatment of myocardial ischemia.9–15","For patients with severe secondary MR (Stages C and D), it is appropriate to perform mitral valve surgery concurrently with CABG for myocardial ischemia treatment."
id_01090,"In patients with IE and major ischemic stroke, delaying valve surgery for at least 4 weeks may be considered for patients with IE and major ischemic stroke or intracranial hemorrhage if the patient is hemodynamically stable.460,468","For patients with IE and major ischemic stroke or intracranial hemorrhage who are hemodynamically stable, it may be advisable to postpone valve surgery for a minimum of 4 weeks."
id_01570,"In asymptomatic patients with moderate or severe AS and normal LV systolic function as assessed by echocardiography within the past year, it is reason­ able to proceed with elective low-risk NCS.3–5 *Modified from the “2020 ACC/AHA Guideline for the Management of Pa­ tients With Valvular Heart Disease.”6","For patients without symptoms who have moderate or severe aortic stenosis and normal left ventricular systolic function confirmed by echocardiography in the last year, it is appropriate to undergo elective low-risk non-cardiac surgery."
id_00131,It is reasonable to use running tap water or sterile saline solutions for wound irrigation instead of antiseptic agents such as povidone-iodine.,Using running tap water or sterile saline for wound irrigation is a sensible alternative to antiseptic agents like povidone-iodine.
id_00611,"In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assess- ment, electrocardiography, and cardiac imaging are recommended at periodic intervals depending on age (every 1-2 years in children and adolescents and every 3-5 years in adults) and change in clinical status (Figures 1 and 2, Table 7).1–5","For those with a positive genotype but no phenotypic expression of HCM, it is advised to conduct regular clinical evaluations, electrocardiograms, and cardiac imaging at intervals based on age—every 1-2 years for children and adolescents, and every 3-5 years for adults—as well as any changes in clinical condition."
id_01091,"In patients with ischemic stroke or TIA and mechanical heart valves, treatment with dabigatran causes harm.*457 *A similar recommendation in another guideline is worded slightly differently; however, the process used to reach consensus was the same in both cases.","For patients who have experienced an ischemic stroke or TIA and have mechanical heart valves, using dabigatran is detrimental."
id_01571,Patients with severe mitral stenosis (MS) should be evaluated for the need for mitral valve (MV) interven­ tion before elective NCS.1–17,"Before undergoing elective non-cardiac surgery, individuals with severe mitral stenosis should be assessed to determine if mitral valve intervention is necessary."
id_00132,It is reasonable to cover clean superficial wounds and abrasions with an occlusive dressing to promote wound healing.,Applying an occlusive dressing to clean superficial wounds and abrasions is advisable to enhance healing.
id_01092,"In patients with stroke or TIA and LV thrombus, anticoagulation with therapeutic warfarin for at least 3 months is recommended to reduce the risk of recurrent stroke.504–508","For patients experiencing stroke or TIA with LV thrombus, it is advised to administer therapeutic warfarin for a minimum of 3 months to lower the risk of another stroke."
id_02531,"In patients who use recreational drugs (eg, cannabis, synthetic cannabinoids, cocaine, heroin, methamphet- amine), misuse alcohol or prescription medications (eg, stimulants and opioids), or have a substance use disorder, counseling to stop or appropriate substance use disorder treatments (eg, pharmacological, behav- ioral, or multimodal) as appropriate are reasonable to reduce stroke risk.521–531 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals who consume recreational drugs (such as cannabis, synthetic cannabinoids, cocaine, heroin, methamphetamine), misuse alcohol or prescription drugs (like stimulants and opioids), or have a substance use disorder, it is advisable to provide counseling to cease use or to administer suitable treatments for substance use disorder (including pharmacological, behavioral, or multimodal approaches) to effectively lower the risk of stroke."
id_00612,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is reasonable.6,7","For those who have a positive genotype but do not exhibit the phenotype for HCM, engaging in competitive sports at any level is considered reasonable."
id_01572,"In patients with severe MS who cannot undergo MV intervention before NCS, perioperative invasive hemodynamic monitoring is reasonable to guide management to reduce the risk of cardiovascular complications.","For patients with severe MS who are unable to have MV intervention prior to NCS, it is advisable to use perioperative invasive hemodynamic monitoring to help manage and lower the risk of cardiovascular complications."
id_02051,"In patients with chronic severe secondary MR from atrial annular dilation with preserved LV systolic function (LVEF ≥50%) who have severe persistent symptoms (NYHA class III or IV) despite therapy for HF and therapy for associated AF or other comorbidities (Stage D), mitral valve surgery may be considered.16–20","For patients experiencing chronic severe secondary mitral regurgitation due to atrial annular dilation, with maintained left ventricular systolic function (LVEF ≥50%) and enduring severe symptoms (NYHA class III or IV) despite heart failure treatment and management of associated atrial fibrillation or other comorbidities (Stage D), mitral valve surgery can be considered."
id_02052,"In patients with chronic severe secondary MR related to LV systolic dysfunction (LVEF <50%) who have persistent severe symptoms (NYHA class III or IV) while on optimal GDMT for HF (Stage D), mitral valve surgery may be considered.9,12,21–43","For patients with chronic severe secondary mitral regurgitation due to left ventricular systolic dysfunction (LVEF below 50%) who continue to experience severe symptoms (NYHA class III or IV) despite receiving optimal guideline-directed medical therapy for heart failure (Stage D), mitral valve surgery can be considered."
id_00613,"In individuals who are genotype-positive, phenotype-negative for HCM, ICD is not recommended for primary prevention.2–6,8","For those with a positive genotype but negative phenotype for HCM, an ICD is not advised for primary prevention."
id_01093,"In patients with stroke or TIA in the setting of acute MI, it is reasonable to perform advanced cardiac imaging (eg, contrasted echocar- diogram or cardiac MRI) to assess for the presence of LV thrombus.","For patients experiencing a stroke or TIA alongside an acute MI, it is advisable to conduct advanced cardiac imaging, such as a contrasted echocardiogram or cardiac MRI, to evaluate for LV thrombus."
id_00133,"If a person with superficial wound or abrasion develops redness, swelling, foul-smelling wound drainage, increased pain, or fever, it is reasonable to remove the dressing, inspect the wound, and obtain medical care. Recommendation-Specific Supportive Text","If an individual with a superficial wound or abrasion experiences redness, swelling, malodorous discharge, heightened pain, or fever, it is advisable to take off the dressing, examine the wound, and seek medical attention."
id_02532,"In pregnant or early postpartum (within 6 weeks of delivery), patients with severe hypertension (2 measurements of SBP ≥160 mm Hg or DBP ≥110 mm Hg, 15 minutes apart), BP-lowering treatment to a target <160/110 mm Hg as soon as possible is recommended to reduce the risk of fatal maternal ICH.551–558","For patients who are pregnant or within six weeks postpartum and experiencing severe hypertension (with two blood pressure readings of SBP ≥160 mm Hg or DBP ≥110 mm Hg taken 15 minutes apart), it is advised to promptly administer BP-lowering treatment to achieve a target below 160/110 mm Hg to minimize the risk of fatal maternal intracerebral hemorrhage."
id_01573,"In patients with severe MS who cannot undergo MV intervention before NCS, perioperative heart-rate control (eg, beta blockers, calcium channel blockers [CCBs], ivabradine, digoxin) may be considered to prolong diastolic filling time and decrease periopera­ tive cardiovascular complications.18–21","For patients with severe mitral stenosis who are unable to have mitral valve intervention prior to non-cardiac surgery, controlling heart rate perioperatively with agents such as beta blockers, calcium channel blockers, ivabradine, or digoxin may be considered to extend diastolic filling time and reduce cardiovascular complications during the perioperative period."
id_02053,"In patients with CAD and chronic severe secondary MR related to LV systolic dysfunction (LVEF <50%) (Stage D) who are undergoing mitral valve surgery because of severe symptoms (NYHA class III or IV) that persist despite GDMT for HF, chordal-sparing mitral valve replacement may be reasonable to choose over downsized annuloplasty repair.9,12,21–32,44–47","For patients with CAD and chronic severe secondary MR due to LV systolic dysfunction (LVEF <50%) (Stage D) who continue to experience severe symptoms (NYHA class III or IV) despite GDMT for HF and are undergoing mitral valve surgery, opting for chordal-sparing mitral valve replacement might be a reasonable alternative to downsized annuloplasty repair."
id_00614,"In adult patients with HCM, a comprehensive, systematic noninvasive SCD risk assessment at initial evaluation and every 1 to 2 years thereafter is recommended and should include evaluation of these risk factors (Figures 1 and 3, Table 8)1–25: a.   Personal history of cardiac arrest or sustained ventricular arrhythmias; b.   Personal history of syncope suspected by clinical history to be arrhythmic; c.   Family history in close relative of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias; d.   Maximal LV wall thickness, EF, LV apical aneurysm; e.   NSVT episodes on continuous ambulatory electrocardiographic monitoring.","For adult patients with HCM, it is advised to conduct a thorough and systematic noninvasive SCD risk assessment during the initial evaluation and subsequently every 1 to 2 years. This assessment should encompass the following risk factors: a. Personal history of cardiac arrest or sustained ventricular arrhythmias; b. Personal history of syncope suspected to be arrhythmic based on clinical history; c. Family history of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias in close relatives; d. Maximal LV wall thickness, EF, LV apical aneurysm; e. NSVT episodes observed on continuous ambulatory electrocardiographic monitoring."
id_00134,"For a person with a suspected spinal injury, the first aid provider should have the person remain as still as possible (unless safety considerations warrant movement) and activate the emergency response system.","If a spinal injury is suspected, the first aid responder should ensure the individual stays immobile unless movement is necessary for safety, and should contact emergency services."
id_02533,"In patients with HDP, including chronic hyperten- sion in pregnancy, treatment with antihypertensive medication to a goal BP of <140/90 mm Hg is reasonable to reduce the risk of pregnancy- associated stroke.559–566","For patients with hypertensive disorders of pregnancy, such as chronic hypertension during pregnancy, it is advisable to use antihypertensive drugs to achieve a target blood pressure below 140/90 mm Hg to lower the risk of stroke related to pregnancy."
id_01094,"In patients with stroke or TIA and new LV thrombus (<3 months), the safety of antico- agulation with a direct oral anticoagulant to reduce risk of recurrent stroke is uncertain.509","For patients who have experienced a stroke or TIA and have developed a new LV thrombus within the past three months, the safety of using a direct oral anticoagulant to lower the risk of another stroke is unclear."
id_02054,"In patients with TR, TTE is indicated to evaluate the presence and severity of TR, determine the etiology, measure the sizes of the right- sided chambers and inferior vena cava, assess RV systolic function, estimate pulmonary artery systolic pressure, and characterize any associated left-sided heart disease.1,2","For patients with TR, TTE is recommended to assess the presence and severity of TR, identify its cause, evaluate the dimensions of the right-sided chambers and inferior vena cava, assess RV systolic function, estimate pulmonary artery systolic pressure, and identify any related left-sided heart disease."
id_01574,"In patients with suspected moderate or severe val­ vular regurgitation, preoperative echocardiography is recommended before elective NCS to guide periop­ erative management.*","For patients suspected of having moderate or severe valvular regurgitation, it is advised to perform preoperative echocardiography prior to elective non-cardiac surgery to assist in perioperative management."
id_00135,A person with signs and symptoms of a concus- sion should be immediately removed from activity (play/sports) and not allowed to return to activity until evaluated by a health care professional.,Anyone exhibiting concussion symptoms should be promptly taken out of activity (such as play or sports) and not permitted to resume until assessed by a healthcare professional.
id_02055,"In patients with TR, invasive measurement of the cardiac index, right-sided diastolic pressures, pulmonary artery pressures, and pulmonary vascular resistance, as well as right ventriculography, can be useful when clinical and noninvasive data are discordant or inadequate.3–5","For patients with TR, when clinical and noninvasive data are inconsistent or insufficient, it may be beneficial to perform invasive assessments of the cardiac index, right-sided diastolic pressures, pulmonary artery pressures, and pulmonary vascular resistance, along with right ventriculography."
id_02534,"In adults, screening for a history of certain adverse pregnancy outcomes (APOs), including HDP, preterm birth, gestational diabetes, and placental disorders, followed by subsequent evalu- ation and management of vascular risk factors, is recommended to reduce the risk of stroke. Other intervention","It is advised that adults be screened for a history of specific adverse pregnancy outcomes, such as hypertensive disorders of pregnancy, preterm birth, gestational diabetes, and placental disorders, and then evaluated and managed for vascular risk factors to lower the risk of stroke."
id_01575,"In patients with VHD who meet indications for valvular intervention based on clinical presentation and severity of regurgitation, the need for valvular intervention should be considered before elective elevated-risk NCS to reduce perioperative risk.*1–3","For patients with VHD who qualify for valvular intervention due to their clinical symptoms and regurgitation severity, it is advisable to evaluate the necessity of this intervention prior to elective high-risk NCS to minimize perioperative risk."
id_01095,"In patients with stroke or TIA in the setting of acute anterior MI with reduced ejection fraction (EF; <50%) but no evidence of LV thrombus, empirical anticoagulation for at least","For patients experiencing a stroke or TIA alongside acute anterior MI with an ejection fraction below 50% and without signs of LV thrombus, it is advised to initiate empirical anticoagulation for a minimum duration."
id_00615,"For adult patients with HCM who are not otherwise identified as high risk for SCD, or in whom a decision to proceed with ICD placement remains uncertain after clinical assessment that includes personal/ family history, echocardiography, and ambulatory electrocardiographic monitoring, CMR imaging is beneficial to assess for maximum LV wall thickness, EF, LV apical aneurysm, and extent of myocardial fibrosis with LGE (Table 8).1,11,12,15–20","For adult patients with HCM who are not classified as high risk for SCD, or when the decision to implant an ICD is still uncertain after evaluating personal/family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum LV wall thickness, EF, LV apical aneurysm, and the degree of myocardial fibrosis using LGE."
id_00136,"For a person with signs or symptoms of severe head injury (such as loss of consciousness, worsening headache, vomiting, altered mental status, seizures, visual changes, swelling, or deformities of the scalp), EMS should be activated. Recommendation-Specific Supportive Text","If an individual exhibits signs or symptoms indicative of a severe head injury, including loss of consciousness, worsening headache, vomiting, altered mental status, seizures, visual disturbances, scalp swelling, or deformities, emergency medical services should be contacted."
id_00616,"For patients who are ≥16 years of age with HCM, it is reasonable to obtain echocardiography-derived left atrial diameter and maximal LVOT gradient to aid in calculating an estimated 5-year sudden death risk that may be useful during shared decision-making for ICD placement (Table 8).2,22","For patients aged 16 years and older with HCM, it is advisable to measure the left atrial diameter and maximal LVOT gradient via echocardiography to help estimate the 5-year risk of sudden death, which can be beneficial in shared decision-making regarding ICD placement (Table 8)."
id_02056,"In patients with signs and symptoms of right-sided HF attributable to severe TR (Stages C and D), diuretics can be useful.",Diuretics may be beneficial for patients exhibiting signs and symptoms of right-sided heart failure due to severe tricuspid regurgitation (Stages C and D).
id_01576,"In asymptomatic patients with moderate or severe MR, normal LV systolic function, and estimated PA systolic pressure <50 mm Hg, it is reasonable to perform elective NCS.*45","For asymptomatic patients with moderate or severe mitral regurgitation, normal left ventricular systolic function, and an estimated pulmonary artery systolic pressure below 50 mm Hg, elective non-cardiac surgery is considered reasonable."
id_02535,"In patients with a history of HDP or other APOs, early evaluation and management of chronic hypertension are recommended to reduce the risk of stroke.609–613","For patients with a history of HDP or other APOs, it is advised to assess and manage chronic hypertension early to lower the risk of stroke."
id_01096,"In patients with ischemic stroke or TIA and left atrial or left atrial appendage thrombus in the setting of ischemic, nonischemic, or restrictive cardiomyopathy and LV dysfunction, antico- agulant therapy with warfarin is recommended for at least 3 months to reduce the risk of recurrent stroke or TIA.","For patients experiencing ischemic stroke or TIA who have a thrombus in the left atrium or left atrial appendage due to ischemic, nonischemic, or restrictive cardiomyopathy and left ventricular dysfunction, it is advised to administer warfarin as an anticoagulant for a minimum of 3 months to lower the risk of another stroke or TIA."
id_00137,A person with a painful extremity injury that limits use should avoid activities that cause pain and seek medical attention.,Individuals experiencing a painful injury in a limb that restricts movement should refrain from activities that induce pain and consult a healthcare professional.
id_02536,"In adults, screening for a history of endometriosis is reasonable to inform the risk of stroke.649–653 Other intervention","For adults, evaluating a history of endometriosis is advisable to assess stroke risk."
id_01097,"In patients with ischemic stroke or TIA in the setting of a mechanical assist device, treatment with warfarin and aspirin can be beneficial to reduce the risk of recurrent stroke or TIA.516–523","For patients experiencing an ischemic stroke or TIA while using a mechanical assist device, administering warfarin alongside aspirin may help lower the risk of another stroke or TIA."
id_02537,"In individuals with endometriosis, vascular risk factor evaluation and modification of vascular risk factors are reasonable to reduce the risk of stroke.649–653","For those with endometriosis, assessing and adjusting vascular risk factors is advisable to lower the likelihood of stroke."
id_01577,"In asymptomatic patients with moderate or severe aor­ tic regurgitation and normal LV systolic function (LVEF >55%), it is reasonable to perform elective NCS.*6 *Modified from the “2020 ACC/AHA Guideline for the Management of Pa­ tients With Valvular Heart Disease.”3","For patients without symptoms who have moderate or severe aortic regurgitation and normal left ventricular systolic function (LVEF greater than 55%), it is appropriate to consider elective non-cardiac surgery."
id_01098,"In patients with ischemic stroke or TIA in the setting of LV noncompaction, treatment with warfarin can be beneficial to reduce the risk of recurrent stroke or TIA.","For patients experiencing ischemic stroke or TIA due to LV noncompaction, using warfarin may help lower the risk of another stroke or TIA."
id_01578,"For patients who undergo successful transcatheter aortic valve implantation (TAVI), it is reasonable to perform NCS early* as clinically indicated.1–3","For patients who have had a successful transcatheter aortic valve implantation (TAVI), it is appropriate to conduct NCS early when clinically necessary."
id_02057,"In patients with signs and symptoms of right-sided HF attributable to severe secondary TR (Stages C and D), therapies to treat the primary cause of HF (eg, pulmonary vasodilators to reduce elevated pulmonary artery pressures, GDMT for HF with reduced LVEF, or rhythm control of AF) can be useful1,2","For patients exhibiting signs and symptoms of right-sided heart failure due to severe secondary tricuspid regurgitation (Stages C and D), addressing the underlying cause of heart failure—such as using pulmonary vasodilators to lower high pulmonary artery pressures, guideline-directed medical therapy for heart failure with reduced left ventricular ejection fraction, or rhythm control for atrial fibrillation—can be beneficial."
id_02058,"In patients with severe TR (Stages C and D) undergoing left-sided valve surgery, tricuspid valve surgery is recommended.1–8","For patients with severe tricuspid regurgitation (Stages C and D) who are having left-sided valve surgery, it is advised to perform tricuspid valve surgery."
id_00618,"For children and adolescents with HCM who have a borderline risk for SCD, or in whom a decision to proceed with ICD placement remains uncertain after clinical assessment that includes personal and family history, echocardiography, and ambulatory electro- cardiographic monitoring, CMR imaging is beneficial to assess for extent of myocardial fibrosis with LGE (Table 8).9–11","In children and adolescents with HCM who have an uncertain risk of SCD, or when the decision to implant an ICD is still unclear after evaluating personal and family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful for assessing the extent of myocardial fibrosis using LGE (Table 8)."
id_00138,It can be useful for first aid providers to apply cold (such as with ice and water surrounded by a damp cloth) to an acute sprain or strain for pain and swelling. Cold application should be limited to 20 to 30 minutes per application without direct contact on the skin to avoid cold injury.,"First aid responders may find it beneficial to use cold therapy, like ice wrapped in a damp cloth, on a new sprain or strain to reduce pain and swelling. Limit each application to 20 to 30 minutes and avoid direct skin contact to prevent cold injury."
id_00617,"For children and adolescents with HCM, a compre- hensive, systematic noninvasive SCD risk assess- ment at initial evaluation and every 1 to 2 years thereafter is recommended and should include evaluation of these risk factors (Figures 1 and 3, Table 8)1–8: a.   Personal history of cardiac arrest or sustained ventricular arrhythmias; b.   Personal history of syncope suspected by clinical history to be arrhythmic; c.   Family history in close relative of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias; d.   Maximal LV wall thickness, EF, LV apical aneu- rysm; e.   NSVT episodes on continuous ambulatory elec- trocardiographic monitoring.","For children and adolescents with HCM, it is advised to conduct a thorough and systematic noninvasive SCD risk assessment during the initial evaluation and every 1 to 2 years thereafter, which should include assessing the following risk factors: a. Personal history of cardiac arrest or sustained ventricular arrhythmias; b. Personal history of syncope suspected to be arrhythmic based on clinical history; c. Family history of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias in close relatives; d. Maximal LV wall thickness, EF, LV apical aneurysm; e. NSVT episodes detected through continuous ambulatory electrocardiographic monitoring."
id_02538,"In individuals considering CHC, lower doses of ethinyl estradiol are recommended to minimize potential increased stroke risk.658–663","For those contemplating CHC use, it is advised to opt for lower doses of ethinyl estradiol to reduce the potential risk of stroke."
id_00139,First aid providers may consider applying a com- pression wrap after an acute ankle sprain or strain to promote comfort after an injury. Application of the compression wrap should be performed with- out compromising circulation. Recommendation-Specific Supportive Text,"First aid responders might apply a compression wrap following a sudden ankle sprain or strain to enhance comfort, ensuring it does not impede circulation."
id_01099,"In patients with ischemic stroke or TIA in sinus rhythm with ischemic or nonischemic cardio- myopathy and reduced EF without evidence of left atrial or LV thrombus, the effectiveness of anticoagulation compared with antiplatelet therapy is uncertain, and the choice should be individualized.524–528","For patients experiencing ischemic stroke or TIA who have sinus rhythm, ischemic or nonischemic cardiomyopathy, and reduced ejection fraction without left atrial or LV thrombus, the relative effectiveness of anticoagulation versus antiplatelet therapy remains unclear, necessitating a personalized treatment decision."
id_01579,"For patients who undergo MV TEER, it is reasonable to perform NCS after the successful MV intervention as clinically indicated.4 *Evidence supports the safety of NCS within 30 days of TAVI, if indicated.","For patients receiving MV TEER, it is appropriate to conduct NCS following a successful MV procedure when clinically warranted. Evidence indicates that NCS is safe within 30 days post-TAVI, if necessary."
id_00619,"For patients <16 years of age with HCM, it is rea- sonable to calculate an estimated 5-year sudden death risk that includes echocardiographic param- eters (interventricular septal thickness in diastole, LV posterior wall thickness in end-diastole, left atrial diameter, maximal LVOT gradient) and genotype, which may be useful during shared decision-making for ICD placement (Table 8).1,12","For patients under 16 with HCM, it is advisable to estimate a 5-year sudden death risk using echocardiographic parameters (such as interventricular septal thickness during diastole, LV posterior wall thickness at end-diastole, left atrial diameter, and maximal LVOT gradient) along with genotype, as this information can aid in shared decision-making regarding ICD placement (Table 8)."
id_02059,"In patients with progressive TR (Stage B) undergoing left-sided valve surgery, tricuspid valve surgery can be beneficial in the context of either 1) tricuspid annular dilation (tricuspid annulus end diastolic diameter >4.0 cm) or 2) prior signs and symptoms of right-sided HF.3–10","For patients with progressive TR (Stage B) who are having left-sided valve surgery, performing tricuspid valve surgery may be advantageous if there is either 1) dilation of the tricuspid annulus (end diastolic diameter >4.0 cm) or 2) a history of signs and symptoms of right-sided heart failure."
id_02539,"In individuals with specific stroke risk factors (ie, age >35 years, tobacco use, hypertension, or migraine with aura) who are considering contra- ception, shared decision-making is recommended to determine the best contraceptive choice to bal- ance the risk of stroke from contraception and the risk of stroke with pregnancy.","For individuals with certain stroke risk factors, such as being over 35, using tobacco, having hypertension, or experiencing migraines with aura, it is advised to engage in shared decision-making to select the most suitable contraceptive method that balances the stroke risk associated with contraception against the stroke risk during pregnancy."
id_01100,"In patients with stroke or TIA and LV assist devices (LVADs), treatment with dabigatran instead of warfarin for the primary or second- ary prevention of ischemic stroke or TIA causes harm.529","For patients with stroke or TIA who have LV assist devices (LVADs), using dabigatran rather than warfarin for primary or secondary prevention of ischemic stroke or TIA is harmful."
id_01580,"In patients with rapid AF identified in the setting of NCS, it is reasonable to treat potential underlying triggers contributing to AF and rapid ventricular response (eg, sepsis, anemia, pain).*1–5","For patients experiencing rapid atrial fibrillation during NCS, addressing possible underlying causes such as sepsis, anemia, or pain that may contribute to AF and a rapid ventricular response is advisable."
id_00140,"If a fracture is associated with an open wound and severe bleeding, the First Aid for Severe External Bleeding and First Aid for Life- Threatening Extremity Bleeding That Is Not Controlled by Direct Pressure recommendations should be followed.","In cases where a fracture is accompanied by an open wound and significant bleeding, adhere to the guidelines for First Aid for Severe External Bleeding and for Life-Threatening Extremity Bleeding that cannot be managed with direct pressure."
id_00620,"In patients with HCM, application of individual clinical judgment is recommended when assessing the prognostic strength of conventional risk marker(s) within the clinical profile of the individual patient, as well as a thorough and balanced discussion of the evidence, benefits, and estimated risks to engage the fully informed patient’s active participation in ICD decision-making.1–5","For patients with HCM, it is advised to use personal clinical judgment to evaluate the prognostic value of traditional risk markers in the patient's clinical profile, alongside a comprehensive and balanced discussion of the evidence, benefits, and potential risks, to ensure the patient is fully informed and actively involved in the ICD decision-making process."
id_02060,"In patients with signs and symptoms of right-sided HF and severe primary TR (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.11–14","For patients exhibiting symptoms of right-sided heart failure and severe primary tricuspid regurgitation (Stage D), performing isolated tricuspid valve surgery may help alleviate symptoms and decrease the frequency of hospital readmissions."
id_00141,"If a fractured extremity is blue, purple, or pale, the emergency response system should be activated immediately.","Activate the emergency response system right away if a broken limb appears blue, purple, or pale."
id_02540,"In individuals with specific stroke risk factors (ie, age >35 years, tobacco use, hypertension, or migraine with aura) who are considering contra- ception, progestin-only contraception or nonhor- monal contraception is reasonable to prevent the increased stroke risk associated with estrogen- containing contraception.370,661–670","For individuals with certain stroke risk factors, such as being over 35, smoking, having high blood pressure, or experiencing migraines with aura, it is advisable to use progestin-only or non-hormonal contraception to avoid the heightened stroke risk linked to estrogen-containing contraceptives."
id_01101,"In patients with a nonlacunar ischemic stroke of undetermined cause and a PFO, recom- mendations for PFO closure versus medical management should be made jointly by the patient, a cardiologist, and a neurologist, taking into account the probability of a causal role for the PFO.","For patients experiencing a nonlacunar ischemic stroke of unknown origin with a PFO, the decision between PFO closure and medical treatment should be collaboratively determined by the patient, cardiologist, and neurologist, considering the likelihood that the PFO is causally involved."
id_00621,"For patients with HCM and previous documented cardiac arrest or sustained VT, ICD placement is recommended (Figure 3, Table 8).2–6","ICD implantation is advised for patients with HCM who have a history of documented cardiac arrest or sustained VT (Figure 3, Table 8).2–6"
id_02061,"In patients with signs and symptoms of right- sided HF and severe isolated secondary TR attributable to annular dilation (in the absence of pulmonary hypertension or left-sided disease) who are poorly responsive to medical therapy (Stage D), isolated tricuspid valve surgery can be beneficial to reduce symptoms and recurrent hospitalizations.11,12,15–19","For patients exhibiting signs and symptoms of right-sided heart failure and severe isolated secondary tricuspid regurgitation due to annular dilation, without pulmonary hypertension or left-sided disease, and who do not respond well to medical treatment (Stage D), isolated tricuspid valve surgery may help alleviate symptoms and decrease the frequency of hospital readmissions."
id_01581,"In patients with new-onset AF identified in the set­ ting of NCS, initiation of postoperative anticoagula­ tion therapy can be beneficial after considering the competing risks associated with thromboembolism and perioperative bleeding.*4,6 Postdischarge","For patients experiencing new-onset AF during NCS, starting anticoagulation therapy post-surgery may be advantageous after evaluating the competing risks of thromboembolism and bleeding during the perioperative period."
id_02541,Screening for a history of premature ovarian failure (before 40 years of age) and early meno- pause (before 45 years of age) can be beneficial to inform the risk of stroke.674–678 Other interventions,Assessing for a history of premature ovarian failure (occurring before age 40) and early menopause (occurring before age 45) can be advantageous in evaluating stroke risk.
id_01582,"In patients with new-onset AF identified in the set­ ting of NCS, outpatient follow-up for thromboembolic risk stratification and AF surveillance are recom­ mended given a high risk of AF recurrence.*7–11 *Adapted from the “2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation.”12","For patients newly diagnosed with AF during NCS, it is advised to have outpatient follow-up to assess thromboembolic risk and monitor AF due to the high likelihood of recurrence."
id_00142,"Splinting of a fractured extremity can be useful to reduce pain, reduce risk for further injury, and facilitate transport to a medical facility.","Applying a splint to a broken limb can help alleviate pain, minimize the chance of additional injury, and aid in transporting the patient to a healthcare facility."
id_02062,"In asymptomatic patients with severe primary TR (Stage C) and progressive RV dilation or systolic dysfunction, isolated tricuspid valve surgery may be considered.12,20","For asymptomatic individuals with severe primary TR (Stage C) experiencing progressive right ventricular dilation or systolic dysfunction, isolated tricuspid valve surgery can be contemplated."
id_02542,"In patients with premature ovarian failure (meno- pause before 40 years of age) or early meno- pause (before 45 years of age), evaluation and modification of vascular risk factors are recom- mended to reduce the elevated stroke risk in this population.674,675,677–679","For individuals experiencing premature ovarian failure (menopause before age 40) or early menopause (before age 45), it is advised to assess and adjust vascular risk factors to mitigate the increased risk of stroke in this group."
id_01102,"In patients 18 to 60 years of age with a nonla- cunar ischemic stroke of undetermined cause despite a thorough evaluation and a PFO with high-risk anatomic features,* it is reasonable to choose closure with a transcatheter device and long-term antiplatelet therapy over anti- platelet therapy alone for preventing recurrent stroke.552–557","For patients aged 18 to 60 who have experienced a non-lacunar ischemic stroke of unknown origin after comprehensive assessment and possess a PFO with high-risk anatomical characteristics, opting for closure using a transcatheter device combined with long-term antiplatelet therapy is a reasonable choice over solely using antiplatelet therapy to prevent recurrent strokes."
id_00622,"For adult patients with HCM with ≥1 major risk factors for SCD, it is reasonable to offer an ICD. These major risk factors include (Figure 3, Table 8)2,3,7–21: a.   Sudden death judged definitively or likely attributable to HCM in ≥1 first-degree or close relatives who are ≤50 years of age; b.   Massive LVH ≥30 mm in any LV segment; c.   ≥1 recent episodes of syncope suspected by clinical history to be arrhythmic (ie, unlikely to be of neurocardiogenic [vasovagal] etiology, or related to LVOTO); d.    LV apical aneurysm with transmural scar or LGE; e.    LV systolic dysfunction (EF <50%).","For adult patients with HCM who have one or more significant risk factors for SCD, it is advisable to consider an ICD. These key risk factors include: a. Sudden death in one or more first-degree or close relatives aged 50 or younger, likely or definitely due to HCM; b. Massive LVH of 30 mm or more in any LV segment; c. One or more recent syncope episodes suspected to be arrhythmic based on clinical history (i.e., unlikely to be neurocardiogenic or related to LVOTO); d. LV apical aneurysm with transmural scar or LGE; e. LV systolic dysfunction with an EF below 50%."
id_00623,"For children with HCM who have ≥1 conventional risk factors, including unexplained syncope, massive LVH, NSVT, or family history of early HCM-related SCD, ICD placement is reasonable after considering the relatively high complication rates of long-term ICD placement in younger patients (Figure 3, Table 8).22–30","In children with HCM who present with one or more traditional risk factors—such as unexplained syncope, significant LVH, NSVT, or a family history of early SCD related to HCM—considering ICD placement is advisable, while taking into account the relatively high complication rates associated with long-term ICD use in younger individuals (Figure 3, Table 8)."
id_01103,"In patients 18 to 60 years of age with a nonla- cunar ischemic stroke of undetermined cause despite a thorough evaluation and a PFO without high-risk anatomic features,* the ben- efit of closure with a transcatheter device and long-term antiplatelet therapy over antiplatelet therapy alone for preventing recurrent stroke is not well established,552–557","For patients aged 18 to 60 who have experienced a non-lacunar ischemic stroke of unknown origin after comprehensive assessment and possess a PFO lacking high-risk anatomical characteristics, the advantage of using a transcatheter device for closure combined with long-term antiplatelet therapy, compared to antiplatelet therapy alone, in preventing recurrent strokes is not clearly determined."
id_02543,"In transgender women and gender-diverse indi- viduals taking estrogens for gender affirmation, evaluation and modification of risk factors can be beneficial to reduce the risk of stroke.700–703","For transgender women and gender-diverse individuals using estrogens for gender affirmation, assessing and adjusting risk factors may help lower the likelihood of stroke."
id_02063,"In patients with signs and symptoms of right- sided HF and severe TR (Stage D) who have undergone previous left-sided valve surgery, reoperation with isolated tricuspid valve surgery may be considered in the absence of severe pulmonary hypertension or severe RV systolic dysfunction.1,2,11,18","For patients exhibiting right-sided heart failure symptoms and severe tricuspid regurgitation (Stage D) who have previously had left-sided valve surgery, isolated tricuspid valve surgery can be contemplated if severe pulmonary hypertension or severe right ventricular systolic dysfunction is not present."
id_00144,Covering open wounds associated with a suspected fracture with a clean dressing may be useful to lower the risk for further contamination and infection. Recommendation-Specific Supportive Text,Applying a clean dressing to open wounds linked to a suspected fracture can help reduce the risk of additional contamination and infection.
id_00143,It may be reasonable to treat a deformed frac- tured extremity in the position found unless straightening the fracture is necessary to facilitate safe and prompt transport to a medical facility.,Treating a deformed fractured limb in its current position might be appropriate unless realigning the fracture is essential for ensuring safe and quick transport to a healthcare facility.
id_02064,"For patients with mixed valve disease, TTE is recommended to assess the etiology, severity, and pathophysiological impact.","TTE is advised for evaluating the cause, severity, and physiological effects in patients with mixed valve disease."
id_01583,"Patients with cardiovascular implantable electronic devices (CIED) having elective NCS should have a management plan developed before surgery if elec­ tromagnetic interference (EMI) is anticipated, includ­ ing identification of the type of CIED (eg, pacemaker, implantable cardioverter-defibrillator [ICD], implant­ able monitor), manufacturer, and model.1–6","Before undergoing elective non-cardiac surgery, patients with cardiovascular implantable electronic devices (CIEDs) should have a pre-surgical management plan in place if electromagnetic interference (EMI) is expected. This plan should include identifying the CIED type (such as pacemaker, implantable cardioverter-defibrillator [ICD], or implantable monitor), as well as the manufacturer and model."
id_01584,"Patients who are pacemaker-dependent having surgeries above the umbilicus with anticipated EMI should have the pacemaker reprogrammed or have a magnet placed on the generator to provide an asyn­ chronous mode to avoid pacing inhibition.1,7","For patients reliant on pacemakers undergoing surgeries above the umbilicus where EMI is expected, the pacemaker should be reprogrammed or a magnet should be applied to the generator to enable asynchronous pacing and prevent inhibition."
id_00624,"For patients with HCM with ≥1 major SCD risk factors, discussion of the estimated 5-year sudden death risk and mortality rates can be useful during the shared decision-making process for ICD placement (Figure 3, Table 8).3,19,29,30","For patients with HCM who have one or more major risk factors for SCD, discussing the estimated 5-year risk of sudden death and mortality rates can aid in the shared decision-making process regarding ICD implantation (Figure 3, Table 8)."
id_01104,"In patients 18 to 60 years of age with a nonlacunar ischemic stroke of undetermined cause despite a thorough evaluation and a PFO, the comparative benefit of closure with a transcatheter device versus warfarin is unknown.554 *In the evidence, each study defines high-risk anatomic features in a different way.","For patients aged 18 to 60 who have experienced a nonlacunar ischemic stroke of unknown origin after comprehensive assessment and have a PFO, the relative advantage of using a transcatheter device for closure compared to warfarin remains unclear. Each study in the evidence varies in its definition of high-risk anatomical features."
id_01105,"In patients with ischemic stroke or TIA and Fontan palliation, anticoagulation with warfarin is recommended to reduce the risk of recur- rent stroke or TIA.572,573","For patients who have experienced an ischemic stroke or TIA and have undergone Fontan palliation, it is advised to use warfarin for anticoagulation to lower the risk of another stroke or TIA."
id_00145,"Thermal burns should be cooled immediately, preferably with clean running water.","Thermal burns need to be cooled right away, ideally using clean running water."
id_02544,"In men 45 to 80 years of age with confirmed hypogonadism who are considering testosterone therapy, initiation or continuation of testosterone replacement therapy is reasonable and does not increase the risk of stroke.704–706","For men aged 45 to 80 with diagnosed hypogonadism contemplating testosterone treatment, starting or maintaining testosterone replacement therapy is appropriate and does not elevate stroke risk."
id_01585,"Pacemaker-dependent patients with a transvenous ICD undergoing surgery above the umbilicus with anticipated EMI should have the device repro­ grammed*; if the patient is not pacemaker- dependent, then either reprogramming or a magnet placed on the generator can be used to inhibit tachytherapies or inappropriate shocks.8,9","For patients reliant on a pacemaker with a transvenous ICD undergoing surgery above the umbilicus where EMI is expected, the device should be reprogrammed. If the patient is not pacemaker-dependent, either reprogramming or placing a magnet on the generator can be used to prevent tachytherapies or inappropriate shocks."
id_00626,"In pediatric patients with HCM, it can be useful to consider additional factors such as extensive LGE on contrast-enhanced CMR imaging and systolic dysfunction in risk stratification for ICD shared decision-making (Figure 3, Table 8).34,35","For pediatric patients with HCM, evaluating additional elements like significant LGE on contrast-enhanced CMR imaging and systolic dysfunction can aid in risk stratification for ICD shared decision-making (Figure 3, Table 8)."
id_00625,"In select adult patients with HCM and without major SCD risk factors after clinical assessment, or in whom the decision to proceed with ICD placement remains otherwise uncertain, ICD may be considered in patients with extensive LGE by contrast-enhanced CMR imaging or NSVT present on ambulatory moni- toring (Figure 3, Table 8).2,3,16,19,31–33","For certain adult patients with HCM who lack significant SCD risk factors following clinical evaluation, or when the decision to implant an ICD is still unclear, an ICD might be considered if there is substantial LGE detected via contrast-enhanced CMR imaging or if NSVT is observed during ambulatory monitoring."
id_00146,Preadolescent children with thermal burns being actively cooled with running water should be monitored for signs or symptoms of hypothermia.,Children in the preadolescent age group who are receiving active cooling with running water for thermal burns should be observed for any indications of hypothermia.
id_02065,"In patients with ambiguous symptoms that are suspected to be attributable to mixed mitral valve disease, further assessment of filling pressure by using biomarkers or invasive hemodynamic measurements at rest or with exercise is reasonable.","For patients presenting with unclear symptoms potentially linked to mixed mitral valve disease, it is advisable to evaluate filling pressure through biomarkers or invasive hemodynamic testing, either at rest or during exercise."
id_02545,"In patients with left ventricular systolic dysfunction (ejection fraction ≤35%–40%) and no evidence of AF or left ventricular thrombus, anticoagulation is not indicated to prevent stroke and is associ- ated with a higher bleeding risk.706,708–711","For patients with left ventricular systolic dysfunction (ejection fraction ≤35%–40%) who do not have atrial fibrillation or a left ventricular thrombus, anticoagulation is not recommended for stroke prevention due to an increased risk of bleeding."
id_01586,Patients who have a pacemaker or ICD repro­ grammed to asynchronous pacing or have tachy­ therapies programmed off before surgery should have device functioning restored in the postoperative period before hospital discharge.10,"Before hospital discharge, patients with a pacemaker or ICD adjusted to asynchronous pacing or with tachytherapies deactivated prior to surgery should have their device settings restored postoperatively."
id_02066,"In symptomatic patients with combined AS and AR and a peak transvalvular jet velocity of at least 4.0 m/s or a mean transvalvular gradient of at least 40 mm Hg, AVR is recommended.1,2","For patients exhibiting symptoms of both AS and AR, AVR is advised if the peak transvalvular jet velocity reaches 4.0 m/s or higher, or if the mean transvalvular gradient is 40 mm Hg or more."
id_02546,"In patients with diabetes or other common vascular risk factors and no prior stroke, the use of aspirin to prevent a first stroke is not well established.727–731","For individuals with diabetes or other typical vascular risk factors who have not experienced a stroke, the efficacy of aspirin in preventing an initial stroke is not clearly supported."
id_01106,"In patients with cyanotic congenital heart disease and other complex lesions, ischemic stroke or TIA of presumed cardioembolic origin, therapy with warfarin is reasonable to reduce the risk of recurrent stroke or TIA. Downloaded from http://ahajournals.org by on June 19, 2025","For patients with cyanotic congenital heart disease and other intricate lesions who experience an ischemic stroke or TIA likely due to cardioembolism, using warfarin is a sensible approach to lower the risk of another stroke or TIA."
id_01107,"In patients with stroke or TIA found to have a left-sided cardiac tumor, resection of the tumor can be beneficial to reduce the risk of recurrent stroke.586–588","For patients who have experienced a stroke or TIA and are diagnosed with a left-sided cardiac tumor, removing the tumor may help lower the risk of another stroke."
id_00627,"In patients with HCM who are receiving an ICD, either a single-chamber transvenous ICD or a subcutaneous ICD is recommended after a shared decision-making discussion that takes into consideration patient preferences, age, lifestyle, and potential need for pacing for bradycardia or VT termination.1–6","For patients with HCM undergoing ICD implantation, it is advised to choose either a single-chamber transvenous ICD or a subcutaneous ICD following a shared decision-making process that evaluates patient preferences, age, lifestyle, and the possible requirement for pacing to address bradycardia or terminate VT."
id_00148,"If clean running water is not available, it may be reasonable to cool superficial burns (with the skin intact) with ice wrapped in cloth.","In the absence of clean running water, it might be appropriate to use ice wrapped in cloth to cool superficial burns with intact skin."
id_01587,Patients with leadless pacemakers who are pacemaker-dependent having surgeries with antici­ pated EMI above the umbilicus should have their pace­ makers reprogrammed to an asynchronous mode.11,"For pacemaker-dependent patients with leadless pacemakers undergoing surgeries expected to cause EMI above the umbilicus, their pacemakers should be reprogrammed to an asynchronous mode."
id_02067,"In asymptomatic patients with combined AS and AR who have a jet velocity of ≥4.0 m/s with an LVEF <50%, SAVR is recommended.1,2","For asymptomatic individuals with both AS and AR, a jet velocity of 4.0 m/s or greater and an LVEF below 50% indicate a recommendation for SAVR."
id_02547,"In patients with established, stable coronary artery disease and a low bleeding risk, the addition of ticagrelor to aspirin beyond 12 months for a period up to 3 years may be beneficial to reduce the rate of ischemic stroke.732","For patients with stable coronary artery disease and minimal risk of bleeding, extending ticagrelor in combination with aspirin for up to 3 years after the initial 12 months may help lower the incidence of ischemic stroke."
id_02068,"In patients with a surgical or transcatheter prosthetic valve and in patients who have had valve repair, an initial postprocedural TTE study is recommended for evaluation of valve hemodynamics and ventricular function.1–4","For patients with a surgical or transcatheter prosthetic valve, as well as those who have undergone valve repair, it is advised to conduct an initial postprocedural TTE study to assess valve hemodynamics and ventricular function."
id_00628,"In patients with HCM who are receiving a transvenous ICD, single-coil ICD leads are recommended in preference to dual-coil leads, if defibrillation threshold is deemed adequate.7–9","For patients with HCM undergoing transvenous ICD implantation, it is advised to use single-coil ICD leads over dual-coil leads, provided the defibrillation threshold is considered sufficient."
id_01108,"In patients with ischemic stroke or TIA after an extracranial carotid or vertebral arterial dis- section, treatment with antithrombotic therapy for at least 3 months is indicated to prevent recurrent stroke or TIA.","For patients who have experienced an ischemic stroke or TIA following an extracranial carotid or vertebral artery dissection, it is recommended to administer antithrombotic therapy for a minimum of 3 months to avert a recurrence of stroke or TIA."
id_00147,It may be reasonable to cool thermal burns for 5 to 20 minutes.,Cooling thermal burns for a duration of 5 to 20 minutes might be advisable.
id_02548,"In individuals ≥70 years of age with at least 1 additional cardiovascular risk factor, the use of aspi- rin is not beneficial to prevent a first stroke.360,733","For people aged 70 and older with at least one other cardiovascular risk factor, aspirin does not help in preventing an initial stroke."
id_01588,"For patients with subcutaneous ICD having noncardiac or nonthoracic surgery with anticipated EMI above the groin, it is reasonable to reprogram the device or use a magnet to temporarily disable tachytherapies.12 *For pacemaker-dependent patients with an ICD, tachytherapies should be disabled and the device should be reprogrammed to an asynchronous mode to avoid pacing inhibition.","For individuals with a subcutaneous ICD undergoing noncardiac or nonthoracic procedures where EMI is expected above the groin, it is advisable to either reprogram the device or apply a magnet to temporarily deactivate tachytherapies. For those who are pacemaker-dependent with an ICD, tachytherapies must be deactivated, and the device should be set to an asynchronous mode to prevent pacing inhibition."
id_00149,"A person with a full-thickness burn or with a partial- thickness burn that is larger than the person’s palm or involves the person’s face, hands, feet, or genitals should promptly seek evaluation by a health care professional.","Individuals with a full-thickness burn, or a partial-thickness burn exceeding the size of their palm or affecting their face, hands, feet, or genitals, should immediately consult a healthcare professional for assessment."
id_01109,"In patients with ischemic stroke or TIA who are <3 months after an extracranial carotid or vertebral arterial dissection, it is reasonable to use either aspirin or warfarin to prevent recur- rent stroke or TIA.593,594","For patients who have experienced an ischemic stroke or TIA within 3 months following an extracranial carotid or vertebral arterial dissection, using either aspirin or warfarin to prevent another stroke or TIA is considered reasonable."
id_01589,"In patients with a history of stroke or transient isch­ emic attack, it is reasonable to delay elective NCS for ≥3 months after the most recent cerebrovascular event to reduce the incidence of recurrent stroke, MACE, or both.1,2","For patients with a prior stroke or transient ischemic attack, postponing elective non-cardiac surgery for at least three months following the latest cerebrovascular event is advisable to lower the risk of recurrent stroke, major adverse cardiovascular events, or both."
id_02549,"In patients with chronic kidney disease, the use of aspirin is not effective to prevent a first stroke.734","For individuals with chronic kidney disease, aspirin does not effectively prevent an initial stroke."
id_00629,"In patients with HCM who are receiving an ICD, dual-chamber ICDs are reasonable for patients with a need for atrial or atrioventricular sequential pacing for bradycardia/conduction abnormalities, or as an attempt to relieve symptoms of obstructive HCM (most commonly in patients >65 years of age).10–13","For patients with HCM receiving an ICD, it is appropriate to consider dual-chamber ICDs for those requiring atrial or atrioventricular sequential pacing due to bradycardia or conduction issues, or to alleviate symptoms of obstructive HCM, particularly in individuals over 65 years old."
id_00150,"For a person with evidence of smoke inhalation injury such as facial burns, difficulty breathing, singed nasal hairs, or soot around the nose or mouth, EMS should be activated.","If someone shows signs of smoke inhalation injury, like facial burns, breathing difficulties, singed nasal hairs, or soot near the nose or mouth, emergency medical services should be called."
id_02069,"In patients with a prosthetic valve or prior valve repair and a change in clinical symptoms or signs suggesting valve dysfunction, repeat TTE is recommended.","For patients with a prosthetic valve or previous valve repair who exhibit new clinical symptoms or signs indicating valve dysfunction, it is advised to perform a repeat TTE."
id_00630,"In selected adult patients with nonobstructive HCM receiving an ICD who have NYHA class II to ambula- tory class IV HF, left bundle branch block (LBBB), and LVEF <50%, cardiac resynchronization therapy (CRT) for symptom reduction is reasonable.14–18","For certain adult patients with nonobstructive HCM who are receiving an ICD and exhibit NYHA class II to ambulatory class IV heart failure, left bundle branch block (LBBB), and an LVEF below 50%, it is reasonable to consider cardiac resynchronization therapy (CRT) to alleviate symptoms."
id_02550,We recommend that epinephrine be administered for patients in cardiac arrest.,We advise administering epinephrine to patients experiencing cardiac arrest.
id_01110,"In patients with stroke or TIA and extracranial carotid or vertebral artery dissection who have recurrent events despite antithrombotic therapy, endovascular therapy may be consid- ered to prevent recurrent stroke or TIA.595,596","For patients experiencing stroke or TIA with extracranial carotid or vertebral artery dissection who continue to have recurrent events despite antithrombotic treatment, endovascular therapy might be an option to prevent further stroke or TIA."
id_00151,"A person with thermal burns should promptly remove all jewelry, belts, and other tight items from burned areas.","Individuals with thermal burns should quickly take off any jewelry, belts, or other constrictive items from the affected areas."
id_01590,"In patients scheduled for NCS, obstructive sleep apnea (OSA) screening using validated question­ naires is reasonable to assess the risk of periopera­ tive complications.1–3","For patients undergoing NCS, it is advisable to use validated questionnaires to screen for obstructive sleep apnea (OSA) to evaluate the risk of perioperative complications."
id_02070,"In patients with a prosthetic valve replacement or prior valve repair and clinical symptoms or signs that suggest prosthetic valve dysfunction, additional imaging with TEE, gated cardiac CT, or fluoroscopy is recommended, even if TTE does not show valve dysfunction.","For patients who have undergone prosthetic valve replacement or previous valve repair and exhibit clinical symptoms or signs indicative of prosthetic valve dysfunction, it is advised to perform further imaging with TEE, gated cardiac CT, or fluoroscopy, even if TTE does not reveal valve dysfunction."
id_01591,"In patients currently on statins and scheduled for NCS, continuation of statin therapy is recommended to reduce the risk of MACE.1–3","For patients taking statins who are planning to undergo NCS, it is advised to maintain statin therapy to lower the risk of MACE."
id_02551,It is reasonable to administer epinephrine 1 mg every 3 to 5 minutes for cardiac arrest.,Administering 1 mg of epinephrine at intervals of 3 to 5 minutes during cardiac arrest is considered appropriate.
id_00631,"In patients with HCM in whom a decision has been made for ICD implantation and who have paroxysmal atrial tachycardias or AF, dual-chamber ICDs may be reasonable, but this decision must be balanced against higher complication rates of dual-chamber devices.19–24","For patients with HCM who are candidates for ICD implantation and experience paroxysmal atrial tachycardias or AF, considering dual-chamber ICDs can be appropriate; however, this choice should be weighed against the increased complication rates associated with dual-chamber devices."
id_00152,It is reasonable to give over-the-counter pain medications for pain from thermal burns.,Administering non-prescription pain relievers for discomfort caused by thermal burns is considered appropriate.
id_02071,"In patients with a bioprosthetic surgical valve, TTE at 5 and 10 years and then annually after implantation is reasonable, even in the absence of a change in clinical status.","For patients with a bioprosthetic surgical valve, it is advisable to perform a TTE at 5 and 10 years post-implantation, followed by yearly evaluations, regardless of any changes in clinical condition."
id_01111,"In patients with ischemic stroke or TIA of unknown source despite thorough diagnostic evaluation and no other thrombotic history who are found to have prothrombin 20210A mutation, activated protein C resistance, elevated factor VIII levels, or deficiencies of protein C, protein S, or antithrombin III, anti- platelet therapy is reasonable to reduce the risk of recurrent stroke or TIA.600–606","For patients experiencing an ischemic stroke or TIA of unknown origin, who have undergone comprehensive diagnostic assessment and lack any other thrombotic history, and are identified with prothrombin 20210A mutation, activated protein C resistance, increased factor VIII levels, or deficiencies in protein C, protein S, or antithrombin III, it is advisable to consider antiplatelet therapy to lower the risk of subsequent stroke or TIA."
id_00632,"In patients with obstructive HCM and symptoms* attributable to LVOTO, nonvasodilating beta blockers, titrated to effectiveness or maximally tolerated doses, are recommended.1–3 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with obstructive hypertrophic cardiomyopathy experiencing symptoms due to left ventricular outflow tract obstruction, it is advised to use nonvasodilating beta blockers, adjusted to either effective or the highest tolerable doses."
id_02072,"In patients with a bioprosthetic TAVI, TTE annually is reasonable. Table 21.  AS/MR Mixed Valve Disease Severe AS Severe MR Surgical Risk Procedure SAVR candidate Primary MR Repairable valve Low intermediate SAVR Surgical mitral valve repair SAVR candidate Primary MR Valve not repairable Low intermediate SAVR Surgical mitral valve replacement TAVI candidate Primary Repairable valve High prohibitive TAVI Mitral TEER* SAVR candidate TAVI candidate Secondary MR Low intermediate SAVR Surgical mitral valve repair/mitral valve replacement or TAVI Mitral TEER* TAVI candidate Secondary MR High prohibitive TAVI Mitral TEER* *Consider TEER as a later staged procedure if symptoms and severe MR persist after treatment of the AS. AS indicates aortic stenosis; MR, mitral regurgitation; SAVR, surgical aortic valve replacement; TAVI, transcatheter aortic valve implantation; and TEER, transcatheter edge-to-edge repair. Downloaded from http://ahajournals.org by on June 19, 2025","For patients with a bioprosthetic TAVI, it is advisable to perform a TTE every year."
id_02552,"With respect to timing, for cardiac arrest with a nonshockable rhythm, it is reasonable to administer epinephrine as soon as feasible.","For cardiac arrest with a nonshockable rhythm, it is advisable to give epinephrine at the earliest possible opportunity."
id_00153,"After cooling, for small partial-thickness burns being managed at home, it may be reasonable to apply petrolatum, petrolatum-based antibiotic ointment, honey, or aloe vera and a clean nonadherent dressing to open burn wounds.","Following cooling, for minor partial-thickness burns treated at home, it is advisable to use petrolatum, a petrolatum-based antibiotic ointment, honey, or aloe vera, along with a clean non-stick dressing on open burn wounds."
id_01592,"In statin-naïve adult patients who meet criteria for statin use based on ASCVD history or 10-year risk assessment and are scheduled for NCS, periopera­ tive initiation of statin is recommended with intention of long-term use.4,5","For adults who have not previously taken statins and qualify for their use due to ASCVD history or a 10-year risk evaluation, it is advised to start statin therapy around the time of non-cardiac surgery, with the plan for continued long-term use."
id_01112,"In patients with ischemic stroke or TIA who have an isolated antiphospholipid antibody but do not fulfill the criteria for antiphospho- lipid syndrome, antiplatelet therapy alone is recommended to reduce the risk of recurrent stroke.612","For patients experiencing an ischemic stroke or TIA with a single antiphospholipid antibody but not meeting the criteria for antiphospholipid syndrome, it is advised to use antiplatelet therapy alone to lower the risk of another stroke."
id_01593,"In select* patients on chronic renin-angiotensin- aldosterone system inhibitors (RAASi) for hypertension undergoing elevated-risk NCS, omission 24 hours before surgery may be beneficial to limit intraoperative hypotension.1–6","For certain patients taking chronic RAAS inhibitors for hypertension who are undergoing high-risk non-cardiac surgery, it may be advantageous to withhold the medication 24 hours prior to surgery to reduce the risk of intraoperative hypotension."
id_00633,"For patients with obstructive HCM who have persistent symptoms* attributable to LVOTO despite beta blockers or nondihydropyridine calcium channel blockers, adding a myosin inhibitor (adult patients only), or disopyramide (in combination with an atrioventricular nodal blocking agent), or SRT performed at experienced centers,§ is recommended.7–14","For adult patients with obstructive HCM experiencing ongoing symptoms due to LVOTO despite treatment with beta blockers or nondihydropyridine calcium channel blockers, it is advised to add a myosin inhibitor, or use disopyramide alongside an atrioventricular nodal blocking agent, or consider SRT at specialized centers."
id_02073,"For patients who require heart valve replacement, the choice of prosthetic valve should be based on a shared decision-making process that accounts for the patient’s values and preferences and includes discussion of the indications for and risks of anticoagulant therapy and the potential need for and risks associated with valve reintervention.","For patients needing heart valve replacement, selecting a prosthetic valve should involve a collaborative decision-making approach that considers the patient's values and preferences, while also discussing the reasons for and risks of anticoagulant therapy, as well as the potential necessity and risks of valve reintervention."
id_02553,Vasopressin alone or vasopressin+ methylprednisolone in combination with epinephrine may be considered in cardiac arrest but offers no advantage as a substitute for epinephrine.,"Vasopressin, either by itself or with methylprednisolone alongside epinephrine, can be considered during cardiac arrest, but it does not provide any benefit over using epinephrine alone."
id_00634,"For patients with obstructive HCM and acute hypotension who do not respond to fluid administration, intravenous phenylephrine (or other vasoconstrictors without inotropic activity), alone or in combination with beta-blocking drugs, is recommended.15","For patients with obstructive HCM experiencing acute hypotension unresponsive to fluid therapy, it is advised to use intravenous phenylephrine or other vasoconstrictors lacking inotropic effects, either alone or alongside beta-blockers."
id_00154,"After cooling, while awaiting evaluation by a health care professional, it may be reasonable to loosely cover a burn that has intact skin or an intact blister with a clean cloth or nonadherent dry dressing. Recommendation-Specific Supportive Text","Once cooled, it might be appropriate to gently cover a burn with unbroken skin or an intact blister using a clean cloth or a non-stick dry dressing while waiting for a healthcare professional's assessment."
id_01113,"In patients with ischemic stroke or TIA with confirmed antiphospholipid syndrome treated with warfarin, it is reasonable to choose a target INR between 2 and 3 over a target INR >3 to effectively balance the risk of excessive bleeding against the risk of thrombosis.613–615","For patients with ischemic stroke or TIA who have confirmed antiphospholipid syndrome and are on warfarin, aiming for a target INR of 2 to 3 is advisable to appropriately balance the risks of bleeding and thrombosis, rather than targeting an INR greater than 3."
id_01114,"In patients with ischemic stroke or TIA who meet the criteria for the antiphospholipid syndrome, it is reasonable to anticoagulate with warfarin to reduce the risk of recurrent stroke or TIA.615","For patients with ischemic stroke or TIA who qualify for antiphospholipid syndrome, using warfarin for anticoagulation is a sensible approach to lower the risk of another stroke or TIA."
id_02074,"For patients of any age requiring valve replacement for whom anticoagulant therapy is contraindicated, cannot be managed appropriately, or is not desired, a bioprosthetic valve is recommended.","A bioprosthetic valve is advised for patients of any age needing valve replacement when anticoagulant therapy is unsuitable, unmanageable, or unwanted."
id_01594,"In patients on chronic RAASi for HFrEF, periopera­ tive continuation is reasonable.†1,2 *Patients with controlled BP and undergoing elevated-risk surgical procedures. †Modified from the “2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.”7","For patients with HFrEF on long-term RAASi therapy, it is advisable to maintain the medication during the perioperative period, particularly for those with stable blood pressure undergoing high-risk surgeries."
id_02554,"With respect to timing, for cardiac arrest with a shockable rhythm, it may be reasonable to administer epinephrine after initial defibrillation attempts have failed.","Regarding timing, it might be appropriate to give epinephrine if initial defibrillation attempts do not succeed in cases of cardiac arrest with a shockable rhythm."
id_00155,"When a permanent tooth becomes avulsed (knocked out), initial actions include removing visible debris from the tooth by brief rinsing (<10 seconds), taking care not to damage the tooth or attached tissue, and attempting to replant the tooth in the socket.","If a permanent tooth is avulsed, promptly rinse off any visible debris for less than 10 seconds, ensuring the tooth and attached tissue remain intact, and try to reinsert the tooth into its socket."
id_02555,High-dose epinephrine is not recommended for routine use in cardiac arrest.,Routine administration of high-dose epinephrine is not advised during cardiac arrest.
id_01595,"In patients undergoing NCS, initiation of low-dose clonidine perioperatively is not recommended to reduce cardiovascular risk.1","For patients having NCS, starting low-dose clonidine around the time of surgery is not advised for lowering cardiovascular risk."
id_01115,"In patients with ischemic stroke or TIA, antiphospholipid syndrome with history of thrombosis and triple-positive antiphospholipid antibodies (ie, lupus anticoagulant, anticardio- lipin, and anti– β2 glycoprotein-I), rivaroxaban is not recommended because it is associated with excess thrombotic events compared with warfarin.616–618","For patients who have experienced an ischemic stroke or TIA and have antiphospholipid syndrome with a history of thrombosis and triple-positive antiphospholipid antibodies (including lupus anticoagulant, anticardiolipin, and anti-β2 glycoprotein-I), rivaroxaban is not advised due to a higher risk of thrombotic events compared to warfarin."
id_00635,"For patients with obstructive HCM and persistent dyspnea with clinical evidence of volume overload and high left-sided filling pressures despite other HCM GDMT, cautious use of low-dose oral diuretics may be considered.","In patients with obstructive HCM experiencing ongoing shortness of breath and signs of volume overload with elevated left-sided filling pressures, despite other HCM guideline-directed medical therapy, the careful administration of low-dose oral diuretics can be contemplated."
id_02075,"For patients <50 years of age who do not have a contraindication to anticoagulation and require AVR, it is reasonable to choose a mechanical aortic prosthesis over a bioprosthetic valve.1","For patients under 50 years old without contraindications to anticoagulation, opting for a mechanical aortic valve instead of a bioprosthetic one is a reasonable choice for AVR."
id_01116,"In patients with ischemic stroke or TIA with hyperhomocysteinemia, supplementation with folate, vitamin B6, and vitamin B12 is not effective for preventing subsequent stroke.625,626","For patients experiencing ischemic stroke or TIA who have elevated homocysteine levels, taking supplements of folate, vitamin B6, and vitamin B12 does not help in preventing future strokes."
id_00156,"When a permanent tooth is avulsed, the person should seek dental or medical care immediately. They should bring the tooth if not successfully replanted.","If a permanent tooth is knocked out, the individual should promptly seek dental or medical attention, bringing the tooth along if it has not been successfully replanted."
id_02076,"For patients 50 to 65 years of age who require AVR and who do not have a contraindication to anticoagulation, it is reasonable to individualize the choice of either a mechanical or bioprosthetic AVR, with consideration of individual patient factors and after informed shared decision-making.1–10","For patients aged 50 to 65 needing AVR without contraindications to anticoagulation, it is appropriate to tailor the decision between mechanical and bioprosthetic AVR based on personal patient factors and through informed shared decision-making."
id_02556,Amiodarone or lidocaine may be considered for ventricular fibrillation/pulseless ventricular tachycardia that is unresponsive to defibrillation.,"For ventricular fibrillation or pulseless ventricular tachycardia that does not respond to defibrillation, amiodarone or lidocaine can be considered."
id_01596,"For patients with CAD undergoing elective NCS, management of perioperative antiplatelet therapy and timing of surgery should be determined by a multidisciplinary team with shared decision-making to weigh the risks of bleeding, thrombosis, and con­ sequences of delayed surgery.1–7 Timing of NCS After PCI","For patients with CAD scheduled for elective NCS, a multidisciplinary team should collaboratively decide on perioperative antiplatelet therapy and surgery timing, considering the risks of bleeding, thrombosis, and the implications of postponing surgery."
id_01117,"In patients with ischemic stroke or TIA in the setting of AF and cancer, it is reasonable to consider anticoagulation with DOACs in preference to warfarin for stroke preven- tion.647–650","For patients with ischemic stroke or TIA who have both AF and cancer, opting for DOACs over warfarin for stroke prevention is a reasonable consideration."
id_00157,"If an avulsed permanent tooth cannot be immediately replanted, it can be beneficial to place the tooth in Hanks Balanced Salt Solution, oral rehydration salt solutions, propolis, or rice water (if preprepared), or to wrap the tooth in cling film to prevent dehydration.","If a permanent tooth is avulsed and cannot be replanted right away, it is advantageous to store the tooth in Hanks Balanced Salt Solution, oral rehydration salt solutions, propolis, or preprepared rice water, or to wrap it in cling film to avoid dehydration."
id_00637,"In patients with obstructive HCM who remain symptomatic despite GDMT, SRT in eligible patients,* performed at experienced HCM centers,† is recom- mended for relieving LVOTO (Tables 4 and 5).1–3","For patients with obstructive HCM who continue to experience symptoms despite GDMT, it is advised that eligible individuals undergo SRT at specialized HCM centers to alleviate LVOTO."
id_01597,"In patients with recent coronary artery balloon angioplasty without stent placement, elective NCS should be delayed for a minimum of 14 days to minimize perioperative MACE.8,9","For patients who have undergone recent coronary artery balloon angioplasty without stent insertion, elective non-cardiac surgery should be postponed for at least 14 days to reduce the risk of perioperative major adverse cardiac events."
id_02077,"In patients >65 years of age who require AVR, it is reasonable to choose a bioprosthesis over a mechanical valve.1","For patients older than 65 needing AVR, opting for a bioprosthesis instead of a mechanical valve is advisable."
id_02557,"For patients with OHCA, use of steroids during CPR is of uncertain benefit.",The benefit of administering steroids during CPR for patients experiencing OHCA is uncertain.
id_00158,"If an avulsed permanent tooth cannot be immedi- ately replanted and the aforementioned solutions or interventions are not available, storage of the tooth in cow’s milk or saliva may be considered.","If a knocked-out permanent tooth cannot be replanted right away and the previously mentioned solutions or interventions are unavailable, consider storing the tooth in cow's milk or saliva."
id_02078,"For patients <65 years of age who have an indication for mitral valve replacement, do not have a contraindication to anticoagulation, and are unable to undergo mitral valve repair, it is reasonable to choose a mechanical mitral prosthesis over a bioprosthetic valve.1,7,10,11","For patients under 65 years old who require mitral valve replacement, have no contraindications to anticoagulation, and cannot have mitral valve repair, opting for a mechanical mitral prosthesis instead of a bioprosthetic valve is advisable."
id_01598,"In patients with DES-PCI placed for ACS who require elective NCS with interruption of ≥1 anti­ platelet agents, surgery should ideally be delayed ≥12 months to minimize perioperative MACE.5,10–15","For patients with DES-PCI for ACS needing elective NCS with interruption of one or more antiplatelet agents, it is preferable to postpone surgery for at least 12 months to reduce the risk of perioperative MACE."
id_00638,"In symptomatic patients with obstructive HCM who have associated cardiac disease requiring surgical treatment (eg, associated anomalous papillary muscle, markedly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel CAD, valvular aortic stenosis), surgical myectomy, performed at experienced HCM centers,† is recommended (Tables 4 and 5).4–7","For patients with obstructive HCM who exhibit symptoms and have concurrent cardiac conditions necessitating surgery (such as anomalous papillary muscle, significantly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel CAD, or valvular aortic stenosis), it is advised to undergo surgical myectomy at specialized HCM centers."
id_00636,"For patients with obstructive HCM, discontinuation of vasodilators (eg, angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be reasonable because these agents can worsen symptoms caused by dynamic outflow tract obstruction.","For individuals with obstructive hypertrophic cardiomyopathy, it may be advisable to stop using vasodilators (such as angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and dihydropyridine calcium channel blockers) or digoxin, as these medications can exacerbate symptoms due to dynamic outflow tract obstruction."
id_02558,Routine administration of calcium for treatment of cardiac arrest is not recommended.,The regular use of calcium in treating cardiac arrest is not advised.
id_00639,"In adult patients with obstructive HCM who remain severely symptomatic, despite GDMT and in whom surgery is contraindicated or the risk is considered unacceptable because of serious comorbidities or advanced age, alcohol septal ablation in eligible patients,* performed at experienced HCM centers,† is recommended (Tables 4 and 5).8–10","For adult patients with obstructive HCM who continue to experience severe symptoms despite GDMT, and for whom surgery is either contraindicated or deemed too risky due to significant comorbidities or advanced age, alcohol septal ablation is advised for eligible patients, provided it is conducted at specialized HCM centers."
id_00159,"If an avulsed permanent tooth cannot be immedi- ately replanted and none of the above storage mediums are available, a probiotic, egg white, or almond milk may be considered.","If a knocked-out permanent tooth cannot be replanted right away and the previously mentioned storage solutions are unavailable, consider using a probiotic, egg white, or almond milk."
id_01599,"In patients with DES-PCI placed for CCD who require elective NCS with interruption of ≥1 anti­ platelet agents, it is reasonable to delay surgery for ≥6 months after PCI to minimize perioperative MACE.16–24","For patients with DES-PCI for CCD needing elective NCS with interruption of one or more antiplatelet agents, postponing surgery for at least 6 months post-PCI is advisable to reduce perioperative MACE."
id_01119,"In patients with SCD with prior ischemic stroke or TIA for whom transfusion therapy is not available or practical, treatment with hydroxyurea is reasonable for the prevention of recurrent ischemic stroke.659–665","For patients with SCD who have experienced an ischemic stroke or TIA and cannot access or feasibly undergo transfusion therapy, using hydroxyurea is a sensible option to prevent another ischemic stroke."
id_02559,Routine use of sodium bicarbonate is not recommended for patients in cardiac arrest.,Sodium bicarbonate should not be routinely administered to patients experiencing cardiac arrest.
id_02079,"For patients ≥65 years of age who require mitral valve replacement and are unable to undergo mitral valve repair, it is reasonable to choose a bioprosthesis over a mechanical valve.1,7,11","For patients aged 65 and older who need mitral valve replacement and cannot have mitral valve repair, opting for a bioprosthesis instead of a mechanical valve is advisable."
id_01120,"In patients with ischemic stroke or TIA and symptoms attributed to giant cell arteri- tis, immediate initiation of oral high-dose glucocorticoids is recommended to reduce recurrent stroke risk.672–681","For patients experiencing ischemic stroke or TIA with symptoms linked to giant cell arteritis, it is advised to promptly start high-dose oral glucocorticoids to lower the risk of recurrent stroke."
id_00160,"A person who sustains a high-velocity eye injury (such as injuries from grinding, nailing, or machinery), penetrating eye injury from a sharp or metal object, irregular pupil after trauma, eye bleeding after trauma, or loss of vision after trauma should seek immediate medical attention.","Individuals experiencing a high-speed eye injury (like those from grinding, nailing, or machinery), a penetrating eye injury from a sharp or metallic object, an irregular pupil following trauma, eye bleeding post-trauma, or vision loss after trauma should promptly seek medical care."
id_02560,Routine use of magnesium for cardiac arrest is not recommended.,Magnesium is not advised for regular use during cardiac arrest.
id_02080,"In patients <50 years of age who prefer a bioprosthetic AVR and have appropriate anatomy, replacement of the aortic valve by a pulmonic autograft (the Ross procedure) may be considered at a Comprehensive Valve Center.12–14","For patients under 50 years old with suitable anatomy who opt for a bioprosthetic aortic valve replacement, the Ross procedure, which involves using a pulmonic autograft, can be considered at a Comprehensive Valve Center."
id_00161,A person who has persistent foreign-body sensation in the eye should seek immediate medical attention.,Anyone experiencing a continuous sensation of a foreign object in the eye should promptly consult a medical professional.
id_01600,"In patients with DES-PCI who require time-sensitive NCS with interruption of ≥1 antiplatelet agents, NCS may be considered ≥3 months after PCI if the risk of delaying surgery outweighs the risk of MACE.5,23,24","For patients with DES-PCI needing urgent NCS and interruption of one or more antiplatelet agents, NCS can be contemplated at least 3 months post-PCI if the risk of postponing surgery exceeds the risk of MACE."
id_00640,"In patients with obstructive HCM, earlier (NYHA class II) surgical myectomy performed at comprehensive HCM centers (Tables 4 and 5) may be reasonable in the presence of additional clinical factors, including3,11–22: a.   Severe and progressive pulmonary hypertension thought to be attributable to LVOTO or associated MR; b.   Left atrial enlargement with ≥1 episodes of symptomatic AF; c.   Poor functional capacity attributable to LVOTO as documented on treadmill exercise testing; d.   Children and young adults with very high resting","For patients with obstructive HCM, undergoing early surgical myectomy (NYHA class II) at specialized HCM centers (Tables 4 and 5) may be advisable when additional clinical factors are present, such as: a. Severe and worsening pulmonary hypertension likely due to LVOTO or related MR; b. Left atrial enlargement with one or more episodes of symptomatic AF; c. Reduced functional capacity due to LVOTO as shown by treadmill exercise testing; d. Children and young adults with significantly high resting gradients."
id_01118,"In patients with sickle cell disease (SCD) and prior ischemic stroke or TIA, chronic blood transfusion(s) to reduce hemoglobin S to <30% of total hemoglobin is recommended for the prevention of recurrent ischemic stroke.655–658","For patients with sickle cell disease who have experienced an ischemic stroke or TIA, it is advised to maintain chronic blood transfusions to lower hemoglobin S to less than 30% of total hemoglobin to prevent recurrent ischemic strokes."
id_02081,"In patients with a mechanical prosthetic valve, anticoagulation with a VKA is recommended.1–5","For patients with a mechanical prosthetic valve, it is advised to use a VKA for anticoagulation."
id_01601,"In patients with prior PCI undergoing NCS, it is recommended to continue aspirin* (75-100 mg), if possible, to reduce the risk of cardiac events.27–30","For patients with a history of PCI who are undergoing NCS, it is advised to maintain aspirin* (75-100 mg) therapy, if feasible, to lower the risk of cardiac events."
id_00641,"For symptomatic patients with obstructive HCM, SRT in eligible patients,* performed at experienced HCM centers† (Tables 4 and 5), may be considered as an alternative to escalation of medical therapy after shared decision-making including risks and benefits of all treatment options.1,10,23–25","For patients with obstructive HCM who exhibit symptoms, SRT can be considered as an alternative to intensifying medical treatment, provided it is performed at specialized HCM centers and after a shared decision-making process that evaluates the risks and benefits of all available treatment options."
id_01121,"In patients with ischemic stroke or TIA and diagnosis of giant cell arteritis, methotrexate or tocilizumab therapy adjunctive to steroids is reasonable to lower the risk of recurrent stroke.682–690","For patients diagnosed with giant cell arteritis who have experienced an ischemic stroke or TIA, it is advisable to use methotrexate or tocilizumab alongside steroids to reduce the likelihood of another stroke."
id_00642,"In patients with nonobstructive HCM with preserved EF and symptoms of exertional angina or dyspnea, beta blockers or nondihydropyridine calcium channel blockers are recommended.1–5","For patients with nonobstructive HCM who have preserved EF and experience symptoms of exertional angina or dyspnea, it is advised to use beta blockers or nondihydropyridine calcium channel blockers."
id_00162,"A person who develops a foreign-body sensa- tion in the eye associated with contact lens use should remove the contact lens, discontinue con- tact lens use, and seek medical attention.","If an individual experiences a sensation of a foreign body in the eye while wearing contact lenses, they should take out the lens, stop using contact lenses, and consult a healthcare professional."
id_01602,"In patients with CAD who require time-sensitive NCS within 30 days of PCI with BMS or <3 months of PCI with DES, DAPT should be con­ tinued unless the risk of bleeding outweighs the benefit of the prevention of stent thrombosis.23,31","For patients with CAD needing urgent NCS within 30 days post-PCI with BMS or under 3 months post-PCI with DES, DAPT should be maintained unless the bleeding risk surpasses the benefit of preventing stent thrombosis."
id_02562,Coronary angiography should be performed emergently for all cardiac arrest patients with suspected cardiac cause of arrest and,Emergency coronary angiography is indicated for all patients who experience cardiac arrest with a suspected cardiac origin.
id_01122,"In patients with ischemic stroke or TIA and diagnosis of primary CNS angiitis, induc- tion therapy with glucocorticoids and/or immunosuppressants followed by long-term maintenance therapy with steroid-sparing immunosuppressants is reasonable to lower the risk of stroke recurrence.691–696","For patients diagnosed with primary CNS angiitis who have experienced an ischemic stroke or TIA, it is advisable to initiate treatment with glucocorticoids and/or immunosuppressants, followed by prolonged maintenance therapy using steroid-sparing immunosuppressants, to reduce the likelihood of recurrent strokes."
id_02561,Use of ECPR for patients with cardiac arrest refractory to standard ACLS is reasonable in select patients when provided within an appropriately trained and equipped system of care.,"ECPR may be considered for certain patients experiencing cardiac arrest unresponsive to standard ACLS, provided it is administered within a system of care that is properly trained and equipped."
id_02082,"For patients with a mechanical bileaflet or current-generation single-tilting disk AVR and no risk factors for thromboembolism, anticoagulation with a VKA to achieve an INR of 2.5 is recommended.6–8","For patients with a mechanical bileaflet or modern single-tilting disk aortic valve replacement and without thromboembolism risk factors, it is advised to use a VKA to maintain an INR of 2.5."
id_00643,"In patients with nonobstructive HCM with preserved EF, it is reasonable to add oral diuretics when exertional dyspnea persists despite the use of beta blockers or nondihydropyridine calcium channel blockers.","For patients with nonobstructive HCM and preserved EF, it is appropriate to introduce oral diuretics if exertional dyspnea continues despite treatment with beta blockers or nondihydropyridine calcium channel blockers."
id_00163,A person with a foreign-body sensation in the eye should not rub their eye.,Individuals experiencing a sensation of a foreign object in their eye should avoid rubbing it.
id_01123,"In patients with ischemic stroke or TIA and confirmed diagnosis of giant cell arteritis, infliximab is associated with recurrent ocular symptoms and markers of disease activity and should not be administered.697–704","For patients diagnosed with ischemic stroke or TIA and giant cell arteritis, infliximab is linked to recurring eye symptoms and indicators of active disease, and its use is not recommended."
id_01603,"In patients with prior PCI in whom OAC monotherapy must be discontinued before NCS, aspirin should be substituted when feasible in the perioperative period until OAC can be safely reinitiated.27–29","For patients with a history of PCI who need to stop OAC monotherapy before NCS, aspirin should be used as a replacement during the perioperative period when possible, until it is safe to resume OAC."
id_00164,"Taping a hard plastic eye shield, paper cup, or plastic cup over the eye can help prevent unintentional touching of the eye.","Covering the eye with a taped hard plastic shield, paper cup, or plastic cup can effectively prevent accidental contact with the eye."
id_02083,"For patients with a mechanical AVR and additional risk factors for thromboembolism (eg, AF, previous thromboembolism, LV dysfunction, hypercoagulable state) or an older-generation prosthesis (eg, ball-in-cage), anticoagulation with a VKA is indicated to achieve an INR of 3.0.9,10","Patients with a mechanical aortic valve replacement and extra thromboembolism risk factors (such as atrial fibrillation, past thromboembolism, left ventricular dysfunction, or a hypercoagulable condition) or those with an older prosthesis type (like ball-in-cage) should receive anticoagulation therapy with a vitamin K antagonist to maintain an INR of 3.0."
id_00644,"In patients with nonobstructive HCM with preserved EF, the usefulness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in the treatment of symptoms (angina and dyspnea) is not well established.6","For patients with nonobstructive HCM and preserved EF, the effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in alleviating symptoms such as angina and dyspnea remains uncertain."
id_02563,"Emergent coronary angiography is reasonable for selected adult patients without ST-elevation on electrocardiogram but with elevated risk of significant coronary artery disease where revascularization may provide benefit, such as those with shock, electrical instability, signs of significant ongoing myocardial damage, or ongoing ischemia.","For certain adult patients who do not show ST-elevation on an electrocardiogram but are at high risk for significant coronary artery disease, urgent coronary angiography is advisable if revascularization could be beneficial, particularly in cases of shock, electrical instability, indications of substantial ongoing myocardial injury, or persistent ischemia."
id_01124,"In patients with ischemic stroke or TIA and infectious vasculitis such as varicella zoster virus (VZV) cerebral vasculitis, neurosyphilis, or bacterial meningitis, treating the underlying infectious etiology is indicated to reduce the risk of stroke.710–716","For patients experiencing ischemic stroke or TIA due to infectious vasculitis, including conditions like varicella zoster virus (VZV) cerebral vasculitis, neurosyphilis, or bacterial meningitis, addressing the root infectious cause is recommended to lower the stroke risk."
id_02084,"For patients with a mechanical mitral valve replacement, anticoagulation with a VKA is indicated to achieve an INR of 3.0.9,11",Patients with a mechanical mitral valve replacement should receive VKA anticoagulation to maintain an INR of 3.0.
id_02564,"Independent of a patient’s neurologic status, coronary angiography is reasonable in all post–cardiac arrest patients for whom coronary angiography is otherwise indicated.","Regardless of a patient's neurological condition, it is appropriate to perform coronary angiography on all post-cardiac arrest patients when it is otherwise warranted."
id_01604,"In select patients after PCI who have a high throm­ botic risk, perioperative bridging with intravenous antiplatelet therapy may be considered <6 months after DES or <30 days after BMS if NCS cannot be deferred.32,33 Perioperative Antiplatelet Management in Patients Without Prior PCI","For certain patients with elevated thrombotic risk following PCI, intravenous antiplatelet therapy bridging may be contemplated within 6 months post-DES or 30 days post-BMS if non-cardiac surgery cannot be postponed."
id_01125,"In patients with ischemic stroke or TIA in the context of HIV vasculopathy, daily aspirin plus HIV viral control with combined antiretroviral therapy is reasonable to reduce the risk of recurrent stroke.717–723","For patients experiencing ischemic stroke or TIA due to HIV vasculopathy, it is advisable to use daily aspirin alongside combined antiretroviral therapy to manage HIV viral load, as this can help lower the risk of another stroke."
id_00645,"In highly selected patients with apical HCM with severe dyspnea or angina (NYHA functional class III or class IV) despite maximal medical therapy, and with preserved EF and small LV cavity size (LV end-diastolic volume <50 mL/m2 and LV stroke volume <30 mL/m2), apical myectomy by experi- enced surgeons at comprehensive centers may be considered to reduce symptoms.7","For patients with apical HCM experiencing severe dyspnea or angina (NYHA class III or IV) who do not respond to optimal medical treatment, and who have preserved EF and a small LV cavity (LV end-diastolic volume <50 mL/m2 and LV stroke volume <30 mL/m2), apical myectomy performed by skilled surgeons at specialized centers may be an option to alleviate symptoms."
id_00165,"It is reasonable for a person with a foreign body in the eye from a low-energy mechanism (eg, dust, dirt, other object blown into the eye by wind; eyelash in the eye) to attempt to remove the for- eign body by allowing natural tears to wash out the object or by irrigating the eye with tap water or a commercial eye wash solution.","For an individual with a foreign object in the eye due to a low-energy source (such as dust, dirt, or an object carried by the wind, or an eyelash), it is advisable to try removing the object by letting natural tears flush it out or by rinsing the eye with tap water or a commercial eye wash solution."
id_02565,"Emergent coronary angiography is not recommended over a delayed or selective strategy in patients with ROSC after cardiac arrest in the absence of ST-segment elevation, shock, electrical instability, signs of significant myocardial damage, and ongoing ischemia.","Immediate coronary angiography is not advised over a delayed or selective approach for patients with ROSC following cardiac arrest if there is no ST-segment elevation, shock, electrical instability, significant myocardial damage, or ongoing ischemia."
id_00166,It is reasonable to take over-the-counter oral acetaminophen or NSAIDs to treat residual discomfort after ocular foreign-body removal. Recommendation-Specific Supportive Text,Taking over-the-counter oral acetaminophen or NSAIDs is a sensible option for alleviating lingering discomfort following the removal of a foreign body from the eye.
id_01605,"In patients with CCD without prior PCI undergoing elective NCS, it may be reasonable to continue aspirin in selected patients when the risk of cardiac events outweighs the risk of bleeding.27,34,35","For patients with CCD who have not had prior PCI and are undergoing elective NCS, continuing aspirin may be appropriate for certain individuals if the potential for cardiac events surpasses the bleeding risk."
id_02085,"For patients with a bioprosthetic TAVI, aspirin 75 to 100 mg daily is reasonable in the absence of other indications for oral anticoagulants.12–14","For individuals with a bioprosthetic TAVI, administering aspirin at a dose of 75 to 100 mg per day is appropriate if there are no other reasons to use oral anticoagulants."
id_02086,"For all patients with a bioprosthetic SAVR or mitral valve replacement, aspirin 75 to 100 mg daily is reasonable in the absence of other indications for oral anticoagulants.9,15–18","A daily dose of aspirin ranging from 75 to 100 mg is advisable for patients with a bioprosthetic SAVR or mitral valve replacement, provided there are no other reasons to use oral anticoagulants."
id_00646,"In asymptomatic patients with nonobstructive HCM, the benefit of beta blockers or calcium channel blockers is not well established.","For asymptomatic individuals with nonobstructive HCM, the advantages of using beta blockers or calcium channel blockers remain uncertain."
id_01606,"In patients with CAD but without prior PCI who are undergoing elective noncarotid NCS, routine initiation of aspirin is not beneficial.27,36 *Platelet adenosine diphosphate receptor (P2Y12) monotherapy may be con­ sidered if surgical bleeding risks are acceptable or if aspirin is not tolerated.","For patients with CAD who have not had prior PCI and are undergoing elective noncarotid NCS, starting aspirin routinely does not provide benefit. Consider platelet adenosine diphosphate receptor (P2Y12) monotherapy if the risk of surgical bleeding is acceptable or if aspirin cannot be tolerated."
id_02566,"We recommend all adults who do not follow commands after ROSC, irrespective of arrest location or presenting rhythm, receive treatment that includes a deliberate strategy for temperature control.","We advise that every adult who is unresponsive to commands post-ROSC, regardless of where the arrest occurred or the initial rhythm, should undergo treatment incorporating a targeted temperature management strategy."
id_01126,"In patients with ischemic stroke or TIA and cystathionine β-synthase deficiency, pyridoxine (in responsive patients) and a low-methionine, cysteine-enhanced diet supplemented with pyridoxine, vitamin B12, and folate are recommended to reduce plasma homocysteine to population normal levels and thereby reduce the risk of recurrent ischemic stroke.739,740","For patients experiencing ischemic stroke or TIA who have cystathionine β-synthase deficiency, it is advised to use pyridoxine in those who respond to it, along with a diet low in methionine and enriched with cysteine, supplemented with pyridoxine, vitamin B12, and folate, to lower plasma homocysteine to normal population levels and thus decrease the risk of recurrent ischemic stroke."
id_00167,A person experiencing epistaxis should sit with their head slightly forward with their nostrils pinched for 10 to 15 minutes.,"If someone has a nosebleed, they should lean slightly forward and pinch their nostrils for 10 to 15 minutes."
id_01127,"In patients with ischemic stroke or TIA and Anderson-Fabry disease, agalsidase alfa or agalsidase beta is of uncertain value in preventing recurrent stroke or TIA.741","For patients with ischemic stroke or TIA who have Anderson-Fabry disease, the effectiveness of agalsidase alfa or agalsidase beta in preventing recurrent stroke or TIA remains uncertain."
id_00647,"For younger (eg, ≤45 years of age) patients with nonobstructive HCM due to a pathogenic or likely pathogenic cardiac sarcomere genetic variant, and a mild phenotype,* valsartan may be beneficial to slow adverse cardiac remodeling.8 *Mild phenotype indicates NYHA functional class I or II, maximal LV wall thick- ness 13 to 25 mm, no secondary prevention ICDs, no history of appropriate ICD shocks, and no AF.","Valsartan may be advantageous in slowing adverse cardiac remodeling in younger patients (e.g., 45 years or younger) with nonobstructive HCM caused by a pathogenic or likely pathogenic cardiac sarcomere genetic variant and exhibiting a mild phenotype, which includes NYHA functional class I or II, maximal LV wall thickness of 13 to 25 mm, absence of secondary prevention ICDs, no history of appropriate ICD shocks, and no atrial fibrillation."
id_01607,"For patients with CVD receiving OAC who require elective NCS, a multidisciplinary team-based approach to time-based* interruption is recom­ mended to balance the competing risks of thromboembolism and perioperative bleeding (Tables 13 and 14).1–7 OAC Bridging","For patients with cardiovascular disease on oral anticoagulation needing elective non-cardiac surgery, it is advised to use a multidisciplinary team approach to manage the timing of anticoagulation interruption, balancing the risks of thromboembolism and bleeding during surgery."
id_02567,We recommend selecting and maintaining a constant temperature between 32° C and 37.5° C during postarrest temperature control.,We advise choosing and consistently keeping the temperature within the range of 32°C to 37.5°C for postarrest temperature management.
id_00168,A person experiencing epistaxis that does not stop after 15 minutes of continuous manual pressure or who becomes lightheaded from epistaxis should seek medical attention.,"If a person has a nosebleed that persists despite applying manual pressure for 15 minutes or feels lightheaded due to the nosebleed, they should obtain medical care."
id_00648,"In patients with HCM who develop systolic dysfunction with an LVEF <50%, GDMT for HF with reduced EF is recommended.1–3","For patients with HCM experiencing systolic dysfunction and an LVEF below 50%, it is advised to implement GDMT for heart failure with reduced EF."
id_02087,"For patients with a bioprosthetic SAVR or mitral valve replacement who are at low risk of bleeding, anticoagulation with a VKA to achieve an INR of 2.5 is reasonable for at least 3 months and for as long as 6 months after surgical replacement.15,19–25","For patients who have undergone bioprosthetic SAVR or mitral valve replacement and have a low bleeding risk, it is appropriate to use a VKA for anticoagulation to maintain an INR of 2.5 for a minimum of 3 months and up to 6 months following the surgery."
id_01128,"In patients with carotid web in the distribu- tion of ischemic stroke and TIA, without other attributable causes of stroke, antiplatelet therapy is recommended to prevent recurrent ischemic stroke or TIA.748,749","For patients with a carotid web linked to ischemic stroke or TIA, and no other identifiable stroke causes, it is advised to use antiplatelet therapy to prevent further ischemic strokes or TIAs."
id_02088,"For patients with a mechanical SAVR or mitral valve replacement who are managed with a VKA and have an indication for antiplatelet therapy, addition of aspirin 75 to 100 mg daily may be considered when the risk of bleeding is low.26","For patients with a mechanical SAVR or mitral valve replacement on VKA therapy who require antiplatelet treatment, aspirin 75 to 100 mg daily can be considered if the bleeding risk is minimal."
id_02568,We recommend hospitals develop protocols for postarrest temperature control.,Hospitals are advised to establish guidelines for managing temperature after cardiac arrest.
id_00169,"A person with epistaxis due to trauma should seek medical attention if they experience signs of brain in- jury, obvious nasal deformity, or signs of facial fracture.","If someone has a nosebleed from an injury, they should consult a doctor if they show symptoms of brain injury, have a clear nasal deformity, or exhibit signs of a facial fracture."
id_01608,"In patients with CVD and high thrombotic risk (Table 14) undergoing NCS where interruption of vitamin K antagonist (VKA) is required, preoperative bridging with parenteral heparin can be effective to reduce thromboembolic risk.8–10","For patients with cardiovascular disease and elevated thrombotic risk (refer to Table 14) who need to pause vitamin K antagonist therapy before non-cardiac surgery, using parenteral heparin as a bridging strategy can effectively lower the risk of thromboembolism."
id_00649,"In patients with HCM and systolic dysfunction, diagnostic testing to assess for concomitant causes of systolic dysfunction (eg, CAD) is recommended.4,5","For patients with HCM experiencing systolic dysfunction, it is advised to conduct diagnostic tests to evaluate for additional causes of systolic dysfunction, such as CAD."
id_02569,It is reasonable that temperature control be maintained for at least 24 h after achieving target temperature.,Maintaining temperature control for a minimum of 24 hours after reaching the target temperature is advisable.
id_00650,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite GDMT), CPET should be performed to quantify the degree of functional limitation and aid in selection of patients for heart transplantation or mechanical circulatory support.6,7 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with nonobstructive hypertrophic cardiomyopathy and severe heart failure (classified as NYHA class III or IV despite guideline-directed medical therapy), cardiopulmonary exercise testing is recommended to assess the extent of functional impairment and assist in identifying candidates for heart transplantation or mechanical circulatory support."
id_00170,"It is reasonable for a person experiencing epistaxis who is taking anticoagulant or antiplatelet medication, or who has a blood-clotting disorder, to seek care from a health care professional, unless bleeding has stopped.","Individuals with epistaxis who are on anticoagulant or antiplatelet therapy, or have a clotting disorder, should consider consulting a healthcare provider unless the bleeding has ceased."
id_01129,"In patients with carotid web in the distribution of ischemic stroke refractory to medical man- agement, with no other attributable cause of stroke despite comprehensive workup, carotid stenting or CEA may be considered to prevent recurrent ischemic stroke.748–750","For patients experiencing ischemic stroke due to a carotid web, who do not respond to medical treatment and have no other identified stroke cause after thorough evaluation, carotid stenting or carotid endarterectomy (CEA) can be considered to prevent further ischemic strokes."
id_01130,"In patients with fibromuscular dysplasia (FMD) and a history of ischemic stroke or TIA without other attributable causes, antiplatelet therapy, BP control, and lifestyle modification are recommended for the prevention of future ischemic events.752,753","For patients with fibromuscular dysplasia (FMD) who have experienced an ischemic stroke or TIA with no other identifiable causes, it is advised to use antiplatelet therapy, manage blood pressure, and implement lifestyle changes to prevent future ischemic events."
id_01609,"In patients with preoperative OAC interruption, resumption of OAC is reasonable after hemostasis is achieved.9 *Timing of preoperative interruption is based on patient-specific factors (eg, thrombotic risk, age, sex, body weight, renal clearance), surgical bleeding risk, and drug factors (eg, pharmacokinetics, dosing, drug interactions).","For patients who have had their OAC therapy paused before surgery, it is advisable to restart OAC once hemostasis is confirmed. The timing for stopping OAC before surgery depends on individual patient factors such as thrombotic risk, age, sex, body weight, renal function, the risk of surgical bleeding, and drug-related factors like pharmacokinetics, dosing, and interactions."
id_02090,"For patients with a bioprosthetic TAVI who are at low risk of bleeding, dual- antiplatelet therapy with aspirin 75 to 100 mg and clopidogrel 75 mg may be reasonable for 3 to 6 months after valve implantation.12,13,29","For patients with a bioprosthetic TAVI and a low bleeding risk, it may be appropriate to administer dual antiplatelet therapy consisting of aspirin 75 to 100 mg and clopidogrel 75 mg for a duration of 3 to 6 months following valve implantation."
id_01610,"In patients on stable doses of beta blockers under­ going NCS, beta blockers should be continued through the perioperative period as appropriate based on the clinical circumstances.1,2","For patients receiving consistent beta blocker doses who are undergoing NCS, it is advisable to maintain beta blocker therapy throughout the perioperative period, tailored to the clinical situation."
id_02570,There is insufficient evidence to recommend a specific therapeutic temperature for different subgroups of cardiac arrest patients.,The evidence is inadequate to suggest a particular therapeutic temperature for various subgroups of cardiac arrest patients.
id_02089,"For patients with a mechanical On-X AVR and no thromboembolic risk factors, use of a VKA targeted to a lower INR (1.5–2.0) may be reasonable starting ≥3 months after surgery, with continuation of aspirin 75 to 100 mg daily.27,28","For patients with a mechanical On-X AVR who do not have thromboembolic risk factors, it may be appropriate to use a VKA aimed at a reduced INR range of 1.5–2.0, beginning at least 3 months post-surgery, while continuing daily aspirin at a dose of 75 to 100 mg."
id_00171,The usefulness of cryotherapy (ice) for managing epistaxis in the first aid setting is unknown. Recommendation-Specific Supportive Text,The effectiveness of using cryotherapy (ice) to treat epistaxis in a first aid context is not established.
id_00651,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite GDMT) or with life-threatening ventricular arrhythmias refractory to maximal GDMT, assessment for heart transplantation in accordance with current listing criteria is recommended.8–13","For patients with nonobstructive HCM experiencing severe heart failure (NYHA class III or IV despite optimal GDMT) or those with life-threatening ventricular arrhythmias unresponsive to maximum GDMT, evaluation for heart transplantation following current listing criteria is advised."
id_01131,"In patients with a history of ischemic stroke or TIA attributable to dissection, with FMD, and no evidence of intraluminal thrombus, it is reasonable to administer antiplatelet therapy for the prevention of future ischemic events.","For patients with a history of ischemic stroke or TIA due to dissection, who have FMD and lack intraluminal thrombus, it is appropriate to use antiplatelet therapy to prevent future ischemic events."
id_02571,It may be reasonable to actively prevent fever in patients unresponsive to verbal commands after initial temperature control.,Actively preventing fever might be advisable for patients who do not respond to verbal commands following initial temperature management.
id_01611,"In patients scheduled for elective NCS who have a new indication for beta blockade, beta blockers may be initiated far enough before surgery (optimally >7 days) to permit assessments of tolerability and drug titration if needed.3","For patients undergoing elective non-cardiac surgery with a new need for beta blockers, these medications should ideally be started more than 7 days prior to the procedure to allow for evaluation of tolerance and dosage adjustments if necessary."
id_00172,"In patients who require coronary revascu- larization, treatment decisions should be based on clinical indication, regardless of sex1-7 or race or ethnicity,8-10 and efforts to reduce disparities of care are war- ranted.11,12","For patients needing coronary revascularization, treatment choices should be guided by clinical necessity without considering sex, race, or ethnicity, and actions to minimize care disparities are justified."
id_02091,"For patients with a bioprosthetic TAVI who are at low risk of bleeding, anticoagulation with a VKA to achieve an INR of 2.5 may be reasonable for at least 3 months after valve implantation.23,31–33","For patients with a bioprosthetic TAVI and a low bleeding risk, it may be appropriate to use a VKA to maintain an INR of 2.5 for a minimum of 3 months following valve implantation."
id_00652,"In patients with HCM who develop persistent systolic dysfunction (LVEF <50%), cardiac myosin inhibitors should be discontinued.14","For patients with HCM experiencing ongoing systolic dysfunction (LVEF below 50%), it is advised to stop using cardiac myosin inhibitors."
id_02092,"For patients with bioprosthetic TAVI, treatment with low-dose rivaroxaban (10 mg daily) plus aspirin (75–100 mg) is contraindicated in the absence of other indications for oral anticoagulants.30","In patients with bioprosthetic TAVI, administering low-dose rivaroxaban (10 mg daily) alongside aspirin (75–100 mg) is not recommended unless there are additional reasons for using oral anticoagulants."
id_01132,"In patients with cervical carotid artery FMD and recurrent ischemic stroke without other attributable causes despite optimal medical management, carotid angioplasty with or without stenting may be reasonable to prevent ischemic stroke.754","For patients with cervical carotid artery FMD who experience recurrent ischemic strokes without other identifiable causes despite receiving optimal medical treatment, carotid angioplasty, with or without stenting, could be a reasonable option to prevent further ischemic strokes."
id_02572,Patients with spontaneous hypothermia after ROSC unresponsive to verbal commands should not routinely be actively or passively rewarmed faster than 0.5° C per hour.,Patients experiencing spontaneous hypothermia after ROSC who do not respond to verbal commands should not typically undergo active or passive rewarming at a rate exceeding 0.5°C per hour.
id_01612,"In patients with or at risk for diabetes who are scheduled for elective NCS, preoperative hemoglobin A1c (HbA1C) testing is reasonable if it has not been performed in ≤3 months.1–4","For patients with or at risk of diabetes undergoing elective non-cardiac surgery, it is advisable to conduct preoperative hemoglobin A1c testing if it hasn't been done within the last three months."
id_00653,"For patients with HCM who develop systolic dysfunction (LVEF <50%), it is reasonable to discontinue previously indicated negative inotropic agents (specifically, verapamil, diltiazem, or disopyramide).","For patients with HCM experiencing systolic dysfunction (LVEF <50%), it is advisable to stop using previously recommended negative inotropic drugs, such as verapamil, diltiazem, or disopyramide."
id_01133,"In patients with vertebrobasilar dolichoectasia and a history of ischemic stroke or TIA without other attributable causes, the use of antiplatelet or anticoagulant therapy is reasonable for the prevention of recurrent ischemic events.760–764","For patients with vertebrobasilar dolichoectasia who have experienced an ischemic stroke or TIA with no other identifiable causes, it is appropriate to consider antiplatelet or anticoagulant therapy to prevent further ischemic incidents."
id_00173,"In patients undergoing revascularization, deci- sions should be patient centered—that is, considerate of the patient’s preferences and goals, cultural beliefs, health literacy, and social determinants of health—and made in collabora- tion with the patient’s support system.1,2","For patients undergoing revascularization, decisions should focus on the patient's preferences and objectives, cultural values, health literacy, and social health factors, and should be made in partnership with the patient's support network."
id_01613,"In patients scheduled for NCS, SGLT2i should be discontinued 3 to 4 days* days before surgery to reduce the risk of perioperative metabolic acidosis.5–7","For patients undergoing NCS, discontinue SGLT2i 3 to 4 days prior to surgery to minimize the risk of perioperative metabolic acidosis."
id_02093,"For patients with a mechanical valve prosthesis, anticoagulation with the direct thrombin inhibitor, dabigatran, is contraindicated.4,5","Dabigatran, a direct thrombin inhibitor, should not be used for anticoagulation in patients with a mechanical valve prosthesis."
id_01134,"In patients with ESUS, treatment with direct oral anticoagulants is not recommended to reduce risk of secondary stroke.779,780","For patients with ESUS, using direct oral anticoagulants is not advised to lower the risk of a secondary stroke."
id_02094,"For patients with a mechanical valve prosthesis, the use of anti-Xa direct oral anticoagulants has not been assessed and is not recommended.34–37","The use of anti-Xa direct oral anticoagulants is not advised for patients with a mechanical valve prosthesis, as their efficacy has not been evaluated."
id_00174,"In patients undergoing coronary angiography or revascularization, adequate information about benefits, risks, therapeutic conse- quences, and potential alternatives in the performance of percutaneous and surgi- cal myocardial revascularization should be given, when feasible, with sufficient time for informed decision-making to improve clinical outcomes.3-5","For patients receiving coronary angiography or revascularization, it is important to provide comprehensive details on the benefits, risks, therapeutic outcomes, and possible alternatives of percutaneous and surgical myocardial revascularization, allowing ample time for informed decision-making to enhance clinical results."
id_02573,The benefit of strategies other than rapid infusion of cold intravenous fluids for prehospital cooling is unclear.,The effectiveness of methods besides the quick administration of cold IV fluids for cooling before hospital arrival is uncertain.
id_01614,"In patients with diabetes or impaired glucose toler­ ance, continuation of metformin during the periop­ erative period is reasonable to maintain glycemic control.8–12 *Canagliflozin, dapagliflozin, and empagliflozin should be stopped ≥3 days and ertugliflozin ≥4 days before scheduled surgery.13","For individuals with diabetes or glucose intolerance, it is advisable to continue metformin throughout the perioperative period to manage blood sugar levels. Canagliflozin, dapagliflozin, and empagliflozin should be discontinued at least 3 days prior to planned surgery, while ertugliflozin should be stopped at least 4 days before."
id_00175,"In patients for whom the optimal treatment strategy is unclear, a Heart Team approach that includes representatives from interven- tional cardiology, cardiac surgery, and clinical cardiology is recommended to improve patient outcomes.1-7","For patients where the best treatment plan is uncertain, it is advised to use a Heart Team approach involving specialists from interventional cardiology, cardiac surgery, and clinical cardiology to enhance patient outcomes."
id_02574,We do not recommend the routine use of rapid infusion of cold intravenous fluids for prehospital cooling of patients after ROSC. Recommendation-Specific Supportive Text,We advise against the regular practice of rapidly infusing cold IV fluids for cooling patients in the prehospital setting following ROSC.
id_01135,"In patients with ESUS, treatment with ticagre- lor is not recommended to reduce the risk of secondary stroke.781","For patients with ESUS, using ticagrelor is not advised for lowering the risk of a secondary stroke."
id_00655,"In patients with HCM and persistent LVEF <50%, ICD placement can be beneficial.3,20","For patients with HCM and a sustained LVEF below 50%, ICD implantation may be advantageous."
id_02575,We recommend treatment of clinically apparent seizures in adult survivors of cardiac arrest.,We advise treating seizures that are clinically evident in adult cardiac arrest survivors.
id_01615,"In patients undergoing NCS, use of a volatile-based anesthetic agent or total intravenous anesthesia is reasonable for general anesthesia with no apparent difference in associated cardiovascular events (eg, MI, ischemia).1–3","For patients having NCS, it is acceptable to use either a volatile-based anesthetic or total intravenous anesthesia for general anesthesia, as there is no evident difference in related cardiovascular events such as myocardial infarction or ischemia."
id_00176,"In patients who are being considered for CABG, calculation of the STS risk score is recommended to help stratify patient risk.1,2","For patients evaluated for CABG, it is advised to calculate the STS risk score to assist in risk stratification."
id_00654,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite GDMT) who are candidates for heart transplantation, continuous-flow LVAD therapy is reasonable as a bridge to heart transplantation.15–19","For patients with nonobstructive HCM experiencing advanced heart failure (NYHA class III to IV) who remain symptomatic despite GDMT and are eligible for heart transplantation, using continuous-flow LVAD therapy as a bridge to transplantation is a reasonable option."
id_02095,"For patients with mechanical heart valves who are undergoing minor procedures (eg, dental extractions or cataract removal) where bleeding is easily controlled, continuation of VKA anticoagulation with a therapeutic INR is recommended.","It is advised that patients with mechanical heart valves maintain VKA anticoagulation with a therapeutic INR during minor procedures, such as dental extractions or cataract surgery, where bleeding can be easily managed."
id_01616,"In patients undergoing NCS where neuraxial is feasible, either neuraxial or general anesthesia is reasonable with no apparent difference in associated cardiovascular events.4–6","For patients having NCS where neuraxial anesthesia is possible, choosing between neuraxial or general anesthesia is appropriate, as there is no evident difference in cardiovascular event risk."
id_01136,"In patients with noncardioembolic ischemic stroke or TIA, antiplatelet therapy is indicated in preference to oral anticoagulation to reduce the risk of recurrent ischemic stroke and other cardiovascular events while minimizing the risk of bleeding.789,790","For patients who have experienced a noncardioembolic ischemic stroke or TIA, it is recommended to use antiplatelet therapy instead of oral anticoagulation to lower the risk of another ischemic stroke and other cardiovascular incidents, while also reducing the likelihood of bleeding."
id_00656,"In patients with HCM and LVEF <50%, NYHA functional class II to class IV symptoms despite GDMT, and LBBB, CRT can be beneficial to improve symptoms.21–25","For patients with HCM, LVEF below 50%, and NYHA class II to IV symptoms that persist despite GDMT, CRT may help alleviate symptoms if LBBB is present."
id_00177,"In patients with multivessel CAD, an assessment of CAD complexity, such as the SYNTAX score, may be useful to guide revascularization.1-4","For patients with multivessel coronary artery disease, evaluating the complexity of the condition, for instance using the SYNTAX score, can aid in directing revascularization decisions."
id_00657,"In patients with HCM and clinical AF, anticoagulation is recommended with direct-acting oral anticoagu- lants (DOACs) as first-line option and vitamin K antagonists as second-line option, independent of CHA2DS2-VASc score.1–5","For patients with HCM and clinical AF, it is advised to use direct-acting oral anticoagulants (DOACs) as the primary choice for anticoagulation, with vitamin K antagonists as the secondary option, regardless of the CHA2DS2-VASc score."
id_02096,"For patients with a bileaflet mechanical AVR and no other risk factors for thromboembolism who are undergoing invasive procedures, temporary interruption of VKA anticoagulation, without bridging agents while the INR is subtherapeutic, is recommended.","For patients with a bileaflet mechanical AVR and no additional thromboembolism risk factors undergoing invasive procedures, it is advised to temporarily stop VKA anticoagulation without using bridging agents when the INR is below therapeutic levels."
id_02576,We recommend promptly performing and interpreting electroencephalography (EEG) for the diagnosis of seizures in patients who do not follow commands after ROSC.,We advise conducting and analyzing an electroencephalogram (EEG) without delay to diagnose seizures in patients who remain unresponsive to commands following ROSC.
id_01137,"For patients with noncardioembolic ischemic stroke or TIA, aspirin 50 to 325 mg daily, clopidogrel 75 mg, or the combination of aspi- rin 25 mg and extended-release dipyridamole 200 mg twice daily is indicated for secondary prevention of ischemic stroke.*791–794","For secondary prevention of ischemic stroke in patients with noncardioembolic ischemic stroke or TIA, it is recommended to use aspirin at a dose of 50 to 325 mg daily, clopidogrel 75 mg daily, or a combination of aspirin 25 mg with extended-release dipyridamole 200 mg taken twice daily."
id_02577,Monitoring EEG repeatedly or continuously is reasonable for patients who do not follow commands after ROSC.,It is advisable to perform repeated or continuous EEG monitoring for patients who remain unresponsive to commands following ROSC.
id_01617,"For patients undergoing major abdominal surgery, the use of epidural analgesia for postoperative pain relief is reasonable to decrease the incidence of perioperative cardiac events.1,2","For individuals having major abdominal surgery, employing epidural analgesia for pain management after the procedure is advisable to reduce the risk of cardiac events during the perioperative period."
id_02097,"For patients with a mechanical valve prosthesis receiving VKA therapy who require immediate/ emergency noncardiac surgery or an invasive procedure, administration of 4-factor prothrombin complex concentrate (or its activated form) is reasonable.","For patients with a mechanical valve prosthesis on VKA therapy needing urgent or emergency noncardiac surgery or an invasive procedure, it is reasonable to administer 4-factor prothrombin complex concentrate or its activated form."
id_00658,"In patients with HCM and subclinical AF detected by internal or external cardiac device or monitor of >24 hours’ duration for a given episode, anticoagulation is recommended with DOACs as first-line option and vitamin K antagonists as second-line option, inde- pendent of CHA2DS2-VASc score.1,6–8","For patients with HCM who have subclinical AF identified by an internal or external cardiac device or monitor lasting more than 24 hours per episode, anticoagulation is advised, with DOACs as the preferred first-line treatment and vitamin K antagonists as the second-line choice, regardless of the CHA2DS2-VASc score."
id_01618,"For patients with a hip fracture waiting for surgi­ cal repair, epidural analgesia may be considered to decrease the incidence of preoperative cardiac events.3",Epidural analgesia can be considered for patients with a hip fracture awaiting surgical repair to reduce the risk of preoperative cardiac events.
id_01138,"For patients already taking aspirin at the time of noncardioembolic ischemic stroke or TIA, the effectiveness of increasing the dose of aspirin or changing to another antiplatelet medication is not well established.410,798–800","For patients on aspirin during a noncardioembolic ischemic stroke or TIA, the benefits of either increasing the aspirin dose or switching to a different antiplatelet drug remain uncertain."
id_02578,Treatment of nonconvulsive seizures (diagnosed by EEG only) is reasonable in adult survivors of cardiac arrest.,It is appropriate to treat nonconvulsive seizures identified solely by EEG in adults who have survived cardiac arrest.
id_00178,"In patients with angina or an anginal equiva- lent, undocumented ischemia, and angio- graphically intermediate stenoses, the use of fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR) is recommended to guide the decision to proceed with PCI.1-6","For patients experiencing angina or similar symptoms, with unverified ischemia and angiographically moderate stenoses, it is advised to use fractional flow reserve (FFR) or instantaneous wave-free ratio (iFR) to determine whether to proceed with PCI."
id_00179,"In stable patients with angiographically inter- mediate stenoses and FFR >0.80 or iFR >0.89, PCI should not be performed.7-10","For patients who are stable and have angiographically intermediate stenoses with an FFR greater than 0.80 or an iFR greater than 0.89, PCI is not recommended."
id_00659,"In patients with AF in whom rate control strategy is planned, beta blockers, verapamil, or diltiazem are recommended, with the choice of agents according to patient preferences and comorbid conditions.9,10","For patients with AF where a rate control approach is intended, it is advised to use beta blockers, verapamil, or diltiazem, selecting the medication based on patient preferences and existing comorbidities."
id_02098,"For patients with bioprosthetic heart valves or annuloplasty rings who are receiving anticoagulation for AF, it is reasonable to consider the need for bridging anticoagulant therapy around the time of invasive procedures on the basis of the CHA2DS2-VASc score weighed against the risk of bleeding.","For patients with bioprosthetic heart valves or annuloplasty rings on anticoagulation for AF, evaluating the necessity of bridging anticoagulant therapy during invasive procedures should be based on the CHA2DS2-VASc score and balanced against bleeding risk."
id_01619,"In patients with CVD undergoing NCS, maintenance of normothermia is reasonable to avoid perioperative complications overall.1–5","For patients with cardiovascular disease undergoing non-cardiac surgery, it is advisable to maintain normal body temperature to prevent perioperative complications."
id_01139,"In patients with ischemic stroke or TIA, voluntary hospital-based or outpatient-focused quality monitoring and improvement programs are recommended to improve short-term and long-term adherence to nationally accepted, evidence-based guidelines for secondary stroke prevention.","For patients who have experienced an ischemic stroke or TIA, it is advised to implement voluntary quality monitoring and improvement initiatives within hospitals or outpatient settings to enhance adherence to nationally recognized, evidence-based guidelines for secondary stroke prevention in both the short and long term."
id_02579,A therapeutic trial of a nonsedating antiseizure medication may be reasonable in adult survivors of cardiac arrest with EEG patterns on the ictal-interictal continuum.,It may be appropriate to consider a trial of a nonsedating antiseizure drug in adult cardiac arrest survivors who exhibit EEG patterns on the ictal-interictal continuum.
id_02099,"For patients who are undergoing invasive procedures and have 1) a mechanical AVR and any thromboembolic risk factor, 2) an older-generation mechanical AVR, or 3) a mechanical mitral valve replacement, bridging anticoagulation therapy during the preoperative time interval when the INR is subtherapeutic is reasonable on an individualized basis, with the risks of bleeding weighed against the benefits of thromboembolism prevention.","For patients undergoing invasive procedures who have 1) a mechanical aortic valve replacement (AVR) with any thromboembolic risk factor, 2) an older-generation mechanical AVR, or 3) a mechanical mitral valve replacement, it is reasonable to consider bridging anticoagulation therapy during the preoperative period when the INR is below therapeutic levels, balancing the bleeding risks against the benefits of preventing thromboembolism on an individual basis."
id_01620,"In patients with acute, severe hemodynamic instabil­ ity and cardiopulmonary dysfunction undergoing urgent or emergency NCS, temporary MCS devices may be used preemptively or as rescue therapy.1–5","For patients experiencing acute, severe hemodynamic instability and cardiopulmonary dysfunction who are undergoing urgent or emergency non-cardiac surgery, temporary mechanical circulatory support devices can be employed either proactively or as a rescue measure."
id_01140,"In patients with ischemic stroke or TIA, a mul- tidisciplinary outpatient team-based approach (ie, care provision with active medication adjust- ment from advanced practice providers, nurses, or pharmacists) can be effective to control BP, lipids, and other vascular risk factors.810–817","For patients who have experienced an ischemic stroke or TIA, managing blood pressure, lipids, and other vascular risk factors can be effectively achieved through a multidisciplinary outpatient team approach, involving active medication adjustments by advanced practice providers, nurses, or pharmacists."
id_02580,The same antiseizure medications used for treatment of seizures caused by other etiologies may be considered for seizures detected after cardiac arrest.,Antiseizure medications that are used for seizures from other causes can also be considered for those occurring after cardiac arrest.
id_02100,"For patients with mechanical valves and uncontrollable bleeding who require immediate reversal of anticoagulation, administration of 4-factor prothrombin complex (or its activated form) is reasonable.","Administering 4-factor prothrombin complex, or its activated variant, is advisable for patients with mechanical valves experiencing uncontrollable bleeding who need rapid anticoagulation reversal."
id_00660,"In patients with HCM and subclinical AF detected by internal or external device or monitor, of >5 minutes’ duration but <24 hours’ duration for a given episode, anticoagulation with DOACs as first-line option and vitamin K antagonists as second-line option can be beneficial, taking into consideration duration of AF episodes, total AF burden, underlying risk factors, and bleeding risk.1,6–8,11","For patients with HCM who have subclinical AF episodes lasting more than 5 minutes but less than 24 hours, identified by internal or external monitoring devices, using DOACs as the primary anticoagulation choice and vitamin K antagonists as a secondary option may be advantageous, considering the duration and total burden of AF, as well as underlying risk factors and bleeding risk."
id_00181,"In patients with STEMI and ischemic symp- toms for <12 hours, PCI should be performed to improve survival.1-5","For patients experiencing STEMI with ischemic symptoms lasting less than 12 hours, performing PCI is recommended to enhance survival."
id_00180,"In patients with intermediate stenosis of the left main artery, intravascular ultrasound (IVUS) is reasonable to help define lesion severity.1-5","For patients with moderate narrowing of the left main artery, using intravascular ultrasound (IVUS) is a sensible approach to assess the severity of the lesion."
id_00661,"In patients with HCM and poorly tolerated AF, a rhythm-control strategy with cardioversion or antiar- rhythmic drugs can be beneficial with the choice of an agent according to AF symptom severity, patient preferences, and comorbid conditions.9,12–24","For patients with HCM experiencing poorly tolerated AF, employing a rhythm-control approach using cardioversion or antiarrhythmic medications may be advantageous, with the selection of the agent based on the severity of AF symptoms, patient preferences, and existing comorbidities."
id_01621,"In patients with CVD undergoing NCS, the use of PA catheterization may be considered when under­ lying medical conditions that significantly affect hemodynamics (eg, decompensated HF, severe valvular disease, combined shock states, PH) cannot be corrected before surgery.1,2","For patients with cardiovascular disease undergoing non-cardiac surgery, pulmonary artery catheterization might be considered if there are underlying medical conditions that significantly impact hemodynamics, such as decompensated heart failure, severe valvular disease, combined shock states, or pulmonary hypertension, which cannot be corrected prior to the procedure."
id_02581,Seizure prophylaxis in adult survivors of cardiac arrest is not recommended.,It is advised against using seizure prevention measures in adult cardiac arrest survivors.
id_02101,"For patients with mechanical valves and uncontrollable bleeding who have received 4-factor prothrombin concentrate complex, adjunctive use of intravenous vitamin K is reasonable if resumption of VKA therapy is not anticipated for 7 days.","In patients with mechanical valves experiencing uncontrollable bleeding who have been given 4-factor prothrombin complex concentrate, it is reasonable to administer intravenous vitamin K if restarting VKA therapy is not expected within 7 days."
id_00182,"In patients with STEMI and cardiogenic shock or hemodynamic instability, PCI or CABG (when PCI is not feasible) is indicated to improve survival, irrespective of the time delay from MI onset.6,7","For patients experiencing STEMI with cardiogenic shock or hemodynamic instability, PCI is recommended to enhance survival, and if PCI is not possible, CABG should be performed, regardless of the time elapsed since the onset of MI."
id_00662,"In patients with HCM and symptomatic AF, as part of an AF rhythm-control strategy, catheter ablation for AF can be effective when drug therapy is ineffective, contraindicated, or not the patient’s preference.12,25,26","For patients with HCM experiencing symptomatic AF, catheter ablation may be a viable option for AF rhythm control if medication is ineffective, unsuitable, or not preferred by the patient."
id_01141,"In patients presenting to their primary care provider as the first contact after TIA or minor stroke, it is reasonable to use a decision sup- port tool that improves diagnostic accuracy, stratifies patients in risk categories to support appropriate triage, and prompts the initiation of medications and counseling for lifestyle modification for secondary stroke prevention to reduce the 90-day risk of recurrent stroke or TIA.818","For patients who first consult their primary care provider following a TIA or minor stroke, employing a decision support tool is advisable to enhance diagnostic precision, categorize patients by risk for proper triage, and initiate medication and lifestyle counseling for secondary stroke prevention, thereby lowering the risk of recurrent stroke or TIA within 90 days."
id_01622,"In patients with CVD undergoing NCS, routine use of PA catheterization is not recommended to reduce morbidity or mortality.3 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with cardiovascular disease undergoing non-cardiac surgery, it is not advised to routinely use pulmonary artery catheterization to decrease morbidity or mortality."
id_01142,"In patients with ischemic stroke or TIA, behavior change interventions targeting stroke literacy, lifestyle factors, and medica- tion adherence are recommended to reduce cardiovascular events.131,134,840","For patients who have experienced an ischemic stroke or TIA, it is advised to implement behavior change strategies that focus on improving stroke literacy, lifestyle habits, and medication adherence to decrease the risk of cardiovascular events."
id_02582,Organ donation should be considered in all patients resuscitated from cardiac arrest who meet neurological criteria for death.,Organ donation ought to be evaluated for every patient who has been revived from cardiac arrest and fulfills the neurological criteria for death.
id_00663,"In patients with HCM and AF who require surgical myectomy, concomitant surgical AF ablation proce- dure can be beneficial for AF rhythm control.13,27–29 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with HCM and AF undergoing surgical myectomy, performing a simultaneous surgical AF ablation procedure may aid in controlling AF rhythm."
id_02102,"For patients with bioprosthetic valves or annuloplasty rings who are receiving a direct oral anticoagulant and who require immediate reversal of anticoagulation because of uncontrollable bleeding, treatment with idarucizumab (for dabigatran) or andexanet alfa (for anti-Xa agents) is reasonable.1–5","For patients with bioprosthetic valves or annuloplasty rings on direct oral anticoagulants who need urgent anticoagulation reversal due to uncontrollable bleeding, using idarucizumab for dabigatran or andexanet alfa for anti-Xa agents is advisable."
id_00183,"In patients with STEMI who have mechanical complications (eg, ventricular septal rupture, mitral valve insufficiency because of papillary muscle infarction or rupture, or free wall rup- ture), CABG is recommended at the time of surgery, with the goal of improving survival.8,9","For patients experiencing STEMI with mechanical complications such as ventricular septal rupture, mitral valve insufficiency due to papillary muscle infarction or rupture, or free wall rupture, it is advised to perform CABG during surgery to enhance survival rates."
id_02103,"For patients with a mechanical prosthetic valve and supratherapeutic INR (>5.0) who are not actively bleeding, the benefit of individualized treatment with oral vitamin K, in addition to temporary withdrawal of the VKA, is uncertain.","In patients with a mechanical prosthetic valve and an INR above 5.0 who are not experiencing active bleeding, the advantage of personalized treatment with oral vitamin K, alongside temporarily stopping the VKA, remains unclear."
id_02583,Organ donation should be considered in all patients resuscitated from cardiac arrest before planned withdrawal of life-sustaining therapies.,"Before planning to withdraw life-sustaining treatments, organ donation should be evaluated for all patients who have been resuscitated from cardiac arrest."
id_01143,"In patients with ischemic stroke or TIA, teaching self-management skills or using behavior change theory (eg, motivational interviewing) can be ben- eficial in improving medication adherence.840–843","For patients who have experienced an ischemic stroke or TIA, employing self-management education or behavior change strategies, such as motivational interviewing, may help enhance adherence to medication."
id_01623,"In patients having NCS with expected blood loss, tranexamic acid is reasonable to reduce intraoperative blood loss, reduce transfusions, and avoid anemia.1–3","For patients undergoing NCS with anticipated blood loss, it is appropriate to use tranexamic acid to minimize intraoperative bleeding, decrease the need for transfusions, and prevent anemia."
id_00184,"In patients with STEMI who are treated with fibrinolytic therapy, angiography within 3 to 24 hours with the intent to perform PCI is reason- able to improve clinical outcomes.14-20","For patients with STEMI receiving fibrinolytic therapy, undergoing angiography within 3 to 24 hours with the aim of performing PCI is advisable to enhance clinical outcomes."
id_00664,"In patients with HCM and recurrent, poorly toler- ated life-threatening ventricular tachyarrhythmias refractory to maximal antiarrhythmic drug therapy and ablation, heart transplantation assessment is indicated in accordance with current listing criteria.1,2","For patients with HCM experiencing recurrent, poorly tolerated life-threatening ventricular tachyarrhythmias that do not respond to maximum antiarrhythmic drug therapy and ablation, evaluation for heart transplantation should be considered based on current listing criteria."
id_00185,"In patients with STEMI who are stable and presenting 12 to 24 hours after symptom onset, PCI is reasonable to improve clinical outcomes.21,22","For stable patients with STEMI presenting 12 to 24 hours after symptoms begin, performing PCI can be beneficial for enhancing clinical outcomes."
id_02584,Decisions about organ donation should follow local legal and regulatory requirements.,Organ donation decisions must comply with local laws and regulations.
id_01144,"In patients with stroke or TIA, combined exercise-based and behavior change interven- tions are probably indicated in preference to behavior interventions alone, exercise interven- tions alone, or usual care to reduce physiologi- cal stroke risk factors such as SBP.111–113,829","For patients who have experienced a stroke or TIA, it is likely advisable to prioritize a combination of exercise-based and behavior change interventions over solely behavior interventions, solely exercise interventions, or standard care to lower physiological stroke risk factors like SBP."
id_01624,"In patients with iron deficiency anemia having elec­ tive NCS, iron therapy (either oral or intravenous) administered preoperatively is reasonable to reduce blood transfusions and to increase hemoglobin.4–18","For patients with iron deficiency anemia undergoing elective non-cardiac surgery, administering iron therapy (either orally or intravenously) before the operation is advisable to decrease the need for blood transfusions and to raise hemoglobin levels."
id_00665,"In children with HCM and recurrent ventricular arrhythmias despite beta-blocker use, antiarrhythmic drug therapy (eg, amiodarone,3,4 mexiletine,6 sotalol3,4) is recommended, with the choice of agent guided by age, underlying comorbidities, severity of disease, patient prefer- ences, and balance of efficacy and safety.","For children with HCM experiencing recurrent ventricular arrhythmias despite beta-blocker treatment, it is advised to use antiarrhythmic medications such as amiodarone, mexiletine, or sotalol, with the selection based on age, existing health conditions, disease severity, patient preferences, and the balance between effectiveness and safety."
id_02104,"In patients with a mechanical AVR who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is reasonable to increase the INR goal from 2.5 (range, 2.0–3.0) to 3.0 (range, 2.5–3.5) or to add daily low-dose aspirin (75– 100 mg), with assessment of bleeding risk.","For patients with a mechanical aortic valve replacement who suffer a stroke or systemic embolism while maintaining a therapeutic INR on VKA anticoagulation, it is advisable to either raise the INR target to 3.0 (range, 2.5–3.5) or incorporate a daily low-dose aspirin (75–100 mg), while evaluating the risk of bleeding."
id_02585,Organ donation is an important outcome that should be considered in the development and evaluation of systems of care.,The significance of organ donation should be taken into account when designing and assessing care systems.
id_01145,"In patients with TIA or nondisabling stroke, engagement in targeted secondary prevention programs (eg, cardiac rehabilitation programs or exercise and lifestyle counseling programs) can be beneficial to reduce risk factors and recurrent ischemic events.133,134","For patients who have experienced a TIA or a nondisabling stroke, participating in specific secondary prevention initiatives, such as cardiac rehabilitation or exercise and lifestyle counseling, may help lower risk factors and prevent recurrent ischemic events."
id_01625,"In patients with known CVD, symptoms of CVD, or age ≥65 years with cardiovascular risk factors undergoing elevated-risk NCS, it may be reasonable to measure cTn at 24 and 48 hours after surgery to identify myocardial injury.1–4","For patients with established CVD, those exhibiting CVD symptoms, or individuals aged 65 and older with cardiovascular risk factors undergoing high-risk non-cardiac surgery, measuring cTn at 24 and 48 hours post-surgery may be advisable to detect myocardial injury."
id_00666,"In patients with HCM and pacing-capable ICDs, programming antitachycardia pacing is recommended to minimize risk of shocks.7,8","For patients with HCM who have ICDs capable of pacing, it is advised to program antitachycardia pacing to reduce the likelihood of shocks."
id_00186,"In patients with STEMI in whom PCI is not feasible or successful, with a large area of myocardium at risk, emergency or urgent CABG can be effective as a reperfusion modality to improve clinical outcomes.23,24","For patients with STEMI where PCI cannot be performed or has failed, and a significant myocardial area is at risk, emergency or urgent CABG may serve as an effective reperfusion strategy to enhance clinical outcomes."
id_02586,It is reasonable for researchers studying cardiac arrest to develop and implement methods to promote recruitment and representation of participants from diverse backgrounds.,Researchers investigating cardiac arrest should consider creating and applying strategies to enhance the recruitment and inclusion of participants from varied backgrounds.
id_02106,"In patients with a bioprosthetic surgical or transcatheter aortic valve or bioprosthetic mitral valve who experience a stroke or systemic embolic event while on antiplatelet therapy, VKA anticoagulation, instead of antiplatelet therapy may be considered after assessment of bleeding risk.1,2","For patients with a bioprosthetic aortic or mitral valve who suffer a stroke or systemic embolism while on antiplatelet therapy, VKA anticoagulation may be considered as an alternative to antiplatelet therapy after evaluating the risk of bleeding."
id_01626,"In patients undergoing low-risk NCS, routine post­ operative screening with cTn levels is not indicated without signs or symptoms suggestive of myocardial ischemia or MI.5,6 MINS Management","For patients having low-risk NCS, routine postoperative cTn level screening is unnecessary unless there are signs or symptoms indicating myocardial ischemia or MI."
id_02105,"In patients with a mechanical mitral valve replacement who experience a stroke or systemic embolic event while in therapeutic range on VKA anticoagulation, it is reasonable to increase the INR goal from 3.0 (range, 2.5–3.5) to 4.0 (range, 3.5–4.0) or to add daily low-dose aspirin (75–100 mg), with assessment of bleeding risk.","For patients with a mechanical mitral valve replacement who suffer a stroke or systemic embolism despite being within the therapeutic range on VKA anticoagulation, it is advisable to either raise the INR target to 4.0 (range, 3.5–4.0) or introduce a daily low-dose aspirin regimen (75–100 mg), while evaluating the risk of bleeding."
id_01146,"For patients with disabling stroke who are discharged from acute services, engaging in targeted secondary prevention programs (eg, an adapted cardiac rehabilitation program or struc- tured exercise including aerobic activity and healthy lifestyle counseling) can be beneficial to reduce vascular risk factors and mortality.111,844","Patients with debilitating stroke who leave acute care services may benefit from participating in specific secondary prevention programs, such as modified cardiac rehabilitation or structured exercise involving aerobic activities and lifestyle counseling, to lower vascular risk factors and mortality."
id_02587,It is beneficial for researchers studying cardiac arrest to collect and report complete demographic data.,Researchers examining cardiac arrest should gather and disclose comprehensive demographic information.
id_01627,"In patients who develop MINS, especially in those not previously known to have excess cardiovascular risk, outpatient follow-up is reasonable for optimiza­ tion of cardiovascular risk factors.4,7–10","For patients experiencing MINS, particularly those without a prior history of elevated cardiovascular risk, it is advisable to conduct outpatient follow-up to optimize cardiovascular risk factors."
id_00667,"In patients with HCM and recurrent symptomatic sustained monomorphic VT, or recurrent ICD shocks despite optimal device programming, and in whom antiarrhythmic drug therapy is either ineffective, not tolerated, or not preferred, catheter ablation can be useful for reducing arrhythmia burden.9–11 *Indicates the LOE for amiodarone. †Indicates the LOE for dofetilide, mexi- letine, or sotalol.","For patients with HCM experiencing recurrent symptomatic sustained monomorphic VT or frequent ICD shocks despite optimal device settings, and where antiarrhythmic drugs are ineffective, intolerable, or undesirable, catheter ablation may be beneficial in decreasing arrhythmia burden."
id_01147,"In patients with stroke or TIA, provision of health information or advice about stroke prevention is essential; however, information or advice alone, in the absence of a behavioral intervention, is not an effective means to change modifiable, lifestyle-related risk factors in order to reduce future ischemic events.129,829,845","For patients who have experienced a stroke or TIA, delivering health information or guidance on stroke prevention is crucial; nonetheless, without accompanying behavioral interventions, such information or advice alone is insufficient to alter modifiable lifestyle-related risk factors to prevent future ischemic events."
id_02107,"In patients with suspected mechanical prosthetic valve thrombosis, urgent evaluation with TTE, TEE, fluoroscopy, and/ or multidetector CT imaging is indicated to assess valve function, leaflet motion, and the presence and extent of thrombus.1–7","For patients suspected of having mechanical prosthetic valve thrombosis, it is crucial to promptly evaluate valve function, leaflet motion, and thrombus presence and extent using TTE, TEE, fluoroscopy, and/or multidetector CT imaging."
id_00187,"In patients with STEMI complicated by ongo- ing ischemia, acute severe heart failure, or life- threatening arrhythmia, PCI can be beneficial to improve clinical outcomes, irrespective of time delay from MI onset.","For patients experiencing STEMI with persistent ischemia, acute severe heart failure, or life-threatening arrhythmias, PCI may enhance clinical outcomes, regardless of the time elapsed since the MI began."
id_01628,"In patients who develop MINS, antithrombotic ther­ apy may be considered to reduce thromboembolic events.4,11","For patients with MINS, considering antithrombotic therapy could help decrease the risk of thromboembolic events."
id_01148,"In patients with stroke or TIA, evaluating and addressing social determinants of health (eg, literacy level, language proficiency, medica- tion affordability, food insecurity, housing, and transportation barriers) when managing stroke risk factors is recommended to reduce healthcare disparities.","For patients who have experienced a stroke or TIA, it is advised to assess and address social determinants of health, such as literacy, language skills, medication costs, food insecurity, housing, and transportation challenges, in order to manage stroke risk factors and minimize healthcare disparities."
id_00668,"For patients with HCM, mild- to moderate-intensity* recreational† exercise is beneficial to improve cardiorespiratory fitness, physical functioning, and quality of life, and for overall health in keeping with physical activity guidelines for the general population.1–3","Patients with HCM can enhance their cardiorespiratory fitness, physical functioning, and quality of life, as well as overall health, by engaging in mild- to moderate-intensity recreational exercise, aligning with general population physical activity guidelines."
id_02108,"For patients with a thrombosed left-sided mechanical prosthetic heart valve who present with symptoms of valve obstruction, urgent initial treatment with either slow-infusion, low- dose fibrinolytic therapy or emergency surgery is recommended.1–12","For patients experiencing symptoms of obstruction due to a thrombosed mechanical prosthetic heart valve on the left side, it is advised to promptly initiate treatment with either a slow-infusion, low-dose fibrinolytic therapy or perform emergency surgery."
id_02588,"In patients with stroke, including spontaneous ICH, design and implementation of stroke public education programs for diverse popula- tions focused on early recognition and the need to seek emergency care rapidly is useful to reduce time to diagnosis and treatment.31–35","For patients experiencing a stroke, such as spontaneous intracerebral hemorrhage, creating and executing public education initiatives aimed at diverse groups to promote early recognition and prompt emergency care is beneficial in shortening the time to diagnosis and treatment."
id_00189,"In patients with STEMI, emergency CABG should not be performed after failed primary PCI: •  In the absence of ischemia or a large area of myocardium at risk, or •  If surgical revascularization is not feasible because of a no-reflow state or poor distal targets.","For patients with STEMI, emergency CABG is not advised following unsuccessful primary PCI unless there is ischemia or a significant myocardial area at risk, or if surgical revascularization is impractical due to a no-reflow condition or inadequate distal targets."
id_01149,"In patients with stroke or TIA, monitoring the achievement of nationally accepted, evidence- based performance measures is recommended to allow inequities to be identified and addressed.","For patients who have experienced a stroke or TIA, it is advised to track adherence to nationally recognized, evidence-based performance standards to identify and rectify disparities."
id_00669,"For athletes with HCM, a comprehensive evaluation and shared decision-making about sports participation with an expert professional is recommended.4",Athletes diagnosed with HCM should undergo a thorough assessment and engage in collaborative decision-making with a specialist regarding their involvement in sports.
id_00188,"In asymptomatic stable patients with STEMI who have a totally occluded infarct artery >24 hours after symptom onset and are without evidence of severe ischemia, PCI should not be performed.25,26","For asymptomatic stable patients with STEMI and a completely blocked infarct artery more than 24 hours after symptoms begin, and who show no signs of severe ischemia, PCI is not recommended."
id_00670,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive sports of any intensity is reasonable.5,6","For individuals with a positive genotype but negative phenotype for HCM, engaging in competitive sports at any level is considered reasonable."
id_02109,"In patients with suspected bioprosthetic valve thrombosis, 3D TEE or 4D CT imaging can be useful to rule out leaflet thrombosis.1–5","For patients suspected of having bioprosthetic valve thrombosis, utilizing 3D TEE or 4D CT imaging can help exclude the presence of leaflet thrombosis."
id_01629,"Patients who develop STEMI after NCS should be considered for GDMT, including consideration of ICA, balancing bleeding and thrombotic risks with the severity of the clinical presentation.1–3 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing STEMI following NCS, GDMT should be evaluated, including the potential for ICA, while weighing the risks of bleeding and thrombosis against the clinical severity."
id_01150,"In patients with stroke or TIA, systematic adoption of the Agency for Healthcare Research and Quality Universal Precautions Toolkit for Health Literacy is recommended to integrate health literacy into the secondary prevention of stroke.","For patients who have experienced a stroke or TIA, it is advised to systematically implement the Agency for Healthcare Research and Quality's Universal Precautions Toolkit for Health Literacy to incorporate health literacy into stroke secondary prevention."
id_02110,"In patients with suspected or confirmed bioprosthetic valve thrombosis who are hemodynamically stable and have no contraindications to anticoagulation, initial treatment with a VKA is reasonable.1–6","For patients with suspected or confirmed bioprosthetic valve thrombosis who are hemodynamically stable and have no contraindications to anticoagulation, starting treatment with a VKA is advisable."
id_02589,"In patients with sudden onset of neurological symptoms or signs attributable to potential spontaneous ICH, use of stroke recogni- tion and severity tools is recommended for dispatch personnel and first responders to identify potential stroke and facilitate rapid transport to reduce time to diagnosis and treatment.36–41","For patients experiencing sudden neurological symptoms or signs suggestive of possible spontaneous intracerebral hemorrhage, it is advised that dispatch personnel and first responders employ stroke recognition and severity assessment tools to identify potential strokes and expedite transport, thereby minimizing the time to diagnosis and treatment."
id_02590,"In patients with stroke symptoms attributable to potential spontaneous ICH, immediate activation of the emergency response system (9-1-1 in North America) is recommended to reduce time to diagnosis and treatment.32,42","For patients exhibiting stroke symptoms possibly due to spontaneous intracerebral hemorrhage, it is advised to promptly contact emergency services (such as 9-1-1 in North America) to minimize the delay in diagnosis and treatment."
id_00190,"In selected hemodynamically stable patients with STEMI and multivessel disease, after successful primary PCI, staged PCI of a sig- nificant non-infarct artery stenosis is recom- mended to reduce the risk of death or MI.1-4","For certain hemodynamically stable patients with STEMI and multivessel disease, it is advised to perform staged PCI on a significant non-infarct artery stenosis following successful primary PCI to lower the risk of death or myocardial infarction."
id_01630,Patients who develop NSTEMI after NCS should receive medical therapy as recommended for patients with spontaneous MI but after consideration of postoperative bleeding risks and hemodynamic status.,"For patients experiencing NSTEMI following NCS, medical treatment should align with guidelines for spontaneous MI, taking into account the risks of postoperative bleeding and their hemodynamic condition."
id_01631,"Patients who develop NSTEMI after NCS can be considered for ICA, balancing bleeding and throm­ botic risks with the severity of clinical presentation.2,3","For patients experiencing NSTEMI following NCS, ICA may be considered, weighing the bleeding and thrombotic risks against the severity of their clinical condition."
id_02111,"In patients with suspected mechanical or bioprosthetic valve stenosis, TTE and TEE are recommended to diagnosis the cause and severity of valve obstruction, assess ventricular function, and estimate pulmonary artery systolic pressure.1,2","For patients suspected of having mechanical or bioprosthetic valve stenosis, it is advised to use TTE and TEE to determine the cause and severity of the obstruction, evaluate ventricular function, and estimate pulmonary artery systolic pressure."
id_02591,"In patients with potential spontaneous ICH, early notification by emergency medical ser- vices (EMS) staff to the receiving hospital is recommended to improve time to diagnosis and treatment.43,44","For patients suspected of having spontaneous ICH, it is advised that EMS personnel promptly alert the receiving hospital to enhance the speed of diagnosis and treatment."
id_01151,"In patients from urban, predominantly minority, or low-socioeconomic-status groups with stroke or TIA, the optimal intervention model for improving stroke risk factor control and reducing disparities is unknown.815,856–859","For patients from urban areas, predominantly minority backgrounds, or low socioeconomic status who have experienced a stroke or TIA, the best approach to enhance control of stroke risk factors and minimize disparities remains unidentified."
id_00671,"For patients with HCM, participation in vigorous* recreational activities is reasonable after an annual comprehensive evaluation and shared decision-making with an expert professional who balances potential benefits and risks, with this process being repeated annually.4,5,7,8","Patients with HCM may reasonably engage in vigorous recreational activities following a yearly thorough assessment and collaborative decision-making with a specialist who weighs the potential benefits and risks, with this evaluation repeated each year."
id_00191,"In selected patients with STEMI with com- plex multivessel non-infarct artery disease, after successful primary PCI, elective CABG is reasonable to reduce the risk of cardiac events.","For certain patients with STEMI who have complex multivessel disease in non-infarct arteries, undergoing elective CABG following successful primary PCI is advisable to lower the risk of cardiac events."
id_01632,"In patients with HF, vital signs and evidence of clinical congestion should be assessed at each encounter to guide overall management, includ- ing adjustment of diuretics and other medica- tions.1–6","For patients with heart failure, evaluate vital signs and signs of clinical congestion at every visit to inform management decisions, such as modifying diuretics and other medications."
id_02112,"In patients with mechanical valve stenosis, fluoroscopy or cine-CT is recommended to assess motion of the mechanical valve leaflets.","For patients with mechanical valve stenosis, it is advised to use fluoroscopy or cine-CT to evaluate the movement of the mechanical valve leaflets."
id_00192,"In selected hemodynamically stable patients with STEMI and low-complexity multivessel disease, PCI of a non-infarct artery stenosis may be considered at the time of primary PCI to reduce cardiac event rates.1,2,5-7","For certain hemodynamically stable patients with STEMI and uncomplicated multivessel disease, performing PCI on a non-infarct artery stenosis during the initial PCI may be an option to lower cardiac event rates."
id_02592,"In patients with spontaneous ICH, regional systems of stroke care are recommended so all potentially beneficial therapies can be made available when appropriate as rapidly as possible‚ including, at minimum, (a) health care facilities that provide initial spontaneous ICH care, including diagnosis and treatment, and (b) health care facilities with neurocritical care and neurosurgical capabilities.45","For patients experiencing spontaneous intracerebral hemorrhage (ICH), it is advised to establish regional stroke care systems to ensure that all potentially beneficial treatments are accessible promptly when needed. This should include, at a minimum, (a) healthcare facilities equipped for the initial management of spontaneous ICH, encompassing diagnosis and treatment, and (b) facilities with neurocritical care and neurosurgical resources."
id_00672,"For patients with HCM who are capable of a high level of physical performance, participation in competitive sports† may be considered after review by an expert provider with experience managing athletes with HCM who conducts an annual comprehensive evaluation and shared decision- making that balances potential benefits and risks.5,9–14",Patients with HCM who can perform at a high physical level may consider engaging in competitive sports† following an assessment by a specialist experienced in managing athletes with HCM. This should include an annual thorough evaluation and a shared decision-making process that weighs the potential benefits and risks.
id_01152,"Patients with AF, regardless of sex1 and gender diversity, race and ethnicity,2 or adverse social determinants of health (SDOH),3,4* should be equitably offered guideline-directed stroke risk reduction therapies as well as rate or rhythm control strategies and LRFM as indicated to improve quality of life (QOL) and prevent adverse outcomes. *Including lower income, lower education, inadequate or lack of insurance cov- erage, or rurality.3–5","All patients with AF, irrespective of sex, gender identity, race, ethnicity, or negative social determinants of health such as low income, limited education, insufficient insurance, or rural residence, should be equally provided with guideline-recommended therapies for stroke risk reduction, as well as rate or rhythm control strategies and LRFM, to enhance quality of life and avert negative outcomes."
id_00673,"For most patients with HCM, universal restriction from vigorous physical activity or competitive sports is not indicated.5,11–13","For the majority of patients with HCM, it is not necessary to universally prohibit vigorous physical activity or participation in competitive sports."
id_00193,"In patients with STEMI complicated by car- diogenic shock, routine PCI of a non-infarct artery at the time of primary PCI should not be performed because of the higher risk of death or renal failure.8-10 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing STEMI with accompanying cardiogenic shock, performing routine PCI on a non-infarct artery during the initial PCI is not advised due to an increased risk of mortality or renal failure."
id_01153,"In patients with AF, the use of evidence-based decision aids might be useful to guide stroke reduction therapy treatment decisions throughout the disease course to improve engagement, decisional quality, and patient satisfaction.1–4","For patients with AF, employing evidence-based decision aids can be beneficial in directing stroke prevention therapy choices during the disease progression, enhancing engagement, decision quality, and patient satisfaction."
id_02113,"In patients with bioprosthetic valve stenosis, 3D TEE or 4D CT imaging can be useful to rule out leaflet thrombosis.3–7","For patients with bioprosthetic valve stenosis, 3D TEE or 4D CT imaging may be beneficial in excluding leaflet thrombosis."
id_01633,"In patients with symptomatic HF, clinical factors indicating the presence of advanced HF should be sought via the history and physical examina- tion.7–12","For patients with symptomatic heart failure, clinical indicators of advanced heart failure should be identified through history taking and physical examination."
id_00194,"In patients with NSTE-ACS who are at ele- vated risk of recurrent ischemic events and are appropriate candidates for revascular- ization, an invasive strategy with the intent to proceed with revascularization is indi- cated to reduce cardiovascular events.1-4","For patients with NSTE-ACS at high risk for recurrent ischemic events and suitable for revascularization, an invasive approach aimed at revascularization is recommended to decrease cardiovascular events."
id_00674,"For patients with HCM, it is reasonable to follow Federal Motor Carrier Safety Administration cardiovascular disease guidelines that permit driving commercial motor vehicles, if they do not have an ICD or any major risk factors for SCD and are using a GDMT plan.1","For individuals with HCM, it is appropriate to adhere to the Federal Motor Carrier Safety Administration's cardiovascular disease guidelines allowing commercial vehicle operation, provided they lack an ICD, have no significant SCD risk factors, and are on a GDMT regimen."
id_01634,"In patients with cardiomyopathy, a 3-generation family history should be obtained or updated when assessing the cause of the cardiomyopa- thy to identify possible inherited disease.13,14","For patients with cardiomyopathy, it is important to gather or update a family history spanning three generations to determine if the condition may be inherited."
id_02114,"In patients with symptomatic severe stenosis of a bioprosthetic or mechanical prosthetic valve, repeat surgical intervention is indicated unless surgical risk is high or prohibitive.1–3","For patients experiencing symptoms due to severe stenosis of a bioprosthetic or mechanical valve, another surgical procedure is recommended unless the surgical risk is deemed high or prohibitive."
id_01154,"In patients with newly diagnosed AF, a transthoracic echocardiogram1–4 to assess cardiac structure, laboratory testing to include a complete blood count, metabolic panel, and thyroid function,5–7 and when clinical suspicion exists, targeted testing to assess for other medical conditions associated with AF are recommended to determine stroke and bleeding risk factors, as well as underlying conditions that will guide further management.","For patients newly diagnosed with AF, it is advised to perform a transthoracic echocardiogram to evaluate cardiac structure, conduct laboratory tests including a complete blood count, metabolic panel, and thyroid function tests, and, if clinically indicated, carry out specific tests for other conditions linked to AF to identify stroke and bleeding risk factors and underlying conditions that will inform subsequent management."
id_00195,"In patients with NSTE-ACS and cardiogenic shock who are appropriate candidates for revascularization, emergency revascular- ization is recommended to reduce risk of death.5-9","For patients experiencing NSTE-ACS and cardiogenic shock who qualify for revascularization, urgent revascularization is advised to lower the risk of mortality."
id_02593,"In patients with potential stroke, including spontaneous ICH, in geographic regions where mobile stroke units (MSUs) operate, such mobile units are reasonable to enable more rapid diagnosis and treatment than achievable by ambulance transfer to the clos- est stroke-capable facility.46,47","For patients who may be experiencing a stroke, such as spontaneous intracerebral hemorrhage, in areas where mobile stroke units are available, utilizing these units is advisable for faster diagnosis and treatment compared to ambulance transport to the nearest stroke-capable facility."
id_02594,"In patients with potential spontaneous ICH, first responder training in stroke evaluation and care with the ability to provide airway and circulatory support when necessary is reason- able to detect and manage prehospital neuro- logical deterioration (ND).48,49","For patients at risk of spontaneous ICH, it is advisable for first responders to be trained in stroke assessment and care, including airway and circulatory support, to identify and address prehospital neurological deterioration."
id_01155,"In patients with newly diagnosed AF, protocolized testing for ischemia, acute coronary syndrome (ACS), and pulmonary embolism (PE) should not routinely be performed to assess the etiology of AF unless there are additional signs or symptoms to indicate those disorders.8–10","For patients newly diagnosed with AF, standardized tests for ischemia, acute coronary syndrome (ACS), and pulmonary embolism (PE) should not be routinely conducted to determine the cause of AF unless there are other signs or symptoms suggesting these conditions."
id_01635,"In patients presenting with HF, a thorough history and physical examination should direct diagnos- tic strategies to uncover specific causes that may warrant disease-specific management.15,16","For patients with heart failure, a comprehensive history and physical exam should guide diagnostic approaches to identify particular causes that may require targeted disease management."
id_02115,"For severely symptomatic patients with bioprosthetic aortic valve stenosis and high or prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center.4,5","For patients with severe symptoms from bioprosthetic aortic valve stenosis who face high or prohibitive surgical risks, undergoing a transcatheter ViV procedure at a Comprehensive Valve Center is a reasonable option."
id_00196,"In appropriate patients with NSTE-ACS who have refractory angina or hemody- namic or electrical instability, an immediate invasive strategy with intent to perform revascularization is indicated to improve outcomes.10","For suitable patients with NSTE-ACS experiencing persistent angina or hemodynamic or electrical instability, an immediate invasive approach aimed at revascularization is recommended to enhance outcomes."
id_00675,"For pilot aircrew with a diagnosis of HCM, it is reasonable to follow Federal Aviation Administration guidelines that permit consideration of multicrew flying duties, provided they are asymptomatic, are deemed low risk for SCD, and can complete a maxi- mal treadmill stress test at 85% peak heart rate.2","For aircrew pilots diagnosed with HCM, it is appropriate to adhere to Federal Aviation Administration guidelines allowing them to be considered for multicrew flying roles, as long as they show no symptoms, are assessed as low risk for sudden cardiac death, and can successfully perform a maximal treadmill stress test reaching 85% of their peak heart rate."
id_00676,"It is reasonable for patients with HCM to consider occupations that require manual labor, heavy lifting, or a high level of physical performance after a comprehensive clinical evaluation, risk stratification for SCD, and implementation of GDMT in the con- text of shared decision-making.","Patients with HCM may contemplate engaging in jobs involving manual labor, heavy lifting, or intense physical activity following a thorough clinical assessment, SCD risk evaluation, and the application of GDMT, all within a shared decision-making framework."
id_01156,"Among individuals without a known history of AF, it is recommended that an initial AF diagnosis be made by a clinician using visual interpretation of the electrocardiographic signals, regardless of the type of rhythm or monitoring device.1–5","For individuals with no prior AF history, a clinician should visually interpret electrocardiographic signals to initially diagnose AF, irrespective of the rhythm type or monitoring device used."
id_02595,"In patients with spontaneous ICH, focused history, physical examination, and routine labo- ratory work and tests on hospital admission (eg, complete blood count, prothrombin time/ international normalized ratio [INR]/partial thromboplastin time, creatinine/estimated glomerular filtration rate, glucose, cardiac tro- ponin and ECG, toxicology screen, and inflam- matory markers) should be performed to help identify the type of hemorrhage, active medical issues, and risk of unfavorable outcomes.67–72","For patients with spontaneous ICH, a detailed history, physical examination, and standard laboratory tests upon hospital admission (such as complete blood count, prothrombin time/INR/partial thromboplastin time, creatinine/estimated glomerular filtration rate, glucose, cardiac troponin and ECG, toxicology screen, and inflammatory markers) should be conducted to determine the hemorrhage type, identify active medical issues, and assess the risk of adverse outcomes."
id_01636,"In patients presenting with HF, a thorough history and physical examination should be obtained and performed to identify cardiac and noncardiac disorders, lifestyle and behavioral factors, and social determinants of health that might cause or accelerate the development or progression of HF.","For patients with HF, it is essential to conduct a comprehensive history and physical exam to detect cardiac and noncardiac conditions, lifestyle and behavioral influences, and social health determinants that could contribute to or hasten HF onset or progression."
id_02116,"For patients with significant bioprosthetic valve stenosis attributable to suspected or documented valve thrombosis, oral anticoagulation with a VKA is reasonable.6–13",Oral anticoagulation with a VKA is advisable for patients experiencing notable bioprosthetic valve stenosis due to suspected or confirmed valve thrombosis.
id_02596,"In patients presenting with stroke-like symp- toms, rapid neuroimaging with CT or MRI is recommended to confirm the diagnosis of spontaneous ICH.94–96","For patients exhibiting stroke-like symptoms, it is advised to promptly perform neuroimaging using CT or MRI to verify a diagnosis of spontaneous ICH."
id_01637,"For patients presenting with HF, the specific cause of HF should be explored using addi- tional laboratory testing for appropriate man- agement.1–8","For individuals with heart failure, further laboratory tests should be conducted to identify the underlying cause, ensuring proper management."
id_00197,"In patients with NSTE-ACS who are initially stabilized and are at high risk of clinical events, it is reasonable to choose an early invasive strategy (within 24 hours) over a delayed invasive strategy to improve out- comes.11-16","For patients with NSTE-ACS who have been initially stabilized and are at high risk for clinical events, opting for an early invasive approach (within 24 hours) rather than a delayed one is advisable to enhance outcomes."
id_00677,"For pregnant women with HCM and AF or other indications for anticoagulation, low-molecular-weight heparin or vitamin K antagonists (at maximum therapeutic dose of <5 mg daily) are recommended for stroke prevention.1,2 Recommendations for Occupation in Patients With HCM (Continued) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","For pregnant women with hypertrophic cardiomyopathy (HCM) and atrial fibrillation (AF) or other reasons requiring anticoagulation, it is advised to use low-molecular-weight heparin or vitamin K antagonists (not exceeding a daily dose of 5 mg) to prevent stroke."
id_02117,"In patients with suspected mechanical or bioprosthetic valve regurgitation, TTE and TEE are recommended to determine the cause and severity of the leak, assess ventricular function, and estimate pulmonary artery systolic pressure.1–4","For patients suspected of having regurgitation in mechanical or bioprosthetic valves, it is advised to use TTE and TEE to identify the cause and severity of the leak, evaluate ventricular function, and estimate pulmonary artery systolic pressure."
id_01157,"In patients with an intracardiac rhythm device capable of a diagnosis of AF, such as from an atrial pacemaker lead, a diagnosis of AF should only be made after it is visually confirmed by reviewing intracardiac tracings to exclude signal artifacts and other arrhythmias.6–9","For patients with an intracardiac rhythm device that can detect atrial fibrillation, like an atrial pacemaker lead, AF should be diagnosed only after visually confirming intracardiac tracings to rule out signal artifacts and other arrhythmias."
id_00678,"In pregnant women with HCM, selected beta blockers should be administered for symptoms related to outflow tract obstruction or arrhythmias, with monitoring of fetal growth.3,4","For pregnant women with HCM, specific beta blockers should be given to manage symptoms of outflow tract obstruction or arrhythmias, while monitoring fetal growth."
id_00198,"In patients with NSTE-ACS who are initially stabilized and are at intermediate or low risk of clinical events, an invasive strategy with intent to perform revascularization is reason- able before hospital discharge to improve outcomes.11-16","For patients with NSTE-ACS who have been initially stabilized and present an intermediate or low risk of clinical events, it is advisable to pursue an invasive strategy aimed at revascularization before hospital discharge to enhance outcomes."
id_01638,"For patients who are diagnosed with HF, laboratory evaluation should include com- plete blood count, urinalysis, serum electro- lytes, blood urea nitrogen, serum creatinine, glucose, lipid profile, liver function tests, iron studies, and thyroid-stimulating hormone to optimize management.","For individuals diagnosed with heart failure, laboratory assessments should encompass a complete blood count, urinalysis, serum electrolytes, blood urea nitrogen, serum creatinine, glucose, lipid profile, liver function tests, iron studies, and thyroid-stimulating hormone to enhance management."
id_02597,"In patients with spontaneous ICH and/or IVH, serial head CT can be useful within the first 24 hours after symptom onset to evaluate for hemorrhage expansion.97–99","For patients experiencing spontaneous ICH and/or IVH, conducting serial head CT scans within the initial 24 hours after symptoms begin can help assess the potential for hemorrhage expansion."
id_00679,"In most pregnant women with HCM, vaginal delivery is recommended as the first-choice delivery option.3,5","For the majority of pregnant women with HCM, vaginal delivery is advised as the preferred method of childbirth."
id_00199,"In patients with NSTE-ACS who have failed PCI and have ongoing ischemia, hemodynamic compromise, or threatened occlusion of an artery with substantial myocardium at risk, who are appropriate candidates for CABG, emer- gency CABG is reasonable.5-7,17","For patients with NSTE-ACS experiencing unsuccessful PCI and persistent ischemia, hemodynamic instability, or an artery at risk of significant myocardial damage, emergency CABG is advisable if they are suitable candidates."
id_02598,"In patients with spontaneous ICH and/or IVH and with low GCS score or ND, serial head CT can be useful to evaluate for hemorrhage expansion, development of hydrocephalus, brain swelling, or herniation.100–102 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing spontaneous intracerebral or intraventricular hemorrhage with a low Glasgow Coma Scale score or neurological deterioration, repeated head CT scans may be beneficial to assess for hemorrhage expansion, hydrocephalus, brain swelling, or herniation."
id_02118,"In patients undergoing a transcatheter procedure for paravalvular prosthetic regurgitation, 3D TEE is recommended for intraprocedural guidance.4–7","For patients having a transcatheter procedure to address paravalvular prosthetic regurgitation, it is advised to use 3D TEE for guidance during the procedure."
id_01158,"For patients who have had a systemic thromboembolic event without a known history of AF and in whom maximum sensitivity to detect AF is sought, an implantable cardiac monitor is reasonable.10,11","An implantable cardiac monitor is appropriate for patients who experienced a systemic thromboembolic event without a known history of atrial fibrillation, and where maximum sensitivity for detecting atrial fibrillation is desired."
id_01639,"For all patients presenting with HF, a 12-lead ECG should be performed at the initial encoun- ter to optimize management.",A 12-lead ECG should be conducted at the first visit for any patient with heart failure to enhance treatment.
id_02599,"In patients with spontaneous ICH, CT angiog- raphy (CTA) within the first few hours of ICH onset may be reasonable to identify patients at risk for subsequent HE.103–108","For patients experiencing spontaneous ICH, performing CT angiography (CTA) within the initial hours after onset might be appropriate to detect those at risk for later HE."
id_02119,"In patients with intractable hemolysis or HF attributable to prosthetic transvalvular or paravalvular leak, surgery is recommended unless surgical risk is high or prohibitive.1–4","For patients experiencing severe hemolysis or heart failure due to prosthetic transvalvular or paravalvular leaks, surgery is advised unless the surgical risk is deemed high or prohibitive."
id_00200,"In patients with NSTE-ACS who present in cardiogenic shock, routine multivessel PCI of non-culprit lesions in the same setting should not be performed.18,19","For patients with NSTE-ACS experiencing cardiogenic shock, performing routine multivessel PCI on non-culprit lesions during the same procedure is not advised."
id_00680,"In affected families with HCM, preconceptional and prenatal reproductive and genetic counseling should be offered.3–6","For families impacted by HCM, reproductive and genetic counseling should be provided before conception and during pregnancy."
id_01160,"Among patients with AF in whom cardiac monitor- ing is advised, it is reasonable to recommend use of a consumer-accessible electrocardiographic device that provides a high-quality tracing to detect recur- rences.13","For patients with AF who require cardiac monitoring, it is appropriate to suggest using a consumer-accessible electrocardiographic device that delivers high-quality tracings to identify recurrences."
id_02120,"In asymptomatic patients with severe prosthetic regurgitation and low operative risk, surgery is reasonable.1–4",Surgery is advisable for asymptomatic patients experiencing severe prosthetic regurgitation who have a low risk for surgery.
id_01640,"In patients presenting with dyspnea, measure- ment of B-type natriuretic peptide (BNP) or N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) is useful to support a diagnosis or exclusion of HF.1–12","For patients experiencing dyspnea, assessing B-type natriuretic peptide (BNP) or N-terminal prohormone of B-type natriuretic peptide (NT-proBNP) is beneficial for confirming or ruling out heart failure."
id_01159,"Among patients with a diagnosis of AF, it is reason- able to infer AF frequency, duration, and burden using automated algorithms available from electrocardio- graphic monitors, implantable cardiac monitors, and cardiac rhythm devices with an atrial lead, recognizing that periodic review can be required to exclude other arrythmias.1,4,5,12","For patients diagnosed with AF, it is appropriate to determine the frequency, duration, and burden of AF using automated algorithms from ECG monitors, implantable cardiac monitors, and cardiac rhythm devices with an atrial lead, while acknowledging that periodic evaluations may be necessary to rule out other arrhythmias."
id_01161,"Patients at increased risk of AF should receive com- prehensive guideline-directed LRFM for AF, targeting obesity,1 physical inactivity,2 unhealthy alcohol con- sumption,3 smoking,4 diabetes,5 and hypertension.6","Individuals with a higher likelihood of developing AF should undergo thorough guideline-based LRFM for AF, focusing on obesity,1 lack of physical activity,2 excessive alcohol intake,3 smoking,4 diabetes,5 and high blood pressure.6"
id_00201,"In patients with SIHD and multivessel CAD appropriate for CABG with severe left ventric- ular systolic dysfunction (left ventricular ejec- tion fraction <35%), CABG is recommended to improve survival.1,2","For patients with SIHD and multivessel CAD who are suitable candidates for CABG and have severe left ventricular systolic dysfunction (ejection fraction below 35%), CABG is advised to enhance survival."
id_02600,"In patients with spontaneous ICH, using non- contrast computed tomography (NCCT) mark- ers of HE to identify patients at risk for HE may be reasonable.106","For patients with spontaneous ICH, it may be appropriate to use non-contrast computed tomography (NCCT) markers to identify those at risk for HE."
id_00681,"For pregnant women with HCM, care should be coordinated between their cardiologist and an obstetrician. For patients with HCM who are deemed high risk, consultation is advised with an expert in maternal-fetal medicine.","Pregnant women with HCM should have their care managed jointly by a cardiologist and an obstetrician, and those considered high risk should consult a maternal-fetal medicine specialist."
id_01641,"In patients with chronic HF, measurements of BNP or NT-proBNP levels are recommended for risk stratification.11,13–29","For patients with chronic heart failure, assessing BNP or NT-proBNP levels is advised for risk stratification."
id_01642,"In patients hospitalized for HF, measurement of BNP or NT-proBNP levels at admission is recommended to establish prognosis.11,13–19","For patients admitted with heart failure, it is advised to measure BNP or NT-proBNP levels upon admission to determine prognosis."
id_02121,"In patients with prosthetic paravalvular regurgitation with the following: 1) either intractable hemolysis or NYHA class III or IV symptoms and 2) who are at high or prohibitive surgical risk and 3) have anatomic features suitable for catheter-based therapy, percutaneous repair of paravalvular leak is reasonable when performed at a Comprehensive Valve Center.5–9","For patients experiencing prosthetic paravalvular regurgitation with either uncontrollable hemolysis or NYHA class III or IV symptoms, who also face high or prohibitive surgical risks and possess anatomical characteristics amenable to catheter-based intervention, it is reasonable to consider percutaneous repair of the paravalvular leak at a Comprehensive Valve Center."
id_00202,"In selected patients with SIHD and multivessel CAD appropriate for CABG and mild-to-moder- ate left ventricular systolic dysfunction (ejection fraction 35%–50%), CABG (to include a left internal mammary artery [LIMA] graft to the LAD) is reasonable to improve survival.3-8 Left main CAD","For patients with stable ischemic heart disease (SIHD) and multivessel coronary artery disease (CAD) who are suitable candidates for coronary artery bypass grafting (CABG) and have mild-to-moderate left ventricular systolic dysfunction (ejection fraction between 35% and 50%), undergoing CABG with a left internal mammary artery (LIMA) graft to the left anterior descending artery (LAD) is a reasonable option to enhance survival."
id_00682,"For women with clinically stable HCM who wish to become pregnant, it is reasonable to advise that pregnancy is generally safe as part of a shared discussion regarding potential maternal and fetal risks, and initiation of GDMT.7–10","For women with clinically stable hypertrophic cardiomyopathy considering pregnancy, it is appropriate to suggest that pregnancy is typically safe, as part of a collaborative discussion about possible maternal and fetal risks and the start of guideline-directed medical therapy."
id_02601,"In patients with lobar spontaneous ICH and age <70 years, deep/posterior fossa spon- taneous ICH and age <45 years, or deep/ posterior fossa and age 45 to 70 years with- out history of hypertension, acute CTA plus consideration of venography is recommended to exclude macrovascular causes or cerebral venous thrombosis.117,118","For patients under 70 with lobar spontaneous ICH, those under 45 with deep/posterior fossa spontaneous ICH, or those aged 45 to 70 with deep/posterior fossa ICH and no hypertension history, it is advised to perform an acute CTA and consider venography to rule out macrovascular causes or cerebral venous thrombosis."
id_02602,"In patients with spontaneous IVH and no detectable parenchymal hemorrhage, catheter intra-arterial digital subtraction angiography (DSA) is recommended to exclude a macro- vascular cause.119","For patients with spontaneous intraventricular hemorrhage (IVH) and no visible parenchymal bleeding, catheter-based intra-arterial digital subtraction angiography (DSA) is advised to rule out a macrovascular cause."
id_00203,"In patients with SIHD and significant left main stenosis, CABG is recommended to improve survival.9-12","For patients with SIHD and notable left main stenosis, CABG is advised to enhance survival."
id_02122,"For patients with severe HF symptoms caused by bioprosthetic valve regurgitation who are at high to prohibitive surgical risk, a transcatheter ViV procedure is reasonable when performed at a Comprehensive Valve Center.10–12","For patients experiencing severe heart failure symptoms due to bioprosthetic valve regurgitation and who face high or prohibitive surgical risks, undergoing a transcatheter valve-in-valve procedure at a Comprehensive Valve Center is a reasonable option."
id_00683,"In pregnant women with HCM, cardioversion for new or recurrent AF, particularly if symptomatic, is reasonable.6,11","Cardioversion is advisable for pregnant women with HCM experiencing new or recurrent AF, especially if they show symptoms."
id_01643,"In patients at risk of developing HF, BNP or NT-proBNP–based screening followed by team-based care, including a cardiovascular specialist, can be useful to prevent the devel- opment of LV dysfunction or new-onset HF.30,31","For patients at risk of heart failure, screening with BNP or NT-proBNP followed by collaborative care involving a cardiovascular specialist may help prevent the onset of left ventricular dysfunction or new heart failure."
id_01163,"In individuals with AF,* moderate-to-vigorous exercise training to a target of 210 minutes per week is rec- ommended to reduce AF symptoms1–3 and burden,2,3 increase maintenance of sinus rhythm,3–5 increase functional capacity, and improve QOL.3,5,6 *In patients without AF related to excessive exercise training.","For individuals with AF, it is advised to engage in moderate-to-vigorous exercise for 210 minutes weekly to alleviate AF symptoms and burden, enhance sinus rhythm maintenance, boost functional capacity, and improve quality of life, provided the AF is not linked to excessive exercise training."
id_00204,"In selected patients with SIHD and significant left main stenosis for whom PCI can provide equivalent revascularization to that possible with CABG, PCI is reasonable to improve survival.9 Multivessel CAD","For certain patients with SIHD and significant left main stenosis where PCI offers revascularization comparable to CABG, opting for PCI is a reasonable approach to enhance survival."
id_00684,"In pregnant women with HCM, general or epidural anesthesia is reasonable, with precautions to avoid hypotension.8","For pregnant women with HCM, it is advisable to use general or epidural anesthesia, taking care to prevent hypotension."
id_01164,"Patients with a history of AF who smoke cigarettes should be strongly advised to quit smoking and should receive GDMT for tobacco cessation1,2 to mitigate increased risks of AF-related cardiovascular complications and other adverse outcomes.3–6",Individuals with a history of atrial fibrillation who smoke should be firmly encouraged to stop smoking and be provided with guideline-directed medical therapy for tobacco cessation to reduce the heightened risk of cardiovascular complications related to AF and other negative outcomes.
id_02123,"In patients at risk of IE (eg, those with congenital or acquired VHD, previous IE, prosthetic heart valves, certain congenital or heritable heart malformations, immunodeficiency states, or injection drug use) who have unexplained fever blood, culture samples should be obtained.1","For patients susceptible to IE, such as those with congenital or acquired VHD, a history of IE, prosthetic heart valves, specific congenital or inherited heart defects, immunodeficiency conditions, or who use injection drugs, blood cultures should be collected if they present with an unexplained fever."
id_02603,"In patients with spontaneous ICH and a CTA or magnetic resonance angiography (MRA) suggestive of a macrovascular cause, catheter intra-arterial DSA should be performed as soon as possible to confirm and manage underlying intracranial vascular malformations.117,118,120–122","For patients experiencing spontaneous intracerebral hemorrhage with CTA or MRA indicating a macrovascular origin, catheter intra-arterial DSA should be conducted promptly to verify and address any intracranial vascular malformations."
id_02124,"In patients with the recent onset of left-sided valve regurgitation, at least 2 sets of blood culture samples should be obtained.1–12","For patients who have recently developed left-sided valve regurgitation, a minimum of two sets of blood cultures should be collected."
id_01162,"In patients with AF who are overweight or obese (with body mass index [BMI] >27 kg/m2), weight loss is recommended, with an ideal target of at least 10% weight loss to reduce AF symptoms, burden, recurrence, and progression to persistent AF.1–4","For patients with atrial fibrillation (AF) who have a BMI greater than 27 kg/m², it is advised to lose weight, aiming for a minimum of 10% reduction, to alleviate AF symptoms, decrease its burden, and prevent its recurrence and progression to persistent AF."
id_00205,"In patients with SIHD, normal ejection frac- tion, significant stenosis in 3 major coronary arteries (with or without proximal LAD), and anatomy suitable for CABG, CABG may be reasonable to improve survival.10,13-15","For patients with SIHD, normal ejection fraction, and significant stenosis in three major coronary arteries (including or excluding the proximal LAD), who have anatomy appropriate for CABG, undergoing CABG might be a reasonable option to enhance survival."
id_00685,"In pregnant women with HCM, it is reasonable to perform serial echocardiography, particularly during the second or third trimester when hemodynamic load is highest, or if clinical symptoms develop.","For pregnant women with HCM, conducting regular echocardiograms is advisable, especially in the second or third trimester when hemodynamic stress peaks, or if symptoms arise."
id_01645,"In first-degree relatives of selected patients with genetic or inherited cardiomyopathies, genetic screening and counseling are recom- mended to detect cardiac disease and prompt consideration of treatments to decrease HF progression and sudden death.1,2",Genetic screening and counseling are advised for first-degree relatives of certain patients with genetic or inherited cardiomyopathies to identify cardiac disease and consider early interventions to reduce the risk of heart failure progression and sudden death.
id_01165,Patients with AF seeking a rhythm-control strategy should minimize or eliminate alcohol consumption to reduce AF recurrence and burden.1–3,Patients with AF who opt for a rhythm-control approach should reduce or abstain from alcohol intake to decrease the recurrence and impact of AF.
id_02125,"In patients with suspected IE, the Modified Duke Criteria should be used for diagnosis (Tables 24 and 25).2–10","For diagnosing patients with suspected infective endocarditis, the Modified Duke Criteria should be applied (refer to Tables 24 and 25)."
id_00686,"In pregnant women with HCM, fetal echocardiography may be considered for diagnosis of fetal HCM in the context of prenatal counseling.","For pregnant women with HCM, fetal echocardiography can be contemplated to diagnose fetal HCM during prenatal counseling."
id_02604,"In patients with (a) lobar spontaneous ICH and age <70 years, (b) deep/posterior fossa ICH and age <45 years, or (c) deep/posterior fossa and age 45 to 70 years without history of hypertension and negative noninvasive imaging (CTA±venography and MRI/MRA), catheter intra-arterial DSA is reasonable to exclude a macrovascular cause.117,118,120–122","For patients with (a) lobar spontaneous intracerebral hemorrhage (ICH) under 70 years old, (b) deep or posterior fossa ICH under 45 years old, or (c) deep or posterior fossa ICH aged 45 to 70 years without a history of hypertension and negative results on noninvasive imaging (CTA±venography and MRI/MRA), it is reasonable to use catheter intra-arterial digital subtraction angiography (DSA) to rule out a macrovascular cause."
id_01644,"In patients hospitalized for HF, a predischarge BNP or NT-proBNP level can be useful to inform the trajectory of the patient and estab- lish a postdischarge prognosis.14,17,20–29","For patients admitted with heart failure, measuring BNP or NT-proBNP levels before discharge can help assess the patient's progress and predict their prognosis after leaving the hospital."
id_02605,"In patients with spontaneous ICH with a negative CTA/venography, it is reasonable to perform MRI and MRA to establish a nonmac- rovascular cause of ICH (such as CAA, deep perforating vasculopathy, cavernous malforma- tion, or malignancy).118,123,124","For patients experiencing spontaneous intracerebral hemorrhage with a negative CTA or venography, conducting an MRI and MRA is advisable to identify a non-macrovascular cause of the hemorrhage, such as cerebral amyloid angiopathy, deep perforating vasculopathy, cavernous malformation, or malignancy."
id_00206,"In patients with SIHD, normal ejection frac- tion, significant stenosis in 3 major coronary arteries (with or without proximal LAD), and anatomy suitable for PCI, the usefulness of PCI to improve survival is uncertain.14-24 Stenosis in the proximal LAD artery","For patients with SIHD, normal ejection fraction, and significant stenosis in three major coronary arteries (including or excluding the proximal LAD), where the anatomy is appropriate for PCI, the benefit of PCI in enhancing survival remains unclear."
id_01646,"In select patients with nonischemic cardio- myopathy, referral for genetic counseling and testing is reasonable to identify conditions that could guide treatment for patients and family members.3,4","For certain individuals with nonischemic cardiomyopathy, it is advisable to consider genetic counseling and testing to detect conditions that may inform treatment strategies for both the patients and their relatives."
id_01166,"For patients with AF, recommending caffeine abstention to prevent AF episodes is of no benefit, although it may reduce symptoms in patients who report caffeine triggers or worsens AF symptoms.1–9","Advising patients with AF to avoid caffeine does not prevent AF episodes, but it may alleviate symptoms in those who experience caffeine as a trigger or find it exacerbates their AF symptoms."
id_02606,"In patients with spontaneous ICH who undergo CT or MRI at admission, CTA plus consideration of venography or MRA plus con- sideration of venography performed acutely can be useful to exclude macrovascular causes or cerebral venous thrombosis.118","For patients with spontaneous ICH who receive a CT or MRI upon admission, performing a CTA with possible venography or an MRA with potential venography acutely can be beneficial to rule out macrovascular causes or cerebral venous thrombosis."
id_00207,"In patients with SIHD, normal left ventricular ejection fraction, and significant stenosis in the proximal LAD, the usefulness of coronary revascularization to improve survival is uncer- tain.10,14,17,24-27 Single- or double-vessel disease not involving the proximal LAD","For patients with stable ischemic heart disease, normal left ventricular ejection fraction, and significant narrowing in the proximal left anterior descending artery, the benefit of coronary revascularization for enhancing survival is unclear."
id_01167,"For patients with AF and hypertension, optimal BP control is recommended to reduce AF recurrence and AF-related cardiovascular events.1–7",It is advised that patients with atrial fibrillation and hypertension maintain optimal blood pressure control to decrease the recurrence of atrial fibrillation and related cardiovascular events.
id_02126,"Patients with IE should be evaluated and managed with consultation with a multispecialty Heart Valve Team, which includes an infectious disease specialist, cardiologist, and cardiac surgeon; a cardiac anesthesiologist for surgically managed patients11; and a neurologist for patients with neurological events.11–13","Patients with infective endocarditis should be assessed and treated in collaboration with a multidisciplinary Heart Valve Team, comprising an infectious disease expert, a cardiologist, and a cardiac surgeon. For those undergoing surgery, a cardiac anesthesiologist should be involved, and a neurologist should be consulted for patients experiencing neurological events."
id_02127,"In patients with suspected IE, TTE is recommended to identify vegetations, characterize the hemodynamic severity of valvular lesions, assess ventricular function and pulmonary pressures, and detect complications.14–23","For patients with suspected infective endocarditis, it is advised to use transthoracic echocardiography to detect vegetations, evaluate the hemodynamic severity of valve lesions, assess ventricular function and pulmonary pressures, and identify any complications."
id_01647,"In patients with suspected or new-onset HF, or those presenting with acute decompensated HF, a chest x-ray should be performed to assess heart size and pulmonary congestion and to detect alternative cardiac, pulmonary, and other diseases that may cause or contrib- ute to the patient’s symptoms.1,2","For patients with suspected or newly diagnosed heart failure, or those experiencing acute decompensated heart failure, a chest x-ray is recommended to evaluate heart size, check for pulmonary congestion, and identify other cardiac, pulmonary, or additional conditions that might be causing or contributing to the symptoms."
id_00687,"In patients with HCM, adherence to the ACC/AHA primary prevention guideline is recommended to reduce risk of cardiovascular events.1","For patients with HCM, following the ACC/AHA primary prevention guideline is advised to lower the risk of cardiovascular events."
id_00688,"In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are recommended for achieving and maintaining weight loss1 and possibly lowering the risk of developing LVOTO, HF, and AF.2–4","For patients with HCM who are overweight or obese, it is advised to provide counseling and implement comprehensive lifestyle changes to achieve and sustain weight loss, which may help reduce the risk of LVOTO, HF, and AF."
id_00208,"In patients with SIHD, normal left ventricular ejection fraction, and 1- or 2-vessel CAD not involving the proximal LAD, coronary revas- cularization is not recommended to improve survival.10,14,16,26,28,29","For patients with stable ischemic heart disease, normal left ventricular ejection fraction, and 1- or 2-vessel coronary artery disease excluding the proximal left anterior descending artery, coronary revascularization is not advised for enhancing survival."
id_02607,"In patients with spontaneous ICH and a nega- tive catheter intra-arterial DSA and no clear microvascular diagnosis or other defined structural lesion, it may be reasonable to per- form a repeat catheter intra-arterial DSA 3 to 6 months after ICH onset to identify a previ- ously obscured vascular lesion.125","For patients with spontaneous intracerebral hemorrhage (ICH) who have a negative catheter intra-arterial digital subtraction angiography (DSA) and lack a clear microvascular diagnosis or identifiable structural lesion, it might be advisable to conduct a follow-up catheter intra-arterial DSA 3 to 6 months after the ICH onset to detect any vascular lesion that was initially hidden."
id_01648,"In patients with suspected or newly diag- nosed HF, transthoracic echocardiography (TTE) should be performed during initial evaluation to assess cardiac structure and function.3","For patients with suspected or newly diagnosed heart failure, an initial evaluation should include transthoracic echocardiography to evaluate cardiac structure and function."
id_02128,"In all patients with known or suspected IE and nondiagnostic TTE results, when complications have developed or are clinically suspected or when intracardiac device leads are present, TEE is recommended.21,23–40","For patients with confirmed or suspected IE who have nondiagnostic TTE results, TEE is advised if complications have arisen or are clinically suspected, or if intracardiac device leads are present."
id_01168,"Among patients with AF, it may be reasonable to screen for obstructive sleep apnea, given its high prevalence in patients with AF, although the role of treatment of sleep-disordered breathing (SDB) to maintain sinus rhythm is uncertain.1–13","For patients with atrial fibrillation, screening for obstructive sleep apnea could be considered due to its common occurrence in these individuals, despite the unclear impact of treating sleep-disordered breathing on maintaining sinus rhythm."
id_02608,"In patients with spontaneous ICH requiring acute BP lowering, careful titration to ensure continuous smooth and sustained control of BP, avoiding peaks and large variability in SBP, can be beneficial for improving functional out- comes.138","For patients with spontaneous intracerebral hemorrhage needing rapid blood pressure reduction, it is advantageous to meticulously adjust treatment to maintain consistent and stable blood pressure control, preventing spikes and significant fluctuations in systolic blood pressure, to enhance functional outcomes."
id_00209,"In patients with SIHD who have ≥1 coronary arteries that are not anatomically or function- ally significant (<70% diameter of non–left main coronary artery stenosis, FFR >0.80), coronary revascularization should not be performed with the primary or sole intent to improve survival.26,30 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with SIHD who have one or more coronary arteries that are neither anatomically nor functionally significant (less than 70% stenosis in non-left main coronary arteries, FFR greater than 0.80), coronary revascularization should not be conducted with the primary or sole purpose of enhancing survival."
id_00689,"In patients with HCM and hypertension, lifestyle modifications and medical therapy for hypertension are recommended,1 with preference for beta blockers and nondihydropyridine calcium channel blockers in patients with obstructive HCM.","For patients with HCM and high blood pressure, it is advised to implement lifestyle changes and antihypertensive treatment, prioritizing beta blockers and nondihydropyridine calcium channel blockers for those with obstructive HCM."
id_01649,"In patients with HF who have had a significant clinical change, or who have received GDMT and are being considered for invasive procedures or device therapy, repeat measurement of EF, degree of structural remodeling, and valvular function are useful to inform therapeutic interven- tions.4–7","For patients with heart failure who have experienced a notable clinical change or have been on guideline-directed medical therapy and are candidates for invasive procedures or device therapy, reassessing ejection fraction, structural remodeling extent, and valvular function is beneficial for guiding treatment decisions."
id_00690,"In patients with HCM, assessment for symptoms of sleep-disordered breathing is recommended, and, if present, referral to a sleep medicine specialist for evaluation and treatment is recommended.5–8","For patients with HCM, it is advised to evaluate for symptoms of sleep-disordered breathing, and if symptoms are detected, a referral to a sleep medicine specialist for further evaluation and treatment is advised."
id_00210,"In patients with SIHD and multivessel CAD appropriate for either CABG or PCI, revas- cularization is reasonable to lower the risk of cardiovascular events such as spontaneous MI, unplanned urgent revascularizations, or cardiac death.1-8","For patients with SIHD and multivessel CAD who are suitable candidates for CABG or PCI, revascularization is advisable to reduce the likelihood of cardiovascular events, including spontaneous MI, unplanned urgent revascularizations, or cardiac death."
id_02129,"In patients with IE who have a change in clinical signs or symptoms (eg, new murmur, embolism, persistent fever, HF, abscess, or atrioventricular heart block) and in patients at high risk of complications (eg, extensive infected tissue, large vegetation on initial echocardiogram, or staphylococcal, enterococcal, or fungal infections), TTE and/or TEE are recommended for reevaluation.24,31,41–46","For patients with infective endocarditis (IE) experiencing altered clinical signs or symptoms, such as a new murmur, embolism, ongoing fever, heart failure, abscess, or atrioventricular heart block, as well as those at high risk for complications, including extensive infected tissue, large vegetation on the initial echocardiogram, or infections caused by staphylococci, enterococci, or fungi, reevaluation with TTE and/or TEE is advised."
id_01169,"Patients with AF should receive comprehensive care addressing guideline-directed LRFM, AF symptoms, risk of stroke, and other associated medical conditions to reduce AF burden, progression, or consequences.1–3","Patients with atrial fibrillation should be provided with thorough care that targets guideline-recommended lifestyle and risk factor management, addresses AF symptoms, mitigates stroke risk, and treats other related medical issues to lessen the burden, progression, or impact of AF."
id_02609,"In patients with spontaneous ICH in whom acute BP lowering is considered, initiating treatment within 2 hours of ICH onset and reaching target within 1 hour can be beneficial to reduce the risk of HE and improve func- tional outcome.139,140 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing spontaneous ICH, starting blood pressure reduction within 2 hours of onset and achieving the target within 1 hour may help decrease the risk of HE and enhance functional outcomes."
id_00211,"In patients with refractory angina despite medical therapy and with significant coronary artery stenoses amenable to revascularization, revascularization is recommended to improve symptoms.1-6","For patients experiencing refractory angina that persists despite medical treatment and who have significant coronary artery stenoses suitable for revascularization, revascularization is advised to alleviate symptoms."
id_01650,"In patients for whom echocardiography is inadequate, alternative imaging (eg, cardiac magnetic resonance [CMR], cardiac computed tomography [CT], radionuclide imaging) is rec- ommended for assessment of LVEF.8–15","For patients where echocardiography is insufficient, it is advised to use alternative imaging methods such as cardiac magnetic resonance (CMR), cardiac computed tomography (CT), or radionuclide imaging to evaluate LVEF."
id_01171,"Patients with AF should be evaluated for their annual risk of thromboembolic events using a validated clinical risk score, such as CHA2DS2-VASc.1–4",Patients with atrial fibrillation should have their yearly risk of thromboembolic events assessed using a validated clinical risk score like CHA2DS2-VASc.
id_02610,"In patients with spontaneous ICH of mild to moderate severity presenting with SBP between 150 and 220 mm Hg, acute lower- ing of SBP to a target of 140 mm Hg with the goal of maintaining in the range of 130 to 150 mm Hg is safe and may be reasonable for improving functional outcomes.138,141–147","For patients experiencing spontaneous intracerebral hemorrhage of mild to moderate severity with systolic blood pressure between 150 and 220 mm Hg, it is safe and potentially beneficial for functional outcomes to acutely reduce SBP to a target of 140 mm Hg, aiming to maintain it between 130 and 150 mm Hg."
id_01651,"In patients with HF or cardiomyopathy, CMR can be useful for diagnosis or manage- ment.16–23","For individuals with heart failure or cardiomyopathy, cardiac magnetic resonance imaging may aid in diagnosis or management."
id_02131,"In patients being considered for an early change to oral antibiotic therapy for the treatment of stable IE, a baseline TEE before switching to oral therapy and a repeat TEE","For patients evaluated for an early transition to oral antibiotics for stable IE treatment, perform a baseline TEE before the switch and repeat the TEE."
id_02130,"In patients undergoing valve surgery for IE, intraoperative TEE is recommended.47–50","For patients having valve surgery due to IE, it is advised to use intraoperative TEE."
id_00212,"In patients with angina but no anatomic or physiological criteria for revascularization, nei- ther CABG nor PCI should be performed.7,8","For patients with angina who lack anatomical or physiological indications for revascularization, both CABG and PCI are not recommended."
id_01170,"In patients with AF, use of clinical care pathways, such as nurse-led AF clinics, is reasonable to promote comprehensive, team-based care and to enhance adherence to evidence-based therapies for AF and associated conditions.4–6","For patients with AF, implementing clinical care pathways like nurse-led AF clinics is advisable to support thorough, team-oriented care and improve adherence to evidence-based treatments for AF and related conditions."
id_01172,"Patients with AF should be evaluated for factors that specifically indicate a higher risk of bleeding, such as previous bleeding and use of drugs that increase bleeding risk, in order to identify possible interven- tions to prevent bleeding on anticoagulation.5–7","Patients with AF need assessment for factors that elevate bleeding risk, like past bleeding incidents and medications that heighten bleeding risk, to identify potential interventions to prevent bleeding while on anticoagulation."
id_02611,"In patients with spontaneous ICH presenting with large or severe ICH or those requir- ing surgical decompression, the safety and efficacy of intensive BP lowering are not well established.148","For patients with spontaneous ICH who have large or severe hemorrhages or need surgical decompression, the safety and effectiveness of aggressive BP reduction remain uncertain."
id_01652,"In patients with HF, an evaluation for possible ischemic heart disease can be useful to identify the cause and guide management.24–27","For patients with heart failure, assessing for potential ischemic heart disease can be beneficial in determining the cause and directing treatment."
id_02612,"In patients with spontaneous ICH of mild to moderate severity presenting with SBP >150 mm Hg, acute lowering of SBP to <130 mm Hg is potentially harmful.146,149,150","For patients experiencing spontaneous ICH of mild to moderate severity with an SBP exceeding 150 mm Hg, rapidly reducing SBP to below 130 mm Hg may be detrimental."
id_00213,"In patients who require revascularization for significant left main CAD with high-complexity CAD, it is recommended to choose CABG over PCI to improve survival.1,2","For patients needing revascularization due to significant left main coronary artery disease with highly complex CAD, CABG is advised over PCI to enhance survival."
id_02132,"In patients with Staphylococcus aureus bacteremia without a known source, TEE is reasonable to diagnose possible IE.11,36,52–56","For patients with Staphylococcus aureus bacteremia of unknown origin, performing a TEE is advisable to identify potential IE."
id_01653,"In patients with HF and coronary artery disease (CAD) who are candidates for coronary revas- cularization, noninvasive stress imaging (stress echocardiography, single-photon emission CT [SPECT], CMR, or positron emission tomog- raphy [PET]) may be considered for detection of myocardial ischemia to help guide coronary revascularization.28–32","For patients with heart failure (HF) and coronary artery disease (CAD) who are eligible for coronary revascularization, noninvasive stress imaging techniques such as stress echocardiography, single-photon emission computed tomography (SPECT), cardiovascular magnetic resonance (CMR), or positron emission tomography (PET) can be considered to identify myocardial ischemia and assist in guiding coronary revascularization decisions."
id_02133,"In patients with a prosthetic valve in the presence of persistent fever without bacteremia or a new murmur, a TEE is reasonable to aid in the diagnosis of IE.57–60","For patients with a prosthetic valve experiencing ongoing fever without bacteremia or a new heart murmur, it is reasonable to perform a TEE to assist in diagnosing IE."
id_02613,"In patients with anticoagulant-associated spontaneous ICH, anticoagulation should be discontinued immediately and rapid reversal of anticoagulation should be performed as soon as possible after diagnosis of spontaneous ICH to improve survival.162 VKAs","For patients experiencing anticoagulant-related spontaneous intracerebral hemorrhage (ICH), anticoagulation must be stopped right away, and anticoagulation reversal should be conducted promptly after diagnosing spontaneous ICH to enhance survival."
id_01173,"Patients with AF at intermediate annual risk of thromboembolic events by risk scores (eg, equiva- lent to CHA2DS2-VASc score of 1 in men or 2 in women), who remain uncertain about the benefit of anticoagulation, can benefit from consideration of factors that might modify their risk of stroke to help inform the decision.*","Patients with AF who have an intermediate yearly risk of thromboembolic events, as indicated by risk scores (such as a CHA2DS2-VASc score of 1 for men or 2 for women), and are unsure about the advantages of anticoagulation, may find it helpful to evaluate additional factors that could alter their stroke risk to aid in decision-making."
id_02134,"In patients in whom the anatomy cannot be clearly delineated by echocardiography in the setting of suspected paravalvular infections, CT imaging is reasonable.37,61–68","For patients where echocardiography fails to clearly define the anatomy in suspected paravalvular infections, CT imaging is a reasonable option."
id_01174,"In patients who are deemed at high risk for stroke, bleeding risk scores should not be used in isolation to determine eligibility for oral anticoagulation but instead to identify and modify bleeding risk factors and to inform medical decision-making.8–10 *Factors may include AF burden or other features in Table 3.","For patients considered at high risk for stroke, bleeding risk scores should not solely dictate the eligibility for oral anticoagulation. Instead, they should be used to identify and adjust bleeding risk factors and guide clinical decisions, potentially considering factors like AF burden or other characteristics listed in Table 3."
id_00215,"In patients with diabetes and multivessel CAD with the involvement of the LAD, who are appropriate candidates for CABG, CABG (with a LIMA to the LAD) is recommended in pref- erence to PCI to reduce mortality and repeat revascularizations.1-8","For patients with diabetes and multivessel coronary artery disease involving the left anterior descending artery, who are suitable for coronary artery bypass grafting, it is advised to opt for CABG (using a left internal mammary artery graft to the LAD) over percutaneous coronary intervention to lower mortality and the need for repeat revascularizations."
id_00214,"In patients who require revascularization for multivessel CAD with complex or diffuse CAD (eg, SYNTAX score >33), it is reasonable to choose CABG over PCI to confer a survival advantage.2-5","For patients needing revascularization due to multivessel coronary artery disease with complex or widespread CAD (such as a SYNTAX score above 33), opting for CABG instead of PCI is advisable to enhance survival."
id_01654,"In patients with HF in the absence of: 1) clinical status change, 2) treatment interventions that might have had a significant effect on cardiac function, or 3) candidacy for invasive proce- dures or device therapy, routine repeat assess- ment of LV function is not indicated.","For patients with heart failure, routine reassessment of left ventricular function is not warranted unless there is a change in clinical status, recent treatment interventions that could significantly impact cardiac function, or consideration for invasive procedures or device therapy."
id_02614,"In patients with VKA-associated spontaneous ICH and INR ≥2.0, 4-factor (4-F) prothrombin complex concentrate (PCC) is recommended in preference to fresh-frozen plasma (FFP) to achieve rapid correction of INR and limit HE.163","For patients experiencing VKA-related spontaneous ICH with an INR of 2.0 or higher, it is advised to use 4-factor prothrombin complex concentrate (PCC) over fresh-frozen plasma (FFP) to quickly correct INR and reduce HE."
id_01655,"In patients with HF, endomyocardial biopsy may be useful when a specific diagnosis is sus- pected that would influence therapy.1,2","For patients with heart failure, an endomyocardial biopsy can be beneficial if a particular diagnosis is suspected that could alter treatment."
id_00216,"In patients with diabetes who have multivessel CAD amenable to PCI and an indication for revascularization and are poor candidates for surgery, PCI can be useful to reduce long-term ischemic outcomes.9,10","For diabetic patients with multivessel coronary artery disease who are suitable for PCI, require revascularization, and are not ideal surgical candidates, PCI may effectively lower long-term ischemic risks."
id_01175,"In patients diagnosed with AF who have an estimated annual risk of stroke or thromboembolic events ≥2%, selection of therapy to reduce the risk of stroke should be based on the risk of thromboembolism, regardless of whether the AF pattern is paroxysmal, persistent, long-standing persistent, or permanent.1–3","For patients with AF and an estimated annual stroke or thromboembolic event risk of 2% or higher, therapy to lower stroke risk should be chosen based on thromboembolism risk, irrespective of whether the AF is paroxysmal, persistent, long-standing persistent, or permanent."
id_02615,"In patients with VKA-associated spontaneous ICH, intravenous vitamin K should be adminis- tered directly after coagulation factor replace- ment (PCC or other) to prevent later increase in INR and subsequent HE.164,165","For patients experiencing spontaneous ICH linked to VKA, intravenous vitamin K should be given immediately following coagulation factor replacement (such as PCC or alternatives) to avert a later rise in INR and subsequent HE."
id_02135,"In patients classified by Modified Duke Criteria as having “possible IE,” 18F-fluorodeoxyglucose PET/CT is reasonable as adjunct diagnostic imaging.69–71","For patients identified as ""possible IE"" according to the Modified Duke Criteria, using 18F-fluorodeoxyglucose PET/CT as supplementary diagnostic imaging is considered appropriate."
id_02136,"In patients with nosocomial S. aureus bacteremia with a known portal of entry from an extracardiac source, TEE might be considered to detect concomitant staphylococcal IE.22,53,54,72–74","For patients with hospital-acquired S. aureus bacteremia originating from a non-cardiac source, TEE may be considered to identify concurrent staphylococcal infective endocarditis."
id_01176,"In patients with AF at risk for stroke, reevaluation of the need for and choice of stroke risk reduction therapy at periodic intervals is recommended to reassess stroke and bleeding risk, net clinical benefit, and proper dosing.4,5","For patients with AF who are at risk of stroke, it is advised to periodically reassess the necessity and selection of stroke risk reduction therapy to evaluate stroke and bleeding risk, overall clinical benefit, and appropriate dosing."
id_02616,"In patients with VKA-associated spontaneous ICH with INR of 1.3 to 1.9, it may be reason- able to use PCC to achieve rapid correction of INR and limit HE.162,164 DOACs","For patients experiencing VKA-related spontaneous ICH with an INR between 1.3 and 1.9, using PCC to quickly correct the INR and reduce HE may be appropriate."
id_00217,"In patients with diabetes who have left main stenosis and low- or intermediate-complexity CAD in the rest of the coronary anatomy, PCI may be considered an alternative to CABG to reduce major adverse cardiovascular out- comes.5,11","For diabetic patients with left main stenosis and low- or intermediate-complexity coronary artery disease elsewhere, PCI can be an alternative to CABG to lower the risk of major adverse cardiovascular events."
id_01656,"In selected patients with HF with persistent or worsening symptoms, signs, diagnostic param- eters, and in whom hemodynamics are uncer- tain, invasive hemodynamic monitoring can be useful to guide management.","For certain patients with heart failure who continue to experience or have worsening symptoms, signs, and diagnostic indicators, and where hemodynamic status is unclear, invasive hemodynamic monitoring may be beneficial for guiding treatment."
id_01657,"In patients with HF, routine use of invasive hemodynamic monitoring is not recom- mended.3,4","For patients with heart failure, invasive hemodynamic monitoring should not be routinely employed."
id_02617,"In patients with direct factor Xa inhibitor–asso- ciated spontaneous ICH, andexanet alfa is reasonable to reverse the anticoagulant effect of factor Xa inhibitors.166,167","For patients experiencing spontaneous intracerebral hemorrhage linked to direct factor Xa inhibitors, using andexanet alfa to counteract the anticoagulant effects of these inhibitors is a reasonable option."
id_02137,"In patients with IE, appropriate antibiotic therapy should be initiated and continued after blood cultures are obtained, with guidance from antibiotic sensitivity data and the infectious disease experts on the MDT.1–7","For patients with IE, start and maintain suitable antibiotic treatment following blood culture collection, using antibiotic sensitivity results and advice from infectious disease specialists on the MDT."
id_01177,"For patients with AF and an estimated annual thromboembolic risk of ≥2% per year (eg, CHA2DS2-VASc score of ≥2 in men and ≥3 in women), anticoagulation is recommended to prevent stroke and systemic thromboembolism.1–7","Anticoagulation is advised for patients with atrial fibrillation who have an estimated annual thromboembolic risk of 2% or higher, such as those with a CHA2DS2-VASc score of 2 or more in men and 3 or more in women, to prevent stroke and systemic thromboembolism."
id_02138,Patients with suspected or confirmed IE associated with drug use should be referred to addiction treatment for opioid substitution therapy.8–10,Patients with suspected or confirmed infective endocarditis linked to drug use should be directed to addiction treatment for opioid replacement therapy.
id_01658,"For patients undergoing routine evaluation of HF, endomyocardial biopsy should not be per- formed because of the risk of complications.5,6",Endomyocardial biopsy should be avoided in patients undergoing standard HF evaluation due to the potential for complications.
id_01178,"In patients with AF who do not have a history of moderate to severe rheumatic mitral stenosis or a mechanical heart valve, and who are candidates for anticoagulation, DOACs are recommended over warfarin to reduce the risk of mortality, stroke, systemic embolism, and ICH.1–7","For patients with atrial fibrillation who are eligible for anticoagulation and do not have moderate to severe rheumatic mitral stenosis or a mechanical heart valve, direct oral anticoagulants (DOACs) are preferred over warfarin to lower the risk of death, stroke, systemic embolism, and intracranial hemorrhage."
id_02618,"In patients with dabigatran-associated spon- taneous ICH, idarucizumab is reasonable to reverse the anticoagulant effect of dabiga- tran.168","For patients experiencing spontaneous intracerebral hemorrhage linked to dabigatran, using idarucizumab to counteract dabigatran's anticoagulant effect is advisable."
id_00219,"In patients with previous CABG and refractory angina on GDMT that is attributable to LAD disease, it is reasonable to choose CABG over PCI when an internal mammary artery (IMA) can be used as a conduit to the LAD.3,4","For patients with prior CABG and persistent angina despite GDMT due to LAD disease, opting for CABG instead of PCI is advisable if an internal mammary artery can be utilized as a conduit to the LAD."
id_02139,"In patients with IE and with evidence of cerebral embolism or stroke, regardless of the other indications for anticoagulation, it is reasonable to temporarily discontinue anticoagulation.11–24","For patients with IE who show signs of cerebral embolism or stroke, it is advisable to pause anticoagulation therapy temporarily, irrespective of any other reasons for its use."
id_01179,"For patients with AF and an estimated annual thromboembolic risk of ≥1% but <2% per year (equivalent to CHA2DS2-VASc score of 1 in men and 2 in women), anticoagulation is reasonable to prevent stroke and systemic thromboembolism.1,3","For patients with atrial fibrillation and an estimated annual thromboembolic risk between 1% and 2% (corresponding to a CHA2DS2-VASc score of 1 for men and 2 for women), it is reasonable to use anticoagulation to prevent stroke and systemic thromboembolism."
id_00220,"In patients with previous CABG and complex CAD, it may be reasonable to choose CABG over PCI when an IMA can be used as a con- duit to the LAD.3,4","For patients with a history of CABG and complex CAD, opting for CABG instead of PCI might be advisable if an IMA can serve as a conduit to the LAD."
id_00218,"In patients with previous CABG with a patent LIMA to the LAD who need repeat revascu- larization, if PCI is feasible, it is reasonable to choose PCI over CABG.1,2","For patients with a prior CABG and a functioning LIMA to the LAD requiring additional revascularization, opting for PCI over CABG is advisable if PCI is a viable option."
id_02619,"In patients with direct factor Xa inhibitor– associated spontaneous ICH, a 4-F PCC or activated PCC (aPCC) may be considered to improve hemostasis.169–171","For patients experiencing spontaneous intracerebral hemorrhage linked to direct factor Xa inhibitors, considering the use of a 4-factor prothrombin complex concentrate or activated prothrombin complex concentrate may enhance hemostasis."
id_01660,"In patients with HF, assessment and documen- tation of NYHA functional classification are recommended to determine eligibility for treat- ments.1–3","For patients with heart failure, it is advised to evaluate and record the NYHA functional classification to establish treatment eligibility."
id_01659,"In selected adult patients with NYHA class III HF and history of a HF hospitalization in the past year or elevated natriuretic peptide levels, on maximally tolerated stable doses of GDMT with optimal device therapy, the use- fulness of wireless monitoring of PA pressure by an implanted hemodynamic monitor to reduce the risk of subsequent HF hospitaliza- tions is uncertain.1–4 Value Statement: Uncertain Value (B-NR)","For certain adult patients with NYHA class III heart failure who have either been hospitalized for heart failure in the past year or have high natriuretic peptide levels, and are on the highest tolerable stable doses of guideline-directed medical therapy with optimal device therapy, the benefit of using an implanted hemodynamic monitor for wireless pulmonary artery pressure monitoring to lower the risk of future heart failure hospitalizations remains unclear."
id_01180,"In patients with AF without risk factors for stroke, aspirin monotherapy for prevention of thromboem- bolic events is of no benefit.10,11","For patients with atrial fibrillation who have no stroke risk factors, using aspirin alone does not help prevent thromboembolic events."
id_02620,"In patients with dabigatran- or factor Xa inhibi- tor–associated spontaneous ICH, when the DOAC agent was taken within the previous few hours, activated charcoal may be reason- able to prevent absorption of the DOAC.172–174","For patients experiencing spontaneous intracerebral hemorrhage linked to dabigatran or factor Xa inhibitors, administering activated charcoal might be appropriate to inhibit DOAC absorption if the medication was ingested in the last few hours."
id_01661,"In selected ambulatory patients with HF, cardiopulmonary exercise testing (CPET) is recommended to determine appropriateness of advanced treatments (eg, LVAD, heart transplant).4–8","For certain ambulatory patients with heart failure, it is advised to use cardiopulmonary exercise testing (CPET) to assess the suitability for advanced therapies such as LVAD or heart transplantation."
id_00221,"In patients with multivessel CAD amenable to treatment with either PCI or CABG who are unable to access, tolerate, or adhere to DAPT for the appropriate duration of treatment, CABG is reasonable in preference to PCI.1-10","For patients with multivessel CAD who can be treated with either PCI or CABG but cannot access, tolerate, or adhere to DAPT for the necessary treatment duration, opting for CABG over PCI is advisable."
id_01181,"For patients with AF receiving DOACs, optimal man- agement of drug interactions is recommended for those receiving concomitant therapy with interacting drugs, especially CYP3A4 and/or p-glycoprotein inhibitors or inducers (Table 13).1–7","For patients with AF on DOACs, it is advised to carefully manage drug interactions, particularly when they are also taking drugs that interact, such as CYP3A4 and/or p-glycoprotein inhibitors or inducers."
id_02140,"In patients with left-sided IE caused by streptococcus, Enterococcus faecalis, S. aureus, or coagulase-negative staphylococci deemed stable by the MDT after initial intravenous antibiotics, a change to oral antibiotic therapy may be considered if TEE before the switch to oral therapy shows no paravalvular infection, if frequent and appropriate follow-up can be assured by the care team, and if a follow-up TEE can be performed 1 to 3 days before the completion of the antibiotic course.25","For patients with left-sided IE due to streptococcus, Enterococcus faecalis, S. aureus, or coagulase-negative staphylococci who are considered stable by the MDT after initial IV antibiotics, transitioning to oral antibiotics may be an option if a TEE prior to the switch confirms the absence of paravalvular infection, frequent and proper follow-up by the care team is ensured, and a follow-up TEE is conducted 1 to 3 days before completing the antibiotic regimen."
id_01662,"In ambulatory patients with HF, performing a CPET or 6-minute walk test is reasonable to assess functional capacity.4,5,9–16","For ambulatory patients with heart failure, it is reasonable to evaluate functional capacity using a CPET or a 6-minute walk test."
id_02141,"In patients receiving VKA anticoagulation at the time of IE diagnosis, temporary discontinuation of VKA anticoagulation may be considered.13,26–34","For patients on VKA anticoagulation when diagnosed with IE, it may be advisable to temporarily pause VKA anticoagulation."
id_00222,"In pregnant patients with STEMI not caused by spontaneous coronary artery dissection (SCAD), it is reasonable to perform primary PCI as the preferred revascularization strategy.1,2","For pregnant patients experiencing STEMI not due to SCAD, primary PCI is a suitable choice for revascularization."
id_01182,"For patients with AF receiving warfarin,* a target INR between 2 and 3 is recommended, as well as optimal management of drug-drug interactions, consistency in vitamin K dietary intake, and routine INR monitoring to improve time in therapeutic range and to minimize risks of preventable thromboembolism or major bleed- ing.8–10","For patients with atrial fibrillation on warfarin, it is advised to maintain an INR target of 2 to 3, ensure effective management of drug interactions, maintain consistent vitamin K intake, and regularly monitor INR to enhance time within the therapeutic range and reduce the risk of preventable thromboembolism or significant bleeding."
id_02621,"In patients with dabigatran-associated sponta- neous ICH, when idarucizumab is not available, aPCC or PCCs may be considered to improve hemostasis.175,176","For patients experiencing spontaneous intracerebral hemorrhage linked to dabigatran, if idarucizumab is unavailable, aPCC or PCCs can be considered to enhance hemostasis."
id_02142,"Patients with known VHD should not receive antibiotics before blood cultures are obtained for unexplained fever.22,35,36",Patients diagnosed with VHD should avoid taking antibiotics prior to obtaining blood cultures for an unexplained fever.
id_02622,"In patients with dabigatran-associated spontaneous ICH, when idarucizumab is not available, renal replacement therapy (RRT) may be considered to reduce dabigatran concentration.177 Heparins","For patients experiencing spontaneous intracerebral hemorrhage linked to dabigatran, if idarucizumab is unavailable, renal replacement therapy can be considered to lower dabigatran levels."
id_02143,Decisions about the timing of surgical intervention for IE should be made by a Heart Valve Team.1–6,The timing for surgical intervention in IE should be determined by a Heart Valve Team.
id_00223,"In pregnant patients with NSTE-ACS, an inva- sive strategy is reasonable if medical therapy is ineffective for the management of life- threatening complications.1,2","For pregnant patients experiencing NSTE-ACS, pursuing an invasive approach is appropriate when medical treatment fails to manage life-threatening complications."
id_01183,"In patients with stroke or TIA of undetermined cause, initial cardiac monitoring and, if needed, extended monitoring with an implantable loop recorder are reasonable to improve detection of AF.1 Table 13.  Continued Class VKA Direct Thrombin Inhibitor Factor Xa Inhibitor Name Warfarin Dabigatran Rivaroxaban Apixaban Edoxaban Appropriate use based on liver function (Child-Pugh score)† Child-Pugh A (mild) Not mentioned in the labeling No dose adjustment needed No dose adjustment needed No dose adjustment needed No dose adjustment needed Child-Pugh B (moderate) Use with caution Avoid use Use with caution Use with caution Child-Pugh C (severe) Avoid use Avoid use Avoid use Avoid use Information obtained from manufacturer package inserts.13,14,20–22 Adapted with permission from pgs. 28-31 of Kido et al.23 Copyright 2021 American College of","For patients experiencing a stroke or TIA with an unknown origin, it is advisable to begin with cardiac monitoring and, if necessary, proceed to extended monitoring using an implantable loop recorder to enhance the detection of AF."
id_00224,"In older adults, as in all patients, the treatment strategy for CAD should be based on an indi- vidual patient’s preferences, cognitive function, and life expectancy.1,2 Downloaded from http://ahajournals.org by on June 19, 2025","For older adults, similar to all patients, the approach to managing CAD should consider the individual's preferences, cognitive abilities, and anticipated lifespan."
id_02623,"In patients with unfractionated heparin (UFH)– associated spontaneous ICH, intravenous protamine is reasonable to reverse the antico- agulant effect of heparin.178","For patients experiencing spontaneous intracerebral hemorrhage (ICH) linked to unfractionated heparin (UFH), administering intravenous protamine is a reasonable approach to counteract the anticoagulant effects of heparin."
id_01184,"For patients with a device-detected atrial high-rate episode (AHRE) lasting ≥24 hours1 and with a CHA2DS2-VASc score ≥2 or equivalent stroke risk,2 it is reasonable to initiate oral anticoagulation3 within a SDM framework that considers episode duration and individual patient risk.","For patients experiencing a device-detected atrial high-rate episode (AHRE) lasting 24 hours or more, and having a CHA2DS2-VASc score of 2 or higher, or an equivalent stroke risk, it is appropriate to start oral anticoagulation within a shared decision-making framework that evaluates the episode's duration and the patient's individual risk."
id_01663,"In ambulatory patients with unexplained dys- pnea, CPET is reasonable to evaluate the cause of dyspnea.17,18","For outpatients experiencing unexplained shortness of breath, conducting a CPET is a sensible approach to determine the underlying cause."
id_01664,"In ambulatory or hospitalized patients with HF, validated multivariable risk scores can be useful to estimate subsequent risk of mortality.1–14","For patients with heart failure who are either outpatients or in the hospital, using validated multivariable risk scores can help predict future mortality risk."
id_02624,"In patients with low-molecular-weight heparin (LMWH)–associated spontaneous ICH, intrave- nous protamine may be considered to partially reverse the anticoagulant effect of heparin.178","For patients experiencing spontaneous intracerebral hemorrhage (ICH) linked to low-molecular-weight heparin (LMWH), intravenous protamine can be considered to partially counteract the anticoagulant effects of heparin."
id_00225,"In patients with CKD undergoing contrast media injection for coronary angiography, measures should be taken to minimize the risk of contrast-induced acute kidney injury (AKI).1-3","For patients with CKD receiving contrast media for coronary angiography, steps should be implemented to reduce the likelihood of contrast-induced acute kidney injury (AKI)."
id_02144,"In patients with IE who present with valve dysfunction resulting in symptoms of HF, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is indicated.7–19","For patients with IE experiencing valve dysfunction that leads to HF symptoms, it is recommended to perform early surgery during the initial hospital stay, prior to finishing the complete antibiotic treatment."
id_01665,"In patients with hypertension, blood pressure should be controlled in accordance with GDMT for hypertension to prevent symptomatic HF.1–9","For patients with hypertension, manage blood pressure following GDMT guidelines for hypertension to avert symptomatic heart failure."
id_01185,"For patients with a device-detected AHRE last- ing between 5 minutes and 24 hours and with a CHA2DS2-VASc score ≥3 or equivalent stroke risk,2 it may be reasonable to initiate anticoagulation within a SDM framework that considers episode duration and individual patient risk.","For patients experiencing a device-detected AHRE lasting from 5 minutes to 24 hours and having a CHA2DS2-VASc score of 3 or higher, or an equivalent stroke risk, it might be appropriate to start anticoagulation within a shared decision-making framework that evaluates the duration of the episode and the patient's individual risk."
id_00226,"In patients with STEMI and CKD, coronary angiography and revascularization are recom- mended, with adequate measures to reduce the risk of AKI.","For patients with STEMI and CKD, it is advised to perform coronary angiography and revascularization while implementing appropriate strategies to minimize the risk of AKI."
id_02625,"For patients with spontaneous ICH being treated with aspirin and who require emer- gency neurosurgery, platelet transfusion might be considered to reduce postoperative bleed- ing and mortality.206","In patients with spontaneous ICH on aspirin therapy who need urgent neurosurgery, platelet transfusion may be considered to decrease postoperative bleeding and mortality."
id_02145,"In patients with left-sided IE caused by S. aureus, a fungal organism, or other highly resistant organisms, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is indicated.7,9,15,20–35","For patients with left-sided infective endocarditis due to S. aureus, a fungal pathogen, or other highly resistant organisms, early surgical intervention is recommended during the initial hospital stay and prior to completing the full antibiotic treatment."
id_02626,"For patients with spontaneous ICH being treated with antiplatelet agents, the effective- ness of desmopressin with or without platelet transfusions to reduce the expansion of the hematoma is uncertain.207–209","The effectiveness of desmopressin, alone or combined with platelet transfusions, in preventing hematoma expansion in patients with spontaneous ICH on antiplatelet therapy remains uncertain."
id_01666,"In patients with type 2 diabetes and either established CVD or at high cardiovascular risk, SGLT2i should be used to prevent hospitaliza- tions for HF.10–12","For patients with type 2 diabetes who have established cardiovascular disease or are at high risk for cardiovascular issues, SGLT2 inhibitors should be utilized to prevent heart failure-related hospitalizations."
id_01186,"Patients with a device-detected AHRE lasting <5 minutes and without another indication for oral anticoagulation should not receive oral anticoagulation.4,5",Oral anticoagulation should not be administered to patients who have a device-detected AHRE lasting less than 5 minutes and no other reason for anticoagulation.
id_02146,"In patients with IE complicated by heart block, annular or aortic abscess, or destructive penetrating lesions, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is indicated.7,9,36–44","For patients with IE who develop heart block, annular or aortic abscess, or destructive penetrating lesions, it is recommended to perform early surgery during the initial hospital stay and prior to finishing a complete course of antibiotics."
id_01667,"In the general population, healthy lifestyle hab- its such as regular physical activity, maintaining normal weight, healthy dietary patterns, and avoiding smoking are helpful to reduce future risk of HF.13–21","For the general population, engaging in regular exercise, keeping a normal weight, following a healthy diet, and refraining from smoking can help lower the future risk of heart failure."
id_01187,"In patients with AF, a moderate to high risk of stroke (CHA2DS2-VASc score ≥2), and a contraindication (Table 14) to long-term oral anticoagulation due to a nonreversible cause, percutaneous LAAO (pLAAO) is reasonable.1–4","For patients with atrial fibrillation who have a moderate to high stroke risk (CHA2DS2-VASc score of 2 or more) and cannot undergo long-term oral anticoagulation due to an irreversible contraindication (refer to Table 14), considering percutaneous left atrial appendage occlusion (pLAAO) is appropriate."
id_02147,"In patients with IE and evidence of persistent infection as manifested by persistent bacteremia or fevers lasting >5 days after onset of appropriate antimicrobial therapy, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) for IE is indicated.7,9,15,25,26,45–48","For patients with IE who exhibit ongoing infection, such as persistent bacteremia or fevers persisting beyond 5 days after starting suitable antimicrobial treatment, early surgical intervention for IE is recommended during the initial hospital stay and prior to finishing the complete antibiotic course."
id_02627,"For patients with spontaneous ICH being treated with aspirin and not scheduled for emergency surgery, platelet transfusions are potentially harmful and should not be adminis- tered.210","In patients with spontaneous ICH who are on aspirin and not planned for urgent surgery, administering platelet transfusions may be detrimental and should be avoided."
id_00228,"In low-risk patients with NSTE-ACS and CKD, it is reasonable to weigh the risk of coronary angiography and revascularization against the potential benefit.","For low-risk patients with NSTE-ACS and CKD, it is advisable to consider the potential benefits of coronary angiography and revascularization in relation to their risks."
id_00227,"In high-risk patients with NSTE-ACS and CKD, it is reasonable to perform coronary angiography and revascularization, with ade- quate measures to reduce the risk of AKI.4,5","For patients at high risk with NSTE-ACS and CKD, conducting coronary angiography and revascularization is advisable, provided that appropriate precautions are taken to minimize the risk of AKI."
id_02628,"In patients with spontaneous ICH (with or without the spot sign), the effectiveness of recombinant factor VIIa to improve functional outcome is unclear.218,219","The impact of recombinant factor VIIa on enhancing functional outcomes in patients with spontaneous ICH, regardless of the presence of the spot sign, remains uncertain."
id_01668,"For patients at risk of developing HF, natriuretic peptide biomarker–based screening followed by team-based care, including a cardiovascular specialist optimizing GDMT, can be useful to prevent the development of LV dysfunction (systolic or diastolic) or new-onset HF.22,23","Screening patients at risk for heart failure using natriuretic peptide biomarkers, followed by collaborative care with a cardiovascular specialist to optimize guideline-directed medical therapy, may help prevent the onset of left ventricular dysfunction (either systolic or diastolic) or new heart failure."
id_02148,"In all patients with definite endocarditis and an implanted cardiac electronic device, complete removal of the pacemaker or defibrillator systems, including all leads and the generator, is indicated.49–55","For patients diagnosed with confirmed endocarditis who have a cardiac electronic device implanted, it is recommended to entirely extract the pacemaker or defibrillator systems, encompassing all leads and the generator."
id_01188,"In patients with AF and a moderate to high risk of stroke and a high risk of major bleeding on oral anti- coagulation, pLAAO may be a reasonable alternative to oral anticoagulation based on patient preference, with careful consideration of procedural risk and with the understanding that the evidence for oral antico- agulation is more extensive.1–3,5,6","For patients with atrial fibrillation who have a moderate to high stroke risk and a significant risk of major bleeding from oral anticoagulants, percutaneous left atrial appendage occlusion (pLAAO) can be considered as an alternative to oral anticoagulation, taking into account patient preference, the procedural risks, and acknowledging that there is more comprehensive evidence supporting oral anticoagulation."
id_00229,"In asymptomatic patients with stable CAD and CKD, routine angiography and revasculariza- tion are not recommended if there is no com- pelling indication.6","For asymptomatic individuals with stable coronary artery disease and chronic kidney disease, routine angiography and revascularization should be avoided unless there is a strong indication."
id_02149,"For patients with prosthetic valve endocarditis and relapsing infection (defined as recurrence of bacteremia after a complete course of appropriate antibiotics and subsequent negative blood culture results) without other identifiable source of infection, surgery is recommended.7","Surgery is advised for patients with prosthetic valve endocarditis experiencing recurrent infection, characterized by the return of bacteremia following a full course of suitable antibiotics and negative blood cultures, when no other infection source is identified."
id_01669,"In the general population, validated multivari- able risk scores can be useful to estimate sub- sequent risk of incident HF.24–26",Validated multivariable risk scores can be beneficial for predicting future risk of developing heart failure in the general population.
id_01190,"In patients with AF undergoing cardiac surgery and LAA exclusion, a surgical technique resulting in absence of flow across the suture line and a stump of <1 cm as determined by intraoperative trans- esophageal echocardiography should be used.1,4,5","For patients with AF having cardiac surgery and LAA exclusion, employ a surgical method that ensures no flow across the suture line and a stump less than 1 cm, as verified by intraoperative transesophageal echocardiography."
id_00230,"In patients with non–left main or noncomplex CAD who are undergoing noncardiac sur- gery, routine coronary revascularization is not recommended solely to reduce perioperative cardiovascular events.1","For patients with non-left main or uncomplicated coronary artery disease undergoing noncardiac surgery, routine coronary revascularization is not advised solely for the purpose of decreasing perioperative cardiovascular events."
id_02629,"In patients with spontaneous ICH (with or without the spot sign, black hole sign, or blend sign), the effectiveness of TXA to improve functional outcome is not well estab- lished.220–222","The efficacy of TXA in enhancing functional outcomes for patients with spontaneous ICH, regardless of the presence of the spot sign, black hole sign, or blend sign, remains uncertain."
id_01189,"In patients with AF undergoing cardiac surgery with a CHA2DS2-VASc score ≥2 or equivalent stroke risk, surgical LAA exclusion, in addition to continued anti- coagulation, is indicated to reduce the risk of stroke and systemic embolism.1–3","For patients with atrial fibrillation undergoing cardiac surgery who have a CHA2DS2-VASc score of 2 or higher, or a similar stroke risk, it is recommended to perform surgical left atrial appendage exclusion alongside ongoing anticoagulation to lower the risk of stroke and systemic embolism."
id_01670,"In patients with LVEF ≤40%, ACEi should be used to prevent symptomatic HF and reduce mortality.1–4","For patients with LVEF of 40% or less, ACE inhibitors are recommended to prevent symptomatic heart failure and lower mortality rates."
id_02150,"In patients with recurrent endocarditis and continued intravenous drug use, consultation with addiction medicine is recommended to discuss the long-term prognosis for the patient’s refraining from actions that risk reinfection before repeat surgical intervention is considered.56–60","For patients experiencing recurrent endocarditis who continue intravenous drug use, it is advised to consult with addiction medicine to evaluate the patient's long-term likelihood of avoiding behaviors that could lead to reinfection prior to considering repeat surgical intervention."
id_02630,"In patients with spontaneous ICH, provision of care in a specialized inpatient (eg, stroke) unit with a multidisciplinary team is recommended to improve outcomes and reduce mortality.231,232","For patients experiencing spontaneous intracerebral hemorrhage, it is advised to receive treatment in a specialized inpatient unit, such as a stroke unit, with a multidisciplinary team to enhance outcomes and lower mortality rates."
id_00231,"In patients with ventricular fibrillation, polymor- phic ventricular tachycardia (VT), or cardiac arrest, revascularization of significant CAD is recommended to improve survival.1-4","For patients experiencing ventricular fibrillation, polymorphic ventricular tachycardia, or cardiac arrest, it is advised to perform revascularization of significant coronary artery disease to enhance survival."
id_02631,"In patients with spontaneous ICH, provision of care at centers that can provide the full range of high-acuity care and expertise is recom- mended to improve outcomes.233","For patients experiencing spontaneous ICH, it is advised to receive treatment at facilities equipped to deliver comprehensive high-acuity care and specialized expertise to enhance outcomes."
id_01191,"In patients with AF undergoing cardiac surgery with CHA2DS2-VASc score ≥2 or equivalent stroke risk, the benefit of surgical LAA exclusion in the absence of continued anticoagulation to reduce the risk of stroke and systemic embolism is uncertain.1–3","For patients with AF who are having cardiac surgery and have a CHA2DS2-VASc score of 2 or higher, or a similar risk of stroke, the advantage of surgically excluding the LAA without ongoing anticoagulation to lower the risk of stroke and systemic embolism remains unclear."
id_01671,"In patients with a recent or remote history of MI or ACS, statins should be used to prevent symptomatic HF and adverse cardiovascular events.5–9","For individuals with a past or recent history of myocardial infarction or acute coronary syndrome, statins are recommended to prevent symptomatic heart failure and negative cardiovascular outcomes."
id_00232,"In patients with CAD and suspected scar- mediated sustained monomorphic VT, revas- cularization is not recommended for the sole purpose of preventing recurrent VT.5-9","For patients with CAD and suspected scar-mediated sustained monomorphic VT, revascularization should not be performed solely to prevent recurrent VT."
id_01192,"In patients with AF receiving dabigatran who develop life-threatening bleeding, treatment with idarucizumab is recommended to rapidly reverse dabigatran’s anticoagulation effect.1–3","For patients with atrial fibrillation on dabigatran experiencing life-threatening bleeding, idarucizumab is advised to quickly counteract the anticoagulant effects of dabigatran."
id_01672,"In patients with a recent MI and LVEF ≤40% who are intolerant to ACEi, ARB should be used to prevent symptomatic HF and reduce mortal- ity.10","For patients with a recent MI and LVEF of 40% or less who cannot tolerate ACE inhibitors, ARBs should be administered to prevent symptomatic heart failure and decrease mortality."
id_02152,"In patients with native left-sided valve endocarditis who exhibit mobile vegetations >10 mm in length (with or without clinical evidence of embolic phenomenon), early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) may be considered.20,61–63,67","For patients with native left-sided valve endocarditis and mobile vegetations exceeding 10 mm in length, early surgical intervention can be contemplated during the initial hospital stay and prior to finishing a complete course of antibiotics, regardless of the presence of clinical embolic events."
id_00233,"In patients with SCAD who have hemody- namic instability or ongoing ischemia despite conservative therapy, revascularization may be considered if feasible.1-5","For patients with SCAD experiencing hemodynamic instability or persistent ischemia despite conservative treatment, revascularization can be considered if it is possible."
id_02632,"In patients with spontaneous ICH and clini- cal hydrocephalus, transfer to centers with neurosurgical capabilities for definitive hydro- cephalus management (eg, EVD placement and monitoring) is recommended to reduce mortality.233,234","For patients experiencing spontaneous intracerebral hemorrhage and clinical hydrocephalus, it is advised to transfer them to facilities with neurosurgical expertise for definitive hydrocephalus treatment, such as the placement and monitoring of an external ventricular drain, to decrease mortality."
id_01673,"In patients with a recent or remote history of MI or acute coronary syndrome (ACS) and LVEF ≤40%, evidence-based beta blockers should be used to reduce mortality.11–13","For patients with a history of myocardial infarction or acute coronary syndrome and a left ventricular ejection fraction of 40% or less, beta blockers supported by evidence should be administered to lower mortality rates."
id_00234,Routine revascularization for SCAD should not be performed.1-5,Revascularization should not be routinely conducted for SCAD.
id_01193,"In patients with AF receiving dabigatran who develop life-threatening bleeding, treatment with activated prothrombin complex concentrate (PCC) is reason- able to reverse dabigatran’s anticoagulation effect if idarucizumab is unavailable.4,5","For patients with atrial fibrillation on dabigatran experiencing life-threatening bleeding, using activated prothrombin complex concentrate (PCC) is a suitable option to counteract the anticoagulation effect of dabigatran when idarucizumab is not accessible."
id_02633,"In patients with spontaneous ICH, care delivery that includes multidisciplinary teams trained in neurological assessment is recom- mended to improve outcomes.99,235,236","For patients with spontaneous intracerebral hemorrhage, it is advised to involve multidisciplinary teams skilled in neurological evaluation to enhance outcomes."
id_02153,"In patients with IE and an indication for surgery who have suffered a stroke but have no evidence of intracranial hemorrhage or extensive neurological damage, operation without delay may be considered.68–70","For patients with IE who require surgery and have experienced a stroke without signs of intracranial bleeding or significant neurological injury, immediate surgery may be an option."
id_02151,"In patients with IE who present with recurrent emboli and persistent vegetations despite appropriate antibiotic therapy, early surgery (during initial hospitalization and before completion of a full therapeutic course of antibiotics) is reasonable.53,61–66","For patients with IE experiencing repeated embolic events and ongoing vegetations despite suitable antibiotic treatment, it is advisable to consider early surgery during the initial hospital stay and prior to finishing the complete antibiotic regimen."
id_02634,"In hospitalized patients with spontaneous ICH who require hospital transfer but do not have adequate airway protection, cannot support adequate gas exchange, and/or do not have a stable hemodynamic profile, appropriate life-sustaining therapies should be initiated before transportation to prevent acute medical decompensation in transport.","For hospitalized patients with spontaneous ICH needing transfer who lack sufficient airway protection, cannot maintain adequate gas exchange, or have unstable hemodynamics, necessary life-sustaining treatments should be started prior to transport to avert acute medical deterioration during transit."
id_02154,"For patients with IE and major ischemic stroke with extensive neurological damage or intracranial hemorrhage, if the patient is hemodynamically stable, delaying valve surgery for at least 4 weeks may be considered.68,71","In patients with IE who have suffered a major ischemic stroke with significant neurological injury or intracranial bleeding, and are hemodynamically stable, it may be advisable to postpone valve surgery for a minimum of 4 weeks."
id_01194,"In patients with AF receiving warfarin who develop life-threatening bleeding, treatment with 4-factor prothrombin complex concentrate (if available) in addition to intravenous vitamin K is recommended to rapidly achieve INR correction over fresh frozen plasma and intravenous vitamin K treatment.8–10","For patients with AF on warfarin experiencing life-threatening bleeding, it is advised to use 4-factor prothrombin complex concentrate (when accessible) along with intravenous vitamin K to quickly correct INR, rather than using fresh frozen plasma and intravenous vitamin K alone."
id_01674,"In patients who are at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT and have reasonable expectation of meaningful survival for >1 year, an ICD is recommended for primary prevention of sudden cardiac death (SCD) to reduce total mortality.14","For patients who are more than 40 days after an MI, have an LVEF of 30% or less, exhibit NYHA class I symptoms while on GDMT, and are expected to survive meaningfully for over a year, an ICD is advised for primary prevention of sudden cardiac death to lower overall mortality."
id_00235,"In patients with cardiac allograft vasculopathy and severe, proximal, discrete coronary lesions, revascularization with PCI is reasonable.1,2","For patients with cardiac allograft vasculopathy and significant, proximal, isolated coronary lesions, it is reasonable to consider revascularization through PCI."
id_01675,"In patients with LVEF ≤40%, beta blockers should be used to prevent symptomatic HF.12,13","For patients with an LVEF of 40% or less, beta blockers are recommended to prevent symptomatic heart failure."
id_00236,"In patients with ACS undergoing PCI, a radial approach is indicated in preference to a femoral approach to reduce the risk of death, vascular complications, or bleeding.1-4","For patients with ACS undergoing PCI, opting for a radial approach over a femoral one is recommended to lower the risk of mortality, vascular complications, or bleeding."
id_02155,Women with suspected valve disease who are considering pregnancy should undergo a clinical evaluation and TTE before pregnancy.1–5,Women who may have valve disease and are planning to become pregnant should receive a clinical assessment and transthoracic echocardiography prior to conception.
id_01195,"In patients with AF who develop major gastrointestinal bleeding, resumption of oral anticoagulation therapy may be reasonable after correction of reversible causes of bleeding and reassessment of its long-term benefits and risks with a multidisciplinary team approach during SDM with patients.11,12 *B-NR LOE applies to data on apixaban or rivaroxaban. †C-LD LOE applies to data on edoxaban.","For patients with atrial fibrillation experiencing significant gastrointestinal bleeding, it might be appropriate to restart oral anticoagulation therapy after addressing reversible bleeding causes and evaluating the long-term benefits and risks with a multidisciplinary team during shared decision-making with the patient. *B-NR LOE pertains to apixaban or rivaroxaban data. †C-LD LOE pertains to edoxaban data."
id_01676,"In patients with LVEF <50%, thiazolidinediones should not be used because they increase the risk of HF, including hospitalizations.15",Thiazolidinediones should be avoided in patients with LVEF below 50% due to an increased risk of heart failure and related hospitalizations.
id_02156,Women with severe valve disease (Stages C and D) who are considering pregnancy should undergo pre-pregnancy counseling by a cardiologist with expertise in managing women with VHD during pregnancy.1–5,Women with advanced valve disease (Stages C and D) contemplating pregnancy should receive pre-pregnancy counseling from a cardiologist experienced in handling VHD in pregnant women.
id_01196,"In patients with AF and conditions associated with very high risk of thromboembolic events (>5%/year), such as rheumatic heart disease or a mechanical heart valve, early (1-2 weeks) resumption of antico- agulation after ICH is reasonable to reduce the risk of thromboembolic events.1","For patients with atrial fibrillation and conditions linked to a very high risk of thromboembolic events (over 5% annually), like rheumatic heart disease or a mechanical heart valve, it is advisable to restart anticoagulation within 1-2 weeks after an intracerebral hemorrhage to lower the risk of thromboembolic events."
id_02636,"In patients with moderate to severe spontaneous ICH, IVH, hydrocephalus, or infratentorial loca- tion, provision of care in a neuro-specific ICU compared with a general ICU is reasonable to improve outcomes and reduce mortality.235,239–241","For patients experiencing moderate to severe spontaneous ICH, IVH, hydrocephalus, or infratentorial location, it is advisable to provide care in a neuro-specific ICU rather than a general ICU to enhance outcomes and lower mortality rates."
id_00237,"In patients with SIHD undergoing PCI, the radial approach is recommended to reduce access site bleeding and vascular complica- tions.4-7","For patients with SIHD undergoing PCI, using the radial approach is advised to minimize bleeding and vascular complications at the access site."
id_01197,"In patients with AF and ICH, delayed (4-8 weeks) resumption of anticoagulation may be considered to balance the risks of thromboembolic and hemorrhagic complications after careful risk benefit assessment.2–5","For patients with AF and ICH, resuming anticoagulation after a delay of 4-8 weeks can be contemplated to weigh the risks of thromboembolic versus hemorrhagic complications, following a thorough risk-benefit evaluation."
id_01677,"In patients with LVEF <50%, nondihydropyri- dine calcium channel blockers with negative inotropic effects may be harmful.16,17","For patients with an LVEF below 50%, using nondihydropyridine calcium channel blockers that have negative inotropic effects could be detrimental."
id_02637,"In patients with IVH or infratentorial ICH loca- tion, transfer to centers with neurosurgical capabilities might be reasonable to improve outcomes.102,233,234","For patients with IVH or infratentorial ICH, it may be beneficial to transfer them to facilities with neurosurgical expertise to enhance outcomes."
id_02157,"Pregnant women with severe valve disease (Stages C and D) should be monitored in a tertiary-care center with a dedicated Heart Valve Team of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.1–12","Women who are pregnant and have severe valve disease (Stages C and D) should receive care at a tertiary center, where a specialized Heart Valve Team comprising cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians experienced in managing high-risk cardiac conditions during pregnancy can monitor them."
id_00238,"In patients undergoing PCI, DES should be used in preference to BMS to prevent reste- nosis, MI, or acute stent thrombosis.1-4","For patients receiving PCI, DES is recommended over BMS to reduce the risk of restenosis, myocardial infarction, or acute stent thrombosis."
id_02638,"In patients with larger supratentorial ICH, transfer to centers with neurosurgical capa- bilities may be reasonable to improve out- comes.233,234","For patients with larger supratentorial ICH, it may be advisable to transfer them to facilities with neurosurgical capabilities to potentially enhance outcomes."
id_01198,"In patients with AF and conditions associated with high risk of recurrent ICH (eg, cerebral amyloid angiopathy) anticoagulation-sparing strategies (eg, LAAO) may be considered to reduce the risk of recurrent hemorrhage.6,7","For patients with atrial fibrillation and a high risk of recurrent intracerebral hemorrhage, such as those with cerebral amyloid angiopathy, considering anticoagulation-sparing approaches like left atrial appendage occlusion may help lower the risk of further bleeding."
id_01678,"Patients with HF should receive care from multidisciplinary teams to facilitate the imple- mentation of GDMT, address potential barriers to self-care, reduce the risk of subsequent rehospitalization for HF, and improve survival.1–4","Patients with heart failure should be managed by multidisciplinary teams to ensure the application of guideline-directed medical therapy, overcome self-care obstacles, lower the likelihood of future heart failure rehospitalizations, and enhance survival rates."
id_02158,"In asymptomatic women with severe valve disease (Stage C1) who are considering pregnancy, exercise testing is reasonable before pregnancy for risk assessment.3–5,11,13–15","For asymptomatic women with severe valve disease (Stage C1) contemplating pregnancy, it is advisable to conduct exercise testing prior to pregnancy for evaluating risk."
id_02635,"In patients with spontaneous ICH without indi- cations for ICU admission at presentation, ini- tial provision of care in a stroke unit compared with a general ward is reasonable to reduce mortality and improve outcomes.231,237,238","For patients with spontaneous intracerebral hemorrhage who do not require ICU admission initially, it is advisable to provide care in a stroke unit rather than a general ward to decrease mortality and enhance outcomes."
id_00239,"In patients undergoing coronary stent implan- tation, IVUS can be useful for procedural guidance, particularly in cases of left main or complex coronary artery stenting, to reduce ischemic events.1-10","For patients receiving coronary stents, IVUS may aid in procedural guidance, especially for left main or complex coronary artery stenting, to minimize ischemic events."
id_01679,"Patients with HF should receive specific edu- cation and support to facilitate HF self-care in a multidisciplinary manner.2,5–9",Individuals with heart failure should be provided with targeted education and support to promote self-management of their condition through a multidisciplinary approach.
id_02159,"In pregnant women with VHD, beta-blocker medications are reasonable as required for heart rate control or treatment of arrhythmias.1–6","For pregnant women with VHD, using beta-blockers is appropriate when needed to manage heart rate or treat arrhythmias."
id_02639,"In patients with spontaneous ICH, the use of standardized protocols and/or order sets is recommended to reduce disability and mortal- ity.256–259","For patients with spontaneous ICH, it is advised to implement standardized protocols and/or order sets to decrease disability and mortality."
id_00240,"In patients undergoing coronary stent implan- tation, OCT is a reasonable alternative to IVUS for procedural guidance, except in ostial left main disease.11-13","For patients receiving coronary stents, OCT can be suitably used instead of IVUS for procedural guidance, except in cases of ostial left main disease."
id_01199,"In patients with AF on warfarin anticoagulation and an annual predicted risk of thromboembolism of ≥5% undergoing pacemaker or defibrillator implantation or generator change, continued anticoagulation is rec- ommended in preference to interruption of warfarin and bridging anticoagulation with heparin to reduce the risk of pocket hematoma.5–7","For patients with atrial fibrillation on warfarin who have an annual thromboembolism risk of 5% or higher and are undergoing pacemaker or defibrillator implantation or generator replacement, it is advised to maintain anticoagulation with warfarin rather than interrupting it and using heparin bridging, to minimize the risk of pocket hematoma."
id_01680,"In patients with HF, vaccinating against respi- ratory illnesses is reasonable to reduce mor- tality.10–16","For patients with heart failure, it is advisable to vaccinate against respiratory diseases to lower mortality rates."
id_01200,"In patients with AF with CHA2DS2-VASc score ≥2 or equivalent risk of stroke, on DOAC anticoagulation and undergoing pacemaker or defibrillator implanta- tion or generator change, either uninterrupted or interrupted DOAC is reasonable.8–10","For patients with atrial fibrillation and a CHA2DS2-VASc score of 2 or higher, or a similar stroke risk, who are on DOAC anticoagulation and are having a pacemaker or defibrillator implanted or a generator replaced, it is reasonable to continue DOAC either without interruption or with a brief interruption."
id_02640,"In patients with spontaneous ICH, a formal dysphagia screening protocol should be imple- mented before initiation of oral intake to reduce disability and the risk of pneumonia.256,260–265","For patients with spontaneous ICH, a structured dysphagia screening should be conducted prior to starting oral intake to minimize disability and pneumonia risk."
id_02160,"In pregnant women with VHD and HF symptoms (Stage D), diuretic medications are reasonable if needed for volume overload.7,8","For pregnant women experiencing Stage D VHD with heart failure symptoms, using diuretics is appropriate if there is a need to manage volume overload."
id_00241,"In patients with stent failure, IVUS or OCT is reasonable to determine the mechanism of stent failure.14-17","For patients experiencing stent failure, using IVUS or OCT to identify the cause of the failure is advisable."
id_01681,"In adults with HF, screening for depression,17,18 social isolation,19–22 frailty,23,24 and low health literacy25,26 as risk factors for poor self-care is reasonable to improve management.","For adults with heart failure, it is advisable to screen for depression, social isolation, frailty, and low health literacy as these are risk factors that can hinder effective self-care management."
id_01201,"In patients with AF on DOAC and scheduled to undergo an invasive procedure or surgery that cannot be performed safely on uninterrupted antico- agulation, the timing of interruption of DOAC should be guided by the specific agent, renal function, and the bleeding risk of the procedure (Table 18).4,11,12","For patients with atrial fibrillation taking DOACs who are scheduled for surgery or an invasive procedure where continuous anticoagulation is unsafe, the timing for stopping DOACs should be determined based on the specific medication, kidney function, and the procedure's bleeding risk (refer to Table 18)."
id_02641,"In patients with spontaneous ICH, continu- ous cardiac monitoring for the first 24 to 72 hours of admission is reasonable to monitor for cardiac arrhythmias and new cardiac ischemia.266–268","For patients with spontaneous intracerebral hemorrhage, it is advisable to conduct continuous cardiac monitoring during the initial 24 to 72 hours after admission to detect any cardiac arrhythmias or new cardiac ischemia."
id_02161,"In pregnant women with VHD, ACE inhibitors and ARBs should not be given because of fetal risk.6,9–11",ACE inhibitors and ARBs should be avoided in pregnant women with VHD due to the risk they pose to the fetus.
id_01682,"For patients with stage C HF, avoiding exces- sive sodium intake is reasonable to reduce congestive symptoms.1–6","For individuals with stage C heart failure, it is advisable to limit sodium consumption to alleviate congestive symptoms."
id_02162,"In symptomatic women with severe VHD who are considering pregnancy, intervention before pregnancy is recommended on the basis of standard indications.1–11 Downloaded from http://ahajournals.org by on June 19, 2025","For women with severe valvular heart disease who have symptoms and are planning to become pregnant, it is advised to undergo intervention prior to pregnancy according to standard guidelines."
id_01202,"In patients with AF on DOAC that has been inter- rupted for an invasive procedure or surgery, in gen- eral, resumption of anticoagulation the day after low bleeding risk surgery and between the evening of the second day and the evening of the third day after high bleeding risk surgery is reasonable, as long as hemostasis has been achieved and further bleeding is not anticipated.4","For patients with AF on DOAC who have paused treatment for surgery or an invasive procedure, it is generally advisable to restart anticoagulation the day following low bleeding risk surgery, and between the evening of the second and third days after high bleeding risk surgery, provided that hemostasis is secured and no further bleeding is expected."
id_02642,"In patients with spontaneous ICH, diagnos- tic laboratory and radiographic testing for infection on admission and throughout the hospital course is reasonable to improve out- comes.269–273 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with spontaneous intracerebral hemorrhage, it is advisable to conduct diagnostic laboratory and imaging tests for infection upon admission and during the hospital stay to enhance outcomes."
id_00242,"In patients with STEMI, routine aspiration throm- bectomy before primary PCI is not useful.1-5","For patients experiencing STEMI, performing routine aspiration thrombectomy prior to primary PCI is ineffective."
id_00243,"In patients with fibrotic or heavily calcified lesions, plaque modification with rotational atherectomy can be useful to improve proce- dural success.1-3","For patients with fibrotic or significantly calcified lesions, using rotational atherectomy for plaque modification may enhance procedural success."
id_01683,"For patients with HF who are able to par- ticipate, exercise training (or regular physical activity) is recommended to improve functional status, exercise performance, and QOL.1–9","Exercise training or regular physical activity is advised for patients with heart failure who can engage in it, as it enhances functional status, exercise capacity, and quality of life."
id_02163,"In women who require a valve intervention before pregnancy, the choice of prosthetic valve should be based on a shared decision- making process that accounts for the patient’s values and preferences, including discussion of the risks of mechanical valves during pregnancy and the reduced durability of bioprosthetic valves in young women.","For women needing valve intervention prior to pregnancy, selecting a prosthetic valve should involve a collaborative decision-making approach that considers the patient's values and preferences, addressing the risks associated with mechanical valves during pregnancy and the shorter lifespan of bioprosthetic valves in younger women."
id_01203,"In patients with AF and an increased risk for stroke who undergo PCI, DOACs are preferred over VKAs in combination with APT to reduce the risk of clinically relevant bleeding.1–5","For patients with atrial fibrillation and elevated stroke risk undergoing PCI, using DOACs instead of VKAs alongside antiplatelet therapy is recommended to lower the risk of clinically significant bleeding."
id_02643,"In nonambulatory patients with spontaneous ICH, intermittent pneumatic compression (IPC) starting on the day of diagnosis is recommended for VTE (DVT and pulmonary embolism [PE]) prophylaxis.275,276","For nonambulatory patients with spontaneous intracerebral hemorrhage, it is advised to initiate intermittent pneumatic compression on the day of diagnosis to prevent venous thromboembolism, including deep vein thrombosis and pulmonary embolism."
id_01684,"In patients with HF, a cardiac rehabilitation program can be useful to improve functional capacity, exercise tolerance, and health-related QOL.1,2,5,6,8 Table 11.  Potential Barriers to Effective HF Self-Care and Example Interventions Potential Barrier Example Screening Tools Example Interventions Medical Barriers Cognitive impairment48–50 Mini-Cog Mini-Mental State Examination (MMSE) Montreal Cognitive Assessment (MoCA) Home health aide Home meal deliveries Adult day care Geriatric psychiatry referral Memory care support groups Depression51,52 Hamilton Depression Rating Scale (HAM-D) Beck Depression Inventory-II (BDI-II) Patient Health Questionnaire-9 (PHQ-9) Psychotherapy Selective serotonin reuptake inhibitors Nurse-led support Substance use disorders53 Tobacco, Alcohol, Prescription medication, and other Sub- stance use (TAPS) Referral to social work services and community support partners Referral for addiction psychiatry consultation Frailty54 Fried frailty phenotype Cardiac rehabilitation Registered dietitian nutritionist evaluation for malnutrition Social Barriers Financial burden of HF treatments55 COmprehensive Score for financial Toxicity–Functional As- sessment of Chronic Illness Therapy (COST-FACIT) PharmD referral to review prescription assistance eligibilities Food insecurity56,57 Hunger Vital Sign, 2 items US Household Food Security Survey Module, 6 items Determine eligibility for the Supplemental Nutrition Assistance Program (SNAP) Connect patients with community partners such as food pantries/ food banks Home meal deliveries Registered dietitian nutritionist evaluation for potential malnutrition Homelessness or housing insecurity58–60 Homelessness Screening Clinical Reminder (HSCR) Referral to local housing services Connect patients with community housing partners Intimate partner violence or elder abuse61,62 Humiliation, Afraid, Rape, Kick (HARK) questionnaire Partner Violence Screen (PVS) Woman Abuse Screening Tool (WAST) Referral to social work services and community support partners Limited English proficiency or other language barriers63 Routinely inquire in which language the patient is most comfortable conversing Access to interpreter services covering a wide range of languag- es, ideally in person or, alternatively, via video platform Printed educational materials in a range of appropriate languages Low health literacy64 Short Assessment of Health Literacy (SAHL) Rapid Estimate of Adult Literacy in Medicine–Short Form (REALM-SF) Brief Health Literacy Screen (BHLS), 3 items Agency for Healthcare Research and Quality (AHRQ) Health Lit- eracy Universal Precautions Toolkit Written education tools provided at sixth grade reading level or below Graphic educational documents Social isolation or low social support65 Patient-Reported Outcomes Measurement Information System (PROMIS) Social Isolation Short Form Determine eligibility for home care services Support group referral Transport limitations","For patients with heart failure, participating in a cardiac rehabilitation program may be beneficial for enhancing functional capacity, exercise tolerance, and health-related quality of life."
id_01204,"In most patients with AF who take oral anticoagulation and undergo PCI, early discontinuation of aspirin (1-4 wk) and continuation of dual antithrombotic therapy with OAC and a P2Y12 inhibitor is preferred over triple therapy (OAC, P2Y12 inhibitor, and aspirin) to reduce the risk of clinically relevant bleeding.1–4,6","For most patients with atrial fibrillation on oral anticoagulation undergoing PCI, it is advisable to stop aspirin early (within 1-4 weeks) and continue with dual antithrombotic therapy consisting of an oral anticoagulant and a P2Y12 inhibitor, rather than triple therapy including aspirin, to minimize the risk of significant bleeding."
id_02644,"In nonambulatory patients with spontaneous ICH, low-dose UFH or LMWH can be useful to reduce the risk for PE.277–280","For patients with spontaneous ICH who are nonambulatory, administering low-dose UFH or LMWH may help lower the risk of PE."
id_00245,"In select patients with previous CABG under- going PCI of a SVG, the use of an embolic protection device, when technically feasible, is reasonable to decrease the risk of distal embolization.1-3","For certain patients with a history of CABG undergoing PCI of a SVG, employing an embolic protection device, if technically possible, is advisable to reduce the risk of distal embolization."
id_02164,"In asymptomatic women with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage C1) who are considering pregnancy, PMBC at a Comprehensive Valve Center is reasonable before pregnancy for those who have favorable valve morphology.1–5,12,13","For asymptomatic women with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage C1) contemplating pregnancy, it is advisable to undergo percutaneous mitral balloon commissurotomy at a Comprehensive Valve Center prior to pregnancy if they have suitable valve morphology."
id_01205,"In patients with AF and CCD (beyond 1 year after revascularization or CAD not requiring coronary revascularization) without history of stent thrombosis, oral anticoagulation monotherapy is recommended over the combination therapy of OAC and single APT (aspirin or P2Y12 inhibitor) to decrease the risk of major bleeding.1–3","For patients with AF and CCD (more than one year post-revascularization or CAD not needing coronary revascularization) who have no history of stent thrombosis, oral anticoagulation alone is advised instead of combining OAC with single APT (aspirin or a P2Y12 inhibitor) to reduce the risk of major bleeding."
id_01685,"In patients with HF who have fluid retention, diuretics are recommended to relieve conges- tion, improve symptoms, and prevent worsen- ing HF.1–5","For patients with heart failure experiencing fluid retention, diuretics are advised to alleviate congestion, enhance symptoms, and prevent the progression of heart failure."
id_02165,"In women of childbearing age who require valve replacement, bioprosthetic valves are preferred over mechanical valves because of the increased maternal and fetal risks of mechanical heart valves in pregnancy.14","For women of childbearing age needing valve replacement, bioprosthetic valves are favored over mechanical ones due to the heightened risks to both mother and fetus associated with mechanical valves during pregnancy."
id_02645,"In nonambulatory patients with spontaneous ICH, initiating low-dose UFH or LMWH prophy- laxis at 24 to 48 hours from ICH onset may be reasonable to optimize the benefits of prevent- ing thrombosis relative to the risk of HE.277,281,282","For nonambulatory patients experiencing spontaneous ICH, starting low-dose UFH or LMWH prophylaxis 24 to 48 hours after the onset of ICH might be advisable to balance the prevention of thrombosis against the risk of HE."
id_00246,"In patients with previous CABG, if PCI of a diseased native coronary artery is feasible, then it is reasonable to choose PCI of the native coronary artery over PCI of the severely diseased SVG.4-6","For patients who have undergone CABG, opting for PCI of a treatable native coronary artery is advisable over PCI of a significantly diseased SVG, if feasible."
id_01206,"In patients with AF and concomitant stable PAD, monotherapy oral anticoagulation is reasonable over dual therapy (anticoagulation plus aspirin or P2Y12 inhibitors) to reduce the risk of bleeding.1–5","For patients with AF and stable PAD, using oral anticoagulation alone is advisable instead of combining it with aspirin or P2Y12 inhibitors to minimize bleeding risk."
id_00244,"In patients with fibrotic or heavily calcified lesions, plaque modification with orbital ather- ectomy, balloon atherotomy, laser angioplasty, or intracoronary lithotripsy may be considered to improve procedural success.4-8","For patients with fibrotic or significantly calcified lesions, considering plaque modification through orbital atherectomy, balloon atherotomy, laser angioplasty, or intracoronary lithotripsy can enhance procedural success."
id_02646,"In nonambulatory patients with spontaneous ICH, graduated compression stockings of knee-high or thigh-high length alone are not beneficial for VTE prophylaxis.276,278,283,284 Treatment","For nonambulatory patients with spontaneous ICH, using knee-high or thigh-high graduated compression stockings alone does not effectively prevent VTE."
id_01686,"For patients with HF and congestive symptoms, addition of a thiazide (eg, metolazone) to treat- ment with a loop diuretic should be reserved for patients who do not respond to moderate- or high-dose loop diuretics to minimize electro- lyte abnormalities.6","For patients with heart failure and congestion, a thiazide such as metolazone should be added to loop diuretic therapy only if moderate or high doses of the loop diuretic are ineffective, in order to reduce the risk of electrolyte imbalances."
id_00247,"In patients with a chronic occlusion of a SVG, percutaneous revascularization of the SVG should not be performed.7,8","For patients with a chronically occluded SVG, percutaneous revascularization should be avoided."
id_02166,"In asymptomatic women with severe AS (aortic velocity ≥4.0 m/s or mean pressure gradient ≥40 mm Hg, Stage C) who are considering pregnancy, valve intervention before pregnancy is reasonable.","For asymptomatic women with severe aortic stenosis (aortic velocity of 4.0 m/s or higher, or a mean pressure gradient of 40 mm Hg or more, Stage C) who are planning to become pregnant, it is advisable to consider valve intervention prior to pregnancy."
id_01687,"In patients with HFrEF and NYHA class II to III symptoms, the use of ARNi is recommended to reduce morbidity and mortality.1–5","For patients experiencing NYHA class II to III symptoms with HFrEF, it is advised to use ARNi to decrease morbidity and mortality."
id_01207,"For patients with AF at elevated risk for stroke and CKD stage 3, treatment with warfarin or, preferably, evidence-based doses of direct thrombin or factor Xa inhibitors (Table 19) is recommended to reduce the risk of stroke.1–3","For patients with AF who have an increased risk of stroke and are in CKD stage 3, it is advised to use warfarin or, preferably, direct thrombin or factor Xa inhibitors at evidence-based doses (see Table 19) to lower the stroke risk."
id_00248,"In patients with suitable anatomy who have refractory angina on medical therapy, after treatment of non-CTO lesions, the benefit of PCI of a CTO to improve symptoms is uncer- tain.1-4","For patients with appropriate anatomy experiencing refractory angina despite medical treatment, the advantage of performing PCI on a CTO to alleviate symptoms remains unclear after addressing non-CTO lesions."
id_02647,"For patients with acute spontaneous ICH and proximal DVT who are not yet candidates for anticoagulation, the temporary use of a retrievable filter is reasonable as a bridge until anticoagulation can be initiated.285","For patients experiencing acute spontaneous intracerebral hemorrhage and proximal deep vein thrombosis who cannot yet start anticoagulation therapy, it is reasonable to temporarily use a retrievable filter as a transitional measure until anticoagulation is feasible."
id_02167,"In asymptomatic women with severe AS (aortic velocity ≥4.0 m/s or mean pressure gradient ≥40 mm Hg, Stage C1) who are considering pregnancy, do not meet COR 1 criteria for intervention, and have a preconception evaluation confirming the absence of symptoms (including normal exercise stress testing and serum BNP measurements), medical management during pregnancy may be considered to avoid prosthetic valve replacement.","For asymptomatic women with severe aortic stenosis (aortic velocity of at least 4.0 m/s or mean pressure gradient of at least 40 mm Hg, Stage C1) who are planning pregnancy, do not qualify for COR 1 intervention, and have undergone preconception evaluation showing no symptoms (including normal results from exercise stress testing and serum BNP levels), medical management during pregnancy can be considered to prevent prosthetic valve replacement."
id_00249,"In patients who develop clinical in-stent reste- nosis (ISR) for whom repeat PCI is planned, a DES should be used to improve outcomes if anatomic factors are appropriate and the patient is able to comply with DAPT.1-4","For patients experiencing clinical in-stent restenosis (ISR) and scheduled for repeat PCI, a DES should be utilized to enhance outcomes, provided that anatomical conditions are suitable and the patient can adhere to DAPT."
id_01688,"In patients with previous or current symptoms of chronic HFrEF, the use of ACEi is beneficial to reduce morbidity and mortality when the use of ARNi is not feasible.6–13","For patients with past or present symptoms of chronic HFrEF, ACE inhibitors are advantageous in lowering morbidity and mortality when ARNi cannot be used."
id_02648,"For patients with acute spontaneous ICH and proximal DVT or PE, delaying treatment with UFH or LMWH for 1 to 2 weeks after the onset of ICH might be considered.286,287","In patients experiencing acute spontaneous ICH along with proximal DVT or PE, it may be advisable to postpone the initiation of UFH or LMWH therapy for 1 to 2 weeks following the onset of ICH."
id_01208,"For patients with AF at elevated risk for stroke and CKD stage 4, treatment with warfarin or labeled doses of DOACs is reasonable to reduce the risk of stroke.4,5","For patients with AF who have a high stroke risk and are in CKD stage 4, using warfarin or approved doses of DOACs is advisable to lower stroke risk."
id_02168,"In asymptomatic women with severe MR (Stage C1) and a valve suitable for repair who are considering pregnancy, valve repair before pregnancy at a Comprehensive Valve Center may be considered but only after detailed discussion with the patient about the risks and benefits of the surgery and its effect on future pregnancies.","For asymptomatic women with severe MR (Stage C1) who have a repairable valve and are planning pregnancy, undergoing valve repair at a Comprehensive Valve Center can be an option, provided there is a thorough discussion with the patient regarding the surgery's risks, benefits, and its impact on future pregnancies."
id_02649,"In patients with spontaneous ICH, frequent neurological assessments (including GCS) should be performed by ED nurses in the early hyperacute phase of care to assess change in status, neurological examination, or level of consciousness.61,292–294","For patients experiencing spontaneous ICH, ED nurses should conduct regular neurological evaluations, including the GCS, during the initial hyperacute phase to monitor any changes in status, neurological function, or consciousness level."
id_00250,"In patients with symptomatic recurrent dif- fuse ISR with an indication for revasculariza- tion, CABG can be useful over repeat PCI to reduce recurrent events.","For patients experiencing symptomatic recurrent diffuse ISR who require revascularization, opting for CABG instead of repeat PCI may be beneficial in minimizing recurrent events."
id_02169,"In pregnant women with severe AS (mean pressure gradient ≥40 mm Hg, Stage D), valve intervention during pregnancy is reasonable if there is hemodynamic deterioration or if there are NYHA class III or IV HF symptoms.1–7","For pregnant women with severe aortic stenosis (mean pressure gradient ≥40 mm Hg, Stage D), it is reasonable to consider valve intervention during pregnancy if there is hemodynamic decline or if they experience NYHA class III or IV heart failure symptoms."
id_01209,"For patients with AF at elevated risk for stroke and who have end-stage CKD (CrCl <15 mL/min) or are on dialysis, it might be reasonable to prescribe warfarin (INR 2.0-3.0) or an evidence-based dose of apixaban for oral anticoagulation to reduce the risk of stroke.6,7","For patients with atrial fibrillation at high stroke risk and end-stage chronic kidney disease (CrCl <15 mL/min) or those undergoing dialysis, prescribing warfarin (INR 2.0-3.0) or an evidence-supported dose of apixaban for oral anticoagulation may be a reasonable approach to lower stroke risk."
id_01689,"In patients with previous or current symptoms of chronic HFrEF who are intolerant to ACEi because of cough or angioedema and when the use of ARNi is not feasible, the use of ARB is rec- ommended to reduce morbidity and mortality.14–18 Value Statement: High Value (A)","For patients with past or present symptoms of chronic HFrEF who cannot tolerate ACE inhibitors due to cough or angioedema, and when ARNi use is not possible, ARBs are advised to decrease morbidity and mortality."
id_02650,"In patients with spontaneous ICH, frequent neurological assessments in the ICU and stroke unit are reasonable for up to 72 hours of admission to detect early ND.99,245,292,294","For patients with spontaneous intracerebral hemorrhage, conducting regular neurological evaluations in the ICU and stroke unit is advisable for the first 72 hours after admission to identify early neurological deterioration."
id_00251,"In patients who develop recurrent ISR, brachy- therapy may be considered to improve symp- toms.5","For patients with recurrent ISR, brachytherapy can be considered to alleviate symptoms."
id_02170,"In pregnant women with severe rheumatic MS (mitral valve area ≤1.5 cm2, Stage D) and with valve morphology favorable for PMBC who remain symptomatic with NYHA class III or IV HF symptoms despite medical therapy, PMBC is reasonable during pregnancy if it is performed at a Comprehensive Valve Center.8–12","For pregnant women with severe rheumatic mitral stenosis (mitral valve area ≤1.5 cm², Stage D) and suitable valve morphology for percutaneous mitral balloon commissurotomy (PMBC) who continue to experience NYHA class III or IV heart failure symptoms despite medical treatment, undergoing PMBC during pregnancy is advisable if conducted at a Comprehensive Valve Center."
id_01210,"In patients with rheumatic mitral stenosis or mitral stenosis of moderate or greater severity and history of AF, long-term anticoagulation with warfarin is recommended over DOACs, independent of the CHA2DS2-VASc score to prevent cardiovascular events, including stroke or death.1","For patients with rheumatic mitral stenosis or moderate to severe mitral stenosis who have a history of atrial fibrillation, it is advised to use long-term warfarin anticoagulation instead of DOACs, regardless of the CHA2DS2-VASc score, to prevent cardiovascular events such as stroke or death."
id_01690,"In patients with chronic symptomatic HFrEF NYHA class II or III who tolerate an ACEi or ARB, replacement by an ARNi is recommended to further reduce morbidity and mortality.1–5 Value Statement: High Value (A)","For patients with chronic symptomatic HFrEF classified as NYHA class II or III who can tolerate an ACEi or ARB, it is advised to switch to an ARNi to further decrease morbidity and mortality."
id_01691,"ARNi should not be administered concomi- tantly with ACEi or within 36 hours of the last dose of an ACEi.30,31",ARNi should not be given alongside ACEi or within 36 hours following the last ACEi dose.
id_02651,"In patients with spontaneous ICH, specialized nurse stroke competencies can be effective in improving outcome and mortality.295–297","For patients experiencing spontaneous ICH, utilizing specialized stroke nursing skills can effectively enhance outcomes and reduce mortality."
id_00252,"In selected high-risk patients, elective inser- tion of an appropriate hemodynamic support device as an adjunct to PCI may be reason- able to prevent hemodynamic compromise during PCI.1,2","For certain high-risk patients, it may be advisable to electively use a suitable hemodynamic support device alongside PCI to avert hemodynamic instability during the procedure."
id_02171,"In pregnant women with severe valve regurgitation and with NYHA class IV HF symptoms (Stage D) refractory to medical therapy, valve surgery is reasonable during pregnancy.13–16","For pregnant women experiencing severe valve regurgitation and NYHA class IV heart failure symptoms (Stage D) that do not respond to medical treatment, undergoing valve surgery during pregnancy is a reasonable option."
id_01211,"In patients with AF and valve disease other than moderate or greater mitral stenosis or a mechanical heart valve, DOACs are recommended over VKAs.2–8","For patients with atrial fibrillation and valve disease, excluding those with moderate or severe mitral stenosis or a mechanical heart valve, direct oral anticoagulants are preferred over vitamin K antagonists."
id_01212,"For patients with AFL, anticoagulant therapy is recommended according to the same risk profile used for AF.1–3","For individuals with AFL, anticoagulant treatment should be administered based on the same risk criteria applied to AF.1–3"
id_02172,"In pregnant women with VHD, valve surgeries should not be performed in the absence of severe HF symptoms refractory to medical therapy.13–16",Valve surgeries should be avoided in pregnant women with VHD unless they exhibit severe heart failure symptoms that do not respond to medical treatment.
id_01692,ARNi should not be administered to patients with any history of angioedema.32–35,Patients with any history of angioedema should not receive ARNi.
id_02652,"In patients with spontaneous ICH, monitoring serum glucose is recommended to reduce the risk of hyperglycemia and hypoglycemia.256,299","For patients with spontaneous intracerebral hemorrhage, it is advised to monitor blood glucose levels to minimize the risk of both hyperglycemia and hypoglycemia."
id_01693,"ACEi should not be administered to patients with any history of angioedema.36–39 *See Section 7.2, “Diuretics and Decongestion Strategies in Patients with",Patients with any history of angioedema should not receive ACE inhibitors.
id_01213,"In patients with AFL who undergo successful cardioversion or ablation resulting in restoration of sinus rhythm, anticoagulation should be continued for at least 4 weeks postprocedure.1–4","For patients with AFL who achieve sinus rhythm restoration through successful cardioversion or ablation, anticoagulation therapy should be maintained for a minimum of 4 weeks following the procedure."
id_00253,"In patients undergoing PCI, a loading dose of aspirin, followed by daily dosing, is recom- mended to reduce ischemic events.1-4* *Contraindications to ticagrelor: previous intracranial hemorrhage or ongoing bleeding. Contraindications to prasugrel: previous intracranial hemorrhage, previ- ous ischemic stroke or transient ischemic attack, or ongoing bleeding. Prasugrel should be used with caution at a lower dose in patients ≥75 years of age or with a body weight <60 kg. Downloaded from http://ahajournals.org by on June 19, 2025","For patients undergoing PCI, it is advised to administer an initial high dose of aspirin, followed by a daily dose, to minimize ischemic events.1-4* *Ticagrelor should not be used in cases of previous intracranial hemorrhage or active bleeding. Prasugrel is contraindicated in patients with a history of intracranial hemorrhage, ischemic stroke, transient ischemic attack, or active bleeding. In patients aged 75 or older or weighing less than 60 kg, prasugrel should be used cautiously at a reduced dose."
id_02653,"In patients with spontaneous ICH, treating hypoglycemia (<40–60 mg/d, <2.2–3.3 mmol/L) is recommended to reduce mortal- ity.299–301","For patients experiencing spontaneous ICH, it is advised to manage hypoglycemia (below 40–60 mg/dL or 2.2–3.3 mmol/L) to decrease mortality."
id_02173,"Women with a prosthetic valve should undergo pre-pregnancy assessment, including echocardiography, by a cardiologist with expertise in managing women with VHD during pregnancy.","Women with a prosthetic valve should have a pre-pregnancy evaluation, including an echocardiogram, conducted by a cardiologist experienced in handling VHD in pregnant women."
id_00254,"In patients with ACS undergoing PCI, a load- ing dose of P2Y12 inhibitor, followed by daily dosing, is recommended to reduce ischemic events.5-15","For patients with ACS receiving PCI, it is advised to administer a loading dose of a P2Y12 inhibitor, followed by daily doses, to decrease ischemic events."
id_01214,"Patients with typical AFL who have undergone suc- cessful CTI ablation and have had AF previously detected before AFL ablation should receive ongoing oral anticoagulation postablation as indicated for AF.5,6",Patients with typical AFL who have successfully undergone CTI ablation and have a history of AF prior to AFL ablation should continue oral anticoagulation therapy post-ablation as recommended for AF.
id_01694,"In patients with HFrEF, with current or previ- ous symptoms, use of 1 of the 3 beta blockers proven to reduce mortality (eg, bisoprolol, carvedilol, sustained-release metoprolol succi- nate) is recommended to reduce mortality and hospitalizations.1–3 Value Statement: High Value (A)","For patients with HFrEF who have present or past symptoms, it is advised to administer one of the three beta blockers shown to lower mortality, such as bisoprolol, carvedilol, or sustained-release metoprolol succinate, to decrease mortality and hospital admissions."
id_01215,"Patients with typical AFL who have undergone suc- cessful CTI ablation and are deemed to be at high thromboembolic risk, without any known previous history of AF, should receive close follow-up and arrhythmia monitoring to detect silent AF if they are not receiving ongoing anticoagulation in view of significant risk of AF.7–9","Patients with typical AFL who have successfully undergone CTI ablation and are considered at high risk for thromboembolism, without any prior AF history, should be closely monitored for arrhythmias to identify silent AF if they are not on continuous anticoagulation due to the significant risk of AF."
id_02654,"In patients with spontaneous ICH, treating moderate to severe hyperglycemia (>180– 200 mg/dL, >10.0–11.1 mmol/L) is reason- able to improve outcomes.78,302–307","For patients experiencing spontaneous intracerebral hemorrhage, managing moderate to severe hyperglycemia (greater than 180–200 mg/dL or 10.0–11.1 mmol/L) is advisable to enhance outcomes."
id_00255,"In patients with SIHD undergoing PCI, a loading dose of clopidogrel, followed by daily dosing, is recommended to reduce ischemic events.8,12,15-19","For patients with SIHD undergoing PCI, it is advised to administer an initial loading dose of clopidogrel, followed by daily doses, to decrease ischemic events."
id_02655,"In patients with spontaneous ICH, pharma- cologically treating an elevated temperature may be reasonable to improve functional out- comes.311–313","For patients with spontaneous ICH, managing a high temperature with medication might be advisable to enhance functional outcomes."
id_02175,Women with mechanical heart valves considering pregnancy should be counselled that pregnancy is high risk and that there is no anticoagulation strategy that is consistently safe for the mother and baby.3–6,Women with mechanical heart valves who are contemplating pregnancy should be advised that it poses significant risks and that no anticoagulation approach is reliably safe for both the mother and the child.
id_01695,"In patients with HFrEF and NYHA class II to IV symptoms, an MRA (spironolactone or eplere- none) is recommended to reduce morbidity and mortality, if eGFR is >30 mL/min/1.73 m2 and serum potassium is <5.0 mEq/L. Careful moni- toring of potassium, renal function, and diuretic dosing should be performed at initiation and closely monitored thereafter to minimize risk of hyperkalemia and renal insufficiency.1–3 Value Statement: High Value (A)","For patients with HFrEF and NYHA class II to IV symptoms, it is advised to use an MRA (spironolactone or eplerenone) to decrease morbidity and mortality, provided that eGFR exceeds 30 mL/min/1.73 m² and serum potassium is below 5.0 mEq/L. Potassium levels, kidney function, and diuretic dosing should be carefully monitored at the start and closely observed thereafter to reduce the risk of hyperkalemia and renal impairment. Value Statement: High Value (A)"
id_00256,"In patients undergoing PCI within 24 hours after fibrinolytic therapy, a loading dose of 300 mg of clopidogrel, followed by daily dosing, is recommended to reduce ischemic events.5","For patients receiving PCI within 24 hours post-fibrinolytic therapy, it is advised to administer a 300 mg loading dose of clopidogrel, followed by daily doses, to decrease ischemic events."
id_01696,"In patients taking MRA whose serum potas- sium cannot be maintained at <5.5 mEq/L, MRA should be discontinued to avoid life- threatening hyperkalemia.8,9","For patients on MRA who cannot maintain serum potassium levels below 5.5 mEq/L, discontinuing MRA is necessary to prevent life-threatening hyperkalemia."
id_01216,"In patients with typical AFL who have undergone successful CTI ablation without any known previous history of AF who are at high risk for development of AF (eg, LA enlargement, inducible AF, chronic obstructive pulmonary disease [COPD], HF), it may be reasonable to prescribe long-term anticoagulation if thromboembolic risk assessment suggests high risk (>2% annual risk) for stroke.5,10–13 *This section refers to typical right-sided (CTI-dependent) AFL. Left-sided AFLs or atrial tachycardias (ATs) that develop after ablation of AF should be anticoagulated and managed in a manner similar to AF. “Typical” AFL is defined as either typical counterclockwise AFL when the macroreentrant circuit is de- pendent on the CTI using the isthmus from the patient’s right to left or typical clockwise AFL when the macroreentrant circuit is dependent on the CTI and uses this isthmus from the patient’s left to right. “Atypical” AFL is not dependent on the CTI and may arise from a macroreentrant circuit in the LA, such as perimitral or","For patients with typical AFL who have successfully undergone CTI ablation and have no prior AF history but are at high risk for AF development (e.g., LA enlargement, inducible AF, COPD, HF), long-term anticoagulation may be advisable if the thromboembolic risk assessment indicates a high stroke risk (>2% annual risk). This applies to typical right-sided (CTI-dependent) AFL. Left-sided AFLs or atrial tachycardias (ATs) emerging post-AF ablation should be anticoagulated and managed similarly to AF. ""Typical"" AFL refers to either typical counterclockwise AFL, where the macroreentrant circuit relies on the CTI using the isthmus from right to left, or typical clockwise AFL, where the circuit depends on the CTI using the isthmus from left to right. ""Atypical"" AFL does not rely on the CTI and may originate from a macroreentrant circuit in the LA, such as perimitral."
id_02176,Pregnant women with a mechanical prosthetic valve who have prosthetic valve obstruction or experience an embolic event should undergo a TEE.7–9,Pregnant women with a mechanical prosthetic valve who develop prosthetic valve obstruction or have an embolic event should receive a TEE.
id_00257,"In patients with ACS undergoing PCI, it is reasonable to use ticagrelor or prasugrel in preference to clopidogrel to reduce ischemic events, including stent thrombosis.6,14,20","For patients with ACS receiving PCI, opting for ticagrelor or prasugrel over clopidogrel is advisable to lower the risk of ischemic events, such as stent thrombosis."
id_02174,"Pregnant women with a mechanical prosthesis should be monitored in a tertiary-care center with a dedicated MDT of cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians with expertise in the management of high-risk cardiac conditions during pregnancy.1–3","Pregnant patients with a mechanical heart valve should receive care at a tertiary center where a specialized multidisciplinary team, including cardiologists, surgeons, anesthesiologists, and maternal-fetal medicine obstetricians, is experienced in managing high-risk cardiac conditions during pregnancy."
id_01217,"In patients with AF, SDM with the patient is recom- mended to discuss rhythm- versus rate-control strategies (taking into consideration clinical presen- tation, comorbidity burden, medication profile, and patient preferences), discuss therapeutic options, and for assessing long-term benefits.1–3","For patients with AF, it is advised to engage in shared decision-making with the patient to evaluate rhythm versus rate control strategies, considering clinical presentation, comorbidities, medication profile, and patient preferences, as well as to discuss treatment options and assess long-term benefits."
id_02177,Pregnant women with mechanical prostheses should receive therapeutic anticoagulation with frequent monitoring during pregnancy.1–10,Pregnant women with mechanical heart valves should undergo therapeutic anticoagulation with regular monitoring throughout pregnancy.
id_01697,"In patients with symptomatic chronic HFrEF, SGLT2i are recommended to reduce hospital- ization for HF and cardiovascular mortality, irre- spective of the presence of type 2 diabetes.1,2 Value Statement: Intermediate Value (A)","For patients with symptomatic chronic HFrEF, it is advised to use SGLT2 inhibitors to decrease the risk of heart failure-related hospitalizations and cardiovascular death, regardless of whether type 2 diabetes is present."
id_01218,"In patients with AF without HF who are candidates for select rate-control strategies, heart rate target should be guided by underlying patient symptoms, in general aiming at a resting heart rate of <100 to 110 bpm.2,4–6","For patients with AF but not HF, eligible for specific rate-control methods, the heart rate target should be determined by patient symptoms, generally aiming for a resting heart rate below 100 to 110 bpm."
id_00258,"In patients <75 years of age undergoing PCI within 24 hours after fibrinolytic therapy, ticagrelor may be a reasonable alternative to clopidogrel to reduce ischemic events.21","For patients younger than 75 years who undergo PCI within 24 hours following fibrinolytic therapy, ticagrelor could be a suitable alternative to clopidogrel for reducing ischemic events."
id_02657,"In patients with spontaneous ICH, impaired consciousness, and confirmed electrographic seizures, antiseizure drugs should be adminis- tered to reduce morbidity.325,326","For patients experiencing spontaneous intracerebral hemorrhage, impaired consciousness, and confirmed electrographic seizures, antiseizure medications should be given to decrease morbidity."
id_02178,"Women with mechanical heart valves who cannot maintain therapeutic anticoagulation with frequent monitoring should be counseled against pregnancy.7,8,10–15",Women with mechanical heart valves who are unable to sustain therapeutic anticoagulation despite regular monitoring should be advised to avoid pregnancy.
id_00259,"In patients undergoing PCI who have a history of stroke or transient ischemic attack, prasug- rel should not be administered.6",Prasugrel should be avoided in patients with a history of stroke or transient ischemic attack who are undergoing PCI.
id_02658,"In patients with spontaneous ICH and clinical seizures, antiseizure drugs are recommended to improve functional outcomes and prevent brain injury from prolonged recurrent seizures.","For patients experiencing spontaneous intracerebral hemorrhage and clinical seizures, it is advised to use antiseizure medications to enhance functional recovery and avert brain damage from extended recurrent seizures."
id_02656,"In patients with spontaneous ICH, the usefulness of therapeutic hypothermia (<35° C/95 °F) to decrease peri-ICH edema is unclear.314–317",The effectiveness of therapeutic hypothermia (below 35°C/95°F) in reducing peri-ICH edema in patients with spontaneous intracerebral hemorrhage is uncertain.
id_01698,"For patients self-identified as African American with NYHA class III-IV HFrEF who are receiv- ing optimal medical therapy, the combination of hydralazine and isosorbide dinitrate is rec- ommended to improve symptoms and reduce morbidity and mortality.1,2 Value Statement: High Value (B-NR)","For African American patients with NYHA class III-IV HFrEF on optimal medical treatment, it is advised to use a combination of hydralazine and isosorbide dinitrate to enhance symptoms and decrease morbidity and mortality."
id_01219,"In patients with AF with rapid ventricular response who are hemodynamically stable, beta blockers or nondihydropyridine calcium channel blockers (vera- pamil, diltiazem; provided that EF >40%) are recom- mended for acute rate control (Figure 17).1–4","For patients with atrial fibrillation and a rapid ventricular response who remain hemodynamically stable, it is advised to use beta blockers or nondihydropyridine calcium channel blockers (such as verapamil or diltiazem, assuming the ejection fraction is greater than 40%) for immediate rate management."
id_01699,"In patients with current or previous symp- tomatic HFrEF who cannot be given first-line agents, such as ARNi, ACEi, or ARB, because of drug intolerance or renal insufficiency, a combination of hydralazine and isosorbide dini- trate might be considered to reduce morbidity and mortality.4,5","For patients with symptomatic HFrEF, either current or past, who cannot tolerate first-line treatments like ARNi, ACEi, or ARB due to drug intolerance or kidney issues, using a combination of hydralazine and isosorbide dinitrate may be an option to decrease morbidity and mortality."
id_02659,"In patients with spontaneous ICH and unex- plained abnormal or fluctuating mental status or suspicion of seizures, continuous electro- encephalography (≥24 hours) is reasonable to diagnose electrographic seizures and epilepti- form discharges.327","For patients experiencing spontaneous intracerebral hemorrhage with unexplained abnormal or variable mental status or suspected seizures, it is advisable to use continuous electroencephalography (for at least 24 hours) to identify electrographic seizures and epileptiform discharges."
id_02179,"Women with mechanical heart valves and their providers should use shared decision- making to choose an anticoagulation strategy for pregnancy. Women should be informed that VKA during pregnancy is associated with the lowest likelihood of maternal complications but the highest likelihood of miscarriage, fetal death, and congenital abnormalities, particularly if taken during the first trimester and if the warfarin dose exceeds 5 mg/d.3–6,11,14,16","Women with mechanical heart valves and their healthcare providers should engage in shared decision-making to determine an anticoagulation plan for pregnancy. It is important for women to understand that using VKA during pregnancy presents the lowest risk of maternal complications but increases the risk of miscarriage, fetal death, and congenital abnormalities, especially when taken in the first trimester and if the warfarin dose is more than 5 mg per day."
id_00260,"In patients undergoing PCI who are P2Y12 inhibitor naïve, intravenous cangrelor may be reasonable to reduce periprocedural ischemic events.1-3","For patients who have not previously received a P2Y12 inhibitor and are undergoing PCI, administering intravenous cangrelor can be a reasonable option to decrease the risk of ischemic events during the procedure."
id_01700,"In patients with HF class II to IV symptoms, omega-3 polyunsaturated fatty acid (PUFA) supplementation may be reasonable to use as adjunctive therapy to reduce mortality and car- diovascular hospitalizations.1–4","For patients exhibiting HF class II to IV symptoms, it may be appropriate to consider omega-3 polyunsaturated fatty acid (PUFA) supplementation as an additional treatment to lower mortality and cardiovascular hospitalizations."
id_02660,"In patients with spontaneous ICH without evidence of seizures, prophylactic antiseizure medication is not beneficial to improve func- tional outcomes, long-term seizure control, or mortality.328–331 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing spontaneous intracerebral hemorrhage without seizure activity, using antiseizure medications as a preventive measure does not enhance functional recovery, long-term seizure management, or survival rates."
id_01220,"In patients with AF with rapid ventricular response in whom beta blockers and nondihydropyridine calcium channel blockers are ineffective or contraindicated, digoxin can be considered for acute rate control, either alone or in combination with the aforemen- tioned agents.5–9","For patients with AF experiencing rapid ventricular response where beta blockers and nondihydropyridine calcium channel blockers are either ineffective or not suitable, digoxin may be used for acute rate control, either by itself or alongside the previously mentioned medications."
id_02180,"Pregnant women with mechanical valve prostheses who are on warfarin should switch to twice-daily LMWH (with a target anti-Xa level of 0.8 U/mL to 1.2 U/mL at 4 to 6 hours after dose) or intravenous UFH (with an activated partial thromboplastin time [aPTT] 2 times control) at least 1 week before planned delivery.5,8,13,17–20","Women who are pregnant and have mechanical heart valves on warfarin should transition to twice-daily LMWH, aiming for an anti-Xa level between 0.8 U/mL and 1.2 U/mL 4 to 6 hours post-dose, or to intravenous UFH, maintaining an aPTT twice the control, at least one week prior to the scheduled delivery."
id_01221,"In patients with AF with rapid ventricular response, the addition of intravenous magnesium to standard rate-control measures is reasonable to achieve and maintain rate control.10,11","For patients experiencing AF with a rapid ventricular response, incorporating intravenous magnesium alongside standard rate-control strategies is a reasonable approach to achieve and sustain rate control."
id_00261,"In patients with ACS undergoing PCI with large thrombus burden, no-reflow, or slow flow, intravenous glycoprotein IIb/IIIa inhibitor agents are reasonable to improve procedural success.1,2","For patients with ACS undergoing PCI who have a significant thrombus burden, experience no-reflow, or slow flow, it is reasonable to use intravenous glycoprotein IIb/IIIa inhibitors to enhance procedural success."
id_02661,"In patients with spontaneous ICH or IVH and hydrocephalus that is contributing to decreased level of consciousness, ventricular drainage should be performed to reduce mor- tality.347–350","For patients experiencing spontaneous ICH or IVH with hydrocephalus leading to reduced consciousness, ventricular drainage is advised to lower mortality rates."
id_00262,"In patients with SIHD undergoing PCI, the routine use of an intravenous glycoprotein IIb/ IIIa inhibitor agent is not recommended.3-5","For patients with SIHD receiving PCI, it is not advised to routinely administer an intravenous glycoprotein IIb/IIIa inhibitor."
id_02181,Pregnant women with mechanical valve prostheses who are on LMWH should switch to UFH (with an aPTT 2 times control) at least 36 hours before planned delivery.19–21,"Pregnant women with mechanical heart valves on LMWH should transition to UFH, maintaining an aPTT twice the control, at least 36 hours prior to scheduled delivery."
id_01222,"In patients with AF with rapid ventricular response who are critically ill and/or in decompensated HF in whom beta blockers and nondihydropyridine calcium channel blockers are ineffective or contraindicated, intravenous amiodarone may be considered for acute rate control.*12,13","For critically ill patients with AF and rapid ventricular response, or those with decompensated heart failure where beta blockers and nondihydropyridine calcium channel blockers are either ineffective or contraindicated, intravenous amiodarone can be considered for acute rate control."
id_01701,"In patients with HF who experience hyperkale- mia (serum potassium level ≥5.5 mEq/L) while taking a renin-angiotensin-aldosterone system inhibitor (RAASi), the effectiveness of potas- sium binders (patiromer, sodium zirconium cyclosilicate) to improve outcomes by facilitat- ing continuation of RAASi therapy is uncer- tain.5,6","For patients with heart failure (HF) who develop hyperkalemia (serum potassium level ≥5.5 mEq/L) while on a renin-angiotensin-aldosterone system inhibitor (RAASi), the benefit of using potassium binders like patiromer or sodium zirconium cyclosilicate to enhance outcomes by allowing continued RAASi therapy remains uncertain."
id_02182,Pregnant women with valve prostheses should stop UFH at least 6 hours before planned vaginal delivery.19–21,Women who are pregnant and have valve prostheses should discontinue UFH a minimum of 6 hours prior to a scheduled vaginal delivery.
id_02662,"In patients with moderate to severe spon- taneous ICH or IVH with a reduced level of consciousness, ICP monitoring and treatment might be considered to reduce mortality and improve outcomes.159,351–356","For patients experiencing moderate to severe spontaneous ICH or IVH with decreased consciousness, considering ICP monitoring and management may help lower mortality and enhance outcomes."
id_00263,"In patients undergoing PCI, administration of intravenous unfractionated heparin (UFH) is useful to reduce ischemic events.","For patients receiving PCI, using intravenous unfractionated heparin (UFH) is beneficial in decreasing ischemic events."
id_01702,"In patients with chronic HFrEF without a spe- cific indication (eg, venous thromboembolism [VTE], AF, a previous thromboembolic event, or a cardioembolic source), anticoagulation is not recommended.7–9","For patients with chronic HFrEF who do not have a specific indication such as venous thromboembolism, atrial fibrillation, a prior thromboembolic event, or a cardioembolic source, anticoagulation is not advised."
id_01703,"In patients with HFrEF, dihydropyridine calcium channel-blocking drugs are not recommended treatment for HF.1,2","For patients with HFrEF, dihydropyridine calcium channel blockers are not advised as a treatment for heart failure."
id_01223,"In patients with AF, beta blockers or nondihydropyri- dine calcium channel blockers (diltiazem, verapamil) are recommended for long-term rate control with the choice of agent according to underlying substrate and comorbid conditions.1,2","For patients with AF, long-term rate control is advised using beta blockers or nondihydropyridine calcium channel blockers (such as diltiazem or verapamil), with the selection based on the underlying condition and any comorbidities."
id_02183,"If labor begins or urgent delivery is required in a woman therapeutically anticoagulated with a VKA, cesarean section should be performed after reversal of anticoagulation.3,22,23","In cases where a woman on therapeutic VKA anticoagulation goes into labor or needs an urgent delivery, a cesarean section should be conducted following the reversal of anticoagulation."
id_02663,"In patients with spontaneous ICH, the efficacy of early prophylactic hyperosmolar therapy for improving outcomes is not well estab- lished.357–361","For patients with spontaneous ICH, the effectiveness of initiating prophylactic hyperosmolar therapy early to enhance outcomes remains uncertain."
id_01224,"For patients with AF in whom measuring serum digoxin levels is indicated, it is reasonable to target levels <1.2 ng/mL.3–6","For patients with atrial fibrillation requiring serum digoxin level monitoring, aiming for levels below 1.2 ng/mL is advisable."
id_00264,"In patients with heparin-induced thrombocyto- penia undergoing PCI, bivalirudin or argatro- ban should be used to replace UFH to avoid thrombotic complications.1,2","For patients experiencing heparin-induced thrombocytopenia who are undergoing PCI, it is advised to substitute UFH with bivalirudin or argatroban to prevent thrombotic complications."
id_01704,"In patients with HFrEF, vitamins, nutritional supplements, and hormonal therapy are not recommended other than to correct specific deficiencies.3–9","For patients with HFrEF, it is advised against using vitamins, nutritional supplements, and hormonal therapy except to address particular deficiencies."
id_00265,"In patients undergoing PCI, bivalirudin may be a reasonable alternative to UFH to reduce bleeding.3-12","For patients receiving PCI, bivalirudin can be considered as a suitable substitute for UFH to decrease bleeding risk."
id_02185,"For pregnant women with mechanical prostheses who require >5 mg/d of warfarin to achieve a therapeutic INR, dose-adjusted LMWH (with a target anti-Xa level of 0.8 to","For pregnant women with mechanical prosthetic heart valves needing more than 5 mg/day of warfarin to maintain a therapeutic INR, adjust the dose of LMWH to target an anti-Xa level of 0.8."
id_02664,"In patients with spontaneous ICH, bolus hyperosmolar therapy may be considered for transiently reducing ICP.362–364","For patients experiencing spontaneous ICH, administering a bolus of hyperosmolar therapy can be contemplated to temporarily lower ICP."
id_02665,"In patients with spontaneous ICH, corticoste- roids should not be administered for treatment of elevated ICP.365–369 Downloaded from http://ahajournals.org by on June 19, 2025",Corticosteroids should not be used to treat increased intracranial pressure in patients with spontaneous intracerebral hemorrhage.
id_01225,"In patients with AF and HF symptoms, digoxin is reasonable for long-term rate control in combination with other rate-controlling agents, or as monotherapy if other agents are not preferred, not tolerated, or contraindicated.7–9","For patients with AF and HF symptoms, digoxin can be considered for long-term rate control alongside other rate-controlling medications, or as a single therapy if other options are unsuitable, not tolerated, or contraindicated."
id_02184,"For pregnant women with mechanical prostheses who require a dose of warfarin ≤5 mg/d to maintain a therapeutic INR, continuation of warfarin for all 3 trimesters is reasonable after full discussion with the patient about risks and benefits.3,6,16,18,22,24,25","For pregnant women with mechanical heart valves needing warfarin doses of 5 mg/day or less to sustain a therapeutic INR, it is reasonable to continue warfarin throughout all three trimesters after thoroughly discussing the risks and benefits with the patient."
id_00266,"In patients treated with upstream subcutane- ous enoxaparin for unstable angina or NSTE- ACS, the use of intravenous enoxaparin may be considered at the time of PCI to reduce ischemic events.13-17","For patients receiving subcutaneous enoxaparin for unstable angina or NSTE-ACS, intravenous enoxaparin can be considered during PCI to decrease ischemic events."
id_01706,"In patients with HFrEF, class IC antiarrhythmic medications and dronedarone may increase the risk of mortality.14–16","For patients with HFrEF, the use of class IC antiarrhythmic drugs and dronedarone can elevate the risk of death."
id_02666,"For patients with supratentorial ICH of >20- to 30-mL volume with GCS scores in the moder- ate range (5–12), minimally invasive hematoma evacuation with endoscopic or stereotactic aspiration with or without thrombolytic use can be useful to reduce mortality compared with medical management alone.379–388","For patients experiencing supratentorial intracerebral hemorrhage with a volume exceeding 20 to 30 mL and Glasgow Coma Scale scores between 5 and 12, minimally invasive hematoma removal using endoscopic or stereotactic aspiration, optionally combined with thrombolytics, may help lower mortality rates compared to solely medical management."
id_01227,"In patients with AF and uncontrolled rapid ventricular response refractory to rate-control medications (who are not candidates for or in whom rhythm control has been unsuccessful), AVNA can be useful to improve symptoms and QOL.3–6","For patients with AF experiencing uncontrolled rapid ventricular response that does not respond to rate-control drugs, and who are unsuitable for or have not benefited from rhythm control, AVNA may help alleviate symptoms and enhance QOL."
id_01226,"In patients with AF and a persistently rapid ventricular response who undergo AVNA, initial pacemaker lower rate programming should be 80 to 90 bpm to reduce the risk of sudden death.1,2","For patients with AF experiencing a consistently rapid ventricular response who receive AVNA, the initial pacemaker lower rate should be set to 80 to 90 bpm to minimize the risk of sudden death."
id_02186,"For pregnant women with mechanical prostheses who require a dose of warfarin >5 mg/d to achieve a therapeutic INR, and for whom dose-adjusted LMWH is unavailable, dose-adjusted continuous intravenous UFH during the first trimester (with aPTT 2 times control), followed by warfarin for the second and third trimesters, is reasonable.3,6,11,16 Downloaded from http://ahajournals.org by on June 19, 2025","For pregnant women with mechanical heart valves needing more than 5 mg/day of warfarin to maintain a therapeutic INR, and when dose-adjusted LMWH is not an option, it is reasonable to use dose-adjusted continuous IV UFH during the first trimester (targeting an aPTT twice the control), then switch to warfarin for the second and third trimesters."
id_00267,"In patients on therapeutic subcutaneous enoxaparin, in whom the last dose was admin- istered within 12 hours of PCI, UFH should not be used for PCI and may increase bleed- ing.14,18,19","For patients receiving therapeutic subcutaneous enoxaparin with their last dose given within 12 hours prior to PCI, UFH should be avoided during PCI as it may elevate the risk of bleeding."
id_01707,"In patients with HFrEF, thiazolidinediones increase the risk of worsening HF symptoms and hospitalizations.17–21","For patients with HFrEF, thiazolidinediones elevate the risk of exacerbating heart failure symptoms and increasing hospital admissions."
id_01705,"In patients with HFrEF, nondihydropyridine calcium channel-blocking drugs are not recom- mended.10–13",Nondihydropyridine calcium channel blockers are not advised for patients with HFrEF.
id_02187,"For hemodynamically stable pregnant women with obstructive left-sided mechanical valve thrombosis, it is reasonable to manage with slow-infusion, low-dose fibrinolytic therapy.26","For pregnant women who are hemodynamically stable and have obstructive thrombosis of a left-sided mechanical valve, administering low-dose fibrinolytic therapy via slow infusion is a reasonable management approach."
id_00268,"For patients undergoing CABG, establishment of multidisciplinary, evidence-based periopera- tive management programs is recommended to optimize analgesia, minimize opioid expo- sure, prevent complications and to reduce time to extubation, length of stay, and health care costs.1-3","It is advised to implement multidisciplinary, evidence-based perioperative management programs for patients undergoing CABG to enhance pain control, limit opioid use, prevent complications, and decrease extubation time, hospital stay duration, and healthcare expenses."
id_01228,"In patients with AF who are planned to undergo AVNA, implantation of a pacemaker before the ablation (ie, before or same day of ablation) is recommended to ensure adequacy of the pacing leads before performing ablation.7–9","For patients with AF scheduled for AVNA, it is advised to implant a pacemaker prior to or on the same day as the ablation to confirm the adequacy of the pacing leads before proceeding with the ablation."
id_02667,"For patients with supratentorial ICH of >20- to 30-mL volume with GCS scores in the moderate range (5–12) being considered for hematoma evacuation, it may be reasonable to select minimally invasive hematoma evacu- ation over conventional craniotomy to improve functional outcomes.382,383,385–387,389,390","For patients with supratentorial ICH exceeding 20 to 30 mL in volume and GCS scores between 5 and 12, considering hematoma evacuation, opting for minimally invasive techniques instead of traditional craniotomy might be advisable to enhance functional outcomes."
id_01708,"In patients with type 2 diabetes and high cardiovascular risk, the dipeptidyl pepti- dase-4 (DPP-4) inhibitors saxagliptin and alogliptin increase the risk of HF hospitaliza- tion and should be avoided in patients with HF.22–24","For patients with type 2 diabetes who are at high risk for cardiovascular issues, the use of DPP-4 inhibitors such as saxagliptin and alogliptin raises the likelihood of hospitalization due to heart failure and should be avoided in those with heart failure."
id_00269,"In patients undergoing isolated CABG, the use of a radial artery is recommended in prefer- ence to a saphenous vein conduit to graft the second most important, significantly stenosed, non–LAD vessel to improve long-term cardiac outcomes.1-3","For patients having isolated CABG, it is advised to use a radial artery instead of a saphenous vein conduit for grafting the second most critical, significantly narrowed, non-LAD vessel to enhance long-term cardiac outcomes."
id_02668,"For patients with supratentorial ICH of >20- to 30-mL volume with GCS scores in the moderate range (5–12), the effectiveness of minimally invasive hematoma evacuation with endoscopic or stereotactic aspiration with or without thrombolytic use to improve functional outcomes is uncertain.379–385,387,388 Downloaded from http://ahajournals.org by on June 19, 2025","The benefit of minimally invasive hematoma removal using endoscopic or stereotactic aspiration, with or without thrombolytics, for patients with supratentorial ICH volumes exceeding 20 to 30 mL and moderate GCS scores (5–12) remains unclear."
id_01709,"In patients with HFrEF, NSAIDs worsen HF symptoms and should be avoided or withdrawn whenever possible.25–28","For patients with HFrEF, NSAIDs exacerbate heart failure symptoms and should be avoided or discontinued whenever feasible."
id_01229,"In patients with AF with normal EF undergoing AVNA, conduction system pacing of the His bundle10–13 or left bundle area12,13 may be reasonable.","For patients with AF and normal EF undergoing AVNA, pacing of the His bundle or left bundle area may be considered appropriate."
id_02188,"For pregnant women with mechanical prostheses who require a warfarin dose >5 mg/d to achieve a therapeutic INR, dose- adjusted LMWH (with a target anti-Xa level of 0.8 to 1.2 U/mL at 4 to 6 hours after dose) at least 2 times per day for all 3 trimesters may be considered.3,6,14–16,27","For pregnant women with mechanical heart valves needing more than 5 mg/day of warfarin to maintain a therapeutic INR, it may be advisable to use dose-adjusted LMWH, targeting an anti-Xa level of 0.8 to 1.2 U/mL 4 to 6 hours post-dose, administered at least twice daily throughout all three trimesters."
id_02669,"For patients with spontaneous ICH, large IVH, and impaired level of consciousness, EVD is recommended in preference to medical man- agement alone to reduce mortality.347–349","For patients experiencing spontaneous ICH, significant IVH, and decreased consciousness, EVD is advised over solely medical management to lower mortality rates."
id_01230,"In patients with reduced LV function and persistent (or high burden) AF, a trial of rhythm control should be recommended to evaluate whether AF is contributing to the reduced LV function.1–6","For patients with diminished LV function and ongoing or significant AF, it is advisable to attempt rhythm control to assess if AF is affecting the reduced LV function."
id_02189,"For pregnant women with mechanical prostheses who require a dose of warfarin ≤5 mg/d to maintain a therapeutic INR, dose-adjusted LMWH at least 2 times per day during the first trimester, followed by warfarin for the second and third trimesters, may be considered.1–3,6,12,16,22","For pregnant women with mechanical heart valves needing ≤5 mg/day of warfarin to sustain a therapeutic INR, it may be advisable to use dose-adjusted LMWH twice daily in the first trimester, then switch to warfarin for the second and third trimesters."
id_00270,"In patients undergoing CABG, an IMA, prefer- ably the left, should be used to bypass the LAD when bypass of the LAD is indicated to improve survival and reduce recurrent isch- emic events.4-9","For patients receiving CABG, the left IMA should ideally be utilized to bypass the LAD when indicated, as this improves survival and decreases recurrent ischemic events."
id_02190,"For pregnant women with mechanical prostheses, aspirin 75 to 100 mg daily may be considered, in addition to anticoagulation, if needed for other indications.28","For pregnant women with mechanical prosthetic heart valves, a daily dose of 75 to 100 mg of aspirin can be considered alongside anticoagulation therapy if required for other reasons."
id_01231,"In patients with symptomatic AF, rhythm control can be useful to improve symptoms.7–11","For patients experiencing symptoms from AF, rhythm control may be beneficial for symptom improvement."
id_00271,"In patients undergoing CABG, bilateral IMA (BIMA) grafting by experienced operators can be beneficial in appropriate patients to improve long-term cardiac outcomes.3,10-12","For patients receiving CABG, utilizing BIMA grafting by skilled surgeons may enhance long-term cardiac outcomes in suitable candidates."
id_01710,"In patients with HFrEF, titration of guideline- directed medication dosing to achieve target doses showed to be efficacious in RCTs is rec- ommended, to reduce cardiovascular mortality and HF hospitalizations, unless not well toler- ated.1–10","For patients with HFrEF, it is advised to adjust the doses of guideline-recommended medications to reach target levels proven effective in RCTs, to lower cardiovascular mortality and HF hospitalizations, unless the patient cannot tolerate it."
id_02670,"For patients with a GCS score >3 and primary IVH or IVH extension from spontaneous supra- tentorial ICH of <30-mL volume requiring EVD, minimally invasive IVH evacuation with EVD plus thrombolytic is safe and is reasonable compared with EVD alone to reduce mortality.415–418","For patients with a GCS score greater than 3 and primary IVH or IVH extension from spontaneous supratentorial ICH with a volume less than 30 mL who require EVD, using minimally invasive IVH evacuation with EVD and thrombolytic therapy is safe and a reasonable option compared to EVD alone for reducing mortality."
id_01711,"In patients with HFrEF, titration and optimiza- tion of guideline-directed medications as frequently as every 1 to 2 weeks depending on the patient’s symptoms, vital signs, and labora- tory findings can be useful to optimize manage- ment.","For patients with HFrEF, adjusting and optimizing guideline-recommended medications every 1 to 2 weeks, based on the patient's symptoms, vital signs, and lab results, can be beneficial for optimal management."
id_02191,"For pregnant women with mechanical prostheses, LMWH should not be administered unless anti-Xa levels are monitored 4 to 6 hours after administration and dose is adjusted according to levels.8–10,15,27",LMWH should only be given to pregnant women with mechanical prostheses if anti-Xa levels are checked 4 to 6 hours post-administration and the dosage is modified based on these levels.
id_01232,"In patients with a recent diagnosis of AF (<1 year), rhythm control can be useful to reduce hospitaliza- tions, stroke, and mortality.12–14","For patients diagnosed with AF within the past year, rhythm control may help decrease hospital admissions, stroke risk, and mortality."
id_02671,"For patients with a GCS score >3 and pri- mary IVH or IVH extension from spontane- ous supratentorial ICH of <30-mL volume requiring EVD, the effectiveness of minimally invasive IVH evacuation with EVD plus throm- bolytic use to improve functional outcomes is uncertain.382,407,415–419","For patients with a GCS score greater than 3 and primary IVH or IVH extension from spontaneous supratentorial ICH with a volume less than 30 mL who require EVD, the benefit of minimally invasive IVH evacuation using EVD combined with thrombolytics to enhance functional outcomes remains unclear."
id_00272,"In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have significant CAD, CABG is recommended with a goal of reducing ischemic events.1-11","For patients having valve, aortic, or other heart surgeries with notable CAD, CABG is advised to minimize ischemic events."
id_02192,"For patients with mechanical valve prostheses, anticoagulation with the direct thrombin inhibitor, dabigatran, should not be administered.29",Patients with mechanical valve prostheses should not receive anticoagulation treatment with the direct thrombin inhibitor dabigatran.
id_02672,"For patients with severe spontaneous ICH‚ large IVH, and impaired level of consciousness, the efficacy of EVD for improving functional out- comes is not well established.347–349","The effectiveness of EVD in enhancing functional outcomes for patients with severe spontaneous ICH, extensive IVH, and reduced consciousness levels is not clearly determined."
id_01712,"For patients with symptomatic (NYHA class II to III) stable chronic HFrEF (LVEF ≤35%) who are receiving GDMT, including a beta blocker at maximum tolerated dose, and who are in sinus rhythm with a heart rate of ≥70 bpm at rest, ivabradine can be beneficial to reduce HF hospitalizations and cardiovascular death.1,2","For patients with stable chronic HFrEF (LVEF ≤35%) classified as NYHA class II to III, who are on GDMT including a maximally tolerated dose of a beta blocker, and have a resting heart rate of ≥70 bpm while in sinus rhythm, ivabradine may help decrease the risk of HF hospitalizations and cardiovascular mortality."
id_01233,"In patients with AF and HF, rhythm control can be useful for improving symptoms and improving out- comes, such as mortality and hospitalizations for HF and ischemia.15–19","For patients with AF and HF, rhythm control may be beneficial in alleviating symptoms and enhancing outcomes, including reducing mortality and hospitalizations due to HF and ischemia."
id_01713,"In patients with symptomatic HFrEF despite GDMT (or who are unable to tolerate GDMT), digoxin might be considered to decrease hospi- talizations for HF.1,2","For patients with symptomatic HFrEF who do not respond to or cannot tolerate GDMT, digoxin may be considered to reduce HF-related hospitalizations."
id_02193,The use of anti-Xa direct oral anticoagulants with mechanical heart valves in pregnancy has not been assessed and is not recommended.30–32,"Anti-Xa direct oral anticoagulants are not advised for use with mechanical heart valves during pregnancy, as their effects have not been evaluated."
id_01234,"In patients with AF, rhythm-control strategies can be useful to reduce the likelihood of AF progression.20–27","For patients with AF, employing rhythm-control strategies may help decrease the risk of AF progression."
id_00274,"In patients undergoing CABG, the routine use of epiaortic ultrasound scanning can be useful to evaluate the presence, location, and severity of plaque in the ascending aorta to reduce the incidence of atheroembolic complications.1-10","For patients having CABG, regularly employing epiaortic ultrasound scanning can help assess the presence, location, and severity of plaque in the ascending aorta, thereby decreasing the risk of atheroembolic complications."
id_00273,"In patients undergoing valve surgery, aortic surgery, or other cardiac operations who have intermediate CAD, CABG may be reasonable with a goal of reducing ischemic events.5,7,10,12 Table 12.  Best Practices for the Use of Bypass Conduits in CABG Objectively assess palmar arch completeness and ulnar compensation before harvesting the radial artery. Use the arm with the best ulnar compensation for radial artery harvesting.","For patients having valve, aortic, or other heart surgeries with moderate coronary artery disease, CABG can be considered to decrease ischemic events. Objectively evaluate the completeness of the palmar arch and ulnar compensation prior to radial artery harvesting, and select the arm with superior ulnar compensation for this procedure."
id_02673,"For patients with spontaneous supratentorial ICH of <30-mL volume and IVH requiring EVD, the usefulness of minimally invasive IVH evacuation with neuroendoscopy plus EVD, with or without thrombolytic, to improve func- tional outcomes and reduce permanent shunt dependence is uncertain.419,420","The effectiveness of using minimally invasive neuroendoscopic IVH evacuation combined with EVD, with or without thrombolytics, to enhance functional outcomes and decrease the need for permanent shunts in patients with spontaneous supratentorial ICH of less than 30 mL and IVH requiring EVD remains uncertain."
id_01714,"In selected high-risk patients with HFrEF and recent worsening of HF already on GDMT, an oral soluble guanylate cyclase stimulator (vericiguat) may be considered to reduce HF hospitalization and cardiovascular death.1","For certain high-risk patients with HFrEF experiencing recent HF deterioration despite being on GDMT, considering an oral soluble guanylate cyclase stimulator like vericiguat could help decrease the risk of HF hospitalization and cardiovascular mortality."
id_02194,"In patients undergoing TAVI, 1) contrast- enhanced coronary CT angiography (in patients with a low pretest probability for CAD) or 2) an invasive coronary angiogram is recommended to assess coronary anatomy and guide revascularization.","For patients undergoing TAVI, it is advised to use either 1) contrast-enhanced coronary CT angiography for those with a low pretest probability of CAD, or 2) an invasive coronary angiogram to evaluate coronary anatomy and assist in planning revascularization."
id_02674,"For most patients with spontaneous supra- tentorial ICH of moderate or greater severity, the usefulness of craniotomy for hemorrhage evacuation to improve functional outcomes or mortality is uncertain.380,382,384,393,429–431","For the majority of patients experiencing spontaneous supratentorial intracerebral hemorrhage of moderate or greater severity, the benefit of craniotomy for hemorrhage removal in enhancing functional outcomes or reducing mortality remains unclear."
id_00275,"In patients with significant calcification of the aorta, the use of techniques to avoid aortic manipulation (off-pump techniques or beating heart) is reasonable to decrease the incidence of perioperative stroke when performed by experienced surgeons.1,2","For patients with notable aortic calcification, employing methods that minimize aortic handling, such as off-pump or beating heart techniques, is advisable to reduce the risk of perioperative stroke, provided they are executed by skilled surgeons."
id_01235,"In patients with AF where symptoms associated with AF are uncertain, a trial of rhythm control (eg, cardio- version or pharmacological therapy) may be useful to determine what if any symptoms are attributable to AF.28–32","For patients with AF who have unclear symptoms related to the condition, attempting rhythm control, such as cardioversion or medication, can help identify whether any symptoms are due to AF."
id_00276,"In patients with significant pulmonary disease, off-pump surgery may be reasonable to reduce perioperative risk when performed by experienced surgeons.2-6","For patients with severe lung disease, opting for off-pump surgery could be a sensible choice to lower perioperative risk if conducted by skilled surgeons."
id_02675,"In patients with supratentorial ICH who are deteriorating, craniotomy for hematoma evacu- ation might be considered as a lifesaving measure.382,384,429,432","For patients experiencing deterioration due to supratentorial ICH, considering craniotomy for hematoma removal could be a critical lifesaving intervention."
id_02195,"In patients undergoing TAVI with significant left main or proximal CAD with or without angina, revascularization by PCI before TAVI is reasonable.1,2","For patients receiving TAVI who have significant left main or proximal CAD, whether or not they experience angina, it is reasonable to perform PCI for revascularization prior to TAVI."
id_01715,"In patients with nonischemic DCM or ischemic heart disease at least 40 days post-MI with LVEF ≤35% and NYHA class II or III symp- toms on chronic GDMT, who have reasonable expectation of meaningful survival for >1 year, ICD therapy is recommended for primary pre- vention of SCD to reduce total mortality.1–9 Value Statement: High Value (A)","For patients with nonischemic dilated cardiomyopathy or ischemic heart disease who are at least 40 days post-myocardial infarction, have a left ventricular ejection fraction of 35% or less, and exhibit NYHA class II or III symptoms while on long-term guideline-directed medical therapy, ICD therapy is advised for primary prevention of sudden cardiac death to lower overall mortality, provided they have a reasonable expectation of surviving more than one year."
id_00277,"In patients undergoing CABG, an intraopera- tive continuous insulin infusion should be initiated to maintain serum glucose level <180 mg/dL to reduce sternal wound infection.1-3","For patients having CABG, a continuous insulin infusion during surgery should be started to keep serum glucose levels below 180 mg/dL, thereby reducing the risk of sternal wound infection."
id_02676,"For patients with cerebellar ICH who are deteriorating neurologically, have brainstem compression and/or hydrocephalus from ventricular obstruction, or have cerebellar ICH volume ≥15 mL, immediate surgical removal of the hemorrhage with or without EVD is recom- mended in preference to medical management alone to reduce mortality.442–444","For patients experiencing neurological decline due to cerebellar ICH, who exhibit brainstem compression, hydrocephalus from blocked ventricles, or have a cerebellar ICH volume of 15 mL or more, prompt surgical evacuation of the hemorrhage, with or without EVD, is advised over solely medical treatment to decrease mortality."
id_01236,"In patients with AF, rhythm-control strategies may be useful to reduce the likelihood of development of dementia or worsening cardiac structural abnormali- ties.33–45","For patients with AF, employing rhythm-control strategies can help decrease the risk of dementia onset or the progression of cardiac structural abnormalities."
id_01237,"In patients with AF duration of ≥48 hours, a","For patients with atrial fibrillation lasting 48 hours or more, a"
id_01716,"In patients at least 40 days post-MI with LVEF ≤30% and NYHA class I symptoms while receiving GDMT, who have reasonable expec- tation of meaningful survival for >1 year, ICD therapy is recommended for primary prevention of SCD to reduce total mortality.6","For patients who are over 40 days post-myocardial infarction, have a left ventricular ejection fraction of 30% or less, and exhibit NYHA class I symptoms while on guideline-directed medical therapy, ICD therapy is advised for primary prevention of sudden cardiac death to decrease overall mortality, provided they have a reasonable expectation of surviving more than one year."
id_01717,"For patients who have LVEF ≤35%, sinus rhythm, left bundle branch block (LBBB) with a QRS duration ≥150 ms, and NYHA class II, III, or ambulatory IV symptoms on GDMT, CRT is indicated to reduce total mortality, reduce hospi- talizations, and improve symptoms and QOL.16–21 Value Statement: High Value (B-NR)","CRT is recommended for patients with LVEF ≤35%, sinus rhythm, left bundle branch block (LBBB) with a QRS duration of ≥150 ms, and NYHA class II, III, or ambulatory IV symptoms on GDMT, to decrease overall mortality, lower hospitalization rates, and enhance symptoms and quality of life."
id_02196,"In patients with significant AS and significant CAD (luminal reduction >70% diameter, fractional flow reserve <0.8, instantaneous wave-free ratio <0.89) consisting of complex bifurcation left main and/or multivessel CAD with a SYNTAX (Synergy Between Percutaneous Coronary Intervention With Taxus and Cardiac Surgery) score >33, SAVR and CABG are reasonable and preferred over TAVI and PCI.3,4","For patients with severe aortic stenosis and significant coronary artery disease (defined by a luminal reduction greater than 70%, fractional flow reserve below 0.8, or instantaneous wave-free ratio under 0.89) involving complex bifurcation of the left main and/or multivessel disease with a SYNTAX score exceeding 33, surgical aortic valve replacement combined with coronary artery bypass grafting is advisable and favored over transcatheter aortic valve implantation and percutaneous coronary intervention."
id_02197,"In patients with symptoms of angina, objective evidence of ischemia, decreased LV systolic function, history of CAD, or coronary risk factors (including men >40 years of age and postmenopausal women), invasive coronary angiography is indicated before valve intervention.1–8","For patients exhibiting angina symptoms, objective signs of ischemia, reduced left ventricular systolic function, a history of coronary artery disease, or coronary risk factors (such as men over 40 and postmenopausal women), invasive coronary angiography should be performed prior to valve intervention."
id_02198,"In patients with chronic severe secondary MR, invasive coronary angiography should be performed as part of the evaluation.9–11","For patients with chronic severe secondary MR, conducting invasive coronary angiography is recommended as part of the assessment."
id_00278,"In patients undergoing CABG, the use of continuous intravenous insulin to achieve and maintain an early postoperative blood glucose concentration of <180 mg/dL while avoid- ing hypoglycemia is indicated to reduce the incidence of adverse events, including deep sternal wound infection.3-6","For patients undergoing CABG, administering continuous intravenous insulin to maintain early postoperative blood glucose levels below 180 mg/dL, while preventing hypoglycemia, is recommended to decrease the risk of adverse events, such as deep sternal wound infections."
id_01238,"In patients with AF undergoing cardioversion, thera- peutic anticoagulation should be established before cardioversion and continued for at least 4 weeks afterwards without interruption to prevent thromboembolism.2–7","For patients with atrial fibrillation undergoing cardioversion, anticoagulation therapy must be initiated prior to the procedure and maintained for a minimum of 4 weeks post-cardioversion without any breaks to prevent thromboembolism."
id_01718,"For patients who have LVEF ≤35%, sinus rhythm, a non-LBBB pattern with a QRS duration ≥150 ms, and NYHA class II, III, or ambulatory class IV symptoms on GDMT, CRT can be useful to reduce total mortality, reduce hospitalizations, and improve symp- toms and QOL.16–21,28–33","CRT may be beneficial for patients with LVEF ≤35%, sinus rhythm, a non-LBBB pattern with a QRS duration of ≥150 ms, and NYHA class II, III, or ambulatory class IV symptoms while on GDMT, as it can lower overall mortality, decrease hospitalizations, and enhance symptoms and quality of life."
id_02677,"In patients with supratentorial ICH who are in a coma, have large hematomas with significant midline shift, or have elevated ICP refractory to medical management, decompressive crani- ectomy with or without hematoma evacuation may be considered to reduce mortality.453–460","For patients with supratentorial ICH who are comatose, possess large hematomas causing substantial midline shift, or exhibit elevated ICP unresponsive to medical treatment, decompressive craniectomy, with or without hematoma removal, may be an option to lower mortality."
id_02678,"In patients with supratentorial ICH who are in a coma, have large hematomas with significant midline shift, or have elevated ICP refractory to medical management, effectiveness of decompressive craniectomy with or without hematoma evacuation to improve functional outcomes is uncertain.458–462","For patients with supratentorial ICH who are comatose, have substantial hematomas causing notable midline shift, or experience elevated ICP unresponsive to medical treatment, the benefit of decompressive craniectomy, with or without hematoma removal, in enhancing functional outcomes remains unclear."
id_00279,"In patients undergoing CABG, a comprehen- sive approach to reduce sternal wound infec- tion is recommended.7-14","For patients having CABG, it is advised to implement a thorough strategy to minimize sternal wound infections."
id_01719,"In patients with high-degree or complete heart block and LVEF of 36% to 50%, CRT is reasonable to reduce total mortality, reduce hospitalizations, and improve symptoms and QOL.34,35 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing high-degree or complete heart block with an LVEF between 36% and 50%, it is advisable to consider CRT to decrease overall mortality, lessen hospital admissions, and enhance symptoms and quality of life."
id_01239,"In patients with AF in whom cardioversion is deferred due to LAA thrombus detected on precardioversion imaging, therapeutic anticoagulation should be insti- tuted for at least 3 to 6 weeks, after which imaging should be repeated before cardioversion.1,8","For patients with AF where cardioversion is postponed because a thrombus in the LAA is found on precardioversion imaging, therapeutic anticoagulation should be administered for a minimum of 3 to 6 weeks, followed by repeat imaging prior to cardioversion."
id_02199,"In selected patients with a low to intermediate pretest probability of CAD, contrast-enhanced coronary CT angiography is reasonable to exclude the presence of significant obstructive CAD.12–18","For patients with a low to intermediate likelihood of CAD, it is appropriate to use contrast-enhanced coronary CT angiography to rule out significant obstructive CAD."
id_02679,"In patients with spontaneous ICH, administer- ing a baseline measure of overall hemorrhage severity is recommended as part of the initial evaluation to provide an overall measure of clinical severity.472–474","For patients with spontaneous ICH, it is advised to include a baseline assessment of hemorrhage severity in the initial evaluation to gauge the overall clinical severity."
id_00280,"In patients undergoing CABG, the usefulness of continuous intravenous insulin designed to achieve a target intraoperative blood glucose concentration <140 mg/dL is uncertain.4,15","For patients having CABG, the benefit of using continuous intravenous insulin to maintain an intraoperative blood glucose level below 140 mg/dL is unclear."
id_01240,"In patients with AF and previous LAAO who are not on anticoagulation, imaging evaluation to assess the adequacy of LAAO and exclude device-related throm- bosis before cardioversion may be reasonable.9–19","For patients with atrial fibrillation and a history of left atrial appendage occlusion not receiving anticoagulation, it may be appropriate to perform imaging to evaluate the effectiveness of the LAAO and rule out device-related thrombosis prior to cardioversion."
id_02680,"In patients with spontaneous ICH, a baseline severity score might be reasonable to provide a general framework for communication with the patient and their caregivers.472,473","For patients experiencing spontaneous ICH, establishing an initial severity score could be useful as a general guide for discussions with the patient and their caregivers."
id_00281,"In patients undergoing CABG who are already taking daily aspirin preoperatively, it is recom- mended that they continue taking aspirin until the time of surgery to reduce ischemic events.1-7","For patients scheduled for CABG who are on a daily aspirin regimen before surgery, it is advised to maintain aspirin use up to the surgery date to minimize ischemic events."
id_01241,"In patients with AF and previous LAAO with residual leak, pericardioversion anticoagulation may be considered and continued thereafter.9–11,20","For patients with AF who have undergone LAAO and have a residual leak, anticoagulation before and after cardioversion can be considered."
id_02200,"In patients undergoing valve repair or replacement with significant proximal CAD (≥70% reduction in luminal diameter in major coronary arteries or ≥50% reduction in luminal diameter in the left main coronary artery and/or physiologically significance), CABG is reasonable for selective patients.19,20","For patients with significant proximal coronary artery disease—defined as a luminal diameter reduction of 70% or more in major coronary arteries, or 50% or more in the left main coronary artery, or physiologically significant—undergoing valve repair or replacement, coronary artery bypass grafting (CABG) may be appropriate for certain individuals."
id_01720,"For patients who have LVEF ≤35%, sinus rhythm, LBBB with a QRS duration of 120 to 149 ms, and NYHA class II, III, or ambu- latory IV symptoms on GDMT, CRT can be useful to reduce total mortality, reduce hospitalizations, and improve symptoms and QOL.16–21,28–33","For patients with an LVEF of 35% or less, sinus rhythm, LBBB with a QRS duration between 120 and 149 ms, and NYHA class II, III, or ambulatory IV symptoms while on GDMT, CRT may be beneficial in lowering overall mortality, decreasing hospital admissions, and enhancing symptoms and quality of life."
id_02681,"In patients with spontaneous ICH, a baseline severity score should not be used as the sole basis for forecasting individual prognosis or limiting life-sustaining treatment.475,476","For patients with spontaneous ICH, a baseline severity score should not be the only factor in predicting individual outcomes or deciding to withhold life-sustaining treatment."
id_01721,"In patients with AF and LVEF ≤35% on GDMT, CRT can be useful to reduce total mortality, improve symptoms and QOL, and increase LVEF, if: a) the patient requires ventricular pac- ing or otherwise meets CRT criteria and b) atrioventricular nodal ablation or pharmacologi- cal rate control will allow near 100% ventricu- lar pacing with CRT.16–21,28–33","For patients with AF and an LVEF of 35% or less who are on GDMT, CRT may be beneficial for decreasing overall mortality, alleviating symptoms, enhancing quality of life, and boosting LVEF, provided that: a) the patient needs ventricular pacing or fulfills CRT criteria, and b) atrioventricular nodal ablation or pharmacological rate control can achieve nearly 100% ventricular pacing with CRT."
id_02201,"In patients with VHD and AF for whom surgical intervention is planned, the potential symptomatic benefits and additional procedural risks of adjunctive arrhythmia surgery at the time of cardiac valvular surgery should be discussed with the patient.1–11","For patients with VHD and AF who are scheduled for surgery, it is important to discuss with them the possible symptomatic advantages and extra procedural risks of performing arrhythmia surgery alongside cardiac valvular surgery."
id_02202,"For symptomatic patients with paroxysmal or persistent AF who are undergoing valvular surgery, surgical pulmonary vein isolation or a maze procedure can be beneficial to reduce symptoms and prevent recurrent arrhythmias.1,2,12–15","For patients with symptoms of paroxysmal or persistent atrial fibrillation undergoing valve surgery, performing surgical pulmonary vein isolation or a maze procedure may help alleviate symptoms and prevent arrhythmia recurrence."
id_01242,"In patients with reported AF duration of <48 hours (not in the setting of cardiac surgery) and who are not on anticoagulation, precardioversion imaging to exclude intracardiac thrombus may be considered ins those who are at elevated thromboembolic risk (CHA2DS2-VASc score ≥2 or equivalent).21,22","For patients with atrial fibrillation lasting less than 48 hours (excluding those post-cardiac surgery) who are not receiving anticoagulation, imaging before cardioversion to rule out intracardiac thrombus can be considered for those with a high thromboembolic risk (CHA2DS2-VASc score of 2 or higher, or similar)."
id_00282,"In patients referred for urgent CABG, clopi- dogrel and ticagrelor should be discontinued for at least 24 hours before surgery to reduce major bleeding complications.8-11","For patients scheduled for urgent CABG, clopidogrel and ticagrelor must be stopped at least 24 hours prior to surgery to minimize the risk of major bleeding complications."
id_00283,"In patients undergoing CABG, discontinuation of short-acting glycoprotein IIb/IIIa inhibitors (eptifibatide and tirofiban) for 4 hours and abciximab for 12 hours before surgery is rec- ommended to reduce the risk of bleeding and transfusion.12-14","For patients scheduled for CABG, it is advised to stop short-acting glycoprotein IIb/IIIa inhibitors (eptifibatide and tirofiban) 4 hours prior and abciximab 12 hours before the procedure to minimize bleeding and the need for transfusions."
id_02682,"In patients with spontaneous ICH who do not have preexisting documented requests for life- sustaining therapy limitations, aggressive care, including postponement of new DNAR orders or withdrawal of medical support until at least the second full day of hospitalization, is reasonable to decrease mortality and improve functional outcome.479–484","For patients with spontaneous ICH without prior documented limitations on life-sustaining treatments, it is reasonable to pursue intensive care, including delaying new DNAR orders or the withdrawal of medical support, until at least the second full day of hospitalization to reduce mortality and enhance functional outcomes."
id_01722,"For patients on GDMT who have LVEF ≤35% and are undergoing placement of a new or replacement device implantation with anticipated requirement for significant (>40%) ventricular pacing, CRT can be useful to reduce total mortality, reduce hospitalizations, and improve symptoms and QOL.16–21,28–33","For patients receiving GDMT with an LVEF of 35% or less who are having a new or replacement device implanted and are expected to need substantial ventricular pacing (over 40%), CRT may be beneficial in lowering overall mortality, decreasing hospital admissions, and enhancing symptoms and quality of life."
id_02203,"For patients with AF or atrial flutter who are undergoing valve surgery, LA appendage ligation/excision is reasonable to reduce the risk of thromboembolic events.16–19","For individuals with atrial fibrillation or atrial flutter undergoing valve surgery, it is advisable to consider LA appendage ligation or excision to lower the risk of thromboembolic events."
id_01723,"In patients with genetic arrhythmogenic car- diomyopathy with high-risk features of sudden death, with EF ≤45%, implantation of ICD is reasonable to decrease sudden death.36,37","For patients with genetic arrhythmogenic cardiomyopathy who have high-risk factors for sudden death and an EF of 45% or less, it is advisable to implant an ICD to reduce the risk of sudden death."
id_01243,"In patients with low thromboembolic risks (CHA2DS2-VASc 0-1 or equivalent) and AF duration of <12 hours, the benefit of precardioversion imaging or pericardioversion anticoagulation is uncertain given the low incidence of pericardioversion thromboembolic events in this population.21,22","For patients with low thromboembolic risk (CHA2DS2-VASc score of 0-1 or similar) and atrial fibrillation lasting less than 12 hours, the advantage of imaging before cardioversion or anticoagulation during cardioversion is unclear due to the low occurrence of thromboembolic events in this group."
id_01244,"In patients with hemodynamic instability attributable to AF, immediate electrical cardioversion should be performed to restore sinus rhythm.1","For patients experiencing hemodynamic instability due to AF, prompt electrical cardioversion is necessary to reestablish sinus rhythm."
id_02683,"In patients with spontaneous ICH who are unable to fully participate in medical decision- making, use of a shared decision-making model between surrogates and physicians is reasonable to optimize the alignment of care with patient wishes and surrogate satisfac- tion.485","For patients with spontaneous ICH who cannot actively engage in medical decisions, it is advisable to employ a shared decision-making approach between surrogates and physicians to better align care with the patient's preferences and enhance surrogate satisfaction."
id_01724,"For patients who have LVEF ≤35%, sinus rhythm, a non-LBBB pattern with QRS dura- tion of 120 to 149 ms, and NYHA class III or ambulatory class IV on GDMT, CRT may be considered to reduce total mortality, reduce hospitalizations, and improve symptoms and QOL.16–21,28–33","For patients with an LVEF of 35% or less, sinus rhythm, a non-LBBB pattern with a QRS duration between 120 and 149 ms, and who are classified as NYHA class III or ambulatory class IV while on GDMT, CRT can be considered to decrease overall mortality, lower hospitalization rates, and enhance symptoms and quality of life."
id_02204,"In patients undergoing LA surgical ablation of atrial arrhythmias and/or LA appendage ligation/excision, anticoagulation therapy is reasonable for at least 3 months after the procedure.20–22","For patients receiving LA surgical ablation for atrial arrhythmias and/or undergoing LA appendage ligation or excision, it is advisable to continue anticoagulation therapy for a minimum of 3 months post-procedure."
id_00284,"In patients undergoing elective CABG who receive P2Y12 receptor inhibitors before sur- gery, it is reasonable to discontinue clopidogrel for 5 days, ticagrelor for 3 days, and prasugrel for 7 days before CABG to reduce risk of major bleeding and blood product transfu- sion.8,9,11,15-23","For patients scheduled for elective CABG who are on P2Y12 receptor inhibitors, it is advisable to stop clopidogrel 5 days, ticagrelor 3 days, and prasugrel 7 days prior to surgery to minimize the risk of significant bleeding and the need for blood transfusions."
id_00285,"In patients undergoing elective CABG who are not already taking aspirin, the initiation of aspi- rin (100–300 mg daily) in the immediate pre- operative period (<24 hours before surgery) is not recommended.24,25","For patients scheduled for elective CABG who are not on aspirin, starting aspirin (100–300 mg daily) within 24 hours before surgery is not advised."
id_02684,"In patients with spontaneous ICH who have DNAR status, limiting other medical and surgi- cal interventions, unless explicitly specified by the patient or surrogate, is associated with increased patient mortality.180,479,486,487","For patients with spontaneous ICH and DNAR status, restricting additional medical and surgical interventions, unless clearly directed by the patient or their surrogate, correlates with higher mortality rates."
id_01245,"In patients with AF who are hemodynamically stable, electrical cardioversion can be performed as initial rhythm-control strategy or after unsuccessful pharmacological cardioversion.2","For patients with AF who are hemodynamically stable, electrical cardioversion may be used as the first rhythm-control approach or following the failure of pharmacological cardioversion."
id_02205,"For patients without atrial arrhythmias who are undergoing valvular surgery, LA appendage occlusion/exclusion/amputation is potentially harmful.23","LA appendage occlusion, exclusion, or amputation may be detrimental for patients undergoing valvular surgery who do not have atrial arrhythmias."
id_01725,"For patients who have LVEF ≤30%, ischemic cause of HF, sinus rhythm, LBBB with a QRS duration ≥150 ms, and NYHA class I symp- toms on GDMT, CRT may be considered to reduce hospitalizations and improve symptoms and QOL.16–21,28–33","For patients with an LVEF of 30% or less, heart failure due to ischemia, sinus rhythm, LBBB with a QRS duration of 150 ms or more, and NYHA class I symptoms while on GDMT, CRT can be considered to decrease hospital admissions and enhance symptoms and quality of life."
id_00286,"In patients undergoing CABG, who do not have a contraindication to beta blockers, the administration of beta blockers before surgery can be beneficial to reduce the incidence of postoperative atrial fibrillation.1-8","For patients scheduled for CABG without contraindications to beta blockers, administering these medications preoperatively may help decrease the occurrence of atrial fibrillation after surgery."
id_01246,"In patients with AF undergoing electrical cardiover- sion, energy delivery should be confirmed to be syn- chronized to the QRS to reduce the risk of inducing VF.3","For patients with AF undergoing electrical cardioversion, ensure that energy delivery is synchronized with the QRS complex to minimize the risk of triggering VF."
id_01726,"In patients with QRS duration <120 ms, CRT is not recommended.36–41",CRT is not advised for patients whose QRS duration is less than 120 ms.
id_02206,"In patients with clinically suspected moderate or greater degrees of valvular stenosis or regurgitation who are undergoing noncardiac surgery, preoperative echocardiography is recommended.","For patients with a clinical suspicion of moderate or more severe valvular stenosis or regurgitation undergoing noncardiac surgery, it is advised to perform a preoperative echocardiogram."
id_02685,"In patients with spontaneous ICH, multidisci- plinary rehabilitation, including regular team meetings and discharge planning, should be performed to improve functional outcome and reduce morbidity and mortality.231,232","For patients with spontaneous ICH, engaging in multidisciplinary rehabilitation that involves regular team meetings and discharge planning is recommended to enhance functional outcomes and decrease morbidity and mortality."
id_02686,"In patients with spontaneous ICH with mild to moderate severity, early supported discharge is beneficial to increase the likelihood of patients living at home at 3 months.490","For patients experiencing spontaneous ICH of mild to moderate severity, early supported discharge enhances the probability of them residing at home after three months."
id_00287,"In patients undergoing CABG, preoperative amiodarone is reasonable to reduce the inci- dence of postoperative atrial fibrillation.9-11","For patients having CABG, administering amiodarone before surgery is advisable to lower the risk of atrial fibrillation after the operation."
id_01247,"For patients with AF undergoing elective electrical cardioversion, the use of biphasic energy of at least 200 J as initial energy can be beneficial to improve success of initial electrical shock.4,5","For patients with AF undergoing elective electrical cardioversion, starting with a biphasic energy of at least 200 J may enhance the success rate of the initial shock."
id_01727,"For patients with NYHA class I or II symptoms and non-LBBB pattern with QRS duration <150 ms, CRT is not recommended.16–21,28–33",CRT is not advised for patients exhibiting NYHA class I or II symptoms with a non-LBBB pattern and a QRS duration of less than 150 ms.
id_02207,"In patients who meet standard indications for intervention for VHD (replacement and repair) on the basis of symptoms and disease severity, intervention should be performed before elective noncardiac surgery to reduce perioperative risk if possible, depending on the urgency and risk of the noncardiac procedure.1","For patients eligible for VHD intervention (replacement and repair) due to symptoms and disease severity, the procedure should be conducted prior to elective noncardiac surgery to minimize perioperative risk, contingent on the urgency and risk associated with the noncardiac procedure."
id_00288,"In patients undergoing CABG, who do not have a contraindication to beta blockers, preoperative use of beta blockers may be effective in reducing in-hospital and 30-day mortality rates.12-18","For patients having CABG without contraindications to beta blockers, administering beta blockers before surgery may effectively lower mortality rates both in-hospital and at 30 days."
id_02687,"In patients with spontaneous ICH with moder- ate severity, early rehabilitation beginning 24 to 48 hours after onset (including ADL train- ing, stretching, functional task training) may be considered to improve functional outcome and reduce mortality.491,492","For patients experiencing moderate spontaneous ICH, initiating rehabilitation, such as ADL training, stretching, and functional task exercises, within 24 to 48 hours of onset may be considered to enhance functional outcomes and decrease mortality."
id_02208,"In asymptomatic patients with moderate or greater degrees of AS and normal LV systolic function, it is reasonable to perform elective noncardiac surgery.1–3","For asymptomatic patients with moderate or more severe aortic stenosis and normal left ventricular systolic function, elective noncardiac surgery is considered reasonable."
id_01728,"For patients whose comorbidities or frailty limit survival with good functional capacity to <1 year, ICD and cardiac resynchronization therapy with defibrillation (CRT-D) are not indi- cated.1–9,16–21",ICD and cardiac resynchronization therapy with defibrillation (CRT-D) are not recommended for patients whose comorbidities or frailty restrict their survival with adequate functional capacity to less than one year.
id_01248,"In patients with AF undergoing elective cardiover- sion, with longer duration of AF or unsuccessful initial shock, optimization of electrode vector, use of higher energy, and pretreatment with antiarrhythmic drugs can facilitate success of electrical cardioversion.5–9","For patients with atrial fibrillation undergoing elective cardioversion, especially those with prolonged AF or an unsuccessful initial shock, adjusting the electrode placement, increasing the energy level, and using antiarrhythmic drugs beforehand can enhance the success rate of electrical cardioversion."
id_02688,"In patients with spontaneous ICH without depression, fluoxetine therapy is not effective to enhance poststroke functional status.493–497",Fluoxetine treatment does not improve poststroke functional outcomes in patients with spontaneous ICH who do not have depression.
id_00289,"In patients undergoing CABG, the role of preop- erative beta blockers for the prevention of acute postoperative myocardial ischemia, stroke, AKI, or ventricular arrhythmia is uncertain.12-14,18","The effectiveness of preoperative beta blockers in preventing acute postoperative myocardial ischemia, stroke, acute kidney injury, or ventricular arrhythmia in patients undergoing CABG is unclear."
id_02209,"In asymptomatic patients with moderate or greater degrees of rheumatic MS with less than severe pulmonary hypertension (pulmonary artery systolic pressure <50 mm Hg), it is reasonable to perform elective noncardiac surgery.","For asymptomatic patients with moderate or more severe rheumatic mitral stenosis and pulmonary hypertension that is not severe (pulmonary artery systolic pressure under 50 mm Hg), elective noncardiac surgery is considered appropriate."
id_01249,"In patients with obesity and AF, use of manual pressure augmentation and/or further escalation of electrical energy may be beneficial to improve suc- cess of electrical cardioversion.10","For patients with obesity and atrial fibrillation, applying manual pressure or increasing the electrical energy may enhance the success rate of electrical cardioversion."
id_01729,"In selected patients with HF, reduced EF (EF ≤35%), and suitable coronary anatomy, surgical revascularization plus GDMT is beneficial to improve symptoms, cardiovascular hospitaliza- tions, and long-term all-cause mortality.1–8","For certain patients with heart failure, an ejection fraction of 35% or less, and appropriate coronary anatomy, combining surgical revascularization with guideline-directed medical therapy is advantageous for alleviating symptoms, reducing cardiovascular hospitalizations, and decreasing long-term all-cause mortality."
id_02689,"In patients with spontaneous ICH, very early and intense mobilization within the first 24 hours is associated with lower likelihood of good recovery.498,499","For patients experiencing spontaneous ICH, initiating very early and vigorous mobilization within the initial 24 hours is linked to a reduced chance of favorable recovery."
id_01250,"For patients with AF, pharmacological cardioversion is reasonable as an alternative to electrical cardiover- sion for those who are hemodynamically stable or in situations when electrical cardioversion is preferred but cannot be performed.1","For patients with atrial fibrillation, using medication to achieve cardioversion is a suitable alternative to electrical cardioversion for individuals who are hemodynamically stable or when electrical cardioversion is desired but not feasible."
id_01730,"In patients with HF, VHD should be managed in a multidisciplinary manner in accordance with clini- cal practice guidelines for VHD to prevent wors- ening of HF and adverse clinical outcomes.1–11","For patients with heart failure, valvular heart disease should be addressed through a multidisciplinary approach following clinical practice guidelines for valvular heart disease to avert the progression of heart failure and negative clinical outcomes."
id_00290,"In selected patients undergoing PCI, shorter- duration DAPT (1–3 months) is reasonable, with subsequent transition to P2Y12 inhibitor monotherapy to reduce the risk of bleeding events.1-4","For certain patients receiving PCI, it is appropriate to consider a shorter DAPT course of 1–3 months, followed by switching to P2Y12 inhibitor monotherapy to minimize bleeding risk."
id_00291,"In patients undergoing CABG, aspirin (100–325 mg daily) should be initiated within 6 hours postoperatively and then continued indefinitely to reduce the occurrence of SVG closure and adverse cardiovascular events.1-7","For patients having CABG, start aspirin (100–325 mg daily) within 6 hours after surgery and maintain it indefinitely to lower the risk of SVG closure and negative cardiovascular outcomes."
id_02210,"In asymptomatic patients with moderate or greater degrees of MR and normal LV systolic function with less than severe pulmonary hypertension (pulmonary artery systolic pressure <50 mm Hg), it is reasonable to perform elective noncardiac surgery.4–7","For patients without symptoms who have moderate or greater mitral regurgitation and normal left ventricular systolic function, along with pulmonary artery systolic pressure under 50 mm Hg indicating less than severe pulmonary hypertension, elective noncardiac surgery is considered appropriate."
id_02690,"In patients with spontaneous ICH and mod- erate to severe depression, appropriate evidence-based treatments including psycho- therapy and pharmacotherapy are useful to reduce symptoms of depression.507,508","For patients experiencing spontaneous ICH along with moderate to severe depression, utilizing evidence-based interventions such as psychotherapy and pharmacotherapy is beneficial for alleviating depressive symptoms."
id_01251,"For patients with AF, ibutilide2,3 is reasonable for pharmacological cardioversion for patients without depressed LV function (LVEF <40%).","For patients with atrial fibrillation, using ibutilide for pharmacological cardioversion is appropriate for those whose left ventricular function is not reduced (LVEF ≥40%)."
id_02211,"In asymptomatic patients with moderate or greater degrees of AR and normal LV systolic function, it is reasonable to perform elective noncardiac surgery.8","For patients without symptoms who have moderate or more severe AR and normal LV systolic function, elective noncardiac surgery can be reasonably considered."
id_01731,"In patients with chronic severe secondary MR and HFrEF, optimization of GDMT is recom- mended before any intervention for secondary MR related to LV dysfunction.3–5,12–14","For patients with chronic severe secondary MR and HFrEF, it is advised to optimize GDMT prior to any intervention addressing secondary MR due to LV dysfunction."
id_00292,"In selected patients undergoing CABG, DAPT with aspirin and ticagrelor or clopidogrel for 1 year may be reasonable to improve vein graft patency compared with aspirin alone.8-10","For certain patients receiving CABG, using DAPT with aspirin and ticagrelor or clopidogrel for one year might be advisable to enhance vein graft patency compared to using aspirin alone."
id_02691,"In patients with spontaneous ICH, administra- tion of depression and anxiety screening tools in the postacute period is recommended to identify patients with poststroke depression and anxiety.509","For patients experiencing spontaneous ICH, it is advised to use screening tools for depression and anxiety during the postacute phase to detect poststroke depression and anxiety."
id_01732,"In patients with HFmrEF, SGLT2i can be ben- eficial in decreasing HF hospitalizations and cardiovascular mortality.1","For patients with HFmrEF, SGLT2 inhibitors may help reduce hospital admissions due to heart failure and lower the risk of cardiovascular death."
id_00293,"In patients with SIHD and normal left ven- tricular function, the routine use of chronic oral beta blockers is not beneficial to reduce cardiovascular events after complete revascu- larization.1-6","For patients with SIHD and normal left ventricular function, chronic oral beta blockers do not provide a benefit in reducing cardiovascular events following complete revascularization."
id_02692,"In patients with spontaneous ICH, administra- tion of a cognitive screening tool in the post- acute period is useful to identify patients with cognitive impairment and dementia.510","For patients experiencing spontaneous ICH, employing a cognitive screening tool during the post-acute phase is beneficial for detecting cognitive impairment and dementia."
id_01252,"For patients with AF, intravenous amiodarone is rea- sonable for pharmacological cardioversion, although time to conversion is generally longer than with other agents (8-12 hours).4–8","Intravenous amiodarone is a suitable option for pharmacological cardioversion in patients with AF, though it typically takes longer to achieve conversion compared to other medications (8-12 hours)."
id_02212,"In patients with known or suspected aortic disease, aortic diameters should be mea- sured at reproducible anatomic landmarks perpendicular to axis of blood flow, and these measurement methods should be reported in a clear and consistent manner. In cases of asymmetric or oval contour, the longest diam- eter and its perpendicular diameter should be reported.3,4","For patients with confirmed or suspected aortic disease, measure aortic diameters at consistent anatomical landmarks perpendicular to the blood flow axis, and ensure these measurement techniques are clearly and consistently documented. If the contour is asymmetric or oval, report both the longest diameter and its perpendicular diameter."
id_02213,"In patients with known or suspected aortic disease, episodic and cumulative ionizing radi- ation doses should be kept as low as feasible while maintaining diagnostic image quality.5-7","For patients with confirmed or potential aortic disease, ionizing radiation exposure should be minimized as much as possible without compromising the quality of diagnostic images."
id_02693,"In patients with spontaneous ICH and cogni- tive impairment, referral for cognitive therapy is reasonable to improve cognitive out- comes.511–515","For patients experiencing spontaneous ICH and cognitive impairment, it is advisable to refer them for cognitive therapy to enhance cognitive outcomes."
id_01253,"For patients with recurrent AF occurring outside the setting of a hospital, the “pill-in-the-pocket” (PITP) approach with a single oral dose of flecainide9–11 or propafenone,10–14 with a concomitant atrioventricular nodal blocking agent,15 is reasonable for pharmaco- logical cardioversion if previously tested in a moni- tored setting.16–18","For patients experiencing recurrent atrial fibrillation outside of a hospital, using a single oral dose of flecainide or propafenone alongside an atrioventricular nodal blocking agent is a reasonable pharmacological cardioversion strategy, provided it has been previously tested in a monitored environment."
id_00294,"In patients after CABG, beta blockers are recommended and should be started as soon as possible to reduce the incidence or clinical sequelae of postoperative atrial fibrillation.1-7","For patients post-CABG, initiating beta blockers promptly is advised to decrease the occurrence or effects of postoperative atrial fibrillation."
id_01733,"Among patients with current or previous symp- tomatic HFmrEF (LVEF, 41%–49%), use of evidence-based beta blockers for HFrEF, ARNi, ACEi, or ARB, and MRAs may be considered to reduce the risk of HF hospitalization and cardiovascular mortality, particularly among patients with LVEF on the lower end of this spectrum.2–9","For patients with current or past symptomatic HFmrEF (LVEF, 41%–49%), considering the use of evidence-based beta blockers for HFrEF, ARNi, ACEi, or ARB, and MRAs can help lower the risk of heart failure hospitalization and cardiovascular death, especially in those with LVEF at the lower range of this category."
id_01254,"For patients with AF, use of intravenous procainamide may be considered for pharmacological cardioversion when other intravenous agents are contraindicated or not preferred.19",Intravenous procainamide can be considered for pharmacological cardioversion in patients with AF when other intravenous medications are either contraindicated or not favored.
id_00295,"In patients with atrial fibrillation who are undergoing PCI and are taking oral anticoagu- lant therapy, it is recommended to discontinue aspirin treatment after 1 to 4 weeks while maintaining P2Y12 inhibitors in addition to a non–vitamin K oral anticoagulant (rivaroxaban, dabigatran, apixaban, or edoxaban) or warfarin to reduce the risk of bleeding.1-7","For patients with atrial fibrillation undergoing PCI and on oral anticoagulant therapy, it is advised to stop aspirin after 1 to 4 weeks, while continuing P2Y12 inhibitors alongside a non–vitamin K oral anticoagulant (such as rivaroxaban, dabigatran, apixaban, or edoxaban) or warfarin, to minimize bleeding risk."
id_02694,"In patients with spontaneous ICH and pre- existing or new mood disorders requiring pharmacotherapy, continuation or initiation of SSRIs after ICH can be beneficial for the treatment of mood disorders.508,516–518","For patients with spontaneous intracerebral hemorrhage (ICH) who have existing or newly diagnosed mood disorders that need medication, starting or continuing SSRIs post-ICH may be advantageous for managing these mood disorders."
id_01734,"In patients with HFimpEF after treatment, GDMT should be continued to prevent relapse of HF and LV dysfunction, even in patients who may become asymptomatic.1","For patients with HFimpEF following treatment, it is important to maintain GDMT to avert the recurrence of HF and LV dysfunction, even if the patients become asymptomatic."
id_01255,"For patients with AF and no previous MI, or known or suspected significant structural heart disease, or ven- tricular scar or fibrosis, use of flecainide3–5 or propafe- none5–12 is reasonable for long-term maintenance of sinus rhythm.","For patients with atrial fibrillation who have no history of myocardial infarction, or have known or suspected significant structural heart disease, or ventricular scar or fibrosis, it is reasonable to use flecainide or propafenone for the long-term maintenance of sinus rhythm."
id_02214,"In patients with known or suspected aortic disease, when performing CT or MR imaging, it is recommended that the root and ascending aortic diameters be measured from inner-edge to inner-edge, using an electrocardiographic- synchronized technique. If there are aortic wall abnormalities, such as atherosclerosis or discrete wall thickening (more common in the distal aorta), the outer-edge to outer-edge diameter should be reported (Table 4).","For patients with confirmed or suspected aortic disease undergoing CT or MR imaging, it is advised to measure the root and ascending aortic diameters from inner-edge to inner-edge using an ECG-synchronized method. In cases of aortic wall abnormalities like atherosclerosis or localized wall thickening, which are more prevalent in the distal aorta, the outer-edge to outer-edge diameter should be documented (refer to Table 4)."
id_01735,Patients with HFpEF and hypertension should have medication titrated to attain blood pres- sure targets in accordance with published clini- cal practice guidelines to prevent morbidity.1–3,"For patients with HFpEF and hypertension, medications should be adjusted to achieve blood pressure goals as outlined in established clinical practice guidelines to reduce morbidity."
id_02695,"In patients with spontaneous ICH and cogni- tive impairment, treatment with cholinesterase inhibitors or memantine might be considered to improve cognitive outcomes.519–521","For patients experiencing spontaneous intracerebral hemorrhage and cognitive deficits, considering the use of cholinesterase inhibitors or memantine may enhance cognitive outcomes."
id_01256,"For patients with AF without recent decompensated HF or severe LV dysfunction, use of dronedarone5,13–15 is reasonable for long-term maintenance of sinus rhythm.","For patients with AF who do not have recent decompensated heart failure or significant left ventricular dysfunction, it is appropriate to consider dronedarone for the long-term maintenance of sinus rhythm."
id_01736,"In patients with HFpEF, SGLT2i can be ben- eficial in decreasing HF hospitalizations and cardiovascular mortality.4","For patients with HFpEF, SGLT2i may help reduce hospital admissions due to heart failure and lower the risk of cardiovascular death."
id_02215,"In patients with known or suspected aortic disease, the aortic root diameter should be recorded as maximum sinus to sinus mea- surement. In the setting of known asymmetry, multiple measurements should be reported, and both short- and long-axis images of the root should be obtained to avoid underestima- tion of the diameter.","For patients with confirmed or suspected aortic disease, the aortic root diameter should be documented as the largest sinus-to-sinus measurement. If asymmetry is present, several measurements should be provided, and images of the root in both short and long axes should be captured to prevent underestimating the diameter."
id_02216,"In patients with known or suspected aortic disease, it is reasonable that a dilated root or ascending aorta be indexed to patient height or BSA in the report, to aid in clinical risk assessment.8-11","For patients with confirmed or suspected aortic disease, indexing a dilated root or ascending aorta to the patient's height or body surface area in the report is advisable to assist in clinical risk evaluation."
id_00296,"In patients with atrial fibrillation who are undergoing PCI, are taking oral anticoagu- lant therapy, and are treated with DAPT or a P2Y12 inhibitor monotherapy, it is reasonable to choose a non–vitamin K oral anticoagulant over warfarin to reduce the risk of bleeding.1,3,4","For patients with atrial fibrillation undergoing PCI and on oral anticoagulant therapy, who are also receiving DAPT or a P2Y12 inhibitor alone, opting for a non–vitamin K oral anticoagulant instead of warfarin is advisable to lower bleeding risk."
id_00297,"In patients who have undergone revasculariza- tion, a comprehensive cardiac rehabilitation program (home based or center based) should be prescribed either before hospital discharge or during the first outpatient visit to reduce deaths and hospital readmissions and improve quality of life.1-4","For patients who have had revascularization, a thorough cardiac rehabilitation program, whether conducted at home or in a center, should be recommended either prior to hospital discharge or at the initial outpatient appointment to decrease mortality and hospital readmissions and enhance quality of life."
id_02696,"In patients with spontaneous ICH in whom the risk for recurrent ICH may facilitate prognosti- cation or management decisions, it is reason- able to incorporate the following risk factors for ICH recurrence into decision-making: (a) lobar location of the initial ICH; (b) older age; (c) presence, number, and lobar location of microbleeds on MRI; (d) presence of dissemi- nated cortical superficial siderosis on MRI; (e) poorly controlled hypertension; (f) Asian or Black race; and (g) presence of apolipopro- tein E ε2 or ε4 alleles.562–571","For patients with spontaneous ICH where assessing the risk of recurrence could aid in prognosis or management, it is advisable to consider the following risk factors for ICH recurrence in decision-making: (a) initial ICH in a lobar location; (b) advanced age; (c) presence, quantity, and lobar location of microbleeds on MRI; (d) presence of disseminated cortical superficial siderosis on MRI; (e) uncontrolled hypertension; (f) Asian or Black ethnicity; and (g) presence of apolipoprotein E ε2 or ε4 alleles."
id_01737,"In patients with HFpEF, management of AF can be useful to improve symptoms.","For patients with HFpEF, addressing AF may be beneficial for symptom improvement."
id_02697,"In patients with spontaneous ICH, BP control is recommended to prevent hemorrhage recur- rence.563,581","For patients with spontaneous intracerebral hemorrhage, managing blood pressure is advised to prevent the recurrence of bleeding."
id_02217,"In patients with known or suspected aortic disease, when performing echocardiography, it is reasonable to measure the aorta from leading-edge to leading-edge, perpendicular to the axis of blood flow.","For patients with confirmed or suspected aortic disease, it is advisable to measure the aorta from leading-edge to leading-edge, perpendicular to the blood flow axis, during echocardiography."
id_00298,"Patients who have undergone revasculariza- tion should be educated about CVD risk factors and their modification to reduce car- diovascular events.5-7 Downloaded from http://ahajournals.org by on June 19, 2025",Individuals who have received revascularization should be informed about cardiovascular disease risk factors and how to modify them to decrease the likelihood of cardiovascular events.
id_01257,"For patients with AF without significant baseline QT interval prolongation or uncorrected hypokalemia or hypomagnesemia, use of dofetilide1,5,16 5–7,10,17,18 is reasonable for long-term maintenance of sinus rhythm, with proper dose selection based on kidney function and close monitoring of the QT interval, serum potassium and magnesium concentrations, and kidney function.","For patients with atrial fibrillation who do not have significant baseline QT interval prolongation or untreated low potassium or magnesium levels, it is appropriate to use dofetilide for long-term sinus rhythm maintenance. This should involve selecting the dose according to renal function and closely monitoring the QT interval, as well as serum potassium, magnesium levels, and renal function."
id_02218,"For patients with acute aortic disease that requires urgent repair, a multidisciplinary team should determine the most suitable interven- tion.","For patients with acute aortic disease needing immediate repair, a multidisciplinary team should decide on the most appropriate intervention."
id_01738,"In selected patients with HFpEF, MRAs may be considered to decrease hospitalizations, par- ticularly among patients with LVEF on the lower end of this spectrum.5–7","For certain patients with HFpEF, MRAs can be considered to reduce hospital admissions, especially in those with LVEF at the lower range of this category."
id_01258,"For patients with AF and normal LV function, use of low-dose amiodarone (100-200 mg/d) is rea- sonable for long-term maintenance of sinus rhy thm2,5,17–22 but, in view of its adverse effect pro- file,5,23,24 should be reserved for patients in whom other rhythm control strategies are ineffective, not preferred, or contraindicated.","For patients with atrial fibrillation and normal left ventricular function, it is appropriate to use low-dose amiodarone (100-200 mg/day) for long-term sinus rhythm maintenance. However, due to its side effect profile, it should be reserved for those who do not respond to, cannot tolerate, or have contraindications to other rhythm control methods."
id_02698,"In patients with spontaneous ICH, it is reason- able to lower BP to an SBP of 130 mm Hg and diastolic BP (DBP) of 80 mm Hg for long- term management to prevent hemorrhage recurrence.581,582","For long-term management in patients with spontaneous intracerebral hemorrhage, it is advisable to reduce blood pressure to a systolic level of 130 mm Hg and a diastolic level of 80 mm Hg to prevent recurrence of hemorrhage."
id_00299,"In patients who use tobacco and have undergone coronary revascularization, a combination of behavioral interventions plus pharmacotherapy is recommended to maxi- mize cessation and reduce adverse cardiac events.1-3","For patients who smoke and have had coronary revascularization, it is advised to combine behavioral therapies with medication to optimize quitting and decrease negative cardiac outcomes."
id_01739,"In selected patients with HFpEF, the use of ARB may be considered to decrease hospital- izations, particularly among patients with LVEF on the lower end of this spectrum.8,9","For certain patients with HFpEF, ARBs might be considered to reduce hospital admissions, especially for those with LVEF at the lower range of this category."
id_01259,"For patients with AF without significant baseline QT interval prolongation, hypokalemia, hypomag- nesemia, or bradycardia, use of sotalol5–7,10,17,18 may be considered for long-term maintenance of sinus rhythm, with proper dose selection based on kidney function and close monitoring of the QT interval, heart rate, serum potassium and magnesium con- centrations, and kidney function.","For patients with atrial fibrillation who do not have significant baseline QT interval prolongation, low potassium or magnesium levels, or slow heart rate, sotalol may be considered for long-term sinus rhythm maintenance. This should involve appropriate dosing according to renal function and careful monitoring of the QT interval, heart rate, and serum potassium and magnesium levels."
id_02699,"In patients with spontaneous ICH and condi- tions placing them at high risk of thromboem- bolic events, for example, a mechanical valve or LVAD, early resumption of anticoagulation to prevent thromboembolic complications is reasonable.586,587","For patients with spontaneous intracerebral hemorrhage who are at elevated risk for thromboembolic events, such as those with a mechanical valve or LVAD, it is reasonable to restart anticoagulation early to prevent thromboembolic complications."
id_01260,"Patients with AF who are initiating, increasing the dose of, or reinitiating dofetilide therapy should be admitted for a minimum of 3 days to a facility that can provide continuous electrocardiographic monitoring, calculations of CrCl, and cardiac resuscitation, given the potential for proarrhythmia.1–7","Patients with atrial fibrillation starting, increasing, or resuming dofetilide treatment should be hospitalized for at least three days in a facility equipped for continuous ECG monitoring, CrCl assessment, and cardiac resuscitation due to the risk of proarrhythmia."
id_02219,"For patients who are asymptomatic with extensive aortic disease, or who may benefit from complex open and endovascular aortic repairs, or with multiple comorbidities for whom intervention is considered, referral to a high-volume center (performing at least 30-40 aortic procedures annually) with expe- rienced surgeons in a Multidisciplinary Aortic Team is reasonable to optimize treatment outcomes.1-6","Referring asymptomatic patients with extensive aortic disease, those who could gain from complex open and endovascular aortic repairs, or individuals with multiple comorbidities requiring intervention to a high-volume center (conducting a minimum of 30-40 aortic procedures per year) with skilled surgeons in a Multidisciplinary Aortic Team is advisable to enhance treatment outcomes."
id_00300,"In patients who use tobacco and have under- gone coronary revascularization, smoking ces- sation interventions are recommended during hospitalization and should include supportive follow-up for at least 1 month after discharge to facilitate tobacco cessation and reduce morbidity and mortality.4-6","For patients who use tobacco and have had coronary revascularization, it is advised to implement smoking cessation interventions during their hospital stay, with supportive follow-up for a minimum of one month post-discharge, to aid in quitting tobacco and decrease morbidity and mortality."
id_01740,"In selected patients with HFpEF, ARNi may be considered to decrease hospitalizations, par- ticularly among patients with LVEF on the lower end of this spectrum.10,11","For certain patients with HFpEF, ARNi can be contemplated to reduce hospital admissions, especially in those whose LVEF is at the lower range of this category."
id_02220,"In patients with aortic disease, shared deci- sion-making is recommended when determin- ing the appropriate thresholds for intervention, deciding on the type of surgical repair, choos- ing between open surgical versus endovascu- lar approaches; and in medical management and surveillance.1-6","For patients with aortic disease, it is advised to engage in shared decision-making to establish suitable intervention thresholds, select the type of surgical repair, choose between open surgical and endovascular methods, and manage medical treatment and monitoring."
id_00301,"In patients who have undergone coronary revascularization who have symptoms of depression, anxiety, or stress, treatment with cognitive behavioral therapy, psychological counseling, and/or pharmacological interven- tions is beneficial to improve quality of life and cardiac outcomes.1-7","For patients who have had coronary revascularization and exhibit symptoms of depression, anxiety, or stress, utilizing cognitive behavioral therapy, psychological counseling, and/or medication is advantageous for enhancing quality of life and cardiac outcomes."
id_01261,"In patients with AF, it is reasonable to initiate sotalol therapy in a facility that can provide continuous electrocardiographic monitoring, calculations of CrCl, and cardiac resuscitation, given the potential for proarrhythmia and bradycardia.4,8–10","For patients with AF, starting sotalol treatment in a setting equipped for continuous ECG monitoring, CrCl assessment, and cardiac resuscitation is advisable due to the risks of proarrhythmia and bradycardia."
id_02221,"In patients with aortic disease who are contem- plating pregnancy or who are pregnant, shared decision-making is recommended when con- sidering the cardiovascular risks of pregnancy, the diameter thresholds for prophylactic aortic surgery, and the mode of delivery.","For patients with aortic disease who are pregnant or planning to become pregnant, it is advised to engage in shared decision-making regarding the cardiovascular risks associated with pregnancy, the size criteria for preventive aortic surgery, and the choice of delivery method."
id_02700,"In patients with spontaneous ICH with an indi- cation for antiplatelet therapy, resumption of antiplatelet therapy may be reasonable for the prevention of thromboembolic events based on consideration of benefit and risk.588,589","For patients experiencing spontaneous intracerebral hemorrhage who require antiplatelet therapy, restarting antiplatelet treatment could be considered to prevent thromboembolic events, taking into account the benefits and risks."
id_01741,"In patients with HFpEF, routine use of nitrates or phosphodiesterase-5 inhibitors to increase activity or QOL is ineffective.12,13 *See Section 7.2, “Diuretics and Decongestion Strategies in Patients with HF,” and Section 10.2, “Management of Atrial Fibrillation (AF) in HF” for recom- mendations for use of diuretics and management of AF in HF. Downloaded from http://ahajournals.org by on June 19, 2025","For patients with HFpEF, using nitrates or phosphodiesterase-5 inhibitors routinely to enhance activity or quality of life is not effective. Refer to Section 7.2 for diuretic and decongestion strategies in HF patients, and Section 10.2 for managing atrial fibrillation in HF."
id_00302,"In patients who have undergone coronary revascularization, it may be reasonable to screen for depression and refer or treat when it is indicated to improve quality of life and recovery.8,9","For patients who have had coronary revascularization, screening for depression and providing referral or treatment when necessary can be beneficial for enhancing quality of life and recovery."
id_02701,"In patients with nonvalvular atrial fibrillation (AF) and spontaneous ICH, the resumption of anti- coagulation to prevent thromboembolic events and reduce all-cause mortality may be consid- ered based on weighing benefit and risk.590–595","For patients with nonvalvular atrial fibrillation (AF) who have experienced spontaneous intracerebral hemorrhage (ICH), restarting anticoagulation therapy to prevent thromboembolic events and lower all-cause mortality can be contemplated by evaluating the benefits against the risks."
id_01742,Patients for whom there is a clinical suspi- cion for cardiac amyloidosis*1–5 should have screening for serum and urine monoclonal light chains with serum and urine immuno- fixation electrophoresis and serum free light chains.6,"For patients with a clinical suspicion of cardiac amyloidosis, screening should include serum and urine monoclonal light chains using serum and urine immunofixation electrophoresis, along with serum free light chains."
id_00303,"With the goal of improving patient outcomes, it is recommended that cardiac surgery and PCI programs participate in state, regional, or national clinical data registries and receive periodic reports of their risk-adjusted out- comes as a quality assessment and improve- ment strategy.1-8","To enhance patient outcomes, it is advised that cardiac surgery and PCI programs engage in state, regional, or national clinical data registries and obtain regular reports on their risk-adjusted outcomes as a strategy for quality assessment and improvement."
id_02702,"In patients with AF and spontaneous ICH in whom the decision is made to restart antico- agulation, initiation of anticoagulation ≈7 to 8 weeks after ICH may be considered after weighing specific patient characteristics to optimize the balance of risks and benefits.596,597","For patients with AF who have experienced spontaneous ICH and are considered for resuming anticoagulation, starting anticoagulation approximately 7 to 8 weeks post-ICH can be contemplated after evaluating individual patient factors to optimize the risk-benefit balance."
id_01262,"In patients with AF who are initiating PITP dosing of flecainide and propafenone with concomitant atrioventricular nodal blocking drugs, it is reasonable to receive the first dose in a facility that can provide continuous electrocardiographic monitoring, given the potential for proarrhythmia.9–13","For patients with atrial fibrillation starting on PITP doses of flecainide and propafenone alongside atrioventricular nodal blocking agents, it is advisable to administer the initial dose in a setting equipped for continuous ECG monitoring due to the risk of proarrhythmia."
id_01743,"In patients with high clinical suspicion for car- diac amyloidosis, without evidence of serum or urine monoclonal light chains, bone scintigra- phy should be performed to confirm the pres- ence of transthyretin cardiac amyloidosis.7","For patients highly suspected of having cardiac amyloidosis and lacking serum or urine monoclonal light chains, bone scintigraphy is recommended to confirm transthyretin cardiac amyloidosis."
id_02703,"In patients with AF and spontaneous ICH deemed ineligible for anticoagulation, left atrial appendage closure may be considered to reduce the risk of thromboembolic events.598–602","For patients with atrial fibrillation and spontaneous intracerebral hemorrhage who cannot receive anticoagulation, left atrial appendage closure can be an option to lower the risk of thromboembolic events."
id_02222,"In patients with aortic root/ascending aortic aneurysms or aortic dissection, obtaining a multigenerational family history of TAD, unex- plained sudden deaths, and peripheral and intracranial aneurysms is ­recommended.1-3","For patients with aortic root or ascending aortic aneurysms, or aortic dissection, it is advised to gather a multigenerational family history of thoracic aortic disease, unexplained sudden deaths, and peripheral or intracranial aneurysms."
id_01263,"In patients with symptomatic AF in whom anti- arrhythmic drugs have been ineffective, contra- indicated, not tolerated or not preferred, and continued rhythm control is desired, cath- eter ablation is useful to improve symptoms.1–10","For patients with symptomatic atrial fibrillation where anti-arrhythmic medications are ineffective, unsuitable, intolerable, or not favored, and ongoing rhythm control is needed, catheter ablation is beneficial for symptom improvement."
id_02223,"In patients with aortic root/ascending aortic aneurysms or aortic dissection and risk factors for HTAD (Table 8, Figure 17), genetic testing to identify pathogenic/ likely pathogenic variants (ie, mutations) is ­recommended.4-6","For patients with aortic root or ascending aortic aneurysms, or aortic dissection who have risk factors for HTAD (refer to Table 8, Figure 17), it is advised to conduct genetic testing to detect pathogenic or likely pathogenic variants (mutations)."
id_00304,"With the goal of improving patient outcomes, it is reasonable for cardiac surgery and PCI pro- grams to have a quality improvement program that routinely 1) reviews institutional quality programs and outcomes, 2) reviews individual operator outcomes, 3) provides peer review of difficult or complicated cases, and 4) performs random case reviews.9,10","To enhance patient outcomes, cardiac surgery and PCI programs should consider implementing a quality improvement initiative that regularly 1) evaluates institutional quality programs and outcomes, 2) assesses individual operator results, 3) conducts peer reviews of challenging or complex cases, and 4) carries out random case evaluations."
id_02224,"In patients with an established pathogenic or likely pathogenic variant in a gene predispos- ing to HTAD, it is recommended that genetic counseling be provided and the patient’s clini- cal management be informed by the specific gene and variant in the gene.7-9","For patients with a confirmed pathogenic or likely pathogenic variant in a gene associated with HTAD, genetic counseling should be offered, and clinical management should be guided by the specific gene and its variant."
id_01264,"In selected patients (generally younger with few comorbidities) with symptomatic parox- ysmal AF in whom rhythm control is desired, catheter ablation is useful as first-line therapy to improve symptoms and reduce progression to persistent AF.11–16","For certain patients, typically younger individuals with minimal comorbidities, who have symptomatic paroxysmal AF and require rhythm control, catheter ablation is beneficial as an initial treatment to alleviate symptoms and prevent progression to persistent AF."
id_00305,"Smaller volume cardiac surgery and PCI programs may consider affiliating with a high- volume center to improve patient care. Downloaded from http://ahajournals.org by on June 19, 2025",Programs with lower volumes in cardiac surgery and PCI might enhance patient care by partnering with a high-volume center.
id_02704,"In patients with spontaneous ICH and an estab- lished indication for statin pharmacotherapy, the risks and benefits of statin therapy on ICH out- comes and recurrence relative to overall preven- tion of cardiovascular events are uncertain.605–609","For patients with spontaneous intracerebral hemorrhage who have a clear indication for statin use, the impact of statin therapy on ICH outcomes and recurrence, compared to its role in preventing cardiovascular events, remains unclear."
id_01744,"In patients for whom a diagnosis of transthyre- tin cardiac amyloidosis is made, genetic testing with TTR gene sequencing is recommended to differentiate hereditary variant from wild-type transthyretin cardiac amyloidosis.8 *LV wall thickness ≥14 mm in conjunction with fatigue, dyspnea, or edema, especially in the context of discordance between wall thickness on echocardiogram and QRS voltage on ECG, and in the context of aortic ste- nosis, HFpEF, carpal tunnel syndrome, spinal stenosis, and autonomic or sensory polyneuropathy.","For patients diagnosed with transthyretin cardiac amyloidosis, TTR gene sequencing is advised to distinguish between hereditary and wild-type forms. Consider this especially when left ventricular wall thickness is ≥14 mm along with symptoms like fatigue, dyspnea, or edema, particularly if there is a mismatch between echocardiogram wall thickness and QRS voltage on ECG, and in cases of aortic stenosis, HFpEF, carpal tunnel syndrome, spinal stenosis, or autonomic or sensory polyneuropathy."
id_01265,"In patients with symptomatic or clinically significant AFL, catheter ablation is useful for improving symptoms.17–19",Catheter ablation is beneficial for alleviating symptoms in patients with symptomatic or clinically significant AFL.17–19
id_02225,"In patients with TAD who have a pathogenic/ likely pathogenic variant, genetic testing of at- risk biological relatives (ie, cascade testing) is recommended.6,10,11 In family members who are found by genetic screening to have inherited the pathogenic/likely pathogenic variant, aortic imaging with TTE (if aortic root and ascending aorta are adequately visualized, otherwise with CT or MRI) is recommended.4,5,12","For patients with TAD carrying a pathogenic or likely pathogenic variant, it is advised to conduct genetic testing on at-risk biological relatives, known as cascade testing. If genetic screening reveals that family members have inherited the pathogenic or likely pathogenic variant, it is recommended to perform aortic imaging using TTE, provided the aortic root and ascending aorta are clearly visible; otherwise, CT or MRI should be used."
id_01745,"In select patients with wild-type or variant trans- thyretin cardiac amyloidosis and NYHA class I to III HF symptoms, transthyretin tetramer sta- bilizer therapy (tafamidis) is indicated to reduce cardiovascular morbidity and mortality.1 Value Statement: Low Value (B-NR)","For certain patients with wild-type or variant transthyretin cardiac amyloidosis experiencing NYHA class I to III heart failure symptoms, tafamidis, a transthyretin tetramer stabilizer, is recommended to decrease cardiovascular morbidity and mortality. Value Statement: Low Value (B-NR)"
id_00306,"In patients with suspected ACS, a 12-lead ECG should be acquired and interpreted within 10 minutes of first medical contact (FMC)* to identify patients with STEMI.1,2","For patients with suspected ACS, a 12-lead ECG must be obtained and analyzed within 10 minutes of initial medical contact to detect those with STEMI."
id_02705,"In patients with spontaneous ICH, regular long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) is potentially harmful because of the increased risk of ICH.610,611","For patients with spontaneous intracerebral hemorrhage (ICH), the consistent long-term use of nonsteroidal anti-inflammatory drugs (NSAIDs) may be detrimental due to the heightened risk of ICH."
id_01266,"In patients who are undergoing ablation for AF, ablation of additional clinically significant supraventricular arrhythmias can be useful to reduce the likelihood of future arrhythmia.17,18,20–27","For patients receiving ablation for atrial fibrillation, targeting other clinically significant supraventricular arrhythmias during the procedure may help decrease the risk of future arrhythmias."
id_01746,"In patients with cardiac amyloidosis and AF, anticoagulation is reasonable to reduce the risk of stroke regardless of the CHA2DS2-VASc (congestive heart failure, hypertension, age ≥75 years, diabetes mellitus, stroke or transient ischemic attack [TIA], vascular disease, age 65 to 74 years, sex category) score.3,4","For patients with cardiac amyloidosis and atrial fibrillation, it is advisable to use anticoagulation to lower the risk of stroke, irrespective of the CHA2DS2-VASc score."
id_02226,"In a family with aortic root/ascending aor- tic aneurysms or aortic dissection, if the disease-causing variant is not identified with genetic testing, screening aortic imag- ing (as per recommendation 4) of at-risk biological relatives (ie, cascade testing) is ­recommended.13-15","For families with aortic root or ascending aortic aneurysms or dissection, if genetic testing does not reveal the causative variant, it is advised to conduct screening aortic imaging (following recommendation 4) for biological relatives at risk, known as cascade testing."
id_02706,"In patients with spontaneous ICH, lifestyle modification is reasonable to reduce BP.632","For patients with spontaneous intracerebral hemorrhage, it is advisable to modify lifestyle to lower blood pressure."
id_00307,"In patients with suspected ACS in which the initial ECG is nondiagnostic of STEMI, serial ECGs to detect potential ischemic changes should be performed, especially when clinical suspicion of ACS is high, symptoms are persistent, or the clinical condition deteriorates.†3,4 STEMI","For patients suspected of having ACS where the initial ECG does not diagnose STEMI, repeated ECGs should be conducted to identify possible ischemic changes, particularly if there is a strong clinical suspicion of ACS, ongoing symptoms, or worsening clinical condition."
id_02707,"In patients with spontaneous ICH, avoiding heavy alcohol consumption is reasonable to reduce hypertension and risk of ICH recurrence.633–635","For patients with spontaneous ICH, it is advisable to refrain from excessive alcohol intake to lower hypertension and the likelihood of ICH recurrence."
id_01267,"In patients (other than younger with few comorbidities) with symptomatic paroxysmal or persistent AF who are being managed with a rhythm-control strategy, catheter ablation as first-line therapy can be useful to improve symptoms.11–13,28 Cost Value Statement: Intermediate B-R","For patients with symptomatic paroxysmal or persistent atrial fibrillation, except younger individuals with minimal comorbidities, catheter ablation may be beneficial as an initial treatment in a rhythm-control approach to alleviate symptoms."
id_00308,"In patients with suspected STEMI, immediate emergency medical services (EMS) transport to a PCI-capable hospital for primary PCI (PPCI‡) is the recommended triage strategy, with an FMC–to-first-device time system goal of ≤90 minutes.5–7","For patients with suspected STEMI, the advised triage approach is prompt transport by emergency medical services to a hospital equipped for PCI, aiming for a system goal of ≤90 minutes from first medical contact to device deployment."
id_01747,"In patients with advanced HF, when consistent with the patient’s goals of care, timely refer- ral for HF specialty care is recommended to review HF management and assess suitability for advanced HF therapies (eg, LVAD, cardiac transplantation, palliative care, and palliative inotropes).1–6","For patients with advanced heart failure, it is advisable to promptly refer them to a heart failure specialist, in alignment with their care goals, to evaluate heart failure management and determine eligibility for advanced therapies such as LVAD, cardiac transplantation, palliative care, and palliative inotropes."
id_02227,"In patients with aortic root/ascending aor- tic aneurysms or aortic dissection, in the absence of either a known family history of TAD or pathogenic/likely pathogenic variant, screening aortic imaging (as per recommen- dation 4) of first-degree relatives is recom- mended.13","For individuals with aortic root or ascending aortic aneurysms or aortic dissection, and without a known family history of thoracic aortic disease or a pathogenic/likely pathogenic variant, it is advised to conduct screening aortic imaging of first-degree relatives, following recommendation 4."
id_01748,"For patients with advanced HF and hypona- tremia, the benefit of fluid restriction to reduce congestive symptoms is uncertain.1–4",The advantage of fluid restriction for alleviating congestive symptoms in patients with advanced heart failure and hyponatremia is unclear.
id_01268,"In selected* patients with asymptomatic or minimally symptomatic AF, catheter ablation may be useful for reducing progression of AF and its associated complications.31–39 *Younger patients with few comorbidities and a moderate to high burden of AF or persistent AF and AFL.","For certain patients with asymptomatic or minimally symptomatic atrial fibrillation, catheter ablation can be beneficial in decreasing the progression of AF and its related complications, particularly in younger individuals with minimal comorbidities and a moderate to high frequency of AF or persistent AF and AFL."
id_02708,"In patients with spontaneous ICH, lifestyle modification, including supervised training and counseling, may be reasonable to improve functional recovery.636,637 Patient and caregiver education","For patients experiencing spontaneous ICH, it may be beneficial to enhance functional recovery through lifestyle changes, such as guided exercise and counseling, along with education for both patients and caregivers."
id_00309,"In patients with suspected STEMI, early advance notification of the receiving PCI-capable hospital by EMS personnel and activation of the cardiac catheterization team is recommended to reduce time to reperfusion.1,8,9 *FMC indicates the time point when the patient is initially assessed by a health care professional who can obtain and interpret the ECG and deliver initial inter- ventions (eg, defibrillation). †Modified from the “2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain.”10 ‡PPCI refers to emergency PCI in the setting of STEMI to achieve reperfusion in patients without previous fibrinolytic treatment.","For patients with suspected STEMI, it is advised that EMS personnel promptly inform the PCI-capable hospital and activate the cardiac catheterization team to minimize reperfusion time."
id_01269,"In patients undergoing ablation for AF, PVI is recom- mended as the primary lesion set for all patients unless a different specific trigger is identified.1–7","For patients receiving ablation for atrial fibrillation, pulmonary vein isolation should be the initial lesion set for everyone, unless a distinct trigger is identified."
id_02228,"In asymptomatic patients with aneurysms of the aortic root or ascending aorta with nonsyndromic heritable thoracic aortic dis- ease (nsHTAD) and no identified genetic cause, determining the timing of surgical repair requires shared decision-making and is informed by known aortic diameters at the time of aortic dissection, TAA repair, or both in affected family members.1-4","For asymptomatic individuals with aortic root or ascending aorta aneurysms due to nonsyndromic heritable thoracic aortic disease (nsHTAD) without a known genetic cause, the timing of surgical intervention should be decided collaboratively, guided by the aortic diameters observed during dissection or thoracic aortic aneurysm repair in family members."
id_01749,"In patients with advanced (stage D) HF refrac- tory to GDMT and device therapy who are eligible for and awaiting MCS or cardiac trans- plantation, continuous intravenous inotropic support is reasonable as “bridge therapy.”1–4","For patients with advanced stage D heart failure who do not respond to guideline-directed medical and device therapy and are candidates for mechanical circulatory support or heart transplantation, continuous intravenous inotropic therapy is a reasonable option as bridge therapy."
id_02709,"In patients with spontaneous ICH, psychoso- cial education for the caregiver can be ben- eficial to increase patients’ activity level and participation and/or quality of life.638","For patients with spontaneous ICH, providing psychosocial education to caregivers may help enhance the patients' activity levels, participation, and/or quality of life."
id_00310,"In patients with suspected ACS, acquisition and interpretation of an ECG within 10 minutes is recommended to help guide patient management.*1,2 Table 4.  Types of Acute Myocardial Infarction According to the Universal Definition of Myocardial Infarction Type 1* Caused by acute coronary atherothrombosis, usually precipitated by atherosclerotic plaque disruption (rupture or erosion) and often associated with partial or complete vessel thrombosis. Type 2","For patients with suspected acute coronary syndrome (ACS), it is advised to obtain and interpret an ECG within 10 minutes to assist in directing patient care."
id_02229,In asymptomatic patients with aneurysms of the aortic root or ascending aorta with nsHTAD and no identified genetic cause but no information on aortic diameters at the time of dissection or aneurysm repair in affected family members and who have no high-risk features for adverse aortic events (Table 9) it is recommended to repair the aorta when the maximal diameter reaches ≥5.0 cm.1,"For asymptomatic individuals with aortic root or ascending aorta aneurysms associated with nsHTAD, lacking a genetic cause and without data on aortic diameters during dissection or repair in affected relatives, and who do not exhibit high-risk features for adverse aortic events (refer to Table 9), aortic repair is advised when the maximum diameter is ≥5.0 cm."
id_01270,"In patients undergoing ablation for AF, the value of other endpoints beyond PVI such as noninducibility and ablation of additional anatomic ablation targets (eg, posterior wall sites, low voltage areas, complex fractionated electrograms, rotors) is uncertain.8–18","For patients receiving ablation for atrial fibrillation, the significance of endpoints other than pulmonary vein isolation, such as achieving noninducibility and targeting additional anatomical sites (e.g., posterior wall, low voltage regions, complex fractionated electrograms, rotors), remains unclear."
id_01750,"In select patients with stage D HF, despite optimal GDMT and device therapy who are ineligible for either MCS or cardiac transplan- tation, continuous intravenous inotropic sup- port may be considered as palliative therapy for symptom control and improvement in func- tional status.5–7","For certain patients with stage D heart failure who do not qualify for mechanical circulatory support or heart transplantation, and have already received optimal guideline-directed medical and device therapy, continuous intravenous inotropic support can be considered as a palliative measure to manage symptoms and enhance functional status."
id_02230,"In patients with aneurysms of the aortic root or ascending aorta with nsHTAD and no identified genetic cause and a maximal aortic diameter of ≥4.5 cm, who have high-risk fea- tures for adverse aortic events (Table 9), or who are undergoing cardiac surgery for other indications, aortic repair is reasonable when performed by experienced surgeons in a Mul- tidisciplinary Aortic Team.5","For patients with aortic root or ascending aorta aneurysms associated with nsHTAD, lacking a genetic cause, and having a maximal aortic diameter of 4.5 cm or greater, it is advisable to consider aortic repair if they exhibit high-risk features for adverse aortic events (see Table 9) or are undergoing cardiac surgery for other reasons, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_02710,"In patients with spontaneous ICH, practical sup- port and training for the caregiver are reason- able to improve patients’ standing balance.639","For patients with spontaneous ICH, providing practical support and training to the caregiver is advisable to enhance the patients' standing balance."
id_00311,"In patients with suspected ACS in whom the initial ECG is nondiagnostic, serial 12-lead ECGs should be performed to detect potential ischemic changes, especially when clinical suspicion of ACS is high, symptoms are persistent, or clinical condition deteriorates.*3","For patients with suspected ACS and an initial ECG that is inconclusive, repeated 12-lead ECGs are recommended to identify possible ischemic changes, particularly when there is a strong clinical suspicion of ACS, ongoing symptoms, or worsening clinical status."
id_00791,"For term and late preterm newborn infants ≥34 weeks’ gestation who do not require resuscitation, delayed cord clamping (DCC) (≥30 seconds) can be beneficial when compared to early cord clamping (<30 seconds).","For newborns born at or after 34 weeks' gestation who do not need resuscitation, delaying cord clamping for at least 30 seconds may be advantageous compared to clamping before 30 seconds."
id_01271,"In patients with recurrent symptomatic AF after catheter ablation, repeat catheter ablation or antiarrhythmic drug therapy is useful to improve symptoms and freedom from AF.1–11","For patients experiencing recurrent symptomatic atrial fibrillation following catheter ablation, undergoing another catheter ablation or using antiarrhythmic medications is beneficial for alleviating symptoms and achieving freedom from atrial fibrillation."
id_00312,"In patients with suspected ACS, cTn should be measured as soon as possible, preferably using a high-sensitivity cTn (hs-cTn) assay.*4–7","For patients with suspected ACS, cTn should be assessed promptly, ideally with a high-sensitivity cTn (hs-cTn) test."
id_01751,"In patients with HF, long-term use of either continuous or intermittent intravenous inotropic agents, for reasons other than palliative care or as a bridge to advanced therapies, is potentially harmful.5,6,8–11","For patients with heart failure, prolonged administration of intravenous inotropic agents, whether continuous or intermittent, is potentially detrimental unless used for palliative care or as a transition to advanced treatments."
id_02711,"When considering primary prevention of ICH, it may be reasonable to incorporate any available MRI results demonstrating cerebral microbleed burden or cortical superficial sid- erosis to inform shared decision-making about stroke prevention treatment plans.25,564,644–648","For primary ICH prevention, it might be advisable to use MRI findings that show cerebral microbleeds or cortical superficial siderosis to guide collaborative decisions on stroke prevention strategies."
id_01272,"In some patients who have undergone catheter ablation of AF, short-term antiarrhythmic drug therapy after ablation can be useful to reduce early recur- rences of atrial arrhythmia and hospitalization.12–16","For certain patients who have had catheter ablation for AF, using antiarrhythmic drugs temporarily after the procedure may help decrease early atrial arrhythmia recurrences and the need for hospitalization."
id_00792,"For nonvigorous term and late preterm infants (35–42 weeks’ gestation), intact cord milking may be reasonable when compared to early cord clamping (<30 seconds).","For nonvigorous infants born at term or late preterm (35–42 weeks’ gestation), intact cord milking might be a reasonable alternative to early cord clamping (within 30 seconds)."
id_01752,"In select patients with advanced HFrEF with NYHA class IV symptoms who are deemed to be dependent on continuous intravenous inotropes or temporary MCS, durable LVAD implantation is effective to improve functional status, QOL, and survival.1–18","For certain patients with advanced HFrEF exhibiting NYHA class IV symptoms and reliant on ongoing intravenous inotropes or temporary MCS, the implantation of a durable LVAD effectively enhances functional status, quality of life, and survival."
id_02232,"In adults with Marfan syndrome, after the initial TTE, a CT or MRI of the thoracic aorta is reasonable to confirm the aortic diameters and assess the remainder of the thoracic aorta. Downloaded from http://ahajournals.org by on June 19, 2025","For adults diagnosed with Marfan syndrome, following the initial transthoracic echocardiogram (TTE), it is advisable to perform a CT or MRI of the thoracic aorta to verify aortic measurements and evaluate the rest of the thoracic aorta."
id_02231,"In patients with Marfan syndrome, a TTE is recommended at the time of initial diagnosis, to determine the diameters of the aortic root and ascending aorta, and 6 months thereafter, to determine the rate of aortic growth; if the aortic diameters are stable, an annual surveillance TTE is recommended.1 If the aortic root, ascending aorta, or both are not adequately visualized on TTE, a CT or MRI of the thoracic aorta is recommended.2","For individuals diagnosed with Marfan syndrome, an initial TTE is advised to measure the aortic root and ascending aorta diameters, followed by another TTE in 6 months to assess aortic growth rate; if these diameters remain stable, an annual TTE is suggested. If TTE does not clearly visualize the aortic root or ascending aorta, a CT or MRI of the thoracic aorta should be performed."
id_02712,"For patients with HCM or at risk for HCM, shared decision-making is recommended in developing a plan of care (including but not limited to decisions regarding genetic evaluation, activity, lifestyle, and therapy choices) that includes a full disclosure of the risks, benefits, and anticipated outcomes of all options, as well the opportunity for the patient to express their goals and concerns.4–9","For individuals diagnosed with or at risk for HCM, it is advised to engage in shared decision-making when formulating a care plan. This plan should encompass decisions about genetic testing, activity, lifestyle, and treatment options, ensuring a comprehensive discussion of the risks, benefits, and expected results of each choice, while also allowing the patient to communicate their objectives and concerns."
id_01273,"In patients on warfarin who are undergoing catheter ablation of AF, catheter ablation should be performed on uninterrupted therapeutic anticoagula- tion with a goal INR of 2.0 to 3.0.1","For patients receiving warfarin and undergoing catheter ablation for atrial fibrillation, the procedure should be conducted without interrupting therapeutic anticoagulation, aiming for an INR between 2.0 and 3.0."
id_00313,"In patients with suspected ACS with an initial hs-cTn or cTn that is nondiagnostic, the recommended time intervals for repeat measurements after the initial sample collection (time zero) are 1 to 2 hours for hs-cTn and 3 to 6 hours for conventional cTn assays.*8–12 *Adapted from the “2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain.”13","For patients suspected of having ACS with an initial nondiagnostic hs-cTn or cTn, it is advised to repeat hs-cTn measurements 1 to 2 hours after the initial sample (time zero) and conventional cTn assays 3 to 6 hours later."
id_00793,"For term and late preterm newborn infants ≥34 weeks’ gestation who do not require ­resuscitation, intact cord milking is not known to be beneficial when compared to DCC (≥30 seconds). Recommendation-Specific Supportive Text","For newborns at or beyond 34 weeks' gestation who are full-term or late preterm and do not need resuscitation, intact cord milking has not been shown to offer advantages over delayed cord clamping of 30 seconds or more."
id_01753,"In select patients with advanced HFrEF who have NYHA class IV symptoms despite GDMT, durable MCS can be beneficial to improve symptoms, improve functional class, and reduce mortality.2,4,7,10,12–17,19 Value Statement: Uncertain Value (B-NR)","For certain patients with advanced HFrEF experiencing NYHA class IV symptoms despite GDMT, long-term MCS may be advantageous for alleviating symptoms, enhancing functional class, and decreasing mortality. Value Statement: Uncertain Value (B-NR)"
id_00314,"Patients with cardiac arrest and STEMI who have been resuscitated should preferentially be transferred by EMS to a PPCI-capable center.1,2",Patients experiencing cardiac arrest and STEMI who have been revived should ideally be transported by EMS to a center equipped for PPCI.
id_01274,"In patients on a DOAC who are undergoing catheter ablation of AF, catheter ablation should be performed with either continuous or minimally interrupted oral anticoagulation.2–10","For patients taking a DOAC and undergoing catheter ablation for AF, the procedure should be conducted with either uninterrupted or minimally interrupted oral anticoagulation."
id_02713,"In patients with HCM in whom septal reduc- tion therapy (SRT) is indicated, the procedure should be performed at experienced centers (comprehensive or primary HCM centers) with demonstrated excellence in clinical out- comes for these procedures10–12 (Table 3 and","For patients with HCM who require septal reduction therapy (SRT), the procedure ought to be conducted at specialized centers (comprehensive or primary HCM centers) that have proven success in clinical outcomes for these procedures."
id_01754,"In patients with advanced HFrEF and hemody- namic compromise and shock, temporary MCS, including percutaneous and extracorporeal ventricular assist devices, are reasonable as a “bridge to recovery” or “bridge to decision.”25–29","For patients experiencing advanced HFrEF with hemodynamic instability and shock, it is reasonable to use temporary mechanical circulatory support, such as percutaneous and extracorporeal ventricular assist devices, as a ""bridge to recovery"" or ""bridge to decision."""
id_02714,"In patients with HCM, consultation with or referral to a comprehensive or primary HCM center is reasonable to aid in complex disease-related management decisions13–22 (Table 3).","For patients with HCM, it is advisable to seek consultation or referral to a specialized or primary HCM center to assist with intricate management decisions related to the disease."
id_02233,"In patients with Marfan syndrome who have undergone aortic root replacement, surveil- lance imaging of the thoracic aorta by MRI (or CT) is recommended to evaluate for distal TAD, initially annually and then, if normal in diameter and unchanged after 2 years, every other year.3-6","For patients with Marfan syndrome who have had aortic root replacement, it is advised to perform surveillance imaging of the thoracic aorta using MRI or CT to assess for distal TAD. This should be done annually at first, and if the aorta remains normal in size and stable after two years, the imaging can be conducted every two years."
id_00315,"Patients who have been resuscitated after cardiac arrest and are noncomatose or who are comatose with favorable prognostic features and with evidence of STEMI, should undergo PPCI to improve survival.3–7",Patients resuscitated from cardiac arrest who are either noncomatose or comatose with positive prognostic indicators and show signs of STEMI should receive PPCI to enhance survival.
id_00795,"For preterm newborn infants between 28 and 34 weeks’ gestation who do not require resuscitation and in whom DCC cannot be performed, intact cord milking may be reasonable.","For preterm infants born between 28 and 34 weeks of gestation who do not need resuscitation and where delayed cord clamping is not possible, intact cord milking might be a suitable option."
id_00794,"For preterm newborn infants <34 weeks’ gestation who do not require resuscitation, delaying cord clamping (≥30 seconds) can be beneficial when compared to early cord clamping (<30 seconds).","For preterm infants born before 34 weeks of gestation who do not need resuscitation, postponing cord clamping for at least 30 seconds may be advantageous compared to clamping it earlier than 30 seconds."
id_01755,"For selected patients with advanced HF despite GDMT, cardiac transplantation is indi- cated to improve survival and QOL.1–3 Value Statement: Intermediate Value (C-LD)","Cardiac transplantation is recommended for certain patients with advanced heart failure who do not respond to guideline-directed medical therapy, as it enhances survival and quality of life. Value Statement: Intermediate Value (C-LD)"
id_02234,"In patients with Marfan syndrome who have undergone aortic root replacement, surveil- lance imaging every 3 to 5 years for potential AAA is reasonable.2,6","For patients with Marfan syndrome who have had aortic root replacement, it is advisable to perform surveillance imaging every 3 to 5 years to monitor for possible AAA."
id_01275,"In patients who have undergone catheter ablation of AF, oral anticoagulation should be continued for at least 3 months after the procedure with a longer duration determined by underlying risk.11","For patients who have had catheter ablation for AF, oral anticoagulation should be maintained for a minimum of 3 months post-procedure, with an extended duration based on their underlying risk."
id_02715,"In patients with suspected HCM, compre- hensive physical examination and complete medical and 3-generation family history is recommended as part of the initial diagnostic assessment23–28 (Table 5 and Table 6). Downloaded from http://ahajournals.org by on June 19, 2025","For individuals suspected of having HCM, it is advised to conduct a thorough physical examination along with a detailed medical history and a family history spanning three generations as part of the initial diagnostic evaluation."
id_00796,"For preterm newborn infants <28 weeks’ gestation, intact cord milking is not recommended. Recommendation-Specific Supportive Text",Intact cord milking is not advised for preterm infants born before 28 weeks of gestation.
id_02235,"In patients with Marfan syndrome, treatment with either a beta blocker or an ARB, in maxi- mally tolerated doses (unless contraindicated), is recommended to reduce the rate of aortic dilation.1,2","For patients with Marfan syndrome, it is advised to use a beta blocker or an ARB at the highest tolerable doses (unless contraindicated) to slow the progression of aortic dilation."
id_00316,"In patients with cardiac arrest who are comatose, have unfavorable prognostic features, and evi- dence of STEMI, PPCI may be reasonable after individualized assessment.4,7","For comatose patients experiencing cardiac arrest with poor prognostic indicators and signs of STEMI, PPCI could be considered appropriate following a personalized evaluation."
id_01756,"In patients hospitalized with HF, severity of con- gestion and adequacy of perfusion should be assessed to guide triage and initial therapy.1–5","For patients admitted with heart failure, evaluate the extent of congestion and the sufficiency of perfusion to inform triage and initial treatment."
id_01276,"In patients who have undergone catheter ablation of AF, continuation of longer-term oral anticoagulation should be dictated according to the patients’ stroke risk (eg, CHA2DS2-VASc score ≥2).11–17","For patients who have received catheter ablation for AF, the decision to maintain long-term oral anticoagulation should be based on their stroke risk, such as a CHA2DS2-VASc score of 2 or higher."
id_02236,"In patients with Marfan syndrome, the use of both a beta blocker and an ARB, in maximally tolerated doses (unless contraindicated), is reasonable to reduce the rate of aortic dila- tion.3,4","For patients with Marfan syndrome, it is advisable to administer both a beta blocker and an ARB at the highest tolerable doses (unless contraindicated) to slow the progression of aortic dilation."
id_02716,"In patients with suspected HCM, a transtho- racic echocardiogram (TTE) is recommended in the initial evaluation.29–34","For the initial assessment of patients suspected to have HCM, a transthoracic echocardiogram (TTE) is advised."
id_01757,"In patients hospitalized with HF, the common precipitating factors and the overall patient trajectory should be assessed to guide appro- priate therapy.5,6 Goals for Optimization and Continuation of GDMT","For patients admitted with heart failure, evaluate the usual triggers and the patient's overall progression to inform suitable treatment."
id_00797,"It can be beneficial to use a T-piece resuscitator instead of a self-inflating bag, with or without a positive end-expiratory pressure valve, for administering positive-pressure ventilation to newborn infants, particularly for preterm infants. Recommendation-Specific Supportive Text","Using a T-piece resuscitator may be advantageous over a self-inflating bag, whether or not it includes a positive end-expiratory pressure valve, for delivering positive-pressure ventilation to newborns, especially those born preterm."
id_00317,"In resuscitated patients who are comatose after cardiac arrest, electrically and hemodynamically stable, and without evidence of STEMI, immediate angiography is not recommended due to lack of benefit.8–14","For comatose patients who have been resuscitated following cardiac arrest, are electrically and hemodynamically stable, and show no signs of STEMI, immediate angiography is not advised as it offers no benefit."
id_02237,"In patients with Marfan syndrome and an aortic root diameter of ≥5.0 cm, surgery to replace the aortic root and ascending aorta is recommended.1-4","For individuals with Marfan syndrome whose aortic root measures 5.0 cm or larger, it is advised to perform surgery to replace the aortic root and ascending aorta."
id_01277,"In patients with bradycardia requiring cardiac- implanted electronic devices who have normal atrioventricular conduction, device selection and pro- gramming strategies to maintain atrioventricular syn- chrony and minimize ventricular pacing should be used to reduce the incidence and progression of AF. 1–6","For patients with bradycardia who need cardiac-implanted electronic devices and have normal atrioventricular conduction, it is recommended to choose and program devices in a way that preserves atrioventricular synchrony and limits ventricular pacing to decrease the occurrence and progression of atrial fibrillation."
id_02717,"For patients with HCM who experience a change in clinical status or a new clinical event, repeat TTE is recommended.35,38,43–46",It is advised to perform a repeat TTE for patients with HCM who undergo a change in clinical condition or encounter a new clinical event.
id_00318,"In patients with ACS and confirmed hypoxia (oxygen saturation <90%), supplemental oxygen to increase oxygen saturations to ≥90% is recommended to improve myocardial oxygen supply and decrease anginal symptoms.1","For patients experiencing ACS with confirmed hypoxia (oxygen saturation below 90%), it is advised to administer supplemental oxygen to raise oxygen saturation levels to 90% or higher, enhancing myocardial oxygen supply and reducing anginal symptoms."
id_01278,"In selected patients with a pacemaker and symptomatic atrial tachyarrhythmias, antitachycar- dia atrial pacing and ventricular pacing minimiza- tion may be useful for reducing symptoms.7–13 (Continued ) Downloaded from http://ahajournals.org by on June 19, 2025","For certain patients with a pacemaker experiencing symptomatic atrial tachyarrhythmias, utilizing antitachycardia atrial pacing and minimizing ventricular pacing can help alleviate symptoms."
id_00798,It may be reasonable to use a supraglottic airway as the primary interface to administer PPV instead of a face mask for newborn infants delivered at ≥34 0/7 weeks’ gestation. Recommendation-Specific Supportive Text,"Using a supraglottic airway as the main method for delivering positive pressure ventilation, rather than a face mask, might be appropriate for newborns born at or beyond 34 weeks of gestation."
id_02718,"For patients with HCM and resting left ventricular outflow tract gradient <50 mm Hg, a TTE with provocative maneuvers is recommended.47–50","For patients with HCM and a resting left ventricular outflow tract gradient of less than 50 mm Hg, it is advised to perform a TTE with provocative maneuvers."
id_01758,"For patients admitted with HF, treatment should address reversible factors, establish optimal volume status, and advance GDMT toward targets for outpatient therapy.6","In patients hospitalized with heart failure, care should focus on correcting reversible causes, achieving optimal fluid balance, and progressing guideline-directed medical therapy to outpatient targets."
id_00319,"In patients with ACS and oxygen saturations ≥90%, routine administration of supplemental oxygen is not recommended because it does not improve cardiovascular outcomes.2–4","For patients with ACS who have oxygen saturations of 90% or higher, routinely providing supplemental oxygen is not advised, as it does not enhance cardiovascular outcomes."
id_01279,"In patients with AF who require significant ventricular pacing, conduction system pacing may be useful to reduce progression of AF.14,15","For patients with AF needing substantial ventricular pacing, conduction system pacing can help mitigate AF progression."
id_00799,"In patients with aSAH, use of clinical scales (eg, the Hunt and Hess [HH] grade or World Federation of Neurosurgical Societies [WFNS] grade) is recom- mended to determine initial clinical sever- ity and predict outcome.28,29","For patients with aSAH, it is advised to utilize clinical scales, such as the Hunt and Hess (HH) grade or the World Federation of Neurosurgical Societies (WFNS) grade, to assess initial clinical severity and forecast outcomes."
id_01759,"In patients with HFrEF requiring hospitalization, preexisting GDMT should be continued and optimized to improve outcomes, unless contra- indicated.1–5","For patients with HFrEF who need hospitalization, existing GDMT should be maintained and enhanced to improve outcomes, unless contraindicated."
id_02719,"For symptomatic patients with HCM who do not have a resting or provocable outflow tract gradient ≥50 mm Hg on TTE, exercise TTE is recommended for the detection and quantifi- cation of dynamic LVOTO.49–54","For patients with HCM who exhibit symptoms but lack a resting or inducible outflow tract gradient of ≥50 mm Hg on TTE, exercise TTE is advised to detect and measure dynamic LVOTO."
id_02238,"In patients with Marfan syndrome, an aortic root diameter of ≥4.5 cm, and features associ- ated with an increased risk of aortic dissection (see Table 10), surgery to replace the aortic root and ascending aorta is reasonable, when performed by experienced surgeons in a Mul- tidisciplinary Aortic Team.1,3,4","For patients with Marfan syndrome who have an aortic root diameter of 4.5 cm or greater and exhibit characteristics linked to a heightened risk of aortic dissection (refer to Table 10), it is advisable to consider surgical replacement of the aortic root and ascending aorta, provided it is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_02239,"In patients with Marfan syndrome and a maxi- mal cross-sectional aortic root area (cm2) to patient height (m) ratio of ≥10, surgery to replace the aortic root and ascending aorta is reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.5","For patients with Marfan syndrome, it is advisable to consider surgical replacement of the aortic root and ascending aorta when the ratio of maximal cross-sectional aortic root area (cm²) to patient height (m) is ≥10, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_00800,"In patients with high-grade aSAH, aneu- rysm treatment is reasonable, after careful discussion of likely prognosis with family members, to optimize patient outcome.28,30","For patients with high-grade aSAH, treating the aneurysm is advisable, following thorough discussions with family about the expected prognosis, to enhance the patient's outcome."
id_00320,"In patients with ACS, an initial oral loading dose of aspirin, followed by daily low-dose aspirin, is recommended to reduce death and MACE.1–5","For patients with ACS, it is advised to start with an oral loading dose of aspirin, then continue with a daily low-dose aspirin to decrease mortality and MACE."
id_01280,"In patients with AF, specialized atrial pacing algorithms designed to suppress AF are not useful for reducing the incidence or slowing the progression of AF.12,16–18","For patients with AF, atrial pacing algorithms specifically developed to prevent AF do not effectively decrease the occurrence or hinder the advancement of AF."
id_01760,"In patients experiencing mild decrease of renal function or asymptomatic reduction of blood pressure during HF hospitalization, diuresis and other GDMT should not routinely be discontin- ued.6–11","For patients with a slight decline in kidney function or an asymptomatic drop in blood pressure during heart failure hospitalization, diuretics and other guideline-directed medical therapies should generally be continued."
id_02720,"For patients with HCM undergoing surgical septal myectomy, intraoperative transesopha- geal echocardiogram (TEE) is recommended to assess mitral valve anatomy and function and adequacy of septal myectomy.55–58","In patients with HCM who are having surgical septal myectomy, it is advised to use intraoperative transesophageal echocardiogram (TEE) to evaluate the mitral valve's structure and function, as well as the sufficiency of the septal myectomy."
id_00321,"In patients with ACS, an oral P2Y12 inhibitor should be administered in addition to aspirin to reduce MACE.1–5","For patients with ACS, a P2Y12 inhibitor taken orally should be given alongside aspirin to decrease MACE."
id_00801,"In patients with aSAH and advanced age, aneurysm treatment is reasonable, after care- ful discussion of prognosis with family mem- bers, to improve survival and outcome.31–33","For patients with aSAH who are elderly, it is advisable to consider aneurysm treatment, following a thorough discussion of prognosis with family members, to enhance survival and outcomes."
id_01281,"For patients with AF who are undergoing cardiac surgery, concomitant surgical ablation can be beneficial to reduce the risk of recurrent AF.1–3","For patients with atrial fibrillation undergoing heart surgery, performing surgical ablation at the same time may help lower the likelihood of AF recurrence."
id_02240,"In patients with Marfan syndrome and an aor- tic diameter approaching surgical threshold, who are candidates for valve-sparing root replacement (VSRR) and have a very low surgical risk, surgery to replace the aortic root and ascending aorta may be reasonable when performed by experienced surgeons in a Mul- tidisciplinary Aortic Team.2-4","For patients with Marfan syndrome whose aortic diameter is nearing the surgical threshold, and who are suitable for valve-sparing root replacement (VSRR) with minimal surgical risk, it may be appropriate to consider aortic root and ascending aorta replacement by skilled surgeons within a Multidisciplinary Aortic Team."
id_01761,"In patients with HFrEF, GDMT should be initi- ated during hospitalization after clinical stability is achieved.2,3,5,12–18","For patients with HFrEF, GDMT ought to be started during their hospital stay once clinical stability is attained."
id_02241,"In patients with Marfan syndrome and a nondissected aneurysm of the aortic arch, descending thoracic aorta, or abdominal aorta of ≥5.0 cm, surgical intervention to replace the aneurysmal segment is ­reasonable.","For patients with Marfan syndrome who have a nondissected aneurysm measuring 5.0 cm or larger in the aortic arch, descending thoracic aorta, or abdominal aorta, it is advisable to surgically replace the affected segment."
id_01282,"In patients undergoing surgical ablation, anticoagulation therapy is reasonable for at least","For patients receiving surgical ablation, it is advisable to administer anticoagulation therapy for a minimum of"
id_00322,"In patients with a history of stroke or transient ischemic attack, prasugrel should not be adminis- tered because of worse net clinical outcomes.*†4 In-Hospital Management in Patients With NSTE-ACS",Prasugrel should not be given to patients with a history of stroke or transient ischemic attack due to poorer overall clinical outcomes.
id_00802,"In patients with aSAH who do not improve after correction of modifiable conditions and are deemed unsalvageable because of evi- dence of irreversible neurological injury, treat- ment of the aneurysm is not beneficial.34,35","For patients with aSAH who show no improvement after addressing modifiable factors and are considered beyond recovery due to irreversible neurological damage, treating the aneurysm is not advantageous."
id_02721,"For patients with HCM undergoing alcohol septal ablation, TTE or intraoperative TEE with intracoronary ultrasound-enhancing contrast injection of the candidate’s septal perforator(s) is recommended.31,59–63","It is advised that patients with HCM undergoing alcohol septal ablation receive TTE or intraoperative TEE, along with intracoronary ultrasound-enhancing contrast injection into the candidate's septal perforator(s)."
id_01762,"In patients with HFrEF, if discontinuation of GDMT is necessary during hospitalization, it should be reinitiated and further optimized as soon as possible.19–22","For patients with HFrEF, if GDMT must be stopped during a hospital stay, it should be restarted and further optimized at the earliest opportunity."
id_02722,"For patients with HCM who have undergone SRT, TTE within 3 to 6 months after the proce- dure is recommended to evaluate the proce- dural results.17,64–66",It is advised that patients with HCM who have had SRT undergo a TTE 3 to 6 months post-procedure to assess the outcomes.
id_00803,"In patients with acute onset of severe headache, prompt diagnostic workup and evaluation are recommended to diagnose/ exclude aSAH and minimize morbidity and mortality.43–46","For patients experiencing a sudden severe headache, immediate diagnostic assessment is advised to confirm or rule out aSAH and reduce the risk of complications and death."
id_00323,"In patients with NSTE-ACS undergoing PCI, prasugrel or ticagrelor is recommended to reduce MACE and stent thrombosis.4–6","For patients with NSTE-ACS undergoing PCI, it is advised to use prasugrel or ticagrelor to decrease MACE and stent thrombosis."
id_02242,"In patients with Loeys-Dietz syndrome, a baseline TTE is recommended to determine the diameters of the aortic root and ascending aorta, and 6 months thereafter to determine the rate of aortic growth; if the aortic diam- eters are stable, annual surveillance TTE is recommended.1-3","For patients with Loeys-Dietz syndrome, an initial TTE is advised to assess the aortic root and ascending aorta diameters, followed by another TTE in 6 months to evaluate the aortic growth rate; if the diameters remain stable, a TTE should be conducted annually for monitoring."
id_01283,"For patients with symptomatic, persistent AF refractory to antiarrhythmic drug therapy, a hybrid epi- cardial and endocardial ablation might be reasonable to reduce the risk of recurrent atrial arrhythmia.5–7 Recommendations for the Role of Pacemakers and ICDs for the Prevention and Treatment of AF (Continued ) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing symptomatic, persistent atrial fibrillation that does not respond to antiarrhythmic drugs, considering a combined epicardial and endocardial ablation could be a reasonable approach to lower the risk of recurrent atrial arrhythmias."
id_01763,Patients with HF admitted with evidence of significant fluid overload should be promptly treated with intravenous loop diuretics to improve symptoms and reduce morbidity.1,"For patients with heart failure who are admitted showing signs of substantial fluid overload, immediate treatment with intravenous loop diuretics is advised to alleviate symptoms and decrease morbidity."
id_02723,"Screening: In first-degree relatives of patients with HCM, a TTE is recommended as part of initial family screening and periodic follow-up 31–33,35,36,61 (Figure 1, Table 6).","For initial family screening and regular follow-up in first-degree relatives of individuals with HCM, a TTE is advised."
id_02243,"In patients with Loeys-Dietz syndrome and a dilated or dissected aorta and/or arterial branches at baseline, annual surveillance imaging of the affected aorta and arteries with MRI or CT is recommended.1","For patients with Loeys-Dietz syndrome who have an enlarged or dissected aorta and/or arterial branches initially, it is advised to perform yearly imaging of the affected aorta and arteries using MRI or CT."
id_00324,"In patients with NSTE-ACS who are managed without planned invasive evaluation, ticagrelor is recommended to reduce MACE.5,7","For patients with NSTE-ACS who are treated without a scheduled invasive assessment, ticagrelor is advised to lower MACE."
id_00804,"In patients with acute onset of severe head- ache who present >6 hours from symptom onset or who have a new neurological defi- cit, a noncontrast head CT and, if negative for aSAH, lumbar puncture (LP) should be performed to diagnose/exclude aSAH.47,48","For patients experiencing a sudden severe headache who arrive more than 6 hours after symptoms begin or exhibit a new neurological deficit, a noncontrast head CT should be conducted, followed by a lumbar puncture if the CT is negative, to diagnose or rule out aSAH."
id_02244,"In patients with Loeys-Dietz syndrome, a baseline MRI or CT from head to pelvis is recommended to evaluate the entire aorta and its branches for aneurysm, dissection, and tortuosity.1-4","For individuals with Loeys-Dietz syndrome, it is advised to perform an initial MRI or CT scan from head to pelvis to assess the entire aorta and its branches for aneurysms, dissections, and tortuosity."
id_01764,"For patients hospitalized with HF, therapy with diuretics and other guideline-directed medica- tions should be titrated with a goal to resolve clinical evidence of congestion to reduce symp- toms and rehospitalizations.1–6","In patients admitted with heart failure, adjust diuretics and other guideline-recommended treatments to eliminate signs of congestion, aiming to alleviate symptoms and decrease the likelihood of rehospitalization."
id_00325,"In patients with NSTE-ACS, clopidogrel is recommended to reduce MACE when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.1","For patients with NSTE-ACS, clopidogrel is advised to lower MACE if prasugrel or ticagrelor are not available, not tolerated, or contraindicated."
id_01284,"In patients who present with a new diagnosis of HFrEF and AF, arrhythmia-induced cardiomyopathy should be suspected, and an early and aggressive approach to AF rhythm control is recommended.1,2","For patients newly diagnosed with HFrEF and AF, consider arrhythmia-induced cardiomyopathy and promptly pursue an assertive strategy for AF rhythm management."
id_02724,"Screening: In individuals who are genotype- positive or phenotype-negative, serial echocar- diography is recommended at periodic intervals depending on age (1 to 2 years in children and adolescents, 3 to 5 years in adults) and change in clinical status (Table 6; Figure 1).28,67,69–71","For those who have a positive genotype but no phenotypic expression, it is advised to perform serial echocardiography at regular intervals based on age—every 1 to 2 years for children and adolescents, and every 3 to 5 years for adults—or if there is a change in clinical status (refer to Table 6; Figure 1)."
id_00805,"In patients with acute onset of severe head- ache who present <6 hours from symptom onset and without new neurological deficit, a noncontrast head CT performed on a high-quality scanner and interpreted by a board-certified neuroradiologist is reason- able to diagnose/exclude aSAH.49–53","For patients experiencing a sudden severe headache within 6 hours of symptom onset and without any new neurological deficits, it is appropriate to use a noncontrast head CT on a high-quality scanner, interpreted by a board-certified neuroradiologist, to diagnose or rule out aSAH."
id_01765,"For patients requiring diuretic treatment during hospitalization for HF, the discharge regimen should include a plan for adjustment of diuret- ics to decrease rehospitalizations.7","For patients needing diuretics while hospitalized for heart failure, the discharge plan should incorporate a strategy for adjusting diuretics to reduce the risk of rehospitalization."
id_00326,"In patients with NSTE-ACS planned for an inva- sive strategy with timing of angiography antici- pated to be >24 hours, upstream treatment with clopidogrel or ticagrelor may be considered to reduce MACE.1,5,8 In-Hospital Management in Patients With STEMI","For patients with NSTE-ACS scheduled for an invasive strategy where angiography is expected to occur after 24 hours, initiating treatment with clopidogrel or ticagrelor beforehand may be considered to decrease MACE."
id_01285,"In appropriate patients with AF and HFrEF who are on GDMT, and with reasonable expectation of proce- dural benefit (Figure 24), catheter ablation is benefi- cial to improve symptoms, QOL, ventricular function, and cardiovascular outcomes.3–13","For suitable patients with AF and HFrEF receiving GDMT, and where procedural benefits are reasonably anticipated (Figure 24), catheter ablation is advantageous for enhancing symptoms, quality of life, ventricular function, and cardiovascular outcomes."
id_00806,"In patients with acute onset of severe headache without a new neurological deficit, application of the Ottawa SAH Rule may be reasonable to identify those at high risk for aSAH.45,54,55 Evaluation for cause of aSAH","For patients experiencing a sudden severe headache without any new neurological symptoms, it may be appropriate to use the Ottawa SAH Rule to determine those at high risk for aSAH."
id_02245,"In patients with Loeys-Dietz syndrome with- out dilation of the aorta distal to the aortic root or ascending aorta and without dilated or dissected arterial branches, surveillance imaging from chest to pelvis with MRI (or CT) every 2 years is reasonable, but imaging may be more frequent depending on family ­history.","For patients with Loeys-Dietz syndrome who do not have dilation of the aorta beyond the aortic root or ascending aorta, and without dilated or dissected arterial branches, it is advisable to conduct surveillance imaging from the chest to the pelvis using MRI (or CT) every two years, although more frequent imaging may be warranted based on family history."
id_01286,"In appropriate patients with symptomatic AF and HFpEF with reasonable expectation of benefit, catheter ablation can be useful to improve symptoms and improve QOL.14,15","For suitable patients experiencing symptomatic AF and HFpEF, where a beneficial outcome is reasonably anticipated, catheter ablation may be beneficial for alleviating symptoms and enhancing quality of life."
id_02725,"For patients with HCM, TEE can be useful if TTE is inconclusive in clinical decision-making regarding medical therapy, and in situations such as planning for myectomy, exclusion of subaortic membrane or mitral regurgitation secondary to structural abnormalities of the mitral valve apparatus, or in the assessment of the feasibility of alcohol septal ablation.55–58","For individuals with HCM, TEE may be beneficial when TTE does not provide sufficient information for clinical decisions about medical treatment, and in cases like myectomy planning, ruling out subaortic membrane or mitral regurgitation due to structural issues with the mitral valve apparatus, or evaluating the suitability of alcohol septal ablation."
id_01287,"In patients with AF and HF, digoxin is reasonable for rate control, in combination with other rate-controlling agents or as monotherapy if other agents are not tolerated.16,17","For patients with atrial fibrillation and heart failure, using digoxin for rate control is appropriate, either alongside other rate-controlling medications or alone if other medications are not well-tolerated."
id_01766,"In patients hospitalized with HF when diuresis is inadequate to relieve symptoms and signs of congestion, it is reasonable to intensify the diuretic regimen using either: a. higher doses of intravenous loop diuretics.1,3); or b. addition of a second diuretic.3","For patients admitted with heart failure where diuresis fails to alleviate congestion symptoms and signs, it is appropriate to enhance the diuretic treatment by either: a. increasing the dosage of intravenous loop diuretics; or b. adding a second diuretic."
id_00327,"In patients with STEMI managed with PPCI, prasugrel or ticagrelor should be administered to reduce MACE and stent thrombosis.4,5,9,10","For patients with STEMI undergoing PPCI, prasugrel or ticagrelor should be given to decrease MACE and stent thrombosis."
id_02246,"In patients with Loeys-Dietz syndrome with- out dilation of the cerebral arteries on initial screening, periodic imaging surveillance for cerebral aneurysms with MRI or CT every 2 to","For patients with Loeys-Dietz syndrome who do not show cerebral artery dilation on initial screening, regular imaging checks for cerebral aneurysms using MRI or CT should be conducted every 2 to"
id_02726,"For patients with HCM in whom the diagnoses of apical HCM, apical aneurysm, or atypical patterns of hypertrophy is inconclusive on TTE, the use of an intravenous ultrasound-enhanc- ing agent is reasonable particularly if other imaging modalities such as cardiovascular mag- netic resonance (CMR) are not readily available or contraindicated.72,73","For patients with HCM where the diagnosis of apical HCM, apical aneurysm, or unusual hypertrophy patterns is uncertain on TTE, it is reasonable to use an intravenous ultrasound-enhancing agent, especially if other imaging methods like cardiovascular magnetic resonance (CMR) are unavailable or contraindicated."
id_00807,"In patients with spontaneous SAH with high level of concern for aneurysmal source and a negative or inconclusive CT angiography (CTA), digital subtraction angiography (DSA) is indicated to diag- nose/exclude cerebral aneurysm(s).56–59","For patients with spontaneous SAH who are highly suspected of having an aneurysmal origin and have a negative or inconclusive CT angiography (CTA), digital subtraction angiography (DSA) is recommended to confirm or rule out cerebral aneurysms."
id_02727,"For asymptomatic patients with HCM who do not have a resting or provocable outflow tract gradient ≥50 mm Hg on standard TTE, exer- cise TTE is reasonable for the detection and quantification of dynamic LVOTO.43,48,49,51–54","For asymptomatic HCM patients without a resting or inducible outflow tract gradient of ≥50 mm Hg on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO."
id_02247,"In patients with Loeys-Dietz syndrome, treat- ment with a beta blocker or an ARB (unless contraindicated), or both, in maximally toler- ated doses, is reasonable.","For patients with Loeys-Dietz syndrome, it is advisable to administer a beta blocker or an ARB, or both, at the highest tolerable doses, unless contraindicated."
id_01767,"In patients who are admitted with decompen- sated HF, in the absence of systemic hypoten- sion, intravenous nitroglycerin or nitroprusside may be considered as an adjuvant to diuretic therapy for relief of dyspnea.1,2","For patients admitted with decompensated heart failure, and without systemic hypotension, intravenous nitroglycerin or nitroprusside can be used alongside diuretics to alleviate dyspnea."
id_01288,"In patients with AF and HF with rapid ventricular rates in whom beta blockers or calcium channel blockers are contraindicated or ineffective, intravenous amiodarone is reasonable for acute rate control.†18,19","For patients with AF and HF experiencing rapid ventricular rates, where beta blockers or calcium channel blockers are either unsuitable or ineffective, intravenous amiodarone is a reasonable option for acute rate control."
id_00328,"In patients with STEMI managed with PPCI, clopidogrel is recommended to reduce MACE and stent thrombosis when prasugrel or ticagrelor are unavailable, cannot be tolerated, or are contraindicated.11","For patients with STEMI undergoing PPCI, clopidogrel is advised to decrease MACE and stent thrombosis if prasugrel or ticagrelor are not available, not tolerated, or contraindicated."
id_02728,"For patients suspected to have HCM in whom echocardiography is inconclusive, CMR imaging is indicated for diagnostic clarification.74–80","If echocardiography results are inconclusive in patients suspected of having HCM, CMR imaging is recommended for further diagnostic clarification."
id_01768,"In patients hospitalized with HF, prophylaxis for VTE is recommended to prevent venous throm- boembolic disease.1–3","For patients admitted with heart failure, it is advised to implement VTE prophylaxis to avert venous thromboembolic disease."
id_00808,"In patients with SAH from confirmed cerebral aneurysm(s), DSA can be useful to determine the optimal strategy for aneurysm intervention.60,61 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with SAH due to verified cerebral aneurysms, DSA may aid in identifying the best approach for aneurysm treatment."
id_00329,"In patients with STEMI managed with fibrinolytic therapy, clopidogrel should be administered concurrently to reduce death and MACE.2,3 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization”12 and the †”2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Manage- ment of Patients With Chronic Coronary Disease.”13","For patients experiencing STEMI who are treated with fibrinolytic therapy, clopidogrel should be given simultaneously to decrease mortality and major adverse cardiovascular events."
id_02248,"In patients with Loeys-Dietz syndrome and aortic dilation, the surgical threshold for prophylactic aortic root and ascending aortic replacement should be informed by the spe- cific genetic variant, aortic diameter, aortic growth rate, extra-aortic features, family his- tory, patient age and sex, and physician and patient preferences (Table 11).1-9","For patients with Loeys-Dietz syndrome experiencing aortic dilation, the decision to proceed with prophylactic replacement of the aortic root and ascending aorta should be guided by the particular genetic variant, aortic size, rate of aortic enlargement, additional non-aortic characteristics, family history, age and sex of the patient, as well as the preferences of both the physician and patient (Table 11).1-9"
id_01769,"In patients with cardiogenic shock, intravenous inotropic support should be used to maintain systemic perfusion and preserve end-organ performance.1–8","For patients experiencing cardiogenic shock, intravenous inotropic therapy is recommended to sustain systemic perfusion and protect end-organ function."
id_01289,"In patients with AF, HFrEF (LVEF <50%), and refractory rapid ventricular response who are not candidates for or in whom rhythm control has failed, AVNA and biventricular pacing therapy can be useful to improve symptoms, QOL, and EF.20–23","For patients with AF, HFrEF (LVEF <50%), and persistent rapid ventricular response who are unsuitable for rhythm control or have not benefited from it, AVNA combined with biventricular pacing therapy may be beneficial for enhancing symptoms, quality of life, and ejection fraction."
id_02249,"In patients with Loeys-Dietz syndrome attrib- utable to a pathogenic variant in TGFBR1, TGFBR2, or SMAD3, surgery to replace the intact aortic arch, descending aorta, or abdominal aorta at a diameter of ≥4.5 cm may be considered, with the specific genetic variant, patient age, aortic growth rate, family history, presence of high-risk features (Table 11), and surgical risk informing the decision.","For individuals with Loeys-Dietz syndrome due to a pathogenic variant in TGFBR1, TGFBR2, or SMAD3, surgical replacement of the intact aortic arch, descending aorta, or abdominal aorta may be considered when the diameter reaches 4.5 cm or more, taking into account the specific genetic variant, patient age, rate of aortic enlargement, family history, high-risk features (Table 11), and surgical risk."
id_00330,"Among patients with ACS undergoing PCI who have not received a P2Y12 inhibitor, intravenous cangrelor may be reasonable to reduce periprocedural ischemic events.*1–4 *Reproduced from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”5","For patients with ACS undergoing PCI who have not been administered a P2Y12 inhibitor, using intravenous cangrelor could be a reasonable option to decrease ischemic events during the procedure."
id_00809,"For patients with aSAH, timely transfer from hospitals with low case volume to higher-volume centers with multidisci- plinary neurointensive care services, com- prehensive stroke center capabilities, and experienced cerebrovascular surgeons/ neuroendovascular interventionalists is recommended to improve outcomes.67–77","For patients with aSAH, it is advised to promptly transfer them from low-volume hospitals to high-volume centers that offer multidisciplinary neurointensive care, comprehensive stroke center facilities, and have skilled cerebrovascular surgeons or neuroendovascular specialists to enhance outcomes."
id_02729,"For patients with left ventricular hypertrophy in whom there is a suspicion of alternative diagnoses including infiltrative or storage disease as well as athlete’s heart, CMR imag- ing is useful74–80 (Figure 1).",CMR imaging is beneficial for patients with left ventricular hypertrophy when alternative diagnoses such as infiltrative or storage diseases and athlete's heart are suspected.
id_01770,"In patients with cardiogenic shock, temporary MCS is reasonable when end-organ function cannot be maintained by pharmacologic means to support cardiac function.9–17","For patients experiencing cardiogenic shock, it is appropriate to consider temporary mechanical circulatory support when medications alone are insufficient to sustain end-organ function."
id_02250,"In patients with Turner syndrome, TTE and cardiac MRI are recommended at the time of diagnosis to evaluate for BAV, aortic root and ascending aortic dilation, aortic coarctation, and other congenital heart defects.1-9","For individuals diagnosed with Turner syndrome, it is advised to perform TTE and cardiac MRI to assess for BAV, dilation of the aortic root and ascending aorta, aortic coarctation, and other congenital heart anomalies."
id_00811,"In patients with aSAH and unsecured aneurysm, frequent blood pressure (BP) monitoring and BP control with short- acting medication(s) is recommended to avoid severe hypotension, hypertension, and BP variability.","For patients with aSAH and an unsecured aneurysm, it is advised to regularly monitor blood pressure and manage it using short-acting medications to prevent severe hypotension, hypertension, and fluctuations in blood pressure."
id_00810,"For patients with aSAH, care should be provided in a dedicated neurocritical care unit by a multidisciplinary team.78–80 Table 3.  Ottawa SAH Rule For alert patients >15 y of age with new severe nontraumatic headache reaching maximum intensity within 1 h. Patients require additional investigation for SAH if they meet any of the following criteria:","Patients with aSAH should receive treatment in a specialized neurocritical care unit managed by a multidisciplinary team. For alert patients over 15 years old experiencing a new, severe, nontraumatic headache that peaks within an hour, further evaluation for SAH is necessary if any of the following criteria are met."
id_01290,"In patients with AF, HF, and implanted biventricular pacing therapy in whom an effective pacing percentage cannot be achieved with pharmacological therapy, AVNA can be beneficial to improve functional class,24,25 reduce the risk of ICD shock,26 and improve survival.24,25","For patients with AF, HF, and biventricular pacing devices who cannot attain an effective pacing percentage through medication, AVNA may help enhance functional class, decrease the likelihood of ICD shocks, and increase survival rates."
id_00331,"In patients with ACS undergoing PCI with large thrombus burden, no-reflow, or slow flow, adjunctive use of an intravenous or intracoronary glycoprotein IIb/IIIa inhibitor is reasonable to improve procedural success and reduce infarct size.*,1,2","For patients with ACS undergoing PCI who have a significant thrombus burden, experience no-reflow, or have slow flow, it is advisable to use an intravenous or intracoronary glycoprotein IIb/IIIa inhibitor as an adjunct to enhance procedural success and minimize infarct size."
id_02731,"For patients with obstructive HCM in whom the anatomic mechanism of obstruction is inconclusive on echocardiography, CMR imag- ing is indicated to inform the selection and planning of SRT.88–92","For patients with obstructive HCM where echocardiography does not clearly define the anatomical cause of obstruction, CMR imaging is recommended to guide the choice and planning of SRT."
id_02730,"For patients with HCM who are not oth- erwise identified as high risk for sudden cardiac death (SCD), or in whom a decision to proceed with implantable cardioverter-defibrillator (ICD) remains uncertain after clinical assessment that includes personal/family history, echocar- diography, and ambulatory electrocar- diographic monitoring, CMR imaging is beneficial to assess for maximum left ven- tricular (LV) wall thickness, ejection frac- tion (EF), LV apical aneurysm, and extent of myocardial fibrosis with late gadolinium enhancement.38,74–87","For patients with HCM who are not clearly at high risk for sudden cardiac death (SCD), or when the decision to implant an ICD is still uncertain after evaluating personal/family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum left ventricular (LV) wall thickness, ejection fraction (EF), LV apical aneurysm, and the degree of myocardial fibrosis using late gadolinium enhancement."
id_01771,"In patients with cardiogenic shock, manage- ment by a multidisciplinary team experienced in shock is reasonable.17–22","For patients experiencing cardiogenic shock, it is advisable to have their care coordinated by a multidisciplinary team with expertise in shock management."
id_01291,"In patients with AF-induced cardiomyopathy who have recovered LV function, long-term surveillance can be beneficial to detect recurrent AF in view of the high risk of recurrence of arrhythmia-induced cardiomyopathy.27,28","For patients with cardiomyopathy caused by atrial fibrillation who have regained left ventricular function, ongoing monitoring can be advantageous to identify recurrent atrial fibrillation due to the high likelihood of arrhythmia-induced cardiomyopathy returning."
id_02251,"In patients with Turner syndrome who are ≥15 years old, the use of the ASI (ratio of aortic diameter [cm] to BSA [m2]) is recommended to define the degree of aortic dilation and assess the risk of aortic ­dissection.9,10,11","For patients aged 15 years or older with Turner syndrome, it is advised to use the ASI, which is the ratio of aortic diameter in centimeters to body surface area in square meters, to determine the extent of aortic dilation and evaluate the risk of aortic dissection."
id_00332,"In patients with ACS, glycoprotein IIb/IIIa inhibitors should not be administered routinely due to lack of ischemic benefit and increased risk of bleeding.3–5 *Adapted from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”6","For patients with ACS, glycoprotein IIb/IIIa inhibitors should not be used regularly, as they do not provide ischemic benefits and raise the risk of bleeding."
id_01772,"In patients presenting with cardiogenic shock, placement of a PA line may be considered to define hemodynamic subsets and appropriate management strategies.23–27","For patients with cardiogenic shock, considering the insertion of a PA line can help identify hemodynamic categories and guide suitable management approaches."
id_00812,"In patients with aSAH who are receiving anticoagulants, emergency anticoagula- tion reversal with appropriate reversal agents should be performed to prevent rebleeding.","For patients with aSAH on anticoagulants, urgent reversal of anticoagulation using suitable agents is necessary to avert rebleeding."
id_01292,"In patients with suspected AF-induced cardiomyopathy or refractory HF symptoms undergoing pharmacological rate-control therapy for AF, a stricter rate-control strategy (target heart rate <80 bpm at rest and <110 bpm during moderate exercise) may be reasonable.29–31","For patients with suspected AF-induced cardiomyopathy or persistent heart failure symptoms receiving medication for AF rate control, aiming for a stricter heart rate target of less than 80 bpm at rest and under 110 bpm during moderate activity may be appropriate."
id_00333,"In patients with NSTE-ACS, intravenous unfractionated heparin (UFH) is useful to reduce ischemic events.†1–4",Intravenous unfractionated heparin (UFH) is beneficial in lowering ischemic events in patients with NSTE-ACS.
id_02732,"For patients with HCM, repeat contrast- enhanced CMR imaging on a periodic basis (every 3 to 5 years) for the purpose of SCD risk stratification may be considered to evaluate changes in late gadolinium enhancement and other morphologic changes, including EF, development of api- cal aneurysm, or LV wall thickness (Figure 1,","For individuals with HCM, it may be advisable to periodically perform contrast-enhanced CMR imaging every 3 to 5 years to assess SCD risk by evaluating alterations in late gadolinium enhancement and other morphological changes, such as EF, apical aneurysm formation, or LV wall thickness."
id_00813,"In patients with aSAH, routine use of anti- fibrinolytic therapy is not useful to improve functional outcome.85–87","For patients with aSAH, regular administration of antifibrinolytic therapy does not enhance functional outcomes."
id_01773,"For patients who are not rapidly responding to initial shock measures, triage to centers that can provide temporary MCS may be consid- ered to optimize management.17–22",Patients who do not quickly respond to initial shock interventions may be referred to facilities capable of offering temporary mechanical circulatory support to enhance treatment.
id_01293,"In patients with AF and HFrEF who undergo AVNA, conduction system pacing of the His bundle or left bundle branch area may be reasonable as an alterna- tive to biventricular pacing to improve symptoms, QOL, and LV function.32–35","For patients with AF and HFrEF undergoing AVNA, pacing the His bundle or left bundle branch conduction system could be a viable alternative to biventricular pacing to enhance symptoms, quality of life, and left ventricular function."
id_02252,"In patients with Turner syndrome without risk factors for aortic dissection (Table 12), sur- veillance imaging with TTE or MRI to evalu- ate the aorta is recommended every 5 years in children and every 10 years in adults, as well as before planning a ­pregnancy.9,10,11","For patients with Turner syndrome who do not have risk factors for aortic dissection (refer to Table 12), it is advised to perform surveillance imaging of the aorta using TTE or MRI every 5 years in children and every 10 years in adults, in addition to prior to planning a pregnancy."
id_02733,"In adult patients with suspected HCM, cardiac CT may be considered for diagnosis if the echocardiogram is not diagnostic and CMR imaging is unavailable.34,93,94 Recommendations for Echocardiography (Continued) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","For adult patients with suspected HCM, consider using cardiac CT for diagnosis if the echocardiogram results are inconclusive and CMR imaging cannot be accessed."
id_02253,"In patients with Turner syndrome and an ASI >2.3 cm/m2, surveillance imaging of the aorta is recommended at least ­annually.9 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with Turner syndrome and an ASI greater than 2.3 cm/m², it is advised to conduct aortic surveillance imaging at least once a year."
id_00334,"In patients with NSTE-ACS in whom an early invasive approach is not anticipated, either enoxaparin or fondaparinux are recommended alternatives to UFH to reduce ischemic events.5–11 Anticoagulant Therapy in Patients Undergoing Coronary Revascularization","For patients with NSTE-ACS who are not expected to undergo an early invasive strategy, enoxaparin or fondaparinux are suggested as alternatives to UFH to decrease ischemic events."
id_00814,"For patients with aSAH, surgical or endovascular treatment of the ruptured aneurysm should be performed as early as feasible after presentation, preferably within 24 hours of onset, to improve outcome.40,98–104 Treatment goal","For patients with aSAH, it is advised to conduct surgical or endovascular intervention on the ruptured aneurysm as soon as possible after presentation, ideally within 24 hours of onset, to enhance outcomes."
id_02254,"In patients with Turner syndrome and risk factors for aortic dissection (Table 12), surveil- lance aortic imaging at an interval depending on the aortic diameter, ASI, and aortic growth rate is recommended (­Figure 18).9","For patients with Turner syndrome who have risk factors for aortic dissection (refer to Table 12), it is advised to conduct surveillance aortic imaging at intervals based on the aortic diameter, ASI, and the rate of aortic growth (see Figure 18)."
id_01774,"In patients with high-risk HF, particularly those with recurrent hospitalizations for HFrEF, refer- ral to multidisciplinary HF disease management programs is recommended to reduce the risk of hospitalization.1–4","For patients at high risk of heart failure, especially those frequently hospitalized for HFrEF, it is advised to refer them to multidisciplinary heart failure management programs to lower hospitalization risk."
id_01294,"In patients with an onset of unexplained AF before 30 years of age, electrophysiological study to evaluate and treat reentrant supraventricular tachyarrhythmias with a targeted ablation may be reasonable because of the high prevalence of reen- trant arrhythmias in this group.1–3","For patients experiencing unexplained atrial fibrillation before the age of 30, it may be appropriate to conduct an electrophysiological study to assess and address reentrant supraventricular tachyarrhythmias through targeted ablation, given the high incidence of reentrant arrhythmias in this population."
id_00815,"For patients with aSAH, complete oblit- eration of the ruptured aneurysm is indi- cated whenever feasible to reduce the risk of rebleeding and retreatment.105–107","For patients with aSAH, achieving full obliteration of the ruptured aneurysm is recommended whenever possible to minimize the risk of rebleeding and the need for further treatment."
id_02734,"In patients with HCM, a 12-lead ECG is recommended in the initial evalu- ation and as part of periodic follow-up (every 1 to 2 years)95–97 (Figure 1,","For individuals with HCM, it is advised to perform a 12-lead ECG during the initial assessment and regularly thereafter, every 1 to 2 years."
id_00335,"In patients with ACS undergoing coronary revascularization (CABG or PCI) in the same admission, parenteral anticoagulation should be continued until revascularization to reduce ischemic events.12,13 Anticoagulant Therapy to Support PCI in ACS (STEMI and NSTE-ACS)","For patients with ACS who are receiving coronary revascularization (either CABG or PCI) during the same hospital stay, parenteral anticoagulation should be maintained until the revascularization procedure is completed to minimize ischemic events."
id_01295,"In patents with an onset of AF before 45 years of age without obvious risk factors for AF, referral for genetic counseling, genetic testing for rare patho- genic variants, and surveillance for cardiomyopathy or arrhythmia syndromes may be reasonable.4,5","For patients who develop AF before the age of 45 without clear risk factors, it may be appropriate to consider genetic counseling, testing for rare pathogenic variants, and monitoring for cardiomyopathy or arrhythmia syndromes."
id_00336,"In patients with ACS undergoing PCI, intravenous UFH is useful to reduce ischemic events.†",Intravenous UFH is beneficial for reducing ischemic events in patients with ACS who are undergoing PCI.
id_01775,"In patients hospitalized with worsening HF, patient-centered discharge instructions with a clear plan for transitional care should be pro- vided before hospital discharge.5,6","For patients admitted with deteriorating heart failure, it is essential to deliver personalized discharge instructions and a well-defined transitional care plan prior to their release from the hospital."
id_02255,"In patients with Turnery syndrome who are ≥15 years old and have an ASI of ≥2.5 cm/m2 plus risk factors for aortic dissection (Table 12), surgical intervention to replace the aortic root, ascending aorta, or both is reasonable.9,10","For patients aged 15 years or older with Turner syndrome and an ASI of 2.5 cm/m2 or greater, along with risk factors for aortic dissection (refer to Table 12), it is advisable to consider surgical replacement of the aortic root, ascending aorta, or both."
id_02735,"In patients with HCM, 24- to 48-hour ambu- latory electrocardiographic monitoring is recommended in the initial evaluation and as part of periodic follow-up (every 1 to 2 years) to identify patients who are at risk for SCD and guide management of arrhythmias (Figure 1).98–100","For patients with HCM, it is advised to conduct 24- to 48-hour ambulatory ECG monitoring during the initial assessment and periodically every 1 to 2 years to detect those at risk for SCD and to manage arrhythmias effectively."
id_00816,"For patients with aSAH in whom com- plete obliteration of the ruptured aneu- rysm by either clipping or primary coiling treatment is not feasible in the acute phase, partial obliteration to secure the rupture site and retreatment in a delayed fashion in those with functional recovery are reasonable to prevent rebleeding. Modality of treatment: general","In patients with aSAH where full obliteration of the ruptured aneurysm via clipping or primary coiling is not possible during the acute phase, partial obliteration to stabilize the rupture site followed by delayed retreatment in those who achieve functional recovery is a reasonable approach to prevent rebleeding. Treatment modality: general."
id_01776,"In patients hospitalized with worsening HF, participation in systems that allow benchmark- ing to performance measures is reasonable to increase use of evidence-based therapy, and to improve quality of care.7–10","For patients admitted with deteriorating heart failure, engaging in systems that enable performance measure benchmarking is advisable to enhance the application of evidence-based treatments and elevate care quality."
id_01296,"In athletes who develop AF, catheter ablation with PVI is a reasonable strategy for rhythm control because of its effectiveness and low risk of detrimental effect on exercise capacity.1,2","For athletes experiencing AF, employing catheter ablation with PVI is a sensible approach for rhythm management due to its efficacy and minimal impact on exercise capacity."
id_00817,"For patients with aSAH from ruptured aneurysms of the posterior circulation that are amenable to coiling, coiling is indicated in preference to clipping to improve outcome.108–110","For patients with aSAH due to ruptured aneurysms in the posterior circulation that can be treated with coiling, coiling is recommended over clipping to enhance outcomes."
id_00337,"In patients with STEMI undergoing PCI, bivalirudin is useful as an alternative to UFH to reduce mortality and bleeding.†14–19","For patients with STEMI receiving PCI, bivalirudin serves as an effective substitute for UFH to lower mortality and bleeding."
id_02256,"In patients with a BAV, TTE is indicated to evaluate valve morphology and function, to evaluate the diameter of the aortic root and ascending aorta, and to evaluate for aortic coarctation and other associated cardiovascu- lar defects.1-4","For patients with a BAV, TTE is recommended to assess valve structure and performance, measure the aortic root and ascending aorta diameters, and check for aortic coarctation and other related cardiovascular anomalies."
id_01297,"In patients with AF and class III obesity (BMI ≥ 40 kg/m2), DOACs are reasonable to choose over warfarin for stroke risk reduction.1–5","For patients with atrial fibrillation and class III obesity (BMI of 40 kg/m2 or higher), selecting DOACs instead of warfarin for reducing stroke risk is a reasonable option."
id_02257,"In patients with a BAV, CT or MRI of the tho- racic aorta is indicated when the diameter and morphology of the aortic root, ascending aorta, or both cannot be assessed accurately or completely by TTE.1","For patients with a BAV, a CT or MRI of the thoracic aorta is recommended if the aortic root, ascending aorta, or both cannot be fully or accurately evaluated using TTE."
id_02736,"In patients with HCM who develop palpita- tions or lightheadedness, extended (>24 hours) electrocardiographic monitoring or event recording is recommended, which should not be considered diagnostic unless patients have had symptoms while being monitored.101","For patients with HCM experiencing palpitations or lightheadedness, it is advised to conduct extended electrocardiographic monitoring or event recording for more than 24 hours; however, this should only be deemed diagnostic if symptoms occur during the monitoring period."
id_02737,"In first-degree relatives of patients with HCM, a 12-lead ECG is recommended as a component of the screening algorithm95–97 (Figure 1, Table 6).","For screening first-degree relatives of individuals with HCM, it is advised to include a 12-lead ECG as part of the evaluation process."
id_01777,"In patients being discharged after hospital- ization for worsening HF, an early follow-up, generally within 7 days of hospital discharge, is reasonable to optimize care and reduce rehos- pitalization.11,12","For patients discharged following hospitalization due to worsening heart failure, scheduling a follow-up appointment within 7 days is advisable to enhance care and minimize the risk of readmission."
id_01298,"In patients with AF who have undergone bariatric surgery, warfarin may be reasonable to choose over DOACs for stroke risk reduction in view of concerns about DOAC drug absorption.6,7 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with atrial fibrillation who have had bariatric surgery, opting for warfarin instead of direct oral anticoagulants (DOACs) might be advisable for reducing stroke risk due to potential issues with DOAC absorption."
id_02258,"In patients with a BAV and either HTAD or phenotypic features concerning for Loeys- Dietz syndrome, a medical genetics evaluation is recommended.5,6","For patients with a bicuspid aortic valve and either hereditary thoracic aortic disease or characteristics suggestive of Loeys-Dietz syndrome, an evaluation by a medical geneticist is advised."
id_00338,"In patients with NSTE-ACS undergoing PCI, bivalirudin may be reasonable as an alternative to UFH to reduce bleeding.†16,20–23","For patients with NSTE-ACS undergoing PCI, using bivalirudin instead of UFH might be a suitable option to minimize bleeding."
id_01778,"In patients with HFrEF and iron deficiency with or without anemia, intravenous iron replace- ment is reasonable to improve functional status and QOL.1–4","For patients with HFrEF and iron deficiency, whether or not they have anemia, administering intravenous iron is advisable to enhance functional status and quality of life."
id_00818,"For patients with aSAH deemed salvageable and with depressed level of consciousness due to large intrapa- renchymal hematoma, emergency clot evacuation should be performed to reduce mortality.111,112","In patients with aSAH who are considered salvageable and have a decreased level of consciousness from a large intraparenchymal hematoma, urgent clot removal should be conducted to lower mortality."
id_02738,"In patients with HCM who have additional risk factors for atrial fibrillation (AF), such as left atrial dilatation, advanced age, and New York Heart Association (NYHA) class III to class IV heart failure (HF), and who are eligible for anticoagulation, extended ambu- latory monitoring is reasonable to screen for AF as part of initial evaluation and peri- odic follow-up (every 1 to 2 years)102–106 (Figure 1).","For patients with HCM who possess additional atrial fibrillation (AF) risk factors like left atrial enlargement, older age, and NYHA class III or IV heart failure (HF), and who qualify for anticoagulation, it is advisable to conduct extended ambulatory monitoring to detect AF during the initial assessment and at regular intervals (every 1 to 2 years)."
id_01299,"Patients with AF with rapid anterograde conduction (preexcited AF), and hemodynamic instability should be treated with electrical cardioversion.1,2","For patients experiencing AF with rapid anterograde conduction (preexcited AF) and hemodynamic instability, electrical cardioversion is recommended."
id_00339,"In patients with ACS, intravenous enoxaparin may be considered as an alternative to UFH at the time of PCI to reduce ischemic events.‡7,8,24–26","For patients with ACS, intravenous enoxaparin can be an option instead of UFH during PCI to decrease ischemic events."
id_00819,"For patients with aSAH, the ruptured aneu- rysm should be evaluated by specialist(s) with endovascular and surgical expertise to determine the relative risks and benefits of surgical or endovascular treatment accord- ing to patient and aneurysm characteristics.",Patients with aSAH should have their ruptured aneurysm assessed by specialists skilled in both endovascular and surgical techniques to weigh the risks and benefits of each treatment option based on the characteristics of the patient and the aneurysm.
id_01779,"In patients with HF and anemia, erythropoietin- stimulating agents should not be used to improve morbidity and mortality.5,6 Management of Hypertension","For patients with heart failure and anemia, erythropoietin-stimulating agents should not be utilized to enhance morbidity and mortality outcomes."
id_00340,"In patients with ACS, fondaparinux should not be used to support PCI because of the risk of catheter thrombosis.5,27 STEMI: Anticoagulant Therapy Treated With Fibrinolytic Therapy","For patients with ACS, fondaparinux is not recommended for PCI support due to the potential for catheter thrombosis."
id_02739,"In adult patients with HCM without risk factors for AF and who are eligible for anticoagulation, extended ambulatory monitoring may be considered to assess for asymptomatic paroxysmal AF as part of initial evaluation and periodic follow-up (every 1 to 2 years).102–106","For adult patients with HCM who lack AF risk factors and qualify for anticoagulation, it may be advisable to use extended ambulatory monitoring to detect asymptomatic paroxysmal AF during the initial assessment and at regular intervals (every 1 to 2 years)."
id_01780,"In patients with HFrEF and hypertension, uptitration of GDMT to the maximally tolerated target dose is recommended.7,8 Management of Sleep Disorders","For patients with HFrEF and high blood pressure, it is advised to increase GDMT to the highest dose that is well-tolerated."
id_01300,"For patients with AF with rapid anterograde conduction (preexcited AF), catheter ablation of accessory pathways (APs) is recommended.3–7",Catheter ablation of accessory pathways is advised for patients with atrial fibrillation exhibiting rapid anterograde conduction (preexcited AF).
id_00820,"For patients >70 years of age with aSAH, the superiority of coiling or clipping to improve outcome is not well established.113,114","For patients older than 70 with aSAH, it is unclear whether coiling or clipping offers better outcomes."
id_02259,"In patients with a BAV and a dilated aortic root or ascending aorta, screening of all first- degree relatives by TTE is recommended to evaluate for the presence of a BAV, dilation of the aortic root and ascending aorta, or both; if the diameter and morphology of the aortic root, ascending aorta, or both cannot be assessed accurately or completely by TTE, a cardiac-gated CT or MRI of the thoracic aorta is indicated.7","For patients with a BAV and an enlarged aortic root or ascending aorta, it is advised to screen all first-degree relatives using TTE to check for a BAV, aortic root dilation, ascending aorta dilation, or both; if TTE does not provide a precise or complete assessment of the aortic root or ascending aorta's diameter and morphology, a cardiac-gated CT or MRI of the thoracic aorta should be performed."
id_02740,"For patients with HCM who are candidates for SRT and for whom there is uncertainty regarding the presence or severity of LVOTO on nonin- vasive imaging studies, invasive hemodynamic assessment with cardiac catheterization is recommended.45,107–109","For patients with HCM who are eligible for SRT and where noninvasive imaging does not clearly determine the presence or severity of LVOTO, it is advised to perform invasive hemodynamic evaluation using cardiac catheterization."
id_02260,"In patients with a BAV, screening of all first- degree relatives by TTE is reasonable to evaluate for the presence of a BAV, dilation of the aortic root and ascending aorta, or both.7-10","For individuals with a BAV, it is advisable to screen all first-degree relatives using TTE to assess for a BAV, aortic root dilation, ascending aorta dilation, or both."
id_01301,"In patients with AF with rapid anterograde conduction (preexcited AF) and hemodynamic stability, pharmacological cardioversion with intravenous ibutilide or intravenous procainamide is recommended as an alternative to elective cardioversion.1,8,9","For patients with AF exhibiting rapid anterograde conduction (preexcited AF) who are hemodynamically stable, intravenous ibutilide or procainamide is advised for pharmacological cardioversion as an alternative to elective cardioversion."
id_01781,"In patients with HF and suspicion of sleep-dis- ordered breathing, a formal sleep assessment is reasonable to confirm the diagnosis and differentiate between obstructive and central sleep apnea.9,10","For patients with heart failure and suspected sleep-disordered breathing, conducting a formal sleep evaluation is advisable to verify the diagnosis and distinguish between obstructive and central sleep apnea."
id_00341,"In patients with STEMI treated with fibrinolytic therapy, parenteral anticoagulation should be continued for the duration of the hospital stay (maximum of 8 days) or until revascularization is performed to reduce ischemic events.9,10,27–29","For patients with STEMI receiving fibrinolytic therapy, continue parenteral anticoagulation throughout the hospital stay (up to 8 days) or until revascularization occurs to minimize ischemic events."
id_00821,"For patients <40 years of age with aSAH, clipping of the ruptured aneurysm might be considered the preferred mode of treatment to improve durability of the treatment and outcome.113,115 Modality of treatment: for aneurysms equally suitable for clipping and coiling","For patients under 40 with aSAH, clipping the ruptured aneurysm may be favored to enhance treatment durability and outcomes, especially when both clipping and coiling are viable options."
id_02741,"In patients with HCM with symptoms or evidence of myocardial ischemia, coronary angiography (CT or invasive) is recommended.110","For patients with HCM who exhibit symptoms or signs of myocardial ischemia, it is advised to perform coronary angiography, either via CT or invasive methods."
id_01302,"In adults with congenital heart disease and AF, it is recommended to evaluate for and treat precipitating factors and reversible causes of AF, recognizing that residual hemodynamic sequelae may contribute to the occurrence of the arrhythmia.1,2","For adults with congenital heart disease and atrial fibrillation, it is advised to assess and address any triggering factors and reversible causes of the arrhythmia, while acknowledging that lingering hemodynamic effects may play a role in its development."
id_00822,"For patients with good-grade aSAH from ruptured aneurysms of the anterior circulation equally suitable for both primary coiling and clipping, primary coiling is recommended in preference to clipping to improve 1-year functional outcome.110,116","For patients with good-grade aSAH due to ruptured aneurysms in the anterior circulation who are equally candidates for both primary coiling and clipping, primary coiling is advised over clipping to enhance functional outcomes at one year."
id_02261,"In patients with a BAV who have undergone previous aortic valve repair or replacement and have a diameter of the aortic root, ascending aortic, or both of ≥4.0 cm, lifelong surveillance imaging of the aortic root and ascending aorta by TTE, CT, or MRI is recom- mended at an interval dependent on aortic diameter and rate of growth.1-3","For patients with a BAV who have had prior aortic valve repair or replacement and possess an aortic root or ascending aorta diameter of 4.0 cm or more, continuous lifelong imaging surveillance of these areas using TTE, CT, or MRI is advised, with the frequency determined by the aortic diameter and growth rate."
id_00342,"In patients with STEMI treated with fibrinolytic therapy who are not intended to undergo an invasive approach, enoxaparin is the recommended anticoagulant to reduce ischemic events.9,10,28,29","For patients with STEMI receiving fibrinolytic therapy and not scheduled for an invasive procedure, enoxaparin is advised as the anticoagulant to decrease ischemic events."
id_01782,"In patients with HF and obstructive sleep apnea, continuous positive airway pressure may be reasonable to improve sleep quality and decrease daytime sleepiness.9,11–13","For patients with heart failure and obstructive sleep apnea, using continuous positive airway pressure might be appropriate to enhance sleep quality and reduce daytime drowsiness."
id_02742,"In patients with HCM who are at risk of coro- nary atherosclerosis, coronary angiography (CT or invasive) is recommended before surgi- cal myectomy.111","For patients with HCM who may develop coronary atherosclerosis, it is advised to perform coronary angiography (either CT or invasive) prior to surgical myectomy."
id_00823,"For patients with good-grade aSAH from ruptured aneurysms of the anterior circulation equally suitable for both primary coiling and clipping, both treat- ment options are reasonable to achieve favorable long-term outcome.108,109,117 Endovascular adjuncts","For patients with good-grade aSAH due to ruptured aneurysms in the anterior circulation who are equally candidates for primary coiling or clipping, either treatment option is appropriate for achieving a favorable long-term outcome."
id_00343,"In patients with STEMI treated with fibrinolytic therapy who are not intended to undergo an inva- sive approach, fondaparinux is a recommended alternative to reduce ischemic events.27,30 *At the time of diagnosis and prior to invasive coronary angiography if planned. †Adapted or ‡modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”31","For patients with STEMI receiving fibrinolytic therapy who are not planned for an invasive strategy, fondaparinux is advised as an alternative to decrease ischemic events."
id_01303,"In adults with AF and moderate or complex congeni- tal heart disease, electrophysiological procedures should be performed by operators with expertise in ACHD procedures and in collaboration with an ACHD cardiologist, ideally in specialized centers, when available.3–5","For adults with atrial fibrillation and moderate or complex congenital heart disease, electrophysiological procedures should be conducted by specialists experienced in ACHD procedures, in partnership with an ACHD cardiologist, preferably at specialized centers when possible."
id_02262,"In patients with a BAV and a diameter of the aortic root, ascending aorta, or both of ≥4.0 cm, lifelong surveillance imaging of the aortic root and ascending aorta by TTE, CT, or MRI is recommended at an interval dependent on aortic diameter and rate of growth.4,5","For patients with a BAV and an aortic root or ascending aorta diameter of 4.0 cm or more, it is advised to conduct lifelong surveillance imaging of these areas using TTE, CT, or MRI, with the frequency determined by the aortic diameter and growth rate."
id_01783,"In patients with NYHA class II to IV HFrEF and central sleep apnea, adaptive servo-ventilation causes harm.11,12 Management of Diabetes",Adaptive servo-ventilation is harmful for patients with NYHA class II to IV HFrEF who have central sleep apnea.
id_00344,"In patients with ACS, high-intensity statin therapy is recommended to reduce the risk of MACE.*1–4","For patients with ACS, it is advised to use high-intensity statin therapy to lower the risk of MACE."
id_00824,"For patients with aSAH from ruptured wide-neck aneurysms not amenable to surgical clipping or primary coiling, endo- vascular treatment with stent-assisted coiling or flow diverters is reasonable to reduce the risk of rebleed.118,119","For patients with aSAH due to ruptured wide-neck aneurysms that cannot be treated with surgical clipping or primary coiling, endovascular treatment using stent-assisted coiling or flow diverters is a reasonable option to lower the risk of rebleeding."
id_01784,"In patients with HF and type 2 diabetes, the use of SGLT2i is recommended for the man- agement of hyperglycemia and to reduce HF- related morbidity and mortality.14–17","For patients with heart failure and type 2 diabetes, SGLT2 inhibitors are advised to manage high blood sugar and decrease heart failure-related morbidity and mortality."
id_01304,"In adults with congenital heart disease and symp- tomatic or hemodynamically significant paroxysmal or persistent AF, an initial strategy of rhythm control is recommended regardless of lesion severity as AF in this population is often poorly tolerated.6","For adults with congenital heart disease experiencing symptomatic or hemodynamically significant paroxysmal or persistent atrial fibrillation, it is advised to initially pursue rhythm control, irrespective of the lesion's severity, as AF is frequently poorly tolerated in this group."
id_02743,"For symptomatic patients with HCM who do not have resting or provocable outflow tract gradient ≥50 mm Hg on TTE, exercise TTE is recommended for the detection and quantification of dynamic LVOTO.50,112","For patients with HCM who exhibit symptoms but lack a resting or inducible outflow tract gradient of ≥50 mm Hg on TTE, exercise TTE is advised to identify and measure dynamic LVOTO."
id_00825,"For patients with aSAH from ruptured fusiform/blister aneurysms, the use of flow diverters is reasonable to reduce mortality.120,121",Using flow diverters for patients with aSAH due to ruptured fusiform or blister aneurysms is a reasonable approach to decrease mortality.
id_02263,"In patients with a BAV and a diameter of the aortic root, ascending aorta, or both of ≥5.5 cm, surgery to replace the aortic root, ascending aorta, or both is recom- mended.1-3","For patients with a BAV and an aortic root or ascending aorta measuring 5.5 cm or larger, it is advised to perform surgery to replace the aortic root, ascending aorta, or both."
id_02744,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite guideline-directed management and therapy), cardiopulmonary exercise stress testing should be performed to quantify the degree of functional limi- tation and aid in selection of patients for heart trans- plantation or mechanical circulatory support.113,114","For patients with nonobstructive HCM experiencing severe heart failure (classified as NYHA class III or IV despite receiving guideline-directed treatment), cardiopulmonary exercise stress testing is recommended to assess functional limitations and assist in determining eligibility for heart transplantation or mechanical circulatory support."
id_00345,"In patients with ACS who are already on maximally tolerated statin therapy with low- density lipoprotein cholesterol (LDL-C) ≥70 mg/dL (≥1.8 mmol/L), adding a nonstatin lipid-lowering agent is recommended to further reduce the risk of MACE.†5–7","For patients with ACS on the highest tolerated dose of statins and LDL-C levels of 70 mg/dL (1.8 mmol/L) or higher, it is advised to add a nonstatin lipid-lowering medication to further decrease the risk of MACE."
id_02264,"In patients with a BAV and a cross-­sectional aortic root or ascending aortic area (cm2) to height (m) ratio of ≥10 cm2/m, surgery to replace the aortic root, ascending aorta, or both is reasonable, when performed by expe- rienced surgeons in a Multidisciplinary Aortic Team.3,4","For patients with a BAV and a ratio of aortic root or ascending aortic area (cm²) to height (m) of ≥10 cm²/m, it is advisable to consider surgical replacement of the aortic root, ascending aorta, or both, when conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_01305,"In symptomatic patients with simple congenital heart disease with antiarrhythmic drug–refractory AF, it is reasonable to choose ablation over long-term antiar- rhythmic therapies.4,7","For patients with simple congenital heart disease who have symptomatic AF that does not respond to antiarrhythmic drugs, opting for ablation instead of prolonged antiarrhythmic treatment is a reasonable approach."
id_02745,"In patients with HCM, exercise stress testing is reasonable to determine functional capacity and to provide prognostic information as part of initial evaluation.113,114","For patients with HCM, it is appropriate to conduct exercise stress testing to assess functional capacity and offer prognostic insights during the initial evaluation."
id_01785,Patients with chronic HF with permanent-per- sistent-paroxysmal AF and a CHA2DS2-VASc score of ≥2 (for men) and ≥3 (for women) should receive chronic anticoagulant therapy.1–5,"Individuals with chronic heart failure and permanent, persistent, or paroxysmal atrial fibrillation, who have a CHA2DS2-VASc score of 2 or higher for men and 3 or higher for women, should be prescribed long-term anticoagulant treatment."
id_02265,"In patients with a BAV, a diameter of the aortic root or ascending aorta of 5.0 cm to 5.4 cm, and an additional risk factor for aortic dissec- tion (Table 14), surgery to replace the aortic root, ascending aorta, or both is reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,5","For patients with a BAV, an aortic root or ascending aorta measuring 5.0 cm to 5.4 cm, and an extra risk factor for aortic dissection (refer to Table 14), it is advisable to consider surgical replacement of the aortic root, ascending aorta, or both, provided it is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_00826,"For patients with aSAH from ruptured saccular aneurysms amenable to either primary coiling or clipping, stents or flow diverters should not be used to avoid higher risk of complications.122,123 Recommendations for Surgical and Endovascular Methods for Treatment of Ruptured Cerebral Aneurysms (Continued) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","For patients with aSAH due to ruptured saccular aneurysms that can be treated with either primary coiling or clipping, the use of stents or flow diverters is discouraged to prevent increased complication risks."
id_00346,"In patients with ACS who are statin intolerant, nonstatin lipid-lowering therapy is recommended to lower LDL-C and reduce the risk of MACE.8–10","For patients with ACS who cannot tolerate statins, it is advised to use nonstatin lipid-lowering treatments to decrease LDL-C levels and minimize the risk of MACE."
id_01786,"For patients with chronic HF with permanent- persistent-paroxysmal AF, DOAC is recom- mended over warfarin in eligible patients.2–10","In patients with chronic heart failure and permanent, persistent, or paroxysmal atrial fibrillation, a DOAC is advised over warfarin for those who qualify."
id_01306,"In adults with congenital heart disease with AF undergoing PVI, it may be reasonable to include an ablative strategy in the right atrium directed at reentrant arrhythmia secondary to atriotomy scars and the CTI.8,9","For adults with congenital heart disease and AF undergoing PVI, considering an ablative approach targeting reentrant arrhythmias in the right atrium due to atriotomy scars and the CTI may be appropriate."
id_02746,"For asymptomatic patients with HCM who do not have a resting or provocable outflow tract gradient ≥50 mm Hg on standard TTE, exercise TTE is reasonable for the detection and quantifi- cation of dynamic LVOTO.49,51–54,115","For patients with HCM who show no symptoms and lack a resting or inducible outflow tract gradient of 50 mm Hg or more on standard TTE, it is reasonable to use exercise TTE to detect and measure dynamic LVOTO."
id_02266,"In patients with a BAV who are undergoing surgical aortic valve repair or replacement, and who have a diameter of the aortic root or ascending aorta of ≥4.5 cm, concomitant replacement of the aortic root, ascending aorta, or both is reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,6","For patients with a BAV undergoing surgical repair or replacement of the aortic valve, it is advisable to also replace the aortic root, ascending aorta, or both if the diameter is ≥4.5 cm, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_00347,"In patients with ACS who are already on maximally tolerated statin therapy with LDL-C 55 to 69 mg/dL (≥1.4 to <1.8 mmol/L), adding a nonstatin lipid-lowering agent is reasonable to reduce the risk of MACE.*5–7,11–13","For patients with ACS on the highest tolerated statin dose and LDL-C levels between 55 and 69 mg/dL (≥1.4 to <1.8 mmol/L), it is advisable to add a nonstatin lipid-lowering agent to decrease the risk of MACE."
id_01787,"For patients with HF and symptoms caused by AF, AF ablation is reasonable to improve symp- toms and QOL.11–14","For patients with heart failure experiencing symptoms due to atrial fibrillation, it is reasonable to consider AF ablation to enhance symptoms and quality of life."
id_00827,"In patients with aSAH, the intraoperative use of mannitol or hypertonic saline can be effective in reducing ICP and cerebral edema.135,136","For patients with aSAH, administering mannitol or hypertonic saline during surgery may effectively lower ICP and decrease cerebral edema."
id_02747,"In patients with obstructive HCM, who are being considered for SRT, and in whom functional capac- ity or symptom status is uncertain, exercise stress testing may be reasonable (Figure 1).","For patients with obstructive HCM being evaluated for SRT, where there is uncertainty about functional capacity or symptom status, it may be appropriate to consider exercise stress testing (Figure 1)."
id_00348,"In patients with ACS, the concurrent initiation of ezetimibe in combination with maximally tolerated statin may be considered to reduce the risk of MACE.5 *Modified or †adapted from the “2023 AHA/ACC/ACCP/ASPC/NLA/PCNA Guideline for the Management of Patients With Chronic Coronary Disease.”14","For patients experiencing ACS, starting ezetimibe alongside the highest tolerated dose of statin can be contemplated to lower the risk of MACE."
id_02267,"In patients with a BAV, a diameter of the aortic root or ascending aorta of 5.0 cm to 5.4 cm, no other risk factors for aortic dissection (Table 14), and at low surgical risk, surgery to replace the aortic root, ascending aorta, or both may be reasonable, when performed by experienced surgeons in a Multidisciplinary Aortic Team.1,2,5","For patients with a BAV, where the aortic root or ascending aorta measures between 5.0 cm and 5.4 cm, lacks additional aortic dissection risk factors (refer to Table 14), and presents low surgical risk, it may be appropriate to consider surgical replacement of the aortic root, ascending aorta, or both, provided it is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_00828,"In patients with aSAH, anesthetic goals should include minimizing postprocedural pain, nausea, and vomiting.137–140","For patients with aSAH, the anesthetic objectives should focus on reducing pain, nausea, and vomiting after the procedure."
id_01307,"In adults with AF and moderate or severe forms of congenital heart disease, particularly those with low-flow states such as Fontan circulation, blind- ending cardiac chambers, and cyanosis, it may be reasonable to treat with anticoagulation independent of conventional risk score to reduce risk of thromboembolic events.10","For adults with atrial fibrillation and moderate to severe congenital heart disease, especially those experiencing low-flow conditions like Fontan circulation, blind-ending cardiac chambers, and cyanosis, anticoagulation treatment may be justified regardless of traditional risk scores to lower the risk of thromboembolic events."
id_02748,"In patients with HCM in whom functional capacity or symptom status is uncertain, exercise stress test- ing may be considered every 2 to 3 years (Figure 1).","For patients with HCM where there is uncertainty about their functional capacity or symptom status, conducting an exercise stress test every 2 to 3 years may be advisable (Figure 1)."
id_02268,"In men who are ≥65 years of age who have ever smoked, ultrasound screening for detection of AAA is recommended.1","For men aged 65 and older with a history of smoking, it is advised to undergo ultrasound screening to detect AAA."
id_01308,"In patients undergoing cardiac surgery who are at high risk for postoperative AF, it is reasonable to administer short-term prophylactic beta blockers or amiodarone to reduce the incidence of postoperative AF.1–5","For patients at high risk of postoperative atrial fibrillation following cardiac surgery, short-term use of prophylactic beta blockers or amiodarone is advisable to decrease the occurrence of postoperative AF."
id_00349,"In patients with ACS without contraindications, early (<24 hours) initiation of oral beta-blocker therapy is recommended to reduce risk of reinfarction and ventricular arrhythmias.1–5","For patients with ACS who have no contraindications, it is advised to start oral beta-blocker therapy within 24 hours to lower the risk of reinfarction and ventricular arrhythmias."
id_01309,"In patients undergoing CABG, aortic valve, or ascend- ing aortic aneurysm operations, it is reasonable to perform concomitant posterior left pericardiotomy to reduce the incidence of postoperative AF.6,7","For patients having CABG, aortic valve, or ascending aortic aneurysm surgeries, performing a simultaneous posterior left pericardiotomy is advisable to lower the risk of postoperative atrial fibrillation."
id_00829,"In patients with aSAH, prevention of intraoperative hyperglycemia and hypogly- cemia during aneurysm surgery is reason- able to improve outcomes.141–147","For patients undergoing aneurysm surgery for aSAH, it is advisable to prevent both hyperglycemia and hypoglycemia during the operation to enhance outcomes."
id_01788,"For patients with AF and LVEF ≤50%, if a rhythm control strategy fails or is not desired, and ventricular rates remain rapid despite medi- cal therapy, atrioventricular nodal ablation with implantation of a CRT device is reasonable.15–22","For patients with AF and LVEF ≤50%, if rhythm control is unsuccessful or not preferred, and ventricular rates remain high despite medication, it is reasonable to consider atrioventricular nodal ablation with CRT device implantation."
id_02269,"In men or women who are ≥65 years of age and who are first-degree relatives of patients with AAA, ultrasound screening for detection of AAA is recommended.2,3","For individuals aged 65 or older who have a first-degree relative with AAA, it is advised to undergo ultrasound screening to detect AAA."
id_01789,"For patients with chronic HF and permanent- persistent-paroxysmal AF, chronic anticoagulant therapy is reasonable for men and women with- out additional risk factors.23–26","For individuals with chronic heart failure and permanent, persistent, or paroxysmal atrial fibrillation, it is appropriate to consider long-term anticoagulant therapy for both men and women who do not have other risk factors."
id_00830,"In patients with aSAH and an unsecured ruptured aneurysm, frequent intraopera- tive BP monitoring and BP control are reasonable to prevent ischemia and rerupture.148–153","For patients with aSAH and an unsecured ruptured aneurysm, it is advisable to frequently monitor and manage blood pressure intraoperatively to prevent ischemia and rerupture."
id_02749,"In patients with HCM, evaluation of familial inheritance, including a 3-generation family history, is recommended as part of the initial assessment.23,25–28,117,118","For patients with HCM, it is advised to assess familial inheritance by obtaining a family history spanning three generations as part of the initial evaluation."
id_01790,"In vulnerable patient populations at risk for health disparities, HF risk assessments and multidisciplinary management strategies should target both known risks for CVD and social determinants of health, as a means toward elimination of disparate HF outcomes.1–6","For patient groups susceptible to health disparities, HF risk evaluations and multidisciplinary management approaches should address both established CVD risks and social determinants of health to eliminate unequal HF outcomes."
id_00350,"In high-risk patients with ACS (LVEF ≤40%, hypertension, diabetes mellitus, or STEMI with anterior location), an oral angiotensin-converting enzyme inhibitor (ACEi) or an angiotensin receptor blocker (ARB) is indicated to reduce all-cause death and MACE.1–6","For patients at high risk of ACS, such as those with an LVEF of 40% or less, hypertension, diabetes mellitus, or anterior STEMI, it is recommended to prescribe an oral ACE inhibitor or ARB to lower the risk of all-cause mortality and major adverse cardiovascular events."
id_01310,"In hemodynamically stable cardiac surgery patients with postoperative AF, rate-control (target heart rate, <100 bpm) and/or rhythm-control medications are recommended as initial therapy, with the choice of strategy according to patient symptoms, hemody- namic consequences of the arrhythmia, and physician preference.5,6","For cardiac surgery patients who are hemodynamically stable and develop postoperative atrial fibrillation, it is advised to start with rate-control (aiming for a heart rate below 100 bpm) and/or rhythm-control medications, with the choice of approach based on the patient's symptoms, the hemodynamic impact of the arrhythmia, and the physician's judgment."
id_00831,"In patients with aSAH, intraoperative neuromonitoring may be reasonable to guide anesthetic and operative management.154–159","For patients with aSAH, using intraoperative neuromonitoring can be a sensible approach to direct anesthetic and surgical management."
id_02750,"In patients with HCM, genetic testing is bene- ficial to elucidate the genetic basis to facilitate the identification of family members at risk for developing HCM (cascade testing).119–122","For patients with HCM, genetic testing is advantageous to clarify the genetic cause and aid in identifying family members who may be at risk of developing HCM through cascade testing."
id_00351,"In patients with ACS and LVEF ≤40%, and with HF symptoms and/or diabetes mellitus, a mineralocorticoid receptor antagonist is indicated to reduce all-cause death and MACE.7","For patients experiencing ACS with an LVEF of 40% or less, who also have heart failure symptoms and/or diabetes mellitus, a mineralocorticoid receptor antagonist is recommended to lower the risk of all-cause mortality and major adverse cardiovascular events."
id_01311,"In patients who develop poorly tolerated AF after cardiac surgery, direct current cardioversion in com- bination with antiarrhythmic drug therapy is recom- mended, with consideration of imaging to rule out left appendage thrombus before cardioversion in those patients in whom AF has been present >48 hours and who have not been on anticoagulation.5,6","For patients experiencing poorly tolerated atrial fibrillation following cardiac surgery, it is advised to use direct current cardioversion alongside antiarrhythmic medication. Prior to cardioversion, consider imaging to exclude a left atrial appendage thrombus in patients with atrial fibrillation lasting over 48 hours who have not received anticoagulation therapy."
id_01791,"Evidence of health disparities should be moni- tored and addressed at the clinical practice and the health care system levels.7–13 *This section crosslinks to Section 7.1.1, “Stage C Nonpharmacological In- terventions and Self-Care Support in HF,” where screening and interventions for social determinants of health are now addressed.","Health disparities should be tracked and tackled within clinical practices and the broader healthcare system. This connects to Section 7.1.1, ""Stage C Nonpharmacological Interventions and Self-Care Support in HF,"" which now includes screening and interventions for social determinants of health."
id_02751,"In patients with an atypical clinical presentation of HCM or when another genetic condition is suspected to be the cause, a work-up includ- ing genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy (“HCM phenocopies”) is recommended.123–125","For patients exhibiting unusual clinical signs of HCM or when a different genetic disorder is suspected as the underlying cause, it is advised to conduct an evaluation that includes genetic testing for HCM and other genetic causes of unexplained cardiac hypertrophy, known as ""HCM phenocopies."""
id_02271,"In men or women <65 years of age and who have multiple risk factors (Table 15) or a first-degree relative with AAA, ultrasound screening for AAA may be considered.5,6","For individuals under 65 years old with several risk factors (refer to Table 15) or a first-degree relative with an AAA, ultrasound screening for AAA can be considered."
id_00352,"In patients with ACS who are not considered high risk, an oral ACEi or an ARB is reasonable to reduce MACE.4","For patients with ACS who are not deemed high risk, it is reasonable to use an oral ACEi or ARB to lower the risk of MACE."
id_01792,"In patients who develop cancer therapy–related cardiomyopathy or HF, a multidisciplinary discussion involving the patient about the risk- benefit ratio of cancer therapy interruption, dis- continuation, or continuation is recommended to improve management.1,2","For patients experiencing cardiomyopathy or heart failure due to cancer treatment, it is advised to engage in a multidisciplinary discussion with the patient to evaluate the risks and benefits of pausing, stopping, or continuing cancer therapy to enhance management."
id_00832,"In patients with aSAH and an uncontrolled intraoperative aneurysmal rupture, adenosine may be considered to facilitate aneurysm clip placement by inducing cardiac standstill and temporary profound pause.160,161","For patients experiencing an uncontrolled intraoperative aneurysmal rupture during aSAH, adenosine can be used to induce cardiac standstill and a temporary profound pause, aiding in the placement of an aneurysm clip."
id_02272,"In asymptomatic men or women >75 years who have had a negative initial ultrasound screen, repeat screening for detection of AAA is not recommended.1","For asymptomatic individuals over 75 years old with a negative initial ultrasound screening, further screening for AAA is not advised."
id_02270,"In women who are ≥65 years of age who have ever smoked, ultrasound screening for detection of AAA is reasonable.4,5","For women aged 65 and older with a history of smoking, it is advisable to conduct an ultrasound screening to detect AAA."
id_01312,"In patients who develop postoperative AF after cardiac surgery, it is reasonable to administer anti- coagulation when deemed safe in regard to surgical bleeding for 60 days after surgery unless complica- tions develop and to reevaluate the need for longer term anticoagulation at that time.5,7","For patients experiencing postoperative atrial fibrillation following cardiac surgery, it is advisable to provide anticoagulation therapy for 60 days post-surgery, provided it is safe concerning surgical bleeding, and reassess the necessity for extended anticoagulation if complications arise."
id_00833,"In patients with good-grade aSAH, the routine use of induced mild hypothermia during aneurysm surgery is not benefi- cial.147,162–168","For patients with good-grade aSAH, routinely applying induced mild hypothermia during aneurysm surgery does not provide benefits."
id_00353,All communities should create and maintain regional systems of STEMI care that coordinate prehospital and hospital-based STEMI care processes with the goal of reducing total ischemic time and improving survival in patients with STEMI.1–6,"Every community ought to establish and sustain regional STEMI care systems that integrate prehospital and hospital-based care procedures, aiming to minimize total ischemic time and enhance survival rates in STEMI patients."
id_02752,"In patients with HCM who choose to undergo genetic testing, pre- and posttest genetic coun- seling by an expert in the genetics of cardio- vascular disease is recommended so that risks, benefits, results, and their clinical significance can be reviewed and discussed with the patient in a shared decision-making process.23–25,117","For patients with HCM opting for genetic testing, it is advised that they receive genetic counseling from a cardiovascular genetics specialist both before and after the test, to ensure that the risks, benefits, results, and their clinical implications are thoroughly reviewed and discussed with the patient in a collaborative decision-making process."
id_02273,"In patients with TAA and an average systolic BP (SBP) of ≥130 mm Hg or an average diastolic BP (DBP) of ≥80 mm Hg, the use of antihypertensive medications is recommended to reduce risk of cardiovascular events.1-3","For patients with TAA whose average systolic blood pressure is 130 mm Hg or higher, or average diastolic blood pressure is 80 mm Hg or higher, it is advised to use antihypertensive drugs to lower the risk of cardiovascular events."
id_01793,"In asymptomatic patients with cancer therapy– related cardiomyopathy (EF <50%), ARB, ACEi, and beta blockers are reasonable to prevent progression to HF and improve cardiac function.2–4","For asymptomatic patients with cardiomyopathy due to cancer treatment (EF <50%), using ARBs, ACE inhibitors, and beta blockers is advisable to prevent heart failure progression and enhance cardiac function."
id_02753,"When performing genetic testing in an HCM proband, the initial tier of genes tested should include genes with strong evidence to be disease-causing in HCM.*119,122,127,128 Downloaded from http://ahajournals.org by on June 19, 2025","In an HCM proband undergoing genetic testing, the first set of genes examined should consist of those with robust evidence of being causative for HCM."
id_01313,"In patients who develop AF after cardiac surgery and who are treated with rate-control strategy, at 30- to 60-day follow-up it is reasonable to perform rhythm assessment and, if AF does not revert to sinus rhythm spontaneously, consider cardioversion after an adequate duration of anticoagulation.5,6 *A LOE applies to the data on beta blockers. †B-R LOE applies to the data on nondihydropyridine calcium channel blockers.","For patients experiencing AF post-cardiac surgery and managed with a rate-control approach, it is advisable to evaluate rhythm at a 30- to 60-day follow-up. If AF persists and does not spontaneously revert to sinus rhythm, cardioversion should be considered following sufficient anticoagulation. *A LOE pertains to beta blocker data. †B-R LOE pertains to nondihydropyridine calcium channel blocker data."
id_00354,"In patients with STEMI presenting <12 hours after symptom onset, PPCI should be performed with a goal of FMC to device activation of ≤90 minutes, or ≤120 minutes in patients requiring hospital transfer, to improve survival.1–7","For patients with STEMI who present within 12 hours of symptom onset, PPCI should be conducted aiming for FMC to device activation within 90 minutes, or within 120 minutes if hospital transfer is needed, to enhance survival."
id_01314,Patients with AF who are identified in the setting of acute medical illness or surgery should be coun- seled about the significant risk of recurrent AF after the acute illness is resolved.1–6,Patients diagnosed with AF during an acute medical condition or surgery should be informed about the high likelihood of AF recurrence once the acute condition has subsided.
id_00834,"In patients with aSAH who require mechanical ventilation for >24 hours, implementation of a standardized ICU care bundle is recommended to reduce the duration of mechanical ventilation and hospital-acquired pneumonia.177,178 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with aSAH needing mechanical ventilation for more than 24 hours, it is advised to apply a standardized ICU care bundle to decrease the length of mechanical ventilation and the incidence of hospital-acquired pneumonia."
id_01794,"In patients with cardiovascular risk factors or known cardiac disease being considered for potentially cardiotoxic anticancer therapies, pretherapy evaluation of cardiac function is rea- sonable to establish baseline cardiac function and guide the choice of cancer therapy.2,5–16","For patients with cardiovascular risk factors or existing heart disease who are candidates for potentially cardiotoxic cancer treatments, it is advisable to assess cardiac function before starting therapy to establish a baseline and inform treatment decisions."
id_02274,"In patients with TAA, regardless of cause and in the absence of contraindications, use of beta blockers to achieve target BP goals is reasonable.1,4,5","For patients with TAA, irrespective of the underlying cause and if there are no contraindications, it is advisable to use beta blockers to reach target blood pressure levels."
id_00355,"In patients with ACS and cardiogenic shock or hemodynamic instability, emergency revascularization of the culprit vessel by PCI or CABG is indicated to improve survival, irrespective of time from symptom onset.8–11","For patients experiencing ACS with cardiogenic shock or hemodynamic instability, urgent revascularization of the culprit vessel through PCI or CABG is recommended to enhance survival, regardless of the time elapsed since symptom onset."
id_01795,"In patients with cardiovascular risk factors or known cardiac disease receiving potentially cardiotoxic anticancer therapies, monitoring of cardiac function is reasonable for the early iden- tification of drug-induced cardiomyopathy.2,4,6,8","For patients with cardiovascular risk factors or existing heart disease undergoing potentially cardiotoxic cancer treatments, it is advisable to monitor cardiac function to detect drug-induced cardiomyopathy early."
id_01315,"In patients with AF who are identified in the setting of acute medical illness or surgery, outpatient follow- up for thromboembolic risk stratification and decision-making on OAC initiation or continuation, as well as AF surveillance, can be beneficial given a high risk of AF recurrence.4–9","For patients with AF detected during acute medical conditions or surgery, it can be advantageous to conduct outpatient follow-up for assessing thromboembolic risk and deciding on the initiation or continuation of OAC, as well as monitoring AF, due to a high likelihood of AF recurrence."
id_00835,"In patients with aSAH who develop severe acute respiratory distress syndrome (ARDS) and life-threatening hypoxemia, rescue maneuvers such as prone position- ing and alveolar recruitment maneuvers with ICP monitoring may be reasonable to improve oxygenation.179–182 Intravascular volume and electrolyte management","For patients with aSAH experiencing severe ARDS and critical hypoxemia, it may be appropriate to use rescue strategies like prone positioning and alveolar recruitment maneuvers while monitoring ICP to enhance oxygenation."
id_02275,"In patients with TAA, regardless of etiology and in the absence of contraindications, ARB therapy is a reasonable adjunct to beta- blocker therapy to achieve target BP goals.6","For patients with TAA, irrespective of the cause and if no contraindications exist, adding ARB therapy to beta-blocker treatment is a sensible approach to reach target blood pressure goals."
id_02754,"In first-degree relatives of patients with HCM, both clinical screening (ECG and 2D echocar- diogram) and cascade genetic testing (when a pathogenic/likely pathogenic variant has been identified in the proband) should be offered.23,67,123,130–132","For first-degree relatives of individuals with HCM, it is recommended to provide both clinical evaluations (including ECG and 2D echocardiogram) and cascade genetic testing if a pathogenic or likely pathogenic variant is detected in the proband."
id_00836,"In patients with aSAH, close monitor- ing and goal-directed treatment of volume status are reasonable to maintain euvolemia.183–185","For patients with aSAH, it is advisable to closely monitor and manage volume status to ensure euvolemia."
id_02755,"In families where a sudden unexplained death has occurred with a postmortem diagnosis of HCM, postmortem genetic testing is benefi- cial to facilitate cascade genetic testing and clinical screening in first-degree relatives.133,134","In cases where a sudden unexplained death has been attributed to HCM after an autopsy, conducting genetic testing postmortem is advantageous for enabling cascade genetic testing and clinical screening in first-degree relatives."
id_00356,"In patients with STEMI presenting 12 to 24 hours after symptom onset, PPCI is reasonable to improve clinical outcomes.*12–15","For patients with STEMI who present 12 to 24 hours after symptoms begin, it is reasonable to perform PPCI to enhance clinical outcomes."
id_01796,"In patients at risk of cancer therapy–related cardiomyopathy, initiation of beta blockers and ACEi/ARB for the primary prevention of drug-induced cardiomyopathy is of uncertain benefit.17–28","For patients at risk of cardiomyopathy due to cancer treatment, starting beta blockers and ACE inhibitors or ARBs for primary prevention of drug-induced cardiomyopathy has an uncertain benefit."
id_02276,"In patients with TAA and imaging or clinical evidence of atherosclerosis, statin therapy at moderate or high intensity is ­reasonable.1,2","For patients with TAA who show imaging or clinical signs of atherosclerosis, it is appropriate to consider moderate or high-intensity statin therapy."
id_00837,"In patients with aSAH, use of mineralocor- ticoids is reasonable to treat natriuresis and hyponatremia.186,187","For patients with aSAH, administering mineralocorticoids is a sensible approach to manage natriuresis and hyponatremia."
id_02756,"In patients with HCM who have undergone genetic testing, serial reevaluation of the variant(s) identified is recommended to assess for variant reclassification, which may impact diagnosis and cascade genetic testing in family members.135–137 (Figure 1 and Figure 2)","For patients with HCM who have had genetic testing, it is advised to periodically reassess the identified variant(s) to determine if reclassification is necessary, as this could affect diagnosis and genetic testing of family members."
id_00357,"In patients with STEMI presenting >24 hours after symptom onset with the presence of ongoing ischemia or life-threatening arrhythmia, PPCI is reasonable to improve clinical outcomes.†12,14","For patients with STEMI who present more than 24 hours after symptoms begin and have ongoing ischemia or life-threatening arrhythmias, performing PPCI can be a reasonable approach to enhance clinical outcomes."
id_01317,"In patients with hyperthyroidism and AF who have an elevated risk of stroke based on a standard clinical risk score, anticoagulation is recommended until thyroid function has returned to normal and sinus rhythm can be maintained.1,2","For patients with hyperthyroidism and atrial fibrillation who have a high stroke risk according to a standard clinical risk assessment, anticoagulation is advised until thyroid function normalizes and sinus rhythm is stable."
id_01316,"In patients with AF who are identified in the setting of critical illness due to sepsis, the benefits of anticoagulation during critical illness for stroke pre- vention are uncertain.10,11","For patients with atrial fibrillation (AF) experiencing critical illness from sepsis, the advantages of using anticoagulation to prevent stroke during this period are unclear."
id_01797,"In patients being considered for potentially car- diotoxic therapies, serial measurement of car- diac troponin might be reasonable for further risk stratification.29–32","For patients who may undergo therapies with potential cardiotoxic effects, it could be appropriate to measure cardiac troponin levels serially to aid in further risk assessment."
id_02757,"In affected families with HCM, preconception and prenatal reproductive and genetic counsel- ing should be offered.23–25,117","For families impacted by HCM, it is advised to provide reproductive and genetic counseling before conception and during pregnancy."
id_00358,"In patients who are stable with STEMI who have a totally occluded infarct-related artery >24 hours after symptom onset and are without evidence of ongoing ischemia, acute severe HF, or life-threatening arrhythmia, PPCI should not be performed due to lack of benefit.†16,17 *Reproduced or †modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”18","For patients with stable STEMI and a completely blocked infarct-related artery more than 24 hours after symptoms begin, who show no signs of ongoing ischemia, acute severe heart failure, or life-threatening arrhythmias, performing PPCI is not recommended as it offers no benefit."
id_00838,"In patients with aSAH, induction of hyper- volemia is potentially harmful because of the association with excess morbid- ity.188–190 Other","For patients with aSAH, inducing hypervolemia may be detrimental due to its link with increased morbidity."
id_02277,"In patients with TAA who have no evidence of atherosclerosis, the use of statin therapy may be considered.3-6",Statin therapy can be considered for patients with TAA who show no signs of atherosclerosis.
id_02278,"In patients with TAA who smoke cigarettes, smoking cessation efforts are recommended.1,2","For patients with TAA who are cigarette smokers, it is advised to pursue smoking cessation."
id_01318,"In patients with AF and COPD, it is reasonable to use cardioselective beta blockers for rate control of AF, especially where other indications exist (eg, MI and HF).1–3","For patients with AF and COPD, using cardioselective beta blockers for AF rate control is advisable, particularly when there are additional indications such as MI and HF."
id_02758,"In patients with HCM, the usefulness of genetic testing in the assessment of risk of SCD is uncertain.121,137–139","For patients with HCM, the value of genetic testing in evaluating the risk of SCD remains unclear."
id_01798,"In women with a history of HF or cardiomyopathy, including previous peripartum cardiomyopathy, patient-centered counseling regarding contra- ception and the risks of cardiovascular deteriora- tion during pregnancy should be provided.1–8","For women with a history of heart failure or cardiomyopathy, including past peripartum cardiomyopathy, it is important to offer counseling focused on the patient regarding contraception and the potential for cardiovascular decline during pregnancy."
id_00839,"In patients with aSAH whose ruptured aneurysm has been secured, pharmaco- logical or mechanical venous thromboem- bolism (VTE) prophylaxis is recommended to reduce the risk for VTE.191–193","For patients with aSAH who have had their ruptured aneurysm stabilized, it is advised to use pharmacological or mechanical VTE prophylaxis to lower the risk of VTE."
id_01319,"In patients with pulmonary hypertension (PH) with pulmonary vascular disease and AF or AFL, a rhythm-control strategy is reasonable to improve functional status and potentially prolong survival.4–12","For patients with pulmonary hypertension and vascular disease who have AF or AFL, employing a rhythm-control strategy is advisable to enhance functional status and possibly extend survival."
id_02279,"In patients with atherosclerotic TAA and con- comitant aortic atheroma or PAU, the use of low-dose aspirin is reasonable, unless contra- indicated.1,2","For patients with atherosclerotic TAA and accompanying aortic atheroma or PAU, it is advisable to use low-dose aspirin, provided there are no contraindications."
id_01799,"In women with acute HF caused by peripartum cardiomyopathy and LVEF <30%, anticoagula- tion may be reasonable at diagnosis, until 6 to 8 weeks postpartum, although the efficacy and safety are uncertain.9–12","For women experiencing acute heart failure due to peripartum cardiomyopathy with an LVEF below 30%, initiating anticoagulation from diagnosis until 6 to 8 weeks after childbirth might be considered, despite uncertain efficacy and safety."
id_00359,"In patients with STEMI in whom PCI is not feasible or successful, with a large area of myocardium at risk, emergency or urgent CABG surgery can be effective to improve clinical outcomes.*1,2 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”3","For patients experiencing STEMI where PCI cannot be performed or has failed, and there is a significant myocardial area at risk, emergency or urgent CABG surgery may be beneficial in enhancing clinical outcomes."
id_02759,"In patients with HCM who harbor a variant of uncertain significance, the usefulness of clinical genetic testing of phenotype-negative relatives for the purpose of variant reclassifi- cation is uncertain.28,70,118,119","For patients with HCM possessing a variant of uncertain significance, the benefit of conducting clinical genetic testing on relatives without the phenotype to aid in variant reclassification remains unclear."
id_00360,"In patients with STEMI and an estimated time from FMC to device activation of ≤120 minutes or those with a contraindication to fibrinolytic therapy, transfer to a PCI-capable hospital for PPCI is recommended to reduce MACE.1–3","For patients experiencing STEMI with an estimated FMC to device activation time of 120 minutes or less, or those who cannot undergo fibrinolytic therapy, it is advised to transfer them to a PCI-capable hospital for PPCI to lower the risk of MACE."
id_01800,"In women with HF or cardiomyopathy who are pregnant or currently planning for pregnancy, ACEi, ARB, ARNi, MRA, SGLT2i, ivabradine, and vericiguat should not be administered because of significant risks of fetal harm.13–15","For women with heart failure or cardiomyopathy who are pregnant or planning to become pregnant, the use of ACE inhibitors, ARBs, ARNis, MRAs, SGLT2 inhibitors, ivabradine, and vericiguat is contraindicated due to the substantial risk of fetal harm."
id_00840,"In patients with aSAH, effective glycemic control, strict hyperglycemia management, and avoidance of hypoglycemia are rea- sonable to improve outcome.141,142,194,195","For patients with aSAH, it is advisable to maintain effective glycemic control, rigorously manage hyperglycemia, and prevent hypoglycemia to enhance outcomes."
id_01320,"In pregnant patients with AF, DCCV is safe to the patient and fetus and should be performed in the same manner as in patients who are not pregnant.1","For pregnant patients with atrial fibrillation, direct current cardioversion is safe for both the mother and the fetus and should be conducted similarly to how it is done in non-pregnant patients."
id_02280,"In patients with AAA and an average SBP of ≥130 mm Hg, or an average DBP of ≥80 mm Hg, the use of antihypertensive medication is recommended to reduce risk of cardiovascular events.1-3","For patients with an AAA and an average SBP of 130 mm Hg or higher, or an average DBP of 80 mm Hg or higher, it is advised to use antihypertensive drugs to lower the risk of cardiovascular events."
id_02760,"For patients with HCM who have undergone genetic testing and were found to have no pathogenic variants (ie, harbor only benign/ likely benign variants), cascade genetic testing of the family is not useful.118–121","Cascade genetic testing of the family is not beneficial for patients with HCM who have had genetic testing and only possess benign or likely benign variants, with no pathogenic variants detected."
id_02281,"In patients with AAA and evidence of aortic atherosclerosis, statin therapy at moderate or high intensity is recommended.1-3","For patients with AAA and signs of aortic atherosclerosis, it is advised to administer statin therapy at a moderate or high intensity."
id_00361,"In patients with STEMI and symptom onset of <12 hours and anticipated delay to PPCI >120 minutes from FMC, fibrinolytic therapy should be administered in patients without contraindication to reduce MACE.4–10 Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing STEMI with symptoms beginning less than 12 hours ago and an expected delay to PPCI exceeding 120 minutes from FMC, fibrinolytic therapy should be given to those without contraindications to decrease MACE."
id_01801,Performance measures based on professionally developed clinical practice guidelines should be used with the goal of improving quality of care for patients with HF.1–7,Performance metrics derived from expert-formulated clinical practice guidelines should aim to enhance the quality of care for patients with heart failure.
id_01321,"In pregnant individuals with structurally normal hearts and hemodynamically stable AF, pharmacological cardioversion with agents with history of safe use in pregnancy, such as intravenous procainamide, may be considered.1,2","For pregnant patients with normal heart structure and stable hemodynamics experiencing AF, it is advisable to consider pharmacological cardioversion using drugs known to be safe during pregnancy, such as intravenous procainamide."
id_02761,"Ongoing clinical screening is not indicated in genotype-negative relatives in families with genotype-positive HCM, unless the disease- causing variant is downgraded to variant of uncertain significance, likely benign, or benign variant during follow-up.15,135,140,142,143 *Strong evidence HCM genes include, at the time of this publication,","Routine clinical screening is unnecessary for genotype-negative family members in families with genotype-positive HCM, unless the pathogenic variant is reclassified as a variant of uncertain significance, likely benign, or benign during follow-up."
id_00841,"In patients with aSAH with fever refractory to antipyretic medications, the effective- ness of therapeutic temperature manage- ment (TTM) during the acute phase of aSAH is uncertain.196–198","For patients experiencing aSAH with fever that does not respond to antipyretic drugs, the effectiveness of therapeutic temperature management (TTM) in the acute phase of aSAH remains unclear."
id_01802,"Participation in quality improvement programs, including patient registries that provide bench- mark feedback on nationally endorsed, clinical practice guideline–based quality and perfor- mance measures can be beneficial in improving the quality of care for patients with HF.1,2,5,6","Engaging in quality improvement initiatives, such as patient registries that offer benchmark feedback on nationally recognized clinical practice guideline-based quality and performance metrics, can enhance the care quality for patients with heart failure."
id_02282,"In patients with AAA but no evidence of atherosclerosis, statin therapy may be ­considered.4,5","For patients with AAA who do not show signs of atherosclerosis, considering statin therapy is an option."
id_00362,"In patients with STEMI and symptom onset of 12 to 24 hours, transfer to a PCI-capable hospital for PPCI is reasonable to reduce infarct size and MACE.11,12","For patients experiencing STEMI with symptoms beginning 12 to 24 hours prior, it is advisable to transfer them to a hospital equipped for PCI to decrease infarct size and major adverse cardiac events."
id_00842,"In patients with aSAH, use of evidence- based protocols and order sets is recom- mended to improve standardization of care.243–250","For patients with aSAH, it is advised to utilize evidence-based protocols and order sets to enhance the consistency of care."
id_00843,"In patients with aSAH, frequent neuro- logical assessment with a neurological assessment tool such as the GCS or National Institutes of Health Stroke Scale (NIHSS) is recommended to monitor DCI and other secondary complica- tions.246,251–254","For patients with aSAH, it is advised to regularly perform neurological evaluations using tools like the GCS or NIHSS to track DCI and other secondary complications."
id_02762,"In individuals who are genotype-positive, phenotype-negative for HCM, serial clinical assessment, electrocardiography, and cardiac imaging are recommended at periodic intervals depending on age (every 1 to 2 years in chil- dren and adolescents, and every 3 to 5 years in adults) and change in clinical status.28,67,69–71 (Figure 1 and Figure 2, Table 6)","For those with a positive genotype but no phenotypic expression of HCM, it is advised to conduct regular clinical evaluations, electrocardiograms, and cardiac imaging at intervals based on age—every 1 to 2 years for children and adolescents, and every 3 to 5 years for adults—or if there is a change in clinical status."
id_00363,"In patients with only ST-segment depres- sion, except when true posterior STEMI is suspected, fibrinolytic therapy should not be administered due to risk of hemorrhagic stroke and major noncerebral bleeding.13","Fibrinolytic therapy should be avoided in patients presenting solely with ST-segment depression, unless a true posterior STEMI is suspected, due to the risk of hemorrhagic stroke and significant noncerebral bleeding."
id_01323,"In pregnant individuals with persistent AF, rate-control agents with a record of safety in pregnancy, such as beta blockers (eg, propranolol or metoprolol) and digoxin, either alone or in combination with beta blockers, are reasonable as first-line agents.1,2","For pregnant patients with persistent AF, it is reasonable to use rate-control medications known to be safe during pregnancy, such as beta blockers (e.g., propranolol or metoprolol) and digoxin, either alone or combined with beta blockers, as first-line treatments."
id_02283,"In patients with AAA who smoke cigarettes, smoking cessation efforts are recom- mended.1-4","For patients with AAA who are cigarette smokers, it is advised to undertake smoking cessation efforts."
id_01803,"For all patients with HF, palliative and supportive care—including high-quality communication, conveyance of prognosis, clarifying goals of care, shared decision-making, symptom man- agement, and caregiver support—should be provided to improve QOL and relieve suffering.1","For every patient with heart failure, palliative and supportive care should be offered to enhance quality of life and alleviate suffering, encompassing effective communication, prognosis discussion, care goals clarification, collaborative decision-making, symptom management, and caregiver support."
id_02763,"In individuals who are genotype-positive, phe- notype-negative for HCM, participation in com- petitive athletics of any intensity is reasonable.132","For those with a positive genotype but no phenotypic expression of HCM, engaging in competitive sports at any level is considered reasonable."
id_00364,"In patients with STEMI, transfer to a PCI-capable center immediately after fibrinolytic therapy is recommended.1–5","For patients experiencing STEMI, it is advised to promptly transfer them to a center equipped for PCI following fibrinolytic treatment."
id_00844,"In patients with aSAH, frequent vital sign and neurological monitoring is recommended for detection of neu- rological change and prevention of secondary cerebral insults and poor outcomes.244,246,250,255–257 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with aSAH, it is advised to regularly monitor vital signs and neurological status to identify neurological changes and prevent secondary cerebral injuries and adverse outcomes."
id_01324,"Pregnant individuals with AF and elevated risk of stroke may be considered for anticoagulation with the recognition that no anticoagulation strategy is completely safe for both the mother and fetus, and an SDM discussion should take place regarding risks to both mother and fetus (Table 28).3","For pregnant patients with atrial fibrillation and a high stroke risk, anticoagulation can be considered, acknowledging that no strategy is entirely risk-free for mother and fetus; a shared decision-making discussion about potential risks to both should occur (Table 28).3"
id_01322,"In pregnant individuals with AF and without structural heart disease, antiarrhythmic agents with history of safe use in pregnancy (eg, flecainide and sotalol) are reasonable for maintenance of sinus rhythm.1,2","For pregnant individuals with atrial fibrillation and no structural heart disease, it is reasonable to use antiarrhythmic drugs like flecainide and sotalol, which have a history of safe use during pregnancy, to maintain sinus rhythm."
id_02284,"In patients with AAA with concomitant ather- oma and/or PAU, the use of low-dose aspirin may be considered, unless contraindicated.1","For patients with AAA who also have atheroma and/or PAU, low-dose aspirin can be considered, provided there are no contraindications."
id_02764,"In individuals who are genotype-positive, phenotype-negative for HCM, ICD is not recom- mended for primary prevention.28,69–71,132,145","For those with a positive genotype but no phenotypic expression of HCM, an ICD is not advised for primary prevention."
id_01804,"For patients with HF being considered for, or treated with, life-extending therapies, the option for discontinuation should be anticipated and dis- cussed through the continuum of care, including at the time of initiation, and reassessed with changing medical conditions and shifting goals of care.2,3","For patients with heart failure who are being evaluated for or receiving life-prolonging treatments, the possibility of stopping these therapies should be anticipated and addressed throughout their care, starting at the initiation phase and re-evaluated as medical conditions and care objectives evolve."
id_00845,"In patients with aSAH, a validated dysphagia screening protocol should be implemented before initiation of oral intake to reduce the incidence of pneumo- nia.244,246,258–261","For patients with aSAH, a proven dysphagia screening protocol must be conducted prior to starting oral intake to decrease the risk of pneumonia."
id_00365,"In patients with STEMI with suspected failed reperfusion after fibrinolytic therapy, immediate angiography with rescue PCI is recommended to reduce the risk of death or recurrent MI.*6–9","For patients with STEMI who are suspected to have unsuccessful reperfusion following fibrinolytic therapy, it is advised to perform immediate angiography with rescue PCI to lower the risk of mortality or recurrent myocardial infarction."
id_01805,"For patients with HF—particularly stage D HF patients being evaluated for advanced therapies, patients requiring inotropic support or temporary mechanical support, patients experiencing uncontrolled symptoms, major medical decisions, or multimorbidity, frailty, and cognitive impairment—specialist palliative care consultation can be useful to improve QOL and relieve suffering.4–6 Downloaded from http://ahajournals.org by on June 19, 2025","Specialist palliative care consultation may be beneficial for patients with heart failure, especially those in stage D being considered for advanced treatments, those needing inotropic or temporary mechanical support, those with uncontrolled symptoms, facing significant medical decisions, or dealing with multimorbidity, frailty, and cognitive impairment, to enhance quality of life and alleviate suffering."
id_00846,"In patients with aSAH, specialized nursing stroke competencies and certification can be effective to positively affect outcomes, timeliness of care, and adherence to stroke protocols.248,262–264","For patients with aSAH, having nurses with specialized stroke skills and certification can effectively improve outcomes, ensure timely care, and maintain adherence to stroke protocols."
id_00366,"In patients with STEMI treated with fibrino- lytic therapy, early angiography between 2 and 24 hours with the intent to perform PCI is recommended to reduce the rates of death or MI.*1–5,10,11 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”12","For patients with STEMI receiving fibrinolytic therapy, it is advised to conduct early angiography within 2 to 24 hours with the aim of performing PCI to lower the incidence of death or myocardial infarction."
id_02285,"In patients with a dilated thoracic aorta, a TTE is recommended at the time of diag- nosis to assess aortic valve anatomy, aortic valve function, and thoracic aortic diam- eters.1-4","For individuals diagnosed with a dilated thoracic aorta, it is advised to perform a TTE at diagnosis to evaluate the aortic valve's anatomy and function, as well as the diameters of the thoracic aorta."
id_01326,"In patients who are to be initiated on cancer therapies associated with an increased risk of developing AF, increased vigilance for incident AF and treatment of contributing factors is reasonable to decrease morbidity.1,4–6","For patients starting cancer treatments linked to a higher risk of atrial fibrillation, it is prudent to closely monitor for new-onset AF and address contributing factors to reduce morbidity."
id_01806,"For patients with HF, execution of advance care directives can be useful to improve docu- mentation of treatment preferences, delivery of patient-centered care, and dying in preferred place.7","For patients with heart failure, implementing advance care directives may enhance the documentation of treatment preferences, facilitate patient-centered care, and allow dying in the desired location."
id_01325,"In patients with cancer and AF, multidisciplinary com- munication including cardiology, oncology and other clinicians, and SDM with the patient is recommended to optimize cancer and AF treatment and to reduce the risk of drug-drug interactions, QTc prolongation, proarrhythmia, bleeding, and thromboembolism.1–3","For patients with cancer and atrial fibrillation, it is advised to engage in multidisciplinary communication involving cardiology, oncology, and other healthcare providers, along with shared decision-making with the patient, to enhance treatment outcomes for both conditions and minimize the risks of drug interactions, QTc prolongation, proarrhythmia, bleeding, and thromboembolism."
id_02765,"In patients with HCM, a comprehensive, systematic noninvasive SCD risk assessment at initial evaluation and every 1 to 2 years there- after is recommended and should include eval- uation of these risk factors38,78,79,81,83–87,99,146–160 (Figure 1 and Figure 3, Table 7): a.  Personal history of cardiac arrest or sus- tained ventricular arrhythmias b.  Personal history of syncope suspected by clinical history to be arrhythmic c.  Family history in close relative of prema- ture HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias d.  Maximal LV wall thickness, EF, LV apical aneurysm e.  Nonsustained ventricular tachycardia epi- sodes on continuous ambulatory electro- cardiographic monitoring","For patients with HCM, it is advised to conduct a thorough and systematic noninvasive SCD risk assessment at the initial evaluation and subsequently every 1 to 2 years. This assessment should encompass the following risk factors: a. Personal history of cardiac arrest or sustained ventricular arrhythmias b. Personal history of syncope suspected to be arrhythmic based on clinical history c. Family history of premature HCM-related sudden death, cardiac arrest, or sustained ventricular arrhythmias in close relatives d. Maximal LV wall thickness, EF, LV apical aneurysm e. Episodes of nonsustained ventricular tachycardia observed on continuous ambulatory ECG monitoring."
id_02286,"In patients with a dilated thoracic aorta, a CT or MRI at the time of diagnosis is reasonable to assess thoracic aortic anatomy and diam- eters.1,3,5-7","For patients with an enlarged thoracic aorta, it is advisable to perform a CT or MRI at diagnosis to evaluate the anatomy and size of the thoracic aorta."
id_02766,"For patients with HCM who are not otherwise identified as high risk for SCD, or in whom a decision to proceed with ICD placement remains uncertain after clinical assess- ment that includes personal/family history, echocardiography, and ambulatory electro- cardiographic monitoring, CMR imaging is beneficial to assess for maximum LV wall thickness, EF, LV apical aneurysm, and extent of myocardial fibrosis with late gadolinium enhancement78,79,81,83–86,146,155 (Table 7).","For patients with HCM who are not classified as high risk for SCD, or when uncertainty remains about ICD placement after evaluating personal/family history, echocardiography, and ambulatory ECG monitoring, CMR imaging is useful to evaluate maximum LV wall thickness, EF, LV apical aneurysm, and the degree of myocardial fibrosis using late gadolinium enhancement."
id_01327,"In most patients with AF and cancer (remote history or receiving active cancer treatment), DOACs are reasonable to choose over VKAs for stroke risk reduction.7,8","For most patients with atrial fibrillation and cancer, whether in remission or undergoing treatment, direct oral anticoagulants are a suitable option over vitamin K antagonists for reducing stroke risk."
id_00847,"In patients with aSAH and a secured aneurysm, an early, evidence-based mobility algorithm is reasonable to improve level of function at discharge and global functional outcome at 12 months.249,265–268","For patients with aSAH who have a secured aneurysm, implementing an early mobility protocol based on evidence is advisable to enhance functional status at discharge and overall functional outcome after 12 months."
id_00367,"In patients with NSTE-ACS who are at intermediate or high risk of ischemic events and are appropriate candidates for revascularization, an invasive approach with the intent to proceed with revascularization is recommended during hospitalization to reduce MACE.*1–6","For patients with NSTE-ACS at moderate or high risk of ischemic events who are suitable for revascularization, it is advised to adopt an invasive strategy aimed at revascularization during their hospital stay to decrease MACE."
id_01807,"In patients with advanced HF with expected survival <6 months, timely referral to hospice can be useful to improve QOL.8","For patients with advanced heart failure and a life expectancy of less than six months, referring them to hospice care in a timely manner may enhance their quality of life."
id_02287,"In patients with a dilated thoracic aorta, follow-up imaging (with TTE, CT, or MRI, as appropriate based on individual anatomy) in 6 to 12 months is reasonable to determine the rate of aortic enlargement; if stable, surveillance imaging every 6 to 24 months (depending on aortic diameter) is reason- able.1,3,4","For patients with an enlarged thoracic aorta, it is advisable to perform follow-up imaging using TTE, CT, or MRI, depending on the specific anatomy, within 6 to 12 months to assess the rate of aortic growth; if the condition remains stable, conducting surveillance imaging every 6 to 24 months, based on the aortic diameter, is appropriate."
id_00368,"In patients with NSTE-ACS who are at low risk of ischemic events, either a routine invasive or selective invasive approach is recommended to help identify those who may require revascularization and to reduce MACE.1–4,7 Timing of Coronary Angiography for Those in Whom an Invasive Approach Is Planned","For patients with NSTE-ACS at low risk for ischemic events, it is advised to use either a routine or selective invasive strategy to determine the need for revascularization and decrease MACE."
id_02288,"In patients with an AAA of 3.0 cm to 3.9 cm, surveillance ultrasound is ­recommended every 3 years to assess for interval change.1-8","For patients with an AAA measuring between 3.0 cm and 3.9 cm, it is advised to perform a surveillance ultrasound every three years to monitor for changes over time."
id_02767,"For patients who are ≥16 years of age with HCM, it is reasonable to obtain echocardiog- raphy-derived left atrial diameter and maximal left ventricular outflow tract gradient to aid in calculating an estimated 5-year sudden death risk that may be useful during shared deci- sion-making for ICD placement147,157 (Table 7). 4.2. Patient Selection for ICD Placement Recommendations for ICD Placement in High-Risk Patients With HCM Referenced studies that support the recommendations are summarized in Online Data Supplement 12. COR LOE Recommendations","For patients aged 16 and older with HCM, it is advisable to measure the left atrial diameter and the maximal left ventricular outflow tract gradient via echocardiography to estimate the 5-year risk of sudden death, which can assist in shared decision-making regarding ICD placement."
id_01808,"In patients with HF, standardized assessment of patient-reported health status using a vali- dated questionnaire can be useful to provide incremental information for patient functional status, symptom burden, and prognosis.1–19","For patients with heart failure, utilizing a validated questionnaire to systematically evaluate patient-reported health status can offer additional insights into their functional status, symptom severity, and prognosis."
id_00848,"In patients with aSAH with suspected vasospasm or limited neurological exami- nation, CTA or CT perfusion (CTP) can be useful to detect vasospasm and predict DCI.270–275","For patients with aSAH who have suspected vasospasm or restricted neurological assessment, CTA or CT perfusion (CTP) may be beneficial for identifying vasospasm and forecasting DCI."
id_01328,"For patients with AF who are at increased risk of systemic thromboembolism and mild or moderate liver disease (Child-Pugh* class A or B), OAC therapy is reasonable in the absence of clinically significant liver disease–induced coagulopathy or thrombocyto- penia.1–7","For patients with atrial fibrillation at elevated risk of systemic thromboembolism and who have mild or moderate liver disease (Child-Pugh class A or B), it is appropriate to consider oral anticoagulant therapy if there is no clinically significant coagulopathy or thrombocytopenia caused by liver disease."
id_00849,"In patients with aSAH, transcranial Doppler (TCD) ultrasound monitoring is reasonable to detect vasospasm and predict DCI.253,276–280","For patients with aSAH, it is advisable to use transcranial Doppler (TCD) ultrasound to identify vasospasm and forecast DCI."
id_00369,"In patients with NSTE-ACS who have refractory angina or hemodynamic or electrical instability, an immediate invasive strategy with intent to perform revascularization is indicated to reduce MACE.†8–11","For patients with NSTE-ACS experiencing refractory angina or instability in hemodynamics or electrical activity, an urgent invasive approach aimed at revascularization is recommended to decrease MACE."
id_02289,"In men with an AAA of 4.0 cm to 4.9 cm and in women with an AAA of 4.0 cm to 4.4 cm, surveillance ultrasound is recommended annually to assess for interval change.1-8","For men with an AAA measuring 4.0 cm to 4.9 cm and for women with an AAA measuring 4.0 cm to 4.4 cm, it is advised to perform an annual surveillance ultrasound to monitor for changes over time."
id_01809,"In patients at increased risk of PAD (Table 5), a comprehensive medical history and review of symptoms to assess for exertional leg symptoms, lower extremity rest pain, and lower extremity wounds or other ischemic skin changes should be performed.1–4","For patients with a heightened risk of PAD (refer to Table 5), it is essential to conduct a thorough medical history and symptom review to evaluate for leg symptoms during exertion, rest pain in the lower limbs, and any wounds or ischemic changes in the skin of the lower extremities."
id_02768,"In patients with HCM, application of indi- vidual clinical judgment is recommended when assessing the prognostic strength of conventional risk marker(s) within the clinical profile of the individual patient, as well as a thorough and balanced discussion of the evidence, benefits, and estimated risks to engage the fully informed patient’s active par- ticipation in ICD decision-making.13,146,161–163","For patients with HCM, it is advised to use personal clinical judgment to evaluate the prognostic value of traditional risk markers within the patient's clinical profile, alongside a comprehensive and balanced discussion of the evidence, benefits, and potential risks, to ensure the patient is fully informed and actively involved in the ICD decision-making process."
id_00850,"In patients with high-grade aSAH, con- tinuous EEG (cEEG) monitoring can be useful to predict DCI.276,280–292","For patients with high-grade aSAH, continuous EEG monitoring may be beneficial for predicting DCI."
id_01330,"If combined opioid and benzodiazepine poisoning is suspected, it is reasonable to administer nal- oxone first (before other antidotes) for respiratory depression/respiratory arrest.","When opioid and benzodiazepine poisoning is suspected, administering naloxone initially for respiratory depression or arrest is advisable before considering other antidotes."
id_00370,"In patients with NSTE-ACS who are at high risk‡ of ischemic events, it is reasonable to choose an early invasive strategy (within 24 hours) to reduce MACE.†8,9,11,12","For patients with NSTE-ACS at high risk of ischemic events, opting for an early invasive approach within 24 hours is advisable to decrease MACE."
id_02769,"For patients with HCM, and previous documented cardiac arrest or sustained ven- tricular tachycardia, ICD placement is recom- mended146,148,161–163 (Figure 3, Table 7).",ICD implantation is advised for individuals with HCM who have a history of cardiac arrest or sustained ventricular tachycardia.
id_01810,"In patients at increased risk of PAD (Table 5), a comprehensive vascular examination and inspection of the legs and feet should be performed regularly (Table 6).2,5–8","For patients with a heightened risk of PAD (refer to Table 5), it is essential to routinely conduct a thorough vascular assessment and examine the legs and feet (see Table 6)."
id_00851,"In patients with high-grade aSAH, invasive monitoring of brain tissue oxygenation, lactate/pyruvate ratio, and glutamate may be considered to predict DCI.293–305","For patients with high-grade aSAH, considering invasive monitoring of brain tissue oxygen levels, lactate/pyruvate ratio, and glutamate can help predict DCI."
id_00371,"In patients with NSTE-ACS who are not at high risk and are intended for an invasive strategy, it is reasonable to perform angiography before hospital discharge to reduce MACE.*8,11 *Reproduced or †modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”7 ‡Predictors of risk are outlined in Figure 8.","For patients with NSTE-ACS who are not considered high risk and are planned for an invasive approach, conducting angiography prior to hospital discharge is advisable to decrease MACE."
id_02290,"In men with an AAA of ≥5.0 cm and women with an AAA of ≥4.5 cm, surveillance ultra- sound is recommended every 6 months to assess for interval change.1-8","For men with an AAA measuring 5.0 cm or larger and women with an AAA measuring 4.5 cm or larger, it is advised to perform surveillance ultrasound every 6 months to monitor for changes over time."
id_01331,Flumazenil can be effective in select patients with respiratory depression/respiratory arrest caused by pure benzodiazepine poisoning who do not have ­contraindications to flumazenil.,"Flumazenil may be beneficial for certain patients experiencing respiratory depression or arrest due to isolated benzodiazepine overdose, provided there are no contraindications to its use."
id_01329,"For patients with AF who are at increased risk of systemic thromboembolism and mild or moderate liver disease (Child-Pugh class A or B) and who are deemed to be candidates for anticoagulation, it is reasonable to prescribe DOACs (Child-Pugh class A: any DOAC; Child-Pugh class B: apixaban, dabigatran, or edoxaban) over warfarin.1,7–11","For patients with atrial fibrillation at heightened risk of systemic thromboembolism and with mild or moderate liver disease (Child-Pugh class A or B) who are suitable for anticoagulation, prescribing DOACs is advisable (Child-Pugh class A: any DOAC; Child-Pugh class B: apixaban, dabigatran, or edoxaban) instead of warfarin."
id_02291,"In patients with an AAA that is inadequately defined with ultrasound, surveillance CT is recommended.","For patients whose AAA is not clearly characterized by ultrasound, a follow-up CT scan is advised."
id_00372,"In patients with ACS undergoing PCI, a radial approach is preferred to a femoral approach to reduce bleeding, vascular complications, and death.*1–6 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”7","For patients with ACS receiving PCI, opting for a radial approach over a femoral one is recommended to minimize bleeding, vascular complications, and mortality."
id_02770,"For adult patients with HCM with ≥1 major risk factors for SCD, it is reasonable to offer an ICD. These major risk factors in- clude38,81,87,99,146,149–157,159–161 (Figure 3, Table 7): a.  Sudden death judged definitively or likely attributable to HCM in ≥1 first-degree or close relatives who are ≤50 years of age; b.  Massive left ventricular hypertrophy ≥30 mm in any left ventricular segment; c.  ≥1 Recent episodes of syncope suspected by clinical history to be arrhythmic (ie, unlikely to be of neurocardiogenic [vaso- vagal] etiology, or related to LVOTO); d.  LV apical aneurysm, independent of size; e.  LV systolic dysfunction (EF <50%).","For adult patients with HCM who have one or more major risk factors for SCD, it is advisable to consider an ICD. These major risk factors include: a. Sudden death in one or more first-degree or close relatives aged 50 or younger, likely due to HCM; b. Massive left ventricular hypertrophy of 30 mm or more in any segment; c. One or more recent syncope episodes suspected to be arrhythmic, not neurocardiogenic or related to LVOTO; d. Presence of an LV apical aneurysm, regardless of size; e. LV systolic dysfunction with an EF below 50%."
id_01811,"In patients with history or physical examination find- ings suggestive of PAD (Table 6), the resting ABI, with or without ankle pulse volume recordings (PVR) and/or Doppler waveforms, is recommended to establish the diagnosis.1,2","For patients with indications of PAD from their history or physical exam (refer to Table 6), it is advised to use the resting ABI, optionally accompanied by ankle pulse volume recordings and/or Doppler waveforms, to confirm the diagnosis."
id_02771,"For children with HCM who have ≥1 con- ventional risk factors, including unexplained syncope, massive left ventricular hypertrophy, nonsustained ventricular tachycardia, or family history of early HCM-related SCD, ICD placement is reasonable after considering the relatively high complication rates of long-term ICD placement in younger patients164–171 (Figure 3, Table 7).","For children with HCM presenting with one or more traditional risk factors—such as unexplained syncope, significant left ventricular hypertrophy, nonsustained ventricular tachycardia, or a family history of early SCD related to HCM—considering ICD placement is advisable, while also weighing the relatively high complication rates associated with long-term ICD use in younger patients."
id_00852,"In patients with aSAH, early initiation of enteral nimodipine is beneficial in preventing DCI and improving functional outcomes.316–319","For patients with aSAH, starting enteral nimodipine early is advantageous for preventing DCI and enhancing functional outcomes."
id_01332,Flumazenil has no role in cardiac arrest related to benzodiazepine poisoning.,Flumazenil is not indicated for cardiac arrest caused by benzodiazepine overdose.
id_01812,"The resting ABI should be reported as abnormal (ABI ≤0.90), borderline (ABI 0.91-0.99), normal (ABI","The resting ABI should be classified as abnormal if it is 0.90 or less, borderline if it ranges from 0.91 to 0.99, and normal if it is above 0.99."
id_00373,"Among patients with STEMI undergoing PPCI, manual aspiration thrombectomy should not be performed routinely prior to PCI given lack of clinical benefit.*1–4 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”5","For patients with STEMI undergoing PPCI, routine manual aspiration thrombectomy before PCI is not recommended due to the absence of clinical benefit."
id_02292,"In patients with an AAA that meets criteria for repair, CT is recommended for preoperative planning.","For patients with an AAA eligible for repair, a CT scan is advised for preoperative planning."
id_02772,"For patients ≥16 years of age with HCM and with ≥1 major SCD risk factors, discussion of the estimated 5-year sudden death risk and mortality rates can be useful during the shared decision-making process for ICD place- ment157,161 (Figure 3, Table 7).","For patients aged 16 and older with HCM who have one or more major SCD risk factors, discussing the estimated 5-year risk of sudden death and mortality rates can aid in the shared decision-making process regarding ICD placement (Figure 3, Table 7)."
id_00853,"In patients with aSAH, maintaining euvolemia can be beneficial in preventing DCI and improving functional outcomes.320,321","For patients with aSAH, ensuring euvolemia may help prevent DCI and enhance functional recovery."
id_01333,"Flumazenil administration is associated with harm in patients who are at increased risk for seizures or dysrhythmias. Downloaded from http://ahajournals.org by on June 19, 2025",Flumazenil use can be harmful for patients with a heightened risk of seizures or dysrhythmias.
id_02293,"In patients with aneurysms of the aortic root and ascending aorta who have symptoms attrib- utable to the aneurysm, surgery is ­indicated.1,2",Surgery is recommended for patients with aortic root and ascending aorta aneurysms who exhibit symptoms related to the aneurysm.
id_01813,"In patients at increased risk of PAD (Table 5), screening for PAD with the resting ABI, with or without ankle PVR and/or Doppler waveforms, is reasonable.4–9","For patients with a heightened risk of PAD (refer to Table 5), it is reasonable to screen for PAD using the resting ABI, optionally including ankle PVR and/or Doppler waveforms."
id_00854,"In patients with aSAH and symptomatic vasospasm, elevating systolic BP values may be reasonable to reduce the progres- sion and severity of DCI.322–325","For patients experiencing aSAH with symptomatic vasospasm, increasing systolic blood pressure might be advisable to mitigate the progression and severity of DCI."
id_02773,"In select adult patients with HCM and without major SCD risk factors after clinical assessment, or in whom the decision to proceed with ICD placement remains otherwise uncertain, ICD may be considered in patients with extensive late gadolinium enhancement by contrast- enhanced CMR imaging or nonsustained ventricular tachycardia present on ambulatory monitoring84–86,99,146,157,161,170 (Figure 3, Table 7).","For certain adult patients with HCM who lack significant SCD risk factors following clinical evaluation, or when the decision to implant an ICD is still unclear, an ICD might be considered if there is significant late gadolinium enhancement on contrast-enhanced CMR imaging or if nonsustained ventricular tachycardia is detected during ambulatory monitoring."
id_00374,"In patients with ACS undergoing coronary stent implantation in left main artery or in complex lesions, intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomogra- phy (OCT) is recommended for procedural guidance to reduce ischemic events.*1–11 *Adapted from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”12","For patients with ACS receiving coronary stents in the left main artery or complex lesions, it is advised to use intracoronary imaging with intravascular ultrasound (IVUS) or optical coherence tomography (OCT) for procedural guidance to minimize ischemic events."
id_01334,We recommend that high-dose insulin be administered for hypotension due to β-blocker poisoning refractory to or in conjunction with vasopressor therapy.,We advise administering high-dose insulin for hypotension caused by β-blocker poisoning that does not respond to or is used alongside vasopressor therapy.
id_01335,We recommend that vasopressors be adminis- tered for hypotension due to β-blocker poisoning.,We advise administering vasopressors to treat hypotension resulting from β-blocker toxicity.
id_02294,"In asymptomatic patients with aneurysms of the aortic root or ascending aorta who have a maxi- mum diameter of ≥5.5 cm, surgery is indicated.3-9",Surgery is recommended for asymptomatic individuals with aortic root or ascending aorta aneurysms when the maximum diameter reaches 5.5 cm or more.
id_00855,"In patients with aSAH and severe vaso- spasm, use of intra-arterial vasodilator therapy may be reasonable to reverse cerebral vasospasm and reduce the pro- gression and severity of DCI.326–335","For patients experiencing aSAH with severe vasospasm, administering intra-arterial vasodilator therapy could be a reasonable approach to alleviate cerebral vasospasm and mitigate the progression and severity of DCI."
id_02774,"In select pediatric patients with HCM in whom risk stratification is otherwise less cer- tain, it may be useful to consider additional factors such as extensive late gadolinium enhancement on contrast-enhanced CMR imaging and systolic dysfunction in risk strati- fication172,173 (Figure 3, Table 7).","For certain pediatric patients with HCM where risk stratification is uncertain, considering additional elements like significant late gadolinium enhancement on contrast-enhanced CMR imaging and systolic dysfunction may be beneficial for risk assessment."
id_01814,"In patients not at increased risk of PAD (Table 5) and without history or physical examination findings suggestive of PAD (Table 6), screening for PAD with the ABI is not recommended.10,11 Exercise ABI and Additional Physiological Testing",Screening for PAD using the ABI is not advised for patients who do not have an elevated risk of PAD (refer to Table 5) and lack any history or physical examination indicators of PAD (refer to Table 6).
id_00375,"In selected, hemodynamically stable patients with STEMI and multivessel disease (MVD), after successful PCI of the infarct-related artery, PCI of significantly stenosed* noninfarct-related arteries is recommended to reduce the risk of death or MI and improve angina-related quality of life (QOL).†1–9","For certain hemodynamically stable patients with STEMI and multivessel disease, following successful PCI of the artery causing the infarction, it is advised to perform PCI on other significantly narrowed arteries not related to the infarct to lower the risk of death or myocardial infarction and enhance angina-related quality of life."
id_02775,"In patients with HCM without risk factors, ICD placement should not be performed.85,146",ICD implantation should be avoided in HCM patients who do not present with risk factors.
id_01815,"In patients with suspected PAD, toe pressure/ toe-brachial index (TBI) with waveforms should be performed when the resting ABI is >1.40 (noncompressible).12–17","For patients suspected of having PAD, conduct toe pressure/toe-brachial index (TBI) with waveforms if the resting ABI exceeds 1.40, indicating noncompressibility."
id_01336,"It is reasonable to use a bolus of glucagon, fol- lowed by a continuous infusion, for bradycardia or hypotension due to β-blocker poisoning.","Administering an initial dose of glucagon, followed by a continuous infusion, is a sensible approach for treating bradycardia or hypotension resulting from β-blocker toxicity."
id_02295,"In patients with an aneurysm of the aortic root or ascending aorta of <5.5 cm, whose growth rate confirmed by tomographic imaging is ≥0.3 cm/y in 2 consecutive years, or ≥0.5 cm in 1 year, surgery is ­indicated.10-13",Surgery is recommended for patients with an aortic root or ascending aorta aneurysm smaller than 5.5 cm if tomographic imaging shows a growth rate of at least 0.3 cm per year over two consecutive years or 0.5 cm in a single year.
id_00376,"In appropriate patients with STEMI and complex MVD, after successful PCI of the infarct-related artery, elective CABG surgery for significantly stenosed noninfarct-related arteries involving the left anterior descending artery or left main disease is reasonable to reduce the risk of cardiovascular events.†","For suitable STEMI patients with complex MVD, following successful PCI of the artery causing the infarction, elective CABG surgery on significantly narrowed noninfarct-related arteries, such as those involving the left anterior descending artery or left main disease, is advisable to lower the risk of cardiovascular events."
id_01816,"Patients with suspected chronic symptomatic PAD (ie, exertional nonjoint-related leg symptoms) and normal or borderline resting ABI (>0.90 and ≤1.40, respectively) should undergo exercise treadmill ABI testing to evaluate for PAD.18,19","For patients suspected of having chronic symptomatic PAD, characterized by exertional leg symptoms not related to joints, and who have a resting ABI that is normal or borderline (greater than 0.90 and up to 1.40), exercise treadmill ABI testing is recommended to assess for PAD."
id_00856,"In patients with aSAH and severe vasospasm, cerebral angioplasty may be reasonable to reverse cerebral vasospasm and reduce the progression and severity of DCI.336–344","For patients experiencing aSAH with significant vasospasm, cerebral angioplasty might be an appropriate option to alleviate cerebral vasospasm and mitigate the advancement and intensity of DCI."
id_02776,"In patients with HCM, ICD placement for the sole purpose of participation in competitive athletics should not be performed.174 Downloaded from http://ahajournals.org by on June 19, 2025",ICD implantation should not be conducted in patients with HCM solely to enable participation in competitive sports.
id_00857,"In patients with aSAH, routine use of statin therapy to improve outcomes is not recommended.345,346","For patients with aSAH, it is not advised to routinely use statin therapy to enhance outcomes."
id_02296,"In asymptomatic patients with aneurysms of the aortic root or ascending aorta who have a maximum diameter of ≥5.0 cm, surgery is reasonable when performed by experienced surgeons in a Multidisciplinary Aortic Team.14-17","For asymptomatic individuals with aortic root or ascending aorta aneurysms measuring at least 5.0 cm in diameter, it is advisable to consider surgery if conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_00377,"In selected hemodynamically stable patients with STEMI and low-complexity MVD (those not intended for CABG surgery), multivessel PCI of significantly stenosed noninfarct-related arteries at the time of PPCI may be preferred over a staged approach to reduce the risk of cardiovascular events.10–12","For hemodynamically stable patients with STEMI and uncomplicated MVD who are not candidates for CABG surgery, performing multivessel PCI on significantly narrowed noninfarct-related arteries during PPCI may be favored over a staged procedure to lower the risk of cardiovascular events."
id_01817,"In patients with PAD and an abnormal resting ABI (≤0.90), the exercise treadmill ABI test can be useful to objectively assess the functional status and walking performance.20–25","For patients with PAD and a resting ABI of 0.90 or lower, the exercise treadmill ABI test is beneficial for objectively evaluating functional status and walking ability."
id_00858,"In patients with aSAH, routine use of intra- venous magnesium to improve neurologi- cal outcomes is not recommended.347,348","For patients with aSAH, it is not advised to routinely administer intravenous magnesium to enhance neurological outcomes."
id_02297,"In patients undergoing repair or replace- ment of a tricuspid aortic valve who have a concomitant aneurysm of the ascending aorta with a maximum diameter of ≥4.5 cm, ascending aortic replacement is reasonable when performed by experienced surgeons in a Multidisciplinary Aortic Team.18-21","For patients having tricuspid aortic valve repair or replacement, it is advisable to replace the ascending aorta if there is a concurrent aneurysm with a maximum diameter of 4.5 cm or more, provided the procedure is conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_01337,It is reasonable to utilize extracorporeal life sup- port techniques such as VA-ECMO for life-threat- ening β-blocker poisoning with cardiogenic shock refractory to pharmacological interventions.,Employing extracorporeal life support methods like VA-ECMO is advisable for severe β-blocker poisoning with cardiogenic shock that does not respond to drug treatments.
id_00378,"In patients with STEMI complicated by cardiogenic shock, routine PCI of a noninfarct-related artery at the time of PPCI should not be performed because of the higher risk of death or renal failure.*13–15 *Significantly stenosed refers to lesions that are severely diseased as defined by the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization” as a visually estimated diameter stenosis severity of ≥70% for non–left main disease and ≥50% for left main disease.16 †Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”16","For patients experiencing STEMI with cardiogenic shock, performing PCI on a non-infarct-related artery during PPCI is not recommended due to an increased risk of mortality or renal failure."
id_01338,It may be reasonable to administer atropine for β-blocker–induced bradycardia.,Administering atropine could be a sensible approach for treating bradycardia caused by β-blockers.
id_02778,"In patients with HCM who are receiving an ICD, single-coil ICD leads are recommended in preference to dual coil leads.187","For patients with HCM receiving an ICD, it is advised to choose single-coil ICD leads over dual-coil leads."
id_00379,"In patients with NSTE-ACS with MVD, the mode of revascularization (CABG or multivessel PCI) should be based on the disease complexity and patient’s comorbidities. Multivessel CAD and Candidates for PCI","For patients with NSTE-ACS and multivessel disease, the choice between CABG and multivessel PCI should depend on the complexity of the condition and the patient's other health issues."
id_01818,"In patients with chronic symptomatic PAD, it is reasonable to perform segmental leg pressures with PVR and/or Doppler waveforms in addition to the resting ABI to help delineate the anatomic level of PAD.26,27","For patients with chronic symptomatic PAD, conducting segmental leg pressure measurements with PVR and/or Doppler waveforms alongside the resting ABI is advisable to better identify the anatomical level of PAD."
id_02777,"In patients with HCM who are receiving an ICD, either a single chamber transve- nous ICD or a subcutaneous ICD is recom- mended after a shared decision-making discussion that takes into consideration patient preferences, lifestyle, and expected potential need for pacing for bradycardia or ventricular tachycardia termination.175–190","For patients with HCM who are getting an ICD, it is advised to choose either a single chamber transvenous ICD or a subcutaneous ICD following a shared decision-making process that accounts for the patient's preferences, lifestyle, and the anticipated need for pacing to address bradycardia or terminate ventricular tachycardia."
id_02298,"In patients with a height >1 standard devia- tion above or below the mean who have an asymptomatic aneurysm of the aortic root or ascending aorta and a maximal cross- sectional aortic area/height ratio of ≥10 cm2/m, surgery is reasonable when performed by experienced surgeons in a Multidisciplinary Aortic Team.14,15,22","For patients whose height is more than one standard deviation from the average and who have an asymptomatic aneurysm in the aortic root or ascending aorta with a maximal aortic cross-sectional area-to-height ratio of ≥10 cm²/m, it is advisable to consider surgery when conducted by skilled surgeons within a Multidisciplinary Aortic Team."
id_01339,It may be reasonable to attempt electrical pacing for β-blocker–induced bradycardia.,Attempting electrical pacing for bradycardia caused by β-blockers could be considered appropriate.
id_00859,"For patients with aSAH at risk of DCI, prophylactic hemodynamic augmenta- tion should not be performed to reduce iatrogenic patient harm.189,211,349,350 Downloaded from http://ahajournals.org by on June 19, 2025",Prophylactic hemodynamic augmentation should be avoided in patients with aSAH who are at risk of DCI to prevent iatrogenic harm.
id_02299,"In patients with an aneurysm isolated to the ascending aorta who meet criteria for surgery, aneurysm resection and replacement with an interposition graft should be performed.1,2","For patients with an isolated ascending aorta aneurysm who qualify for surgery, resection of the aneurysm followed by replacement with an interposition graft is recommended."
id_01819,"In patients with suspected CLTI, it is reasonable to use toe pressure/TBI with waveforms, transcutaneous oxygen pressure (TcPO2), and/or skin perfusion pressure (SPP) in addition to ABI for assessment of arterial perfusion and to establish the diagnosis of CLTI.13,28–37 Table 7.  Alternative Diagnosis for Leg Pain or Claudication Not Related to PAD (Normal Physiological Testing) Condition Location Characteristic Effect of Exercise Effect of Rest Effect of Position Other Characteristics Hip arthritis Lateral hip, thigh Aching discomfort After variable degree of exercise Not quickly relieved Improved when not bearing weight Symptoms variable; history of degenerative arthritis Foot/ankle arthritis Ankle, foot, arch Aching pain After variable degree of exercise; may also be present at rest Not quickly relieved May be relieved by not bearing weight Symptoms variable Nerve root compression Radiates down leg Sharp lancinating pain Induced by sitting, standing, or walking (variable) Often present at rest Improved by change in position History of back problems; worse with sitting; relief when supine or standing Spinal stenosis (eg, degenerative disc disease or tumor) Often bilateral buttocks, posterior leg Pain and weakness May mimic claudication Variable relief but can take a long time to recover Relief by lumbar spine flexion Worse with standing and extending spine Symptomatic popliteal (Baker’s) cyst Behind knee, down calf Swelling, tenderness With exercise Also present at rest None Not intermittent Venous claudication Entire leg, worse in calf Tight, bursting pain After walking Subsides slowly Relief speeded by leg elevation History of iliofemoral deep vein thrombosis; edema; signs of venous stasis Chronic compartment syndrome Calf muscles Tight, bursting pain After strenuous exercise (jogging) Subsides very slowly Relief with rest Typically heavy muscled athletes","For patients suspected of having CLTI, it is advisable to use toe pressure/TBI with waveforms, transcutaneous oxygen pressure (TcPO2), and/or skin perfusion pressure (SPP) alongside ABI to evaluate arterial perfusion and confirm the diagnosis of CLTI."
id_01340,It may be reasonable to use hemodialysis for life- threatening atenolol or sotalol poisoning.,Using hemodialysis could be a sensible option for managing life-threatening poisoning from atenolol or sotalol.
id_00860,"In patients with aSAH and acute symptomatic hydrocephalus, urgent CSF diversion (EVD and/or lumbar drainage) should be performed to improve neurological outcome.236,384–387","For patients experiencing aSAH with acute symptomatic hydrocephalus, immediate CSF diversion through EVD or lumbar drainage is recommended to enhance neurological outcomes."
id_02779,"In patients with HCM who are receiving an ICD, dual-chamber ICDs are reasonable for patients with a need for atrial or atrioven- tricular sequential pacing for bradycardia/ conduction abnormalities, or as an attempt to relieve symptoms of obstructive HCM (most commonly in patients >65 years of age).191–198","For patients with HCM receiving an ICD, it is appropriate to consider dual-chamber ICDs for those requiring atrial or atrioventricular sequential pacing due to bradycardia or conduction issues, or to alleviate symptoms of obstructive HCM, particularly in individuals over 65 years old."
id_00380,"In stable patients with NSTE-ACS with MVD but without left main stenosis who are not intended for CABG surgery and undergoing culprit-lesion PCI, PCI of significant nonculprit lesions (at the time of the index procedure or as a staged procedure) is recommended to reduce the risk of MACE.1–6","For stable patients with NSTE-ACS and MVD, who do not have left main stenosis and are not planned for CABG surgery, it is advised to perform PCI on significant nonculprit lesions, either during the initial procedure or as a staged intervention, to lower the risk of MACE."
id_00861,"In patients with aSAH and hydrocephalus who require an EVD, implementation and adherence to an EVD bundled protocol that addresses insertion, management, education, and monitoring are recom- mended to reduce complication and infection rates.388–396","For patients with aSAH and hydrocephalus needing an EVD, it is advised to follow a bundled protocol covering insertion, management, education, and monitoring to lower complication and infection rates."
id_00381,"In patients with NSTE-ACS in whom multivessel PCI is being considered, physiological assessment of a nonculprit stenosis may be considered to guide revascularization decisions.7–9","For patients with NSTE-ACS who are potential candidates for multivessel PCI, evaluating a nonculprit stenosis physiologically can be considered to inform revascularization choices."
id_02300,"In patients undergoing aortic valve repair or replacement with a concomitant ascending aortic aneurysm, a separate aortic valve inter- vention and ascending aortic graft is recom- mended.3-6","For patients having aortic valve repair or replacement alongside an ascending aortic aneurysm, it is advised to perform distinct interventions for the aortic valve and the ascending aortic graft."
id_02780,"In selected adult patients with nonob- structive HCM receiving an ICD who have NYHA class II to ambulatory class IV HF, left bundle branch block (LBBB), and LV ejection fraction (LVEF) <50%, cardiac resynchro- nization therapy for symptom reduction is reasonable.199–203","For certain adult patients with non-obstructive HCM who are receiving an ICD and exhibit NYHA class II to ambulatory class IV heart failure, left bundle branch block, and a left ventricular ejection fraction below 50%, it is reasonable to consider cardiac resynchronization therapy to alleviate symptoms."
id_01820,"In patients with CLTI with nonhealing wounds or gangrene, it can be useful to use toe pressure/ TBI with waveforms, TcPO2, SPP, and/or other local perfusion measures to determine the likelihood of wound healing without or after revascularization.13,14,28,33–36,38","For patients with CLTI who have nonhealing wounds or gangrene, assessing toe pressure/TBI with waveforms, TcPO2, SPP, and/or other local perfusion metrics can help predict the chances of wound healing with or without revascularization."
id_02301,"In patients undergoing aortic root replace- ment with an aortic valve that is unsuitable for sparing or repair, a mechanical or biological valved conduit aortic root replacement is indi- cated.1,2,7,8","For patients requiring aortic root replacement where the aortic valve cannot be preserved or repaired, a mechanical or biological valved conduit should be used."
id_01821,"In patients with functionally limiting claudication with inadequate response to GDMT (including structured exercise) for whom revascularization is being consid- ered, duplex ultrasound, computed tomography angiog- raphy (CTA), magnetic resonance angiography (MRA), or catheter angiography of the lower extremities is use- ful for assessment of anatomy and severity of disease and to determine potential revascularization strategy.1–4","For patients experiencing claudication that limits function and who have not adequately responded to GDMT, including structured exercise, considering revascularization, it is beneficial to use duplex ultrasound, computed tomography angiography (CTA), magnetic resonance angiography (MRA), or catheter angiography of the lower limbs to evaluate anatomical details, disease severity, and to plan a revascularization approach."
id_02781,"In patients with HCM in whom a decision has been made for ICD implantation and who have paroxysmal atrial tachycardias or AF, dual-chamber ICDs may be reasonable, but this decision must be balanced against higher complication rates of dual chamber devices.191–198 Table 7.  Established Clinical Risk Factors for HCM Sudden Death Risk Stratification Family history of sudden death from HCM Sudden death judged definitively or likely attributable to HCM in ≥1 first-degree or close relatives who are ≤50 y of age. Close relatives would generally be second-degree relatives; however, multiple SCDs in tertiary relatives should also be considered relevant. Massive LVH Wall thickness ≥30 mm in any segment within the chamber by echocardiography or CMR imaging; consideration for this morphologic marker is also given to borderline values of ≥28 mm in individual patients at the discretion of the treating cardiologist. For pediatric patients with HCM, an absolute or z-score threshold for wall thickness has not been established; however, a maximal wall that corresponds to a z-score ≥20 (and >10 in conjunction with other risk factors) appears reasonable. Unexplained syncope ≥1 Unexplained episodes involving acute transient loss of consciousness, judged by history unlikely to be of neurocardiogenic (vasovagal) etiology, nor attributable to LVOTO, and especially when occurring within 6 mo of evaluation (events beyond 5 y in the past do not appear to have relevance). HCM with LV systolic dysfunction","For patients with HCM who are candidates for ICD implantation and experience paroxysmal atrial tachycardias or AF, considering dual-chamber ICDs might be appropriate; however, this choice should be weighed against the increased complication rates associated with dual-chamber devices."
id_00382,"In patients with NSTE-ACS complicated by cardiogenic shock, routine PCI of a nonculprit artery at the time of index procedure should not be performed because of the higher risk of death or kidney failure.*10,11 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Re- vascularization.”12","For patients experiencing NSTE-ACS with cardiogenic shock, performing PCI on a nonculprit artery during the initial procedure is not advised due to an increased risk of mortality or renal failure."
id_01342,We recommend administering vasopressors for hypotension from calcium channel blocker (CCB) ­poisoning.,We advise the use of vasopressors to treat low blood pressure resulting from calcium channel blocker (CCB) toxicity.
id_00862,"In patients with aSAH and associated chronic symptomatic hydrocephalus, per- manent CSF diversion is recommended to improve neurological outcome.397–400","For patients with aSAH and chronic symptomatic hydrocephalus, a permanent CSF diversion is advised to enhance neurological outcomes."
id_01822,"In patients with CLTI, duplex ultrasound, CTA, MRA, or catheter angiography is useful to determine revascularization strategy.1–3,5,6","For patients with CLTI, utilizing duplex ultrasound, CTA, MRA, or catheter angiography is beneficial for planning a revascularization approach."
id_00383,"In patients with ACS and cardiogenic shock or hemodynamic instability, emergency revascularization of the culprit vessel by PCI or with CABG is indicated to improve survival, irrespective of time from symptom onset.1–4","For patients experiencing ACS with cardiogenic shock or hemodynamic instability, urgent revascularization of the culprit vessel through PCI or CABG is recommended to enhance survival, regardless of the time elapsed since symptom onset."
id_02302,"In patients undergoing aortic root replace- ment, valve-sparing aortic root replacement is reasonable if the aortic valve is suitable for sparing or repair and when performed by experienced surgeons in a Multidisciplinary Aortic Team.9-21","For patients having aortic root replacement, opting for valve-sparing aortic root replacement is advisable if the aortic valve can be preserved or repaired, provided it is done by skilled surgeons within a Multidisciplinary Aortic Team."
id_00863,"In patients with aSAH, routine fenestration of the lamina terminalis is not indicated for reducing the rate of shunt dependency.401","For patients with aSAH, routinely fenestrating the lamina terminalis is not recommended to decrease shunt dependency rates."
id_02782,"In patients with obstructive HCM and symptoms* attributable to LVOTO, nonva- sodilating beta blockers, titrated to effec- tiveness or maximally tolerated doses, are recommended.204–206","For patients with obstructive HCM experiencing symptoms due to LVOTO, it is advised to use non-vasodilating beta blockers, adjusted to either effective or the highest tolerable doses."
id_01343,We recommend administering high-dose insulin for hypotension due to CCB poisoning.,We advise using high-dose insulin to treat low blood pressure caused by calcium channel blocker poisoning.
id_00384,"In patients with ACS complicated by cardiogenic shock, routine PCI of a noninfarct-related artery at the time of PPCI should not be performed because of the higher risk of death or renal failure.*5–7 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”8","For patients experiencing ACS with cardiogenic shock, performing routine PCI on a noninfarct-related artery during PPCI is not advised due to an increased risk of mortality or renal failure."
id_01823,"In patients with suspected PAD (ie, potential signs and/or symptoms) with inconclusive ABI and physiological testing, noninvasive imaging with duplex ultrasound, CTA, or MRA may be considered to establish the diagnosis of PAD.","For patients suspected of having PAD, who exhibit potential signs or symptoms and have inconclusive ABI and physiological tests, noninvasive imaging such as duplex ultrasound, CTA, or MRA can be considered to confirm the diagnosis of PAD."
id_02303,"In patients with an aortic arch aneurysm who have symptoms attributable to the aneurysm and are at low or intermediate operative risk, open surgical replacement is recommended.","For patients experiencing symptoms due to an aortic arch aneurysm and who are at low or intermediate risk for surgery, it is advised to undergo open surgical replacement."
id_02783,"For patients with obstructive HCM who have persistent severe symptoms* attrib- utable to LVOTO despite beta blockers or non-dihydropyridine calcium channel blockers, either adding disopyramide in combination with 1 of the other drugs, or SRT performed at experienced centers,† is recommended.17,50,210–213","For patients with obstructive HCM experiencing ongoing severe symptoms due to LVOTO despite treatment with beta blockers or non-dihydropyridine calcium channel blockers, it is advised to either add disopyramide to one of these medications or undergo SRT at specialized centers."
id_01344,It is reasonable to administer calcium for CCB ­poisoning.,Administering calcium for CCB poisoning is considered appropriate.
id_00864,"In patients with aSAH and either fluctuat- ing neurological examination, depressed mental state, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, or cortical infarction, cEEG monitoring is reasonable to detect seizures.291,405,406","For patients with aSAH who exhibit fluctuating neurological status, altered consciousness, ruptured MCA aneurysm, severe SAH, ICH, hydrocephalus, or cortical infarction, it is reasonable to use cEEG monitoring to identify seizures."
id_01824,"In the evaluation of patients with PAD, clinicians should assess for and incorporate the presence of PAD-related risk amplifiers (Table 9) when developing patient-focused treatment recommendations. Downloaded from http://ahajournals.org by on June 19, 2025","When evaluating patients with PAD, healthcare providers should identify and integrate PAD-related risk amplifiers (refer to Table 9) into personalized treatment plans."
id_01341,"Intravenous lipid emulsion therapy is not likely to be beneficial for life-threatening β-blocker poisoning. Downloaded from http://ahajournals.org by on June 19, 2025",Intravenous lipid emulsion therapy is unlikely to be effective in treating life-threatening β-blocker poisoning.
id_02304,"In patients with an isolated aortic arch aneurysm who are asymptomatic and have a low operative risk, open surgical replace- ment at an arch diameter of ≥5.5 cm is ­reasonable.1-3","For patients with an isolated aortic arch aneurysm who show no symptoms and have a low risk for surgery, it is reasonable to consider open surgical replacement when the arch diameter reaches 5.5 cm or more."
id_01345,It is reasonable to administer atropine for hemodynam- ically significant bradycardia from CCB poisoning.,Administering atropine is appropriate for hemodynamically significant bradycardia caused by CCB poisoning.
id_00385,"In selected* patients with STEMI and severe or refractory cardiogenic shock, insertion of a microaxial intravascular flow pump is reasonable to reduce death.1","For certain patients with STEMI experiencing severe or unmanageable cardiogenic shock, it is advisable to consider the insertion of a microaxial intravascular flow pump to decrease mortality."
id_01825,"Clinicians and health care systems should actively pursue evidence of health disparities in diagnosis, treatment, and outcomes for patients with PAD and use efforts to limit the impact of these disparities on clinical outcomes.","Healthcare providers and systems should diligently seek out evidence of health disparities in the diagnosis, treatment, and outcomes of patients with PAD and work to minimize the effects of these disparities on clinical results."
id_00865,"In patients with aSAH and high-seizure- risk features (ie, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, and cortical infarction), use of prophylactic antiseizure medication(s) may be reason- able to prevent seizures.407–413","For patients with aSAH who exhibit high-risk factors for seizures, such as a ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, and cortical infarction, it may be appropriate to administer prophylactic antiseizure medication(s) to prevent seizures."
id_02305,"In patients undergoing open surgical repair of an ascending aortic aneurysm, if the aneurys- mal disease extends into the proximal aortic arch, it is reasonable to extend the repair with a hemiarch replacement.4,5","For patients having open surgery to repair an ascending aortic aneurysm, it is advisable to include a hemiarch replacement if the aneurysmal disease involves the proximal aortic arch."
id_00386,"In patients with mechanical complication of ACS, short-term MCS devices are reasonable for hemodynamic stabilization as a bridge to surgery.2–4","For patients experiencing mechanical complications from ACS, using short-term MCS devices is a sensible approach for stabilizing hemodynamics before surgery."
id_02784,"For patients with obstructive HCM and acute hypotension who do not respond to fluid administration, intravenous phenylephrine (or other vasoconstrictors without inotropic activity), alone or in combination with beta-blocking drugs, is recommended.214","For patients experiencing obstructive HCM and acute hypotension who do not improve with fluid therapy, it is advised to use intravenous phenylephrine or other vasoconstrictors lacking inotropic effects, either alone or alongside beta-blockers."
id_01346,It is reasonable to utilize extracorporeal life support techniques such as VA-ECMO for cardiogenic shock due to CCB poisoning that is refractory to pharma- cological interventions.,Employing extracorporeal life support methods like VA-ECMO is advisable for cardiogenic shock caused by CCB poisoning when pharmacological treatments are ineffective.
id_00866,"In patients with aSAH without high- seizure-risk features (ie, ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, and cortical infarction), prophylactic treatment with antiseizure medication is not beneficial.406–408,410,414 Table 4.  Elements for an EVD Infection Control Bundled Protocol388–395 Insertion and technique Management Monitoring and education EVD setup Type of dressing Health care professional training (insertion and management) Aseptic technique Frequency of dressing change Staff education and competency Skin preparation Flushing of EVD system Monitoring number of EVD catheter days EVD insertion location (ICU, OR, other) CSF sampling frequency Monitoring rates of infection EVD insertion health care professional (neuro- surgery, ICU, resident, APP) CSF sampling technique Uniform definition for ventriculostomy-associ- ated infection Catheter selection (size, antibiotic impregnated) EVD manipulation Use of EVD order panel Procedure timeout Catheter or system exchange Nursing handoff EVD clamping and weaning Mobilization safety","For patients with aSAH who do not exhibit high seizure-risk factors such as a ruptured MCA aneurysm, high-grade SAH, ICH, hydrocephalus, or cortical infarction, the use of antiseizure medication as a preventive measure is not advantageous."
id_02785,"For patients with obstructive HCM and persistent dyspnea with clinical evidence of volume overload and high left-sided filling pressures despite other HCM guideline- directed management and therapy, cau- tious use of low-dose oral diuretics may be considered.","For patients with obstructive HCM who continue to experience dyspnea and show signs of volume overload and elevated left-sided filling pressures despite following other HCM guideline-directed treatments, the careful administration of low-dose oral diuretics might be an option."
id_01826,"In older patients (ie, ≥75 years of age) with PAD, assessment for geriatric syndromes (Table 10), such as frailty, sarcopenia, malnutrition, and mobil- ity impairment, can be useful to identify high-risk patients, including before revascularization, and to provide safe and goal-concordant care.1–15","For patients aged 75 and older with PAD, evaluating for geriatric syndromes like frailty, sarcopenia, malnutrition, and mobility issues can help identify those at high risk, including prior to revascularization, to ensure safe and goal-aligned care."
id_02306,"In patients undergoing open surgical repair of an aortic arch aneurysm, if the aneurysmal disease extends into the proximal descending thoracic aorta, an elephant trunk procedure may be considered.6,7","For patients having open surgery to repair an aortic arch aneurysm, an elephant trunk procedure might be an option if the aneurysmal disease involves the proximal descending thoracic aorta."
id_01347,It might be reasonable to attempt electrical pacing for CCB poisoning with refractory bradycardia.,Considering electrical pacing for persistent bradycardia due to CCB poisoning could be a sensible approach.
id_00387,"In patients with AMI and cardiogenic shock, the routine use of intra-aortic balloon pump (IABP) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) is not recommended due to a lack of survival benefit.5–9 *See supportive text.","For patients experiencing AMI with cardiogenic shock, it is advised against routinely using an intra-aortic balloon pump (IABP) or venoarterial extracorporeal membrane oxygenation (VA-ECMO) as they do not improve survival outcomes."
id_01827,"In patients with symptomatic PAD, single antiplatelet therapy is recommended to reduce the risk of MACE.1–4","For patients with symptomatic PAD, it is advised to use single antiplatelet therapy to lower the risk of MACE."
id_02786,"For patients with obstructive HCM, discon- tinuation of vasodilators (eg, angiotensin- converting enzyme inhibitors, angiotensin receptor blockers, dihydropyridine calcium channel blockers) or digoxin may be rea- sonable because these agents can worsen symptoms caused by dynamic outflow tract obstruction.","For individuals with obstructive hypertrophic cardiomyopathy, it may be advisable to stop using vasodilators (such as ACE inhibitors, ARBs, or dihydropyridine calcium channel blockers) or digoxin, as these medications can exacerbate symptoms related to dynamic outflow tract obstruction."
id_00867,"In patients with aSAH, phenytoin for seizure prevention and/or antiseizure prophylaxis is associated with excess morbidity and mortality.407–411,413,415,416 Patients who present with seizures","For patients with aSAH, using phenytoin for seizure prevention or as antiseizure prophylaxis is linked to increased morbidity and mortality."
id_01348,The usefulness of a glucagon bolus and infusion for,The effectiveness of administering a glucagon bolus followed by an infusion for
id_00388,Patients with a mechanical complication of ACS should be managed in a facility with cardiac surgical expertise.,Patients experiencing a mechanical complication from ACS should receive care at a center with cardiac surgery expertise.
id_02307,"In patients with an aortic arch aneurysm who are asymptomatic but meet criteria for inter- vention, but have a high risk from open surgi- cal repair, a hybrid or endovascular approach may be reasonable.","For asymptomatic patients with an aortic arch aneurysm who qualify for intervention but face significant risks from open surgery, considering a hybrid or endovascular method could be appropriate."
id_02787,"For patients with obstructive HCM and severe dyspnea at rest, hypotension, very high rest- ing gradients (eg, >100 mm Hg), as well as all children <6 weeks of age, verapamil is poten- tially harmful.207,215 *Symptoms include effort-related dyspnea or chest pain; and occasionally other exertional symptoms (eg, syncope, near syncope) that are attributed to","Verapamil may be detrimental for individuals with obstructive HCM experiencing severe resting dyspnea, hypotension, extremely high resting gradients (e.g., >100 mm Hg), and for all children under 6 weeks old. Symptoms may include effort-related dyspnea, chest pain, or other exertional symptoms such as syncope or near syncope."
id_00868,"In patients with aSAH who present with seizures, treatment with antiseizure medications for ≤7 days is reasonable to reduce seizure-related complications in the perioperative period.411,417,418","For patients with aSAH experiencing seizures, administering antiseizure medications for up to 7 days is advisable to minimize complications related to seizures during the perioperative period."
id_01828,"In patients with symptomatic PAD, single antiplatelet therapy with clopidogrel alone (75 mg daily) is recommended to reduce the risk of MACE.4","For patients experiencing symptoms of PAD, it is advised to use clopidogrel alone at a dose of 75 mg daily as a single antiplatelet therapy to lower the risk of MACE."
id_02308,"In patients with intact descending TAA, repair is recommended when the diameter is ≥5.5 cm.1,2","For patients with an intact descending thoracic aortic aneurysm, it is advised to perform a repair when the diameter reaches 5.5 cm or more."
id_02788,"In patients with obstructive HCM who remain severely symptomatic despite guideline-directed management and therapy, SRT in eligible patients,* performed at experienced centers,† is recommended for relieving LVOTO17,50,213 (Table 3 and Table 4).","For patients with obstructive HCM who continue to experience severe symptoms despite following guideline-directed management and therapy, SRT is advised for eligible individuals* at specialized centers† to alleviate LVOTO17,50,213 (refer to Table 3 and Table 4)."
id_01349,The usefulness of administering methylene blue for refractory vasodilatory shock due to CCB poisoning is uncertain.,The effectiveness of using methylene blue for treating refractory vasodilatory shock caused by CCB poisoning remains unclear.
id_00869,"In patients with aSAH without prior epilepsy who present with seizures, treat- ment with antiseizure medications beyond 7 days is not effective for reducing future SAH-associated seizure risk.408,410,411","For patients with aSAH who have no history of epilepsy and experience seizures, extending antiseizure medication treatment beyond 7 days does not decrease the risk of future seizures related to SAH."
id_00389,"In patients with a mechanical complication of ACS, short-term MCS devices are reasonable for hemodynamic stabilization as a bridge to surgery.1–3","For patients experiencing mechanical complications from ACS, utilizing short-term MCS devices for hemodynamic stabilization as a temporary measure before surgery is advisable."
id_01829,"In patients with symptomatic PAD, single antiplatelet therapy with aspirin alone (range, 75-325 mg daily) is recommended to reduce the risk of MACE.1–3","For patients experiencing symptoms of PAD, it is advised to use aspirin as a sole antiplatelet treatment (75-325 mg daily) to lower the risk of MACE."
id_02309,"In patients with intact descending TAA and risk factors for rupture (Table 17), repair may be considered at a diameter of <5.5 cm.2-6","For patients with an intact descending TAA and rupture risk factors (refer to Table 17), repair can be contemplated when the diameter is less than 5.5 cm."
id_02789,"In symptomatic patients with obstructive HCM who have associated cardiac disease requiring sur- gical treatment (eg, associated anomalous papillary muscle, markedly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel coronary artery disease, valvular aortic stenosis), surgical myectomy, performed at experienced centers,† is recommended92,216–218 (Table 3 and Table 4).","For patients exhibiting symptoms of obstructive HCM and concurrent cardiac conditions necessitating surgical intervention (such as anomalous papillary muscle, significantly elongated anterior mitral leaflet, intrinsic mitral valve disease, multivessel coronary artery disease, or valvular aortic stenosis), it is advised to undergo surgical myectomy at specialized centers."
id_01350,"The routine use of intravenous lipid emulsion (ILE) therapy for CCB poisoning is not recommended. Downloaded from http://ahajournals.org by on June 19, 2025",Intravenous lipid emulsion (ILE) therapy is not advised as a standard treatment for calcium channel blocker (CCB) poisoning.
id_02310,"In patients at increased risk for perioperative morbidity and mortality (Table 18), it may be reasonable to increase the size threshold for surgery accordingly.7","For patients with a heightened risk of perioperative complications (refer to Table 18), it might be appropriate to adjust the surgical size threshold upward."
id_00390,"In patients post MI, implantable cardioverter- defibrillator (ICD) implantation is recommended in selected patients with an LVEF ≤40% (Table 17) at least 40 days post MI and at least 90 days postrevascularization to reduce death.*1–4","For patients after a myocardial infarction, it is advised to consider implanting an ICD in certain individuals with an LVEF of 40% or less, at a minimum of 40 days following the MI and at least 90 days after revascularization, to decrease mortality."
id_01830,"In patients with symptomatic PAD, low-dose rivaroxaban (2.5 mg twice daily) combined with low-dose aspirin is effective to reduce the risk of MACE and MALE.5,6","For patients experiencing symptoms of PAD, administering low-dose rivaroxaban (2.5 mg twice daily) alongside low-dose aspirin effectively lowers the risk of MACE and MALE."
id_01831,"After endovascular or surgical revascularization for PAD, antiplatelet therapy is recommended.1,7–9",Antiplatelet therapy is advised following either endovascular or surgical revascularization for PAD.
id_01351,We recommend rapid external cooling for life-threatening hyperthermia from cocaine poisoning.,We advise immediate external cooling for severe hyperthermia caused by cocaine toxicity.
id_00870,"In patients with aSAH, use of validated grading scores or patient-reported outcome measures prior to hospital discharge is recommended to screen for physical, cognitive, behavioral, and QOL deficits.39,425–431","For patients with aSAH, it is advised to employ validated grading scales or patient-reported outcome measures before hospital discharge to identify deficits in physical, cognitive, behavioral, and quality of life areas."
id_02790,"In adult patients with obstructive HCM who remain severely symptomatic, despite guideline- directed management and therapy and in whom surgery is contraindicated or the risk is considered unacceptable because of serious comorbidities or advanced age, alcohol septal ablation in eligible patients,* performed at experienced centers,† is recommended219–221 (Table 3 and Table 4).","For adult patients with obstructive hypertrophic cardiomyopathy who continue to experience severe symptoms despite following guideline-directed management and therapy, and for whom surgery is either contraindicated or deemed too risky due to significant comorbidities or advanced age, alcohol septal ablation is advised for eligible individuals, provided it is conducted at experienced centers."
id_00391,"In patients post ACS, ICD implantation is reasonable in patients with clinically relevant ventricular arrhythmias >48 hours and within 40 days post MI to improve survival.*5,6","For patients who have experienced ACS, it is advisable to consider ICD implantation for those with significant ventricular arrhythmias occurring more than 48 hours and within 40 days after an MI to enhance survival."
id_00871,"In patients with aSAH, use of validated screening tools in the postacute period is recommended to identify post-aSAH depression and anxiety.429,432 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with aSAH, it is advised to employ validated screening instruments during the postacute phase to detect depression and anxiety following aSAH."
id_00872,"In patients with aSAH and depression, psychotherapy and pharmacotherapy are recommended to reduce symptoms of depression.429,432–435","For patients experiencing aSAH and depression, it is advised to use psychotherapy and medication to alleviate depressive symptoms."
id_01352,It is reasonable to administer sodium bicarbonate for wide-complex tachycardia or cardiac arrest from cocaine poisoning.,Administering sodium bicarbonate is appropriate for wide-complex tachycardia or cardiac arrest due to cocaine toxicity.
id_00392,"In patients early after MI, usefulness of a temporary wearable cardioverter-defibrillator is uncertain in patients with an LVEF ≤35% to improve survival.7 Bradyarrhythmias",The benefit of a temporary wearable cardioverter-defibrillator for improving survival in patients shortly after an MI with an LVEF of 35% or less is unclear.
id_01832,"After endovascular or surgical revascularization for PAD, low-dose rivaroxaban (2.5 mg twice daily) combined with low-dose aspirin is recommended to reduce the risk of MACE and MALE.7","Following endovascular or surgical revascularization for PAD, it is advised to use low-dose rivaroxaban (2.5 mg twice daily) alongside low-dose aspirin to lower the risk of MACE and MALE."
id_02311,"In patients without Marfan syndrome, Loeys- Dietz syndrome, or vascular Ehlers-Danlos syndrome, who have a descending TAA that meets criteria for intervention and anatomy suitable for endovascular repair, TEVAR is recommended over open ­surgery.1-4","For patients who do not have Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome, and possess a descending thoracic aortic aneurysm (TAA) that qualifies for intervention with anatomy appropriate for endovascular repair, TEVAR is advised instead of open surgery."
id_02312,"In patients with a descending TAA that meets criteria for repair with TEVAR, who have smaller or diseased access vessels, consid- erations for alternative vascular access are recommended.5","For patients with a descending TAA eligible for TEVAR, but with smaller or compromised access vessels, alternative vascular access options should be considered."
id_02791,"In patients with obstructive HCM, earlier (NYHA class II) surgical myectomy performed at com- prehensive HCM centers (Table 3 and Table 4), may be reasonable in the presence of additional clinical factors, including17,222–233: a.  Severe and progressive pulmonary hypertension thought to be attributable to LVOTO or associ- ated mitral regurgitation. b.  Left atrial enlargement with ≥1 episodes of symptomatic AF. c.  Poor functional capacity attributable to LVOTO as documented on treadmill exercise testing. d.  Children and young adults with very high resting LVOT gradients (>100 mm Hg).","For patients with obstructive HCM, it may be appropriate to consider earlier surgical myectomy (NYHA class II) at specialized HCM centers (see Table 3 and Table 4) when additional clinical factors are present, such as: a. Severe and worsening pulmonary hypertension believed to be due to LVOTO or related mitral regurgitation. b. Left atrial enlargement with one or more episodes of symptomatic AF. c. Reduced functional capacity due to LVOTO as shown by treadmill exercise testing. d. Children and young adults with very high resting LVOT gradients (>100 mm Hg)."
id_00393,"In patients presenting with an AMI with sustained evidence of second-degree Mobitz type II atrioventricular block, high-grade atrioventricu- lar block, alternating bundle-branch block, or third-degree atrioventricular block (persistent or infranodal), permanent pacing is indicated.†8,9 *Adapted from the “2017 AHA/ACC/HRS Guideline for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death.” †Adapted from the “2018 ACC/AHA/HRS Guideline on the Evaluation and Management of Patients With Bradycardia and Cardiac Conduction Delay.”","For patients experiencing an AMI with ongoing second-degree Mobitz type II AV block, high-grade AV block, alternating bundle-branch block, or persistent or infranodal third-degree AV block, permanent pacing is recommended."
id_02792,"For severely symptomatic patients with obstructive HCM, SRT in eligible patients,* performed at expe- rienced centers† (Table 3 and Table 4), may be con- sidered as an alternative to escalation of medical therapy after shared decision-making including risks and benefits of all treatment options.10,213,221,234,235","In patients with obstructive HCM who exhibit severe symptoms, SRT can be considered as an alternative to intensifying medical treatment, provided the patient is eligible* and the procedure is conducted at skilled centers† (refer to Table 3 and Table 4), following a shared decision-making process that discusses the risks and benefits of all available treatment options."
id_01353,It is reasonable to administer lidocaine for wide- complex tachycardia from cocaine poisoning.,Administering lidocaine for wide-complex tachycardia due to cocaine toxicity is considered appropriate.
id_00873,"In patients with aSAH, use of a validated screening tool in the postacute period is useful to identify cognitive dysfunc- tion.430,436–439","For patients with aSAH, employing a validated screening tool during the postacute phase is beneficial for detecting cognitive dysfunction."
id_01833,"After endovascular revascularization for PAD, dual antiplatelet therapy with a P2Y12 antagonist and low-dose aspirin is reasonable for at least 1 to 6 months.8–11","Following endovascular revascularization for PAD, it is advisable to administer dual antiplatelet therapy, consisting of a P2Y12 inhibitor and low-dose aspirin, for a duration of 1 to 6 months."
id_02793,"For patients with HCM who are asymptomatic and have normal exercise capacity, SRT is not recommended.224,232",SRT is not advised for patients with HCM who show no symptoms and maintain normal exercise capacity.
id_00874,"In patients with aSAH, an early multidisci- plinary team–based approach to treatment and rehabilitation is recommended to reduce LOS and identify discharge needs.231,440","For patients with aSAH, it is advised to implement an early, team-based multidisciplinary approach for treatment and rehabilitation to shorten LOS and assess discharge requirements."
id_00394,"Patients with ACS and with ongoing angina, hemo- dynamic instability, uncontrolled arrhythmias, sub- optimal reperfusion, or cardiogenic shock should be admitted to a CICU to reduce cardiovascular events.","Patients experiencing ACS accompanied by persistent angina, hemodynamic instability, uncontrolled arrhythmias, inadequate reperfusion, or cardiogenic shock should be admitted to a CICU to minimize cardiovascular events."
id_02313,"In patients with a descending TAA that meets criteria for intervention, who have anatomy unsuitable for endovascular repair, and who are without significant comorbidities and have a life expectancy of at least 10 years, open surgical repair is reasonable.6-9","For patients with a descending thoracic aortic aneurysm eligible for treatment, who cannot undergo endovascular repair due to anatomical constraints, lack major comorbidities, and have a life expectancy of 10 years or more, open surgical repair is a reasonable option."
id_01354,"It is reasonable to administer vasodilators (eg, nitrates, phentolamine, calcium channel blockers) for patients with cocaine-induced coronary vaso- spasm or hypertensive emergencies. Downloaded from http://ahajournals.org by on June 19, 2025","Administering vasodilators, such as nitrates, phentolamine, or calcium channel blockers, is appropriate for patients experiencing coronary vasospasm or hypertensive emergencies due to cocaine use."
id_01834,"After endovascular or surgical revascularization in patients with PAD who require full-intensity anticoagulation for another indication and are not at high risk of bleeding, adding single antiplatelet therapy is reasonable.12,13","For patients with PAD who have undergone endovascular or surgical revascularization and need full-intensity anticoagulation for another reason, it is reasonable to add single antiplatelet therapy if they do not have a high bleeding risk."
id_01355,We recommend that hydroxocobalamin be administered for cyanide poisoning.,We advise administering hydroxocobalamin to treat cyanide poisoning.
id_00875,"In patients with aSAH and no other medi- cal or neurological contraindications, early rehabilitation after the ruptured aneurysm is secured is reasonable to improve func- tional outcome and reduce LOS.267,441–445","For patients with aSAH who have no other medical or neurological contraindications, initiating early rehabilitation once the ruptured aneurysm is secured is advisable to enhance functional outcomes and shorten the length of stay."
id_02314,"In patients with descending TAA who undergo TEVAR with planned left subclavian artery coverage, revascularization of the left subcla- vian artery before TEVAR is recommended to prevent spinal cord injury (SCI)1,2 and poten- tially to reduce stroke risk2 and prevent other ischemic ­complications.","For patients with descending TAA undergoing TEVAR where the left subclavian artery will be covered, it is advised to revascularize the left subclavian artery prior to TEVAR to prevent spinal cord injury and possibly reduce the risk of stroke and other ischemic complications."
id_00395,"In patients with ACS and acute or chronic anemia, blood transfusion to achieve a hemoglobin level ≥10 g/dL may be reasonable to reduce cardiovascular events.1","For patients with ACS and either acute or chronic anemia, it might be appropriate to administer a blood transfusion to reach a hemoglobin level of at least 10 g/dL to potentially lower the risk of cardiovascular events."
id_02795,"In patients with nonobstructive HCM with pre- served EF and symptoms of exertional angina or dyspnea, beta blockers or non-dihydropyridine cal- cium channel blockers are recommended.209,238–246","For patients with nonobstructive HCM who have preserved EF and experience symptoms of exertional angina or dyspnea, it is advised to use beta blockers or non-dihydropyridine calcium channel blockers."
id_01835,"In patients with asymptomatic PAD, single antiplatelet therapy is reasonable to reduce the risk of MACE.","For patients with asymptomatic PAD, it is appropriate to use single antiplatelet therapy to lower the risk of MACE."
id_00396,"In patients with ACS, telemetry monitoring is recommended to reduce cardiovascular events with duration determined by cardiac risk.1,2","For patients with ACS, it is advised to use telemetry monitoring to decrease cardiovascular events, with the monitoring duration based on cardiac risk."
id_02315,"In patients with descending TAA who have undergone TEVAR with left subclavian cover- age and develop SCI that is unresponsive to an increase in BP or a cerebrospinal fluid drain, left subclavian artery revascularization may be considered.3","For patients with descending TAA who have had TEVAR involving left subclavian coverage and experience SCI that does not improve with increased BP or cerebrospinal fluid drainage, revascularization of the left subclavian artery can be considered."
id_01356,We recommend that sodium nitrite be administered for cyanide poisoning when hydroxocobalamin is unavailable.,"If hydroxocobalamin is not accessible, we advise administering sodium nitrite for cyanide poisoning."
id_02316,"In patients with descending TAA undergoing TEVAR in whom celiac artery coverage is being considered, it is reasonable to first con- firm adequate collateralization.1","For patients with descending TAA undergoing TEVAR, it is advisable to verify sufficient collateralization before considering celiac artery coverage."
id_01836,"In patients with symptomatic PAD without recent revascularization, the benefit of dual antiplatelet therapy is uncertain.14,15","For patients with symptomatic PAD who have not undergone recent revascularization, the advantage of dual antiplatelet therapy remains unclear."
id_00876,"In patients with aSAH in a coma, early use of neurostimulants may be reasonable to promote consciousness recovery.446–448","For patients in a coma due to aSAH, initiating neurostimulants early might be advisable to aid in regaining consciousness."
id_02796,"In patients with nonobstructive HCM with preserved EF, it is reasonable to add oral diuretics when exertional dyspnea persists despite the use of beta blockers or non- dihydropyridine calcium channel blockers.","For patients with nonobstructive HCM and preserved EF, it is appropriate to introduce oral diuretics if exertional dyspnea continues despite treatment with beta blockers or non-dihydropyridine calcium channel blockers."
id_02794,"For symptomatic patients with obstructive HCM in whom SRT is an option, mitral valve replace- ment should not be performed for the sole pur- pose of relief of LVOTO.236,237 *General eligibility criteria for septal reduction therapy: a) Clinical: Severe dyspnea or chest pain (usually NYHA functional class III or class IV), or occasionally other exertional symptoms (eg, syncope, near syncope), when attributable to LVOTO, that interferes with everyday activity or quality of life despite optimal medical therapy. b) Hemodynamic: Dynamic LVOT gradient at rest or with physiologic provocation with approximate peak gradient of ≥50 mm Hg, associated with septal hypertrophy and SAM of mitral valve. c) Anatomic: Targeted anterior septal thickness sufficient to perform the procedure safely and effectively in the judgment of the individual operator. †Comprehensive or primary HCM centers with demonstrated excellence in clinical outcomes for these procedures (Table 3 and Table 4). Downloaded from http://ahajournals.org by on June 19, 2025","For patients with obstructive HCM who have symptoms and are candidates for SRT, mitral valve replacement should not be conducted solely to alleviate LVOTO. *Eligibility criteria for septal reduction therapy include: a) Clinical: Severe dyspnea or chest pain (typically NYHA class III or IV), or occasionally other exertional symptoms (e.g., syncope, near syncope) due to LVOTO, affecting daily activities or quality of life despite optimal medical treatment. b) Hemodynamic: Dynamic LVOT gradient at rest or with physiological provocation with a peak gradient of approximately ≥50 mm Hg, linked with septal hypertrophy and SAM of the mitral valve. c) Anatomic: Adequate anterior septal thickness to safely and effectively perform the procedure, as assessed by the operator. †Centers specializing in HCM with proven excellence in clinical outcomes for these procedures (refer to Table 3 and Table 4)."
id_00877,"In patients with aSAH without depres- sion, fluoxetine therapy is not effective to enhance poststroke functional sta- tus.449–452",Fluoxetine treatment does not improve poststroke functional outcomes in patients with aSAH who do not have depression.
id_01357,"In addition to administering hydroxocobalamin or sodium nitrite, it is reasonable to administer sodium thiosulfate for cyanide poisoning.","Alongside hydroxocobalamin or sodium nitrite, administering sodium thiosulfate for cyanide poisoning is advisable."
id_00397,"In patients with ACS, an assessment of LVEF is recommended prior to hospital discharge to guide therapy and for risk stratification.1–3","For patients with ACS, evaluating LVEF before hospital discharge is advised to direct treatment and assess risk."
id_02797,"In patients with nonobstructive HCM with preserved EF, the usefulness of angiotensin- converting enzyme inhibitors and angiotensin receptor blockers in the treatment of symptoms (angina and dyspnea) is not well established.247","For patients with nonobstructive HCM who have a preserved EF, the effectiveness of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for alleviating symptoms like angina and dyspnea remains uncertain."
id_02317,"In patients with ruptured descending TAA who are anatomic candidates for endovascular repair, TEVAR is recommended over open repair because of decreased perioperative death and morbidity.1-5","For patients with ruptured descending TAA who are suitable for endovascular repair, TEVAR is advised instead of open repair due to lower perioperative mortality and complications."
id_00398,"Patients with ACS should be referred to an outpatient CR program prior to hospital discharge to reduce death, MI, hospital readmis- sions, and improve functional status and QOL.1–4","Before leaving the hospital, individuals with ACS should be directed to an outpatient CR program to lower the risks of death, myocardial infarction, and hospital readmissions, as well as to enhance functional status and quality of life."
id_00878,"In adult patients with aSAH, screening and intervention for depression, anxiety, and sexual dysfunction are recommended to improve long-term outcomes.461–465","For adult patients with aSAH, it is advised to screen for and address depression, anxiety, and sexual dysfunction to enhance long-term outcomes."
id_01358,"It is reasonable to administer 100% oxygen for cyanide poisoning. Downloaded from http://ahajournals.org by on June 19, 2025",Administering pure oxygen is a sensible approach for treating cyanide poisoning.
id_00879,"In patients with aSAH, it is reasonable to choose the MoCA over the MMSE to identify cognitive impairment.438,466,467","For patients with aSAH, selecting the MoCA instead of the MMSE to detect cognitive impairment is advisable."
id_00399,"In patients with ACS, a home-based CR program is a reasonable alternative to a center-based CR program to improve functional status and QOL.5–9","For patients with ACS, a home-based CR program can effectively substitute a center-based CR program to enhance functional status and quality of life."
id_02798,"In highly selected patients with apical HCM with severe dyspnea or angina (NYHA class III or class IV) despite maximal medical therapy, and with preserved EF and small LV cavity size (LV end-diastolic volume <50 mL/m2 and LV stroke volume <30 mL/m2), apical myectomy by expe- rienced surgeons at comprehensive centers may be considered to reduce symptoms.248","For patients with apical HCM who experience severe dyspnea or angina (classified as NYHA class III or IV) despite optimal medical treatment, and who have preserved EF and a small LV cavity size (LV end-diastolic volume <50 mL/m2 and LV stroke volume <30 mL/m2), apical myectomy performed by skilled surgeons at specialized centers can be considered to alleviate symptoms."
id_01837,"In patients with symptomatic PAD, the benefit of vorapaxar added to existing antiplatelet therapy is uncertain.16","For patients with symptomatic PAD, the advantage of adding vorapaxar to current antiplatelet treatment remains unclear."
id_02318,"In patients with ruptured descending TAA undergoing TEVAR, intentional coverage of the left subclavian artery, celiac artery, or both may be considered to increase the landing zone for endovascular repair.5-7","For patients with ruptured descending TAA undergoing TEVAR, it may be advisable to intentionally cover the left subclavian artery, the celiac artery, or both to extend the landing zone for endovascular repair."
id_01359,We recommend administration of digoxin-specific antibody fragments (digoxin-Fab) for digoxin or digitoxin poisoning.,We advise using digoxin-specific antibody fragments (digoxin-Fab) to treat poisoning from digoxin or digitoxin.
id_02319,"In patients with descending TAA undergoing TEVAR, review of preoperative CTA of the iliofemoral vessels should be performed to evaluate access.1,2","For patients with descending TAA undergoing TEVAR, a preoperative CTA of the iliofemoral vessels should be reviewed to assess access."
id_01839,"In patients with PAD, treatment with high-intensity statin therapy is indicated, with an aim of achieving a ≥50% reduction in low-density lipoprotein cholesterol (LDL-C) level.1–3","For patients with PAD, high-intensity statin therapy should be administered to achieve at least a 50% decrease in low-density lipoprotein cholesterol (LDL-C) levels."
id_02799,"In asymptomatic patients with non-obstruc- tive HCM, the benefit of beta blockers or cal- cium channel blockers is not well established. 5.3. Management of Patients With HCM and Atrial Fibrillation Recommendations for Management of Atrial Fibrillation Referenced studies that support the recommendations are summarized in Online Data Supplement 16. COR LOE Recommendations","For asymptomatic individuals with non-obstructive HCM, the advantages of using beta blockers or calcium channel blockers remain unclear."
id_00400,"In patients with ACS who are not at high bleeding risk, DAPT with aspirin and an oral P2Y12 inhibi- tor should be administered for at least 1 year to reduce MACE.1–6 Bleeding Reduction Strategies","For patients with ACS who do not have a high risk of bleeding, dual antiplatelet therapy with aspirin and an oral P2Y12 inhibitor should be given for a minimum of one year to lower the risk of major adverse cardiovascular events."
id_00880,"In patients with aSAH, counseling patients and caregivers on the high long-term risk of cognitive dysfunction can be beneficial to identify long-term needs.468 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with aSAH, advising them and their caregivers about the significant long-term risk of cognitive impairment can help in recognizing ongoing needs."
id_01360,It is reasonable to administer digoxin-Fab for poisoning due to Bufo toad venom and yellow oleander.,Administering digoxin-Fab is a sensible approach for treating poisoning from Bufo toad venom and yellow oleander.
id_02320,"In patients with descending TAA undergoing TEVAR, if iliac access is marginal or inade- quate to prevent access-related complications, the use of alternative conduits is recom- mended.1,2","For patients with descending TAA undergoing TEVAR, if iliac access is insufficient or inadequate to avoid access-related complications, it is advised to use alternative conduits."
id_02800,"In patients with HCM and clinical AF, antico- agulation is recommended with direct-acting oral anticoagulants as first-line option and vitamin K antagonists as second-line option, independent of CHA2DS2-VASc score.249–253","For patients with HCM and clinical AF, it is advised to use direct-acting oral anticoagulants as the primary choice for anticoagulation, with vitamin K antagonists as the secondary option, regardless of the CHA2DS2-VASc score."
id_01838,"After surgical revascularization for PAD with a prosthetic graft, dual antiplatelet therapy with a P2Y12 antagonist and low-dose aspirin may be reasonable for at least 1 month.17","Following surgical revascularization for PAD using a prosthetic graft, it may be appropriate to administer dual antiplatelet therapy, consisting of a P2Y12 inhibitor and low-dose aspirin, for a minimum of one month."
id_01840,"In patients with PAD who are on maximally tolerated statin therapy and have an LDL-C level of ≥70 mg/dL, it is reasonable to add PCSK9 inhibitor therapy.1,4–6","For patients with PAD on the highest tolerated dose of statins and an LDL-C level of 70 mg/dL or higher, adding PCSK9 inhibitor therapy is advisable."
id_01361,"It may be reasonable to administer digoxin-Fab to treat poisoning from cardiac glycosides other than digoxin, digitoxin, Bufo toad venom, and yellow oleander.","Administering digoxin-Fab might be appropriate for treating poisoning caused by cardiac glycosides aside from digoxin, digitoxin, Bufo toad venom, and yellow oleander."
id_00401,"In patients with ACS who have tolerated DAPT with ticagrelor, transition to ticagrelor monotherapy ≥1 month post PCI is useful to reduce bleeding risk.7–11","For patients with ACS who have successfully tolerated DAPT with ticagrelor, switching to ticagrelor alone at least one month after PCI is beneficial for reducing bleeding risk."
id_00881,"In patients with aSAH who have under- gone aneurysm repair, perioperative cerebrovascular imaging is recommended to identify remnants or recurrence of the aneurysm that may require further treat- ment.113,116,131","For patients with aSAH who have had aneurysm repair, it is advised to perform cerebrovascular imaging during the perioperative period to detect any remnants or recurrence of the aneurysm that might necessitate additional treatment."
id_02321,"In patients with descending TAA undergo- ing TEVAR who have suitable anatomy, total percutaneous femoral access is a reasonable alternative to open surgi- cal cutdown to avoid access-related ­complications.3-5","For patients with descending TAA undergoing TEVAR and possessing appropriate anatomy, total percutaneous femoral access can be a viable alternative to open surgical cutdown to prevent access-related complications."
id_01362,It may be reasonable to administer atropine for bradydysrhythmias caused by digoxin and other cardiac glycoside poisoning.,Administering atropine could be appropriate for treating bradydysrhythmias resulting from poisoning by digoxin and other cardiac glycosides.
id_00882,"In patients with aSAH who have undergone aneurysm repair, follow-up cerebrovascular imaging is recommended to identify recurrence or regrowth of the treated aneurysm, changes in another known aneurysm, or development of de novo aneurysm(s) that may require further treatment to reduce the risk of aSAH.116,131 Downloaded from http://ahajournals.org by on June 19, 2025","For patients with aSAH who have had aneurysm repair, it is advised to perform follow-up cerebrovascular imaging to detect recurrence or regrowth of the repaired aneurysm, alterations in another known aneurysm, or the emergence of new aneurysm(s) that might necessitate additional treatment to lower the risk of aSAH."
id_01842,"In patients with PAD and hypertension, antihypertensive therapy should be administered to reduce the risk of MACE.1–5","For patients with PAD and high blood pressure, antihypertensive treatment should be given to lower the risk of MACE."
id_00402,"In patients at high risk of gastrointestinal bleeding, a proton pump inhibitor (PPI) is rec- ommended in combination with DAPT, oral antico- agulants, or both to reduce risk of bleeding.12–15","For patients with a high risk of gastrointestinal bleeding, it is advised to use a proton pump inhibitor (PPI) alongside dual antiplatelet therapy (DAPT), oral anticoagulants, or both to minimize bleeding risk."
id_02322,"In patients with intact degenerative TAAA, repair is recommended when the diameter is ≥6.0 cm.1-3","For patients with intact degenerative TAAA, it is advised to perform repair when the diameter reaches 6.0 cm or more."
id_02801,"In patients with HCM and subclinical AF detected by internal or external cardiac device or monitor of >24 hours’ duration for a given episode, anti- coagulation is recommended with direct-acting oral anticoagulants as first-line option and vitamin K antagonists as second-line option, independent of CHA2DS2-VASc score.102,103,249,254","For patients with HCM who have subclinical AF identified by an internal or external cardiac device or monitor lasting more than 24 hours per episode, it is advised to use direct-acting oral anticoagulants as the primary treatment and vitamin K antagonists as a secondary option, regardless of the CHA2DS2-VASc score."
id_02802,"In patients with AF in whom rate control strategy is planned, either beta blockers, verapamil, or diltiazem are recommended, with the choice of agents according to patient preferences and comorbid conditions.104,255","For patients with AF where a rate control strategy is intended, beta blockers, verapamil, or diltiazem are advised, with the selection based on patient preferences and existing comorbidities."
id_01841,"In patients with PAD who are on maximally tolerated statin therapy and have an LDL-C level of ≥70 mg/dL, it is reasonable to add ezetimibe therapy.1,7","For patients with PAD on the highest tolerated dose of statins and an LDL-C level of 70 mg/dL or higher, adding ezetimibe therapy is a reasonable option."
id_00403,"In patients with ACS undergoing PCI, de- escalation of DAPT (switching from ticagrelor or prasugrel to clopidogrel) after 1 month may be reasonable to reduce bleeding risk.16–20","For patients with ACS receiving PCI, transitioning from ticagrelor or prasugrel to clopidogrel after one month might be advisable to lower the risk of bleeding."
id_01843,"In patients with PAD and hypertension, a systolic blood pressure (SBP) goal of <130 mm Hg and a diastolic blood pressure target of <80 mm Hg is recommended.5–9","For patients with PAD and high blood pressure, it is advised to aim for a systolic blood pressure below 130 mm Hg and a diastolic blood pressure under 80 mm Hg."
id_00404,"In patients with ACS undergoing PCI who are at high bleeding risk, transition to single antiplatelet therapy (aspirin or P2Y12 inhibitor) after 1 month may be reasonable to reduce bleeding risk.21","For patients with ACS undergoing PCI who have a high risk of bleeding, switching to single antiplatelet therapy (either aspirin or a P2Y12 inhibitor) after one month might be advisable to lower bleeding risk."
id_02803,"In patients with HCM and subclinical AF detected by internal or external device or moni- tor, of >5 minutes’ but <24 hours’ duration for a given episode, anticoagulation with direct-act- ing oral anticoagulants as first-line option and vitamin K antagonists as second-line option can be beneficial, taking into consideration duration of AF episodes, total AF burden, underlying risk factors, and bleeding risk.102,103,249,254,256","For patients with HCM who have subclinical AF episodes lasting more than 5 minutes but less than 24 hours, detected by internal or external devices, using direct-acting oral anticoagulants as the primary treatment and vitamin K antagonists as a secondary option may be advantageous, considering the duration and total burden of AF episodes, as well as underlying risk factors and bleeding risk."
id_02323,"In patients with intact degenerative TAAA, repair is reasonable when the diameter is ≥5.5 cm and the repair is performed by expe- rienced surgeons in a Multidisciplinary Aortic Team.1-3","For patients with intact degenerative TAAA, it is advisable to consider repair when the diameter reaches 5.5 cm or more, provided that the procedure is carried out by skilled surgeons within a Multidisciplinary Aortic Team."
id_01844,"In patients with PAD and hypertension, the selective use of angiotensin-converting enzyme (ACE) inhibitors or angiotensin-receptor blockers is recommended to reduce the risk of MACE.10–12","For patients with PAD and hypertension, it is advised to selectively use ACE inhibitors or angiotensin-receptor blockers to lower the risk of MACE."
id_01364,"It may be reasonable to administer lidocaine, ­phenytoin, or bretylium to treat ventricular dys- rhythmias caused by digitalis and other cardiac glycoside poisoning until digoxin-Fab can be ad- ministered.","Administering lidocaine, phenytoin, or bretylium might be appropriate for managing ventricular dysrhythmias due to digitalis and other cardiac glycoside toxicity until digoxin-Fab is available."
id_01365,"We do not recommend the use of hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis to treat digoxin poisoning. Downloaded from http://ahajournals.org by on June 19, 2025","The use of hemodialysis, hemofiltration, hemoperfusion, or plasmapheresis is not advised for the treatment of digoxin toxicity."
id_00405,"In patients with ACS who require oral anticoagulant therapy, aspirin should be discontinued after 1 to 4 weeks of triple antithrombotic therapy, with continued use of a P2Y12 inhibitor (preferably clopidogrel) and an oral anticoagulant to reduce bleeding risk.*1–5 *Modified from the “2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization.”6","For patients with ACS needing oral anticoagulant treatment, aspirin should be stopped after 1 to 4 weeks of triple antithrombotic therapy, while maintaining a P2Y12 inhibitor (ideally clopidogrel) and an oral anticoagulant to minimize bleeding risk."
id_01363,It may be reasonable to attempt electrical pacing to treat bradydysrhythmias from digoxin and other cardiac glycoside poisoning.,Attempting electrical pacing could be a sensible approach for managing bradydysrhythmias caused by digoxin and other cardiac glycoside toxicity.
id_02804,"In patients with HCM and poorly tolerated AF, a rhythm control strategy with cardiover- sion or antiarrhythmic drugs can be beneficial with the choice of an agent according to AF symptom severity, patient preferences, and comorbid conditions.104,210,257–268","For patients with HCM experiencing poorly tolerated AF, employing a rhythm control approach using cardioversion or antiarrhythmic medications may be advantageous, with the selection of the agent based on the severity of AF symptoms, patient preferences, and existing comorbidities."
id_02324,"In patients with intact degenerative TAAA who have features associated with an increased risk of rupture (Table 19), repair is reasonable when the diameter is <5.5 cm.4","For patients with intact degenerative TAAA and characteristics linked to a higher rupture risk (see Table 19), it is reasonable to consider repair when the diameter is less than 5.5 cm."
id_02325,"In patients with ruptured TAAA requiring inter- vention, open repair is recommended.1-5","For patients with ruptured TAAA who need intervention, open repair is advised."
id_02805,"In patients with HCM and symptomatic AF, as part of a AF rhythm control strategy, catheter ablation for AF can be effective when drug therapy is ineffective, contraindicated, or not the patient’s preference.257,269,270","For patients with HCM experiencing symptomatic AF, catheter ablation for AF may be an effective rhythm control option when medication is ineffective, unsuitable, or not preferred by the patient."
id_01366,We recommend the administration of intravenous lipid emulsion for local anesthetic poisoning.,We advise administering intravenous lipid emulsion for cases of local anesthetic toxicity.
id_01845,Patients with PAD who smoke cigarettes or use any other forms of tobacco should be advised at every visit to quit or encouraged to maintain cessation.1–3,Patients with PAD who smoke or use any tobacco products should be counseled at each appointment to stop or supported in continuing their abstinence.
id_00406,"In patients after ACS, a fasting lipid panel is recommended 4 to 8 weeks after initiation or dose adjustment of lipid-lowering therapy to assess response or adherence to therapy.*1,2 *Modified from the “2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/ AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cho- lesterol.”3","For patients following an ACS event, it is advised to perform a fasting lipid panel 4 to 8 weeks after starting or adjusting the dosage of lipid-lowering treatment to evaluate the therapy's effectiveness or patient compliance."
id_01846,"Patients with PAD who smoke cigarettes or use any other forms of tobacco should be assisted in developing a plan for quitting that includes pharma- cotherapy (ie, varenicline, bupropion, and/or nicotine replacement therapies) combined with counseling, and/or referral to a smoking cessation program.4–9","Patients with PAD who use cigarettes or other tobacco products should receive help in creating a cessation plan that incorporates pharmacotherapy (such as varenicline, bupropion, and/or nicotine replacement therapies) along with counseling, and/or be referred to a smoking cessation program."
id_02326,"In patients with ruptured TAAA requiring inter- vention, provided that the patient is hemo- dynamically stable, endovascular repair may be reasonable in centers with endovascular expertise and access to appropriate endovas- cular stent grafts.6 Intact TAAA","For patients with a ruptured TAAA who are hemodynamically stable, endovascular repair can be considered in facilities that have the necessary endovascular expertise and suitable stent grafts."
id_00407,"In patients after ACS, low-dose colchicine may be reasonable to reduce risk of MACE.1–5","For patients post-ACS, using low-dose colchicine could be a sensible option to lower the risk of MACE."
id_01367,We recommend the use of benzodiazepines to treat seizures associated with local anesthetic systemic toxicity.,We advise administering benzodiazepines for managing seizures linked to systemic toxicity from local anesthetics.
id_02806,"In patients with HCM and AF who require surgical myectomy, concomitant surgical AF ablation procedure can be beneficial for AF rhythm control.104,258,271–273 5.4. Management of Patients With HCM and Ventricular Arrhythmias Recommendations for the Management of Patients With HCM and Ventricular Arrhythmias Referenced studies that support the recommendations are summarized in Online Data Supplement 17. COR LOE Recommendations","For patients with HCM and AF undergoing surgical myectomy, performing a simultaneous surgical AF ablation may aid in controlling AF rhythm."
id_02327,"In patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syn- drome and intact TAAA requiring intervention, open repair is recommended over endovascu- lar repair.7-9","For patients with Marfan syndrome, Loeys-Dietz syndrome, or vascular Ehlers-Danlos syndrome who need intervention for an intact TAAA, open repair is advised instead of endovascular repair."
id_01847,"Patients with PAD should be advised to avoid exposure to secondhand tobacco smoke in all indoor or enclosed spaces, including work, home, transportation vehicles, and public places.10–14","Individuals with PAD should be instructed to steer clear of secondhand tobacco smoke in any indoor or enclosed areas, such as workplaces, homes, vehicles, and public venues."
id_01368,It is reasonable to administer sodium bicarbonate for life-threatening wide-complex tachycardia associated with local anesthetic toxicity.,Administering sodium bicarbonate is advisable for life-threatening wide-complex tachycardia linked to local anesthetic toxicity.
id_00408,"In patients with ACS without a contraindication, annual influenza vaccination is recommended to reduce the risk of death and MACE.1–4","For patients with ACS who do not have contraindications, it is advised to receive an annual flu vaccine to lower the risk of mortality and major adverse cardiovascular events."
id_02807,"In patients with HCM and recurrent poorly tolerated life-threatening ventricular tachyarrhythmias refractory to maximal anti- arrhythmic drug therapy and ablation, heart transplantation assessment is indicated in accordance with current listing criteria.21,274","For patients with HCM experiencing recurrent, severe, life-threatening ventricular tachyarrhythmias that do not respond to optimal anti-arrhythmic medication and ablation, evaluation for heart transplantation should be considered based on current listing criteria."
id_02328,"In patients with intact degenerative TAAA and suitable anatomy, endovascular repair with fenestrated stent grafts, branched stent grafts, or both may be considered in centers with endovascular expertise and access to appropriate endovascular stent grafts.10-13","For patients with intact degenerative TAAA and appropriate anatomical conditions, endovascular repair using fenestrated or branched stent grafts, or a combination of both, can be considered at centers with expertise in endovascular procedures and access to the necessary stent grafts."
id_00409,An initial assessment of chest pain is recommended to triage patients effectively on the basis of the likelihood that symptoms may be attributable to myocardial ischemia.1-7,It is advised to conduct an initial evaluation of chest pain to efficiently categorize patients according to the probability that their symptoms are due to myocardial ischemia.
id_01369,It is reasonable to administer atropine for life- threatening bradycardia associated with local anesthetic systemic toxicity.,Administering atropine is appropriate for life-threatening bradycardia linked to systemic toxicity from local anesthetics.
id_01849,"In patients with PAD, management of diabetes should be coordinated among members of the health care team.","For patients with PAD, diabetes management should be collaboratively overseen by the healthcare team."
id_01848,"In patients with PAD and type 2 diabetes, use of glucagon-like peptide–1 agonists (liraglutide and semaglutide) and sodium-glucose cotransporter-2 (SGLT-2) inhibitors (canagliflozin, dapagliflozin, and empagliflozin) are effective to reduce the risk of MACE.1–12","For patients with PAD and type 2 diabetes, glucagon-like peptide-1 agonists (such as liraglutide and semaglutide) and sodium-glucose cotransporter-2 inhibitors (including canagliflozin, dapagliflozin, and empagliflozin) effectively lower the risk of MACE."
id_02808,"In children with HCM and recurrent ven- tricular arrhythmias despite beta-blocker use, antiarrhythmic drug therapy (amio- darone,275,276 mexiletine,278 sotalol275,276) is recommended, with the choice of agent guided by age, underlying comorbidities, severity of disease, patient preferences, and balance of efficacy and safety.","For children with HCM experiencing recurrent ventricular arrhythmias despite beta-blocker treatment, it is advised to use antiarrhythmic drugs such as amiodarone, mexiletine, or sotalol, selecting the medication based on the child's age, existing health conditions, disease severity, patient preferences, and the balance between effectiveness and safety."
id_02329,"In patients undergoing open TAAA repair who are at high risk for SCI, cerebrospinal fluid drainage is recommended to reduce the inci- dence of temporary SCI, permanent SCI, or both.1-7","For patients at high risk of spinal cord injury undergoing open TAAA repair, it is advised to use cerebrospinal fluid drainage to decrease the likelihood of temporary or permanent spinal cord injury."
id_02809,"In patients with HCM and pacing-capable ICDs, programming antitachycardia pac- ing is recommended to minimize risk of shocks.279,280","For patients with HCM who have ICDs capable of pacing, it is advised to program antitachycardia pacing to reduce the likelihood of shocks."
id_00410,"Chest pain should not be described as atypical, because it is not helpful in determining the cause and can be misinterpreted as benign in nature. Instead, chest pain should be described as cardiac, possibly cardiac, or noncardiac because these terms are more specific to the potential underlying diagnosis.","Avoid labeling chest pain as atypical, as it does not aid in identifying the cause and may be mistakenly seen as harmless. Rather, classify chest pain as cardiac, possibly cardiac, or noncardiac, as these terms more accurately reflect the potential underlying diagnosis."
id_01850,"In patients with PAD and diabetes, glycemic control may be beneficial to improve limb outcomes.13–16","For patients with PAD and diabetes, managing blood sugar levels could help enhance limb outcomes."
id_01370,"It is reasonable to utilize extracorporeal life support techniques such as VA-ECMO in local anesthetic toxicity with refractory cardiogenic shock. Downloaded from http://ahajournals.org by on June 19, 2025",Employing extracorporeal life support methods like VA-ECMO is appropriate for cases of local anesthetic toxicity that result in cardiogenic shock unresponsive to other treatments.
id_02330,"In patients who experience delayed spinal cord dysfunction after either open or endo- vascular TAAA repair, timely measures to optimize spinal cord perfusion and decrease intrathecal pressure are recommended (Table 20).1-4,8","For patients with delayed spinal cord dysfunction following open or endovascular TAAA repair, it is advised to promptly enhance spinal cord perfusion and reduce intrathecal pressure (Table 20).1-4,8"
id_01371,We recommend administering methylene blue for methemoglobinemia.,We suggest using methylene blue to treat methemoglobinemia.
id_00411,"In patients with chest pain, a focused history that includes characteristics and duration of symptoms relative to presentation as well as associated features, and cardiovascular risk factor assessment should be obtained.","For patients experiencing chest pain, gather a detailed history that covers symptom characteristics, duration in relation to presentation, associated features, and an evaluation of cardiovascular risk factors."
id_01851,Patients with PAD should receive an annual influenza vaccination.1–5,Individuals with PAD are advised to get a flu shot every year.
id_02331,"In patients undergoing open repair of TAAA involving the renal arteries, cold blood or crys- talloid renal perfusion is recommended to pro- vide effective protection against renal injury.1-6","For patients having open TAAA repair that includes the renal arteries, it is advised to use cold blood or crystalloid renal perfusion to effectively safeguard against renal injury."
id_02810,"In patients with HCM and recurrent symp- tomatic sustained monomorphic ventricu- lar tachycardia, or recurrent ICD shocks despite optimal device programming, and in whom antiarrhythmic drug therapy is either ineffective, not tolerated, or not preferred, catheter ablation can be useful for reducing arrhythmia burden.20,281,282 5.5. Management of Patients With HCM and Advanced HF","For patients with HCM experiencing repeated symptomatic sustained monomorphic ventricular tachycardia or frequent ICD shocks despite optimal device settings, and where antiarrhythmic drugs are ineffective, intolerable, or undesirable, catheter ablation may be beneficial in decreasing arrhythmia frequency."
id_02811,"In patients with HCM who develop systolic dysfunction with an LVEF <50%, guideline- directed therapy for HF with reduced EF is recommended.38,283,284","For patients with HCM experiencing systolic dysfunction and an LVEF below 50%, it is advised to follow guideline-directed treatment for heart failure with reduced ejection fraction."
id_01372,Exchange transfusion may be reasonable as a treatment for methemoglobinemia that is not responsive to methylene blue.,Exchange transfusion could be considered a suitable treatment for methemoglobinemia when methylene blue is ineffective.
id_01852,"Patients with PAD should receive the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) vaccination sequence, including the booster(s).","Individuals with PAD are advised to complete the SARS-CoV-2 vaccination series, including any booster doses."
id_00412,"Women who present with chest pain are at risk for underdiagnosis, and potential cardiac causes should always be considered.1-7","Women experiencing chest pain may be at risk of being underdiagnosed, so cardiac causes must always be evaluated."
id_00413,"In women presenting with chest pain, it is recommended to obtain a history that emphasizes accompanying symptoms that are more common in women with ACS.1-7","For women experiencing chest pain, it is advised to gather a history that highlights symptoms more frequently associated with ACS in women."
id_02332,"In patients undergoing open or endovascular TAAA repair who have end-organ ischemia or significant stenoses from atherosclerotic vis- ceral or renal artery disease, additional revas- cularization procedures are recommended.7","For patients having open or endovascular TAAA repair with end-organ ischemia or notable stenosis due to atherosclerotic visceral or renal artery disease, it is advised to perform additional revascularization procedures."
id_02812,"In patients with HCM and systolic dys- function, diagnostic testing to assess for concomitant causes of systolic dysfunc- tion (such as coronary artery disease) is recommended.22,36,285","For patients with HCM and systolic dysfunction, it is advised to perform diagnostic tests to identify any additional causes of systolic dysfunction, like coronary artery disease."
id_01853,"In patients at high cardiovascular risk, a diet emphasizing intake of vegetables, fruits, legumes, nuts, whole grains, and fish can be beneficial for reducing the risk of developing PAD and the risk of MACE.6–15","For individuals with elevated cardiovascular risk, consuming a diet rich in vegetables, fruits, legumes, nuts, whole grains, and fish may help lower the likelihood of developing PAD and experiencing MACE."
id_01373,Hyperbaric oxygen therapy may be reasonable as a treatment for methemoglobinemia that is not responsive to methylene blue.,Hyperbaric oxygen therapy could be considered for treating methemoglobinemia when methylene blue is ineffective.
id_01374,N-acetylcysteine is not recommended as a treatment for methemoglobinemia.,N-acetylcysteine should not be used to treat methemoglobinemia.
id_00414,"In patients with chest pain who are >75 years of age, ACS should be considered when accompanying symptoms such as shortness of breath, syncope, or acute delirium are present, or when an unexplained fall has occurred.1","For patients over 75 experiencing chest pain, consider ACS if they also have symptoms like shortness of breath, syncope, acute delirium, or if they have had an unexplained fall."
id_02333,"In patients undergoing endovascular repair of AAA who have suitable common femoral artery anatomy, ultrasound-guided percutane- ous access and closure is recommended over open cutdown to reduce operative time, blood loss, length of stay, time to wound healing, and pain.1,2","For patients with appropriate common femoral artery anatomy undergoing endovascular AAA repair, it is advised to use ultrasound-guided percutaneous access and closure instead of open cutdown to minimize operative time, blood loss, hospital stay duration, wound healing time, and pain."
id_01854,"In patients with PAD, B-complex vitamin supple- mentation to lower homocysteine levels is not ben- eficial for prevention of MACE.16–18","For patients with PAD, taking B-complex vitamins to reduce homocysteine levels does not help prevent MACE."
id_02813,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite guideline-directed therapy) cardio- pulmonary exercise test should be performed to quantify the degree of functional limita- tion and aid in selection of patients for heart transplantation or mechanical circulatory support.113,114","For patients with nonobstructive HCM experiencing severe heart failure (classified as NYHA class III or IV despite receiving guideline-directed treatment), a cardiopulmonary exercise test should be conducted to assess the extent of functional impairment and assist in determining eligibility for heart transplantation or mechanical circulatory support."
id_02334,"In patients presenting with ruptured AAA who are hemodynamically stable, CT imag- ing is recommended to evaluate whether the AAA is amenable to endovascular repair.1-3","For patients with a ruptured AAA who are hemodynamically stable, it is advised to use CT imaging to assess the feasibility of endovascular repair."
id_02814,"In patients with nonobstructive HCM and advanced HF (NYHA class III to class IV despite guideline-directed therapy) or with life- threatening ventricular arrhythmias refractory to maximal guideline-directed therapy, assess- ment for heart transplantation in accordance with current listing criteria is recommended.21,274,286,287","For patients with nonobstructive HCM experiencing severe heart failure (NYHA class III to IV despite guideline-directed treatment) or those with life-threatening ventricular arrhythmias unresponsive to optimal guideline-directed therapy, evaluation for heart transplantation according to current listing criteria is advised."
id_01375,"Ascorbic acid is not recommended as a treatment for methemoglobinemia. Downloaded from http://ahajournals.org by on June 19, 2025",Ascorbic acid should not be used to treat methemoglobinemia.
id_00415,Cultural competency training is recommended to help achieve the best outcomes in patients of diverse racial and ethnic backgrounds who present with chest pain.,It is advised to undergo cultural competency training to optimize outcomes for patients from various racial and ethnic groups experiencing chest pain.
id_00416,"Among patients of diverse race and ethnicity presenting with chest pain in whom English may not be their primary language, addressing language barriers with the use of formal translation services is recommended.","For patients from various racial and ethnic backgrounds experiencing chest pain and who may not primarily speak English, it is advised to overcome language obstacles by utilizing professional translation services."
id_01855,"In patients with PAD, chelation therapy (eg, EDTA) is not beneficial for prevention of MACE.19,20","For patients with PAD, chelation therapy, such as EDTA, does not help in preventing MACE."
id_02815,"For patients with HCM who develop systolic dysfunction (LVEF <50%), it is reasonable to discontinue previously indicated negative inotropic agents (specifically, verapamil, diltia- zem, or disopyramide).","In patients with HCM experiencing systolic dysfunction (LVEF <50%), it is advisable to stop using previously recommended negative inotropic drugs, such as verapamil, diltiazem, or disopyramide."
id_01856,"In patients with PAD, vitamin D supplementation is not beneficial for prevention of MACE.21–25 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with PAD, taking vitamin D does not help in preventing MACE."
id_02335,"In patients presenting with ruptured AAA who have suitable anatomy, endovas- cular repair is recommended over open repair to reduce the risk of morbidity and ­mortality.1,4-6","For patients with ruptured AAA and appropriate anatomy, endovascular repair is advised instead of open repair to lower morbidity and mortality risks."
id_01376,"For patients in respiratory arrest, rescue breath- ing or bag-mask ventilation should be maintained until spontaneous breathing returns, and standard BLS, ALS, and/or pediatric ALS measures should continue if return of spontaneous breathing does not occur.","In cases of respiratory arrest, continue rescue breathing or bag-mask ventilation until the patient resumes breathing on their own; if spontaneous breathing does not resume, proceed with standard BLS, ALS, or pediatric ALS protocols."
id_02336,"In patients undergoing endovascular repair for ruptured AAA, local anesthesia is preferred to general anesthesia to reduce risk of periop- erative mortality.7-9","For patients receiving endovascular repair for a ruptured AAA, local anesthesia is favored over general anesthesia to lower the risk of perioperative mortality."
id_02816,"In patients with nonobstructive HCM and advanced HF (NYHA functional class III to class IV despite GDMT) who are candidates for heart transplantation, continuous-flow LV assist device therapy is reasonable as a bridge to heart transplantation.288–291","For patients with nonobstructive hypertrophic cardiomyopathy and severe heart failure (NYHA class III to IV despite guideline-directed medical therapy) who are eligible for heart transplantation, using a continuous-flow left ventricular assist device as a bridge to transplantation is a reasonable option."
id_01857,"In patients with claudication, cilostazol is recommended to improve leg symptoms and increase walking distance.1–4","For patients experiencing claudication, cilostazol is advised to alleviate leg symptoms and enhance walking distance."
id_01377,"For patients known or suspected to be in cardiac arrest, in the absence of a proven benefit from the use of naloxone, standard resuscitative measures should take priority over naloxone administration, with a focus on high-quality CPR (compressions plus ventilation).","In cases where cardiac arrest is confirmed or suspected, and no definitive advantage of naloxone is established, prioritize standard resuscitation techniques, emphasizing effective CPR (both compressions and ventilation), over administering naloxone."
id_02337,"In patients with ruptured AAA, permissive hypotension can be beneficial to decrease the rate of bleeding.1,3,10-12","For patients with a ruptured AAA, allowing lower blood pressure may help reduce bleeding rates."
id_02817,"In patients with HCM and LVEF <50%, ICD placement can be beneficial.284","For patients with HCM and an LVEF below 50%, ICD implantation may be advantageous."
id_00417,"In patients with acute chest pain, it is recommended that 9-1-1 be activated by patients or bystanders to initiate transport to the closest ED by emergency medical services (EMS).1","For individuals experiencing acute chest pain, it is advised that either they or nearby individuals call 9-1-1 to ensure transportation to the nearest emergency department by emergency medical services (EMS)."
id_01378,Lay and trained responders should not delay acti- vating emergency response systems while await- ing the patient’s response to naloxone or other interventions.,Both laypersons and trained responders should promptly activate emergency response systems without waiting for the patient to respond to naloxone or other treatments.
id_01858,"In patients with PAD, cilostazol may be useful to reduce restenosis after endovascular therapy for femoropopliteal disease.5–7",Cilostazol can be beneficial in decreasing restenosis following endovascular treatment for femoropopliteal disease in patients with PAD.
id_00418,"In patients presenting with chest pain, a focused cardiovascular examination should be performed initially to aid in the diagnosis of ACS or other potentially serious causes of chest pain (eg, aortic dissection, PE, or esophageal rupture) and to identify complications.","For patients with chest pain, an initial targeted cardiovascular exam is essential to diagnose ACS or other serious causes like aortic dissection, PE, or esophageal rupture, and to detect any complications."
id_02818,"In patients with HCM and LVEF <50%, NYHA functional class II to class IV symptoms despite guideline-direct therapy, and LBBB, CRT can be beneficial to improve symptoms.199–203","For patients with HCM, LVEF below 50%, and NYHA class II to IV symptoms that persist despite guideline-directed treatment, CRT may help alleviate symptoms if LBBB is present."
id_02338,"In patients with unruptured AAA, repair is rec- ommended in those with a maximal aneurysm diameter of ≥5.5 cm in men or ≥5.0 cm in women.1-6 Downloaded from http://ahajournals.org by on June 19, 2025","For individuals with unruptured AAA, surgical intervention is advised for men with an aneurysm diameter of 5.5 cm or greater and for women with a diameter of 5.0 cm or greater."
id_00419,"Unless a noncardiac cause is evident, an ECG should be performed for patients seen in the office setting with stable chest pain; if an ECG is unavailable the patient should be referred to the ED so one can be obtained.1-5","If no noncardiac cause is apparent, patients presenting with stable chest pain in the office should undergo an ECG; if an ECG cannot be performed, the patient should be directed to the ED for this test."
id_01859,"In patients with chronic symptomatic PAD, pentoxifylline is not recommended for treatment of claudication.11,12 Chelation Therapy",Pentoxifylline is not advised for treating claudication in patients with chronic symptomatic PAD.
id_02339,"In patients with unruptured AAA who have symptoms that are attributable to the aneu- rysm, repair is recommended to reduce the risk of rupture.7,8","For patients with symptomatic unruptured AAA, repair is advised to lower the risk of rupture."
id_01379,"For a patient with suspected opioid overdose who has a definite pulse but no normal breathing or only gasping (ie, a respiratory arrest), in addition to providing standard BLS and/or ALS care, it is reasonable for responders to administer naloxone. Downloaded from http://ahajournals.org by on June 19, 2025","In cases of suspected opioid overdose where the patient has a clear pulse but exhibits abnormal breathing or gasping (indicative of respiratory arrest), it is appropriate for responders to give naloxone alongside standard BLS and/or ALS interventions."
id_00420,"Patients with clinical evidence of ACS or other life-threatening causes of acute chest pain seen in the office setting should be transported urgently to the ED, ideally by EMS.1-9","Patients exhibiting clinical signs of ACS or other critical causes of acute chest pain in an office setting should be promptly transported to the ED, preferably via EMS."
id_01860,"In patients with chronic symptomatic PAD, chelation therapy is not recommended for treatment of claudication.13",Chelation therapy is not advised for treating claudication in patients with chronic symptomatic PAD.
id_02820,"For athletes with HCM, a comprehensive evaluation and shared discussion of potential risks of sports participation by an expert provider is recommended.295",Athletes with HCM should undergo a thorough assessment and engage in a collaborative discussion about the potential risks of sports participation with a specialist.
id_02819,"For most patients with HCM, mild- to moderate-intensity recreational* exercise is beneficial to improve cardiorespiratory fit- ness, physical functioning, and quality of life, and for their overall health in keeping with physical activity guidelines for the general population.292–294","For the majority of individuals with HCM, engaging in recreational exercise of mild to moderate intensity is advantageous for enhancing cardiorespiratory fitness, physical function, and quality of life, aligning with general physical activity guidelines for overall health."
id_02340,"In patients with unruptured saccular AAA, intervention to reduce the risk of rupture may be reasonable.9","For patients with unruptured saccular AAA, it might be advisable to consider intervention to lower the risk of rupture."
id_01380,"After return of spontaneous breathing, patients should be observed in a healthcare setting until the risk of recurrent opioid toxicity is low and the patient’s level of consciousness and vital signs have normalized.","Once spontaneous breathing resumes, patients must be monitored in a medical facility until the likelihood of recurrent opioid toxicity is minimal and both their consciousness and vital signs have stabilized."
id_01861,"In patients with PAD, providing general preventive foot self-care education to patients and their family members and support persons is recommended.1–7","It is advised to offer general education on preventive foot self-care to patients with PAD, as well as their family members and support persons."
id_02341,"In patients with unruptured AAA and aneu- rysm growth of ≥0.5 cm in 6 months, repair to reduce the risk of rupture may be reason- able.1-5","For patients with unruptured AAA experiencing an aneurysm enlargement of 0.5 cm or more over 6 months, it may be advisable to consider repair to lower the risk of rupture."
id_02821,"For most patients with HCM, participa- tion in low-intensity competitive sports is reasonable.2,297",Engaging in low-intensity competitive sports is generally appropriate for the majority of individuals with HCM.
id_01381,"If recurrent opioid toxicity develops, repeated small doses or an infusion of naloxone can be ben- eficial. Downloaded from http://ahajournals.org by on June 19, 2025","In cases of recurrent opioid toxicity, administering repeated small doses or a continuous infusion of naloxone may be advantageous."
id_01382,"It is reasonable for lay rescuers to receive training in responding to opioid overdose, including provi- sion of naloxone.","Training laypeople to handle opioid overdoses, including administering naloxone, is advisable."
id_01862,"In patients with PAD, foot inspection by a clinician at every visit is recommended.","For patients with PAD, it is advised that a clinician examine their feet during each appointment."
id_02342,"In patients with nonruptured AAA with low to moderate operative risk and who have anatomy suitable for either open or EVAR, a shared decision-making process weighing the risks and benefits of each approach is recom- mended.1-11","For patients with nonruptured AAA who have a low to moderate risk for surgery and anatomy that allows for either open repair or EVAR, it is advised to engage in shared decision-making to evaluate the risks and benefits of each treatment option."
id_00422,"In all patients presenting to the ED with acute chest pain and suspected ACS, cTn should be measured as soon as possible after presentation.8,9","For every patient arriving at the ED with acute chest pain and a suspicion of ACS, cTn must be assessed promptly upon arrival."
id_00423,"For patients with acute chest pain and suspected ACS initially evaluated in the office setting, delayed transfer to the ED for cTn or other diagnostic testing should be avoided.",Patients with acute chest pain and suspected ACS first assessed in an office setting should not experience delays in being transferred to the ED for cTn or other diagnostic tests.
id_02822,"In individuals who are genotype-positive, phenotype-negative for HCM, participation in competitive athletics of any intensity is reasonable.2,174,297–301","For those with a positive genotype but no phenotypic expression of HCM, engaging in competitive sports at any level is considered reasonable."
id_00421,"In all patients who present with acute chest pain regardless of the setting, an ECG should be acquired and reviewed for STEMI within 10 minutes of arrival.1-3,6,7,10","For every patient experiencing acute chest pain, an ECG must be obtained and evaluated for STEMI within 10 minutes of their arrival, irrespective of the setting."
id_01383,"We recommend giving atropine immediately for severe poisoning, such as bronchospasm, bron- chorrhea, seizures, or significant bradycardia, from organophosphate or carbamate poisoning.","We advise administering atropine right away in cases of severe organophosphate or carbamate poisoning, characterized by symptoms like bronchospasm, bronchorrhea, seizures, or notable bradycardia."
id_02343,"In patients undergoing elective endovascular repair for nonruptured AAA, adherence to manufacturer’s instructions for use is recom- mended.12-16","For patients having elective endovascular repair of nonruptured AAA, it is advised to follow the manufacturer's usage guidelines."
id_01384,We recommend early endotracheal intubation for life-threatening organophosphate or carbamate poisoning.,We advise prompt endotracheal intubation for severe poisoning by organophosphates or carbamates.
id_01863,"In patients with PAD at high risk for ulcers and amputation (Table 12), therapeutic footwear is recommended.8,9",Therapeutic footwear is advised for patients with PAD who are at elevated risk for ulcers and amputation (refer to Table 12).
id_01864,"In patients with PAD, a comprehensive foot evaluation (Table 13) should be performed at least annually to identify risk factors for ulcers and amputation.","For patients with PAD, conduct a thorough foot assessment at least once a year to detect risk factors for ulcers and amputation."
id_02823,"For patients with HCM, participation in high-intensity recreational activities or mod- erate- to high-intensity competitive sports activities may be considered after a compre- hensive evaluation and shared discussion, repeated annually with an expert provider who conveys that the risk of sudden death and ICD shocks may be increased, and with the understanding that eligibility decisions for competitive sports participation often involve third parties (eg, team physicians, consultants, and other institutional leader- ship) acting on behalf of the schools or teams.174,295,298–301","Patients with HCM may consider engaging in high-intensity recreational activities or moderate- to high-intensity competitive sports following a thorough evaluation and annual discussions with an expert provider. This provider should communicate the potential increased risk of sudden death and ICD shocks. Additionally, eligibility for competitive sports often involves decisions made by third parties, such as team physicians, consultants, and institutional leaders representing schools or teams."
id_00425,"Patients with chest pain in whom the initial ECG is consistent with an ACS should be treated according to STEMI and NSTE-ACS guidelines.1,2",Patients experiencing chest pain with an initial ECG indicative of ACS should receive treatment following the guidelines for STEMI and NSTE-ACS.
id_01385,We recommend administration of benzodiazepines to treat seizures and agitation in the setting of organophosphate or carbamate poisoning.,We advise using benzodiazepines to manage seizures and agitation caused by organophosphate or carbamate poisoning.
id_00424,"In patients with chest pain in which an initial ECG is nondiagnostic, serial ECGs to detect potential ischemic changes should be performed, especially when clinical suspicion of ACS is high, symptoms are persistent, or the clinical condition deteriorates.1","For patients experiencing chest pain with an inconclusive initial ECG, repeated ECGs should be conducted to identify possible ischemic changes, particularly if there is a strong suspicion of ACS, symptoms continue, or the patient's condition worsens."
id_02344,"In patients with nonruptured AAA and a high perioperative risk, EVAR is reasonable to reduce the risk of 30-day morbidity, mortality, or both.9,10","For patients with nonruptured AAA who have a high risk during surgery, EVAR is a suitable option to lower the risk of morbidity and/or mortality within 30 days."
id_02824,"In patients with HCM, ICD placement for the sole purpose of participation in competitive athletics should not be performed.2,174,302 *Recreational exercise is done for the purpose of leisure with no requirement for systematic training and without the purpose to excel or compete against others. 6.2. Occupation Recommendations for Occupation in Patients With HCM COR LOE Recommendations","For patients with HCM, an ICD should not be implanted solely to allow participation in competitive sports. Recreational exercise is intended for leisure without the need for structured training or the aim to compete or excel against others."
id_01865,"In patients with PAD, referral to a footcare specialist, when available, is reasonable for ongoing preventive care and longitudinal surveillance.10–16","For patients with PAD, it is advisable to refer them to a footcare specialist, if accessible, for continuous preventive care and long-term monitoring."
id_02345,"For patients with nonruptured AAA, a moderate to high perioperative risk, and anatomy suitable for an FDA-approved fenestrated endovascular device, endovas- cular repair is reasonable over open repair to reduce the risk of perioperative compli- cations.10,11,17,18","For patients with nonruptured AAA who have a moderate to high risk during surgery and anatomy compatible with an FDA-approved fenestrated endovascular device, opting for endovascular repair instead of open repair is advisable to minimize the risk of perioperative complications."
id_01386,We recommend use of appropriate personal pro- tective equipment when caring for patients with organophosphate or carbamate exposure.,We advise wearing suitable personal protective gear when treating patients exposed to organophosphates or carbamates.
id_00426,"In patients with chest pain and intermediate- to-high clinical suspicion for ACS in whom the initial ECG is nondiagnostic, supplemental electrocardiographic leads V7 to V9 are reasonable to rule out posterior MI.3-5","For patients experiencing chest pain with a moderate to high likelihood of ACS and an inconclusive initial ECG, using additional ECG leads V7 to V9 is advisable to exclude posterior MI."
id_01866,"In patients with chronic symptomatic PAD, SET is recommended to improve walking performance, functional status, and QOL.7,16–28","For patients with chronic symptomatic PAD, it is advised to use SET to enhance walking ability, functional capacity, and quality of life."
id_02825,"For patients with HCM, it is reasonable to follow Federal Motor Carrier Safety Administration cardiovascular disease guidelines that permit driving commercial motor vehicles, if they do not have an ICD or any major risk factors for SCD and are following a guideline-directed manage- ment plan.303","For individuals with HCM, it is appropriate to adhere to the Federal Motor Carrier Safety Administration's cardiovascular disease guidelines allowing them to drive commercial vehicles, provided they lack an ICD, have no significant SCD risk factors, and are adhering to a guideline-directed management plan."
id_02346,"For patients with asymptomatic small AAA and concomitant common iliac artery aneurysm(s) ≥3.5 cm, elective repair of both abdominal and iliac aneurysms is recom- mended.1-4",Elective repair is advised for patients with asymptomatic small AAA who also have common iliac artery aneurysms measuring 3.5 cm or larger.
id_02826,"For pilot aircrew with a diagnosis of HCM, it is reasonable to follow Federal Aviation Administration guidelines that permit consid- eration of multicrew flying duties, provided they are asymptomatic, are deemed low risk for SCD, and can complete a maximal tread- mill stress test at 85% peak heart rate.304","For aircrew pilots diagnosed with HCM, it is appropriate to adhere to Federal Aviation Administration guidelines allowing for the possibility of multicrew flying roles, as long as they show no symptoms, are assessed as having a low risk for sudden cardiac death, and can successfully perform a maximal treadmill stress test reaching 85% of their peak heart rate."
id_01387,We recommend dermal decontamination for exter- nal organophosphate or carbamate exposure.,We advise performing skin decontamination for exposure to external organophosphates or carbamates.
id_01867,"In patients with chronic symptomatic PAD, a structured community-based exercise program with behavioral change techniques is effective to improve walking performance, functional status, and QOL.5–15","For patients with chronic symptomatic PAD, participating in a community-based exercise program that incorporates behavioral change strategies effectively enhances walking ability, functional status, and quality of life."
id_00427,"In patients presenting with acute chest pain, a chest radiograph is useful to evaluate for other potential cardiac, pulmonary, and thoracic causes of symptoms. Downloaded from http://ahajournals.org by on June 19, 2025","For patients experiencing sudden chest pain, a chest X-ray is beneficial for assessing other possible cardiac, lung, and thoracic origins of the symptoms."
id_01388,The use of pralidoxime is reasonable for organo- phosphate poisoning.,Administering pralidoxime is appropriate for treating organophosphate poisoning.
id_01868,"In patients who have undergone revascularization for chronic symptomatic PAD, SET after revascularization is effective to improve walking performance, functional status, and QOL.29–39","For patients with chronic symptomatic PAD who have had revascularization, engaging in SET post-procedure effectively enhances walking ability, functional capacity, and quality of life."
id_00428,"In patients presenting with acute chest pain, serial cTn I or T levels are useful to identify abnormal values and a rising or falling pattern indicative of acute myocardial injury.1-21","For patients with acute chest pain, repeated measurements of cTn I or T levels help detect abnormal values and a trend of increase or decrease, indicating acute myocardial injury."
id_02347,"When treating common iliac artery aneu- rysms or ectasia as part of AAA repair, preservation of at least 1 hypogastric artery is recommended, if anatomically feasible, to decrease the risk of pelvic ­ischemia.5,6","In the repair of AAA involving common iliac artery aneurysms or ectasia, it is advised to maintain at least one hypogastric artery, if possible, to reduce the risk of pelvic ischemia."
id_02828,"For pregnant women with HCM and AF or other indications for anticoagulation, low-molecular- weight heparin or vitamin K antagonists (at maximum therapeutic dose of <5 mg daily) are recommended for stroke prevention.249,250,305","For pregnant women with HCM and AF or other reasons requiring anticoagulation, it is advised to use low-molecular-weight heparin or vitamin K antagonists (with a maximum therapeutic dose of less than 5 mg daily) to prevent stroke."
id_02348,"In patients treated with TEVAR, surveillance imaging with CT is recommended after 1 month and 12 months and, if stable, annually thereafter.1-5","For patients undergoing TEVAR, it is advised to perform surveillance imaging with CT at 1 month and 12 months post-treatment, and annually if the condition remains stable."
id_00429,"In patients presenting with acute chest pain, high-sensitivity cTn is the preferred biomarker because it enables more rapid detection or exclusion of myocardial injury and increases diagnostic accuracy.17,21-25","For patients with acute chest pain, high-sensitivity cTn is the biomarker of choice as it allows for quicker identification or ruling out of myocardial injury and enhances diagnostic precision."
id_02827,"Patients with HCM may consider occupations that require manual labor, heavy lifting, or a high level of physical performance after a comprehensive clinical evaluation, risk stratification for SCD, and implementation of guideline-directed management. Before a shared decision between a clinician and patient is reached, the clinician should convey that risks associated with the physi- cal requirements of these occupations are uncertain. Recommendations for Sports and Activity (Continued) COR LOE Recommendations Downloaded from http://ahajournals.org by on June 19, 2025","Individuals with HCM can contemplate engaging in jobs involving manual labor, heavy lifting, or intense physical activity following a thorough clinical assessment, SCD risk evaluation, and adherence to guideline-based management. Prior to making a joint decision with the patient, the clinician must communicate that the risks linked to the physical demands of these jobs are not well-defined."
id_01869,"In patients with functionally limiting claudication, SET or a structured community-based exercise program should be offered as an initial treatment option.17,18,25,40","For patients experiencing claudication that limits function, an initial treatment option should include either supervised exercise therapy (SET) or a structured exercise program within the community."
id_02349,"In patients treated with TEVAR, longitudinal surveillance with MRI is a reasonable alterna- tive to CT for reduction of long-term radiation exposure or avoidance of an iodinated con- trast allergy.6-9","For patients undergoing TEVAR, ongoing monitoring with MRI is a suitable alternative to CT to minimize long-term radiation exposure or prevent an allergic reaction to iodinated contrast."
id_02829,"In pregnant women with HCM, selected beta blockers should be administered for symptoms related to outflow tract obstruction or arrhyth- mias, with monitoring of fetal growth.306,307","For pregnant women with HCM, specific beta blockers should be used to manage symptoms of outflow tract obstruction or arrhythmias, while monitoring fetal growth."
id_01389,"Use of neuromuscular blockers metabolized by cholinesterase (ie, succinylcholine and mivacu- rium) is not recommended for patients with or- ganophosphate or carbamate poisoning. Downloaded from http://ahajournals.org by on June 19, 2025","For patients with organophosphate or carbamate poisoning, it is advised to avoid neuromuscular blockers that are broken down by cholinesterase, such as succinylcholine and mivacurium."
id_01390,We recommend using sodium bicarbonate to treat life-threatening cardiotoxicity from tricyclic and/or tetracyclic antidepressant poisoning.,We advise administering sodium bicarbonate for the management of life-threatening cardiotoxicity caused by poisoning from tricyclic and/or tetracyclic antidepressants.
id_01870,"In patients with chronic symptomatic PAD, alterna- tive programs of nonwalking structured exercise therapy (eg, arm ergometry, recumbent stepping) can be beneficial to improve walking performance, functional status, and QOL.19,20,41–47","For patients with chronic symptomatic PAD, engaging in nonwalking structured exercise regimens, such as arm ergometry or recumbent stepping, may help enhance walking ability, functional capacity, and quality of life."
id_02830,"In most pregnant women with HCM, vaginal delivery is recommended as the first-choice delivery option.306,308","For the majority of pregnant women with HCM, vaginal delivery is advised as the preferred method of childbirth."
id_00430,"Clinicians should be familiar with the analytical performance and the 99th percentile upper reference limit that defines myocardial injury for the cTn assay used at their institution.23,26",Clinicians must understand the analytical performance and the 99th percentile upper reference limit for myocardial injury as defined by the cTn assay utilized at their institution.
id_02350,"In patients treated with open repair of the thoracic aorta without residual aortopathy, surveillance imaging with a CT or MRI within","For patients undergoing open thoracic aorta repair without remaining aortopathy, follow-up imaging using CT or MRI is recommended."
id_00431,"With availability of cTn, creatine kinase myocardial (CK-MB) isoenzyme and myoglobin are not useful for diagnosis of acute myocardial injury.27-32 Figure 4. Electrocardiographic-Directed Management of Chest Pain ECG indicates electrocardiogram; MI, myocardial infarction; NSTE-ACS, non–ST-segment–elevation acute coronary syndrome; and STEMI, ST- segment–elevation myocardial infarction. Downloaded from http://ahajournals.org by on June 19, 2025","With cTn available, CK-MB isoenzyme and myoglobin are not effective for diagnosing acute myocardial injury."
id_01391,It is reasonable to use sodium bicarbonate to treat life-threatening cardiotoxicity caused by poisoning from sodium channel blockers other than tricyclic or tetracyclic antidepressants.,"Sodium bicarbonate can be appropriately used to manage life-threatening cardiotoxicity resulting from poisoning by sodium channel blockers, excluding tricyclic or tetracyclic antidepressants."
id_01871,"In patients with chronic symptomatic PAD, the use- fulness of structured walking exercise therapy that avoids moderate to severe ischemic symptoms is uncertain.5,45,46","For patients with chronic symptomatic PAD, the benefit of structured walking exercise therapy that prevents moderate to severe ischemic symptoms is unclear."
id_02831,"In affected families with HCM, preconcep- tional and prenatal reproductive and genetic counseling should be offered.302,306,307,308","For families impacted by HCM, reproductive and genetic counseling should be provided before conception and during pregnancy."
id_00432,"In patients presenting with acute chest pain and suspected ACS, clinical decision pathways (CDPs) should categorize patients into low-, intermediate-, and high-risk strata to facilitate disposition and subsequent diagnostic evaluation.1-14","For patients with acute chest pain and suspected ACS, clinical decision pathways should classify them into low, intermediate, and high-risk groups to aid in their management and further diagnostic assessment."
id_02351,"In patients treated with open repair of the thoracic aorta who have residual aortopa- thy or abnormal findings on surveillance imaging, annual surveillance imaging is ­reasonable.","For patients undergoing open thoracic aorta repair who exhibit residual aortopathy or abnormal results on follow-up imaging, it is reasonable to conduct surveillance imaging annually."
id_01392,"It is reasonable to use extracorporeal life sup- port, such as VA-ECMO, to treat refractory cardiogenic shock from sodium channel blocker poisoning.","Utilizing extracorporeal life support, like VA-ECMO, is a sensible approach for managing refractory cardiogenic shock caused by sodium channel blocker poisoning."
id_01872,"In patients with chronic symptomatic PAD, the usefulness of unstructured exercise to improve walking performance, functional status, and QOL is uncertain.10,12,28 Table 14.  Structured Exercise Programs for PAD Supervised Exercise Therapy5,7,16–28,42,52,53","For patients with chronic symptomatic PAD, the effectiveness of unstructured exercise in enhancing walking ability, functional capacity, and quality of life remains unclear."
id_01393,"It may be reasonable to use Vaughan-Williams class Ib antidysrhythmics (eg, lidocaine) to treat life-threatening cardiotoxicity from class Ia or Ic sodium channel blockers.","Using Vaughan-Williams class Ib antidysrhythmics, such as lidocaine, might be an appropriate approach for managing life-threatening cardiotoxicity caused by class Ia or Ic sodium channel blockers."
id_02352,"In patients with AAA treated with EVAR, baseline surveillance imaging with CT is recommended at 1 month postopera- tively1,2; if there is no evidence of endoleak or sac enlargement, continued surveil- lance with duplex ultrasound at 12 months and then annually thereafter is recom- mended.1,3,4","For patients with AAA who have undergone EVAR, it is advised to perform baseline surveillance imaging using CT at 1 month post-surgery; if no endoleak or sac enlargement is detected, further monitoring with duplex ultrasound is recommended at 12 months and annually thereafter."
id_00433,"In the evaluation of patients presenting with acute chest pain and suspected ACS for whom serial troponins are indicated to exclude myocardial injury, recommended time intervals after the initial troponin sample collection (time zero) for repeat measurements are: 1 to 3 hours for high-sensitivity troponin and 3 to 6 hours for conventional troponin assays.15-17","For patients with acute chest pain and suspected ACS requiring serial troponin tests to rule out myocardial injury, it is advised to repeat high-sensitivity troponin measurements 1 to 3 hours after the initial sample (time zero) and conventional troponin assays 3 to 6 hours later."
id_02353,"In patients with AAA treated with EVAR who are undergoing annual surveillance imaging duplex ultrasound, additional cross-sectional imaging with CT or MRI of the abdomen and pelvis every 5 years postoperatively is reason- able.5-8","For patients with AAA who have undergone EVAR and receive yearly surveillance with duplex ultrasound, it is advisable to include cross-sectional imaging using CT or MRI of the abdomen and pelvis every five years after the procedure."
id_01873,"In patients with asymptomatic PAD, it is reasonable to perform revascularization procedures (endovas- cular or surgical) to reconstruct diseased arteries if needed for the safety, feasibility, or effectiveness of other procedures (eg, transfemoral aortic valve replacement, mechanical circulatory support, endovascular aortic aneurysm repair).1–8","For patients with asymptomatic PAD, revascularization procedures (either endovascular or surgical) may be appropriately conducted to restore diseased arteries when necessary to ensure the safety, feasibility, or effectiveness of other interventions, such as transfemoral aortic valve replacement, mechanical circulatory support, or endovascular aortic aneurysm repair."
id_01394,It may be reasonable to use intravenous lipid emulsion to treat life-threatening sodium channel blocker poisoning refractory to other treatment modalities.,Intravenous lipid emulsion might be a suitable option for managing life-threatening sodium channel blocker poisoning that does not respond to other treatments.
id_00434,"To standardize the detection and differentiation of myocardial injury in patients presenting with acute chest pain and suspected ACS, institutions should implement a CDP that includes a protocol for troponin sampling based on their particular assay.18,19",Institutions should establish a CDP with a protocol for troponin testing tailored to their specific assay to ensure consistent identification and differentiation of myocardial injury in patients with acute chest pain and suspected ACS.
id_02833,"For women with clinically stable HCM who wish to become pregnant, it is reasonable to advise that pregnancy is generally safe as part of a shared discussion regarding potential maternal and fetal risks, and initiation of guideline-directed therapy.309–312","For women with clinically stable hypertrophic cardiomyopathy considering pregnancy, it is appropriate to suggest that pregnancy is typically safe, as part of a collaborative discussion about possible maternal and fetal risks and the start of therapy guided by established guidelines."
id_02832,"For pregnant women with HCM, care should be coordinated between their cardiologist and an obstetrician. For patients with HCM who are deemed high risk, consultation is advised with an expert in maternal-fetal medicine.","Pregnant women with HCM should have their care managed collaboratively by a cardiologist and an obstetrician, and those considered high risk should seek advice from a maternal-fetal medicine specialist."
id_01874,"In patients with functionally limiting claudication who are being considered for revascularization, potential benefits with respect to QOL, walking performance, and overall functional status should be weighed against the risks and durability of intervention and possible need for repeated procedures.1–6","For patients with claudication that limits function and are candidates for revascularization, the potential improvements in quality of life, walking ability, and overall function should be balanced against the intervention's risks, longevity, and the possibility of needing additional procedures."
id_02834,"In pregnant women with HCM, cardioversion for new or recurrent AF, particularly if symp- tomatic, is reasonable.302,313","For pregnant women with HCM, performing cardioversion for new or recurrent AF, especially if symptomatic, is advisable."
id_02354,"In patients with AAA treated with EVAR and abnormal findings (Table 21) on any surveil- lance duplex ultrasound, additional cross-sec- tional imaging with CT or MRI is reasonable.9","For patients with AAA who have undergone EVAR and exhibit abnormal results on any surveillance duplex ultrasound (refer to Table 21), it is reasonable to obtain further cross-sectional imaging with CT or MRI."
id_01395,We recommend sedation for severe agitation from sympathomimetic poisoning.,Sedation is advised for managing severe agitation caused by sympathomimetic poisoning.
id_02355,"In patients with AAA treated with complex EVAR, a modified surveillance imaging plan that combines cross-sectional imaging and duplex ultrasound of target vessels is reason- able.10,11","For patients undergoing complex EVAR for AAA, it is reasonable to implement a revised imaging surveillance strategy that integrates cross-sectional imaging with duplex ultrasound of the target vessels."
id_02835,"In pregnant women with HCM, general or epidural anesthesia is reasonable, with precautions to avoid hypotension.310","For pregnant women with HCM, it is advisable to use general or epidural anesthesia while taking measures to prevent hypotension."
id_00435,"In patients with acute chest pain and suspected ACS, previous testing when available should be considered and incorporated into CDPs.20-24","For patients experiencing acute chest pain with a suspicion of ACS, any prior test results should be evaluated and integrated into CDPs."
id_01875,"In patients with functionally limiting claudication and an inadequate response to GDMT (including structured exercise), revascularization is a reasonable treatment option to improve walking function and QOL.7–14","For patients experiencing functionally limiting claudication who do not adequately respond to GDMT, including structured exercise, revascularization is a suitable option to enhance walking ability and quality of life."
id_00436,"For patients with acute chest pain, a normal ECG, and symptoms suggestive of ACS that began at least 3 hours before ED arrival, a single hs-cTn concentration that is below the limit of detection on initial measurement (time zero) is reasonable to exclude myocardial injury.13,25-29","For patients experiencing acute chest pain with a normal ECG and symptoms indicative of ACS that started at least 3 hours prior to arriving at the ED, it is reasonable to rule out myocardial injury if a single hs-cTn level measured at time zero is below the detection limit."
id_01396,We recommend rapid external cooling for life- threatening hyperthermia from sympathomimetic poisoning.,We advise prompt external cooling for severe hyperthermia caused by sympathomimetic toxicity.
id_01397,"Vasodilators, such as phentolamine and/or nitrates, are reasonable for coronary vasospasm from sympathomimetic poisoning.","Phentolamine and/or nitrates, as vasodilators, are appropriate for treating coronary vasospasm caused by sympathomimetic poisoning."
id_00437,Patients with acute chest pain and a 30-day risk of death or MACE <1% should be designated as low risk.1-11,Patients experiencing acute chest pain with a 30-day mortality or major adverse cardiac event risk of less than 1% should be classified as low risk.
id_02356,"In patients with AAA who have undergone open repair, surveillance imaging with CT or MRI of the abdominopelvic aorta within 1 year postoperatively and then every 5 years there- after is reasonable.5,6","For patients with AAA who have had open repair, it is advisable to perform surveillance imaging of the abdominopelvic aorta using CT or MRI within the first year after surgery and subsequently every five years."
id_01876,"In patients with claudication who have had an adequate clinical response to GDMT (including structured exercise), revascularization is not recommended. Revascularization for Claudication: Aortoiliac Disease and Femoro- popliteal Disease (Excluding Common Femoral Artery Disease)","For patients experiencing claudication who have responded well to guideline-directed medical therapy, including structured exercise, revascularization is not advised for aortoiliac and femoropopliteal diseases, excluding common femoral artery disease."
id_01877,"In patients with functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease with inadequate response to GDMT (including structured exercise), endovascular revascularization is effective to improve walking performance and QOL.7–28","For patients experiencing functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease who do not adequately respond to GDMT, including structured exercise, endovascular revascularization effectively enhances walking ability and quality of life."
id_02357,"In patients with a suspected AAS, CT is rec- ommended for initial diagnostic imaging, given its wide availability, accuracy, and speed, as well as the extent of anatomic detail it pro- vides.1-5","For patients suspected of having an AAS, it is advised to use CT for the initial diagnostic imaging due to its broad accessibility, precision, rapid results, and the detailed anatomical information it offers."
id_00438,"In patients with acute chest pain and suspected ACS who are deemed low-risk (<1% 30-day risk of death or MACE), it is reasonable to discharge home without admission or urgent cardiac testing.12-16","For patients experiencing acute chest pain with suspected ACS and assessed as low-risk (less than 1% 30-day risk of death or MACE), it is appropriate to discharge them home without hospital admission or immediate cardiac testing."
id_02837,"In pregnant women with HCM, fetal echocar- diography may be considered for diagnosis of fetal HCM in the context of prenatal counseling. 6.4. Comorbidities Table 9 addresses lifestyle considerations for patients with HCM. Recommendations for Patients With Comorbidities Referenced studies that support the recommendations are summarized in Online Data Supplement 21. COR LOE Recommendations","For pregnant women with HCM, fetal echocardiography can be considered to diagnose fetal HCM as part of prenatal counseling."
id_02836,"In pregnant women with HCM, it is reason- able to perform serial echocardiography, par- ticularly during the second or third trimester when hemodynamic load is highest, or if clini- cal symptoms develop.309","For pregnant women with HCM, conducting regular echocardiograms is advisable, especially in the second or third trimester when the hemodynamic load peaks, or if clinical symptoms arise."
id_02358,"In patients with a suspected AAS, TEE and MRI are reasonable alternatives for initial diagnostic imaging.1-6","For patients with a suspected AAS, TEE and MRI are suitable options for initial diagnostic imaging."
id_02838,"In patients with HCM, adherence to the guidelines on the prevention of atheroscle- rotic cardiovascular disease is recommended to reduce risk of cardiovascular events.294","For patients with HCM, it is advised to follow the guidelines for preventing atherosclerotic cardiovascular disease to lower the risk of cardiovascular events."
id_01878,"In patients with functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease with inadequate response to GDMT (including structured exercise), surgical revascularization is reasonable if perioperative risk is acceptable and technical factors suggest advantages over endovascular approaches.29–31 Revascularization for Claudication: Common Femoral Artery Disease","For patients experiencing functionally limiting claudication and hemodynamically significant aortoiliac or femoropopliteal disease who do not adequately respond to GDMT, including structured exercise, surgical revascularization is a reasonable option if the perioperative risk is acceptable and technical considerations favor it over endovascular methods."
id_01398,"Mechanical circulatory support, such as intra- aortic balloon pump or VA-ECMO, is reasonable for cardiogenic shock from sympathomimetic poi- soning refractory to other treatment measures.","For cardiogenic shock due to sympathomimetic poisoning that does not respond to other treatments, using mechanical circulatory support like an intra-aortic balloon pump or VA-ECMO is a reasonable option."
id_01399,"Prolonged use of physical restraint without sedation is potentially harmful. Downloaded from http://ahajournals.org by on June 19, 2025",Extended application of physical restraint without sedation may be detrimental.
id_02359,"In patients presenting to the hospital with AAS, prompt treatment with anti-impulse therapy with invasive monitoring of BP with an arterial line in an ICU setting is recommended as initial treatment to decrease aortic wall stress.1-5","For patients admitted with AAS, it is advised to initiate anti-impulse therapy and closely monitor blood pressure using an arterial line in an ICU to reduce stress on the aortic wall."
id_01879,"In patients with functionally limiting claudication and hemodynamically significant common femoral artery disease with inadequate response to GDMT (including structured exercise), surgical endarterectomy is reasonable, especially if endovascular approaches adversely affect profunda femoris artery pathways.32,33","For patients experiencing functionally limiting claudication and significant hemodynamic impairment of the common femoral artery who do not adequately respond to GDMT, including structured exercise, surgical endarterectomy is a reasonable option, particularly if endovascular methods negatively impact the profunda femoris artery pathways."
id_00440,"For intermediate-risk patients with acute chest pain, management in an observation unit is reasonable to shorten length of stay and lower cost relative to an inpatient admission.1-7","For patients with acute chest pain who are at intermediate risk, it is reasonable to manage them in an observation unit to reduce both the duration of their stay and the associated costs compared to inpatient admission."
id_02839,"In patients with HCM who are overweight or obese, counseling and comprehensive lifestyle interventions are recommended for achieving and maintaining weight loss294 and possibly lowering the risk of developing LVOTO, HF, and AF.314–316","For patients with HCM who are overweight or obese, it is advised to provide counseling and implement comprehensive lifestyle changes to achieve and sustain weight loss, which may also reduce the risk of LVOTO, HF, and AF."
id_00439,"For intermediate-risk patients with acute chest pain, TTE is recommended as a rapid, bedside test to establish baseline ventricular and valvular function, evaluate for wall motion abnormalities, and to assess for pericardial effusion.","For patients with acute chest pain at intermediate risk, a TTE is advised as a quick, bedside examination to determine baseline ventricular and valvular function, check for wall motion abnormalities, and detect pericardial effusion."
id_01400,It is reasonable to use VA-ECMO for persistent cardiogenic shock or cardiac arrest due to poison- ing that is not responsive to maximal treatment measures.,VA-ECMO may be appropriately utilized for ongoing cardiogenic shock or cardiac arrest resulting from poisoning when maximal treatment efforts fail to yield a response.
id_02360,"Patients with AAS should be treated to an SBP <120 mm Hg or to lowest BP that main- tains adequate end-organ perfusion, as well as to a target heart rate of 60 to 80 bpm.3,6","For patients with AAS, aim to achieve a systolic blood pressure below 120 mm Hg or the lowest level that ensures sufficient end-organ perfusion, and maintain a heart rate between 60 and 80 bpm."
id_00441,"For intermediate-risk patients with acute chest pain and no known CAD eligible for diagnostic testing after a negative or inconclusive evaluation for ACS, CCTA is useful for exclusion of atherosclerotic plaque and obstructive CAD.1-11","For patients at intermediate risk with acute chest pain and no history of CAD, who are suitable for diagnostic testing following a negative or inconclusive ACS assessment, CCTA is beneficial for ruling out atherosclerotic plaque and obstructive CAD."
id_01401,It is reasonable to use VA-ECMO for persistent dysrhythmias due to poisoning when other treat- ment measures fail.,VA-ECMO can be considered for persistent dysrhythmias caused by poisoning when other treatments are ineffective.
id_02840,"In patients with HCM and hypertension, lifestyle modifications and medical therapy for hypertension are recommended294 with preference for beta blockers and non-dihydro- pyridine calcium channel blockers in patients with obstructive HCM.310,316–319","For patients with HCM and high blood pressure, it is advised to implement lifestyle changes and use antihypertensive medication, prioritizing beta blockers and non-dihydropyridine calcium channel blockers for those with obstructive HCM."
id_01880,"In patients with functionally limiting claudication and hemodynamically significant common femoral artery disease with inadequate response to GDMT (including structured exercise), endovascular approaches may be considered in those at high risk for surgical revascularization and/or if anatomical factors are favorable (ie, no adverse effect on profunda femoris artery pathways).33–40 Revascularization for Claudication: Infrapopliteal Disease","For patients experiencing functionally limiting claudication and hemodynamically significant disease of the common femoral artery who do not adequately respond to GDMT, including structured exercise, endovascular methods can be considered if they are at high surgical risk and/or if anatomical conditions are suitable, such as no negative impact on the profunda femoris artery pathways."
id_02361,"In patients with AAS, initial management should include intravenous beta blockers, except in patients with contraindications.2,5,7","For patients with AAS, intravenous beta blockers should be administered initially, unless contraindications are present."
id_02841,"In patients with HCM, assessment for symptoms of sleep disordered breathing is recommended and, if present, referral to a sleep medicine specialist for evaluation and treatment.320–323 ACC/AHA JOINT COMMITTEE MEMBERS","For patients with HCM, it is advised to evaluate for symptoms of sleep disordered breathing, and if detected, to refer them to a sleep medicine specialist for further assessment and management."
id_01881,"In patients with functionally limiting claudication and isolated hemodynamically significant infrapopliteal disease with inadequate response to GDMT (including structured exercise), the effectiveness of endovascular revascularization is unknown.41","For patients experiencing functionally limiting claudication due to isolated hemodynamically significant infrapopliteal disease who do not adequately respond to GDMT, including structured exercise, the efficacy of endovascular revascularization remains uncertain."
id_00442,"For intermediate-risk patients with acute chest pain, moderate-severe ischemia on current or prior (≤1 year) stress testing, and no known CAD established by prior anatomic testing,","For patients at intermediate risk experiencing acute chest pain, who show moderate to severe ischemia on recent or past (within 1 year) stress tests, and have no previously identified CAD from anatomical testing,"
id_01402,"The effectiveness of VA-ECMO for poisoned patients with cardiovascular collapse from causes other than cardiogenic shock has not been estab- lished. Downloaded from http://ahajournals.org by on June 19, 2025",The efficacy of VA-ECMO in treating poisoned patients experiencing cardiovascular collapse due to non-cardiogenic shock remains unproven.
id_01882,"In patients with functionally limiting claudication and isolated hemodynamically significant infrapop- liteal disease with inadequate response to GDMT (including structured exercise), the effectiveness of surgical revascularization is unknown.42","For patients experiencing functionally limiting claudication due to isolated hemodynamically significant infrapopliteal disease who do not adequately respond to GDMT, including structured exercise, the efficacy of surgical revascularization remains uncertain."
id_00443,"For intermediate-risk patients with acute chest pain with evidence of previous mildly abnormal stress test results (≤1 year), CCTA is reasonable for diagnosing obstructive CAD.12,13 Stress Testing","For patients at intermediate risk experiencing acute chest pain and having mildly abnormal stress test results from within the past year, CCTA is a suitable option for diagnosing obstructive CAD."
id_02362,"In patients with AAS, initial management should include intravenous vasodilators if the BP is not well controlled after initiation of intravenous beta-blocker therapy.8","For patients with AAS, if blood pressure remains uncontrolled following the start of intravenous beta-blockers, intravenous vasodilators should be included in the initial treatment."
id_01403,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, stress positron emission tomography/single photon emission CT myocardial perfusion imaging (PET/ SPECT MPI), cardiovascular magnetic resonance (CMR) imaging, or stress echocardiography is recommended to detect the presence and extent of myocardial ischemia, estimate risk of major adverse cardiovascular events (MACE), and guide therapeutic decision-making.*1–23","For patients with CCD experiencing persistent changes in symptoms or functional capacity despite GDMT, it is advised to use stress PET/SPECT MPI, CMR imaging, or stress echocardiography to identify myocardial ischemia, assess the risk of MACE, and inform treatment decisions."
id_02363,"Patients with AAS should be treated with pain control, as needed, to help with hemodynamic management.","For patients with AAS, administer pain relief as necessary to assist in managing hemodynamics."
id_00444,"For intermediate-risk patients with acute chest pain and no known CAD who are eligible for cardiac testing, either exercise ECG, stress echocardiography, stress PET/SPECT MPI, or stress CMR is useful for the diagnosis of myocardial ischemia.1,4,10,14-36 Sequential or Add-on Diagnostic Testing","For patients at intermediate risk with acute chest pain and no history of coronary artery disease who qualify for cardiac evaluation, exercise ECG, stress echocardiography, stress PET/SPECT MPI, or stress CMR can effectively diagnose myocardial ischemia."
id_01883,"In patients who are undergoing surgical revascu- larization for functionally limiting claudication and hemodynamically significant femoropopliteal disease, bypass to the popliteal artery with autogenous vein is recommended in preference to prosthetic graft material.1–5","For patients receiving surgical revascularization due to functionally limiting claudication and significant femoropopliteal disease, it is advised to use an autogenous vein for bypass to the popliteal artery rather than a prosthetic graft."
id_01884,"In patients with CLTI, a multispecialty care team should evaluate and provide comprehensive care with goals of complete wound healing, minimizing tissue loss, and preservation of ambulatory status.1,2","For patients with CLTI, a multidisciplinary team should assess and deliver holistic care aimed at achieving full wound healing, reducing tissue loss, and maintaining the ability to walk."
id_01404,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, invasive coronary angiography (ICA) is recommended for guiding therapeutic decision-making with the goal of improving anginal symptoms.*24–28","For patients with CCD who experience persistent changes in symptoms or functional capacity despite GDMT, it is advised to perform invasive coronary angiography (ICA) to guide treatment decisions aimed at alleviating anginal symptoms.*24–28"
id_02364,"In patients with AAS, it is recommended to treat with long-term beta blockers (unless contraindicated) to control heart rate and BP to reduce late aortic-related adverse events.1-7 Additional antihypertensive agents (particu- larly ARBs and ACEIs) should be added, as necessary, to adequately control BP.","For patients with AAS, long-term beta blocker therapy is advised to manage heart rate and blood pressure, thereby minimizing late aortic-related complications, unless contraindicated. Additional antihypertensive medications, especially ARBs and ACEIs, should be included as needed to ensure proper blood pressure control."
id_01405,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, when selected for rest/stress nuclear MPI, PET is reasonable in preference to SPECT, if available, to improve diagnostic accuracy and decrease the rate of nondiagnostic test results.*29","For patients with CCD experiencing persistent changes in symptoms or functional capacity despite GDMT, choosing PET over SPECT for rest/stress nuclear MPI is advisable, if accessible, to enhance diagnostic precision and reduce nondiagnostic outcomes."
id_00445,"For intermediate-risk patients with acute chest pain and no known CAD, with a coronary artery stenosis of 40% to 90% in a proximal or middle coronary artery on CCTA, FFR-CT can be useful for the diagnosis of vessel-specific ischemia and to guide decision-making regarding the use of coronary revascularization.37-43","For patients at intermediate risk who experience acute chest pain and have no history of coronary artery disease, and who show a 40% to 90% stenosis in a proximal or middle coronary artery on CCTA, FFR-CT may aid in diagnosing vessel-specific ischemia and assist in determining the need for coronary revascularization."
id_01885,"In patients with CLTI, surgical, endovascular, or hybrid revascularization techniques are recommended, when feasible, to minimize tissue loss, heal wounds, relieve pain, and preserve a functional limb.1–14","For patients with CLTI, it is advised to use surgical, endovascular, or hybrid revascularization methods, if possible, to reduce tissue loss, promote wound healing, alleviate pain, and maintain limb functionality."
id_02365,"In patients presenting with suspected or con- firmed acute type A aortic dissection, emer- gency surgical consultation and evaluation and immediate surgical intervention is recom- mended because of the high risk of associated life-threatening complications.1,2","For patients with suspected or confirmed acute type A aortic dissection, it is advised to seek emergency surgical consultation and evaluation, followed by prompt surgical intervention, due to the high risk of life-threatening complications."
id_01886,"In patients with CLTI, an evaluation for revasculariza- tion options by a multispecialty care team is recom- mended before amputation (Table 15). Revascularization Strategy for CLTI","For patients with CLTI, it is advised to assess revascularization options with a multispecialty care team prior to considering amputation (Table 15)."
id_02366,"In patients presenting with acute type A aortic dissection, who are stable enough for transfer, transfer from a low- to a high- volume aortic center is reasonable to improve survival.3,4","For patients with acute type A aortic dissection who are stable for transport, it is advisable to move them from a low-volume to a high-volume aortic center to enhance survival chances."
id_01406,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, exercise treadmill testing can be useful to determine whether the symptoms are consistent with angina pectoris, assess the severity of symptoms, evaluate functional capacity, and guide management.*26,30–32","For patients with CCD experiencing persistent changes in symptoms or functional capacity despite GDMT, exercise treadmill testing may be beneficial to ascertain if the symptoms align with angina pectoris, to evaluate symptom severity, assess functional capacity, and inform management strategies.*26,30–32"
id_00446,"For intermediate-risk patients with acute chest pain and no known CAD, as well as an inconclusive prior stress test, CCTA can be useful for excluding the presence of atherosclerotic plaque and obstructive CAD.","For patients at intermediate risk who experience acute chest pain, have no history of CAD, and have had an inconclusive stress test, CCTA is beneficial for ruling out atherosclerotic plaque and obstructive CAD."
id_01887,"In patients undergoing surgical revascularization for CLTI, bypass to the popliteal or infrapopliteal arteries (ie, tibial, pedal) should be constructed with autog- enous vein if available.14–20","For patients having surgical revascularization for CLTI, an autogenous vein should be used for bypass to the popliteal or infrapopliteal arteries (such as tibial or pedal) if it is available."
id_01407,"In patients with CCD undergoing stress PET MPI or stress CMR imaging, the addition of myocardial blood flow reserve (MBFR) can be useful to improve diagnostic accuracy and enhance risk stratification.*18–23","For patients with CCD who are having stress PET MPI or stress CMR imaging, incorporating myocardial blood flow reserve (MBFR) can be beneficial for increasing diagnostic precision and improving risk assessment."
id_00447,"For intermediate-risk patients with acute chest pain and no known CAD, with an inconclusive CCTA, stress imaging (with echocardiography, PET/SPECT MPI, or CMR) can be useful for the diagnosis of myocardial ischemia.","For patients at intermediate risk who experience acute chest pain without a history of CAD and have an inconclusive CCTA, stress imaging using echocardiography, PET/SPECT MPI, or CMR may aid in diagnosing myocardial ischemia."
id_02367,"In patients presenting with nonhemorrhagic stroke complicating acute type A aortic dis- section, surgical intervention is reasonable over medical therapy to reduce mortality and improve neurologic outcomes.5,6","For patients with nonhemorrhagic stroke due to acute type A aortic dissection, opting for surgical treatment rather than medical management is advisable to lower mortality and enhance neurological outcomes."
id_02368,"In patients with acute type A aortic dissection presenting with renal, mesenteric, or lower extremity malperfusion, it is recommended to proceed to immediate operative repair of the ascending aorta.1,2","For patients experiencing acute type A aortic dissection with renal, mesenteric, or lower extremity malperfusion, immediate surgical repair of the ascending aorta is advised."
id_01888,"In patients with CLTI due to infrainguinal disease, anatomy, available conduit, patient comorbidities, and patient preferences should be considered in selecting the optimal first revascularization strategy (surgical bypass or endovascular revascularization) (Table 16).3,13","For patients with CLTI caused by infrainguinal disease, the choice of the best initial revascularization approach—either surgical bypass or endovascular revascularization—should take into account the anatomy, available conduit, patient comorbidities, and patient preferences."
id_00448,"For intermediate-risk patients with acute chest pain who have known CAD and present with new onset or worsening symptoms, GDMT should be optimized before additional cardiac testing is performed.1,2 Downloaded from http://ahajournals.org by on June 19, 2025","For patients at intermediate risk experiencing acute chest pain with existing CAD and new or worsening symptoms, GDMT should be maximized prior to conducting further cardiac evaluations."
id_01408,"In patients with CCD and a change in symptoms or functional capacity that persists despite GDMT, and who have had previous coronary revascularization, coronary CT angiography (CCTA) is reasonable to evaluate bypass graft or stent patency (for stents ≥3 mm).*33–37 *Modified from the 2021 AHA/ACC/Multisociety Guideline for the Evaluation and Diagnosis of Chest Pain.38","For patients with CCD experiencing persistent changes in symptoms or functional capacity despite GDMT, and who have undergone coronary revascularization, it is reasonable to use coronary CT angiography (CCTA) to assess the patency of bypass grafts or stents (for stents ≥3 mm).*33–37 *Adapted from the 2021 AHA/ACC/Multisociety Guideline for the Evaluation and Diagnosis of Chest Pain.38"
id_00449,"For intermediate-risk patients with acute chest pain who have worsening frequency of symptoms with significant left main, proximal left anterior descending stenosis, or multivessel CAD on prior anatomic testing or history of prior coronary revascularization, ICA is recommended.3-8","For intermediate-risk patients experiencing acute chest pain with increasing symptom frequency and significant stenosis in the left main, proximal left anterior descending artery, or multivessel coronary artery disease as shown in previous anatomic tests or with a history of coronary revascularization, ICA is advised."
id_01409,"In patients with CCD, it is recommended that risk stratification incorporate all available information, including noninvasive, invasive, or both cardiovascular diagnostic testing results or use validated risk scores to classify patients as low (<1%), intermediate (1%-3%), or high (>3%) yearly risk for cardiovascular death or nonfatal MI.1–4 Relationship to Treatment","For patients with CCD, it is advised to use all accessible data, whether from noninvasive, invasive, or both types of cardiovascular diagnostic tests, or to apply validated risk scores to categorize patients into low (<1%), intermediate (1%-3%), or high (>3%) annual risk for cardiovascular death or nonfatal MI."
id_01889,"In patients with CLTI who are candidates for surgical bypass and endovascular revascularization, ultrasound mapping of the great saphenous vein is recom- mended.3,13","For patients with CLTI eligible for both surgical bypass and endovascular revascularization, it is advised to perform ultrasound mapping of the great saphenous vein."
id_02369,"In patients with acute type A aortic dissection presenting with clinically significant mesen- teric (celiac, SMA) malperfusion, either imme- diate operative repair of the ascending aorta or immediate mesenteric revascularization via endovascular or open surgical intervention by those with this expertise before ascending aortic repair is reasonable.3-6","For patients experiencing acute type A aortic dissection with significant mesenteric malperfusion (celiac, SMA), it is reasonable to either proceed with immediate surgical repair of the ascending aorta or perform immediate mesenteric revascularization through endovascular or open surgery by specialists before addressing the ascending aorta."
id_01410,"In patients with CCD, optimization of GDMT is recommended to reduce MACE.*5–7","For patients with CCD, it is advised to optimize GDMT to decrease MACE.*5–7"
id_01890,"In patients with CLTI for whom a surgical approach is selected and a suitable autogenous vein is unavailable, alternative conduits such as prosthetic or cadaveric grafts can be effective for bypass to the popliteal and tibial arteries.21–26","For patients with CLTI who are chosen for surgery and lack an appropriate autogenous vein, prosthetic or cadaveric grafts may serve as effective alternatives for bypassing the popliteal and tibial arteries."
id_00450,"For intermediate-risk patients with acute chest pain and known nonobstructive CAD, CCTA can be useful to determine progression of atherosclerotic plaque and obstructive CAD.9-11","For patients at intermediate risk who experience acute chest pain and have known nonobstructive coronary artery disease, CCTA may be beneficial in assessing the advancement of atherosclerotic plaque and the presence of obstructive coronary artery disease."
id_02370,"In patients with acute type A aortic dissection and a partially dissected aortic root but no significant aortic valve leaflet pathology, aortic valve resuspension is recommended over valve replacement.1-5","For patients experiencing acute type A aortic dissection with a partially dissected aortic root and no major issues with the aortic valve leaflets, it is advised to perform aortic valve resuspension instead of valve replacement."
id_01891,"In patients with CLTI and nonhealing wounds or gangrene, revascularization in a manner that achieves in-line blood flow or maximizes perfusion to the wound bed can be beneficial.27–33","For patients with CLTI and nonhealing wounds or gangrene, performing revascularization to ensure direct blood flow or enhance perfusion to the wound area can be advantageous."
id_01411,"In patients with CCD with newly reduced LV systolic function, clinical heart failure, or both, ICA is recommended to assess coronary anatomy and guide potential revascularization.8,9","For patients with CCD who have newly decreased LV systolic function, clinical heart failure, or both, ICA is advised to evaluate coronary anatomy and direct possible revascularization."
id_00451,"For intermediate-risk patients with acute chest pain and coronary artery stenosis of 40% to 90% in a proximal or middle segment on CCTA, FFR-CT is reasonable for diagnosis of vessel-specific ischemia and to guide decision-making regarding the use of coronary revascularization.12-17","For patients at intermediate risk who present with acute chest pain and have coronary artery stenosis ranging from 40% to 90% in a proximal or middle segment as seen on CCTA, using FFR-CT is a reasonable approach to diagnose vessel-specific ischemia and assist in determining the need for coronary revascularization."
id_00452,"For intermediate-risk patients with acute chest pain and known CAD who have new onset or worsening symptoms, stress imaging (PET/ SPECT MPI, CMR, or stress echocardiography) is reasonable.18-21","For patients at intermediate risk with acute chest pain and established coronary artery disease experiencing new or worsening symptoms, it is appropriate to consider stress imaging such as PET/SPECT MPI, CMR, or stress echocardiography."
id_02371,"In patients with acute type A aortic dissection who have extensive destruction of the aortic root, a root aneurysm, or a known genetic aor- tic disorder, aortic root replacement is recom- mended with a mechanical or biological valved conduit.6-9","For patients experiencing acute type A aortic dissection with significant damage to the aortic root, presence of a root aneurysm, or an identified genetic aortic condition, it is advised to perform aortic root replacement using either a mechanical or biological valved conduit."
id_01412,"In patients with CCD, ICA for risk stratification is not routinely recommended in patients without LV systolic dysfunction, heart failure, stable chest pain refractory to GDMT, and/or noninvasive testing sug- gestive of significant (>50%) left main disease.5–7,10,11 *Modified from the 2021 AHA/ACC/Multisociety Guideline for the Evaluation and Diagnosis of Chest Pain.12","For patients with CCD, ICA for risk assessment is generally not advised unless they have LV systolic dysfunction, heart failure, stable chest pain unresponsive to GDMT, or noninvasive tests indicating significant (>50%) left main disease."
id_01892,"In patients with CLTI with ischemic rest pain (ie, with- out nonhealing wounds or gangrene) attributable to multilevel arterial disease, a revascularization strategy addressing inflow disease first is reasonable.34,35","For patients with CLTI experiencing ischemic rest pain without nonhealing wounds or gangrene due to multilevel arterial disease, it is reasonable to first pursue a revascularization approach targeting inflow disease."
id_02372,"In patients with acute type A aortic dissec- tion undergoing aortic repair, an open distal anastomosis is recommended to improve survival and increase false-lumen thrombosis rates.12-15","For patients with acute type A aortic dissection undergoing aortic repair, performing an open distal anastomosis is advised to enhance survival and raise the rates of false-lumen thrombosis."
id_01893,"Patients with CLTI and diabetic foot ulcers should receive pressure offloading, when possible, to promote tissue growth and wound healing.1–9","For patients with CLTI and diabetic foot ulcers, pressure offloading should be implemented, if feasible, to enhance tissue regeneration and wound healing."
id_01413,"In patients with CCD, clinical follow-up at least annually is recommended to assess for symptoms,1–12 change in functional status, adherence to and adequacy of lifestyle and medical interventions,13–15 and monitoring for complications of CCD and its treatments.16–18","For patients with CCD, it is advised to conduct clinical evaluations at least once a year to monitor symptoms, changes in functional status, compliance with and effectiveness of lifestyle and medical treatments, and to check for complications related to CCD and its therapies."
id_02373,"In patients with acute type A aortic dissec- tion without an intimal tear in the arch or a significant arch aneurysm, hemiarch repair is recommended over more extensive arch replacement.16-18","For patients experiencing acute type A aortic dissection without an intimal tear in the arch or a notable arch aneurysm, hemiarch repair is advised instead of a more extensive arch replacement."
id_00453,"For patients with acute chest pain and suspected ACS who have new ischemic changes on electrocardiography, troponin- confirmed acute myocardial injury, new- onset left ventricular systolic dysfunction (ejection fraction <40%), newly diagnosed moderate-severe ischemia on stress testing, hemodynamic instability, and/or a high clinical decision pathway (CDP) risk score should be designated as high risk for short-term MACE.1-3","Patients experiencing acute chest pain with suspected ACS should be considered at high risk for short-term MACE if they exhibit new ischemic changes on ECG, troponin-confirmed acute myocardial injury, new-onset left ventricular systolic dysfunction (ejection fraction below 40%), newly diagnosed moderate to severe ischemia on stress testing, hemodynamic instability, and/or a high risk score on the clinical decision pathway (CDP)."
id_00454,"For patients with acute chest pain and suspected ACS who are designated as high risk, ICA is recommended.4-7","For individuals experiencing acute chest pain with suspected ACS and classified as high risk, ICA is advised."
id_01414,"In patients with CCD, use of a validated CCD-specific patient-reported health status measure may be reasonable to assess symptoms, functional status, and QOL.19–23","For patients with CCD, employing a validated patient-reported health status tool specific to CCD can be a reasonable approach to evaluate symptoms, functional status, and quality of life."
id_02374,"In patients with acute type A aortic dissec- tion and a dissection flap extending through the arch into the descending thoracic aorta, an extended aortic repair with antegrade stenting of the proximal descending thoracic aorta may be considered to treat malperfu- sion and reduce late distal aortic complica- tions.19,20 Perfusion and Cannulation Strategies","For patients experiencing acute type A aortic dissection with a dissection flap reaching from the arch into the descending thoracic aorta, considering an extended aortic repair that includes antegrade stenting of the proximal descending thoracic aorta may help address malperfusion and decrease the risk of future distal aortic complications."
id_00455,"For high-risk patients with acute chest pain who are troponin positive in whom obstructive CAD has been excluded by CCTA or ICA, CMR or echocardiography can be effective in establishing alternative diagnoses.8-12","For high-risk patients experiencing acute chest pain with positive troponin levels, where obstructive CAD has been ruled out by CCTA or ICA, CMR or echocardiography may be useful in identifying other diagnoses."
id_01894,"Patients with PAD and previous diabetic foot ulcers should be referred for customized footwear that accommodates, protects, and fits the shape of their feet.10–12","Patients with PAD and a history of diabetic foot ulcers should be directed to obtain personalized footwear that conforms to, safeguards, and fits their foot shape."
id_01415,"In patients with CCD, a multidisciplinary team- based approach is recommended to improve health outcomes, facilitate modification of ASCVD risk factors, and improve health service utilization.*1–13 *Modified from the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.14","For patients with CCD, it is advised to employ a multidisciplinary team approach to enhance health outcomes, aid in adjusting ASCVD risk factors, and optimize the use of health services."
id_00456,"In patients with prior CABG surgery presenting with acute chest pain who do not have ACS, performing stress imaging is effective to evaluate for myocardial ischemia or CCTA for graft stenosis or occlusion.1-7","For patients with a history of CABG surgery experiencing acute chest pain without ACS, stress imaging is useful to assess myocardial ischemia, or CCTA can be used to check for graft stenosis or occlusion."
id_01895,Patients with CLTI and foot ulcers who do not have diabetes may be considered for pressure offloading to promote tissue growth and wound healing.,"For patients with CLTI and foot ulcers without diabetes, pressure offloading can be considered to enhance tissue regeneration and wound healing."
id_02375,"In patients with acute type A aortic dissection undergoing surgical repair, axillary cannula- tion, when feasible, is reasonable over femoral cannulation to reduce the risk of stroke or retrograde malperfusion.21,22","For patients with acute type A aortic dissection undergoing surgery, opting for axillary cannulation instead of femoral cannulation is advisable, when possible, to lower the risk of stroke or retrograde malperfusion."
id_01896,"In patients with CLTI, prompt management of foot infection with antibiotics, debridement, and other surgical management is recommended.1–5","For patients with CLTI, it is advised to quickly address foot infections using antibiotics, debridement, and other surgical interventions."
id_01416,"Patients with CCD should receive ongoing individualized education on symptom management, lifestyle changes, and SDOH risk factors to improve knowledge and facilitate behavior change.1","Individuals with CCD should be continuously educated on managing symptoms, modifying lifestyle, and understanding SDOH risk factors to enhance their knowledge and promote behavioral changes."
id_01417,Patients with CCD should receive ongoing individualized education on medication adherence to improve knowledge and facilitate behavior change.2–4,Patients with CCD should be continuously educated on a personal basis about adhering to their medication regimen to enhance understanding and promote behavioral modifications.
id_00457,"In patients with prior CABG surgery presenting with acute chest pain, who do not have ACS8-14 or who have an indeterminate/nondiagnostic stress test, ICA is useful.8","For patients with a history of CABG surgery experiencing acute chest pain, who neither have ACS8-14 nor a conclusive stress test, ICA is beneficial."
id_02376,"In patients with acute type A aortic dis- section undergoing surgical repair who require circulatory arrest, cerebral perfusion is reasonable to improve neurologic out- comes.23-25","For patients with acute type A aortic dissection undergoing surgery that necessitates circulatory arrest, using cerebral perfusion is advisable to enhance neurological outcomes."
id_01897,"In patients with CLTI with nonhealing wounds, wound care should be provided to optimize the wound-healing environment after revascularization with the goal of complete wound healing.6–10","For patients with CLTI and nonhealing wounds, it is essential to deliver wound care to enhance the healing environment following revascularization, aiming for full wound closure."
id_00458,"In patients who experience acute unremitting chest pain while undergoing dialysis, transfer by EMS to an acute care setting is recommended.1-5","For patients undergoing dialysis who have persistent acute chest pain, it is advised to transport them via EMS to an acute care facility."
id_02377,"In patients with acute type A aortic dis- section undergoing surgical repair, direct aortic26,27 or innominate artery28 cannula- tion with imaging guidance is reasonable as an alternative to femoral or axillary ­cannulation.29-31","For patients with acute type A aortic dissection undergoing surgery, it is reasonable to consider direct cannulation of the aorta or innominate artery with imaging guidance as an alternative to femoral or axillary cannulation."
id_01418,"Patients with CCD and their clinicians should engage in shared decision-making particularly when evidence is unclear on the optimal diagnostic or treatment strategy, or when a significant risk or benefit tradeoff exists.1–3","Clinicians and patients with CCD should participate in shared decision-making, especially when the best diagnostic or treatment approach is uncertain or when there are notable risk-benefit considerations."
id_02378,"In all patients with uncomplicated acute type B aortic dissection, medical therapy is recommended as the initial management strategy.1-3","For patients with uncomplicated acute type B aortic dissection, it is advised to begin treatment with medical management."
id_01898,"In patients with CLTI with nonhealing diabetic foot ulcers, hyperbaric oxygen therapy may be considered to assist in wound healing after revascularization.11–14","For patients with CLTI who have diabetic foot ulcers that are not healing, hyperbaric oxygen therapy can be contemplated as an aid for wound healing following revascularization."
id_00459,"In patients presenting with acute chest pain, it is reasonable to consider cocaine and methamphetamine use as a cause of their symptoms.1-3","For patients with sudden chest pain, evaluating the possibility of cocaine and methamphetamine use as a cause of their symptoms is advisable."
id_01899,"In patients with CLTI for whom revascularization is not an option and a lack of outflow to the foot is observed, the usefulness of prostanoids is uncertain.1–3","For patients with CLTI who cannot undergo revascularization and exhibit inadequate blood flow to the foot, the effectiveness of prostanoids remains unclear."
id_01419,"For patients with CCD and angina on GDMT who are engaged in shared decision-making regarding revascularization, a validated decision aid may be considered to improve patient understanding and knowledge about treatment options.4","For patients with CCD and angina on GDMT involved in shared decision-making about revascularization, using a validated decision aid can be considered to enhance their understanding and knowledge of treatment options."
id_02379,"In patients with acute type B aortic dissection and rupture or other complications (Table 27), intervention is recommended.4-6","For patients experiencing acute type B aortic dissection accompanied by rupture or other complications (refer to Table 27), it is advised to proceed with intervention."
id_01420,"In patients with CCD, routine assessment by clinicians and the care team for SDOH is recom- mended to inform patient-centered treatment deci- sions and lifestyle change recommendations.*1–8 *Modified from the 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease.9","For individuals with CCD, it is advised that clinicians and the care team regularly evaluate SDOH to guide personalized treatment choices and lifestyle change suggestions."
id_00460,"For patients with acute chest pain and suspected ACS who are deemed low risk by a CDP, patient decision aids are beneficial to improve understanding and effectively facilitate risk communication.1,2","For individuals experiencing acute chest pain with suspected ACS and classified as low risk by a CDP, using patient decision aids enhances comprehension and aids in effective risk communication."
id_02380,"In patients with uncomplicated acute type B aortic dissection who have high-risk anatomic features (Table 28), endovascular manage- ment may be considered.8,9","For patients with uncomplicated acute type B aortic dissection and high-risk anatomical characteristics (refer to Table 28), endovascular treatment can be considered."
id_01900,"In patients with CLTI for whom revascularization is not an option, arterial intermittent pneumatic compression devices may be considered to augment wound healing or ameliorate ischemic rest pain.4–7","For patients with CLTI who cannot undergo revascularization, using arterial intermittent pneumatic compression devices might be an option to enhance wound healing or reduce ischemic rest pain."
id_00461,"For patients with acute chest pain and suspected ACS who are deemed intermediate risk by a CDP, shared decision-making between the clinician and patient regarding the need for admission, for observation, discharge, or further evaluation in an outpatient setting is recommended for improving patient understanding and reducing low-value testing.1,2","For patients experiencing acute chest pain with suspected ACS classified as intermediate risk by a CDP, it is advised to engage in shared decision-making between the clinician and patient about whether to admit for observation, discharge, or pursue further evaluation in an outpatient setting, to enhance patient comprehension and minimize unnecessary testing."
id_01421,"In patients with CCD, a diet emphasizing vegetables, fruits, legumes, nuts, whole grains, and lean protein is recommended to reduce the risk of CVD events.*1–4","For patients with CCD, it is advised to follow a diet rich in vegetables, fruits, legumes, nuts, whole grains, and lean proteins to lower the risk of CVD events."
id_01901,"In patients with CLTI for whom arterial revascularization is not an option and a lack of outflow to the foot is observed, venous arterialization may be considered for limb preservation.8–12","For patients with CLTI who cannot undergo arterial revascularization and have no outflow to the foot, venous arterialization might be an option for preserving the limb."
id_02381,"In patients with complicated (Table 29) acute type A or type B aortic IMH, urgent repair is recommended.1-3","For patients with complicated acute type A or type B aortic IMH, immediate repair is advised."
id_00462,"In patients with acute chest pain in whom other potentially life-threatening nonischemic cardiac conditions are suspected (eg, aortic pathology, pericardial effusion, endocarditis), TTE is recommended for diagnosis.","For patients experiencing acute chest pain where other serious nonischemic cardiac conditions are suspected, such as aortic abnormalities, pericardial effusion, or endocarditis, it is advised to use TTE for diagnostic purposes."
id_02382,"In patients with uncomplicated acute type A IMH, prompt open surgical repair is recom- mended.1,4-6","For patients with uncomplicated acute type A IMH, immediate open surgical repair is advised."
id_01902,"In patients with CLTI who require amputation, evaluation should be performed by a multispecialty care team (Table 15) to assess for the most distal level of amputation that facilitates healing and provides maximal functional ability.1–6","For patients with CLTI needing amputation, a multispecialty care team should evaluate to determine the most distal amputation level that promotes healing and maximizes functional capacity."
id_01422,"In patients with CCD, reducing the percentage of calories from saturated fat (<6% of total calories) and replacing with dietary monounsaturated and polyunsaturated fat, complex carbohydrates, and dietary fiber can be beneficial to reduce the risk of CVD events.*1–6","For individuals with CCD, lowering saturated fat intake to less than 6% of total calories and substituting it with monounsaturated and polyunsaturated fats, complex carbohydrates, and dietary fiber may help decrease the risk of CVD events."
